<SEC-DOCUMENT>0001654954-19-010948.txt : 20190919
<SEC-HEADER>0001654954-19-010948.hdr.sgml : 20190919
<ACCEPTANCE-DATETIME>20190919164915
ACCESSION NUMBER:		0001654954-19-010948
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		80
FILED AS OF DATE:		20190919
DATE AS OF CHANGE:		20190919

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KNOW LABS, INC.
		CENTRAL INDEX KEY:			0001074828
		STANDARD INDUSTRIAL CLASSIFICATION:	MEASURING & CONTROLLING DEVICES, NEC [3829]
		IRS NUMBER:				900273142
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-231829
		FILM NUMBER:		191102127

	BUSINESS ADDRESS:	
		STREET 1:		500 UNION STREET
		STREET 2:		SUITE 810
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
		BUSINESS PHONE:		206-903-1351

	MAIL ADDRESS:	
		STREET 1:		500 UNION STREET
		STREET 2:		SUITE 810
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VISUALANT INC
		DATE OF NAME CHANGE:	20070220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Visualant, INC
		DATE OF NAME CHANGE:	20050106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STARBERRYS CORP
		DATE OF NAME CHANGE:	20020918
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>knwn_s1a.htm
<DESCRIPTION>AMENDED REGISTRATION STATEMENT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2019 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000">
<!--style header--><br></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
As filed with the Securities and Exchange Commission on
September 19, 2019</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Registration No. 333-213435</font><font style="color: #000000">&#xA0;</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
UNITED STATES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
WASHINGTON, D.C. 20549</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
____________________________________</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
AMENDMENT NO. 1</font> </div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
TO</font> </div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 16px">
FORM S-1</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
REGISTRATION STATEMENT</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
UNDER THE SECURITIES ACT OF 1933</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Commission File Number:</font> 000-30262<font style="color: #000000">&#xA0;&#xA0;&#xA0;&#xA0;</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center"><img src="knwn_s1000.jpg"></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000; font-size: 16px">
KNOW LABS, INC.</font><font style="font-weight: bold; color: #000000">&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: auto; margin-right: auto; margin-bottom: 6px; width: 100%; height: 2px; background-color: #000000">
<!--line--><br></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(Exact name of registrant as specified in charter)</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 52%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
&#xA0;</font> <font style="font-weight: bold; color: #000000">Nevada</font></font></div>
</td>
<td style="vertical-align: top; width: 48%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;90-0273142</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 52%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;(State or other jurisdiction of&#xA0;incorporation or
organization)</font></div>
</td>
<td style="vertical-align: top; width: 48%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;(I.R.S. Employer Identification No.)</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 52%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 48%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 52%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 48%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
3920</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 52%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 48%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(Primary Standard Industrial Classification Number)</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 52%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 48%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 52%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
&#xA0;</font> <font style="font-weight: bold; color: #000000">500
Union Street, Suite 810, Seattle, Washington
USA</font></font></div>
</td>
<td style="vertical-align: bottom; width: 48%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
&#xA0;</font> <font style="font-weight: bold; color: #000000">98101</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 52%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;(Address of principal executive offices)&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 48%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;(Zip Code)</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 20%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 57%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
206-903-1351</font></div>
</td>
<td style="vertical-align: top; width: 23%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 20%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 57%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;(Registrant's telephone number, including area
code)</font></div>
</td>
<td style="vertical-align: top; width: 23%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 20%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 57%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 23%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 20%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 57%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 23%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 20%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 57%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
N/A</font></div>
</td>
<td style="vertical-align: top; width: 23%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 20%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 57%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;(Former name, address, and fiscal year, if changed since last
report)</font></div>
</td>
<td style="vertical-align: top; width: 23%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Ronald P. Erickson, Chairman of the Board</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Know Labs, Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
500 Union Street, Suite 810</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Seattle, WA 98101</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
206-903-1351</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 24px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;(Name,
address, including zip code, and telephone number, including area
code, of agent for service)</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Copies to:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Lawrence W. Horwitz, Esq.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Jessica Lockett, Esq.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Horwitz + Armstrong, A Professional Law Corporation</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
14 Orchard, Suite 200</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Lake Forest, California 92630</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(949) 540-6540</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Approximate
date of commencement of proposed sale to public: <font style="font-weight: bold">As soon as practicable after this Registration
Statement is declared effective.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If any
of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule&#xA0;415 under
the Securities Act of 1933, check the following
box.&#xA0;&#xA0;&#xA0;&#xA0;<font style="color: #000000; font-size: 13px">&#x2612;</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If this
Form is filed to register additional securities for an offering
pursuant to Rule&#xA0;462(b) under the Securities Act, check the
following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same
offering.&#xA0;&#xA0;&#xA0;&#xA0;o</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If this
Form is a post-effective amendment filed pursuant to
Rule&#xA0;462(c) under the Securities Act, check the following box
and list the Securities Act registration statement number of the
earlier effective registration statement for the same
offering.&#xA0;&#xA0;&#xA0;&#xA0;o</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If this
Form is a post-effective amendment filed pursuant to
Rule&#xA0;462(d) under the Securities Act, check the following box
and list the Securities Act registration statement number of the
earlier effective registration statement for the same
offering.&#xA0;&#xA0;&#xA0;&#xA0;o</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of "large accelerated
filer," "accelerated filer" and "smaller reporting company" in
Rule&#xA0;12b-2 of the Exchange Act.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 41%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Large
accelerated filer</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font></div>
</td>
<td style="vertical-align: top; width: 41%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Accelerated
filer</font></div>
</td>
<td style="vertical-align: top; width: 9%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 41%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Non-accelerated
filer (Do not check if a smaller reporting company)</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font></div>
</td>
<td style="vertical-align: top; width: 41%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Smaller
reporting company</font></div>
</td>
<td style="vertical-align: top; width: 9%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2612;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 41%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Emerging
growth company</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font></div>
</td>
<td style="vertical-align: top; width: 41%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 9%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000">
<!--style footer--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
</div>
<div id="pb" style="text-align: center; break-after: page; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: rgb(255, 255, 255);">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
</div>
<div style="null"><font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">CALCULATION
OF REGISTRATION FEE<font style="color: #000000">&#xA0;</font></font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-size: 11px; font-weight: bold;"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-weight: bold;">
Title of Each Class</font> <font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-weight: bold;">
of Securities to</font> <font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-weight: bold;">
be Registered</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="font-size: 11px; font-weight: bold;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Amount to be</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Registered (1)</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="font-size: 11px; font-weight: bold;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Proposed Maximum</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Offering</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Price Per Unit (2)</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="font-size: 11px; font-weight: bold;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Proposed Maximum</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Aggregate</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Offering Price</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="font-size: 11px; font-weight: bold;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Amount of</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Registration Fee</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:12px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Common
Stock, $0.001 par value per share, underlying the
Principal</font> <font style="color: #000000; font-family: Times New Roman; font-size: 13px">of
8% Unsubordinated Convertible Notes (3)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4,242,515</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.53</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">6,491,048</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">786.72</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:12px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Common
Stock, $0.001 par value per share, underlying the
Interest</font> <font style="color: #000000; font-family: Times New Roman; font-size: 13px">of
8% Unsubordinated Convertible Notes (3)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">339,401</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.53</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">519,284</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">62.94</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:12px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Common
Stock, $0.001 par value per share, issuable upon
exercise</font> <font style="color: #000000; font-family: Times New Roman; font-size: 13px">of
Investor Warrants (3)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,121,258</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.53</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,245,525</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">393.36</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:12px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Common
Stock, $0.001 par value per share, issuable upon
exercise</font> <font style="color: #000000; font-family: Times New Roman; font-size: 13px">of
Placement Agent Private Placement Offering Warrants
(5)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">542,102</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.53</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">829,416</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100.53</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:12px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Common
Stock, $0.001 par value per share, underlying conversion of</font>
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">1,016,004
outstanding shares of Series D Preferred Stock
offered</font> <font style="color: #000000; font-family: Times New Roman; font-size: 13px">by
Selling Stockholder (3)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,108,356</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.53</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4,755,785</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">576.40</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:-12px;margin-right:0px;margin-left:12px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Common
Stock, $0.001 par value share, issuable upon exercise
of</font> <font style="color: #000000; font-family: Times New Roman; font-size: 13px">Series
F Preferred Warrants (3)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,984,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.53</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">6,095,520</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">738.78</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">14,337,632</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.53</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">21,936,577</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,658.71</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(1)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">In the event of a
stock split, stock dividend or similar transaction involving our
common stock, in order to prevent dilution, the number of shares
registered shall be automatically increased to cover the additional
shares in accordance with Rule 416(a) under the Securities Act of
1933, as amended (the &#x201C;Securities
Act&#x201D;).&#xA0;</font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(2)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">Estimated in
accordance with Rule 457(c) of the Securities Act, solely for the
purposes of calculating the registration fee based upon the average
of the high and low prices as reported on the Over the Counter
Bulletin Board ("OTCBB") as of May 29, 2019.</font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(3)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">This Registration
Statement covers the resale by our selling shareholders (the
"Selling Shareholders") of:&#xA0;</font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(i)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to 4,242,515
shares of common stock underlying the conversion of principal
amount of registrants 8% Unsubordinated Convertible Notes
(&#x201C;Principal Shares&#x201D;)</font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 12px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(ii)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to 339,402
shares of common stock&#xA0;issuable by the registrant upon the
conversion of interest accrued under the&#xA0;8% Unsubordinated
Convertible Notes (&#x201C;Interest Shares&#x201D;) (The Principal
Shares and Interest Shares are referred to collectively as the
&#x201C;Shares&#x201D;).</font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 36px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(iii)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to 2,121,258
shares (the "Investor Warrant Shares") of common stock issuable
upon the exercise of outstanding investor's warrants (the "Investor
Warrants") at an exercise price of $1.20 that were previously
issued to the Selling Shareholders in connection with 8%
Unsubordinated Convertible Notes offering that closed in a series
of closings between February 15, 2019 and May 28,
2019.</font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 36px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(v)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to 3,108,356
shares of common stock underlying the outstanding Series D
Convertible Preferred Stock which is convertible at any time at an
initial conversion price of $0.25 per share of our common stock
subject to adjustment for certain events (&#x201C;Series D
Shares&#x201D;). There are currently 3,108,356 common shares
estimated to underlying the 1,016,004 issued and outstanding Series
D Shares.</font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 36px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(vi)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to 3,984,000
shares&#xA0;of common stock issuable upon conversion of outstanding
Series F Warrants at an exercise price of $0.25 per share that were
previously issued to one of the Selling Shareholders in connection
with Preferred Stock and Warrant Purchase Agreement dated November
10, 2016 (&#x201C;Series F Warrant
Shares&#x201D;).<br></font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(4)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">We are registering 542,102 shares of our common
stock issuable upon the exercise of outstanding placement agent
warrants (the &#x201C;Placement Agent Warrants&#x201D;) at an
exercise price of $1.20 per share that were previously issued to
Boustead Securities, LLC and its assigns (collectively
&#x201C;Placement Agent&#x201D;) pursuant to an engagement agreement
dated November 6, 2018 (the &#x201C;Boustead Offering Engagement
Agreement&#x201D;) which provides that the Placement Agent shall
receive that certain number of warrants to purchase the common
stock of the Company equal to the number of warrants issued under
the 8% Unsubordinated Convertible Note Offering (the
&#x201C;Offering&#x201D;). In the event of stock splits, stock
dividends or similar transactions involving the common stock, the
number of common shares registered shall, unless otherwise
expressly provided, automatically be deemed to cover the additional
securities to be offered or issued pursuant to Rule 416 promulgated
under the Securities Act of 1933, as amended (the &#x201C;Securities
Act&#x201D;). In the event that the provisions of the agreements
require the registrant to issue more shares than are being
registered in this registration statement, for reasons other than
those stated in Rule 416 of the Securities Act, the registrant will
file a new registration statement to register those additional
shares.</font></font> </div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH
DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL
THE REGISTRANT SHALL FILE&#xA0;A FURTHER AMENDMENT WHICH
SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL
THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION&#xA0;8(A) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT
SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING
PURSUANT TO SAID SECTION&#xA0;8(A), MAY DETERMINE.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">THE
INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED.
WE MAY NOT SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT
FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE.
THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS
NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE
THE OFFER OR SALE IS NOT PERMITTED.<font style="color: #FF4040; font-family: Times New Roman">&#xA0;</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #FF4040; font-family: Times New Roman; font-size: 13px">
Subject to completion, dated September&#xA0;&#xA0; ,
2019</font> </div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Know Labs, Inc.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
500 Union Street, Suite 810</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Seattle, WA 98101</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
206-903-1351</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
PRELIMINARY PROSPECTUS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
This prospectus covers the resale by the Selling Stockholders (the
&#x201C;Selling Stockholders&#x201D;):</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(i)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 4,242,515 shares of common stock underlying the principal, and
up to 339,401 shares underlying the interest accrued,
of registrants 8% Unsubordinated Convertible Notes (the
&#x201C;Notes&#x201D;), which have a conversion price that is the
lesser of $1.00 per share or a twenty five percent (25%) discount
to the price per share paid by investors a future Qualified
Financing (the &#x201C;Shares&#x201D;)</font> </div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(ii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 2,121,258 shares (the "Investor Warrant Shares") of common stock
issuable upon the exercise of outstanding investor's warrants (the
"Investor Warrants") at an exercise price of $1.20 that were
previously issued to the Selling Shareholders in connection with
the Notes Offering that closed in a series of closings between
February 15, 2019 and May 28, 2019.</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(iii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">542,102
shares of our common stock issuable upon the exercise of
outstanding placement agent warrants (the &#x201C;Placement Agent
Warrants&#x201D;) at an exercise price of $1.20 per share that were
previously issued to Boustead Securities, LLC and its assigns
(collectively &#x201C;Placement Agent&#x201D;) pursuant to an
engagement agreement dated November 6, 2018 (the &#x201C;Boustead
Offering Engagement Agreement&#x201D;) which provides that the
Placement Agent shall receive that certain number of warrants to
purchase the common stock of the Company equal to the number of
warrants issued under the 8% Unsubordinated Convertible Note
Offering (the &#x201C;Offering&#x201D;).</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(iv)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 3,108,356 shares of common stock underlying
the outstanding Series D</font> <font style="color: #000000">Convertible Preferred Stock which is convertible
at any time at an initial conversion price of $0.25 per share of
our common stock subject to adjustment for certain events
(&#x201C;Series D Shares&#x201D;). There are currently 3,108,356
common shares estimated to underlying the 1,016,004 issued and
outstanding Series D
Shares.</font></font></font></font> </div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(v)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to</font> 3,984,000<font style="color: #FF0000">&#xA0;</font> <font style="color: #000000">shares
of common stock issuable upon conversion of outstanding</font>
Series F Warrants <font style="color: #000000">at an exercise price
of $0.25 per share, subject to certain adjustments, that were
previously issued to one of the Selling Shareholders in connection
with Preferred Stock and Warrant Purchase Agreement dated November
10, 2016 (&#x201C;Series F Warrant
Shares&#x201D;).</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The common stock covered by this prospectus may be offered for
resale from time to time by the Selling Stockholders identified in
this prospectus in accordance with the terms described in the
section entitled &#x201C;Plan of Distribution.&#x201D;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are not selling any shares of our common stock in this offering
and, as a result, we will not receive any proceeds from the sale of
the common stock covered by this prospectus.&#xA0;All of the net
proceeds from the sale of our common stock will go to the Selling
Stockholders. Upon exercise of the Investor Warrants and Placement
Agent Warrants, however, we will receive up to $1.20 per share, and
Upon exercise of the Series F Warrants, however, we will receive up
to $0.25 per share or such lower price as may result from the
anti-dilution protection features of such warrants. Any proceeds
received from the exercise of such warrants will be used for
general working capital and other corporate purposes.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Selling Stockholders may sell common stock from time to time at
prices established on the Over the Counter Bulletin Board ("OTCBB")
or as negotiated in private transactions, or as otherwise described
under the heading "Plan of Distribution." The common stock may be
sold directly or through agents or broker-dealers acting as agents
on behalf of the Selling Stockholders. The Selling Stockholders may
engage brokers, dealers or agents who may receive commissions or
discounts from the Selling Stockholders. We will pay all the
expenses incident to the registration of the shares; however, we
will not pay for sales commissions or other expenses applicable to
the sale of our common stock registered hereunder.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
common stock is quoted on the OTCQB Marketplace, operated by OTC
Markets Group, under the symbol "KNWN". On May 29, 2019, the last
reported sale price for our common stock on the OTCQB Marketplace
was $1.52 per share.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On May
24, 2018, the Financial Industry Regulatory Authority
(&#x201C;FINRA&#x201D;) announced the effectiveness of a change in
the Company&#x2019;s name from Visualant Incorporated to Know Labs,
Inc. and a change in our ticker symbol from VSUL to the new trading
symbol KNWN which became effective on the opening of trading as of
May 25, 2018. In addition, in connection with the name change and
symbol change, we were assigned the CUSIP number of
499238103.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
INVESTING IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. SEE THE
SECTION ENTITLED "RISK FACTORS" BEGINNING ON PAGE 15 IN THIS
PROSPECTUS. YOU SHOULD CAREFULLY CONSIDER THESE RISK FACTORS, AS
WELL AS THE INFORMATION CONTAINED IN THIS PROSPECTUS, BEFORE YOU
INVEST.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE
SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE
SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR
COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
No dealer, salesperson or any other person is authorized to give
any information or make any representations in connection with this
offering other than those contained in this prospectus and, if
given or made, the information or representations must not be
relied upon as having been authorized by us. This prospectus does
not constitute an offer to sell or a solicitation of an offer to
buy any security other than the securities offered by this
prospectus, or an offer to sell or a solicitation of an offer to
buy any securities by anyone in any jurisdiction in which the offer
or solicitation is not authorized or is unlawful.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #FF0000; font-family: Times New Roman; font-size: 13px">
The date of this prospectus is September __,
2019</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
TABLE OF CONTENTS</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: middle; width: 88%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 9%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 88%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 10%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Page</font></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#PROSPECTUS"><font style="font-family: Times New Roman; font-size: 13px">Prospectus
Summary</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#PROSPECTUS"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;6</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#SUMMARYOFTHEOFFERING"><font style="font-family: Times New Roman; font-size: 13px">Summary of the
Offering</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#SUMMARYOFTHEOFFERING"><font style="font-family: Times New Roman; font-size: 13px">12</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#SUMMARYFINANCIALINFORMATION"><font style="font-family: Times New Roman; font-size: 13px">Summary Financial
Information</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#SUMMARYFINANCIALINFORMATION"><font style="font-family: Times New Roman; font-size: 13px">14</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#RISK"><font style="font-family: Times New Roman; font-size: 13px">Risk
Factors</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#RISK"><font style="font-family: Times New Roman; font-size: 13px">15</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#SPECIALNOTE"><font style="font-family: Times New Roman; font-size: 13px">Special Note
Regarding Forward-Looking Statements</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#SPECIALNOTE"><font style="font-family: Times New Roman; font-size: 13px">26</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#USEOFPROCEEDS"><font style="font-family: Times New Roman; font-size: 13px">Use of
Proceeds</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#USEOFPROCEEDS"><font style="font-family: Times New Roman; font-size: 13px">27</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#PRICERANGEOFOURCOMMONSTOCK"><font style="font-family: Times New Roman; font-size: 13px">Price Range of Our
Common Stock</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#PRICERANGEOFOURCOMMONSTOCK"><font style="font-family: Times New Roman; font-size: 13px">27</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#DIVIDENDPOLICY"><font style="font-family: Times New Roman; font-size: 13px">Dividend
Policy</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#DIVIDENDPOLICY"><font style="font-family: Times New Roman; font-size: 13px">28</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#CAPITALIZATION"><font style="font-family: Times New Roman; font-size: 13px">Capitalization</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#CAPITALIZATION"><font style="font-family: Times New Roman; font-size: 13px">28</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#DILUTION"><font style="font-family: Times New Roman; font-size: 13px">Dilution</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#DILUTION"><font style="font-family: Times New Roman; font-size: 13px">29</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#SELLINGSECURITYHOLDERS"><font style="font-family: Times New Roman; font-size: 13px">Selling Security
Holders</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#SELLINGSECURITYHOLDERS"><font style="font-family: Times New Roman; font-size: 13px">30</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#DESCRIPTION"><font style="font-family: Times New Roman; font-size: 13px">Description of
Securities Registered</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#DESCRIPTION"><font style="font-family: Times New Roman; font-size: 13px">31</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#PLANOFDISTRIBUTION"><font style="font-family: Times New Roman; font-size: 13px">Plan of
Distribution</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#PLANOFDISTRIBUTION"><font style="font-family: Times New Roman; font-size: 13px">33</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#MANAGEMENT"><font style="font-family: Times New Roman; font-size: 13px">Management's
Discussion and Analysis of Financial Condition and Results of
Operations</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#MANAGEMENT"><font style="font-family: Times New Roman; font-size: 13px">36</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#BUSINESS"><font style="font-family: Times New Roman; font-size: 13px">Description of Our
Business</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#BUSINESS"><font style="font-family: Times New Roman; font-size: 13px">43</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#MANAGEMENT2"><font style="font-family: Times New Roman; font-size: 13px">Management</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#MANAGEMENT2"><font style="font-family: Times New Roman; font-size: 13px">47</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#EXECUTIVEANDDIRECTORCOMPENSATION"><font style="font-family: Times New Roman; font-size: 13px">Executive and
Director Compensation</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#EXECUTIVEANDDIRECTORCOMPENSATION"><font style="font-family: Times New Roman; font-size: 13px">52</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#CERTAINRELATIONSHIPS"><font style="font-family: Times New Roman; font-size: 13px">Certain
Relationships and Related Party Transactions</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#CERTAINRELATIONSHIPS"><font style="font-family: Times New Roman; font-size: 13px">56</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#PRINCIPALSTOCKHOLDERS"><font style="font-family: Times New Roman; font-size: 13px">Principal
Stockholders</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#PRINCIPALSTOCKHOLDERS"><font style="font-family: Times New Roman; font-size: 13px">59</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#DESCRIPTIONOFCAPITALSTOCK"><font style="font-family: Times New Roman; font-size: 13px">Description of
Capital Stock</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#DESCRIPTIONOFCAPITALSTOCK"><font style="font-family: Times New Roman; font-size: 13px">61</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#DESCRIPTIONOFSECURITIESBEINGREGISTER"><font style="font-family: Times New Roman; font-size: 13px">Description of
Securities Being Registered</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#DESCRIPTIONOFSECURITIESBEINGREGISTER"><font style="font-family: Times New Roman; font-size: 13px">63</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#LEGALMATTERS"><font style="font-family: Times New Roman; font-size: 13px">Legal
Matters</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#LEGALMATTERS"><font style="font-family: Times New Roman; font-size: 13px">66</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#EXPERTS"><font style="font-family: Times New Roman; font-size: 13px">Experts</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#EXPERTS"><font style="font-family: Times New Roman; font-size: 13px">66</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="#WHEREYOUCANFINDMOREINFORMATION"><font style="font-family: Times New Roman; font-size: 13px">Where You Can Find
More Information</font></a></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><a href="#WHEREYOUCANFINDMOREINFORMATION"><font style="font-family: Times New Roman; font-size: 13px"><br></font></a></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center"><a href="#WHEREYOUCANFINDMOREINFORMATION"><font style="font-family: Times New Roman; font-size: 13px">67</font></a></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 88%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Index
to Financial Statements</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
F-1<br></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">You
should rely only on the information contained in this prospectus
and any applicable prospectus supplement. We have not authorized
anyone to provide you with different or additional information. If
anyone provides you with different or inconsistent information, you
should not rely on it. The information contained in this prospectus
is accurate only as of the date of this prospectus, regardless of
the time of delivery of this prospectus or any sale of securities
described in this prospectus. This prospectus is not an offer to
sell these securities and it is not soliciting an offer to buy
these securities in any jurisdiction where the offer or sale is not
permitted. You should assume that the information appearing in this
prospectus or any prospectus supplement, as well as information we
have previously filed with the Securities and Exchange Commission,
is accurate as of the date on the front of those documents only.
Our business, financial condition, results of operations and
prospects may have changed since those dates.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">For
investors outside the United States: neither we nor the
underwriters have done anything that would permit this offering or
possession or distribution of this prospectus or any free writing
prospectus we may provide to you in connection with this offering
in any jurisdiction where action for that purpose is required,
other than in the United States. You are required to inform
yourselves about and to observe any restrictions relating to this
offering and the distribution of this prospectus and any such free
writing prospectus outside of the United States.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Unless
otherwise indicated, information contained in this prospectus
concerning our industry and the markets in which we operate,
including our general expectations and market position, market
opportunity and market share, is based on information from our own
management estimates and research, as well as from industry and
general publications and research, surveys and studies conducted by
third parties. Management estimates are derived from publicly
available information, our knowledge of our industry and
assumptions based on such information and knowledge, which we
believe to be reasonable. Our management estimates have not been
verified by any independent source, and we have not independently
verified any third-party information. In addition, assumptions and
estimates of our and our industry's future performance are
necessarily subject to a high degree of uncertainty and risk due to
a variety of factors, including those described in "Risk Factors".
These and other factors could cause our future performance to
differ materially from our assumptions and estimates. See "Special
Note Regarding Forward-Looking Statements".</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px">
Our trademarks</font> <font style="color: #000000; font-size: 13px">ChromaID&#x2122; and
Bio-RFID&#x2122;</font> <font style="font-size: 13px">are used
throughout this prospectus. This prospectus also includes
trademarks, trade names and service marks that are the property of
other organizations. Solely for convenience, trademarks and trade
names referred to in this prospectus appear without the &#xAE; and
&#x2122; symbols, but those references are not intended to indicate,
in any way, that we will not assert, to the fullest extent under
applicable law, our rights or that the applicable owner will not
assert its rights, to these trademarks and trade
names.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">5</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="PROSPECTUS">P</a>ROSPECTUS
SUMMARY</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
This summary highlights information contained elsewhere in this
prospectus. This summary does not contain all of the information
you should consider before investing in our common stock. You
should read this entire prospectus carefully, especially the "Risk
Factors" section of this prospectus and our financial statements
and the related notes appearing at the end of this prospectus,
before making an investment decision. As used in this prospectus,
unless the context otherwise requires, references to "we," "us,"
"our," "our company," &#x201C;Know Labs, Inc.&#x201D; and "Know Labs"
refer to Know Labs, Inc. and our wholly-owned subsidiaries
<font style="color: #000000">TransTech Systems, Inc and RAAI
Lighting, Inc.,</font> unless the context otherwise
requires.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
On May 24, 2018, the Financial Industry Regulatory Authority
(&#x201C;FINRA&#x201D;) announced the effectiveness of a change in
our name from Visualant Incorporated to Know Labs, Inc. and a
change in our ticker symbol from VSUL to the new trading symbol
KNWN which became effective on the opening of trading as of May 25,
2018. In addition, in connection with the name change and symbol
change, we were assigned the CUSIP number of
499238103.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
BACKGROUND AND CAPITAL STRUCTURE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Know Labs, Inc., formerly Visualant, Incorporated, was incorporated
under the laws of the State of Nevada in 1998.</font> Since 2007,
we have been focused primarily on research and development of
proprietary technologies which can be used to <font style="color: #000000">authenticate and diagnose a wide variety of
organic and non-organic substances and materials.</font> Our Common
Stock trades on the OTCQB Exchange under the symbol
&#x201C;KNWN.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
BUSINESS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are focused on the development, marketing and sales of a
proprietary technologies which are capable of uniquely
authenticating or diagnosing almost any substance or material using
electromagnetic energy to create, record and detect the unique
&#x201C;signature&#x201D; of the substance. We call these our
&#x201C;ChromaID&#x2122;&#x201D; and &#x201C;Bio-RFID&#x2122;&#x201D;
technologies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Overview</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Historically, the Company focused on the development of our
proprietary ChromaID technology. Using light from low-cost LEDs
(light emitting diodes) we map the color of substances, fluids and
materials and with our proprietary processes we can authenticate,
identify and diagnose based upon the color that is present. The
color is both visible to us as humans but also outside of the
humanly visible color spectrum in the near infra-red and near
ultra-violet and beyond. Our ChromaID scanner sees what we like to
call &#x201C;Nature&#x2019;s Color Fingerprint.&#x201D; Everything in
nature has a unique color identifier and with ChromaID we can see
it, and identify, authenticate and diagnose based upon the color
that is present. Our ChromaID scanner is capable of uniquely
identifying and authenticating almost any substance or liquid using
light to create, record and detect its unique color signature. We
will continue to develop and enhance our ChromaID technology and
extend its capacity. More recently, we have focused upon extensions
and new inventions that are derived from and extend beyond our
ChromaID technology. We call this technology Bio-RFID. The rapid
advances made with our Bio-RFID technology in our laboratory have
caused us to move quickly in to the commercialization phase of our
Company as we work to create revenue generating products for the
marketplace. We will also, as resources permit, pursue licensing
opportunities with third parties who have ready applications for
our technologies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In 2010, we acquired TransTech Systems, Inc. as an adjunct to our
business. TransTech is a distributor of products for employee and
personnel identification and authentication. TransTech has
historically provided substantially all of the Company&#x2019;s
revenues. The financial results from our TransTech subsidiary have
been diminishing as vendors of their products increasingly move to
the Internet and direct sales to their customers. While it does
provide our current revenues it is not central to our current focus
as a Company. Moreover, we have written down any goodwill
associated with its historic acquisition. We continue to closely
monitor this subsidiary. We expect it to wind down completely prior
to the end of our current fiscal year.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">6</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
The Know Labs Technology</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have internally and under contract with third parties developed
proprietary platform technologies to uniquely authenticate or
diagnose almost any material and substance. Our technology utilizes
electromagnetic energy at various points along the electromagnetic
spectrum to perform analytics which allow the user to identify,
authenticate and diagnose depending upon the application and the
unique field of use. The Company&#x2019;s proprietary platform
technologies are called ChromaID and Bio-RFID.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The ChromaID patented technology utilizes light at the photon
(elementary particle of light) level through a series of emitters
and detectors to generate a unique signature or
&#x201C;fingerprint&#x201D; from a scan of almost any solid, liquid
or gaseous material. This signature of reflected or transmitted
light is digitized, creating a unique ChromaID signature. Each
ChromaID signature is comprised of from hundreds to thousands of
specific data points.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The ChromaID technology looks beyond visible light frequencies to
areas of near infra-red and ultraviolet light and beyond that are
outside the humanly visible light spectrum. The data obtained
allows us to create a very specific and unique ChromaID signature
of the substance for a myriad of authentication, verification and
diagnostic applications.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Traditional light-based identification technology, called
spectrophotometry, has relied upon a complex system of prisms,
mirrors and visible light. Spectrophotometers typically have a
higher cost and utilize a form factor (shape and size) more suited
to a laboratory setting and require trained laboratory personnel to
interpret the information. The ChromaID technology uses lower cost
LEDs and photodiodes and specific electromagnetic frequencies
resulting in a more accurate, portable and easy-to-use solution for
a wide variety of applications. The ChromaID technology not only
has significant cost advantages as compared to spectrophotometry,
it is also completely flexible is size, shape and configuration.
The ChromaID scan head can range in size from endoscopic to a scale
that could be the size of a large ceiling-mounted florescent light
fixture.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In normal operation, a ChromaID master or reference scan is
generated and stored in a database. We call this the ChromaID
Reference Library. The scan head can then scan similar materials to
identify, authenticate or diagnose them by comparing the new
ChromaID digital signature scan to that of the original or
reference ChromaID signature or scan result. Over time, we believe
the ChromaID Reference Libraries can become a significant asset of
the Company, providing valuable information in numerous fields of
use. The Reference Libraries for our newly developed Bio-RFID will
have a similar promise regarding their utility and
value.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company&#x2019;s latest technology platform is called Bio-RFID.
Working in our lab over the past year and a half, we have developed
extensions and new inventions derived in part from our ChromaID
technology which we refer to as Bio-RFID technology. We are rapidly
advancing the development of this technology. We have announced
over the past several months that we have successfully been able to
non-invasively ascertain blood glucose levels in humans. We are
building the internal and external development team necessary to
commercialize this newly discovered technology as well as make
additional patent filings covering the intellectual property
created with these new inventions. The first applications of our
Bio-RFID technology will be in a product we call the UBAND&#x2122;.
The first UBAND product will be marketed as a real time calorie
counter. It is a wearable product which will be worn on the wrist
and communicate with a smart phone device via Bluetooth
connectivity. It will provide the user with real time information
on their caloric consumption from carbohydrates.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have also announced the results of laboratory-based comparison
testing between our Bio-RFID technology and the leading continuous
glucose monitors from Abbott Labs (Freestyle Libre&#xAE;) and
DexCom (G5&#xAE;). These results provide evidence of a high degree
of correlation between our Bio-RFID based technology and the
current industry leaders. Our technology is fundamentally
differentiated from these industry leaders as it is completely
non-invasive.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We expect to begin the process of obtaining US Food and Drug
Administration (FDA) approval of our non-invasive continuous blood
glucose monitoring device during calendar year 2019. To guide us in
that undertaking we have announced the hiring of a Chief Medical
Officer and formed a Medical and Regulatory Advisory Board to guide
us through the FDA process. We are unable, however, to estimate the
time necessary for such approval nor the likelihood of success in
that endeavor.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">7</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
ChromaID and Bio-RFID: Foundational Platform
Technologies</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our ChromaID and Bio-RFID technologies provide a platform upon
which a myriad of applications can be developed. As platform
technologies, they are analogous to a smartphone, upon which an
enormous number of previously unforeseen applications have been
developed. ChromaID and Bio-RFID technologies are
&#x201C;enabling&#x201D; technologies that bring the science of
electromagnetic energy to low-cost, real-world commercialization
opportunities across multiple industries. The technologies are
foundational and, as such, the basis upon which the Company
believes a significant business can be built.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As with other foundational technologies, a single application may
reach across multiple industries. The ChromaID technology can, for
example effectively differentiate and identify different brands of
clear vodkas that appear identical to the human eye. By extension,
this same technology can identify pure water from water with
contaminants present. It can provide real time detection of liquid
medicines such as morphine that have been adulterated or
compromised. It can detect if jet fuel has water contamination
present. It could determine when it is time to change oil in a deep
fat fryer. These are but a few of the potential applications of the
ChromaID technology based upon extensions of its ability to
identify different clear liquids.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Similarly, the Bio-RFID technology can non-invasively identity the
presence and quantity of glucose in the human body. By extension,
there may be other molecular structures which this same technology
can identity in the human body which, over time, the Company will
focus upon. They may include the monitoring of drug usage or the
presence of illicit drugs. They may also involve identifying
hormones and various markers of disease.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The cornerstone of a company with a foundational platform
technology is its intellectual property. We have pursued an active
intellectual property strategy and have been granted 12 patents. We
currently have more than 20 patents pending. We possess all right,
title and interest to the issued patents. Ten of the pending
patents are licensed exclusively to us in perpetuity by our
strategic partner, Allied Inventors, a spin-off entity of
Intellectual Ventures, an intellectual property fund.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Our Patents and Intellectual Property</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We believe that our 12 patents, more than 20 patent applications,
three registered trademarks, and our trade secrets, copyrights and
other intellectual property rights are important assets. Our issued
patents will expire at various times between 2027 and 2033. The
duration of our trademark registrations varies from country to
country. However, trademarks are generally valid and may be renewed
indefinitely as long as they are in use and/or their registrations
are properly maintained.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The issued patents cover the fundamental aspects of the Know Labs
ChromaID technology and a growing number of unique applications
ranging, to date, from invisible bar codes to tissue and liquid
analysis. We have filed patents on Bio-RFID technology and will
continue to expand the Company&#x2019;s patent portfolio over time
through internal development efforts as well as through licensing
opportunities with third parties.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Additionally, significant aspects of our technology are trade
secrets which may not be disclosed through the patent filing
process. We intend to be diligent in maintaining our trade
secrets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The patents that have been issued to Know Labs and their dates of
issuance are:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 9, 2011, we were issued US Patent No. 7,996,173 B2
entitled &#x201C;Method, Apparatus and Article to Facilitate
Distributed Evaluation of Objects Using Electromagnetic
Energy,&#x201D; by the United States Office of Patents and
Trademarks. The patent expires August 24, 2029.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 13, 2011, we were issued US Patent No. 8,076,630 B2
entitled &#x201C;System and Method of Evaluating an Object Using
Electromagnetic Energy&#x201D; by the United States Office of
Patents and Trademarks. The patent expires November 7,
2028.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 20, 2011, we were issued US Patent No. 8,081,304 B2
entitled &#x201C;Method, Apparatus and Article to Facilitate
Evaluation of Objects Using Electromagnetic Energy&#x201D; by the
United States Office of Patents and Trademarks. The patent expires
July 28, 2030.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">8</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On October 9, 2012, we were issued US Patent No. 8,285,510 B2
entitled &#x201C;Method, Apparatus, and Article to Facilitate
Distributed Evaluation of Objects Using Electromagnetic
Energy&#x201D; by the United States Office of Patents and
Trademarks. The patent expires July 31, 2027.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On February 5, 2013, we were issued US Patent No. 8,368,878 B2
entitled &#x201C;Method, Apparatus and Article to Facilitate
Evaluation of Objects Using Electromagnetic Energy by the United
States Office of Patents and Trademarks. The patent expires July
31, 2027.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On November 12, 2013, we were issued US Patent No. 8,583,394 B2
entitled &#x201C;Method, Apparatus and Article to Facilitate
Distributed Evaluation of Objects Using Electromagnetic Energy by
the United States Office of Patents and Trademarks. The patent
expires July 31, 2027.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On November 21, 2014, we were issued US Patent No. 8,888,207 B2
entitled &#x201C;Systems, Methods, and Articles Related to
Machine-Readable Indicia and Symbols&#x201D; by the United States
Office of Patents and Trademarks. The patent expires February 7,
2033. This patent describes using ChromaID to see what we call
invisible bar codes and other identifiers.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 23, 2015, we were issued US Patent No. 8,988,666 B2
entitled &#x201C;Method, Apparatus, and Article to Facilitate
Evaluation of Objects Using Electromagnetic Energy&#x201D; by the
United States Office of Patents and Trademarks. The patent expires
July 31, 2027.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 26, 2015, we were issued US Patent No. 9,041,920 B2 entitled
&#x201C;Device for Evaluation of Fluids using Electromagnetic
Energy&#x201D; by the United States Office of Patents and
Trademarks. The patent expires March 12, 2033. This patent
describes a ChromaID fluid sampling devices.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 19, 2016, we were issued US Patent No. 9,316,581 B2
entitled &#x201C;Method, Apparatus, and Article to Facilitate
Evaluation of Substances Using Electromagnetic Energy&#x201D; by the
United States Office of Patents and Trademarks. The patent expires
March 12, 2033. This patent describes an enhancement to the
foundational ChromaID technology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 18, 2017, we were issued US Patent No. 9,625,371 B2
entitled &#x201C;Method, Apparatus, and Article to Facilitate
Evaluation of Substances Using Electromagnetic Energy.&#x201D; The
patent expires July 2027. This patent pertains to the use of
ChromaID technology for the identification and analysis of
biological tissue. It has many potential applications in medical,
industrial and consumer markets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 4, 2018, we were issued US Patent No. 9,869,636 B2,
entitled &#x201C;Device for Evaluation of Fluids Using
Electromagnetic Energy.&#x201D; The patent expires approximately
April 2033. This patent pertains to the use of ChromaID technology
for evaluating and analyzing fluids such as those following through
an IV drip in a hospital or water, for example.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We continue to pursue a patent strategy to expand our unique
intellectual property in the United States and other
countries.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Product Strategy</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are currently undertaking internal development work on potential
products for the consumer marketplace. This development work was
previously being performed through our Consulting Agreement with
Blaze Clinical, and Phillip A. Bosua, who served as our Chief
Product Officer. In his current role as Chief Executive Officer,
Mr. Bosua continues to lead these efforts. We have announced the
development of our UBAND Calorie Counter and our UBAND CGM. We have
also recently announced the engagement of a manufacturing partner
we will work with to bring these products to market. We will make
further announcements regarding these products as development and
manufacturing work on them progresses.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As time and resources permit, we also will engage with partners
through licensing our technology in various fields of use, entering
in to joint venture agreements to develop specific applications of
our technology, and in certain specific instances develop our own
products for the marketplace.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">9</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Currently we are focusing our current efforts on productizing our
Bio-RFID technology as we move it out of the research laboratory
and in to the marketplace.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Research and Development</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our current research and development efforts are primarily focused
improving our Bio-RFID technology, extending its capacity and
developing new and unique applications for the technology. As part
of this effort, we conduct on-going laboratory testing to ensure
that application methods are compatible with the end-user and
regulatory requirements, and that they can be implemented in a
cost-effective manner. We are also actively involved in identifying
new applications. Our current internal team along with outside
consultants have considerable experience working with the
application of our technologies and their application. We engage
third party experts as required to supplement our internal team. We
believe that continued development of new and enhanced technologies
is essential to our future success. We incurred expenses of
$391,014, $570,514 and $79,405 for the six months ended March 31,
2019 and years ended September 30, 2018 and 2017, respectively, on
development activities, On July 6, 2017, we entered into a
Consulting Agreement with Phillip A. Bosua, our Chief Product
Officer to lead our development efforts. He has continued in that
role with expanded responsibilities upon his appointment as Chief
Executive Officer on April 19, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Merger with RAAI Lighting, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, we entered into an Agreement and Plan of Merger
with 500 Union Corporation, a Delaware corporation and a wholly
owned subsidiary of the Company, and RAAI Lighting, Inc., a
Delaware corporation. Pursuant to the Merger Agreement, we have
acquired all the outstanding shares of RAAI&#x2019;s capital stock
through a merger of Merger Sub with and into RAAI (the
&#x201C;Merger&#x201D;), with RAAI surviving the Merger as a wholly
owned subsidiary of the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Under the terms of the Merger Agreement, each share of RAAI common
stock issued and outstanding immediately before the Merger (1,000
shares) were cancelled and we issued 2,000,000 shares of our common
stock. As a result, we issued 2,000,000 shares of its common stock
to Phillip A. Bosua, formerly the sole stockholder of RAAI. The
consideration for the Merger was determined through arms-length
bargaining by the Company and RAAI. The Merger was structured to
qualify as a tax-free reorganization for U.S. federal income tax
purposes. As a result of the Merger, the Company received certain
intellectual property, related to RAAI.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Merger with Know Labs, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, Know Labs, Inc., a Nevada corporation incorporated
on April 3, 2018, and our wholly-owned subsidiary, merged with and
into the Company pursuant to an Agreement and Plan of Merger dated
May 1, 2018. In connection with the merger, our Articles of
Incorporation were effectively amended to change our name to Know
Labs, Inc. by and through the filing of Articles of Merger. This
parent-subsidiary merger was approved by us, the parent, in
accordance with Nevada Revised Statutes Section 92A.180.
Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1,
2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Corporate Name Change and Symbol Change</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On May
24, 2018, the Financial Industry Regulatory Authority
(&#x201C;FINRA&#x201D;) announced the effectiveness of a change in
our name from Know Labs Incorporated to Know Labs, Inc. and a
change in our ticker symbol from VSUL to the new trading symbol
KNWN which became effective on the opening of trading as of May 25,
2018. In addition, in connection with the name change and symbol
change, we were assigned the CUSIP number of
499238103.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are obligated under various non-cancelable operating leases for
our various facilities and certain equipment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">10</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Corporate Offices</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 13, 2017, we leased our executive office located at 500
Union Street, Suite 810, Seattle, Washington, USA, 98101. We lease
943 square feet and the net monthly payment is $2,672. The monthly
payment increases approximately 3% each year and the lease expires
on May 31, 2022.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Lab Facilities and Executive Offices</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, we leased our lab facilities and executive offices
located at 304 Alaskan Way South, Suite 102, Seattle, Washington,
USA, 98101. We leased 2,800 square feet and the net monthly payment
is $4,000. The lease expired on April 30, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On February 1, 2019, we leased our lab facilities and executive
offices located at</font> <font style="font-size: 13px">1517 12th
Ave Suite 203 Seattle, WA 98122</font><font style="color: #000000">. We leased 2,642 square feet and the net monthly
payment is $8,256. The monthly payment increases approximately 3%
on July 1, 2019 and annually thereafter. The lease expires on June
30, 2021 and can be extended.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
TransTech Facilities</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
TransTech is located at 12142 NE Sky Lane, Suite 130, Aurora, OR
97002. TransTech leases a total of approximately 6,340 square feet
of office and warehouse space for its administrative offices,
product inventory and shipping operations. Effective December 1,
2017, TransTech leases this office from December 1, 2017 at $4,465
per month. The monthly payment increases approximately 3% each year
and the lease expires on January 31, 2020. Until December 1, 2017,
TransTech leased this office on a month to month basis at $6,942
per month. The Company expects to exit this facility by June 30,
2019.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Employees</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
As of March 31, 2019, we had twelve full-time employees and two
consultants or consulting groups. Our senior management is located
in the Seattle, Washington office.</font> None of our employees are
subject to a collective bargaining agreement or represented by a
trade or labor union. We believe that we have a good relationship
with our employees.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Legal Proceedings</font> &#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We may
from time to time become a party to various legal proceedings
arising in the ordinary course of our business. We are currently
not a party to any pending legal proceeding that is not ordinary
routine litigation incidental to our business.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Risks That We Face</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
business is subject to a number of risks of which you should be
aware before making an investment decision. <font style="color: #000000">We are exposed to various risks related to our
business and financial position (specifically our need for
additional financing), this offering, our common stock and our
recent reverse stock split.</font> These risks are discussed more
fully in the "Risk Factors" section of this prospectus beginning on
page 15.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Corporate Information</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We were incorporated under the laws of the State of Nevada on
October 8, 1998. Our executive offices are located at 500 Union
Street, Suite 810, Seattle, WA 98101. Our telephone number is (206)
903-1351 and our principal website address is located at
www.knowlabs.co.</font> The information contained on, or that can
be accessed through, our website is not incorporated into and is
not a part of this prospectus. You should not rely on our website
or any such information in making your decision whether to purchase
our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">11</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="SUMMARYOFTHEOFFERING">S</a>UMMARY OF THE OFFERING</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px;"><br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">Securities
offered:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 69%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
14,337,632 shares of common stock, which
includes:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>

<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">(i)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to
4,242,515 shares of common stock underlying the principal, and up
to 339,401 shares underlying the interest accrued, of
registrants 8% Unsubordinated Convertible Notes (the
&#x201C;Notes&#x201D;), which have a conversion price that is the
lesser of $1.00 per share or a twenty five percent (25%) discount
to the price per share paid by investors a future Qualified
Financing (the &#x201C;Shares&#x201D;)</font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">(ii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to
2,121,258 shares (the "Investor Warrant Shares") of common stock
issuable upon the exercise of outstanding investor's warrants (the
"Investor Warrants") at an exercise price of $1.20 that were
previously issued to the Selling Shareholders in connection with
the Notes Offering that closed in a series of closings between
February 15, 2019 and May 28, 2019.</font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">(iii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">542,102
shares of our common stock issuable upon the exercise of
outstanding placement agent warrants (the &#x201C;Placement Agent
Warrants&#x201D;) at an exercise price of $1.20 per share that were
previously issued to Boustead Securities, LLC and its assigns
(collectively &#x201C;Placement Agent&#x201D;) pursuant to the
Boustead Offering Engagement Agreement which provides that the
Placement Agent shall receive that certain number of warrants to
purchase the common stock of the Company equal to the number of
warrants issued under the 8% Unsubordinated Convertible Note
Offering (the &#x201C;Offering&#x201D;).</font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">(iv)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 3,108,356 shares of common stock underlying
the outstanding Series D</font> <font style="color: #000000">Convertible Preferred Stock which is convertible
at any time at an initial conversion price of $0.25 per share of
our common stock subject to adjustment for certain events
(&#x201C;Series D Shares&#x201D;). There are currently 3,108,356
common shares estimated to underlying the 1,016,004 issued and
outstanding Series D Shares.</font></font></font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">(v)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to
3,984,000 shares of common stock issuable upon conversion of
outstanding Series F Warrants at an exercise price of $0.25 per
share, subject to certain adjustments, that were previously issued
to one of the Selling Shareholders in connection with Preferred
Stock and Warrant Purchase Agreement dated November 10, 2016
(&#x201C;Series F Warrant Shares&#x201D;).</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px;"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
&#xA0;</font>Our Common Stock is described in further detail in the
section of the prospectus titled &#x201C;DESCRIPTION OF
SECURITIES&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">Common
stock outstanding before the offering (1):</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 69%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
22,435,464 shares</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">Common
stock to be outstanding after this offering (2):</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 69%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">36,773,096
shares</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">Use of
Proceeds:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 69%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font><font style="color: #000000; font-family: Times New Roman; font-size: 13px">We
will not receive any of the proceeds from the sale of shares of
common stock by the Selling Stockholders. Upon exercise of the
Investor Warrants and Placement Agent Warrants, however, we will
receive up to $1.20 per share, and upon exercise of the Series F
Warrants, we will receive up to $0.25 per share or such lower price
as may result from the anti-dilution protection features of such
warrants. Any proceeds received from the exercise of such warrants
will be used for general working capital and other corporate
purposes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">Terms
of Warrants:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 69%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Investor Warrants and Placement Agent Warrants entitles the holder
thereof to purchase one common share at an exercise price or $1.20
per full share, for a five year period after the date of issuance
(between March-May 2024). Each Series F Warrant entitles the holder
thereof to purchase one common share at an exercise price or $0.25
per full share, for a five year period after the date of issuance
(between November 14, 2021 and May 1, 2022). The price per Warrant
Share shall be subject to adjustment for stock splits,
combinations, and similar recapitalization events and anti-dilution
protection features.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">12</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">Risk
Factors:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 69%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
An investment in our common stock involves a high degree of risk.
You should carefully consider the risk factors set forth under the
"Risk Factors" section hereunder and the other information
contained in this prospectus before making an investment decision
regarding our common stock. Our common stock should not be
purchased by investors who cannot afford the loss of their entire
investment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">OTCQB
Symbol:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 69%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
common stock is currently quoted on the OTCQB (the
&#x201C;OTCQB&#x201D;) under the symbol
&#x201C;KNWN&#x201D;.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">Reverse
Split:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 69%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On June
17, 2015, we effected a 1-for-150 reverse stock split of our common
stock. All warrant, option, share and per share information in this
prospectus gives retroactive effect to the 1-for-150 split with all
numbers rounded up to the nearest whole share.</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 36px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(1)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px">&#xA0;</font>The number of shares of our common
stock outstanding before this offering is based
on&#xA0;<font style="color: #000000">22,435,464</font> shares of
our common stock outstanding as of&#xA0;May 30, 2019, and excludes,
as of that date:</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">2,437,668&#xA0;shares
of our common stock issuable upon the exercise of outstanding stock
options outstanding at a weighted-average exercise price of $1.744
per share;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 60px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">An
unknown number of shares&#xA0;of our common stock issuable upon the
conversion of $2,255,066 of Convertible Notes Payable <font style="color: #000000">(currently 9,020,264 at $0.25 per
share)</font>;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 60px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">547,332&#xA0;additional
shares of our common stock available for future issuance under our
2011 Stock Incentive Plan;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 60px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">1,785,714 shares of
our common stock issuable upon the conversion of Series C
Convertible Preferred Stock, at an exercise price of $0.25, subject
to certain adjustments. These shares of common stock are being
registered in this offering; and</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 60px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">3,108,356 shares of
our common stock issuable upon the conversion of Series D
Convertible Preferred Stock, at an exercise price of $0.25, subject
to certain adjustments.</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 60px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">17,837,090 warrants
to purchase shares of our common stock at an exercise price of
$0.453 subject to certain adjustments.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 36px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(2)</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">This
total includes the following:</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(i)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 4,242,515 shares of common stock underlying the principal amount
of registrants 8% Unsubordinated Convertible Notes
(&#x201C;Principal Shares&#x201D;)</font></div>
</div>
</div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(ii)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 339,401 shares of common
stock</font> issuable by the registrant upon the conversion of
interest accrued under the <font style="color: #000000">8%
Unsubordinated Convertible Notes (&#x201C;Interest Shares&#x201D;)
(The Principal Shares and Interest Shares are referred to
collectively as the &#x201C;Shares&#x201D;).</font></font> </div>
</div>
</div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(iii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 2,121,258 shares (the "Investor Warrant Shares") of common stock
issuable upon the exercise of investor's warrants (the "Investor
Warrants") at an exercise price of $1.20 that were previously
issued to the Selling Shareholders in connection with 8%
Unsubordinated Convertible Notes offering that closed in a series
of closings between February 15, 2019 and May 28,
2019.</font></div>
</div>
</div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(iv)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 3,108,356 shares of common stock underlying
the outstanding Series D</font> <font style="color: #000000">Convertible Preferred Stock which is convertible
at any time at an initial conversion price of $0.25 per share of
our common stock subject to adjustment for certain events
(&#x201C;Series D Shares&#x201D;). There are currently 3,108,356
common shares estimated to underlying the 1,016,004 issued and
outstanding Series D Shares.</font></font></font> </div>
</div>
</div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(v)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">an indeterminate number of shares of common stock
issuable upon conversion of Series D Convertible Preferred Stock.
The Series D</font> <font style="color: #000000">Convertible
Preferred Stock is convertible at any time at an initial conversion
price of $0.25 per share of our common stock subject to adjustment
for certain events (&#x201C;Series D Shares&#x201D;). There are
currently 3,108,356 common shares estimated to underlying the
1,016,004 issued and outstanding Series D
Shares.</font></font></div>
</div>
</div>
<div style="display: table; margin-left: 60px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(vi)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to
3,984,000 shares <font style="color: #000000">of common stock
issuable upon conversion of outstanding Series F Warrants at an
exercise price of $0.25 per share that were previously issued to
one of the Selling Shareholders in connection with Preferred Stock
and Warrant Purchase Agreement dated November 10, 2016
(&#x201C;Series F Warrant Shares&#x201D;).</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">13</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="SUMMARYFINANCIALINFORMATION">S</a>UMMARY FINANCIAL
INFORMATION</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following tables set forth a summary of our historical financial
data as of, and for the period ended on, the dates indicated. We
have derived the statements of operations data for the years ended
September 30, 2018 and 2017 from our audited financial statements
included in this prospectus. Historical results for any prior
period are not necessarily indicative of results to be expected in
any future period. You should read the following summary financial
data together with our financial statements and the related notes
appearing at the end of this prospectus and the
"Capitalization&#x201D; and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" sections of this
prospectus. &#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Statements of Operations Data:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">(in
thousands, except for share and per share data)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:40%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; font-weight: bold; vertical-align: bottom; display: inline-block; width: 80%; font-size: 11px; padding-bottom: 2px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">Six Months
Ended</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td colspan="5" rowspan="1" style="vertical-align:bottom;width:50%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:2%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:96%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">Years Ended
September 30,</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:2%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2019</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">2018</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">2017</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">2016</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">2015</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">2014</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;font-size:11px;display:inline-block;">
<div><font style="font-family:Times New Roman;font-weight:bold;">(Unaudited)</font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;font-size:11px;display:inline-block;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;font-size:11px;display:inline-block;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;font-size:11px;display:inline-block;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;font-size:11px;display:inline-block;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;font-size:11px;display:inline-block;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;font-size:11px;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">STATEMENT OF
OPERATIONS DATA:</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Net
revenue</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,196</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,303</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,874</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">6,024</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">6,291</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,983</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Cost of goods
sold</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">927</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">3,482</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">3,966</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">5,036</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">5,274</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">6,694</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Gross
profit</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">269</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">821</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">908</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">988</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,017</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,289</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Research and
development expenses</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">391</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">570</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">79</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">326</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">363</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">670</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">General and
administrative expenses</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,368</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,088</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,355</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,984</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,180</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Impairment of
goodwill</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">984</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Operating
(loss)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,490</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,258</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(3,243</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,693</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,330</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,561</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Other
expense</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(4</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(658</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">947</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(271</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">1,538</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Net
(loss)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,494</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(3,258</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(3,901</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,746</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,601</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,023</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Income taxes
current benefit</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">30</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(6</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Net
(loss)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(2,494</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,258</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,901</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1,746</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(2,631</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1,017</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Net (loss) per
share</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.14</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.38</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1.01</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1.22</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(2.33</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(2.33</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Weighted average
number of shares</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">18,424,608</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">8,630,891</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,844,840</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,428,763</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,131,622</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">437,049</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Balance Sheet Data:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(in
thousands)</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font><font style="font-size: 11px"></font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:88%;">
<div style="margin-left:0px;"><font style="font-size: 11px"><font style="font-family: Times New Roman">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">As
of</font></font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:88%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-size: 11px"><font style="font-family: Times New Roman">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></font></div>
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">2019</font></font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-size: 11px"><font style="font-family: Times New Roman">BALANCE SHEET
DATA:</font></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-size: 13px; font-family: Times New Roman;"><font style="font-size: 11px">(Unaudited)</font></font></font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total current
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,369</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,944</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total current
liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,286</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total
liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,286</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Stockholders'
(deficiency)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(343</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">14</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="RISK">R</a>ISK FACTORS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Investing in our common stock involves a high degree of risk. You
should carefully consider the risks and uncertainties described
below, together with all of the other information contained in this
prospectus, including our financial statements and the related
notes appearing at the end of this prospectus, before deciding to
invest in our common stock. If any of the following risks actually
occur, our business, prospects, operating results and financial
condition could suffer materially, the trading price of our common
stock could decline and you could lose all or part of your
investment.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Risks Relating to the Company Generally</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We need additional financing to support our technology development
and ongoing operations, pay our debts and maintain ownership of our
intellectual properties.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; background-color: #FFFFFF">
We are currently operating at a loss. We believe that our cash on
hand will be sufficient to fund our operations through December 31,
2019.</font> <font style="color: #000000">We need additional
financing to implement our business plan and to service our ongoing
operations, pay our current debts (described below) and maintain
ownership of our intellectual property. There can be no assurance
that we will be able to secure any needed funding, or that if such
funding is available, the terms or conditions would be acceptable
to us. If we are unable to obtain additional financing when it is
needed, we will need to restructure our operations and/or divest
all or a portion of our business.</font> <font style="color: #000000; background-color: #FFFFFF">&#xA0;We may seek
additional capital through a combination of private and public
equity offerings, debt financings and strategic collaborations.
Debt financing, if obtained, may involve agreements that include
covenants limiting or restricting our ability to take specific
actions, such as incurring additional debt, and could increase our
expenses and require that our assets secure such debt. Equity
financing, if obtained, could result in dilution to our
then-existing stockholders and/or require such stockholders to
waive certain rights and preferences. If such financing is not
available on satisfactory terms, or is not available at all, we may
be required to delay, scale back, eliminate the development of
business opportunities or file for bankruptcy and our operations
and financial condition may be materially adversely
affected.</font><font style="color: #000000">&#xA0;</font> There
can there can be no assurance that we will be able to sell that
number of shares, if any.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We need to continue as a going concern if our business is to
succeed.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Because of our recurring losses and negative cash flows from
operations, the audit report of our independent registered public
accountants on our consolidated financial statements for the year
ended September 30, 2018 contains an explanatory paragraph stating
that there is substantial doubt about our ability to continue as a
going concern.&#xA0; Factors identified in the report include our
historical net losses, negative working capital, and the need for
additional financing to implement our business plan and service our
debt repayments. If we are not able to attain profitability in the
near future our financial condition could deteriorate further,
which would have a material adverse impact on our business and
prospects and result in a significant or complete loss of your
investment. Further, we may be unable to pay our debt obligations
as they become due, which include obligations to secured
creditors.</font> <font style="color: #000000; background-color: #FFFFFF">If we are unable to
continue as a going concern, we might have to liquidate our assets
and the values we receive for our assets in liquidation or
dissolution could be significantly lower than the values reflected
in our financial statements.&#xA0;&#xA0;Additionally, we are
subject to customary operational covenants, including limitations
on our ability to incur liens or additional debt, pay dividends,
redeem stock, make specified investments and engage in merger,
consolidation or asset sale transactions, among other restrictions.
In addition, the inclusion of an explanatory paragraph regarding
substantial doubt about our ability to continue as a going concern
and our lack of cash resources may materially adversely affect our
share price and our ability to raise new capital or to enter into
critical contractual relations with third
parties.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
As of March 31, 2019, we owe approximately $2,733,927 and if we do
not satisfy these obligations, the lenders may have the right to
demand payment in full or exercise other remedies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Erickson and/or entities with which he is affiliated also have
accrued compensation, travel and interest of approximately $478,861
as of March 31, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Including
Mr. Erickson, we owe $2,255,066 under various convertible
promissory notes as of March 31, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We require additional financing, to service and/or repay these debt
obligations. If we raise additional capital through borrowing or
other debt financing, we may incur substantial interest expense. If
and when we raise more equity capital in the future, it will result
in substantial dilution to our current stockholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">15</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We have a history of operating losses and there can be no assurance
that we can achieve or maintain profitability.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We have experienced net losses since inception. As of March 31,
2019, we had an accumulated deficit of $37,285,000 and net losses
in the amount of $2,494,000, $3,258,000 and $3,901,000 for the six
months ended March 31, 2019 and years ended September 30, 2018 and
2017, respectively. There can be no assurance that we will achieve
or maintain profitability.</font>&#xA0;<font style="color: #000000; background-color: #FFFFFF">If we achieve
profitability in the future, we may not be able to sustain
profitability in subsequent periods. Failure to become and remain
profitable would impair our ability to sustain operations and
adversely affect the price of our common stock and our ability to
raise capital. Our operating expenses may increase as we spend
resources on growing our business, and if our revenue does not
correspondingly increase, our operating results and financial
condition will suffer.</font> <font style="color: #000000">Our
ChromaID and Bio-RFID business has produced minimal revenues, and
may not produce significant revenues in the near term, or at all,
which would harm our ability to continue our operations or obtain
additional financing and require us to reduce or discontinue our
operations. You must consider our business and prospects in light
of the risks and difficulties we will encounter as business with an
early-stage technology in a new and rapidly evolving industry. We
may not be able to successfully address these risks and
difficulties, which could significantly harm our business,
operating results and financial condition.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
If the company were to dissolve or wind-up operations, holders of
our common stock would not receive a liquidation
preference.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
If we were to wind-up or dissolve our company and liquidate and
distribute our assets, our common stockholders would share in our
assets only after we satisfy any amounts we owe to our creditors
and preferred equity holders.&#xA0;&#xA0;If our liquidation or
dissolution were attributable to our inability to profitably
operate our business, then it is likely that we would have material
liabilities at the time of liquidation or
dissolution.&#xA0;&#xA0;Accordingly, it is very unlikely that
sufficient assets will remain available after the payment of our
creditors and preferred equity holders to enable common
stockholders to receive any liquidation distribution with respect
to any common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We may not be able to generate sufficient revenue from the
commercialization of our ChromaID and Bio-RFID technology and
related products to achieve or sustain profitability.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are in the early stages of commercializing our ChromaID and
Bio-RFID technology.&#xA0;Failure to develop and sell products
based upon our ChromaID and Bio-RFID technology, grant additional
licenses and obtain royalties or develop other revenue streams will
have a material adverse effect on our business, financial condition
and results of operations.&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
To date, we have generated minimal revenue from sales of our
products. We believe that our commercialization success is
dependent upon our ability to significantly increase the number of
customers that are using our products</font><font style="font-style: italic; color: #000000">.&#xA0;</font> <font style="color: #000000">In addition, demand for our products may not
materialize, or increase as quickly as planned, and we may
therefore be unable to increase our revenue levels as expected. We
are currently not profitable</font><font style="font-style: italic; color: #000000">.&#xA0;</font><font style="color: #000000">Even if we succeed in introducing our technology
and related products to our target markets, we may not be able to
generate sufficient revenue to achieve or sustain
profitability.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
<font style="font-weight: bold">We currently rely in part upon
external resources for engineering and product development
services. If we are unable to secure an engineering or product
development partner or establish satisfactory engineering and
product development capabilities, we may not be able to
successfully commercialize our ChromaID and Bio-RFID
technology</font>.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
success depends upon our ability to develop products that are
accurate and provide solutions for our customers. Achieving the
desired results for our customers requires solving engineering
issues in concert with them. Any failure of our ChromaID and
Bio-RFID technology or related products to meet customer
expectations could result in customers choosing to retain their
existing methods or to adopt systems other than ours.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
not historically had sufficient internal resources which can work
on engineering and product development matters. We have used third
parties in the past and will continue to do so. These resources are
not always readily available and the absence of their availability
could inhibit our research and development efforts and our
responsiveness to our customers. Our inability to secure those
resources could impact our ability to provide engineering and
product development services and could have an impact on our
customers&#x2019; willingness to use our technology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">16</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We are in the early stages of commercialization and our ChromaID
and Bio-RFID technology and related products may never achieve
significant commercial market acceptance.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our success depends on our ability to develop and market products
that are recognized as accurate and cost-effective. Many of our
potential customers may be reluctant to use our new technology.
Market acceptance will depend on many factors, including our
ability to convince potential customers that our ChromaID and
Bio-RFID technology and related products are an attractive
alternative to existing light-based technologies. We will need to
demonstrate that our products provide accurate and cost-effective
alternatives to existing light-based authentication technologies.
Compared to most competing technologies, our technology is
relatively new, and most potential customers have limited knowledge
of, or experience with, our products. Prior to implementing our
technology and related products, potential customers are required
to devote significant time and effort to testing and validating our
products. In addition, during the implementation phase, customers
may be required to devote significant time and effort to training
their personnel on appropriate practices to ensure accurate results
from our technology and products. Any failure of our technology or
related products to meet customer expectations could result in
customers choosing to retain their existing testing methods or to
adopt systems other than ours.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Many factors influence the perception of a system including its use
by leaders in the industry. If we are unable to induce industry
leaders in our target markets to implement and use our technology
and related products, acceptance and adoption of our products could
be slowed. In addition, if our products fail to gain significant
acceptance in the marketplace and we are unable to expand our
customer base, we may never generate sufficient revenue to achieve
or sustain profitability.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Our management has concluded that we have material weaknesses in
our internal controls over financial reporting and that our
disclosure controls and procedures are not effective.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
A material weakness is a deficiency, or a combination of
deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material misstatement
of a company's annual or interim financial statements will not be
prevented or detected on a timely basis. During the audit of our
financial statements for the year ended September 30, 2018, our
management identified material weaknesses in our internal control
over financial reporting. If these weaknesses continue, investors
could lose confidence in the accuracy and completeness of our
financial reports and other disclosures. &#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
In addition, our management has concluded that our disclosure
controls and procedures were not effective due to the lack of an
audit committee &#x201C;financial expert.&#x201D;</font> <font style="color: #000000; background-color: #FFFFFF">These material
weaknesses, if not remediated, create an increased risk of
misstatement of the Company&#x2019;s financial results, which, if
material, may require future restatement thereof. A failure to
implement improved internal controls, or difficulties encountered
in their implementation or execution, could cause future delays in
our reporting obligations and could have a negative effect on us
and the trading price of our common
stock.</font>&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
If components used in our finished products become unavailable, or
third-party manufacturers otherwise experience delays, we may incur
delays in shipment to our customers, which would damage our
business.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We depend on third-party suppliers for substantially all of our
components and products. We purchase these products and components
from third-party suppliers that serve the advanced lighting systems
market and we believe that alternative sources of supply are
readily available for most products and components. However,
consolidation could result in one or more current suppliers being
acquired by a competitor, rendering us unable to continue
purchasing necessary amounts of key components at competitive
prices. In addition, for certain of our customized components,
arrangements for additional or replacement suppliers will take time
and result in delays. We purchase products and components pursuant
to purchase orders placed from time to time in the ordinary course
of business. This means we are vulnerable to unanticipated price
increases and product shortages. Any interruption or delay in the
supply of components and products, or our inability to obtain
components and products from alternate sources at acceptable prices
in a timely manner, could harm our business, financial condition
and results of operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font> <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">17</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
While we believe alternative manufacturers for these products are
available, we have selected these particular manufacturers based on
their ability to consistently produce these products per our
specifications ensuring the best quality product at the most
cost-effective price. We depend on our third-party manufacturers to
satisfy performance and quality specifications and to dedicate
sufficient production capacity within scheduled delivery times.
Accordingly, the loss of all or one of these manufacturers or
delays in obtaining shipments could have a material adverse effect
on our operations until such time as an alternative manufacturer
could be found.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Our&#xA0; wholly-owned TransTech subsidiary revenues are
declining</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
not been able to successfully address this revenue decline, which
is expected to result in winding down this subsidiary during the
three months ending June 30, 2019.&#xA0; The loss of the TransTech
subsidiary revenue will impact the Company&#x2019;s top line
revenues and its operating results and may result in expenses
associated with the winding down. We cannot predict with certainty
how the winding down will affect our overall
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We are dependent on key personnel.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Our success depends to a significant degree upon the continued
contributions of key management and other personnel, some of whom
could be difficult to replace, including Ronald P. Erickson, our
Chairman and Phil Bosua, our Chief Executive Officer. We do not
maintain key person life insurance covering any of our officers.
Our success will depend on the performance of our officers, our
ability to retain and motivate our officers, our ability to
integrate new officers into our operations, and the ability of all
personnel to work together effectively as a team.&#xA0;&#xA0;Our
officers do not currently have employment
agreements.&#xA0;&#xA0;Our failure to retain and recruit officers
and other key personnel could have a material adverse effect on our
business, financial condition and results of
operations.&#xA0;</font> <font style="color: #000000; background-color: #FFFFFF">Our success also
depends on our continued ability to identify, attract, hire, train,
retain and motivate highly skilled technical, managerial,
manufacturing, administrative and sales and marketing personnel.
Competition for these individuals is intense, and we may not be
able to successfully recruit, assimilate or retain sufficiently
qualified personnel. In particular, we may encounter difficulties
in recruiting and retaining a sufficient number of qualified
technical personnel, which could harm our ability to develop new
products and adversely impact our relationships with existing and
future customers. The inability to attract and retain necessary
technical, managerial, manufacturing, administrative and sales and
marketing personnel could harm our ability to obtain new customers
and develop new products and could adversely affect our business
and operating results.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We have limited insurance which may not cover claims by third
parties against us or our officers and directors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have limited directors&#x2019; and officers&#x2019; liability
insurance and commercial liability insurance policies. Claims by
third parties against us may exceed policy amounts and we may not
have amounts to cover these claims. Any significant claims would
have a material adverse effect on our business, financial condition
and results of operations.&#xA0;&#xA0;In addition, our limited
directors&#x2019; and officers&#x2019; liability insurance may affect
our ability to attract and retain directors and
officers.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Our inability to effectively protect our intellectual property
would adversely affect our ability to compete effectively, our
revenue, our financial condition and our results of
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We rely on a combination of patent, trademark, and trade secret
laws, confidentiality procedures and licensing arrangements to
protect our intellectual property rights.</font> <font style="color: #000000; background-color: #FFFFFF">Obtaining and
maintaining a strong patent position is important to our business.
Patent law relating to the scope of claims in the technology fields
in which we operate is complex and uncertain, so we cannot be
assured that we will be able to obtain or maintain patent rights,
or that the patent rights we may obtain will be valuable, provide
an effective barrier to competitors or otherwise provide
competitive advantages. Others have filed, and in the future are
likely to file, patent applications that are similar or identical
to ours or those of our licensors. To determine the priority of
inventions, or demonstrate that we did not derive our invention
from another, we may have to participate in interference or
derivation proceedings in the USPTO or in court that could result
in substantial costs in legal fees and could substantially affect
the scope of our patent protection. We cannot be assured our patent
applications will prevail over those filed by others. Also, our
intellectual property rights may be subject to other challenges by
third parties. Patents we obtain could be challenged in litigation
or in administrative proceedings such as&#xA0;</font><font style="font-style: italic; color: #000000; background-color: #FFFFFF">ex&#xA0;parte&#xA0;</font><font style="color: #000000; background-color: #FFFFFF">reexam,&#xA0;</font><font style="font-style: italic; color: #000000; background-color: #FFFFFF">inter&#xA0;parties</font><font style="color: #000000; background-color: #FFFFFF">&#xA0;review,
or post grant review in the United States or opposition proceedings
in Europe or other jurisdictions.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">18</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
There can be no assurance that:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 1%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
any of our existing patents will continue to be held valid, if
challenged;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
patents will be issued for any of our pending
applications;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
any claims allowed from existing or pending patents will have
sufficient scope or strength to protect us;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
our patents will be issued in the primary countries where our
products are sold in order to protect our rights</font>
<font style="color: #000000">and potential commercial advantage;
or</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
any of our products or technologies will not infringe on the
patents of other companies.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
If we are enjoined from selling our products, or if we are required
to develop new technologies or pay significant monetary damages or
are required to make substantial royalty payments, our business and
results of operations would be harmed.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Obtaining and maintaining a patent portfolio entails significant
expense and resources. Part of the expense includes periodic
maintenance fees, renewal fees, annuity fees, various other
governmental fees on patents and/or applications due in several
stages over the lifetime of patents and/or applications, as well as
the cost associated with complying with numerous procedural
provisions during the patent application process. We may or may not
choose to pursue or maintain protection for particular inventions.
In addition, there are situations in which failure to make certain
payments or noncompliance with certain requirements in the patent
process can result in abandonment or lapse of a patent or patent
application, resulting in partial or complete loss of patent rights
in the relevant jurisdiction. If we choose to forgo patent
protection or allow a patent application or patent to lapse
purposefully or inadvertently, our competitive position could
suffer.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Legal actions to enforce our patent rights can be expensive and may
involve the diversion of significant management time. In addition,
these legal actions could be unsuccessful and could also result in
the invalidation of our patents or a finding that they are
unenforceable. We may or may not choose to pursue litigation or
interferences against those that have infringed on our patents, or
used them without authorization, due to the associated expense and
time commitment of monitoring these activities. If we fail to
protect or to enforce our intellectual property rights
successfully, our competitive position could suffer, which could
have a material adverse effect on our results of operations and
business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Claims by others that our products infringe their patents or other
intellectual property rights could prevent us from manufacturing
and selling some of our products or require us to pay royalties or
incur substantial costs from litigation or development of
non-infringing technology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In recent years, there has been significant litigation in the
United States involving patents and other intellectual property
rights. We may receive notices that claim we have infringed upon
the intellectual property of others. Even if these claims are not
valid, they could subject us to significant costs. Any such claims,
with or without merit, could be time-consuming to defend, result in
costly litigation, divert our attention and resources, cause
product shipment delays or require us to enter into royalty or
licensing agreements. Such royalty or licensing agreements, if
required, may not be available on terms acceptable to us or at all.
We have engaged in litigation and litigation may be necessary in
the future to enforce our intellectual property rights or to
determine the validity and scope of the proprietary rights of
others. Litigation may also be necessary to defend against claims
of infringement or invalidity by others. A successful claim of
intellectual property infringement against us and our failure or
inability to license the infringed technology or develop or license
technology with comparable functionality could have a material
adverse effect on our business, financial condition and operating
results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
If we are unable to secure a sales and marketing partner or
establish satisfactory sales and marketing capabilities at the Know
Labs parent Company level we may not be able to successfully
commercialize our technology.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
.. If we are not successful entering into appropriate collaboration
arrangements, or recruiting sales and marketing personnel or in
building a sales and marketing infrastructure, we will have
difficulty successfully commercializing our technology, which would
adversely affect our business, operating results and financial
condition.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">19</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We may not be able to enter into collaboration agreements on terms
acceptable to us or at all. In addition, even if we enter into such
relationships, we may have limited or no control over the sales,
marketing and distribution activities of these third parties. Our
future revenues may depend heavily on the success of the efforts of
these third parties. If we elect to establish a sales and marketing
infrastructure we may not realize a positive return on this
investment. In addition, we must compete with established and
well-funded pharmaceutical and biotechnology companies to recruit,
hire, train and retain sales and marketing personnel. Factors that
may inhibit our efforts to commercialize technology without
strategic partners or licensees include:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: #ffffff">
<td style="vertical-align: top; width: 1%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">our
inability to recruit and retain adequate numbers of effective sales
and marketing personnel;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: #ffffff">
<td style="vertical-align: top; width: 1%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">the
lack of complementary products to be offered by sales personnel,
which may put us at a competitive disadvantage relative to
companies with more extensive product lines; and</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: #ffffff">
<td style="vertical-align: top; width: 1%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">unforeseen
costs and expenses associated with creating an independent sales
and marketing organization.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Government regulatory approval may be necessary before some of our
products can be sold and there is no assurance such approval will
be granted.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
technology may have a number of potential applications in fields of
use which will require prior governmental regulatory approval
before the technology can be introduced to the marketplace. For
example, we are exploring the use of our technology for certain
medical diagnostic applications, with an initial focus on the
continuous monitoring of blood glucose.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">There
is no assurance that we will be successful in developing continuous
glucose monitoring (CGM) medical applications for our
technology.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If we
were to be successful in developing continuous glucose monitoring
medical applications of our technology, prior approval by the FDA
and other governmental regulatory bodies will be required before
the technology could be introduced into the
marketplace.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">There
is no assurance that such regulatory approval would be obtained for
a continuous glucose monitoring medical diagnostic or other
applications requiring such approval.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The FDA
can refuse to grant, delay, limit or deny approval of an
application for approval of our UBAND CGM for many
reasons.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We may
not obtain the necessary regulatory approvals or clearances to
market these continuous glucose monitoring systems in the United
States or outside of the United States.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Any
delay in, or failure to receive or maintain, approval or clearance
for our products could prevent us from generating revenue from
these products or achieving profitability.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Cybersecurity risks and cyber incidents could result in the
compromise of confidential data or critical data systems and give
rise to potential harm to customers, remediation and other
expenses, expose us to liability under HIPAA, consumer protection
laws, or other common law theories, subject us to litigation and
federal and state governmental inquiries, damage our reputation,
and otherwise be disruptive to our business and
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Cyber
incidents can result from deliberate attacks or unintentional
events. We collect and store on our networks sensitive information,
including intellectual property, proprietary business information
and personally identifiable information of our customers. The
secure maintenance of this information and technology is critical
to our business operations. We have implemented multiple layers of
security measures to protect the confidentiality, integrity and
availability of this data and the systems and devices that store
and transmit such data. We utilize current security technologies,
and our defenses are monitored and routinely tested internally and
by external parties. Despite these efforts, threats from malicious
persons and groups, new vulnerabilities and advanced new attacks
against information systems create risk of cybersecurity incidents.
These incidents can include, but are not limited to, gaining
unauthorized access to digital systems for purposes of
misappropriating assets or sensitive information, corrupting data,
or causing operational disruption. Because the techniques used to
obtain unauthorized access, disable or degrade service, or sabotage
systems change frequently and may not immediately produce signs of
intrusion, we may be unable to anticipate these incidents or
techniques, timely discover them, or implement adequate
preventative measures.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">20</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">These
threats can come from a variety of sources, ranging in
sophistication from an individual hacker to malfeasance by
employees, consultants or other service providers to
state-sponsored attacks. Cyber threats may be generic, or they may
be custom-crafted against our information systems. Over the past
several years, cyber-attacks have become more prevalent and much
harder to detect and defend against. Our network and storage
applications may be vulnerable to cyber-attack, malicious
intrusion, malfeasance, loss of data privacy or other significant
disruption and may be subject to unauthorized access by hackers,
employees, consultants or other service providers. In addition,
hardware, software or applications we develop or procure from third
parties may contain defects in design or manufacture or other
problems that could unexpectedly compromise information security.
Unauthorized parties may also attempt to gain access to our systems
or facilities through fraud, trickery or other forms of deceiving
our employees, contractors and temporary staff.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">There
can be no assurance that we will not be subject to cybersecurity
incidents that bypass our security measures, impact the integrity,
availability or privacy of personal health information or other
data subject to privacy laws or disrupt our information systems,
devices or business, including our ability to deliver services to
our customers. As a result, cybersecurity, physical security and
the continued development and enhancement of our controls,
processes and practices designed to protect our enterprise,
information systems and data from attack, damage or unauthorized
access remain a priority for us. As cyber threats continue to
evolve, we may be required to expend significant additional
resources to continue to modify or enhance our protective measures
or to investigate and remediate any cybersecurity
vulnerabilities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="font-style: italic; color: #000000">We may engage in
acquisitions, mergers, strategic alliances, joint ventures and
divestures that could result in final results that are different
than expected</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
In the normal course of business, we engage in discussions relating
to possible acquisitions, equity investments, mergers, strategic
alliances, joint ventures and divestitures. Such transactions are
accompanied by a number of risks, including the use of significant
amounts of cash, potentially dilutive issuances of equity
securities,</font>&#xA0;<font style="color: #000000">incurrence of
debt on potentially unfavorable terms as well as impairment
expenses related to goodwill and amortization expenses related to
other intangible assets, the possibility that we may pay too much
cash or issue too many of our shares as the purchase price for an
acquisition relative to the economic benefits that we ultimately
derive from such acquisition, and various potential difficulties
involved in integrating acquired businesses into our
operations.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
From time to time, we have also engaged in discussions with
candidates regarding the potential acquisitions of our product
lines, technologies and businesses. If a divestiture such as this
does occur, we cannot be certain that our business, operating
results and financial condition will not be materially and
adversely affected. A successful divestiture depends on various
factors, including our ability to effectively transfer liabilities,
contracts, facilities and employees to any purchaser; identify and
separate the intellectual property to be divested from the
intellectual property that we wish to retain; reduce fixed costs
previously associated with the divested assets or business; and
collect the proceeds from any divestitures.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
If we do not realize the expected benefits of any acquisition or
divestiture transaction, our financial position, results of
operations, cash flows and stock price could be negatively
impacted.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">21</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Our growth strategy depends in part on our ability to execute
successful strategic acquisitions. We have made strategic
acquisitions in the past and may do so in the future, and if the
acquired companies do not perform as expected, this could adversely
affect our operating results, financial condition and existing
business.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We may continue to expand our business through strategic
acquisitions. The success of any acquisition will depend on, among
other things:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">the
availability of suitable candidates;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">higher
than anticipated acquisition costs and expenses;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">competition
from other companies for the purchase of available
candidates;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">our
ability to value those candidates accurately and negotiate
favorable terms for those acquisitions;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">the
availability of funds to finance acquisitions and obtaining any
consents necessary under our credit facility;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">the
ability to establish new informational, operational and financial
systems to meet the needs of our business;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">the
ability to achieve anticipated synergies, including with respect to
complementary products or services; and</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">the
availability of management resources to oversee the integration and
operation of the acquired businesses.</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We may not be successful in effectively integrating acquired
businesses and completing acquisitions in the future. We also may
incur substantial expenses and devote significant management time
and resources in seeking to complete acquisitions. Acquired
businesses may fail to meet our performance expectations. If we do
not achieve the anticipated benefits of an acquisition as rapidly
as expected, or at all, investors or analysts may not perceive the
same benefits of the acquisition as we do. If these risks
materialize, our stock price could be materially adversely
affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We are subject to corporate governance and internal control
requirements, and our costs related to compliance with, or our
failure to comply with existing and future requirements could
adversely affect our business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We must comply with corporate governance requirements under the
Sarbanes-Oxley Act of 2002 and the Dodd&#x2013;Frank Wall Street
Reform and Consumer Protection Act of 2010, as well as additional
rules and regulations currently in place and that may be
subsequently adopted by the SEC and the Public Company Accounting
Oversight Board. These laws, rules, and regulations continue to
evolve and may become increasingly stringent in the future. The
financial cost of compliance with these laws, rules, and
regulations is expected to remain substantial.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our management has concluded that our disclosure controls and
procedures were not effective due to the lack of an audit committee
&#x201C;financial expert.&#x201D; We expect to appoint an additional
independent director to serve as Audit Committee Chairman. This
director will be an &#x201C;audit committee financial expert&#x201D;
as defined by the SEC. However, we cannot assure you that we will
be able to fully comply with these laws, rules, and regulations
that address corporate governance, internal control reporting, and
similar matters in the future. Failure to comply with these laws,
rules and regulations could materially adversely affect our
reputation, financial condition, and the value of our
securities.&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
The exercise prices of certain warrants, convertible notes payable
and the Series A, C, and D Preferred Shares may require further
adjustment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In the
future, if we sell our common stock at a price below $0.25 per
share, the exercise price <font style="color: #000000">of 1,785,715
outstanding shares of Series C Preferred Stock, 3,108,356
outstanding shares Series D Preferred Stock that adjust below $0.25
per share pursuant to the documents governing such instruments. In
addition, the conversion price of a Convertible Note Payable of
$2,255,066 (currently 9,020,264 at $0.25 per share) and the
exercise price of additional outstanding warrants to purchase
12,664,385 shares of common stock would adjust below $0.25 per
share pursuant to the documents governing such
instruments.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">22</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">
We are registering the following as part of the
Offering.</font><br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
(i) up to 2,121,258 shares (the "Investor Warrant Shares") of
common stock issuable upon the exercise of outstanding investor's
warrants (the "Investor Warrants") at an exercise price of $1.20
that were previously issued to the Selling Shareholders in
connection with the Notes Offering that closed in a series of
closings between February 15, 2019 and</font> May 28,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(ii)
542,102 shares of our common stock issuable upon the exercise of
outstanding placement agent warrants (the &#x201C;Placement Agent
Warrants&#x201D;) at an exercise price of $1.20 per share that were
previously issued to Boustead Securities, LLC and its assigns
(collectively &#x201C;Placement Agent&#x201D;) pursuant to the
Boustead Offering Engagement Agreement which provides that the
Placement Agent shall receive that certain number of warrants to
purchase the common stock of the Company equal to the number of
warrants issued under the 8% Unsubordinated Convertible Note
Offering (the &#x201C;Offering&#x201D;).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If we
sell our common stock at a price below $1.20, the exercise price of
the Investor and Placement Agent Warrants is adjusted.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Risks Relating to Our Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="font-style: italic; color: #000000">The price of our
common stock is volatile, which may cause investment losses for our
stockholders</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The market price of our common stock has been and is likely in the
future to be volatile. Our common stock price may fluctuate in
response to factors such as:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Announcements by us regarding liquidity,
significant acquisitions, equity investments and
divestitures,</font> <font style="color: #000000">strategic
relationships, addition or loss of significant customers and
contracts, capital expenditure</font> <font style="color: #000000">commitments and litigation;</font></font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of convertible or equity securities and related warrants for
general or merger and acquisition purposes;</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Issuance or repayment of debt, accounts payable or
convertible debt for general or merger and acquisition</font>
<font style="color: #000000">purposes;</font></font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Sale
of a significant number of shares of our common stock by
stockholders;</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">General
market and economic conditions;</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Quarterly
variations in our operating results;</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Investor
and public relation activities;</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Announcements
of technological innovations;</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">New
product introductions by us or our competitors;</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Competitive
activities; and</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Additions
or departures of key personnel.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
These broad market and industry factors may have a material adverse
effect on the market price of our common stock, regardless of our
actual operating performance. These factors could have a material
adverse effect on our business, financial condition and results of
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Transfers of our securities may be restricted by virtue of state
securities &#x201C;blue sky&#x201D; laws, which prohibit trading
absent compliance with individual state laws. These restrictions
may make it difficult or impossible to sell shares in those
states.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Transfers of our common stock may be restricted under the
securities or securities regulations laws promulgated by various
states and foreign jurisdictions, commonly referred to as
&#x201C;blue sky&#x201D; laws. Absent compliance with such individual
state laws, our common stock may not be traded in such
jurisdictions. Because the securities held by many of our
stockholders have not been registered for resale under the blue sky
laws of any state, the holders of such shares and persons who
desire to purchase them should be aware that there may be
significant state blue sky law restrictions upon the ability of
investors to sell the securities and of purchasers to purchase the
securities. These restrictions may prohibit the secondary trading
of our common stock. Investors should consider the secondary market
for our securities to be a limited one.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">23</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="font-style: italic; color: #000000">Three individual
investors could have significant influence over matters submitted
to stockholders for approval</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As of March 31, 2019, four individuals in the aggregate, assuming
the exercise of all warrants to purchase common stock, hold shares
representing approximately 54% of our common stock on a
fully-converted basis and could be considered a control group for
purposes of SEC rules. However, the agreement with one of these
individuals limits his ownership to 4.99% individually. Beneficial
ownership includes shares over which an individual or entity has
investment or voting power and includes shares that could be issued
upon the exercise of options and warrants within 60 days after the
date of determination. If these persons were to choose to act
together, they would be able to significantly influence all matters
submitted to our stockholders for approval, as well as our
officers, directors, management and affairs. For example, these
persons, if they choose to act together, could significantly
influence the election of directors and approval of any merger,
consolidation or sale of all or substantially all of our assets.
This concentration of voting power could delay or prevent an
acquisition of us on terms that other stockholders may
desire.</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
The sale of a significant number of our shares of common stock
could depress the price of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Sales or issuances of a large number of shares of common stock in
the public market or the perception that sales may occur could
cause the market price of our common stock to decline.</font>
<font style="color: #000000">As of March 31, 2019, we had
22,002,904 shares of common stock issued and outstanding, held by
122 stockholders of record. The number of stockholders, including
beneficial owners holding shares through nominee names, is
approximately 2,300. Each share of common stock entitles its holder
to one vote on each matter submitted to the stockholders for a
vote, and no cumulative voting for directors is
permitted.&#xA0;&#xA0;Stockholders do not have any preemptive
rights to acquire additional securities issued by us.&#xA0;&#xA0;As
of March 31, 2019, there were options outstanding for the purchase
of 2,282,668 common shares, warrants for the purchase of 17,572,583
common shares, and 4,894,071&#xA0;shares of the Company&#x2019;s
common stock issuable upon the conversion of Series A, Series C and
Series D Convertible Preferred Stock. In addition, the Company has
an unknown number of shares (9,020,264 common shares at the current
price of $0.25 per share) are issuable upon conversion of
convertible debentures of $2,255,066. All of which could
potentially dilute future earnings per share.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Significant shares of common stock are held by our principal
stockholders, other company insiders and other large stockholders.
As &#x201C;affiliates&#x201D; of Know Labs, as defined under
Securities and Exchange Commission Rule 144 under the Securities
Act of 1933, our principal stockholders, other of our insiders and
other large stockholders may only sell their shares of common stock
in the public market pursuant to an effective registration
statement or in compliance with Rule 144.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
These options, warrants, convertible notes payable and convertible
preferred stock could result in further dilution to common
stockholders and may affect the market price of the common
stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">Future issuance of</font> <font style="color: #000000; background-color: #FFFFFF">additional shares of
common stock and/or preferred stock could dilute existing
stockholders.</font> <font style="color: #000000">We have and may
issue preferred stock that could have rights that are preferential
to the rights of common stock that could discourage potentially
beneficially transactions to our common
stockholders.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Pursuant to our certificate of incorporation, we currently have
authorized 100,000,000 shares of common stock and 5,000,000 shares
of preferred stock. To the extent that common shares are available
for issuance, subject to compliance with applicable stock exchange
listing rules, our board of directors has the ability to issue
additional shares of common stock in the future for such
consideration as the board of directors may consider sufficient.
The issuance of any additional securities could, among other
things, result in substantial dilution of the percentage ownership
of our stockholders at the time of issuance, result in substantial
dilution of our earnings per share and adversely affect the
prevailing market price for our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
An issuance of additional shares of preferred stock could result in
a class of outstanding securities that would have preferences with
respect to voting rights and dividends and in liquidation over our
common stock and could, upon conversion or otherwise, have all of
the rights of our common stock.&#xA0;&#xA0;Our Board of
Directors&#x2019; authority to issue preferred stock could
discourage potential takeover attempts or could delay or prevent a
change in control through merger, tender offer, proxy contest or
otherwise by making these attempts more difficult or costly to
achieve.&#xA0;&#xA0;The issuance of preferred stock could impair
the voting, dividend and liquidation rights of common stockholders
without their approval.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">24</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Future capital raises may dilute our existing stockholders&#x2019;
ownership and/or have other adverse effects on our
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If we
raise additional capital by issuing equity securities, our existing
stockholders&#x2019; percentage ownership will be reduced and these
stockholders may experience substantial dilution. We may also issue
equity securities that provide for rights, preferences and
privileges senior to those of our common stock. If we raise
additional funds by issuing debt securities, these debt securities
would have rights senior to those of our common stock and the terms
of the debt securities issued could impose significant restrictions
on our operations, including liens on our assets. If we raise
additional funds through collaborations and licensing arrangements,
we may be required to relinquish some rights to our technologies or
candidate products, or to grant licenses on terms that are not
favorable to us.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
We do not anticipate paying any cash dividends on our capital stock
in the foreseeable future.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have never declared or paid cash dividends on our capital stock.
We currently intend to retain all of our future earnings, if any,
to finance the growth and development of our business, and we do
not anticipate paying any cash dividends on our capital stock in
the foreseeable future. In addition, the terms of any future debt
agreements may preclude us from paying dividends. As a result,
capital appreciation, if any, of our common stock will be your sole
source of gain for the foreseeable future.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Anti-takeover provisions may limit the ability of another party to
acquire our company, which could cause our stock price to
decline.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our certificate of incorporation, as amended, our bylaws and Nevada
law contain provisions that could discourage, delay or prevent a
third party from acquiring our company, even if doing so may be
beneficial to our stockholders. In addition, these provisions could
limit the price investors would be willing to pay in the future for
shares of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Our articles of incorporation allow for our board to create new
series of preferred stock without further approval by our
stockholders, which could adversely affect the rights of the
holders of our common stock; our Series A Preferred Stock contains
provisions that restrict our ability to take certain actions
without the consent of at least 66% of the Series A Preferred Stock
then outstanding.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our Board of Directors has the authority to fix and determine the
relative rights and preferences of preferred stock. Our Board of
Directors also has the authority to issue preferred stock without
further stockholder approval. As a result, our Board of Directors
could authorize the issuance of a series of preferred stock that
would grant to holders the preferred right to our assets upon
liquidation, the right to receive dividend payments before
dividends are distributed to the holders of common stock and the
right to the redemption of the shares, together with a premium,
prior to the redemption of our common stock. In addition, our Board
of Directors could authorize the issuance of a series of preferred
stock that has greater voting power than our common stock or that
is convertible into our common stock, which could decrease the
relative voting power of our common stock or result in dilution to
our existing stockholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In addition, our articles of incorporation restrict our ability to
take certain actions without the approval of at least 66% of the
Series A Preferred Stock then outstanding. These actions include,
among other things;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">authorizing,
creating, designating, establishing or issuing an increased number
of shares of Series A Preferred Stock or any other class or series
of capital stock ranking senior to or on a parity with the Series A
Preferred Stock;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">adopting
a plan for the liquidation, dissolution or winding up the affairs
of our company or any recapitalization plan (whether by merger,
consolidation or otherwise);</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">amending,
altering or repealing, whether by merger, consolidation or
otherwise, our articles of incorporation or bylaws in a manner that
would adversely affect any right, preference, privilege or voting
power of the Series A Preferred Stock; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">declaring
or paying any dividend (with certain exceptions) or directly or
indirectly purchase, redeem, repurchase or otherwise acquire any
shares of our capital stock, stock options or convertible
securities (with certain exceptions).</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">25</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000"><a name="SPECIALNOTE">S</a>P</font>ECIAL NOTE REGARDING FORWARD-LOOKING
STATEMENTS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
prospectus includes statements that are, or may be deemed,
"forward-looking statements." In some cases, these forward-looking
statements can be identified by the use of forward-looking
terminology, including the terms "believes", "estimates",
"anticipates", "expects", "plans", "intends", "may", "could",
"might", "will", "should", "approximately" or, in each case, their
negative or other variations thereon or comparable terminology,
although not all forward-looking statements contain these words.
They appear in a number of places throughout this prospectus and
include statements regarding our intentions, beliefs, projections,
outlook, analyses or current expectations concerning, among other
things, our ongoing and planned exploration activities, our results
of operations, financial condition, liquidity, prospects, growth
and strategies, the length of time that we will be able to continue
to fund our operating expenses and capital expenditures, our
expected financing needs and sources of financing, the industry in
which we operate and the trends that may affect the industry or
us.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By
their nature, forward-looking statements involve risks and
uncertainties because they relate to events, competitive dynamics,
and <font style="color: #000000">technologies which are capable of
uniquely authenticating or diagnosing</font> market developments
and depend on the economic circumstances that may or may not occur
in the future or may occur on longer or shorter timelines than
anticipated. Although we believe that we have a reasonable basis
for each forward-looking statement contained in this prospectus, we
caution you that forward-looking statements are not guarantees of
future performance and that our actual results of operations,
financial condition and liquidity, and the development of the
industry in which we operate may differ materially from the
forward-looking statements contained in this prospectus. In
addition, even if our results of operations, financial condition
and liquidity, and the development of the industry in which we
operate are consistent with the forward-looking statements
contained in this prospectus, they may not be predictive of results
or developments in future periods.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Any
forward-looking statements that we make in this prospectus speak
only as of the date of such statement, and we undertake no
obligation to update such statements to reflect events or
circumstances after the date of this prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">You
should also read carefully the factors described in the "Risk
Factors" section of this prospectus to better understand the risks
and uncertainties inherent in our business and underlying any
forward-looking statements. As a result of these factors, we cannot
assure you that the forward-looking statements in this prospectus
will prove to be accurate. Furthermore, if our forward-looking
statements prove to be inaccurate, the inaccuracy may be material.
In light of the significant uncertainties in these forward-looking
statements, you should not regard these statements as a
representation or warranty by us or any other person that we will
achieve our objectives and plans in any specified timeframe, or at
all. We disclaim any obligation to update or revise any
forward-looking statement as a result of new information, future
events or for any other reason.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">26</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
<a name="USEOFPROCEEDS">U</a>SE OF
PROCEEDS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are not selling any shares of our common stock in this offering
and, as a result, we will not receive any proceeds from the sale of
the common stock covered by this prospectus.&#xA0;All of the net
proceeds from the sale of our common stock will go to the Selling
Stockholders. Upon exercise of the Series F Warrants, however, we
will receive up to $0.25 per share or such lower price as may
result from the anti-dilution protection features of such warrants.
Upon exercise of the Private Placement and Placement Agent
Warrants, however, we will receive up to $1.20 per share or such
lower price as may result from the anti-dilution protection
features of such warrants The Warrants may expire without having
been exercised. Even if some or all of these Warrants are
exercised, we cannot predict when they will be exercised and when
we would receive the proceeds. Any proceeds received from the
exercise of such warrants will be used for general working capital
and other corporate purposes. See &#x201C;Selling Security
Holders&#x201D; and &#x201C;Plan of Distribution.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
With the exception of any brokerage fees and commissions which are
the respective obligations of the Selling Stockholders, we are
responsible for the fees, costs and expenses of this Registration
Statement, which includes our legal and accounting fees, printing
costs, and filing and other miscellaneous fees and
expenses.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="PRICERANGEOFOURCOMMONSTOCK">P</a>RICE RANGE OF OUR COMMON
STOCK</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
common stock is currently quoted on the OTCQB under the symbol
"KNWN". The following table sets forth the range of the high and
low sale prices of the common stock for the periods indicated. The
quotations reflect inter-dealer prices, without retail markup,
markdown or commission, and may not represent actual transactions.
Consequently, the information provided below may not be indicative
of our common stock price under different conditions.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Trades
in our common stock may be subject to Rule 15g-9 of the Exchange
Act, which imposes requirements on broker/dealers who sell
securities subject to the rule to persons other than established
customers and accredited investors. For transactions covered by the
rule, broker/dealers must make a special suitability determination
for purchasers of the securities and receive the purchaser&#x2019;s
written agreement to the transaction before the sale.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Period
Ended</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-weight:bold;font-family:Times New Roman;color:#000;">High</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-weight:bold;font-family:Times New Roman;color:#000;">Low</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Year Ending September 30, 2019</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Through
May 30, 2019</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2.00</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.26</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">March
31, 2019</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2.97</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.90</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">December
31, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.44</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.85</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Year Ending September 30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">September
30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5.71</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.62</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">June
30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.65</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.24</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">March
31, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.36</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.21</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">December
31, 2017</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.44</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.20</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Year Ending September 30, 2017</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">September
30, 2017</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.25</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.11</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">June
30, 2017</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.70</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.23</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">March
31, 2017</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.99</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.54</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">December
31, 2016</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.44</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.66</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">As of
May 29, 2019, the high and low sales price of our common stock was
$1.52 per share and $1.54 per share, respectively. As of May 30,
2019, there were <font style="color: #000000">22,435,464</font>
shares of common stock outstanding held by approximately 117
stockholders of record. This number does not include approximately
2,300 beneficial owners whose shares are held in the names of
various security brokers, dealers and registered clearing
agencies.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">27</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="DIVIDENDPOLICY">D</a>IVIDEND
POLICY</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
never declared or paid any cash dividends on our common stock and
intend, for the foreseeable future, to retain any future earnings
to finance the growth and development of our business. Our future
dividend policy will be determined by our Board of Directors on the
basis of various factors, including our results of operations,
financial condition, capital requirements and investment
opportunities.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="CAPITALIZATION">C</a>APITALIZATION</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following table sets forth our cash and cash equivalents and
capitalization as of March 31, 2019 and on a pro forma basis to
give effect to this offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
thousands, except for share and per share data</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="display: table; margin-left: 24px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">(1)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Pro Forma balances
include the issuance of the following:</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(i)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 4,242,515 shares of common stock underlying the principal amount
of registrants 8% Unsubordinated Convertible Notes
(&#x201C;Principal Shares&#x201D;)</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(ii)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 339,401 shares of common
stock</font> issuable by the registrant upon the conversion of
interest accrued under the <font style="color: #000000">8%
Unsubordinated Convertible Notes (&#x201C;Interest Shares&#x201D;)
(The Principal Shares and Interest Shares are referred to
collectively as the &#x201C;Shares&#x201D;).</font></font> </div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(iii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 2,121,258 shares (the "Investor Warrant Shares") of common stock
issuable upon the exercise outstanding investor's warrants (the
"Investor Warrants") at an exercise price of $1.20 that were
previously issued to the Selling Shareholders in connection with 8%
Unsubordinated Convertible Notes offering that closed in a series
of closings between February 15, 2019 and May 28,
2019.</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">(iv)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">542,102
shares of our common stock issuable upon the exercise of
outstanding Placement Agent Warrants at an exercise price of $1.20
per share that were previously issued to Boustead Securities, LLC
and its assigns.</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(v)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 3,108,356 shares of common stock underlying
the outstanding Series D</font> <font style="color: #000000">Convertible Preferred Stock which is convertible
at any time at an initial conversion price of $0.25 per share of
our common stock subject to adjustment for certain events
(&#x201C;Series D Shares&#x201D;). There are currently 3,108,356
common shares estimated to underlying the 1,016,004 issued and
outstanding Series D Shares.</font></font></font>
</font> </div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(vi)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to
3,984,000 shares <font style="color: #000000">of common stock
issuable upon conversion of outstanding Series F Warrants at an
exercise price of $0.25 per share that were previously issued to
one of the Selling Shareholders in connection with Preferred Stock
and Warrant Purchase Agreement dated November 10, 2016
(&#x201C;Series F Warrant Shares&#x201D;).</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">You
should read this table together with the sections entitled "Summary
Financial Data" and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" and our financial
statements and the related notes included elsewhere in this
prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(2)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">The number of
shares of our common stock outstanding before this offering is
based on&#xA0;<font style="color: #000000">22,435,464</font> shares
of our common stock outstanding as of&#xA0;May 30, 2019, and
excludes, as of that date:</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">2,437,668&#xA0;shares
of our common stock issuable upon the exercise of outstanding stock
options outstanding at a weighted-average exercise price of
$1.744&#xA0;per share;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">An
unknown number of shares&#xA0;of our common stock issuable upon the
conversion of $2,255,066 of Convertible Notes Payable <font style="color: #000000">(currently 9,020,264 at $0.25 per
share)</font>;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">547,332&#xA0;additional
shares of our common stock available for future issuance under our
2011 Stock Incentive Plan;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">28</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">1,785,714 shares of
our common stock issuable upon the conversion of Series C
Convertible Preferred Stock, at an exercise price of $0.25, subject
to certain adjustments. These shares of common stock are being
registered in this offering; and</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">3,108,356 shares of
our common stock issuable upon the conversion of Series D
Convertible Preferred Stock, at an exercise price of $0.25, subject
to certain adjustments.</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">17,837,090 warrants
to purchase shares of our common stock at an exercise price of
$0.454 subject to certain adjustments.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The pro
forma information discussed above is to illustrate only and will
change based on the actual public offering price, number of shares
and other terms of this offering determined in
pricing.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="DILUTION">D</a>ILUTION</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
If you invest in our common stock in this offering, your ownership
interest will be immediately diluted to the extent of the
difference between the public offering price per share of our
common stock and the pro forma as adjusted net tangible book value
per share of our common stock immediately after this
offering.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our historical net tangible book value deficit of ($0.___) is the
amount of our total tangible assets less our total liabilities as
of March 31, 2019. Net historical tangible book value (deficit) per
share of ($_________) is our historical net tangible book value
deficit divided by 22,002,904 shares of common stock outstanding as
of March 31, 2019.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Pro forma as adjusted net book value is our pro forma net tangible
book value (deficit), after giving effect to the sale of shares of
our common stock by the Selling Stockholders in this offering at a
public offering price of $0.25 and $1.00. Our pro forma as adjusted
net book value as of March 31, 2019, after giving effect to this
offering would have been approximately ($_________), or ($0.___)
per share. This amount represents an immediate increase in pro
forma as adjusted net tangible book value of $0.__) per share to
our existing stockholders, and an immediate dilution of $0.___ per
share to new investors participating in this offering. Dilution per
share to new investors is determined by subtracting pro forma as
adjusted net tangible book value per share after this offering from
the public offering price per share paid by new
investors.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-size: 13px; font-family: Times New Roman">
The following table illustrates this dilution on a per share
basis:&#xA0;</font></div>
<div>&#xA0; <font style="font-family: Times New Roman; font-size: 10"><br></font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr style="background-color:#cceeff;">
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Assumed
public offering price per share</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;Pro
forma net tangible book value per share as of March 31,
2019</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;Increase
in net tangible book value per share attributable to this
offering</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Pro
forma as adjusted net tangible book value per share after this
offering</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Amount
of dilution in net tangible book value per share to new investors
in this offering</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
number of shares of our common stock outstanding before this
offering is based on&#xA0;<font style="color: #000000">22,435,464</font> shares of our common stock
outstanding as of&#xA0;May 30, 2019, and excludes, as of that
date:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">2,437,668&#xA0;shares
of our common stock issuable upon the exercise of outstanding stock
options outstanding at a weighted-average exercise price of
$1.744&#xA0;per share;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">An
unknown number of shares&#xA0;of our common stock issuable upon the
conversion of $2,255,066 of Convertible Notes Payable <font style="color: #000000">(currently 9,020,264 at $0.25 per
share)</font>;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">547,332&#xA0;additional
shares of our common stock available for future issuance under our
2011 Stock Incentive Plan;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">1,785,714 shares of
our common stock issuable upon the conversion of Series C
Convertible Preferred Stock, at an exercise price of $0.25, subject
to certain adjustments. These shares of common stock are being
registered in this offering; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">3,108,356 shares of
our common stock issuable upon the conversion of Series D
Convertible Preferred Stock, at an exercise price of $0.25, subject
to certain adjustments.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">17,837,090 warrants
to purchase shares of our common stock at an exercise price of
$0.454 subject to certain adjustments.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">29</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We may
choose to raise additional capital through the sale of equity or
convertible debt securities due to market conditions or strategic
considerations even if we believe we have sufficient funds for our
current or future operating plans. To the extent that any of these
options or warrants are exercised, new options are issued under our
equity incentive plans or we issue additional shares of common
stock or other equity securities in the future, there may be
further dilution to new investors participating in this
offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="SELLINGSECURITYHOLDERS">S</a>ELLING SECURITY HOLDERS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
This prospectus covers the resale by our Selling Stockholders of
14,337,632 shares of common stock,
including:</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px;">(i)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 4,242,515 shares of common stock underlying the principal, and
up to 339,401 shares underlying the interest accrued,
of registrants Notes</font> </div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px;">(ii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 2,121,258 shares of common stock issuable
upon the exercise of outstanding Investor's Warrants at an exercise
price of $1.20 that were previously issued to the Selling
Shareholders in connection with the Notes Offering that closed in a
series of closings between February 15, 2019</font> and May 28,
2019.</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px;">(iii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">542,102
shares of our common stock issuable upon the exercise of
outstanding Placement Agent Warrants at an exercise price of $1.20
per share that were previously issued to Boustead Securities, LLC
and its assigns pursuant to the Offering</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px;">(iv)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 3,108,356 shares of common stock underlying
the outstanding Series D</font> <font style="color: #000000">Convertible Preferred Stock which is convertible
at any time at an initial conversion price of $0.25 per share of
our common stock subject to adjustment for certain events
(&#x201C;Series D Shares&#x201D;). There are currently 3,108,356
common shares estimated to underlying the 1,016,004 issued and
outstanding Series D Shares.</font></font></font>
</font> </div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 48px;">
<font style="font-family: Times New Roman; font-size: 13px;">(v)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to
3,984,000 shares of common stock issuable upon conversion of
outstanding Series F Warrants at an exercise price of $0.25 per
share, subject to certain adjustments, that were previously issued
to one of the Selling Shareholders in connection with Preferred
Stock and Warrant Purchase Agreement dated November 10,
2016</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are registering these securities in order to permit the Selling
Stockholders to dispose of its shares of common stock from time to
time. The Selling Stockholders may decide to sell all, some, or
none of the securities listed below. &#xA0;&#xA0;See the section
entitled &#x201C;Plan of Distribution.&#x201D; &#xA0;We cannot
provide an estimate of the number of our securities that the
Selling Stockholders will hold in the future. For purposes of this
table, beneficial ownership is determined in accordance with the
rules of the SEC, and includes voting power and investment power
with respect to such securities.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The Selling Stockholders has had no material relationship with us
or our affiliates during the last three years, other than as a
purchaser of the Notes, Warrants, and Series D Shares and Series F
Warrants from us in the Offering and private placement,
respectively. <font style="color: #212121; font-family: Times New Roman; font-size: 13px">Information
regarding prior securities transactions between the issuer (or any
of its predecessors) and the Selling Shareholders, any affiliates
of the Selling Shareholders, or any person with whom any Selling
Shareholder has a contractual relationship regarding the
transaction (or any predecessors of those persons) is set forth
below the Selling Stockholders table.</font> To our
knowledge, none of the Selling Stockholders are a
registered broker-dealer or an affiliate of a broker-dealer</font>
, with the exception of the Placement Agent, Boustead Securities,
LLC and their assigns. <font style="font-family: Times New Roman; font-size: 13px">All securities
offered by an affiliate of a broker-dealer were purchased by the
seller in the ordinary course of business, and, at the time of the
purchase of the securities to be resold, the seller had no
agreements or understandings, directly or indirectly, with any
person to distribute the securities.</font></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The table below lists the Selling Stockholders and other
information regarding the beneficial ownership of the shares of
common stock by the Selling Stockholders. Column B lists the number
of shares of common stock beneficially owned by the Selling
Stockholders prior to this offering. Column C lists the shares of
common stock covered by this prospectus that may be disposed of by
the Selling Stockholders. Column D lists the warrant shares covered
by this prospectus that may be disposed of by the Selling
Stockholders. Column E lists the number of Placement Agent Warrants
that will be beneficially owned by the Selling Stockholders
assuming all of the shares covered by this prospectus are sold.
Column F lists the number of shares of common stock that will be
beneficially owned by the Selling Stockholders assuming all of the
shares covered by this prospectus are sold. Column G lists the
percentage of shares of common stock that will be beneficially
owned by the Selling Stockholders assuming all of the shares
covered by this prospectus are sold.&#xA0;&#xA0;Beneficial
ownership has been determined in accordance with Rule 13d-3 under
the Exchange Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">30</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:40%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-weight: bold; font-size: 11px;"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-weight: bold;">
Name of Selling Shareholder (A)</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Securities</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Beneficially</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Owned Prior to</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
this</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Offering (B)</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Securities</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Being</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Offered (C)</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Warrant</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Being</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Offered (C)</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Placement</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Agent</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Warrants (D)</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Securities</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Beneficially</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Owned After</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Offering (E)</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
% Beneficial</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Ownership</font> <font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
After Offering (F)</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="text-decoration: underline">Series D Preferred
Stock</font></font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Clayton
A. Struve</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">800,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">3,108,356</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">3,984,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">800,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2.7</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">%</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="text-decoration: underline">Private
Placement</font></font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Vijay
Panikar</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ritesh
Ramesh Sangavi</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Mark
Swaim</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">F
Geddes &amp; S Geddes TTEE Geddes Revocable Trust U/A DTD / F.
Michael Geddes</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Howard
Miller</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">75,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">37,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Jerry
Yang</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">K.
H. Krueger</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">John
Levinsohn</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">75,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">37,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Les
Walter</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Robert
H Stewart</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Joshua
Miksanek</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">30,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">15,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Joseph
W &amp; Patricia G Abrams Family Trust dtd 3/15/1995 / Joseph
Abrams</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Daniel
Cassinelli</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Karl
L Matthies Trust / Karl Matthies</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">300,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">150,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ronald
Oh</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Norman
G Glassman</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Caesar
Capital Group, LLC / Michael Woloshin</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Jon
D and Linda W Gruber Trust</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">700,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">350,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">David
S Nagelberg 2003 Revocable Trust / David
Nagelberg</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Hank
Bannister</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Pensco
Trust, LLC FBO Brian G. Swift Roth IRA</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Potter
Family Trust / Bruce Potter</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">300,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">150,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stephen
Kircher, Scott Kircher JT TEN</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stephen
Kircher, Douglas Kircher JT TEN</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Kircher
Family Trust</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Terry
F and Sandra L Walker</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Eight
Family Trust, Walter Bilofsky, TTEE u/t/a dtd 11/8/99 / Walter
Bilofsky</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Dean
Delis</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Intracostal
Capital LLC / Keith Goodman</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">125,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">62,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Warberg
WF VII, LP / Daniel Warsh</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Bradley
E Sparks</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Kenan
S Block</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,015</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,508</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Daniel
Block</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Steven
Machtinger</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">10,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Jody
Burnham</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Clayton
A. Struve</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">800,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,000,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">500,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">800,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3.5</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ritesh
R Sanghavi</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">David
W Zenk</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Kenneth
Followwill</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Sulinder
Singh Binning</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Marc
R Jalbert</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">35,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">17,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Thomas
Hughes</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Josh
Jacobs</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">6,250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Robert
J Lamoreaux</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Michael
Hoffman</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Srikanth
Tummala</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Boustead
Securities LLC</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">164,985</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Garden
State Securities Inc</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">24,750</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ernest
Pellegrino</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">37,125</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Terry
Brodt</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">37,125</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Peter
Conley</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">176,102</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Brian
Swift</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">71,610</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Michael
Jacks</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">11,550</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Brinson
Lingenfelter</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">18,855</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
Private Placement</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">800,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">4,242,515</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,121,258</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">542,102</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">800,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Interest
expense</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">339,401</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Grand
Total</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">800,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">7,690,272</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">6,105,258</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">542,102</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">800,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:40%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
being registered</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family: Times New Roman; vertical-align: bottom; font-size: 13px; display: inline-block; width: 5%; padding-bottom: 4px;">&#xA0;</font><font style="text-align: right; font-family: Times New Roman; vertical-align: bottom; font-size: 13px; display: inline-block; width: 75%; padding-bottom: 4px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family: Times New Roman; vertical-align: bottom; font-size: 13px; display: inline-block; width: 5%; padding-bottom: 4px;">&#xA0;</font><font style="text-align: right; font-family: Times New Roman; vertical-align: bottom; font-size: 13px; display: inline-block; width: 75%; padding-bottom: 4px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">13,795,530</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">542,102</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">14,337,632</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family: Times New Roman; vertical-align: bottom; font-size: 13px; display: inline-block; width: 5%; padding-bottom: 4px;">&#xA0;</font><font style="text-align: right; font-family: Times New Roman; vertical-align: bottom; font-size: 13px; display: inline-block; width: 75%; padding-bottom: 4px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;&#xA0;*Less than 1% ownership.&#xA0;</font></div>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">31</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #212121">The price of the Company&#x2019;s common stock on
the date the Selling Shareholders acquired</font><font style="font-style: italic; text-decoration: underline; color: #212121">&#xA0;</font>securities
by which they can acquire the offered common stock was as
follows:</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div> </div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">(i)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">the offering price
of the 8% convertible notes, warrants and related securities issued
between January 31, 2019 and May 2019, was set at approximately
$1.00 per share which was the closing price of the Company&#x2019;s
common stock as of January 31, 2019 (the date the offering
commenced). The average closing stock price between January 31,
2019 and May 31, 2019 was approximately $1.57,
and</font> </div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; text-indent: 0px; margin-right: 0px;"> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="text-align: left; margin-left: 48px; text-indent: 0px; margin-right: 0px;"> </div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">(ii)</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">the Series D
Preferred Stock and Series F Warrants were acquired on November 10,
2016 at a stated value of $0.80 per share; the closing price of the
common stock on the date before the agreement was executed was
$1.33 per share.</font> </div>
</div>
</div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">With the exception
of the $361,401 fee paid to Boustead Securities and their
affiliates or assign, no cash fee was paid to the Selling
Shareholders owning the 8% convertible notes, warrants and related
securities, nor the Selling Stockholder owning the Series D
Preferred Stock and Series F Warrants.</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The 8% notes and
warrants will be adjusted proportionately in the event of
dividends, splits, or other reclassifications. With respect to the
conversion and exercise price adjustments for events requiring
adjustments, pursuant to Section 5(a) of the Series D Preferred
Stock, the conversion price will be adjusted proportionately in the
event of dividends in shares, stock splits, or other
reclassifications, and pursuant to Section 5(b) will be adjusted
downwards to match a conversion, exchange or exercise price per
share offered by the Company to another party which is less than
the Conversion Price of the Series D Preferred immediately in
effect prior to such sale or issuance. The stated value of the
Series D Preferred Stock is currently $0.70 per
share.</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #212121; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Information regarding prior securities transactions between the
issuer and Selling Stockholders:</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="text-decoration: underline; color: #212121; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Garden State Securities, Inc.</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #212121; font-family: Times New Roman; font-size: 13px">The
Company issued the following warrants for the issuance of common
stock to Garden State Securities, Inc. or its employees related to
the Clayton A. Struve transactions detailed
below.</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #212121; font-family: Times New Roman; font-size: 13px">Convertible
Promissory Notes, Series C and D Preferred Stock and related
warrants- warrants for the purchase of 837,901 common shares
exercisable at $0.25 per share.</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #212121; font-family: Times New Roman; font-size: 13px">Private
placement being registered- warrants for the purchase of 99,000
shares of common stock exercisable at $1.20 per
share.</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #212121; font-family: Times New Roman; font-size: 13px">None
of the Garden State Securities, Inc. shares have been previously
registered. On March 28, 2019, 10,610 shares of common stock were
issued to an employee of Garden State Securities, Inc. related to
the exercise of a warrant.</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="text-decoration: underline; color: #212121; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Clayton A. Struve</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #212121; font-family: Times New Roman; font-size: 13px">The
Company has engaged in transactions with Mr. Struve, the Preferred
D holder, since approximately 2016. The following is a summary of
transactions with Mr. Struve:</font> </div>
<div> <font style="font-family: Times New Roman; font-size: 10">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Convertible Promissory Note dated September 30,
2016</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">On September 30, 2016, the Company entered into a
$210,000 Convertible Promissory Note with Clayton A. Struve, an
accredited investor of the Company, to fund short-term working
capital. The Convertible Promissory Note accrued interest at a rate
of 10% per annum and was due on March 30, 2017. The Note holder can
convert the Note into common stock at $0.70 per share. During the
year ended September 30, 2017, the Company recorded interest of
$21,000 related to the convertible note. This note was extended in
the Securities Purchase Agreement, General Security Agreement and
Subordination Agreement dated August 14, 2017 with a maturity date
of August 13, 2018. Also, the conversion price of the Debenture was
adjusted to $0.25 per share, subject to certain adjustments. The
balance was increased $75,000 during the year ended September 30,
2018.</font> On November 16, 2018, we signed Amendment 1 to Senior
Secured Convertible Redeemable Notes dated September 30,
2016extending the due dates of the Note to February 27, 2019. On
September 24, 2018, Mr. Struve converted $200,000 of the Note into
800,000 shares of our common stock. <font style="color: #000000">The Company recorded accrued interest of $54,671
as of September 30, 2018.</font></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-style: italic; font-family: Times New Roman; font-size: 13px">
Series C and D Preferred Stock and Warrants</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On August 5, 2016,
the Company closed a Series C Preferred Stock and Warrant Purchase
Agreement with Clayton A. Struve, an accredited investor for the
purchase of $1,250,000 of preferred stock with a conversion price
of $0.70 per share. The preferred stock has a yield of 8% and an
ownership blocker of 4.99%. In addition, Mr. Struve received a
five-year warrant to acquire 1,785,714 shares of common stock at
$0.70 per share. <font style="color: #212121">These were registered
via Form S-1 as amended by Post Effective Amendment made effective
August 21, 2018. No shares have been sold by the Selling
Shareholder.</font></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">32</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">To determine the
effective conversion price, a portion of the proceeds received by
the Company upon issuance of the Series C Preferred Stock was first
allocated to the freestanding warrants issued as part of this
transaction. Given that the warrants will not subsequently be
measured at fair value, the Company determined that the warrants
should receive an allocation of the proceeds based on their
relative fair value. This is based on the understanding that the
FASB staff and the SEC staff believe that a freestanding instrument
issued in a basket transaction should be initially measured at fair
value if it is required to be subsequently measured at fair value
pursuant to US generally accepted accounting principles
(&#x201C;GAAP&#x201D;), with the residual proceeds from the
transaction allocated to any remaining instruments based on their
relative fair values. As such, the warrants were allocated a fair
value of approximately $514,706 upon issuance, with the remaining
$735,294 of proceeds allocated to the Series C Preferred
Stock.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Proportionately,
this allocation resulted in approximately 59% of the face amount of
the Series C Preferred Stock issuance remaining, which applied to
the stated conversion price of $0.70 resulted in an effective
conversion price of approximately $0.41.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Having determined
the effective conversion price, the Company then compared this to
the fair value of the underlying Common Stock as of the commitment
date, which was approximately $1.06 per share, and concluded that
the conversion feature did have an intrinsic value of $0.65 per
share. As such, the Company concluded that the Series C Preferred
Stock did contain a beneficial conversion feature and an accounting
entry and additional financial statement disclosure was
required.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Because our
preferred stock is perpetual, with no stated maturity date, and the
conversions may occur any time from inception, the dividend is
recognized immediately when a beneficial conversion exists at
issuance. During the year ending September 30, 2016, the Company
recognized preferred stock dividends of $1.16 million on Series C
preferred stock related to the beneficial conversion feature
arising from a common stock effective conversion rate of $0.41
versus a current market price of $1.06 per common
share.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On November 14,
2016, the Company issued 187,500 shares of Series D Convertible
Preferred Stock and a warrant to purchase 187,500 shares of common
stock in a private placement to certain accredited investors for
gross proceeds of $150,000 pursuant to a Series D Preferred Stock
and Warrant Purchase Agreement dated November 10,
2016.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The warrants
associated with the November 14, 2016 issuance were allocated a
fair value of approximately $56,539 upon issuance, with the
remaining $63,539 of net proceeds allocated to the Series D
Preferred Stock. Proportionately, this allocation resulted in
approximately 53% of the amount of the Series D Preferred Stock
issuance remaining, which applied to the stated conversion price of
$0.80 resulted in an effective conversion price of approximately
$0.34. Having determined the effective conversion price, the
Company then compared this to the fair value of the underlying
Common Stock as of the commitment date, which was approximately
$1.14 per share, and concluded that the conversion feature did have
an intrinsic value of $0.80 per share. As such, the Company
concluded that the Series D Preferred Stock did contain a
beneficial conversion feature of $150,211 which was recorded as a
beneficial conversion in stockholders&#x2019;
equity.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On December 19,
2016, the Company issued 187,500 shares of Series D Convertible
Preferred Stock and a warrant to purchase 187,500 shares of common
stock in a private placement to an accredited investor for gross
proceeds of $150,000 pursuant to a Series D Preferred Stock and
Warrant Purchase Agreement dated December 14,
2016.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The warrants
associated with the December 19, 2016 issuance were allocated a
fair value of approximately $60,357 upon issuance, with the
remaining $69,643 of net proceeds allocated to the Series D
Preferred Stock. Proportionately, this allocation resulted in
approximately 54% of the amount of the Series D Preferred Stock
issuance remaining, which applied to the stated conversion price of
$0.80 resulted in an effective conversion price of approximately
$0.37. Having determined the effective conversion price, the
Company then compared this to the fair value of the underlying
Common Stock as of the commitment date, which was approximately
$0.81 per share, and concluded that the conversion feature did have
an intrinsic value of $0.44 per share. As such, the Company
concluded that the Series C Preferred Stock did contain a
beneficial conversion feature of $82,232 which was recorded as a
beneficial conversion in stockholders&#x2019;
equity.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Because the
Company&#x2019;s preferred stock is perpetual, with no stated
maturity date, and the conversions may occur any time from
inception, the dividend is recognized immediately when a beneficial
conversion exists at issuance. During the year ending September 30,
2017, the Company recognized preferred stock dividends of $2.3
million on Series D preferred stock related to the beneficial
conversion feature arising from a common stock effective conversion
rate of $0.34 and $0.37 versus the original market price of $1.14
and $1.06 per common share, respectively.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">On
May 1, 2017, the Company issued 357,143 shares of Series D
Convertible Preferred Stock and a warrant to purchase 357,143
shares of common stock in a private placement to an accredited
investor for gross proceeds of $250,000 pursuant to a Series D
Preferred Stock and Warrant Purchase Agreement dated May 1,
2016.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
initial conversion price of the Series D Shares is $0.70 per share,
subject to certain adjustments. The initial exercise price of the
warrant is $0.70 per share, also subject to certain adjustments.
The Company also amended and restated the Certificate of
Designations, resulting in an adjustment to the conversion price of
all currently outstanding Series D Shares to $0.70 per
share.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">On August 14, 2017,</font> the price of the
<font style="color: #000000">Series C and D Preferred Stock</font>
were adjusted to $0.25 per share <font style="color: #000000">pursuant to the documents governing such
instruments. After adjustment there were 3,108,356 shares of</font>
Series D preferred stock authorized.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On July 17, 2018,
the Company filed with the State of Nevada a second Amended and
Restated Certificate of Designation of Preferences, Powers, and
Rights of the Series D Convertible Preferred Stock. The Amended
Certificate restates the prior Certificate of Designation filed on
May 8, 2017 to decrease the number of authorized Series D shares
from 3,906,250 shares to 1,016,014 shares.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">As of June 30, 2019, the Company has 3,108,356
of</font> Series D Preferred Stock outstanding with Clayton A.
Struve, an accredited investor, outstanding. <font style="color: #000000">On August 14, 2017,</font> the price of the
<font style="color: #000000">Series D Stock</font> were adjusted to
$0.25 per share <font style="color: #000000">pursuant to the
documents governing such instruments.</font></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">33</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Securities Purchase Agreement dated August 14,
2017</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">On
August 14, 2017, the Company issued a senior convertible
exchangeable debenture with a principal amount of $360,000 and a
common stock purchase warrant to purchase 1,440,000 shares of
common stock in a private placement to Clayton Struve for gross
proceeds of $300,000 pursuant to a Securities Purchase Agreement
dated August 14, 2017. The debenture accrues interest at 20% per
annum and matures August 13, 2018. The convertible debenture
contains a beneficial conversion valued at $110,629. The warrants
were valued at $111,429. Because the note is immediately
convertible, the warrants and beneficial conversion were expensed
as interest.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">On
the same date, the Company entered into a General Security
Agreement with the Mr. Struve, pursuant to which the Company has
agreed to grant a security interest to the investor in
substantially all of our assets, effective upon the filing of a
UCC-3 termination statement to terminate the security interest held
by Capital Source Business Finance Group in the assets of the
Company. In addition, an entity affiliated with Ronald P. Erickson,
out then Chief Executive Officer, entered into a Subordination
Agreement with the investor pursuant to which all debt owed by us
to such entity is subordinated to amounts owed by us to Mr. Struve
under the Debenture (including amounts that become owing under any
Debentures issued to the investor in the
future).</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
initial conversion price of the Debenture is $0.25 per share,
subject to certain adjustments. The initial exercise price of the
Warrant is $0.25 per share, also subject to certain
adjustments.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">As
part of the Purchase Agreement, the Company granted the investor
&#x201C;piggyback&#x201D; registration rights to register the shares
of common stock issuable upon the conversion of the Debenture and
the exercise of the Warrant with the Securities and Exchange
Commission for resale or other disposition.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
Debenture and the Warrant were issued in a transaction that was not
registered under the Securities Act of 1933, as amended in reliance
upon applicable exemptions from registration under Section 4(a)(2)
of the Act and Rule 506 of SEC Regulation D under the Act.
&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Under
the terms of the Purchase Agreement, Mr. Struve may purchase up to
an aggregate of $1,000,000 principal amount of Debentures (before a
20% original issue discount) (and Warrants to purchase up to an
aggregate of 250,000 shares of common stock). These securities are
being offered on a &#x201C;best efforts&#x201D; basis by the
placement agent.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">During
the year ended September 30, 2017, $156,941 was recorded as
interest expense related to debt discounts, beneficial conversions
and warrants associated with Convertible Promissory
Notes.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">On
December 12, 2017, the Company closed an additional $250,000 and
issued a senior convertible exchangeable debenture with a principal
amount of $300,000 and a common stock purchase warrant to purchase
1,200,000 shares of common stock in a private placement dated
December 12, 2017 with Mr. Struve pursuant to a Securities Purchase
Agreement dated August 14, 2017. The convertible debenture contains
a beneficial conversion valued at $93,174. The warrants were valued
at $123,600. Because the note is immediately convertible, the
warrants and beneficial conversion were expensed as
interest.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">On
March 2, 2018, the Company received gross proceeds of $280,000 in
exchange for issuing a senior convertible redeemable debenture with
a principal amount of $336,000 and a warrant to purchase 1,344,000
shares of common stock in a private placement dated February 28,
2018 with Mr. Struve pursuant to a Securities Purchase Agreement
dated August 14, 2017. The convertible debenture contains a
beneficial conversion valued at $252,932. The warrants were valued
at $348,096. Because the note is immediately convertible, the
warrants and beneficial conversion were expensed as
interest.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">In
connection with the February 28, 2018 private placement, the
placement agent for the debenture and the warrant received a cash
fee of $28,000 and the Company issued warrants to purchase shares
of the Company&#x2019;s common stock to the placement agent or its
affiliates based on 10% of proceeds.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On November 16,
2018, the Company signed Amendment 1 to Senior Secured Convertible
Redeemable Notes dated August 14, 2017 and December 12, 2017,
extending the due dates of the Notes to February 27,
2019.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Convertible Promissory Notes with Clayton A.
Struve</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">As of March 31, 2019, the Company owes Clayton A.
Struve $1,071,000 under convertible promissory or OID notes. The
Company recorded accrued interest of $58,411 as of March 31,
2019.</font> On May 8, 2019, the Company signed Amendment 2 to the
convertible promissory or OID notes, extending the due dates to
September 30, 2019.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">34</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;<br>
</font>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="DESCRIPTION">D</a>ESCRIPTION OF 8%
UNSUBORDINATED NOTE OFFERING AND WARRANTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In early 2019, the Company commenced an Offering of 8%
Unsubordinated Convertible Notes and Warrants. The Notes have a
principal amount of $4,217,290 and bear annual interest of 8%.
Between March 4, 2019 and May 30, 2019, the Company closed a total
of 7 rounds of the private placement for gross proceeds of
$4,242,515 in exchange for issuing Subordinated Convertible Notes
and 2,121,258 Warrants in a private placement to 54 accredited
investors, pursuant to a series of substantially identical
Securities Purchase Agreements, Common Stock Warrants, and related
documents.</font></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;<br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Both the principal amount of and the interest are payable on a
payment-in-kind basis in shares of Common Stock of the Company.
They are due and payable in common stock on the earlier of (a)
mandatory and automatic conversion of the Convertible Notes into a
financing that yields gross proceeds of at least $10,000,000 or (b)
on the one-year anniversary of the Convertible Notes. Investors
will be required to convert their Convertible Notes into Common
Stock in any $10,000,000 financing at a conversion price per share
equal to the lower of (i) $1.00 per share or (ii) a 25% discount to
the price per share paid by investors in the $10,000,000 Financing.
If the Convertible Notes have not been paid or converted prior to
the Maturity Date, the outstanding principal amount of the
Convertible Notes will be automatically converted into shares of
Common Stock at the lesser of (a) $1.00 per share or (b) any
adjusted price resulting from the application of a &#x201C;most
favored nations&#x201D; provision, which requires the issuance of
additional shares of Common Stock to investors if the Company
issues certain securities at less than the then-current conversion
price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Warrants were granted on a 1:0.5 basis (one-half Warrant for
each full share of Common Stock into which the Convertible Notes
are convertible). The Warrants have a five-year term and an
exercise price equal to $1.20 or 120% of the per share conversion
price of the Qualified Financing or other mandatory
conversion.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Convertible Notes are convertible into an aggregate 4,,242,515
shares of Common Stock, subject to certain adjustments, and the
Warrants are initially exercisable for 2,121,258 shares of Common
Stock at an exercise price of $1.20 per share of Common Stock, also
subject to certain adjustments.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In connection with the private placement, the Placement Agent for
the Convertible Notes and the Warrants received a cash fee of
$361,401 and warrants to purchase 542,102 shares of the
Company&#x2019;s common stock, all based on 8% of gross proceeds to
the Company. The placement agent has also received a $25,000
advisory fee.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As part of the Purchase Agreement, the Company entered into a
Registration Rights Agreement, which grants the investors
&#x201C;demand&#x201D; and &#x201C;piggyback&#x201D; registration
rights to register the shares of Common Stock issuable upon the
conversion of the Convertible Notes and the exercise of the
Warrants with the Securities and Exchange Commission for resale or
other disposition. In addition, the Convertible Notes are
subordinated to certain senior debt of the Company pursuant to a
Subordination Agreement executed by the investors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Convertible Notes and Warrants were issued in transactions that
were not registered under the Securities Act of 1933, as amended
(the &#x201C;Act&#x201D;) in reliance upon applicable exemptions from
registration under Section 4(a)(2) of the Act and/or Rule 506 of
SEC Regulation D under the Act. &#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Boustead Securities, LLC a FINRA member, acted as our exclusive
placement agent. They have received a 8% cash fee and 8% in
warrants which are exercisable for 5 years at an exercise price of
$1.20. The Placement Agent Warrants have a cashless exercise
feature.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
DESCRIPTION OF SERIES D PREFERRED STOCK AND WARRANT PURCHASE
AGREEMENT</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We
currently have 5,000,000 shares of Preferred Stock, par value of
$0.001 authorized, of which we have authorized the designation of
1,016,014 shares as Series D Convertible Preferred Stock
(&#x201C;Series D Preferred&#x201D;). On May 8, 2017, we applied with
the State of Nevada for approval of the Certificate of
Designations, Preferences, and Rights of Series D Convertible
Preferred Stock. <font style="color: #000000">On July 17, 2018, we
filed with the State of Nevada a second Amended and Restated
Certificate of Designation of Preferences, Powers, and Rights of
the Series D Convertible Preferred Stock to decrease the number of
authorized Series D Shares from 3,906,250 to&#xA0;1,016,014.</font>
The Series D Preferred Stock is convertible into shares of common
stock at a price of $0.25 per share or by multiplying the number of
Series D Preferred Stock shares by the stated value and dividing by
the conversion price then in effect, subject to certain diluted
events, and has the right to vote the number of shares of common
stock the Series D Preferred Stock would be issuable on conversion,
subject to a 4.99% blocker.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On November 14, 2016, we issued 187,500 shares of Series D
Convertible Preferred Stock and a warrant to purchase 187,500
shares of common stock in a private placement to Clayton Struve for
gross proceeds of $150,000 pursuant to a Series D Preferred Stock
and Warrant Purchase Agreement dated November 10,
2016.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">35</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 19, 2016, we issued 187,500 shares of Series D
Convertible Preferred Stock and a warrant to purchase 187,500
shares of common stock in a private placement to Clayton Struve for
gross proceeds of $150,000 pursuant to a Series D Preferred Stock
and Warrant Purchase Agreement dated December 14,
2016.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On February 23, 2017 we issued 283,861 shares of Series D
Convertible Preferred Stock and a warrant to purchase 283,861
shares of common stock in a private placement to Clayton Struve for
gross proceeds of $200,000 pursuant to a Series D Preferred Stock
and Warrant Purchase Agreement dated May 1, 2016.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2017, we issued 357,143 shares of Series D Convertible
Preferred Stock and a warrant to purchase 357,143 shares of common
stock in a private placement to an accredited investor for gross
proceeds of $250,000 pursuant to a Series D Preferred Stock and
Warrant Purchase Agreement dated May 1, 2016.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Preferred Series D has an annual yield of 8% and an ownership
blocker of 4.99%. In addition, all of the investor warrants
discussed above are exercisable for a term of five years at strike
price of $0.25. The underlying common stock upon the conversion of
the Series D Preferred and Series F Warrants issued were required
to be included in a registration statement as filed by the
Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="PLANOFDISTRIBUTION">P</a>LAN OF
DISTRIBUTION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We are registering under this prospectus (i) up to 4,242,515 shares
of common stock underlying the principal, and up to
339,401 shares underlying the interest accrued, of
registrants 8% Unsubordinated Convertible Notes (the
&#x201C;Notes&#x201D;), which have a conversion price that is the
lesser of $1.00 per share or a twenty five percent (25%) discount
to the price per share paid by investors a future Qualified
Financing (the &#x201C;Shares&#x201D;); (ii) up to 2,121,258 shares
(the "Investor Warrant Shares") of common stock issuable upon the
exercise of outstanding investor's warrants (the "Investor
Warrants") at an exercise price of $1.20 that were previously
issued to the Selling Shareholders in connection with the Notes
Offering that closed in a series of closings between February 15,
2019 and May 28, 2019; and</font> (iii) 542,102 shares of our
common stock issuable upon the exercise of outstanding placement
agent warrants (the &#x201C;Placement Agent Warrants&#x201D;) at an
exercise price of $1.20 per share that were previously issued to
Boustead Securities, LLC and its assigns (collectively
&#x201C;Placement Agent&#x201D;) pursuant to an engagement agreement
dated November 6, 2018 (the &#x201C;Boustead Offering Engagement
Agreement&#x201D;) which provides that the Placement Agent shall
receive that certain number of warrants to purchase the common
stock of the Company equal to the number of warrants issued under
the 8% Unsubordinated Convertible Note Offering (the
&#x201C;Offering&#x201D;). <font style="color: #000000">We are
required under the terms of the Securities Purchase Agreement
between the Company and the investors to register the common stock
issuable upon conversion of the 8% Unsubordinated Convertible
Notes, Investor Warrants and</font> Placement Agent
Warrants.</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Additionally, we are registering under this
prospectus (iv) up to 3,108,356 shares of common stock underlying
the outstanding Series D</font> <font style="color: #000000">Convertible Preferred Stock which is convertible
at any time at an initial conversion price of $0.25 per share of
our common stock subject to adjustment for certain events
(&#x201C;Series D Shares&#x201D;). There are currently 3,108,356
common shares estimated to underlying the 1,016,004 issued and
outstanding Series D Shares,</font></font> <font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">and (v) up to</font> 3,984,000<font style="color: #FF0000">&#xA0;</font> <font style="color: #000000">shares
of common stock issuable upon conversion of outstanding</font>
Series F Warrants which are exercisable <font style="color: #000000">at an exercise price of $0.25 per share, subject
to certain adjustments, that were previously issued to one of the
Selling Shareholders in connection with Preferred Stock and Warrant
Purchase Agreement dated November 10, 2016 (&#x201C;Series F Warrant
Shares&#x201D;). We are registering the common stock
underlying the Series D Shares and Series F Warrant Shares
that may be issued by us to the Selling Stockholders in order to
permit the resale of these shares of common
stock.</font></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are not selling any shares of our common stock in this offering
and, as a result, we will not receive any proceeds from the sale of
the common stock covered by this prospectus.&#xA0;All of the net
proceeds from the sale of our common stock will go to the Selling
Stockholders. We will not receive any of the proceeds from the sale
of shares of common stock by the Selling Stockholders. Upon
exercise of the Investor Warrants and Placement Agent Warrants,
however, we will receive up to $1.20 per share, and upon exercise
of the Series F Warrants, we will receive up to $0.25 per share or
such lower price as may result from the anti-dilution protection
features of such warrants. Any proceeds received from the exercise
of such warrants will be used for general working capital and other
corporate purposes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">36</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Selling Stockholders may decide not to sell any of its shares
of common stock, or may sell all or a portion of its shares of
common stock.&#xA0;&#xA0;The Selling Stockholders will act
independently of us in making decisions with respect to the timing,
manner and size of any sale of shares, and may sell the shares
directly or through one or more broker-dealers or
agents.&#xA0;&#xA0;To the extent that the Selling Stockholders
employs broker-dealers or other agents in connection with the sale
of its stock, the Selling Stockholders will pay any commissions,
discounts or other amounts due to such broker-dealers or
agents.&#xA0;&#xA0;To our knowledge, the Selling Stockholders has
not entered into any agreement, arrangement or understanding with
any particular broker-dealer or market maker with respect to the
sale or distribution of the shares of common stock offered
hereby.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Selling Stockholders, which as used herein includes its donees,
pledgees, transferees or other successors-in-interest selling
shares of common stock or interests in shares of common stock
received after the date of this prospectus from a Selling
Stockholders as a gift, pledge, partnership distribution or other
transfer, may, from time to time, sell, transfer or otherwise
dispose of any or all of its shares of common stock or interests in
shares of common stock on any stock exchange, market or trading
facility on which the shares are traded, or in private
transactions.&#xA0;&#xA0;These dispositions may be at fixed prices,
at prevailing market prices at the time of sale, at prices related
to the prevailing market price, at varying prices determined at the
time of sale, or at negotiated prices.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Selling Stockholders may use any one or more of the following
methods when disposing of shares or interests therein:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">ordinary
brokerage transactions and transactions in which the broker-dealer
solicits purchasers;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">block
trades in which the broker-dealer will attempt to sell the shares
as agent, but may position and resell a portion of the block as
principal to facilitate the transaction;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">purchases
by a broker-dealer as principal and resale by the broker-dealer for
its account;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">an
exchange distribution in accordance with the rules of the
applicable exchange;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">privately
negotiated transactions;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">short
sales effected after the date the Registration Statement of which
this prospectus is a part is declared effective by the
SEC;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">through
the writing or settlement of options or other hedging transactions,
whether through an options exchange or otherwise;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">broker-dealers
may agree with the Selling Stockholders to sell a specified number
of such shares at a stipulated price per share;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">a
combination of any such methods of sale; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 100px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">-</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">any
other method permitted by applicable law.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Selling Stockholders may, from time to time, pledge or grant a
security interest in some or all of the shares of common stock
owned by it and, if it defaults in the performance of its secured
obligations, the pledgees or secured parties may offer and sell the
shares of common stock, from time to time, under this prospectus,
or under an amendment to this prospectus under Rule 424(b)(3) or
other applicable provision of the Securities Act amending the list
of Selling Stockholders to include the pledgee, transferee or other
successors in interest as Selling Stockholders under this
prospectus.&#xA0;&#xA0;The Selling Stockholders also may transfer
the shares of common stock in other circumstances, in which case
the transferees, pledgees or other successors in interest will be
the Selling Stockholders for purposes of this
prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">37</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In connection with the sale of our common stock or interests
therein, the Selling Stockholders may enter into hedging
transactions with broker-dealers or other financial institutions,
which may in turn engage in short sales of the common stock in the
course of hedging the positions they assume.&#xA0;&#xA0;The Selling
Stockholders may also sell shares of our common stock short and
deliver these securities to close out its short positions, or loan
or pledge the common stock to broker-dealers that in turn may sell
these securities.&#xA0;&#xA0;The Selling Stockholders may also
enter into option or other transactions with broker-dealers or
other financial institutions or the creation of one or more
derivative securities which require the delivery to such
broker-dealer or other financial institution of shares offered by
this prospectus, which shares such broker-dealer or other financial
institution may resell pursuant to this prospectus as supplemented
or amended to reflect such transaction.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The aggregate proceeds to the Selling Stockholders from the sale of
the common stock will be the purchase price of the common stock
less discounts or commissions, if any.&#xA0;&#xA0;The Selling
Stockholders reserves the right to accept and, together with its
agents from time to time, to reject, in whole or in part, any
proposed purchase of common stock to be made directly or through
agents.&#xA0;&#xA0;We will not receive any of the proceeds from
these stock sales by the Selling
Stockholders.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Selling Stockholders also may resell all or a portion of its
shares of common stock in open market transactions in reliance upon
Rule 144 under the Securities Act of 1933, provided that it meets
the criteria and conform to the requirements of that
rule.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
To the extent required, the shares of our common stock to be sold,
the names of the Selling Stockholders(s), the respective purchase
prices and public offering prices, the names of any agents, dealer
or underwriter, any applicable commissions or discounts with
respect to a particular offer will be set forth in an accompanying
prospectus supplement or, if appropriate, a post-effective
amendment to the Registration Statement that includes this
prospectus.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In order to comply with the securities laws of some states, if
applicable, the common stock may be sold in these jurisdictions
only through registered or licensed brokers or
dealers.&#xA0;&#xA0;In addition, in some states the common stock
may not be sold unless it has been registered or qualified for sale
or an exemption from registration or qualification requirements is
available and is complied with.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have advised the Selling Stockholders that the anti-manipulation
rules of Regulation M under the Exchange Act may apply to sales of
shares in the market and to the activities of the Selling
Stockholders and its affiliates.&#xA0;&#xA0;In addition, to the
extent applicable we will make copies of this prospectus as it may
be supplemented or amended from time to time available to the
Selling Stockholders for the purpose of satisfying the prospectus
delivery requirements of the Securities Act.&#xA0;&#xA0;The Selling
Stockholders may indemnify any broker-dealer that participates in
transactions involving the sale of the shares against certain
liabilities, including liabilities arising under the Securities
Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We have agreed to indemnify the Selling Stockholders against
liabilities, including liabilities under the Securities Act and
state securities laws, arising out of or based upon any untrue
statement</font> <font style="color: #000000">or alleged untrue
statement</font> <font style="color: #000000">of a material fact
contained in</font> <font style="color: #000000">the Registration
Statement, prospectus, prospectus supplement, or any</font>
<font style="color: #000000">information incorporated by reference
therein, or arising out of or based upon any omission or alleged
omission to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading; provided, however, that we will not
be liable for any liabilities finally adjudicated to be caused
solely by a false statement of material fact contained within
written information provided by such the Selling Stockholders
expressly for the purpose of including it in this Registration
Statement or the prospectus that is part of this Registration
Statement.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We also have agreed with the Selling Stockholders to keep the
Registration Statement of which this prospectus constitutes a part
effective until the earlier of (1) the date on which all of the
shares covered by this prospectus have been sold, or (2) the date
on which all of the shares may be sold without restriction pursuant
to Rule 144 of the Securities Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">38</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="MANAGEMENT">M</a>ANAGEMENT'S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
You should read the following discussion and analysis of our
financial condition and results of operations together with our
financial statements and related notes appearing at the end of this
prospectus. Some of the information contained in this discussion
and analysis or set forth elsewhere in this prospectus, including
information with respect to our plans and strategy for our business
and related financing, includes forward-looking statements that
involve risks and uncertainties. You should read the "Risk Factors"
section of this prospectus for a discussion of important factors
that could cause actual results to differ materially from the
results described in or implied by the forward-looking statements
contained in the following discussion and analysis.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Know Labs, Inc., formerly Visualant, Incorporated, was incorporated
under the laws of the State of Nevada in 1998.</font> Since 2007,
we have been focused primarily on research and development of
proprietary technologies which can be used to <font style="color: #000000">authenticate and diagnose a wide variety of
organic and non-organic substances and materials.</font> Our Common
Stock trades on the OTCQB Exchange under the symbol
&#x201C;KNWN.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Business</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are focused on the development, marketing and sales of a
proprietary technologies which are capable of uniquely
authenticating or diagnosing almost any substance or material using
electromagnetic energy to create, record and detect the unique
&#x201C;signature&#x201D; of the substance. We call these our
&#x201C;ChromaID&#x2122;&#x201D; and &#x201C;Bio-RFID&#x2122;&#x201D;
technologies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Overview</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Historically, the Company focused on the development of our
proprietary ChromaID technology. Using light from low-cost LEDs
(light emitting diodes) we map the color of substances, fluids and
materials and with our proprietary processes we can authenticate,
identify and diagnose based upon the color that is present. The
color is both visible to us as humans but also outside of the
humanly visible color spectrum in the near infra-red and near
ultra-violet and beyond. Our ChromaID scanner sees what we like to
call &#x201C;Nature&#x2019;s Color Fingerprint.&#x201D; Everything in
nature has a unique color identifier and with ChromaID we can see
it, and identify, authenticate and diagnose based upon the color
that is present. Our ChromaID scanner is capable of uniquely
identifying and authenticating almost any substance or liquid using
light to create, record and detect its unique color signature. We
will continue to develop and enhance our ChromaID technology and
extend its capacity. More recently, we have focused upon extensions
and new inventions that are derived from and extend beyond our
ChromaID technology. We call this technology Bio-RFID. The rapid
advances made with our Bio-RFID technology in our laboratory have
caused us to move quickly in to the commercialization phase of our
Company as we work to create revenue generating products for the
marketplace. We will also, as resources permit, pursue licensing
opportunities with third parties who have ready applications for
our technologies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In 2010, we acquired TransTech Systems, Inc. as an adjunct to our
business. TransTech is a distributor of products for employee and
personnel identification and authentication. TransTech has
historically provided substantially all of the Company&#x2019;s
revenues. The financial results from our TransTech subsidiary have
been diminishing as vendors of their products increasingly move to
the Internet and direct sales to their customers. While it does
provide our current revenues it is not central to our current focus
as a Company. Moreover, we have written down any goodwill
associated with its historic acquisition. We continue to closely
monitor this subsidiary. We expect it to wind down completely prior
to the end of our current fiscal year.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">39</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Six Months Ended March 31, 2019 Compared to Six Months Ended March
31, 2018</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following table presents certain consolidated statement of
operations information and presentation of that data as a
percentage of change from year-to-year:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(dollars in thousands).</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="4" rowspan="1" style="vertical-align:bottom;width:48%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:2%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:96%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">Six Months Ended
March 31,</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:2%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">2019</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">2018</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">$
Variance</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">%
Variance</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Revenue</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,196</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,325</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,129</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-48.6</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Cost of
sales</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">927</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">1,851</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(924</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">49.9</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Gross
profit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">269</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">474</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(205</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-43.2</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Research and
development expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">391</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">241</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">150</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-62.2</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Selling, general
and administrative expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">2,368</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">992</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">1,376</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-138.7</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Operating
loss</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(2,490</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(759</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,731</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">2</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Other (expense)
income:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent: 24px; margin-right: 0px; margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Interest
expense</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(17</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,087</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,070</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">98.4</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent: 24px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Other income
(expense)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">13</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">19</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(6</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">31.6</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total other income
(expense)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(4</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,068</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">1,064</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">99.6</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">(Loss) before
income taxes</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,494</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,827</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(667</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-36.5</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent: 24px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Income taxes -
current (benefit)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">0.0</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Net
(loss)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(2,494</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1,827</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(667</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">-36.5</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">%</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Sales</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Net revenue for the six months ended March 31, 2019 decreased
$1,129,000 to $1,196,000 as compared to $2,325,000 for the six
months ended March 31, 2018. The decrease was due to lower sales by
TransTech. We have focused TransTech on maximizing profits at the
lower sales level.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Cost of Sales</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Cost of sales for the six months ended March 31, 2019 decreased
$924,000 to $927,000 as compared to $1,851,000 for the six months
ended March 31, 2018. The decrease was due to lower sales by
TransTech. We have focused TransTech on maximizing profits at the
lower sales level.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Gross profit was $269,000 for the six months ended March 31, 2019
as compared to $474,000 for the six months ended March 31, 2018.
Gross profit was 23.4% for the six months ended March 31, 2019 as
compared to 20.4% for the six months ended March 31, 2018. We have
focused TransTech on maximizing profits at the current sales
level.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Research and Development Expenses</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Research and development expenses for the six months ended March
31, 2019 increased $150,000 to $391,000 as compared to $241,000 for
the six months ended March 31, 2018. The increase was due to
expenditures related to the development of our</font>
Bio-RFID&#x2122; technology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Selling, General and Administrative Expenses</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Selling, general and administrative expenses for the six months
ended March 31, 2019 increased $1,376,000 to $2,368,000 as compared
to $992,000 for the six months ended March 31,
2018.</font>&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The increase primarily was due to (i) increased corporate
development expense of $389,000; (ii) increased stock based
compensation of $835,000; (iii) increased other expenses of
$152,000. As part of the selling, general and administrative
expenses for the six months ended March 31, 2019, we recorded
$467,000 of investor relation expenses and business development
expenses.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Other Income (Expense)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Other expense for the six months ended March 31, 2019 was $4,000 as
compared to other expense of $1,068,000 for the six months ended
March 31, 2018. The other expense for the six months ended March
31, 2019 included (i) interest expense of $17,000; offset by other
income of $13,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">40</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The other expense for the six months ended March 31, 2018 included
(i) interest expense of $1,087,000; offset by (ii) other income of
$19,000. The interest expense related a senior convertible
exchangeable debenture issued on December 12, 2017 and February 28,
2018 in conjunction with a Securities Purchase Agreement dated
August 14, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Net (Loss) Profit</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The net loss for the three months ended March 31, 2019</font>,
included <font style="color: #000000">non-cash expenses of
$1,091,000. The non-cash items include (i) depreciation and
amortization of $133,000; (ii) stock based compensation of
$600,000; (iii) issuance of capital stock for services and expenses
of $349,000; and (iii) other of $9,000. TransTech&#x2019;s net loss
from operations was $36,000 for the six months ended March 31, 2019
as compared to a net income from operations of $38,000 for the six
months ended March 31, 2018.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The net loss for the six months ended March 31, 2018</font>,
included <font style="color: #000000">non-cash expenses of non-cash
items of $1,272,000.</font> <font style="color: #000000">The
non-cash items include (i) depreciation and amortization of
$30,000; (ii) stock based compensation of $71,000; (iii) conversion
of interest and amortization of debt discount of $539,000; (iv)
conversion of accrued liabilities of $492,000; (v) issuance of
warrants for debt conversion of $110,000; and (vi) other of
$30,000.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We expect losses to continue as we commercialize our</font>
ChromaID&#x2122; and <font style="color: #000000">Bio-RFID&#x2122;</font>technology.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Year Ended September 30, 2018 Compared to Year Ended September 30,
2017</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following table presents certain consolidated statement of
operations information and presentation of that data as a
percentage of change from year-to-year:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(dollars in thousands).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font><font style="font-size: 11px"></font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-size: 11px"><font style="font-family: Times New Roman">&#xA0;</font></font></div>
</td>
<td colspan="4" rowspan="1" style="vertical-align:bottom;width:48%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:2%;padding-bottom:2px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:96%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Years Ended
September 30,</font></font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:2%;padding-bottom:2px;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-size: 11px"><font style="font-family: Times New Roman">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">2018</font></font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">2017</font></font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">$
Variance</font></font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;">%
Variance</font></font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:10%;padding-bottom:2px;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Revenue</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,303</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,874</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(571</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-11.7</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Cost of
sales</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">3,482</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">3,966</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(484</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">12.2</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Gross
profit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">821</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">908</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(87</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-9.6</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Research and
development expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">570</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">79</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">491</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-621.5</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Selling, general
and administrative expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,088</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(579</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">18.8</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Impairment of
goodwill</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">984</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(984</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">100.0</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Operating
loss</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(2,258</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(3,243</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">985</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">30.4</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Other (expense)
income:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent: 24px; margin-right: 0px; margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Interest
expense</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,195</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(377</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(818</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-217.0</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent: 24px; margin-right: 0px; margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Other income
(expense)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">25</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(63</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">88</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">139.7</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent: 24px; margin-right: 0px; margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">(Loss) on change-
derivative liability warrants</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(218</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">218</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100.0</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent: 24px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Gain on debt
settlements</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">170</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">170</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">100.0</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total other income
(expense)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(658</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(342</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-52.0</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">(Loss) before
income taxes</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(3,258</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(3,901</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">643</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">16.5</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent: 24px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Income taxes -
current (benefit)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">0.0</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Net
(loss)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,258</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,901</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">643</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">16.5</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">%</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Sales</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Net revenue for the year ended September 30, 2018 decreased
$571,000 to $4,303,000 as compared to $4,874,000 for the year ended
September 30, 2017. The decrease was due to lower sales by
TransTech. We have focused TransTech on maximizing profits at the
lower sales level.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">41</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Cost of Sales</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Cost of sales for the year ended September 30, 2018 decreased
$484,000 to $3,482,000 as compared to $3,966,000 for the year ended
September 30, 2017. The decrease was due to lower sales by
TransTech. We have focused TransTech on maximizing profits at the
lower sales level.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Gross profit was $821,000 for the year ended September 30, 2018 as
compared to $908,000 for the year ended September 30, 2017. Gross
profit was 19.1% for the year ended September 30, 2018 as compared
to 18.6% for the year ended September 30, 2017. We have focused
TransTech on maximizing profits at the lower sales
level.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Research and Development Expenses</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Research and development expenses for the year ended September 30,
2018 increased $491,000 to $570,000 as compared to $79,000 for the
year ended September 30, 2017. The increase was due to expenditures
related to the Consulting and Services Agreement with Phillip A.
Bosua, our Chief Product Officer for product development, including
the development of our</font> Bio-RFID&#x2122;
technology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Selling, General and Administrative Expenses</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Selling, general and administrative expenses for year ended
September 30, 2018 decreased $579,000 to $2,509,000 as compared to
$3,088,000 for the year ended September 30,
2017.</font>&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The decrease primarily was due to (i) reduced payroll, bad debt and
other expenses of $465,000 at TransTech; (ii) decreased corporate
development expense of $425,000; (iii) decreased other corporate
expenses of $217,000; and (iv) offset by increased stock based
compensation expenses of $581,000 . As part of the selling, general
and administrative expenses for the three months ended September
30, 2018, we recorded $198,000 of investor relation expenses and
corporate development expenses.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Impairment of Goodwill</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our TransTech business is very capital intensive. We reviewed
TransTech&#x2019;s operations based on its overall financial
constraints and determined the value has been impaired. We recorded
an impairment of goodwill associated with TransTech of $984,000
during the year ended September 30, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Other Income (Expense)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Other expense for the year ended September 30, 2018 was $1,000,000
as compared to other expense of $657,000 for the year ended
September 30, 2017. The other expense for the year ended September
30, 2018 included (i) interest expense of $1,195,000; offset by
(ii) other income of $25,000 and (iii) gain on debt settlements of
$170,000. The interest expense related a senior convertible
exchangeable debenture issued on December 12, 2017 and February 28,
2018 in conjunction with a Securities Purchase Agreement dated
August 14, 2017. The gain on debt settlements and forgiveness of
accounts payable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The other expense for the year ended September 30, 2017 included
(i) change in the value of derivatives of $218,000; (ii) interest
expense of $377,000; (iii) other expense of $63,000. The decrease
is a result of the decline of the derivative liability as our
underlying stock price has declined and conversion of interest and
amortization of debt discount of $227,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Net (Loss)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Net loss for the year ended September 30, 2018 was $3,258,000 as
compared to $3,901,000 for the year ended September 30, 2017. The
net loss for the year ended September 30, 2018</font>, included
<font style="color: #000000">non-cash expenses of $1,935,000. The
non-cash items include (i) depreciation and amortization of
$133,000; (ii) issuance of capital stock for services and expenses
of $440,000; (iii) stock based compensation of $291,000; (iv)
conversion of interest and amortization of debt discount of
$539,000; (v) conversion of accrued liabilities of $492,000; (vi)
issuance of common stock for conversion of liabilities of $200,000;
and (vii) other of $10,000; (viii) offset by non cash gain on
accounts payable of $170,000. TransTech&#x2019;s net income from
operations was $49,000 for the year ended September 30, 2018 as
compared to a net loss from operations of ($256,000) for the year
ended September 30, 2017.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">42</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The net loss for the year ended September 30, 2017</font>, included
<font style="color: #000000">non-cash expenses of non-cash items of
$2,397,000. The non-cash items include (i) depreciation and
amortization of $81,000; (ii) issuance of capital stock for
services and expenses of $548,000; (iii) stock based compensation
of $38,000; (iv) bad debt losses and provision on loss on accounts
receivable of $141,000; (v) impairment of goodwill of $984,000;
(vi) loss on sale of assets $113,000; (vii) conversion of interest
and amortization of debt discount of $227,000; and (viii)
reclassification of derivative liability of $410,000; offset by
(ix) loss on change- derivative liability warrants of
$145,000.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We expect losses to continue as we commercialize our</font>
ChromaID&#x2122; and <font style="color: #000000">Bio-RFID&#x2122;</font>technology.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Liquidity and Capital Resources</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Liquidity
is the ability of a company to generate funds to support its
current and future operations, satisfy its obligations, and
otherwise operate on an ongoing basis. Significant factors in the
management of liquidity are funds generated by operations, levels
of accounts receivable and accounts payable and capital
expenditures.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We had cash of approximately $3,062,000 and net working capital
deficit of approximately $1,338,000 (net of convertible notes
payable and notes payable) as of March 31, 2019.&#xA0;&#xA0;We have
experienced net losses since inception and we expect losses to
continue as we commercialize our ChromaID&#x2122; technology. As of
March 31, 2019, we had an accumulated deficit of $37,285,000 and
net losses in the amount of $2,494,000, $3,258,000 and $3,901,000
for the six months ended March 31, 2019 and years ended September
30, 2018 and 2017, respectively.</font> <font style="color: #000000; background-color: #FFFFFF">We believe that our
cash on hand will be sufficient to fund our operations through
December 31, 2019.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 4, 2019, we closed rounds of a private placement and
received gross proceeds of $2,409,975 in exchange for issuing
Subordinated Convertible Notes and Warrants in a private placement
to 26 accredited investors, pursuant to a series of substantially
identical Securities Purchase Agreements, Common Stock Warrants,
and related documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 18, 2019, we closed round three of a private placement and
received gross proceeds of $1,400,000 in exchange for issuing
Subordinated Convertible Notes and Warrants in a private placement
to 8 accredited investors, pursuant to a series of substantially
identical Securities Purchase Agreements, Common Stock Warrants,
and related documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Convertible Notes have a principal amount of $3,809,975 and
bear annual interest of 8%. Both the principal amount of and the
interest are payable on a payment-in-kind basis in shares of Common
Stock of the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We
expect to continue offering additional Convertible Notes and
Warrants on substantially the same terms until April 15, 2019
(unless extended at our discretion) or until we have raised a
maximum of $5 million in gross proceeds (or such other amount
determined by us).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
opinion of our independent registered public accounting firm on our
audited financial statements as of and for the year ended September
30, 2018 contains an explanatory paragraph regarding substantial
doubt about our ability to continue as a going concern. Our ability
to continue as a going concern is dependent upon raising capital
from financing transactions.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We need additional financing to implement our business plan and to
service our ongoing operations and pay our current debts. There can
be no assurance that we will be able to secure any needed funding,
or that if such funding is available, the terms or conditions would
be acceptable to us. If we are unable to obtain additional
financing when it is needed, we will need to restructure our
operations, and divest all or a portion of our business.</font>
<font style="color: #000000; background-color: #FFFFFF">We may seek
additional capital through a combination of private and public
equity offerings, debt financings and strategic collaborations.
Debt financing, if obtained, may involve agreements that include
covenants limiting or restricting our ability to take specific
actions, such as incurring additional debt, and could increase our
expenses and require that our assets secure such debt. Equity
financing, if obtained, could result in dilution to our
then-existing stockholders and/or require such stockholders to
waive certain rights and preferences. If such financing is not
available on satisfactory terms, or is not available at all, we may
be required to delay, scale back, eliminate the development of
business opportunities or file for bankruptcy and our operations
and financial condition may be materially adversely
affected.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">43</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have financed our corporate operations and our technology
development through the issuance of convertible debentures, the
issuance of preferred stock, the sale common stock, issuance of
common stock in conjunction with an equity line of credit, loans by
our Chairman and the exercise of warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Operating Activities</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Net cash used in operating activities for the six months ended
March 31, 2019 was $1,463,000. This amount was primarily related to
(i) a net loss of $2,494,000; and (ii) working capital changes of
$60,000; offset by (vi) non-cash expenses of $1,091,000. The
non-cash items include (i) depreciation and amortization of
$133,000; (ii) stock based compensation of $600,000; (iii) issuance
of capital stock for services and expenses of $349,000; and (iii)
other of $9,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Investing Activities</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Net cash used in investing activities for the six months ended
March 31, 2019 was $75,000. This amount was primarily related to
the investment in equipment for research and
development.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Financing Activities</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Net cash provided by financing activities for the six months ended
March 31, 2019 was $3,665,000. This amount was primarily related to
issuance of common stock for cash of $3,810,000, offset by
repayments of line of credit of $145,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our contractual cash obligations as of March 31, 2019 are
summarized in the table below:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:50%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 11px; font-weight: bold;">
&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">Less
Than</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">Greater
Than</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:50%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-weight: bold; font-size: 11px;"><font style="font-family: Times New Roman; font-weight: bold;">Contractual Cash
Obligations</font></font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">Total</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">1
Year</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">1-3
Years</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">3-5
Years</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">5
Years</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:50%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Operating
leases</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">389,994</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">187,652</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">196,526</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">5,816</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:50%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Convertible notes
payable</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,255,066</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,255,066</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:50%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Capital
expenditures</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">280,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">60,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">110,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">110,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:50%;">
<div style="margin-left:0px;padding-bottom:4px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,925,060</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,502,718</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">306,526</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">115,816</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font><br>
</div>
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Off-Balance
Sheet Arrangements</font>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We do
not have any off-balance sheet arrangements (as that term is
defined in Item 303 of Regulation S-K) that are reasonably likely
to have a current or future material effect on our financial
condition, revenue or expenses, results of operations, liquidity,
capital expenditures or capital resources.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Critical Accounting Policies and Estimates</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The application of GAAP involves the exercise of varying degrees of
judgment. On an ongoing basis, we evaluate our estimates and
judgments based on historical experience and various other factors
that are believed to be reasonable under the
circumstances.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Actual results may differ from these estimates under different
assumptions or conditions. We believe that of our significant
accounting policies (see summary of significant accounting policies
more fully described in Note 2 to the financial statements set
forth in this report), the following policies involve a higher
degree of judgment and/or complexity:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">44</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Inventories</font> <font style="color: #000000">&#x2013; Inventories
consist primarily of printers and consumable supplies, including
ribbons and cards, badge accessories, capture devices, and access
control components held for resale and are stated at the lower of
cost or market on the&#xA0;first-in, first-out (&#x201C;FIFO&#x201D;)
method.&#xA0;&#xA0;Inventories are considered available for resale
when drop shipped and invoiced directly to a customer from a
vendor, or when physically received by TransTech at a warehouse
location.&#xA0;&#xA0;We recorded a provision for excess and
obsolete inventory whenever an impairment has been identified.
There is a $35,000 reserve for impaired inventory as of March 31,
2019 and September 30, 2018, respectively.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; font-style: italic">
</font><font style="font-weight: bold;">Fair Value Measurements and
Financial Instruments</font> <font style="color: #000000">&#x2013;</font><font style="font-weight: bold">&#xA0;</font>ASC Topic 820, <font style="font-style: italic">Fair Value Measurement and Disclosures</font>,
defines fair value as the exchange price that would be received for
an asset or paid to transfer a liability (an exit price) in the
principal or most advantageous market for the asset or liability in
an orderly transaction between market participants on the
measurement date.&#xA0;&#xA0;This topic also establishes a fair
value hierarchy, which requires classification based on observable
and unobservable inputs when measuring fair value.&#xA0;&#xA0;The
fair value hierarchy distinguishes between assumptions based on
market data (observable inputs) and an entity&#x2019;s own
assumptions (unobservable inputs).&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Derivative financial instruments -</font>We evaluate all of its
financial instruments to determine if such instruments are
derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are
accounted for as liabilities, the derivative instrument is
initially recorded at its fair value and is then re-valued at each
reporting date, with changes in the fair value reported in the
consolidated statements of operations. For stock-based derivative
financial instruments, the Company uses a Black-Scholes-Merton
option pricing model to value the derivative instruments at
inception and on subsequent valuation dates. The classification of
derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is evaluated at the end of
each reporting period. Derivative instrument liabilities are
classified in the balance sheet as current or non-current based on
whether or not net-cash settlement of the derivative instrument
could be required within twelve months of the balance sheet
date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Revenue Recognition</font> <font style="color: #000000">&#x2013; Our
revenue is derived from products and services. Revenue is
considered realized when the products or services have been
provided to the customer, the work has been accepted by the
customer and collectability is&#xA0;reasonably assured.
Furthermore, if an actual measurement of revenue cannot be
determined, the Company defers all revenue recognition until such
time that an actual measurement can be determined. If during the
course of a contract management determines that losses are expected
to be incurred, such costs are charged to operations in the period
such losses are determined. Revenues are deferred when cash has
been received from the customer but the revenue has not been
earned.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Stock Based Compensation</font> <font style="color: #000000">&#x2013; We have share-based compensation plans
under which employees, consultants, suppliers and directors may be
granted restricted stock, as well as options to purchase shares of
our common stock at the fair market value at the time of grant.
Stock-based compensation cost is measured by us at the grant date,
based on the fair value of the award, over the requisite service
period. For options issued to employees, we recognize stock
compensation costs utilizing the fair value methodology over the
related period of benefit.&#xA0;&#xA0;Grants of stock options and
stock to non-employees and other parties are accounted for in
accordance with the ASC 505.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Convertible Securities</font> <font style="color: #000000">&#x2013;</font> Based upon ASC 815-15, we have
adopted a sequencing approach regarding the application of ASC
815-40 to convertible securities issued subsequent to September 30,
2015. We will evaluate our contracts based upon the earliest
issuance date. In the event partial reclassification of contracts
subject to ASC 815-40-25 is necessary, due to our inability to
demonstrate we have sufficient shares authorized and unissued,
shares will be allocated on the basis of issuance date, with the
earliest issuance date receiving first allocation of shares. If a
reclassification of an instrument were required, it would result in
the instrument issued latest being reclassified first.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Quantitative and Qualitative Disclosure about Market
Risk</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
no investments in any market risk sensitive instruments either held
for trading purposes or entered into for other than trading
purposes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">45</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
<a name="BUSINESS">B</a>USINESS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are focused on the development, marketing and sales of a
proprietary technologies which are capable of uniquely
authenticating or diagnosing almost any substance or material using
electromagnetic energy to create, record and detect the unique
&#x201C;signature&#x201D; of the substance. We call these our
&#x201C;ChromaID&#x2122;&#x201D; and &#x201C;Bio-RFID&#x2122;&#x201D;
technologies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Overview</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Historically, the Company focused on the development of our
proprietary ChromaID technology. Using light from low-cost LEDs
(light emitting diodes) we map the color of substances, fluids and
materials and with our proprietary processes we can authenticate,
identify and diagnose based upon the color that is present. The
color is both visible to us as humans but also outside of the
humanly visible color spectrum in the near infra-red and near
ultra-violet and beyond. Our ChromaID scanner sees what we like to
call &#x201C;Nature&#x2019;s Color Fingerprint.&#x201D; Everything in
nature has a unique color identifier and with ChromaID we can see
it, and identify, authenticate and diagnose based upon the color
that is present. Our ChromaID scanner is capable of uniquely
identifying and authenticating almost any substance or liquid using
light to create, record and detect its unique color signature. We
will continue to develop and enhance our ChromaID technology and
extend its capacity. More recently, we have focused upon extensions
and new inventions that are derived from and extend beyond our
ChromaID technology. We call this technology Bio-RFID. The rapid
advances made with our Bio-RFID technology in our laboratory have
caused us to move quickly in to the commercialization phase of our
Company as we work to create revenue generating products for the
marketplace. We will also, as resources permit, pursue licensing
opportunities with third parties who have ready applications for
our technologies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In 2010, we acquired TransTech Systems, Inc. as an adjunct to our
business. TransTech is a distributor of products for employee and
personnel identification and authentication. TransTech has
historically provided substantially all of the Company&#x2019;s
revenues. The financial results from our TransTech subsidiary have
been diminishing as vendors of their products increasingly move to
the Internet and direct sales to their customers. While it does
provide our current revenues it is not central to our current focus
as a Company. Moreover, we have written down any goodwill
associated with its historic acquisition. We continue to closely
monitor this subsidiary. We expect it to wind down completely prior
to the end of our current fiscal year.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
The Know Labs Technology</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have internally and under contract with third parties developed
proprietary platform technologies to uniquely authenticate or
diagnose almost any material and substance. Our technology utilizes
electromagnetic energy at various points along the electromagnetic
spectrum to perform analytics which allow the user to identify,
authenticate and diagnose depending upon the application and the
unique field of use. The Company&#x2019;s proprietary platform
technologies are called ChromaID and Bio-RFID.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The ChromaID patented technology utilizes light at the photon
(elementary particle of light) level through a series of emitters
and detectors to generate a unique signature or
&#x201C;fingerprint&#x201D; from a scan of almost any solid, liquid
or gaseous material. This signature of reflected or transmitted
light is digitized, creating a unique ChromaID signature. Each
ChromaID signature is comprised of from hundreds to thousands of
specific data points.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The ChromaID technology looks beyond visible light frequencies to
areas of near infra-red and ultraviolet light and beyond that are
outside the humanly visible light spectrum. The data obtained
allows us to create a very specific and unique ChromaID signature
of the substance for a myriad of authentication, verification and
diagnostic applications.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Traditional light-based identification technology, called
spectrophotometry, has relied upon a complex system of prisms,
mirrors and visible light. Spectrophotometers typically have a
higher cost and utilize a form factor (shape and size) more suited
to a laboratory setting and require trained laboratory personnel to
interpret the information. The ChromaID technology uses lower cost
LEDs and photodiodes and specific electromagnetic frequencies
resulting in a more accurate, portable and easy-to-use solution for
a wide variety of applications. The ChromaID technology not only
has significant cost advantages as compared to spectrophotometry,
it is also completely flexible is size, shape and configuration.
The ChromaID scan head can range in size from endoscopic to a scale
that could be the size of a large ceiling-mounted florescent light
fixture.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">46</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In normal operation, a ChromaID master or reference scan is
generated and stored in a database. We call this the ChromaID
Reference Library. The scan head can then scan similar materials to
identify, authenticate or diagnose them by comparing the new
ChromaID digital signature scan to that of the original or
reference ChromaID signature or scan result. Over time, we believe
the ChromaID Reference Libraries can become a significant asset of
the Company, providing valuable information in numerous fields of
use. The Reference Libraries for our newly developed Bio-RFID will
have a similar promise regarding their utility and
value.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company&#x2019;s latest technology platform is called Bio-RFID.
Working in our lab over the past year and a half, we have developed
extensions and new inventions derived in part from our ChromaID
technology which we refer to as Bio-RFID technology. We are rapidly
advancing the development of this technology. We have announced
over the past several months that we have successfully been able to
non-invasively ascertain blood glucose levels in humans. We are
building the internal and external development team necessary to
commercialize this newly discovered technology as well as make
additional patent filings covering the intellectual property
created with these new inventions. The first applications of our
Bio-RFID technology will be in a product we call the UBAND&#x2122;.
The first UBAND product will be marketed as a real time calorie
counter. It is a wearable product which will be worn on the wrist
and communicate with a smart phone device via Bluetooth
connectivity. It will provide the user with real time information
on their caloric consumption from carbohydrates.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have also announced the results of laboratory-based comparison
testing between our Bio-RFID technology and the leading continuous
glucose monitors from Abbott Labs (Freestyle Libre&#xAE;) and
DexCom (G5&#xAE;). These results provide evidence of a high degree
of correlation between our Bio-RFID based technology and the
current industry leaders. Our technology is fundamentally
differentiated from these industry leaders as it is completely
non-invasive.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We expect to begin the process of obtaining US Food and Drug
Administration (FDA) approval of our non-invasive continuous blood
glucose monitoring device during calendar year 2019. To guide us in
that undertaking we have announced the hiring of a Chief Medical
Officer and formed a Medical and Regulatory Advisory Board to guide
us through the FDA process. We are unable, however, to estimate the
time necessary for such approval nor the likelihood of success in
that endeavor.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
ChromaID and Bio-RFID: Foundational Platform
Technologies</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our ChromaID and Bio-RFID technologies provide a platform upon
which a myriad of applications can be developed. As platform
technologies, they are analogous to a smartphone, upon which an
enormous number of previously unforeseen applications have been
developed. ChromaID and Bio-RFID technologies are
&#x201C;enabling&#x201D; technologies that bring the science of
electromagnetic energy to low-cost, real-world commercialization
opportunities across multiple industries. The technologies are
foundational and, as such, the basis upon which the Company
believes a significant business can be built.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As with other foundational technologies, a single application may
reach across multiple industries. The ChromaID technology can, for
example effectively differentiate and identify different brands of
clear vodkas that appear identical to the human eye. By extension,
this same technology can identify pure water from water with
contaminants present. It can provide real time detection of liquid
medicines such as morphine that have been adulterated or
compromised. It can detect if jet fuel has water contamination
present. It could determine when it is time to change oil in a deep
fat fryer. These are but a few of the potential applications of the
ChromaID technology based upon extensions of its ability to
identify different clear liquids.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Similarly, the Bio-RFID technology can non-invasively identity the
presence and quantity of glucose in the human body. By extension,
there may be other molecular structures which this same technology
can identity in the human body which, over time, the Company will
focus upon. They may include the monitoring of drug usage or the
presence of illicit drugs. They may also involve identifying
hormones and various markers of disease.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The cornerstone of a company with a foundational platform
technology is its intellectual property. We have pursued an active
intellectual property strategy and have been granted 12 patents. We
currently have more than 20 patents pending. We possess all right,
title and interest to the issued patents. Ten of the pending
patents are licensed exclusively to us in perpetuity by our
strategic partner, Allied Inventors, a spin-off entity of
Intellectual Ventures, an intellectual property fund.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">47</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Our Patents and Intellectual Property</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We believe that our 12 patents, more than 20 patent applications,
three registered trademarks, and our trade secrets, copyrights and
other intellectual property rights are important assets. Our issued
patents will expire at various times between 2027 and 2033. The
duration of our trademark registrations varies from country to
country. However, trademarks are generally valid and may be renewed
indefinitely as long as they are in use and/or their registrations
are properly maintained.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The issued patents cover the fundamental aspects of the Know Labs
ChromaID technology and a growing number of unique applications
ranging, to date, from invisible bar codes to tissue and liquid
analysis. We have filed patents on Bio-RFID technology and will
continue to expand the Company&#x2019;s patent portfolio over time
through internal development efforts as well as through licensing
opportunities with third parties.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Additionally, significant aspects of our technology are trade
secrets which may not be disclosed through the patent filing
process. We intend to be diligent in maintaining our trade
secrets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The patents that have been issued to Know Labs and their dates of
issuance are:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 9, 2011, we were issued US Patent No. 7,996,173 B2
entitled &#x201C;Method, Apparatus and Article to Facilitate
Distributed Evaluation of Objects Using Electromagnetic
Energy,&#x201D; by the United States Office of Patents and
Trademarks. The patent expires August 24, 2029.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 13, 2011, we were issued US Patent No. 8,076,630 B2
entitled &#x201C;System and Method of Evaluating an Object Using
Electromagnetic Energy&#x201D; by the United States Office of
Patents and Trademarks. The patent expires November 7,
2028.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 20, 2011, we were issued US Patent No. 8,081,304 B2
entitled &#x201C;Method, Apparatus and Article to Facilitate
Evaluation of Objects Using Electromagnetic Energy&#x201D; by the
United States Office of Patents and Trademarks. The patent expires
July 28, 2030.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On October 9, 2012, we were issued US Patent No. 8,285,510 B2
entitled &#x201C;Method, Apparatus, and Article to Facilitate
Distributed Evaluation of Objects Using Electromagnetic
Energy&#x201D; by the United States Office of Patents and
Trademarks. The patent expires July 31, 2027.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On February 5, 2013, we were issued US Patent No. 8,368,878 B2
entitled &#x201C;Method, Apparatus and Article to Facilitate
Evaluation of Objects Using Electromagnetic Energy by the United
States Office of Patents and Trademarks. The patent expires July
31, 2027.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On November 12, 2013, we were issued US Patent No. 8,583,394 B2
entitled &#x201C;Method, Apparatus and Article to Facilitate
Distributed Evaluation of Objects Using Electromagnetic Energy by
the United States Office of Patents and Trademarks. The patent
expires July 31, 2027.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On November 21, 2014, we were issued US Patent No. 8,888,207 B2
entitled &#x201C;Systems, Methods, and Articles Related to
Machine-Readable Indicia and Symbols&#x201D; by the United States
Office of Patents and Trademarks. The patent expires February 7,
2033. This patent describes using ChromaID to see what we call
invisible bar codes and other identifiers.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 23, 2015, we were issued US Patent No. 8,988,666 B2
entitled &#x201C;Method, Apparatus, and Article to Facilitate
Evaluation of Objects Using Electromagnetic Energy&#x201D; by the
United States Office of Patents and Trademarks. The patent expires
July 31, 2027.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 26, 2015, we were issued US Patent No. 9,041,920 B2 entitled
&#x201C;Device for Evaluation of Fluids using Electromagnetic
Energy&#x201D; by the United States Office of Patents and
Trademarks. The patent expires March 12, 2033. This patent
describes a ChromaID fluid sampling devices.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">48</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 19, 2016, we were issued US Patent No. 9,316,581 B2
entitled &#x201C;Method, Apparatus, and Article to Facilitate
Evaluation of Substances Using Electromagnetic Energy&#x201D; by the
United States Office of Patents and Trademarks. The patent expires
March 12, 2033. This patent describes an enhancement to the
foundational ChromaID technology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 18, 2017, we were issued US Patent No. 9,625,371 B2
entitled &#x201C;Method, Apparatus, and Article to Facilitate
Evaluation of Substances Using Electromagnetic Energy.&#x201D; The
patent expires July 2027. This patent pertains to the use of
ChromaID technology for the identification and analysis of
biological tissue. It has many potential applications in medical,
industrial and consumer markets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 4, 2018, we were issued US Patent No. 9,869,636 B2,
entitled &#x201C;Device for Evaluation of Fluids Using
Electromagnetic Energy.&#x201D; The patent expires approximately
April 2033. This patent pertains to the use of ChromaID technology
for evaluating and analyzing fluids such as those following through
an IV drip in a hospital or water, for example.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We continue to pursue a patent strategy to expand our unique
intellectual property in the United States and other
countries.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Product Strategy</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are currently undertaking internal development work on potential
products for the consumer marketplace. This development work was
previously being performed through our Consulting Agreement with
Blaze Clinical, and Phillip A. Bosua, who served as our Chief
Product Officer. In his current role as Chief Executive Officer,
Mr. Bosua continues to lead these efforts. We have announced the
development of our UBAND Calorie Counter and our UBAND CGM. We have
also recently announced the engagement of a manufacturing partner
we will work with to bring these products to market. We will make
further announcements regarding these products as development and
manufacturing work on them progresses.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As time and resources permit, we also will engage with partners
through licensing our technology in various fields of use, entering
in to joint venture agreements to develop specific applications of
our technology, and in certain specific instances develop our own
products for the marketplace.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Currently we are focusing our current efforts on productizing our
Bio-RFID technology as we move it out of the research laboratory
and in to the marketplace.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Research and Development</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our current research and development efforts are primarily focused
improving our Bio-RFID technology, extending its capacity and
developing new and unique applications for the technology. As part
of this effort, we conduct on-going laboratory testing to ensure
that application methods are compatible with the end-user and
regulatory requirements, and that they can be implemented in a
cost-effective manner. We are also actively involved in identifying
new applications. Our current internal team along with outside
consultants have considerable experience working with the
application of our technologies and their application. We engage
third party experts as required to supplement our internal team. We
believe that continued development of new and enhanced technologies
is essential to our future success. We incurred expenses of
$391,014, $570,514 and $79,405 for the six months ended March 31,
2019 and years ended September 30, 2018 and 2017, respectively, on
development activities, On July 6, 2017, we entered into a
Consulting Agreement with Phillip A. Bosua, our Chief Product
Officer to lead our development efforts. He has continued in that
role with expanded responsibilities upon his appointment as Chief
Executive Officer on April 19, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">49</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Merger with RAAI Lighting, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, we entered into an Agreement and Plan of Merger
with 500 Union Corporation, a Delaware corporation and a wholly
owned subsidiary of the Company, and RAAI Lighting, Inc., a
Delaware corporation. Pursuant to the Merger Agreement, we have
acquired all the outstanding shares of RAAI&#x2019;s capital stock
through a merger of Merger Sub with and into RAAI (the
&#x201C;Merger&#x201D;), with RAAI surviving the Merger as a wholly
owned subsidiary of the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Under the terms of the Merger Agreement, each share of RAAI common
stock issued and outstanding immediately before the Merger (1,000
shares) were cancelled and we issued 2,000,000 shares of our common
stock. As a result, we issued 2,000,000 shares of its common stock
to Phillip A. Bosua, formerly the sole stockholder of RAAI. The
consideration for the Merger was determined through arms-length
bargaining by the Company and RAAI. The Merger was structured to
qualify as a tax-free reorganization for U.S. federal income tax
purposes. As a result of the Merger, the Company received certain
intellectual property, related to RAAI.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Merger with Know Labs, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, Know Labs, Inc., a Nevada corporation incorporated
on April 3, 2018, and our wholly-owned subsidiary, merged with and
into the Company pursuant to an Agreement and Plan of Merger dated
May 1, 2018. In connection with the merger, our Articles of
Incorporation were effectively amended to change our name to Know
Labs, Inc. by and through the filing of Articles of Merger. This
parent-subsidiary merger was approved by us, the parent, in
accordance with Nevada Revised Statutes Section 92A.180.
Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1,
2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Corporate Name Change and Symbol Change</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On May
24, 2018, the Financial Industry Regulatory Authority
(&#x201C;FINRA&#x201D;) announced the effectiveness of a change in
our name from Know Labs Incorporated to Know Labs, Inc. and a
change in our ticker symbol from VSUL to the new trading symbol
KNWN which became effective on the opening of trading as of May 25,
2018. In addition, in connection with the name change and symbol
change, we were assigned the CUSIP number of
499238103.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="MANAGEMENT2">M</a>ANAGEMENT</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Identification of Directors and Executive Officers</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following table sets forth certain information about our current
directors and executive officers<font style="font-family: Times New Roman">:</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: bottom; width: 25%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold"><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">Name</font></font></font></font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 13%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold"><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">Age</font></font></font></font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 60%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold"><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">Director/
Executive Officer</font></font></font></font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 25%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Directors-</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 13%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 60%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 25%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ronald
P. Erickson</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 13%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">75</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 60%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chairman
and Interim Chief Financial Officer (1)</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 25%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 13%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">45</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 60%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Executive Officer and Director</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 25%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Jon
Pepper</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 13%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">68</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 60%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Director
(2)</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 25%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ichiro
Takesako</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 13%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">60</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 60%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Director</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 25%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">William
A. Owens</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 13%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">79</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 60%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Director
(3)</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">(1)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Chairman of the
Nominating and Corporate Governance Committee.</font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-family: Times New Roman; font-size: 13px">(2)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-family: Times New Roman; font-size: 13px">Chairman of the
Audit Committee.</font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">(3)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">Chairman of the
Compensation Committee.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Term of Office</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Each of our officers is elected by the Company's Board of Directors
to serve until the next annual meeting of Directors or until their
successors are duly elected and qualified. Each of our directors is
elected by the Company's Board of Directors and shall hold office
until the next annual meeting of stockholders and until his/her
successor shall have been duly elected and qualified.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">50</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Background and Business Experience</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Ronald P. Erickson</font> <font style="color: #000000">has been a
director and officer of Know Labs since April 2003. He was
appointed as our CEO and President in November 2009 and as Chairman
of the Board in February 2015. Previously, Mr. Erickson was our
President and Chief Executive Officer from September 2003 through
August 2004, and was Chairman of the Board from August 2004 until
May 2011.&#xA0;Mr. Erickson stepped down as Chief Executive Officer
on April 10, 2018.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
A senior executive with more than 30 years of experience in the
high technology, telecommunications, micro-computer, and digital
media industries, Mr. Erickson was the founder of Know Labs. He is
formerly Chairman, CEO and Co-Founder of Blue Frog Media, a mobile
media and entertainment company; Chairman and CEO of eCharge
Corporation, an Internet-based transaction procession
company,&#xA0;&#xA0;Chairman, CEO and Co-founder of GlobalTel
Resources, a provider of telecommunications services; Chairman,
Interim President and CEO of Egghead Software, Inc. a software
reseller where he was an original investor; Chairman and CEO of
NBI, Inc.; and Co-founder of MicroRim, Inc. the database software
developer. Earlier, Mr. Erickson practiced law in Seattle and
worked in public policy in Washington, DC and New York, NY.
Additionally, Mr. Erickson has been an angel investor and board
member of a number of public and private technology
companies.&#xA0;&#xA0;In addition to his business activities, Mr.
Erickson is Chairman of the Board of Trustees of Central Washington
University where he received his BA degree. He also holds a MA from
the University of Wyoming and a JD from the University of
California, Davis. He is licensed to practice law in the State of
Washington.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Erickson is our founder and was appointed as a director because
of his extensive experience in developing technology
companies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Phillip A. Bosua</font> was appointed a director and Chief
Executive Officer of the Company on April 10, 2018. Previously, Mr.
Bosua served as our Chief Product Officer since August 2017 and we
entered into a Consulting Agreement on July 7, 2017. From September
2012 to February 2015, he was the founder and Chief Executive
Officer of LIFX Inc. (where he developed and marketed an innovative
&#x201C;smart&#x201D; light bulb) and from August 2015 until February
2016 was Vice President Consumer Products at Soraa (which markets
specialty LED light bulbs). From February 2016 to July 2017, Mr.
Bosua was the founder and CEO of RAAI, Inc. (where he continued the
development of his smart lighting technology).&#xA0; From May 2008
to February 2013 he was the Founder and CEO of LimeMouse Apps, a
leading developer of applications for the Apple App
Store.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Bosua was appointed as a director because of his extensive
experience in developing technology companies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Ichiro Takesako</font> <font style="color: #000000">has served as a
director since December 28, 2012. Mr. Takesako has held executive
positions with Sumitomo Precision Products Co., Ltd or Sumitomo
since 1983. Mr. Takesako graduated from Waseda University, Tokyo,
Japan where he majored in Social Science and graduated with a
Degree of Bachelor of Social Science.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In the past few years, Mr. Takesako has held the following
executive position in Sumitomo and its affiliates:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 108px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">June
2008:</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">appointed
as General Manager of Sales and Marketing Department of Micro
Technology Division</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 108px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">April
2009:</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">appointed
as General Manager of Overseas Business Department of Micro
Technology Division, in charge of M&amp;A activity of certain
business segment and assets of Aviza Technology, Inc.</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 108px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">July
2010:</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">appointed
as Executive Director of SPP Process Technology Systems, 100% owned
subsidiary of Sumitomo Precision Products then, stationed in
Newport, Wales</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 108px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">August
2011:</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">appointed
as General Manager, Corporate Strategic Planning Group</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 108px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">January
2013:</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">appointed
as Chief Executive Officer of M2M Technologies, Inc., a company
invested by Sumitomo Precision products</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 108px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">April
2013:</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">appointed
as General Manager of Business Development Department, in parallel
of CEO of M2M Technologies, Inc.</font></div>
</div>
</div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 108px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">April
2014:</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">relieved
from General Manager of Business Development Department and is
responsible for M2M Technologies Inc. as its CEO</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Takesako was appointed as a Director based on his position with
Sumitomo and Sumitomo's significant partnership with the
Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font> <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">51</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Jon Pepper</font> <font style="color: #000000">has served as an
independent director since April 2006. Mr. Pepper founded Pepcom in
1980, and continues as the founding partner of Pepcom, an industry
leader at producing press-only technology showcase events around
the country. Prior to that, Mr. Pepper started the DigitalFocus
newsletter, a ground-breaking newsletter on digital imaging that
was distributed to leading influencers worldwide. Mr. Pepper has
been closely involved with the high technology revolution since the
beginning of the personal computer era. He was formerly a
well-regarded journalist and columnist; his work on technology
subjects appeared in</font> <font style="font-style: italic; color: #000000">The New York
Times</font><font style="color: #000000">,</font> <font style="font-style: italic; color: #000000">Fortune</font><font style="color: #000000">,</font> <font style="font-style: italic; color: #000000">PC Magazine</font><font style="color: #000000">,</font> <font style="font-style: italic; color: #000000">Men's
Journal</font><font style="color: #000000">,</font> <font style="font-style: italic; color: #000000">Working
Woman</font><font style="color: #000000">,</font> <font style="font-style: italic; color: #000000">PC Week</font><font style="color: #000000">,</font> <font style="font-style: italic; color: #000000">Popular Science</font>
<font style="color: #000000">and many other well-known
publications. Pepper was educated at Union College in Schenectady,
New York and the Royal Academy of Fine Arts in
Copenhagen.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Pepper was appointed as a director because of his marketing
skills with technology companies.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
William A. Owens</font> has served as an independent director since
May 24, 2018. Mr. Owens is currently the co-founder and executive
chairman of Red Bison Advisory Group, a company which identifies
opportunities with proven enterprises in China, the Middle East,
and the United States and creates dynamic partnerships focusing on:
natural resources (oil, gas and fertilizer plants), real estate,
and information and communication technology. Most recently, he was
the chairman of the board of CenturyLink Telecom, the third largest
telecommunications company in the United States and was on the
advisory board of SAP USA. Mr. Owens serves on the board of
directors at Wipro Technologies and is a director of the following
private companies: Humm Kombucha, a beverage company and Versium.
Mr. Owens is on the advisory board of the following private
companies: Healthmine, Platform Science, Sarcos, Sierra Nevada
Corporation, and Vodi. Mr. Owens is on the board of trustees at
EastWest Institute, Seattle University, and an advisor to the
Fiscal Responsibility Amendment (CFFRA) Association which aims to
establish a balanced budget amendment to the US Constitution. He is
also a member of the Council of Foreign Relations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">From
2007 to 2015, Mr. Owens was the Chairman and Senior Partner of AEA
Investors Asia, a private equity firm located in Hong Kong, and
Vice Chairman of the NYSE for Asia. Mr. Owens also served as the
Chairman of Eastern Airlines. He has served on over 20 public
boards including Daimler, British American Tobacco, Telstra, Nortel
Networks, and Polycom. Mr. Owens was the CEO/Chairman of Teledesic
LLC, a Bill Gates/Craig McCaw company bringing worldwide broadband
through an extensive satellite network and prior, was the
President, COO/Vice Chairman of Science Applications International
Corporation (SAIC). Mr. Owens has also served on the boards of the
non-for-profit organizations; Fred Hutchinson Cancer Research
Center, Carnegie Corporation of New York, Brookings Institution,
and RAND Corporation.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Mr.
Owens is a four-star US Navy veteran. He was Vice Chairman of the
Joint Chiefs of Staff, the second-ranking United States military
officer with responsibility for reorganizing and restructuring the
armed forces in the post- Cold War era. He is widely recognized for
bringing commercial high-grade technology into the Department of
Defense for military applications</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Mr.
Owens is a 1962 honor graduate of the United States Naval Academy
with a bachelor&#x2019;s degree in mathematics, bachelor&#x2019;s and
master&#x2019;s degrees in politics, philosophy and economics from
Oxford University, and a master&#x2019;s degree in management from
George Washington University.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Mr.
Owen was appointed as a director because of his business skills
with technology companies.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Board of Directors Composition</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The Board has three standing committees to facilitate and assist
the Board in the execution of its responsibilities. The committees
are currently the Audit Committee, the Nominations and Corporate
Governance Committee, and the Compensation Committee. The
Committees were formed in July 2010. The Audit and Compensation
Committees are comprised solely of non-employee, independent
directors. The Nominating and Corporate Governance Committee has aa
management director, Ronald P. Erickson, as Chairman. Charters for
each committee are available on our website at</font> <font style="color: #000000">www.knowlabs.co. The discussion below describes
current membership for each of the standing Board
committees.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">52</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 30%">
<div><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></font></font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></font></font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></font></font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></font></font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-weight: bold; font-family: Times New Roman;">Nominations
and</font></font></font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-weight: bold; font-family: Times New Roman;">Audit</font></font></font></div>
</td>
<td style="vertical-align: bottom; width: 3%;">
<div><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></font></font></div>
</td>
<td style="vertical-align: bottom; width: 32%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-weight: bold; font-family: Times New Roman;">Compensation</font></font></font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></font></font></div>
</td>
<td style="vertical-align: bottom; width: 32%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold"><font style="font-size: 11px; font-weight: bold;"><font style="font-weight: bold; font-family: Times New Roman;">Corporate
Governance</font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 30%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Jon
Pepper (Chairman)</font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">William
A. Owens (Chairman)</font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ron
Erickson (Chairman)</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">William
A. Owens</font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Jon
Pepper</font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 30%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ichiro
Takesako</font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ichiro
Takesako</font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">William
A. Owens</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Jon
Pepper</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">There
are no family relationships among any of our directors or executive
officers.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Communication with our Board of Directors</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
stockholders and other interested parties may communicate with our
Board of Directors by sending written communication in an envelope
addressed to "Board of Directors" in care of the Secretary, 500
Union Street, Suite 810, Seattle, Washington 98101.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Director Independence</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The Board has affirmatively determined that Mr. Pepper, Mr.
Takesako and William A. Owens are each an</font> <font style="color: #000000">independent director. &#xA0;For purposes of making
that determination, the Board used NASDAQ&#x2019;s Listing Rules
even though the Company is not currently listed on
NASDAQ.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Code of Ethics</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
adopted conduct and ethics standards titled the code of ethics,
which is available at www.knowlabs.co. These standards were adopted
by our Board of Directors to promote transparency and integrity.
The standards apply to our Board of Directors, executives and
employees. Waivers of the requirements of our code of ethics or
associated polices with respect to members of our Board of
Directors or executive officers are subject to approval of the full
board.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Audit Committee</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
Board of Directors established an audit committee in July
<font style="color: #000000">2010</font>. Our audit committee
provides assistance to the Board in fulfilling its responsibilities
to our stockholders relating to: (1)&#xA0;maintaining the integrity
of our financial reports, including our compliance with legal and
regulatory requirements, (2)&#xA0;the independent auditor's
qualifications and independence, (3)&#xA0;the performance of our
internal audit function in cooperation with the independent
auditors, and (4)&#xA0;the preparation of the report required by
the rules of the SEC to be included in our annual proxy statement.
Our audit committee is directly responsible for the appointment,
compensation and oversight of the independent auditors (including
the resolution of any disagreements between management and the
independent auditors regarding financial reporting), approving in
advance all auditing services, and approving in advance all
non-audit services provided by the independent auditors. The
independent auditors report directly to the committee. In addition,
our audit committee is to review our annual and quarterly financial
reports in conjunction with the independent auditors and financial
management.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px">
Our Board of Directors has adopted a written charter for the audit
committee, a copy of which is available on our website at</font>
<font style="text-decoration: underline; color: #000000; font-size: 13px">www.knowlabs.co</font><font style="color: #000000; font-size: 13px">.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">53</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Compensation Committee</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
Board of Directors established a compensation committee in July
2010. Our compensation committee is responsible for:
(1)&#xA0;reviewing and approving goals and objectives underlying
the compensation of our Chief Executive Officer, evaluating the
CEO's performance in accordance with those goals and objectives,
and determining and approving the CEO's compensation;
(2)&#xA0;recommending to the board the compensation of executive
officers other than the CEO, subject to board approval;
(3)&#xA0;administering any incentive compensation and equity-based
plans, subject to board approval; (4)&#xA0;preparing the
compensation report required by the rules and regulations of the
SEC for inclusion in our annual proxy statement; and
(5)&#xA0;periodically reviewing the results of our executive
compensation and perquisite programs and making recommendations to
the board with respect to annual compensation (salaries, fees and
equity) for our executive officers and non-employee
directors.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px">
Our Board of Directors has adopted a written charter for the
compensation committee, a copy of which is available on our website
at</font> <font style="text-decoration: underline; color: #000000; font-size: 13px">www.knowlabs.co</font><font style="color: #000000; font-size: 13px">.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Nominations and Governance Committee</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
Board of Directors established the nominations and governance
committee in July 2010 for the purpose of: (1)&#xA0;assisting the
board in identifying individuals qualified to become board members
and recommending to the board the nominees for election as
directors at the next annual meeting of stockholders;
(2)&#xA0;assist the board in determining the size and composition
of the board committees; (3)&#xA0;develop and recommend to the
board the corporate governance principles applicable to us; and
(4)&#xA0;serve in an advisory capacity to the board and the
Chairman of the Board on matters of organization, management
succession planning, major changes in our organizational and the
conduct of board activities.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px">
Our Board of Directors has adopted a written charter for the
nominations and governance committee, a copy of which is available
on our website at</font> <font style="text-decoration: underline; color: #000000; font-size: 13px">www.knowlabs.co</font><font style="color: #000000; font-size: 13px">.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Involvement in Certain Legal Proceedings</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
None of our directors or executive officers has, during the past
ten years:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Had any petition under the federal bankruptcy laws or any state
insolvency law filed by or against, or had a receiver, fiscal
agent, or similar officer appointed by a court for the business or
property of such person, or any partnership in which he was a
general partner at or within two years before the time of such
filing, or any corporation or business association of which he was
an executive officer at or within two years before the time of such
filing;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Been convicted in a criminal proceeding or a named subject of a
pending criminal proceeding (excluding traffic violations and other
minor offenses);</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Been the subject of any order, judgment, or decree, not
subsequently reversed, suspended, or vacated, of any court of
competent jurisdiction, permanently or temporarily enjoining him
from, or otherwise limiting, the following activities:</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25E6;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Acting as a futures commission merchant, introducing broker,
commodity trading advisor, commodity pool operator, floor broker,
leverage transaction merchant, any other person regulated by the
Commodity Futures Trading Commission, or an associated person of
any of the foregoing, or as an investment adviser, underwriter,
broker or dealer in securities, or as an affiliated person,
director or employee of any investment company, bank, savings and
loan association or insurance company, or engaging in or continuing
any conduct or practice in connection with such
activity;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25E6;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Engaging in any type of business practice; or</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25E6;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Engaging in any activity in connection with the purchase or sale of
any security or commodity or in connection with any violation of
federal or state securities laws or federal commodities
laws;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">54</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Been the subject of any order, judgment, or decree, not
subsequently reversed, suspended, or vacated, of any federal or
state authority barring, suspending, or otherwise limiting for more
than 60 days the right of such person to engage in any activity
described in (i) above, or to be associated with persons engaged in
any such activity;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Been found by a court of competent jurisdiction in a civil action
or by the SEC to have violated any federal or state securities law,
where the judgment in such civil action or finding by the SEC has
not been subsequently reversed, suspended, or vacated;
or</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 97%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Been found by a court of competent jurisdiction in a civil action
or by the Commodity Futures Trading Commission to have violated any
federal commodities law, where the judgment in such civil action or
finding by the Commodity Futures Trading Commission has not been
subsequently reversed, suspended, or vacated.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Compliance with Section 16(a) of the Exchange Act</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our executive officers, directors and 10% stockholders are required
under Section 16(a) of the Exchange Act to file reports of
ownership and changes in ownership with the SEC. Copies of these
reports must also be furnished to us.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Based solely on a review of copies of reports furnished to us, as
of September 30, 2018 our executive officers, directors and 10%
holders complied with all filing requirements except as
follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Todd
Martin Sames filed a Form 4 on January 11, 2018 that was required
to be filed on January 15, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Jon
Pepper filed a Form 4 on April 19, 2018 that was required to be
filed on April 12, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ichiro
Takesako filed a Form 4 on April 19, 2018 that was required to be
filed on April 12, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Phillip
Bosua filed a Form 4 on July 10, 2018 that was required to be filed
on June 27, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="EXECUTIVEANDDIRECTORCOMPENSATION">E</a>XECUTIVE AND DIRECTOR
COMPENSATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following table provides information concerning remuneration of
the chief executive officer, the chief financial officer and
another named executive officer for the fiscal years ended
September 30, 2018 and 2017:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Summary Compensation Table</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0px auto 0px 0px; width: 100%; font-size: inherit; font-family: inherit;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 18%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 9%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">All</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 18%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Stock</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Option</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Other</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 18%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Salary</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Bonus</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Awards</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Awards</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Compensation</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Total</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 18%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Name</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Principal
Position</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="border-bottom: 2px solid rgb(0, 0, 0);">
<div style="margin-left: 0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">($)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">($)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">($)
(4)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">($)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">($)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">($)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 18%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Salary-</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 18%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ronald
P. Erickson (1)</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Chairman
of the Board and Interim Chief Financial Officer</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">9/30/2018</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">180,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">21,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">201,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 18%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">9/30/2017</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">180,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">34,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">214,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 18%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 18%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua (2)</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Chief
Executive Officer</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">9/30/2018</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">106,095</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">177,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">640,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">167,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,090,595</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 18%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">9/30/2017</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">8,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">17,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">26,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 18%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 18%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Todd
Martin Sames (4)</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Former
Executive Vice President of Business Development</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">9/30/2018</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">58,846</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">21,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">79,846</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 18%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 19%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">9/30/2017</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">120,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">145,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(1)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">During the years ended September 30, 2018 and
2017, Mr. Erickson was compensated at a monthly salary of $15,000.
As of September 30, 2017 and 2016, Mr. Erickson had accrued but
unpaid salary of $120,000 and $7,500, respectively. This accrual
was based on the tight cash flow of the Company and agreed to by
Mr. Erickson, but there was no formal deferral agreement. There was
no accrued interest paid on the unpaid salary.</font> <font style="color: #000000">The 100,000 of restricted common stock was issued
on January 16, 2018 to Mr. Erickson at the grant date market value
of $0.21 per share.&#xA0;&#xA0;The 200,000 of restricted common
stock was issued on September 7, 2017 to Mr. Erickson at the grant
date market value of $0.17 per
share.&#xA0;<br></font></font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(2)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">On April 10,
2018, we appointed Mr. Bosua as our Chief Executive Officer. During
the period April 10. 2018 to September 30, 2018, Mr. Bosua was
compensated at a monthly salary of $18,750. We entered into a
Consulting Agreement with Mr. Bosua&#x2019;s company, Blaze Clinical
on July 7, 2017. We paid $167,500 during the period October 1,
2017- April 9, 2018. We paid $17,500 during the period July 7, 2017
to September 30, 2017. The 50,000 of restricted common stock was
issued on February 7, 2018 to Mr. Bosua at the grant date market
value of $0.24 per share.&#xA0;&#xA0;The 500,000 of restricted
common stock was issued on June 25, 2018 to Mr. Bosua at the grant
date market value of $0.33 per share.&#xA0;The 50,000 of restricted
common stock was issued on July 14, 2017 to Mr. Bosua at the grant
date market value of $0.17 per share.&#xA0;On July 30, 2018, Mr.
Bosua was awarded a stock option grant for 1,000,000 shares of our
common stock that was awarded at $1.28 per share and was valued at
the black scholes value of $0.64 per
share.&#xA0;<br></font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">55</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(3)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">February 23, 2018 was Mr. Todd
Sames&#x2019;s last date of employment as our Executive Vice
President of Business Development. <font style="color: #000000">We
paid $58,846 during the period October 1, 2017- February 23, 2018.
During the year ended September 30, 2017, Mr. Sames was compensated
at a monthly salary of $10,000. As of September 30, 2017, Mr. Sames
had accrued but unpaid salary of $10,000. This accrual was based on
the tight cash flow of the Company and agreed to by Mr. Sames, but
there was no formal deferral agreement. There was no accrued
interest paid on the unpaid salary.</font> <font style="color: #000000">The 100,000 of restricted common stock was issued
on January 11, 2018 to Mr. Sames at the grant date market value of
$0.21 per share.&#xA0;&#xA0;The 150,000 of restricted common stock
was issued on September 7, 2017 to Mr. Sames at the grant date
market value of $0.17 per share.&#xA0;&#xA0;</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(4)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">These
amounts reflect the grant date market value as required by
Regulation S-K Item 402(n)(2), computed in accordance with FASB ASC
Topic 718.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px">
&#xA0;</font><font style="font-weight: bold; color: #000000">Grants
of Stock Based Awards in Fiscal Year Then Ended September 30,
2018</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Compensation Committee approved the following performance-based
incentive compensation to the Named Executive Officers during the
year ended September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px;">

<table cellpadding="0" cellspacing="0" style="text-align: justify; margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;All
Other</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;All
Other</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Option
Awards;</font></font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><br></font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">&#xA0;Estimated
Future Payouts Under</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">&#xA0;Estimated
Future Payouts Under</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Stock
Awards;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Number
of</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">&#xA0;Non-Equity
Incentive Plan</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">&#xA0;Equity
Incentive Plan</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Number
of</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Securities</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Exercise
or</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Grant
Date</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 10%;">
<div style="margin-left: 0px; padding-bottom: 2px;"><font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; width: 3%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 94%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
&#xA0;Awards</font> <font style="font-size: 13px; font-family: Times\ New\ Roman;">&#xA0;</font>
<font style="font-size: 13px; font-family: Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; width: 3%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; width: 3%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 94%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
&#xA0;Awards</font> <font style="font-size: 13px; font-family: Times\ New\ Roman;">&#xA0;</font>
<font style="font-size: 13px; font-family: Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; width: 3%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 8%;">
<div><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
&#xA0;Shares of</font></div>
</font><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
&#xA0;Underlying</font></div>
</font><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
&#xA0;Base Price of</font></div>
</font><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
&#xA0;Fair Value of</font></div>
</font><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Grant</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Threshold</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Target</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Maximum</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Threshold</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Target</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Maximum</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Stock
or Units</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Options</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Option
Awards</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Stock
and</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 10%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Name</font></div>
</td>
<td style="vertical-align: bottom; width: 10%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Date</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;($)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;($)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;($)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: center; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(#)</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: center; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(#)</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: center; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(#)</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: center; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(#)</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: center; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(#)</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;($/Sh)
(4)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;Option
Awards</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="5" style="vertical-align:bottom;width:44%;">
<div style="margin-left:0px;"><font style="text-align: left; vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;display:inline-block;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:10%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ronald
P. Erickson (1)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">200,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">200,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">200,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.170</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">55,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="2" style="vertical-align:bottom;width:20%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:10%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua (2)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">550,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,000,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.640</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">817,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="2" style="vertical-align:bottom;width:20%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:10%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Todd
Martin Sames (3)</font></div>
</td>
<td style="vertical-align:bottom;width:10%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.210</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:8%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">21,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
&#xA0;&#xA0; <br></div>
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(1)
The restricted common stock was issued on September 7, 2017 to Mr.
Erickson at the grant date market value of $0.17 per
share.&#xA0;&#xA0;The estimated future payments include 100,000
shares to be issued on January 1, 2019 and 2020. The 100,000 of
restricted common stock was issued on January 16, 2018 to Mr.
Erickson at the grant date market value of $0.21 per
share.&#xA0;&#xA0;</font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(2) On April 10, 2018, we appointed Mr. Bosua as our Chief
Executive Officer. The 50,000 of restricted common stock was issued
on February 7, 2018 to Mr. Bosua at the grant date market value of
$0.24 per share.&#xA0;&#xA0;The 500,000 of restricted common stock
was issued on June 25, 2018 to Mr. Bosua at the grant date market
value of $0.33 per share.&#xA0; On July 30, 2018, Mr. Bosua was
awarded a stock option grant for 1,000,000 shares of our common
stock that was awarded at $1.28 per share and was valued at the
black scholes value of $0.64 per share.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
(3)</font> February 23, 2018 was Mr. Todd Sames last date of
employment as our Executive Vice President of Business Development.
<font style="color: #000000">The 100,000 of restricted common stock
was issued on January 11, 2018 to Mr. Sames at the grant date
market value of $0.21 per share.&#xA0;&#xA0;The 150,000 of
restricted common stock was issued on September 7, 2017 to Mr.
Sames at the grant date market value of $0.17 per
share.&#xA0;&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(4) These amounts reflect the grant date market value as required
by Regulation S-K Item 402(n)(2), computed in accordance with FASB
ASC Topic 718.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">56</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Outstanding Equity Awards as of Fiscal Year Then Ended September
30, 2018</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
&#xA0;&#xA0; <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our Named Executive Officers have the following outstanding equity
awards as of September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px;">

<table cellpadding="0" cellspacing="0" style="text-align: justify; font-family: inherit; margin: 0px auto 0px 0px; width: 70%; font-size: inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:27%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="4" rowspan="1" style="vertical-align: bottom; width: 60%;">
<div><font style="text-align: left; padding-bottom:2px;width:2%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:96%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">Option
Awards</font> <font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:2%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Number
of</font></font> Securities</font></font> Underlying</font></font>
Unexercised</font></font> Options</font></font>
Exercisable</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Number
of</font></font> Securities</font></font> Underlying</font></font>
Unexercised</font></font> Options</font></font>
Unexerciseable</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;
<font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Option</font></font>
Exercise</font></font> Price</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Option</font></font></div>
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Expiration</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 27%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Name</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: center; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(#)</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: center; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(#)</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;($)
(4)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Date</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ronald
P. Erickson (1)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua (2)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,000,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.28</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">7/23/2023</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Todd
Martin Sames (3)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
&#xA0; </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Option Exercises and Stock Vested</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our Named Executive Officers did not have any option exercises
during the year ended September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Pension Benefits</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We do not provide any pension benefits.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Nonqualified Deferred Compensation</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We do not have a nonqualified deferral program.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Employment Agreements</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have an employment agreement with Ronald P. Erickson and Phillip
A. Bosua.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Potential Payments upon Termination or Change in
Control</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have the following potential payments upon termination or change
in control with Ronald P. Erickson:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px;">

<table cellpadding="0" cellspacing="0" style="text-align: justify; margin-right:0px;width:80%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Executive</font>
Payments Upon</font> Separation</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">For
Cause</font></font> Termination on</font></font>
9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Early
or</font></font> Normal</font></font> Retirement on</font></font>
9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Not For
Good</font></font>Cause</font></font> Termination
on</font></font>9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Change
in</font></font> Control</font></div>
</font> Termination on</font></font> 9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;"><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Disability
or</font></font> Death on</font></font> 9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Compensation:</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Base
salary (1)</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">180,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">180,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Performance-based
incentive</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;compensation
(2)</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">34,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">34,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock
options</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Benefits
and Perquisites:</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Health
and welfare benefits (3)</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">27,388</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">27,388</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accrued
vacation pay</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">42,231</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">42,231</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">283,619</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">283,619</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
&#xA0;&#xA0; </div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(1)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Reflects a salary
for twelve months.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(2)</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
the vesting of estimated future payments includes 100,000 shares to
be issued on January 1, 2019 and 2020 valued at $0.17 per
share.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(3)</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
the cost of medical benefits for eighteen months.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">57</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have the following potential payments upon termination or change
in control with Phillip A. Bosua:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px;">

<table cellpadding="0" cellspacing="0" style="text-align: justify; margin-right:0px;width:80%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:30%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Early</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Not For
Good</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Change
in</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Executive</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">For
Cause</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">or
Normal</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Cause</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Control</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Disability</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Payments
Upon</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Termination</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Retirement</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Termination</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Termination</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">or
Death</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Separation</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">on
9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">on
9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">on
9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">on
9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">on
9/30/18</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Compensation:</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Base
salary (1)</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">225,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">225,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Performance-based
incentive</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;compensation
(2)</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock
options</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">640,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">640,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:30%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Benefits
and Perquisites:</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Health
and welfare benefits (3)</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13,218</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13,218</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accrued
vacation pay</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:30%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:30%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">878,218</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">878,218</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
&#xA0; <font style="font-family: Times New Roman; font-size: 13px;"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(1)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Reflects a salary
for one year.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(2)</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
the vesting of 1,000,000 shares to be issued upon a change in
control valued at $0.64 per share.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(3)</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
the cost of medical benefits for eighteen months</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We do
not have any <font style="color: #000000">potential payments upon
termination or change in control with our other Named Executive
Officers.</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
DIRECTOR COMPENSATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We primarily use stock options grants to incentive compensation to
attract and retain qualified candidates to serve on the Board. This
compensation reflected the financial condition of the Company. In
setting director compensation, we consider the significant amount
of time that Directors expend in fulfilling their duties to the
Company as well as the skill-level required by our members of the
Board. During year then ended September 30, 2018, Ronald P.
Erickson and Phillip A. Bosua did not receive any compensation for
his service as a director. &#xA0;The compensation disclosed in the
Summary Compensation Table on page 52 represents the total
compensation for Mr. Erickson.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Compensation Paid to Board Members</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We primarily use stock options grants to incentive compensation to
attract and retain qualified candidates to serve on the Board. This
compensation reflected the financial condition of the Company. In
setting director compensation, we consider the significant amount
of time that Directors expend in fulfilling their duties to the
Company as well as the skill-level required by our members of the
Board. During year then ended September 30, 2018, Ronald P.
Erickson and Phillip A. Bosua did not receive any compensation for
his service as a director. &#xA0;The compensation disclosed in the
Summary Compensation Table on page 52 represents the total
compensation for Mr. Erickson and Mr. Bosua.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">58</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Compensation Paid to Board Members</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our independent non-employee directors are not compensated in
cash.&#xA0;&#xA0; The only compensation generally has been in the
form of stock awards. There is no formal stock compensation plan
for independent non-employee directors. Our non-employee directors
received the following compensation during the year ended September
30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px;">

<table cellpadding="0" cellspacing="0" style="text-align: justify; margin: 0px auto 0px 0px; width: 70%; font-size: inherit; font-family: inherit;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 20%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Stock</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Option</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Other</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Name</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Awards
(4)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Awards</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Compensation</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Total</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Jon
Pepper (1)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">18,750</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">18,750</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ichiro
Takesako (2)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">William
A. Owens (3)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align: bottom; width: 20%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">46,750</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">46,750</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
&#xA0; <font style="font-family: Times New Roman; font-size: 13px;"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(1) The 75,000 shares of restricted common stock was issued on
April 10, 2018 to Mr. Pepper at the grant date market value of
$0.25 per share.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(2) The 50,000 shares of restricted common stock was issued on
April 10, 2018 to Mr. Takesako at the grant date market value of
$0.25 per share.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(3) The 50,000 of restricted common stock was issued on May 20,
2018 to Mr. Owens at the grant date market value of $0.31 per
share.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(4)&#xA0;These amounts reflect the grant date market value as
required by Regulation S-K Item 402(n)(2), computed in accordance
with FASB ASC Topic 718.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="CERTAINRELATIONSHIPS">C</a>ERTAIN RELATIONSHIPS AND RELATED PARTY
TRANSACTIONS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Since
October 1, 2016, we have engaged in the following reportable
transactions with our directors, executive officers, holders of
more than 5% of our voting securities and affiliates, or
immediately family members of our directors, executive officers and
holders of more than 5% of our voting securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Transactions with Clayton Struve</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
the following transactions with Clayton Struve:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Convertible Promissory Note dated September 30, 2016</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On September 30, 2016, we entered into a $210,000 Convertible
Promissory Note with Clayton A. Struve, an accredited investor of
the Company, to fund short-term working capital. The Convertible
Promissory Note accrued interest at a rate of 10% per annum and was
due on March 30, 2017. The Note holder can convert the Note into
common stock at $0.70 per share. This note was extended in the
Securities Purchase Agreement, General Security Agreement and
Subordination Agreement dated August 14, 2017 with a maturity date
of August 13, 2018. Also, the conversion price of the Debenture was
adjusted to $0.25 per share, subject to certain adjustments. The
balance was increased $75,000 during the year ended September 30,
2018.</font> On November 16, 2018, we signed Amendment 1 to Senior
Secured Convertible Redeemable Notes dated September 30,
2016extending the due dates of the Note to February 27, 2019. On
September 24, 2018, Mr. Struve converted $200,000 of the Note into
800,000 shares of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Securities Purchase Agreement dated August 14, 2017</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 14, 2017, we issued a senior convertible exchangeable
debenture with a principal amount of $360,000 and a common stock
purchase warrant to purchase 1,440,000 shares of common stock in a
private placement to Clayton Struve for gross proceeds of $300,000
pursuant to a Securities Purchase Agreement dated August 14, 2017.
The debenture accrues interest at 20% per annum and matures August
13, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">59</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On the same date, we entered into a General Security Agreement with
the Mr. Struve, pursuant to which the Company has agreed to grant a
security interest to the investor in substantially all of our
assets, effective upon the filing of a UCC-3 termination statement
to terminate the security interest held by Capital Source Business
Finance Group in the assets of the Company. In addition, an entity
affiliated with Ronald P. Erickson, out then Chief Executive
Officer, entered into a Subordination Agreement with the investor
pursuant to which all debt owed by us to such entity is
subordinated to amounts owed by us to Mr. Struve under the
Debenture (including amounts that become owing under any Debentures
issued to the investor in the future).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The initial conversion price of the Debenture is $0.25 per share,
subject to certain adjustments. The initial exercise price of the
Warrant is $0.25 per share, also subject to certain
adjustments.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As part of the Purchase Agreement, we granted the investor
&#x201C;piggyback&#x201D; registration rights to register the shares
of common stock issuable upon the conversion of the Debenture and
the exercise of the Warrant with the Securities and Exchange
Commission for resale or other disposition.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Debenture and the Warrant were issued in a transaction that was
not registered under the Securities Act of 1933, as amended in
reliance upon applicable exemptions from registration under Section
4(a)(2) of the Act and Rule 506 of SEC Regulation D under the Act.
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Under the terms of the Purchase Agreement, Mr. Struve may purchase
up to an aggregate of $1,000,000 principal amount of Debentures
(before a 20% original issue discount) (and Warrants to purchase up
to an aggregate of 250,000 shares of common stock). These
securities are being offered on a &#x201C;best efforts&#x201D; basis
by the placement agent.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 12, 2017, we closed an additional $250,000 and issued a
senior convertible exchangeable debenture with a principal amount
of $300,000 and a common stock purchase warrant to purchase
1,200,000 shares of common stock in a private placement dated
December 12, 2017 with Mr. Struve pursuant to a Securities Purchase
Agreement dated August 14, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 2, 2018, we received gross proceeds of $280,000 in
exchange for issuing a senior convertible redeemable debenture with
a principal amount of $336,000 and a warrant to purchase 1,344,000
shares of common stock in a private placement dated February 28,
2018 with Mr. Struve pursuant to a Securities Purchase Agreement
dated August 14, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 16, 2018, we signed Amendment 1 to Senior Secured
Convertible Redeemable Notes dated August 14, 2017 and December 12,
2017, extending the due dates of the Notes to February 27, 2019.
<font style="color: #000000">As of March 31, 2019, the Company owes
Clayton A. Struve $1,071,000 under convertible promissory or OID
notes. The Company recorded accrued interest of $58,411 as of March
31, 2019.</font> On May 8, 2019, the Company signed Amendment 2 to
the convertible promissory or OID notes, extending the due dates to
September 30, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Series C and D Preferred Stock and Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">See
page 62 for a description of Series C and D Preferred Stock and
Warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Related Party Transactions with Ronald P. Erickson</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 7, 2017 Mr. Erickson was issued 200,000 of restricted
common stock to at the grant date market value of $0.17 per
share.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On January 16, 2018 Mr. Erickson was issued 100,000 of restricted
common stock on to at the grant date market value of $0.21 per
share.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
January 25, 2018, we entered into amendments to two demand
promissory notes, totaling $600,000 with Mr. Erickson, our Chief
Executive Officer and/or entities in which Mr. Erickson has a
beneficial interest. The amendments extend the due date from
December 31, 2017 to September 30, 2018 and continue to provide for
interest of 3% per annum and a third lien on company assets if not
repaid by September 30, 2018 or converted into convertible
debentures or equity on terms acceptable to the Holder. On March
16, 2018, the demand promissory notes and accrued interest were
converted into convertible notes payable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">60</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 16, 2018, the Company entered into a Note and Account Payable
Conversion Agreement pursuant to which (a) all $664,233 currently
owing under the J3E2A2Z Notes was converted to a Convertible
Redeemable Promissory Note in the principal amount of $664,233, and
(b) all $519,833 of the J3E2A2Z Account Payable was converted into
a Convertible Redeemable Promissory Note in the principal amount of
$519,833 together with a warrant to purchase up to 1,039,666 shares
of common stock of the Company for a period of five years.
<font style="color: #000000">The initial exercise price of the
warrants described above is $0.50 per share, also subject to
certain adjustments. The warrants were valued at $110,545. Because
the note is immediately convertible, the warrants and beneficial
conversion were expensed as interest. The Company recorded accrued
interest of $41,361 as of March 31, 2019.</font> On May 8, 2019,
the Company signed Amendment 1 to the convertible redeemable
promissory notes, extending the due dates to September 30, 2019 and
increasing the interest rate to 6%.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On July 9, 2018, we repaid a $199,935 Business Loan Agreement with
Umpqua Bank from funds previously provided by</font> an entity
affiliated with Ronald P. Erickson, our Chairman of the Board. The
Company paid $27,041 and <font style="color: #000000">issued
800,000 shares of common stock in exchange for the conversion of
this debt. Mr. Erickson is an accredited investor. These shares
were issued in transactions that were not registered under the Act
in reliance upon applicable exemptions from registration under
Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D
under the Act.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Erickson and/or entities with which he is affiliated also have
accrued compensation, travel and interest of approximately $657,551
as of September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Erickson and/or entities with which he is affiliated also have
accrued compensation, travel and interest of approximately $478,861
as of March 31, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Related Party Transaction with Phillip A. Bosua</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On July
14, 2017, we issued 50,000 shares of our common stock to Phillip A.
Bosua under the terms of a consulting agreement dated July 6,
2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
February 7, 2018, we issued 50,000 shares of our common stock to
Phillip A. Bosua under the terms of a consulting agreement dated
July 6, 2017. The fair value of the shares issued was
$12,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
April 10, 2018, we issued 2,000,000 shares of our common stock to
Phillip A. Bosua under the terms of the Merger Agreement with RAAI
common stock. The fair value of the shares issued was
$520,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On June
25, 2018, we issued 500,000 shares of our common stock to Phillip
A. Bosua under the terms of an Employment agreement dated April 10,
2018. The fair value of the shares issued was
$165,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On June
25, 2018, w<font style="color: #000000">e closed a debt conversion
with an entity controlled by Phillip A. Bosua and issued 255,000
shares of common stock in exchange for the conversion of $63,750 in
preexisting debt owed by the Company to this
entity.&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On July 30, 2018, Mr. Bosua was awarded a stock option grant for
1,000,000 shares of our common stock that was awarded at $1.28 per
share and was valued at the black scholes value of $1.22 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stock Issuances to Named Executive Officers and
Directors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 7, 2017, we issued 400,000 shares of restricted common
stock to one Named Executive Officer and two directors for services
during 2015-2017. The shares were issued in accordance with the
2011 Stock Incentive Plan and were valued at $0.17 per share, the
market price of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During January to May 2018, we issued 275,000 shares of restricted
common stock to one Named Executive Officer and two directors for
services during 2018. The shares were issued in accordance with the
2011 Stock Incentive Plan and were valued at $0.246 per share, the
market price of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">61</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stock Option Grant Cancellations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the year ended September 30, 2017, two Named Executive
Officers forfeited stock option grants for 35,366 shares of common
stock at $19.53 per share.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Indemnification</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
articles of incorporation provide that we will indemnify our
directors and officers to the fullest extent permitted by Nevada
law. In addition, we have an Indemnification Agreements with the
current Board of Directors.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Policies and Procedures for Related Person
Transactions</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
operated under a Code of Conduct and Ethics since December 28,
2012. Our Code of Conduct and Ethics requires all employees,
officers and directors, without exception, to avoid the engagement
in activities or relationships that conflict, or would be perceived
to conflict, with our interests.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Prior
to the adoption of our related person transaction policy, there was
a legitimate business reason for all the related person
transactions described above and we believe that, where applicable,
the terms of the transactions are no less favorable to us than
could be obtained from an unrelated person.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
Audit Committee reviews all relationships and transactions in which
we and our directors and executive officers or their immediate
family members are participants to determine whether such persons
have a direct or indirect material interest.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">As
required under SEC rules, transactions that are determined to be
directly or indirectly material to us or a related person are
disclosed.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="PRINCIPALSTOCKHOLDERS">P</a>RINCIPAL STOCKHOLDERS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following table sets forth certain information regarding the
ownership of our common stock as of May 30, 2019
by:&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font> <font style="color: #000000; font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold;">
</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold;">
</font>each director and nominee for director;</font></div>
</div>
</div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">each
person known by us to own beneficially 5% or more of our common
stock;</font></div>
</div>
</div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">each
executive officer named in the summary compensation table elsewhere
in this</font> <font style="color: #000000; font-family: Times New Roman; font-size: 13px">report;
and</font></div>
</div>
</div>
<div style="display: table; margin-left: 36px;">
<div style="display: table-row;">
<div style="display: table-cell; width: 24px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#x25CF;</font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">all
of our current directors and executive officers as a
group.</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The amounts and percentages of common stock beneficially owned are
reported on the basis of regulations of the SEC governing the
determination of beneficial ownership of securities. Under the
rules of the SEC, a person is deemed to be a &#x201C;beneficial
owner&#x201D; of a security if that person has or shares voting
power,&#x201D; which includes the power to vote or to direct the
voting of such security, or has or shares &#x201C;investment
power,&#x201D; which includes the power to dispose of or to direct
the disposition of such security. A person is also deemed to be a
beneficial owner of any securities of which that person has the
right to acquire beneficial ownership within 60 days. Under these
rules more than one person may be deemed a beneficial owner of the
same securities and a person may be deemed to be a beneficial owner
of securities as to which such person has no economic
interest.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Unless otherwise indicated below, each beneficial owner named in
the table has sole voting and sole investment power with respect to
all shares beneficially owned, subject to community property laws
where applicable. The address for each person shown in the table is
c/o Visualant, Inc. 500 Union Street, Suite 810, Seattle
Washington, unless otherwise indicated.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">62</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:5%;font-size:11px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:90%;font-size:11px;display:inline-block;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;Shares
Beneficially Owned</font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:5%;font-size:11px;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:5%;font-size:11px;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;font-weight:bold;width:90%;font-size:11px;display:inline-block;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;Shares
Beneficially Owned</font></div>
</font><font style="text-align: left; vertical-align:bottom;font-weight:bold;width:5%;font-size:11px;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:90%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;Prior to this
Offering</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:90%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;After this
Offering</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;Amount</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">Percentage</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;Amount</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">Percentage</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Directors and
Officers-</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Ronald P. Erickson
(1)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,989,015</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">27.5</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,989,015</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">18.4</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Phillip A. Bosua
(2)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,105,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">13.7</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,105,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">8.4</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jon Pepper
(3)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">288,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1.3</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">288,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">0.8</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Ichiro Takesako
(4)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">200,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">0.9</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">200,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">0.5</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">William A. Owens
(5)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">650,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">2.9</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">650,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">1.8</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total Directors and
Officers (5 in total)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">12,232,015</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">12,232,015</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
* Less than 1%.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(1)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Reflects 1,358,085 shares of shares of common
stock beneficially owned by Ronald P. Erickson or entities
controlled by Mr. Erickson and</font> <font style="color: #000000">warrants to purchase 1,894,666 shares of our
common stock that are exercisable within 60 days, and also includes
4,736,264 shares of our common stock related to convertible debt
that are exercisable within 60 days.</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(2)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
2,855,000 shares of shares of common stock beneficially owned by
Phillip A. Bosua and vested stock option grants to purchase 250,000
shares of our common stock that are exercisable within 60
days.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(3)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Reflects 238,000 shares of shares of common stock
beneficially owned by Jon Pepper</font> <font style="color: #000000">and a vested stock option grant to purchase 50,000
shares of our common stock that are exercisable within 60
days.</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(4)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
150,000 shares of shares of common stock beneficially owned Ichiro
Takesako and a vested stock option grant to purchase 50,000 shares
of our common stock that are exercisable within 60
days.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(5)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
450,000 shares of shares of common stock beneficially owned by
William A. Owens and warrants to purchase 200,000 shares of our
common stock that are exercisable within 60 days.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
&#xA0;Shares Beneficially Owned</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
&#xA0;Shares Beneficially Owned</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 5%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
&#xA0;Prior to this Offering</font> <font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 5%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 5%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
&#xA0;After this Offering</font> <font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 5%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
&#xA0;Amount</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Percentage</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
&#xA0;Amount</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Percentage</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Greater
Than 5% Ownership</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Clayton
A. Struve (1)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">18,763,790</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">47.6</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">18,763,790</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">43.3</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Blocker
at 4.99%</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Blocker
at 4.99%</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ronald
P. Erickson (2)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">7,989,015</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">27.5</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">7,989,015</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">18.4</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua (3)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,105,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13.7</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,105,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">8.4</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Dale
Broadrick (4)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,226,036</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">9.5</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,226,036</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5.9</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
&#xA0;&#xA0; <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-family: Times New Roman">(1)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Reflects 1,800,000 shares beneficially owned by
Clayton A. Struve. This total also includes 7,785,719 warrants to
purchase shares of our common stock, 4,894,071 shares related to
the conversion of preferred stock into our common stock and
4,284,000 shares related to the conversion of debt into our common
stock. The 7,285,719 of warrants, preferred stock and convertible
debt</font> <font style="color: #000000">are currently priced at
$0.25 per share, subject to adjustment. Warrants of 500,000s shares
related to the offering are currently priced at $1.20 per share,
subject to adjustment. The address of Mr. Struve is</font> 175 West
Jackson Blvd., Suite 440, Chicago, IL 60604. <font style="color: #000000">&#xA0;&#xA0;</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(2)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
1,358,085 shares of shares of common stock beneficially owned by
Ronald P. Erickson or entities controlled by Mr. Erickson and
warrants to purchase 1,894,666 shares of our common stock that are
exercisable within 60 days, and also includes 4,736,264 shares of
our common stock related to convertible debt that are exercisable
within 60 days. The address of Mr. Erickson is 500 Union Street,
Suite 810, Seattle, WA 98101.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(3)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
2,855,000 shares of shares of common stock beneficially owned by
Phillip A. Bosua and vested stock option grants to purchase 250,000
shares of our common stock that are exercisable within 60 days. The
address of Mr. Bosua is 500 Union Street, Suite 810, Seattle, WA
98101.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: justify; display: table-cell; width: 24px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(4)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reflects
the shares beneficially owned by&#xA0;Dale Broadrick. This total
includes 1,113,018 shares and a total of 1,113,018 warrants to
purchase shares of our common stock that are exercisable within 60
days. The address of Dale Broadrick is 3003 Brick Church Pike,
Nashville, Tennessee.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">63</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="DESCRIPTIONOFCAPITALSTOCK">D</a>ESCRIPTION OF CAPITAL
STOCK</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
General</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following description of our capital stock and provisions of our
articles of incorporation and bylaws are summaries and are
qualified by reference to our articles of incorporation, as amended
and restated, and our bylaws, as amended and restated. We have
filed copies of these documents with the SEC as exhibits to our
Registration Statement, of which this prospectus forms&#xA0;a
part.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Authorized Capital Stock</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
authorized 105,000,000 shares of capital stock, of which
100,000,000 are shares of voting common stock, par value $0.001 per
share, and 5,000,000 are shares of voting preferred stock, par
value $0.001 per share.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Capital Stock Issued and Outstanding</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
number of shares of our common stock outstanding before this
offering is based on&#xA0;<font style="color: #000000">22,435,464</font> shares of our common stock
outstanding as of&#xA0;May 30, 2019, and excludes, as of that
date:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 24px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">2,437,668&#xA0;shares
of our common stock issuable upon the exercise of outstanding stock
options outstanding at a weighted-average exercise price of $1.744
per share;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 24px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">An
unknown number of shares&#xA0;of our common stock issuable upon the
conversion of $2,255,066 of Convertible Notes Payable <font style="color: #000000">(currently 9,020,264 at $0.25 per
share)</font>;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 24px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">547,332&#xA0;additional
shares of our common stock available for future issuance under our
2011 Stock Incentive Plan;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 24px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">1,785,714 shares of
our common stock issuable upon the conversion of Series C
Convertible Preferred Stock, at an exercise price of $0.25, subject
to certain adjustments. These shares of common stock are being
registered in this offering; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 24px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">3,108,356 shares of
our common stock issuable upon the conversion of Series D
Convertible Preferred Stock, at an exercise price of $0.25, subject
to certain adjustments.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 24px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 24px;">
<div style="display: table-row;">
<div style="text-align: right; display: table-cell; width: 4px; padding-right: 8px;"><font style="font-family: Times New Roman; font-size: 13px;">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">17,837,090 warrants
to purchase shares of our common stock at an exercise price of
$0.454 subject to certain adjustments.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Voting Common Stock</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
We are authorized to issue up to 100,000,000 shares of common stock
with a par value of $0.001.</font> As of May 30, 2019, there were
<font style="color: #000000">22,435,464</font> shares of common
stock outstanding held by approximately 117 stockholders of record.
This number does not include approximately 2,300 beneficial owners
whose shares are held in the names of various security brokers,
dealers and registered clearing agencies. <font style="color: #000000">Each share of common stock entitles its holder to
one vote on each matter submitted to the stockholders for a vote,
and no cumulative voting for directors is
permitted.&#xA0;&#xA0;Stockholders do not have any preemptive
rights to acquire additional securities issued by us.&#xA0;&#xA0;As
of May 30, 2019, there were options outstanding for the purchase of
2,437,668 shares of common stock and warrants for the purchase of
17,837,090 shares of common stock. In addition</font> 1,785,714
shares of our common stock issuable upon the conversion of Series C
Convertible Preferred Stock and 3,108,356 shares of our common
stock issuable upon the conversion of Series D Convertible
Preferred Stock. <font style="color: #000000">In addition, the
Company has an unknown number of shares (9,020,264 common shares at
the current price of $0.25 per share) are issuable upon conversion
of convertible debentures of $2,255,065, all of which could
potentially dilute future earnings per share.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">64</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Holders
of our common stock are entitled to one vote for each share held on
all matters submitted to a vote of stockholders and do not have
cumulative voting rights for the election of directors. An election
of directors by our stockholders shall be determined by a plurality
of the votes cast by the stockholders entitled to vote on the
election. On all other matters, the affirmative vote of the holders
of a majority of the stock present in person or represented by
proxy and entitled to vote is required for approval, unless
otherwise provided in our articles of incorporation, bylaws or
applicable law. Holders of common stock are entitled to receive
proportionately any dividends as may be declared by our Board of
Directors, subject to any preferential dividend rights of
outstanding preferred stock.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In the
event of our liquidation or dissolution, the holders of common
stock are entitled to receive proportionately all assets available
for distribution to stockholders after the payment of all debts and
other liabilities and subject to the prior rights of any
outstanding preferred stock. Holders of common stock have no
preemptive, subscription, redemption or conversion rights. The
rights, preferences and privileges of holders of common stock are
subject to and may be adversely affected by the rights of the
holders of shares of any series of preferred stock that we may
designate and issue in the future.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Voting Preferred Stock</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">As of
September 1, 2018, we are authorized to issue up to 5,000,000
shares of preferred stock with a par value of $0.001 per
share.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Series A Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
There are 23,334 shares Series A Preferred shares authorized.
Series A Preferred is entitled to the number of votes equal to the
number of whole shares of common stock into which the shares of
Series A Preferred held by such holder are then convertible as of
the applicable record date. The Series A Preferred may not be
redeemed without the consent of the holder.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On January 29, 2019, a sole holder of Series A Preferred Stock
converted 20,000 shares into 80,000 shares of common stock. There
are no Series A Preferred Stock outstanding as of March 31,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Series C Preferred Stock and Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On August 11, 2016, we filed a Certificate of Designations,
Preferences, and Rights of Series C Convertible Preferred Stock. On
August 14, 2017,</font> the price of the <font style="color: #000000">Series C Preferred Stock</font> were adjusted to
$0.25 per share <font style="color: #000000">pursuant to the
documents governing such instruments. The Certificate designated
1,785,715 shares as Series C Convertible Preferred Stock at a par
value of $.001 per share that is currently convertible into common
stock at $0.25 per share, with certain adjustments as set forth in
the Certificate.</font><font style="font-size: 13px">&#xA0;</font>The Series C Preferred stock has a
yield of 8% and an ownership blocker of 4.99%.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
As of March 31, 2019, the Company has 1,785,715 shares
of&#xA0;Series C Preferred Stock outstanding.&#xA0;</font> In
addition, a corresponding number of five-year warrants to acquire
1,785,714 shares of common stock at $0.25 per share were issued in
conjunction with the Series C Preferred Shares and remain
outstanding.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Series D Preferred Stock and Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
authorized the designation of 1,016,014 shares as Series D
Convertible Preferred Stock (&#x201C;Series D Preferred&#x201D;).
<font style="color: #000000">On August 14, 2017,</font> the price
of the <font style="color: #000000">Series D Preferred Stock</font>
was adjusted to $0.25 per share <font style="color: #000000">pursuant to the documents governing such
instruments.</font> On May 8, 2017, we applied with the State of
Nevada for approval of the Certificate of Designations,
Preferences, and Rights of Series D Convertible Preferred Stock.
<font style="color: #000000">On July 17, 2018, we filed with the
State of Nevada a second Amended and Restated Certificate of
Designation of Preferences, Powers, and Rights of the Series D
Convertible Preferred Stock to decrease the number of authorized
Series D Shares from 3,906,250
to&#xA0;1,016,014.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Series D Preferred Stock is convertible into shares of common stock
at a price of $0.25 per share or by multiplying the number of
Series D Preferred Stock shares by the stated value and dividing by
the conversion price then in effect, subject to certain diluted
events, and has the right to vote the number of shares of common
stock the Series D Preferred Stock would be issuable on conversion,
subject to a 4.99% blocker. <font style="color: #000000">The
Preferred Series D has an annual yield of 8%.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">65</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In conjunction with Series D Preferred Stock we authorized Series F
Warrants, which are exercisable for a term of five years at strike
price of $0.25. The underlying common stock upon the conversion of
the Series D Preferred and Series F Warrants issued were required
to be included in a registration statement as filed by the
Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As of March 31, 2019, the Company has 1,016,004 shares of Series D
Preferred Stock outstanding, which have a total of 3,108,356 common
stock shares currently conversion if the underlying conversion
price remains $0.25, and there are 3,984,000 Series F warrant
shares.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Series F Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 1, 2018, we filed with the State of Nevada a Certificate
of Designation establishing the Designations, Preferences,
Limitations and Relative Rights of Series F Preferred Stock. The
Designation authorized 500 shares of Series F Preferred Stock. The
Series F Preferred Stock shall only be issued to the current Board
of Directors on the date of the Designation&#x2019;s filing and is
not convertible into common stock. As set forth in the Designation,
the Series F Preferred Stock has no rights to dividends or
liquidation preference and carries rights to vote 100,000 shares of
common stock per share of Series F upon a Trigger Event, as defined
in the Designation. A Trigger Event includes certain unsolicited
bids, tender offers, proxy contests, and significant share
purchases, all as described in the Designation. Unless and until a
Trigger Event, the Series F shall have no right to vote. The Series
F Preferred Stock shall remain issued and outstanding until the
date which is 731 days after the issuance of Series F Preferred
Stock (&#x201C;Explosion Date&#x201D;), unless a Trigger Event
occurs, in which case the Explosion Date shall be extended by 183
days.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Securities Subject to Price Adjustments</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In the
future, if we sell our common stock at a price below $0.25 per
share, the exercise price <font style="color: #000000">of 1,785,715
outstanding shares of Series C Preferred Stock, 3,108,356
outstanding shares Series D Preferred Stock that adjust below $0.25
per share pursuant to the documents governing such instruments. In
addition, the conversion price of a Convertible Note Payable of
$2,255,066 (currently 9,020,264 at $0.25 per share) and the
exercise price of additional outstanding warrants to purchase
12,664,385 shares of common stock would adjust below $0.25 per
share pursuant to the documents governing such
instruments.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">
We are registering the following as part of the
Offering.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
(i) up to 2,121,258 shares (the "Investor Warrant Shares") of
common stock issuable upon the exercise of outstanding investor's
warrants (the "Investor Warrants") at an exercise price of $1.20
that were previously issued to the Selling Shareholders in
connection with the Notes Offering that closed in a series of
closings between February 15, 2019 and</font> May 28,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(ii)
542,102 shares of our common stock issuable upon the exercise of
outstanding placement agent warrants (the &#x201C;Placement Agent
Warrants&#x201D;) at an exercise price of $1.20 per share that were
previously issued to Boustead Securities, LLC and its assigns
(collectively &#x201C;Placement Agent&#x201D;) pursuant to the
Boustead Offering Engagement Agreement which provides that the
Placement Agent shall receive that certain number of warrants to
purchase the common stock of the Company equal to the number of
warrants issued under the 8% Unsubordinated Convertible Note
Offering (the &#x201C;Offering&#x201D;).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If we
sell our common stock at a price below $1.20, the exercise price of
the Investor and Placement Agent Warrants is adjusted.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="DESCRIPTIONOFSECURITIESBEINGREGISTER">D</a>ESCRIPTION OF
SECURITIES BEING REGISTERED</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
This prospectus covers the resale by the Selling Stockholders named
herein of up to</font> 14,337,632 <font style="color: #000000">shares of our common stock. The common stock
covered by this prospectus will be offered for resale from time to
time by the Selling Stockholders identified in this prospectus in
accordance with the terms described in the section entitled
&#x201C;Plan of Distribution.&#x201D; We will not receive any of the
proceeds from the resale of the common stock by the Selling
Stockholders.</font></font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">66</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Common Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
material terms and provisions of our common stock and each other
class of our securities which qualifies or limits our common stock
are described under the caption &#x201C;Description of Capital
Stock&#x201D; in this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Options to Purchase Common Stock</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 21, 2013, an amendment to the Stock Option Plan was approved
by the stockholders of the Company, increasing the number of shares
reserved for issuance under the Plan to 93,333 shares.<font style="font-weight: bold">&#xA0;</font>On April 10, 2018, the Board
approved an amendment to its 2011 Stock Incentive Plan increasing
the number of shares of common stock reserved under the Incentive
Plan from 93,333 to 1,200,000. On August 7, 2018, the Board
approved an amendment to its 2011 Stock Incentive Plan increasing
the number of shares of common stock reserved under the Incentive
Plan from 1,200,000 to 2,000,000 to common shares.&#xA0;On May 22,
2019, the Board approved an amendment to its 2011 Stock Incentive
Plan increasing the number of shares of common stock reserved under
the Incentive Plan from 2,000,000 to 3,000,000 to common
shares.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
There are currently 2,282,668 options to purchase common stock at
an average exercise price of $1.757 per share outstanding as of
March 31, 2019 under the 2011 Stock Incentive Plan. As of March 31,
2019, there is approximately $1,606,089, net of forfeitures, of
total unrecognized costs related to employee granted stock options
that are not vested. These costs are expected to be recognized over
a period of approximately 4.69 years.&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Dividend Policy</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
not previously declared or paid any cash dividends on our common
stock and do not anticipate or contemplate paying dividends on our
common stock in the foreseeable future. We currently intend to use
all of our available funds to finance the growth and development of
our business. We can give no assurances that we will ever have
excess funds available to pay dividends. In addition, our articles
of incorporation restrict our ability to pay any dividends on our
common stock without the approval of 66% of our then outstanding
Series A Preferred Stock.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Anti-Takeover Provisions</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Nevada Revised Statutes</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="text-decoration: underline">
Acquisition of Controlling Interest
Statutes</font>.&#xA0;&#xA0;&#xA0;&#xA0;Nevada's "acquisition of
controlling interest" statutes contain provisions governing the
acquisition of a controlling interest in certain Nevada
corporations. These "control share" laws provide generally that any
person who acquires a "controlling interest" in certain Nevada
corporations may be denied certain voting rights, unless a majority
of the disinterested stockholders of the corporation elects to
restore such voting rights. These statutes provide that a person
acquires a "controlling interest" whenever a person acquires shares
of a subject corporation that, but for the application of these
provisions of the Nevada Revised Statutes, would enable that person
to exercise (1)&#xA0;one-fifth or more, but less than one-third,
(2)&#xA0;one-third or more, but less than a majority or (3)&#xA0;a
majority or more, of all of the voting power of the corporation in
the election of directors. Once an acquirer crosses one of these
thresholds, shares which it acquired in the transaction taking it
over the threshold and within the 90&#xA0;days immediately
preceding the date when the acquiring person acquired or offered to
acquire a controlling interest become "control shares" to which the
voting restrictions described above apply. Our articles of
incorporation and bylaws currently contain no provisions relating
to these statutes, and unless our articles of incorporation or
bylaws in effect on the tenth day after the acquisition of a
controlling interest were to provide otherwise, these laws would
apply to us if we were to (i)&#xA0;have 200 or more stockholders of
record (at least 100 of which have addresses in the State of Nevada
appearing on our stock ledger) and (ii)&#xA0;do business in the
State of Nevada directly or through an affiliated corporation. As
of June 30, 2016 we have less than 200 record stockholders. If
these laws were to apply to us, they might discourage companies or
persons interested in acquiring a significant interest in or
control of the company, regardless of whether such acquisition may
be in the interest of our stockholders.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">67</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="text-decoration: underline">
Combinations with Interested Stockholders
Statutes</font>.&#xA0;&#xA0;&#xA0;&#xA0;Nevada's "combinations with
interested stockholders" statutes prohibit certain business
"combinations" between certain Nevada corporations and any person
deemed to be an "interested stockholder" for two years after the
such person first becomes an "interested stockholder" unless
(i)&#xA0;the corporation's board of directors approves the
combination (or the transaction by which such person becomes an
"interested stockholder") in advance, or (ii)&#xA0;the combination
is approved by the board of directors and sixty percent of the
corporation's voting power not beneficially owned by the interested
stockholder, its affiliates and associates. Furthermore, in the
absence of prior approval certain restrictions may apply even after
such two-year period. For purposes of these statutes, an
"interested stockholder" is any person who is (x)&#xA0;the
beneficial owner, directly or indirectly, of ten percent or more of
the voting power of the outstanding voting shares of the
corporation, or (y)&#xA0;an affiliate or associate of the
corporation and at any time within the two previous years was the
beneficial owner, directly or indirectly, of ten percent or more of
the voting power of the then outstanding shares of the corporation.
The definition of the term "combination" is sufficiently broad to
cover most significant transactions between the corporation and an
"interested stockholder". Subject to certain timing requirements
set forth in the statutes, a corporation may elect not to be
governed by these statutes. We have not included any such provision
in our articles of incorporation.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
effect of these statutes may be to potentially discourage parties
interested in taking control of us from doing so if it cannot
obtain the approval of our Board of Directors.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Articles of Incorporation and Bylaws Provisions</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
articles of incorporation, as amended and restated, and our bylaws,
as amended and restated, contain provisions that could have the
effect of discouraging potential acquisition proposals or tender
offers or delaying or preventing a change in control, including
changes a stockholder might consider favorable. In particular, our
articles of incorporation and bylaws, among other
things:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">permit
our Board of Directors to alter our bylaws without stockholder
approval;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">provide
that vacancies on our Board of Directors may be filled by a
majority of directors in office, although less than a
quorum;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">authorize the
issuance of preferred stock, which can be created and issued by our
Board of Directors without prior stockholder approval, with rights
senior to our common stock, which may render more difficult or
discourage an attempt to obtain control of us by means of a merger,
tender offer, proxy contest or otherwise; and</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">establish advance
notice procedures with respect to stockholder proposals relating to
the nomination of candidates for election as directors and other
business to be brought before stockholder meetings, which notice
must contain information specified in our bylaws.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
addition, our articles of incorporation restrict our ability to
take certain actions without the approval of at least 66% of the
Series A Preferred Stock then outstanding. These actions include,
among other things;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">authorizing,
creating, designating, establishing or issuing an increased number
of shares of Series A Preferred Stock or any other class or series
of capital stock ranking senior to or on a parity with the Series A
Preferred Stock;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">adopting a plan for
the liquidation, dissolution or winding up the affairs of our
company or any recapitalization plan (whether by merger,
consolidation or otherwise);</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">amending, altering
or repealing, whether by merger, consolidation or otherwise, our
articles of incorporation or bylaws in a manner that would
adversely affect any right, preference, privilege or voting power
of the Series A Preferred Stock; and</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 48px;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 24px;">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">declaring or paying
any dividend (with certain exceptions) or directly or indirectly
purchase, redeem, repurchase or otherwise acquire any shares of our
capital stock, stock options or convertible securities (with
certain exceptions).</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">68</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Such
provisions may have the effect of discouraging a third-party from
acquiring us, even if doing so would be beneficial to our
stockholders. These provisions are intended to enhance the
likelihood of continuity and stability in the composition of our
Board of Directors and in the policies formulated by them, and to
discourage some types of transactions that may involve an actual or
threatened change in control of our company. These provisions are
designed to reduce our vulnerability to an unsolicited acquisition
proposal and to discourage some tactics that may be used in proxy
fights. We believe that the benefits of increased protection of our
potential ability to negotiate with the proponent of an unfriendly
or unsolicited proposal to acquire or restructure our company
outweigh the disadvantages of discouraging such proposals because,
among other things, negotiation of such proposals could result in
an improvement of their terms.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">However,
these provisions could have the effect of discouraging others from
making tender offers for our shares that could result from actual
or rumored takeover attempts. These provisions also may have the
effect of preventing changes in our management.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Transfer Agent</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our transfer agent is American Stock Transfer &amp; Trust Company
located at 6201 15th Avenue, Brooklyn, New York 11219, and their
telephone number is (800) 937-5449.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Offer Restrictions Outside the United States</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Other
than in the United States, no action has been taken by us or the
underwriters that would permit a public offering of the securities
offered by this prospectus in any jurisdiction where action for
that purpose is required. The securities offered by this prospectus
may not be offered or sold, directly or indirectly, nor may this
prospectus or any other offering material or advertisements in
connection with the offer and sale of any such securities be
distributed or published in any jurisdiction, except under
circumstances that will result in compliance with the applicable
rules and regulations of that jurisdiction. Persons into whose
possession this prospectus comes are advised to inform themselves
about and to observe any restrictions relating to the offering and
the distribution of this prospectus. This prospectus does not
constitute an offer to sell or a solicitation of an offer to buy
any securities offered by this prospectus in any jurisdiction in
which such an offer or a solicitation is unlawful.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<font style="font-weight: bold"><a name="LEGALMATTERS">L</a>EGAL MATTERS</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Unless
otherwise indicated in the applicable prospectus supplement,
Horwitz + Armstrong, A Professional Law Corporation, Lake Forest,
California, will provide opinions regarding the validity of the
shares of our Common Stock. Horwitz + Armstrong, A Professional Law
Corporation may also provide opinions regarding certain other
matters.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="EXPERTS">E</a>XPERTS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
SD Mayer and Associates, LLP</font>, independent registered public
accounting firm, has audited our financial statements at September
30, 2018 and 2017, and for each of the two years in the period
ended September 30, 2018, as set forth in their report which
includes an explanatory paragraph relating to our ability to
continue as a going concern, included elsewhere in this prospectus.
We have included our financial statements in this prospectus and
elsewhere in this Registration Statement in reliance on
<font style="color: #000000">SD Mayer and Associates,
LLP&#x2019;s</font> report, given on their authority as experts in
accounting and auditing.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Except
as noted below, &#xA0;no expert or counsel named in this prospectus
as having prepared or certified any part of this prospectus or
having given an opinion upon the validity of the securities being
registered or upon other legal matters in connection with the
registration or offering of the shares and warrants and its
underlying securities was employed on a contingency basis, or had,
or is to receive, in connection with the offering, a substantial
interest, direct or indirect, in the registrant or any of its
parents or subsidiaries. Nor was any such person connected with the
registrant or any of its parents or subsidiaries as a promoter,
managing or principal underwriter, voting trustee, director,
officer, or employee.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">69</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="WHEREYOUCANFINDMOREINFORMATION">W</a>HERE YOU CAN FIND MORE
INFORMATION</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
filed with the SEC a Registration Statement on Form&#xA0;S-1 under
the Securities Act of 1933 with respect to the shares of common
stock we are offering to sell. This prospectus, which constitutes
part of the Registration Statement, does not include all of the
information contained in the Registration Statement and the
exhibits, schedules and amendments to the Registration Statement.
For further information with respect to us and our common stock, we
refer you to the Registration Statement and to the exhibits and
schedules to the Registration Statement. Statements contained in
this prospectus about the contents of any contract, agreement or
other document are not necessarily complete, and, in each instance,
we refer you to the copy of the contract, agreement or other
document filed as an exhibit to the Registration Statement. Each of
these statements is qualified in all respects by this
reference.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">You may
read and copy the Registration Statement of which this prospectus
is a part at the SEC's public reference room, which is located at
100&#xA0;F Street, N.E., Room&#xA0;1580, Washington, DC 20549. You
can request copies of the Registration Statement by writing to the
Securities and Exchange Commission and paying a fee for the copying
cost. Please call the SEC at 1-800-SEC-0330 for more information
about the operation of the SEC's public reference room. In
addition, the SEC maintains a website, which is located at
<font style="text-decoration: underline; color: #0000FF">www.sec.gov</font>,
that contains reports, proxy and information statements and other
information regarding issuers that file electronically with the
SEC. You may access the Registration Statement of which this
prospectus is a part at the SEC's website.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We are
subject to the information reporting requirements of the Securities
Exchange Act of 1934 and are required to file reports, proxy
statements and other information with the SEC. All documents filed
with the SEC are available for inspection and copying at the public
reference room and website of the SEC referred to above. We
maintain a website at www.growlifeinc.com. You may access our
reports, proxy statements and other information free of charge at
this website as soon as reasonably practicable after such material
is electronically filed with, or furnished to, the SEC. The
information on such website is not incorporated by reference and is
not a part of this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">70</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">

<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Report of Independent Registered Public Accounting
Firm</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
The Board of Directors and Shareholders</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Know Labs, Inc.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Opinion on the Financial Statements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have audited the accompanying consolidated balance sheets of
Know Labs, Inc. as of September 30, 2018 and 2017, and the related
consolidated statements of operations, stockholders&#x2019; deficit,
and cash flows for each of the two years in the period ended
September 30, 2018 and the related notes (collectively referred to
as the &#x2018;financial statements&#x2019;). In our opinion, the
financial statements referred to above present fairly, in all
material respects, the consolidated financial position of Know
Labs, Inc. at September 30, 2018 and 2017, and the consolidated
results of its operations and its cash flows for each of the two
years in the period ended September 30, 2018, in conformity with
U.S. generally accepted accounting principles.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Basis for Opinion</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
These financial statements are the responsibility of the
Company&#x2019;s management. Our responsibility is to express an
opinion on these financial statements based on our audits. We are a
public accounting firm registered with the PCAOB and required to be
independent with respect to the Company in accordance with the U.S.
federal securities laws and the applicable rules and regulations of
the Securities and Exchange Commission and the PCAOB.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error
or fraud. Our audit included performing procedures to assess the
risks of material misstatement of the financial statements, whether
due to error or fraud, and performing procedures that respond to
those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial
statements. We believe that our audits provide a reasonable basis
for our opinion.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Going Concern Uncertainty</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying consolidated financial statements have been
prepared assuming that the Company will continue as a going
concern.&#xA0; As discussed in Note 2 to the consolidated financial
statements, the Company has sustained a net loss from operations
and has an accumulated deficit since inception.&#xA0; These factors
raise substantial doubt about the Company&#x2019;s ability to
continue as a going concern.&#xA0; Management&#x2019;s plans in this
regard are also described in Note 2.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The consolidated financial statements do not include any
adjustments that might result from the outcome of this
uncertainty.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/ SD
Mayer &amp; Associates, LLP</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SD Mayer &amp; Associates, LLP</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have served as the Company&#x2019;s auditor since
2016</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Seattle, Washington</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
December 21, 2018</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-1</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INCORPORATED AND SUBSIDIARIES</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
CONSOLIDATED BALANCE SHEETS</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
&#xA0;</font>&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30, 2018</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30, 2017</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
ASSETS</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CURRENT
ASSETS:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Cash
and cash equivalents</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">934,407</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">103,181</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accounts
receivable, net of allowance of $60,000 and $60,000,
respectively</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">320,538</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">693,320</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Prepaid
expenses</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">20,140</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">27,687</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Inventories,
net</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">203,582</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">225,909</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
current assets</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,478,667</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,050,097</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">EQUIPMENT,
NET</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">169,333</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">133,204</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">OTHER
ASSETS</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Intangible
assets</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">447,778</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Other
assets</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">7,170</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">5,070</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">TOTAL
ASSETS</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,102,948</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,188,371</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
LIABILITIES AND STOCKHOLDERS' (DEFICIT)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CURRENT
LIABILITIES:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accounts
payable - trade</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,512,617</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,156,646</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accounts
payable - related parties</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,019</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,905</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accrued
expenses</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">72,140</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">24,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accrued
expenses - related parties</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">657,551</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,166,049</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Deferred
revenue</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">55,959</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">63,902</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Convertible
notes payable</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,255,066</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">570,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; margin-left: 12px; padding-bottom: 2px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Notes
payable - current portion of long term debt</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 10%; font-size: 13px; padding-bottom: 2px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 5%; font-size: 13px; border-bottom: 2px solid rgb(0, 0, 0);">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 75%; font-size: 13px; border-bottom: 2px solid rgb(0, 0, 0);">145,186</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 10%; font-size: 13px; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 10%; font-size: 13px; padding-bottom: 2px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 5%; font-size: 13px; border-bottom: 2px solid rgb(0, 0, 0);">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 75%; font-size: 13px; border-bottom: 2px solid rgb(0, 0, 0);">1,165,660</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 10%; font-size: 13px; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
current liabilities</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">4,710,538</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">5,149,162</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">COMMITMENTS
AND CONTINGENCIES</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">STOCKHOLDERS'
DEFICIT</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Preferred
stock - $0.001 par value, 5,000,000 shares authorized, 0 shares
issued and</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">outstanding
at 9/30/2018 and 9/30/2017, respectively</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Series
A Convertible Preferred stock - $0.001 par value, 23,334 shares
authorized, 20,000</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">and
23,334 issued and outstanding at 9/30/2018 and 9/30/2017,
respectively</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">11</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">23</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Series
C Convertible Preferred stock - $0.001 par value, 1,785,715 shares
authorized,</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">1,785,715
shares issued and outstanding at 9/30/2018 and 9/30/2017,
respectively</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,790</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,790</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Series
D&#xA0; Convertible Preferred stock - $0.001 par value, 1,016,014
shares authorized,</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">1,016,004&#xA0;
shares issued and outstanding at 9/30/2018 and 9/30/2017,
respectively</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,015</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,015</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Common
stock - $0.001 par value, 100,000,000 shares authorized, 17,531,502
and 4,655,486 shares</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">issued
and outstanding at 9/30/2018 and 9/30/2017,
respectively</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">17,532</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4,655</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Additional
paid in capital</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">32,163,386</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">27,565,453</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accumulated
deficit</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(34,791,324</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(31,533,727</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
stockholders' deficit</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,607,590</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,960,791</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">TOTAL
LIABILITIES AND STOCKHOLDERS' DEFICIT</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,102,948</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,188,371</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying notes are an integral part of these consolidated
financial statements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-2</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INCORPORATED AND SUBSIDIARIES</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
CONSOLIDATED STATEMENTS OF OPERATIONS</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:30%;">
<div><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">Years
Ended,</font> <font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30, 2018</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30, 2017</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">REVENUE</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4,303,296</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4,874,359</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">COST
OF SALES</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">3,481,673</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">3,966,607</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">GROSS
PROFIT</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">821,623</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">907,752</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">RESEARCH
AND DEVELOPMENT EXPENSES</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">570,514</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">79,405</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">SELLING,
GENERAL AND ADMINISTRATIVE EXPENSES</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,508,846</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,088,178</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">IMPAIRMENT
OF GOODWILL</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">983,645</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">OPERATING
LOSS</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,257,737</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,243,476</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">OTHER
INCOME (EXPENSE):</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Interest
expense</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1,195,329</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(376,974</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Other
income (expense)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,160</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(62,954</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">(Loss)
on change - derivative liability</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(217,828</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Gain
on debt settlements</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">170,309</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left: 48px; padding-bottom: 2px;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Total
other income (expense)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(999,860</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(657,756</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">(LOSS)
BEFORE INCOME TAXES</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,257,597</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,901,232</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Income
taxes - current provision</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">NET
(LOSS)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,257,597</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,901,232</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Basic
and diluted loss per common share attributable to
Visualant,</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Inc.
and subsidiaries common shareholders-</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Basic
and diluted loss per share</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(0.38</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(1.01</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Weighted
average shares of common stock outstanding- basic and
diluted</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">8,630,891</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,844,840</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying notes are an integral part of these consolidated
financial statements.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;
<font style="font-family: Times\ New\ Roman; font-size: 13px;"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-3</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INCORPORATED AND SUBSIDIARIES</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS'
(DEFICIT)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:22%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;display:inline-block;">
<div>
<font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">
Series B</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:18%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:5%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:22%;">
<div style="margin-left:0px;"><font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Series A Convertible</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Redeemable Convertible</font><br></div>
</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Series C Convertible</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Series D Convertible</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Additional</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Total</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:22%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Preferred Stock</font></div>
</font><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Preferred Stock</font><br></div>
</font><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Preferred Stock</font></div>
</font><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Preferred Stock</font></div>
</font><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Common Stock</font></div>
</font><font style="text-align: left; width: 5%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 6%;">
<div style="padding-bottom: 2px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Paid in</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Accumulated</font></div>
</font><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px;">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Stockholders'</font></div>
</font><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:22%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Shares</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Amount</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Shares<br>
</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Amount</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Shares</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Amount</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Shares</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Amount</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Amount</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Amount</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Capital</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Deficit</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">(Deficit)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Balance
as of September 30, 2016</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">23,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">23</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,785,715</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,790</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,356,152</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,356</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">24,259,702</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(27,073,365</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,809,494</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock
compensation expense - employee options</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">37,848</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">37,848</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock for services</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,354,386</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,353</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">545,103</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">546,456</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of Series D Convertible Preferred Stock</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,016,004</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,015</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">998,132</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">999,147</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Benefical
conversion feature of Preferred Stock/dividend</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">559,130</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(559,130</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock for conversion of liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">944,948</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">946</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">755,014</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">755,960</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Write-off
of derivative liability to additional paid in capital</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">410,524</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">410,524</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Net
loss</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,901,232</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,901,232</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Balance
as of September 30, 2017</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">23,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">23</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,785,715</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,790</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,016,004</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,015</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">4,655,486</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">4,655</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">27,565,453</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(31,533,727</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,960,791</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock
compensation expense - employee options</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,899</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,899</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock for services</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,279,676</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,280</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">439,039</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">440,319</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of Series D Convertible Preferred Stock</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">817,802</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">817,802</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Benefical
conversion feature of Preferred Stock/dividend</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock for conversion of liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,435,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,435</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">709,515</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">711,950</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock for cash</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">7,000,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">7,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,743,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,750,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock
based compensation- warrants</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">239,680</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">239,680</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Acquisition
of patent</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,000,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">518,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">520,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock for warrant exercise</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">158,006</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">158</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">79,989</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">80,147</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Conversion
of Series A Convertible Preferred Stock</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(12</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">9</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Net
loss</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,257,597</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(3,257,597</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:22%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Balance
as of September 30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">20,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">11</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,785,715</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,790</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,016,004</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,015</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">17,531,502</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">17,532</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">32,163,386</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(34,791,324</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:6%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,607,591</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying notes are an integral part of these consolidated
financial statements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-4</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INCORPORATED AND SUBSIDIARIES</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 100%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 30%;">
<div><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">Years
Ended,</font> <font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30, 2018</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30, 2017</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
FLOWS FROM OPERATING ACTIVITIES:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Net
loss</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,257,597</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(3,901,232</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Adjustments
to reconcile net loss to net cash (used in)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:36px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">operating
activities</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Depreciation
and amortization</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">132,615</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">81,283</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of capital stock for services and expenses</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">440,319</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">547,838</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Conversion
of interest</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">64,233</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">68,043</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock
based compensation- stock option grans</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,899</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">37,848</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">(Loss)
on sale of assets</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">113,244</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Loss
on change - derivative liability</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(145,282</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Reclassification
of derivative liability</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">410,324</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Amortization
of debt discount</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">475,174</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">158,941</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Conversion
of accrued liabilites- related parties to convertible notes
payable</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">491,802</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Provision
on loss on accounts receivable</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">10,747</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock
based compensation- warrants</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">239,680</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock for conversion of liabilities</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">199,935</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Non
cash gain on accounts payable</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(170,309</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Impairment
of goodwill</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">983,645</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:84px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Bad
debt expense</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">136,217</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Changes
in operating assets and liabilities:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:36px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accounts
receivable</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">362,035</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(20,582</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:36px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Prepaid
expenses</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">7,547</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(7,204</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:36px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Inventory</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">22,327</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">69,309</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:36px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Other
assets</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(2,100</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:36px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accounts
payable - trade and accrued expenses</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(176,495</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">134,382</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:36px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Deferred
revenue</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(7,943</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">63,902</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;NET
CASH (USED IN) OPERATING ACTIVITIES</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(1,117,131</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(1,264,324</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
FLOWS FROM INVESTING ACTIVITIES:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Investment
in BioMedx, Inc.</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(260,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Proceeds
from investment in BioMedx, Inc,</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">290,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Investment
in equipment</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(97,251</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,441</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; margin-left: 12px; padding-bottom: 2px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Proceeds
from sale of equipment</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 10%; font-size: 13px; padding-bottom: 2px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 5%; font-size: 13px; border-bottom: 2px solid rgb(0, 0, 0);">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 75%; font-size: 13px; border-bottom: 2px solid rgb(0, 0, 0);">-</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 10%; font-size: 13px; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 10%; font-size: 13px; padding-bottom: 2px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 5%; font-size: 13px; border-bottom: 2px solid rgb(0, 0, 0);">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 75%; font-size: 13px; border-bottom: 2px solid rgb(0, 0, 0);">1,434</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times\ New\ Roman; vertical-align: bottom; display: inline-block; width: 10%; font-size: 13px; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">NET
CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(97,251</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">33,875</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
FLOWS FROM FINANCING ACTIVITIES:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">(Repayments)
proceeds from line of credit</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(220,539</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">30,321</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Proceeds
from convertible notes payable</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">636,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">690,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Proceeds
from issuance of common and preferred stock, net of
costs</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,750,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">550,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock for warrant exercise</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">80,147</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Repayment
of convertible notes</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(125,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Repayment
of note payable</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(200,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">NET
CASH PROVIDED BY FINANCING ACTIVITIES</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,045,608</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,145,321</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">NET
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">831,226</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(85,128</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
AND CASH EQUIVALENTS, beginning of period</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">103,181</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">188,309</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
AND CASH EQUIVALENTS, end of period</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">934,407</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">103,181</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Supplemental
disclosures of cash flow information:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Interest
paid</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">64,228</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">47,789</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Taxes
paid</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Non-cash
investing and financing activities:</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Beneficial
conversion feature</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">348,096</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Conversion
of convertible debt</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">695,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Benificial
conversion feaature</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">559,130</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Conversion
of convertible debt to preferred shares</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">220,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Related
party accounts converted to notes</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,184,066</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Acquisition
of patents</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">520,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Penalty
on notes payable</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">75,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<font style="color: #000000">The
accompanying notes are an integral part of these consolidated
financial statements.</font>&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-5</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INCORPORATED AND SUBSIDIARIES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
1.</font></div>
</td>
<td style="vertical-align: top; width: 98%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
ORGANIZATION</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Know Labs, Inc. (the &#x201C;Company&#x201D;) was incorporated under
the laws of the State of Nevada in 1998.</font> The Company has
authorized 105,000,000 shares of capital stock, of which
100,000,000 are shares of voting common stock, par value $0.001 per
share, and 5,000,000 are shares preferred stock, par value $0.001
per share.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company is <font style="color: #000000">focused on the development,
marketing and sales of a proprietary technologies which are capable
of uniquely authenticating or diagnosing almost any substance or
material using electromagnetic energy to create, record and detect
the unique &#x201C;signature&#x201D; of the substance. The
Company&#x2019;s call these our &#x201C;ChromaID&#x2122;&#x201D; and
&#x201C;Bio-RFID&#x2122;&#x201D; technologies.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Overview</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Historically, the Company focused on the development of our
proprietary ChromaID technology. Using light from low-cost LEDs
(light emitting diodes) the Company&#x2019;s map the color of
substances, fluids and materials and with our proprietary processes
we can authenticate, identify and diagnose based upon the color
that is present. The color is both visible to us as humans but also
outside of the humanly visible color spectrum in the near infra-red
and near ultra-violet and beyond. The Company&#x2019;s ChromaID
scanner sees what we like to call &#x201C;Nature&#x2019;s Color
Fingerprint.&#x201D; Everything in nature has a unique color
identifier and with ChromaID the Company can see it, and identify,
authenticate and diagnose based upon the color that is present. The
Company&#x2019;s ChromaID scanner is capable of uniquely identifying
and authenticating almost any substance or liquid using light to
create, record and detect its unique color signature. The Company
will continue to develop and enhance its ChromaID technology and
extend its capacity. More recently, the Company has focused upon
extensions and new inventions that are derived from and extend
beyond our ChromaID technology. The Company&#x2019;s call this
technology Bio-RFID. The rapid advances made with our Bio-RFID
technology in our laboratory have caused us to move quickly in to
the commercialization phase of our Company as we work to create
revenue generating products for the marketplace. The Company will
also, as resources permit, pursue licensing opportunities with
third parties who have ready applications for our
technologies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In 2010, the Company acquired TransTech Systems, Inc. as an adjunct
to its business. TransTech is a distributor of products for
employee and personnel identification. TransTech currently provides
substantially all of the Company&#x2019;s revenues.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The Company is in the process of commercializing its
ChromaID&#x2122; and Bio-RFID&#x2122; technology. To date, the
Company has entered into License Agreements with Sumitomo Precision
Products Co., Ltd. In addition, it has a technology license
agreement with Allied Inventors</font>, formerly Xinova
<font style="color: #000000">and Invention Development Management
Company, a subsidiary of Intellectual Ventures.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company believes that its commercialization success is
dependent upon its ability to significantly increase the number of
customers that are purchasing and using its products. To date the
Company has generated minimal revenue from sales of its ChromaID
and Bio-RFID products. The Company is currently not profitable.
Even if the Company succeeds in introducing the ChromaID and
Bio-RFID technology and related products to its target markets, the
Company may not be able to generate sufficient revenue to achieve
or sustain profitability.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
ChromaID was invented by scientists under contract with the
Company. Bio-RFID was invented by individuals working for the
Company. The Company actively pursues a robust intellectual
property strategy and has been granted twelve patents. The Company
also has 20 patents pending. The Company possesses all right, title
and interest to the issued patents. Ten of the pending patents are
licensed exclusively to the Company in perpetuity by the
Company&#x2019;s strategic partner, Allied
Inventors.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Merger with RAAI Lighting, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company entered into an Agreement and Plan
of Merger with 500 Union Corporation, a Delaware corporation and a
wholly owned subsidiary of the Company, and RAAI Lighting, Inc., a
Delaware corporation. Pursuant to the Merger Agreement, we have
acquired all the outstanding shares of RAAI&#x2019;s capital stock
through a merger of Merger Sub with and into RAAI (the
&#x201C;Merger&#x201D;), with RAAI surviving the Merger as a wholly
owned subsidiary of the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Under the terms of the Merger Agreement, each share of RAAI common
stock issued and outstanding immediately before the Merger (1,000
shares) were cancelled and we issued 2,000,000 shares of our common
stock. As a result, we issued 2,000,000 shares of its common stock
to Phillip A. Bosua, formerly the sole stockholder of RAAI. The
consideration for the Merger was determined through arms-length
bargaining by the Company and RAAI. The Merger was structured to
qualify as a tax-free reorganization for U.S. federal income tax
purposes. As a result of the Merger, the Company received certain
intellectual property, related to RAAI.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-6</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Appointment of Director</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Board increased the size of the Board from
three to four members and Phillip A. Bosua was appointed as a
member of the Board. Mr. Bosua&#x2019;s term of office expires at
the next annual meeting of our stockholders. On May 24, 2018, the
Board of Directors increased the size of the Board from four to
five members and appointed (Ret.) Admiral William Owens as a member
of the Board. Admiral Owen&#x2019;s term of office expires at the
next annual meeting of our stockholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Appointment of Officer</font> <font style="color: #000000">&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company appointed Mr. Bosua as Chief
Executive Officer of the Company, replacing Ronald P. Erickson, who
remains Chairman of the Company. Previously, Mr. Bosua served as
the Company&#x2019;s Chief Product Officer since August 2017. The
Company entered into a Consulting Agreement with Mr. Bosua&#x2019;s
company, Blaze Clinical on July 7, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company entered into an Employment Agreement
with Mr. Bosua reflecting Mr. Bosua&#x2019;s appointment as Chief
Executive Officer. The Employment Agreement is for an initial term
of 12 months (subject to earlier termination) and will be
automatically extended for additional 12-month terms unless either
party notifies the other party of its intention to terminate the
Employment Agreement. Mr. Bosua will be paid a base salary of
$225,000 per year, received 500,000 shares of common stock valued
at $0.33 per share and may be entitled to bonuses and equity awards
at the discretion of the Board or a committee of the Board. The
Employment Agreement provides for severance pay equal to 12 months
of base salary if Mr. Bosua is terminated without
&#x201C;cause&#x201D; or voluntarily terminates his employment for
&#x201C;good reason.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company entered into an Amended Employment
Agreement for Ronald P. Erickson which amends the Employment
Agreement dated July 1, 2017. The Agreement expires March 21,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Merger with Know Labs, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, Know Labs, Inc., a Nevada corporation incorporated
on April 3, 2018, and our wholly-owned subsidiary, merged with and
into the Company pursuant to an Agreement and Plan of Merger dated
May 1, 2018. In connection with the merger, our Articles of
Incorporation were effectively amended to change our name to Know
Labs, Inc. by and through the filing of Articles of Merger. This
parent-subsidiary merger was approved by us, the parent, in
accordance with Nevada Revised Statutes Section 92A.180.
Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1,
2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Corporate Name Change and Symbol Change</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On May
24, 2018, the Financial Industry Regulatory Authority
(&#x201C;FINRA&#x201D;) announced the effectiveness of a change in
our name from Visualant Incorporated to Know Labs, Inc. and a
change in our ticker symbol from VSUL to the new trading symbol
KNWN which became effective on the opening of trading as of May 25,
2018. In addition, in connection with the name change and symbol
change, we were assigned the CUSIP number of
499238103.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Closing of Financing on June 25, 2018</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On June 25, 2018, the Company closed a private placement and
received gross proceeds of $1,750,000 in exchange for issuing
7,000,000 shares of common stock and warrants to purchase 3,500,000
shares of common stock in a private placement to accredited
investors pursuant to a series of substantially identical
subscription agreements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The initial exercise price of the warrants described above is $0.25
per share, subject to certain adjustments, and the warrants expire
five years after their issuance.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The shares and the warrants described above were issued in
transactions that were not registered under the Securities Act of
1933, as amended (the &#x201C;Act&#x201D;) in reliance upon
applicable exemptions from registration under Section 4(a)(2) of
the Act and/or Rule 506 of SEC Regulation D under the Act.
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
2.</font></div>
</td>
<td style="vertical-align: top; width: 98%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
GOING CONCERN</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
accompanying financial statements have been prepared on a going
concern basis, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. The
Company incurred net losses of $3,257,597 and $3,901,232 for the
years ended September 30, 2018 and 2017, respectively. Net cash
used in operating activities was $1,117,131 and $1,264,324 for the
years ended September 30, 2018 and 2017, respectively.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company anticipates that it will record losses from operations for
the foreseeable future. As of September 30, 2018, the
Company&#x2019;s accumulated deficit was $34,791,324.&#xA0;&#xA0;The
Company has limited capital resources, and operations to date have
been funded with the proceeds from private equity and debt
financings and loans from Ronald P. Erickson, the Company&#x2019;s
Chief Executive Officer, or entities with which he is affiliated.
These conditions raise substantial doubt about our ability to
continue as a going concern. The audit report prepared by the
Company&#x2019;s independent registered public accounting firm
relating to our financial statements for the year ended September
30, 2018 includes an explanatory paragraph expressing the
substantial doubt about the Company&#x2019;s ability to continue as
a going concern.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-7</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company believe that its cash on hand will be sufficient to fund
our operations until March 31, 2019. <font style="color: #000000">We need additional financing to implement our
business plan and to service our ongoing operations and pay our
current debts. There can be no assurance that we will be able to
secure any needed funding, or that if such funding is available,
the terms or conditions would be acceptable to us. If we are unable
to obtain additional financing when it is needed, we will need to
restructure our operations, and divest all or a portion of our
business.</font> <font style="color: #000000; background-color: #FFFFFF">We may seek additional
capital through a combination of private and public equity
offerings, debt financings and strategic collaborations. Debt
financing, if obtained, may involve agreements that include
covenants limiting or restricting our ability to take specific
actions, such as incurring additional debt, and could increase our
expenses and require that our assets secure such debt. Equity
financing, if obtained, could result in dilution to the
Company&#x2019;s then-existing stockholders and/or require such
stockholders to waive certain rights and preferences. If such
financing is not available on satisfactory terms, or is not
available at all, the Company may be required to delay, scale back,
eliminate the development of business opportunities or file for
bankruptcy and our operations and financial condition may be
materially adversely affected.</font>&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times\ New\ Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 2%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
3.&#xA0;&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING
STANDARDS</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Basis of Presentation</font> <font style="color: #000000">&#x2013;</font> The accompanying unaudited
consolidated financial statements include the accounts of the
Company. Intercompany accounts and transactions have been
eliminated. The preparation of these unaudited condensed
consolidated financial statements were prepared in conformity with
U.S. generally accepted accounting principles
(&#x201C;GAAP&#x201D;).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Principles of Consolidation</font> <font style="color: #000000">&#x2013; The consolidated financial statements
include the accounts of the Company and its wholly owned and
majority-owned subsidiaries, TransTech Systems, Inc and RAAI
Lighting, Inc. Inter-Company items and transactions have been
eliminated in consolidation.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Cash and Cash Equivalents</font> <font style="color: #000000">&#x2013;&#xA0;The Company classifies highly liquid
temporary investments with an original maturity of three months or
less when purchased as cash equivalents. The Company maintains cash
balances at various financial institutions. Balances at US banks
are insured by the Federal Deposit Insurance Corporation up to
$250,000. The Company has not experienced any losses in such
accounts and believes it is not exposed to any significant risk for
cash on deposit.&#xA0;&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Accounts Receivable and Allowance for Doubtful Accounts</font>
<font style="color: #000000">&#x2013; Accounts receivable consist
primarily of amounts due to the Company from normal business
activities. The Company maintains an allowance for doubtful
accounts to reflect the expected non-collection of accounts
receivable based on past collection history and specific risks
identified within the portfolio. If the financial condition of the
customers were to deteriorate resulting in an impairment of their
ability to make payments, or if payments from customers are
significantly delayed, additional allowances might be
required.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Inventories</font> <font style="color: #000000">&#x2013; Inventories
consist primarily of printers and consumable supplies, including
ribbons and cards, badge accessories, capture devices, and access
control components held for resale and are stated at the lower of
cost or market on the&#xA0;first-in, first-out (&#x201C;FIFO&#x201D;)
method.&#xA0;&#xA0;Inventories are considered available for resale
when drop shipped and invoiced directly to a customer from a
vendor, or when physically received by TransTech at a warehouse
location.&#xA0;&#xA0;The Company records a provision for excess and
obsolete inventory whenever an impairment has been identified.
There is a $35,000 reserve for impaired inventory as of September
30, 2018 and 2017, respectively.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Equipment</font> <font style="color: #000000">&#x2013; Equipment
consists of machinery, leasehold improvements, furniture and
fixtures and software, which are stated at cost less accumulated
depreciation and amortization. Depreciation is computed by the
straight-line method over the estimated useful lives or lease
period of the relevant asset, generally 2-10 years, except for
leasehold improvements which are depreciated over 2-3
years.&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Long-Lived Assets</font> <font style="color: #000000">&#x2013; The
Company reviews its long-lived assets for impairment annually or
when changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. Long-lived assets under certain
circumstances are reported at the lower of carrying amount or fair
value. Assets to be disposed of and assets not expected to provide
any future service potential to the Company are recorded at the
lower of carrying amount or fair value (less the projected cost
associated with selling the asset). To the extent carrying values
exceed fair values, an impairment loss is recognized in operating
results.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Intangible Assets</font> &#x2013; Intangible assets are capitalized
and amortized on a straight-line basis over their estimated useful
life, if the life is determinable. If the life is not determinable,
amortization is not recorded. We regularly perform reviews to
determine if facts and circumstances exist which indicate that the
useful lives of our intangible assets are shorter than originally
estimated or the carrying amount of these assets may not be
recoverable. When an indication exists that the carrying amount of
intangible assets may not be recoverable, we assess the
recoverability of our assets by comparing the projected
undiscounted net cash flows associated with the related asset or
group of assets over their remaining lives against their respective
carrying amounts. Such impairment test is based on the lowest level
for which identifiable cash flows are largely independent of the
cash flows of other groups of assets and liabilities. Impairment,
if any, is based on the excess of the carrying amount over the
estimated fair value of those assets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Research, Development and Engineering Expenses</font> &#x2013;
Research, development and engineering expenses consist of the cost
of employees, consultants and contractors who design, engineer and
develop new products and processes as well as materials, supplies
and facilities used in producing prototypes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-8</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company&#x2019;s research and development efforts are primarily
focused improving the core foundational ChromaID technology and
developing new and unique applications for the technology. As part
of this effort, the Company typically conduct testing to ensure
that ChromaID application methods are compatible with the
customer&#x2019;s requirements, and that they can be implemented in
a cost effective manner. The Company is also actively involved in
identifying new application methods. Know Lab&#x2019;s team has
considerable experience working with the application of light-based
technologies and their application to various industries. The
Company believes that its continued development of new and enhanced
technologies relating to our core business is essential to its
future success. The Company spent $570,514 and $79,405 during the
years ended September 30, 2018 and 2017, respectively, on research
and development activities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; font-style: italic">
Fair Value Measurements and Financial Instruments</font>
<font style="color: #000000">&#x2013;</font><font style="font-weight: bold">&#xA0;</font>ASC Topic 820, <font style="font-style: italic">Fair Value Measurement and Disclosures</font>,
defines fair value as the exchange price that would be received for
an asset or paid to transfer a liability (an exit price) in the
principal or most advantageous market for the asset or liability in
an orderly transaction between market participants on the
measurement date.&#xA0;&#xA0;This topic also establishes a fair
value hierarchy, which requires classification based on observable
and unobservable inputs when measuring fair value.&#xA0;&#xA0;The
fair value hierarchy distinguishes between assumptions based on
market data (observable inputs) and an entity&#x2019;s own
assumptions (unobservable inputs).&#xA0;&#xA0;The hierarchy
consists of three levels:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Level 1
&#x2013; Quoted prices in active markets for identical assets and
liabilities;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Level 2
&#x2013; Inputs other than level one inputs that are either directly
or indirectly observable; and.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Level&#xA0;3
- Inputs to the valuation methodology are unobservable and
significant to the fair value measurement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
recorded value of other financial assets and liabilities, which
consist primarily of cash and cash equivalents, accounts
receivable, other current assets, and accounts payable and accrued
expenses approximate the fair value of the respective assets and
liabilities as of September 30, 2018 and 2017 are based upon the
short-term nature of the assets and liabilities.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Derivative Financial Instruments -</font>The Company evaluates all
of its financial instruments to determine if such instruments are
derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are
accounted for as liabilities, the derivative instrument is
initially recorded at its fair value and is then re-valued at each
reporting date, with changes in the fair value reported in the
consolidated statements of operations. For stock-based derivative
financial instruments, the Company uses a Black-Scholes-Merton
option pricing model to value the derivative instruments at
inception and on subsequent valuation dates. The classification of
derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is evaluated at the end of
each reporting period. Derivative instrument liabilities are
classified in the balance sheet as current or non-current based on
whether or not net-cash settlement of the derivative instrument
could be required within twelve months of the balance sheet
date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Revenue Recognition</font> <font style="color: #000000">&#x2013;
Know Lab and TransTech revenue are derived from products and
services. Revenue is considered realized when the products or
services have been provided to the customer, the work has been
accepted by the customer and collectability is&#xA0;reasonably
assured. Furthermore, if an actual measurement of revenue cannot be
determined, the Company defers all revenue recognition until such
time that an actual measurement can be determined. If during the
course of a contract management determines that losses are expected
to be incurred, such costs are charged to operations in the period
such losses are determined. Revenues are deferred when cash has
been received from the customer but the revenue has not been
earned.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Stock Based Compensation</font> <font style="color: #000000">&#x2013; The Company has share-based compensation
plans under which employees, consultants, suppliers and directors
may be granted restricted stock, as well as options to purchase
shares of Company common stock at the fair market value at the time
of grant. Stock-based compensation cost is measured by the Company
at the grant date, based on the fair value of the award, over the
requisite service period. For options issued to employees, the
Company recognizes stock compensation costs utilizing the fair
value methodology over the related period of
benefit.&#xA0;&#xA0;Grants of stock options and stock to
non-employees and other parties are accounted for in accordance
with the ASC 505.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Convertible Securities</font> <font style="color: #000000">&#x2013;</font> Based upon ASC 815-15, we have
adopted a sequencing approach regarding the application of ASC
815-40 to convertible securities. We will evaluate our contracts
based upon the earliest issuance date. In the event partial
reclassification of contracts subject to ASC 815-40-25 is
necessary, due to our inability to demonstrate we have sufficient
shares authorized and unissued, shares will be allocated on the
basis of issuance date, with the earliest issuance date receiving
first allocation of shares. If a reclassification of an instrument
were required, it would result in the instrument issued latest
being reclassified first.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Net Loss per Share</font> <font style="color: #000000">&#x2013;
Under the provisions of ASC 260, &#x201C;Earnings Per Share,&#x201D;
basic loss per common share is computed by dividing net loss
available to common stockholders by the weighted average number of
shares of common stock outstanding for the periods presented.
Diluted net loss per share reflects the potential dilution that
could occur if securities or other contracts to issue common stock
were exercised or converted into common stock or resulted in the
issuance of common stock that would then share in the income of the
Company, subject to anti-dilution limitations. The common stock
equivalents have not been included as they are anti-dilutive. As of
September 30, 2018, there were options outstanding for the purchase
of 2,182,668 common shares, warrants for the purchase of 15,473,398
common shares, 4,914,071 shares of the Company&#x2019;s common stock
issuable upon the conversion of Series A, Series C and Series D
Convertible Preferred Stock. In addition, we have an unknown number
of shares (9,020,264 common shares at the current price of $0.25
per share) are issuable upon conversion of convertible debentures
of $2,255,066. All of which could potentially dilute future
earnings per share. &#xA0;&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-9</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As of September 30, 2017, there were options outstanding for the
purchase of 15,404 common shares, warrants for the purchase of
6,900,356 common shares, 2,825,053&#xA0;shares of the
Company&#x2019;s common stock issuable upon the conversion of Series
A, Series C and Series D Convertible Preferred Stock and up to
332,940 shares of the Company&#x2019;s common stock issuable upon
the exercise of placement agent warrants. In addition, the Company
has an unknown number of shares are issuable upon conversion of
convertible debentures of $570,000. All of which could potentially
dilute future earnings per share. &#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Dividend Policy</font> <font style="color: #000000">&#x2013; The
Company has never paid any cash dividends and intends, for the
foreseeable future, to retain any future earnings for the
development of our business. Our future dividend policy will be
determined by the board of directors on the basis of various
factors, including our results of operations, financial condition,
capital requirements and investment
opportunities.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Use of Estimates</font> <font style="color: #000000">&#x2013; The
preparation of financial statements in conformity with accounting
principles generally accepted in the United States requires
management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during
the reporting period. Actual results could differ from those
estimates.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Recent Accounting Pronouncements</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In July
2015, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (ASU) 2015-11, &#x201C;Simplifying the
Measurement of Inventory,&#x201D; Topic 330, &#x201C;Inventory&#x201D;
(ASU 2015-11). The amendments in ASU 2015-11, which apply to
inventory that is measured using any method other than the last-in,
first-out (LIFO) or retail inventory method, require that entities
measure inventory at the lower of cost and net realizable value.
The amendments in ASU 2015-11 should be applied on a prospective
basis. ASU 2015-11 is effective for fiscal years beginning after
December 15, 2016 and interim periods within those years. The
Company adopted the amendments of ASU 2015-11 effective October 1,
2017. The adoption of this standard did not have a material impact
on the Company&#x2019;s consolidated financial statements for the
year ended September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
March 2016, the FASB issued ASU 2016-09, &#x201C;Improvements to
Employee Share-Based Payment Accounting,&#x201D; Topic 718,
&#x201C;Compensation-Stock Compensation&#x201D; (ASU 2016-09). ASU
2016-09 includes provisions intended to simplify various aspects
related to how share-based payments are accounted for and presented
in the Company&#x2019;s financial statements, including income tax
consequences, forfeitures and classification on the statement of
cash flows. Under previous guidance, excess tax benefits and
deficiencies from share-based compensation arrangements were
recorded in equity when the awards vested or were settled. ASU
2016-09 requires prospective recognition of excess tax benefits and
deficiencies in income tax expense, rather than paid-in-capital.
The Company adopted the amendments of ASU 2016-09 effective October
1, 2017.The adoption of this standard did not have a material
impact on the Company&#x2019;s consolidated statements of income for
the year ended September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
addition, under ASU 2016-09, excess tax income tax benefits from
share-based compensation arrangements are classified as cash flow
from operations, rather than as cash flow from financing
activities. For the year ended September 30, 2018, there were no
excess income tax benefits.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company has elected to continue to estimate the number of
share-based awards expected to vest, as permitted by ASU 2016-09,
rather than electing to account for forfeitures as they
occur.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">ASU
2016-09 requires excess tax benefits and deficiencies to be
prospectively excluded from assumed future proceeds in the
calculation of diluted shares, resulting in an immaterial decrease
in diluted weighted average shares outstanding for the year ended
September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
January 2017, the FASB issued ASU 2017-04, &#x201C;Simplifying the
Test for Goodwill Impairment,&#x201D; Topic 350, &#x201C;Intangibles
&#x2013; Goodwill and Other&#x201D; (ASU 2017-04). The amendments in
ASU 2017-04 simplify the accounting for goodwill impairment for all
entities by requiring impairment charges to be based on the first
step in the current two-step impairment test. An impairment charge
for the amount by which the carrying amount exceeds the reporting
unit&#x2019;s fair value should be recognized; however, the loss
recognized should not exceed the total amount of goodwill allocated
to that reporting unit. The amendments should be applied on a
prospective basis. Early adoption is permitted for annual and
interim goodwill impairment testing dates after January 1, 2017,
and the ASU is effective for the Company&#x2019;s first quarter of
the fiscal year ending September 30, 2020. The Company is currently
evaluating the impact that the adoption of these provisions will
have on its consolidated financial statements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
February 2016, the FASB issued ASU 2016-02, &#x201C;Leases,&#x201D;
Topic 842, &#x201C;Leases&#x201D; (ASU 2016-02). ASU No. 2016-02
requires lessees to recognize a right-of-use asset and
corresponding lease liability for all leases with terms of more
than 12 months. Recognition, measurement and presentation of
expenses will depend on classification as a finance or operating
lease. ASU 2016-02 also requires certain quantitative and
qualitative disclosures. The provisions of ASU 2016-02 are
effective for the Company&#x2019;s first quarter of the fiscal year
ending September 30, 2020, with early adoption permitted. The
Company will apply the transition provisions of ASU 2016-02 at its
adoption date, rather than the earliest comparative period
presented in the financial statements, as permitted by ASU 2018-11,
&#x201C;Leases,&#x201D; Topic 842, &#x201C;Targeted
Improvements,&#x201D; released in July 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
adoption of ASU 2016-02 may result in a material increase to the
Company&#x2019;s consolidated balance sheets for lease liabilities
and right-of-use assets. The Company is also performing a
comprehensive review of its current processes to determine and
implement changes required to support the adoption of this
standard. The Company is currently evaluating the other effects the
adoption of ASU 2016-02 will have on its consolidated financial
statements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-10</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
January 2018, the FASB issued ASU 2018-01, &#x201C;Leases,&#x201D;
Topic 842, &#x201C;Land Easement Practical Expedient for Transition
to Topic 842&#x201D; (ASU 2018-01). ASU 2018-01 permits an entity to
elect a transition practical expedient to not assess, under
Accounting Standards Codification (ASC) 842, land easements that
exist or expired before the standard&#x2019;s effective date that
were not previously accounted for as leases under ASC 840. The
Company plans to elect this practical expedient in implementing ASU
2016-02.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In May
2014, the FASB issued ASU 2014-09, &#x201C;Revenue from Contracts
with Customers,&#x201D; Topic 606, &#x201C;Revenue from Contracts
with Customers&#x201D; (ASU 2014-09). ASU 2014-09 provides guidance
for revenue recognition and will replace most existing revenue
recognition guidance in GAAP when it becomes effective. ASU
2014-09&#x2019;s core principle is that a company will recognize
revenue when it transfers promised goods or services to customers
in an amount that reflects the consideration to which the company
expects to be entitled for the transfer of those goods or services.
ASU 2014-09 permits the use of either the retrospective or
cumulative effect transition method. Additionally, the amendments
in this ASU provide a practical expedient for entities to recognize
the incremental costs of obtaining a contract as an expense when
incurred if the amortization period of the asset that the entity
otherwise would have recognized is one year or less, The Company
plans to elect this practical expedient upon adoption.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In July
2015, the FASB issued ASU 2015-14, &#x201C;Revenue from Contracts
with Customers &#x2013; Deferral of the Effective Date.&#x201D; The
FASB approved the deferral of ASU 2014-09, by extending the new
revenue recognition standard&#x2019;s mandatory effective date by
one year and permitting public companies to apply the new revenue
standard to annual reporting periods beginning after December 15,
2017. The guidance in ASU 2014-09 will be effective for the Company
in the first quarter of the fiscal year ending September 30,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Further
to ASU 2014-09 and ASU 2015-14, the FASB issued ASU 2016-08,
&#x201C;Revenue from Contracts with Customers,&#x201D; Topic 606,
&#x201C;Principal versus Agent Considerations (Reporting Revenue
Gross versus Net)&#x201D; (ASU 2016-08) in March 2016, ASU 2016-12,
&#x201C;Revenue from Contracts with Customers,&#x201D; Topic 606,
&#x201C;Narrow-Scope Improvements and Practical Expedients&#x201D;
(ASU 2016-12) in May 2016 and ASU 2016-20, &#x201C;Revenue from
Contracts with Customers,&#x201D; Topic 606, &#x201C;Technical
Corrections and Improvements&#x201D; (ASU 2016-20) in December 2016.
The amendments in ASU 2016-08 clarify the implementation guidance
on principal versus agent considerations, including indicators to
assist an entity in determining whether it controls a specified
good or service before it is transferred to the customers. ASU
2016-12 addresses narrow-scope improvements to the guidance on
collectability, non-cash consideration, and completed contracts at
transition. Additionally, the amendments in this ASU provide a
practical expedient for contract modifications at transition and an
accounting policy election related to the presentation of sales
taxes and other similar taxes collected from customers. The Company
plans to make such election. The Company also plans to elect the
practical expedient in ASU 2016-20 that provides entities do not
need to disclose the transaction price allocated to performance
obligations when the related contracts have a duration of one year
or less. This includes loyalty rewards, which can be redeemed in
the month subsequent to the quarter earned, and marketing
promotions that cross accounting periods. Both of these classes of
transactions are currently immaterial to the Company. The effective
date and transition requirements for ASU 2016-08, ASU 2016-12 and
ASU 2016-20 are the same as for ASU 2014-09.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company does not plan to early adopt the new revenue recognition
guidance; adoption will be on the modified retrospective basis
beginning in fiscal year 2019. The Company has substantially
concluded its assessment of the impact of the adoption of this
standard on its consolidated financial statements. Most of the
Company&#x2019;s revenue is expected to continue to be generated
from point-of-sale transactions, which ASU 2014-09 treats generally
consistent with current accounting standards. The Company does not
expect this standard will have a material impact on the accounting
for point-of-sale transactions or related areas including the right
of return and customer incentives. Although the impact on the
consolidated financial statements is not expected to be material,
additional disclosures will be required.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In June
2018, the FASB issued ASU 2018-07, &#x201C;Compensation-Stock
Compensation,&#x201D; Topic 718, &#x201C;Improvements to Nonemployee
Share-Based Payment Accounting&#x201D; (ASU 2018-07) as part of its
Simplification Initiative to reduce complexity when accounting for
share-based payments to non-employees. ASU 2018-07 expands the
scope of Topic 718 to more closely align share-based payment
transactions for acquiring goods and services from non-employees
with the accounting for share-based payments to employees, with
certain exceptions. The provisions of ASU 2018-07 are effective for
the Company&#x2019;s first quarter of the fiscal year ending
September 30, 2020, with early adoption permitted.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">4.&#xA0;</font>&#xA0;A<font style="color: #000000">CCOUNTS RECEIVABLE/CUSTOMER
CONCENTRATION</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Accounts receivable were $320,538 and $693,320, net of allowance,
as of September 30, 2018 and 2017, respectively. The Company had
one customer in excess of 10% (25.4%) of the Company&#x2019;s
consolidated revenues for the year ended September 30, 2018. The
Company had four customers in excess of 10% (13.9%, 12.9%, 12.5%
and 11.2%) with accounts receivable in excess of 10% as of
September 30, 2018. The Company has a total allowance for bad debt
in the amount of $60,000 as of September 30,
2018.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">5.&#xA0;</font>&#xA0;I<font style="color: #000000">NVENTORIES</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Inventories were $203,582 and $225,909 as of September 30, 2018 and
2017, respectively. Inventories consist primarily of printers and
consumable supplies, including ribbons and cards, badge
accessories, capture devices, and access control components held
for resale. There was a $35,000 reserve for impaired inventory as
of September 30, 2018 and 2017, respectively.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-11</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
6.&#xA0; NOTES RECEIVABLE FROM BIOMEDX, INC.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 1, 2016, the Company purchased an Original Issue Discount
Convertible Promissory Note from BioMedx, Inc. The Company paid
$260,000 for the Note with a principal amount of $286,000. The Note
matured one year from issuance and bears interest at 5%. The
principal and interest was convertible into BioMedx common stock at
the option of the Company. The Company received 150,000 shares of
BioMedx common stock as partial consideration for purchasing the
Note. In addition, if BioMedx does not repay the Promissory Note,
the Company would have the right to convert the Promissory Note
into 51% of the ownership of BioMedx.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
addition, the Company and BioMedx agreed to negotiate in good faith
to enter into a joint development agreement and subsequent merger
transaction prior to December 31, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Due to
the uncertainty involved with a start-up company, The
Company&#x2019;s management determined that the value of the
Promissory Note and BioMedx common stock was zero at December 31,
2016 and recorded an impairment reserve for the full value as of
December 31, 2016. During the three months ended March 31, 2017,
BioMedx paid the Company $290,608 in full satisfaction of the Note.
The Company recorded the gain as a reduction in SG&amp;A expense
during the three months ended March 31, 2017. In addition, the
Company has not valued the 150,000 shares of BioMedx common
stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">7.&#xA0;</font>&#xA0;F<font style="color: #000000">IXED ASSETS</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Fixed assets, net of accumulated depreciation, was $169,333 and
$133,204 as of September 30, 2018 and 2017, respectively.
Accumulated depreciation was $670,666 and $662,855 as of September
30, 2018 and 2017, respectively. Total depreciation expense was
$60,393 and 38,031 for the years ended September 30, 2018 and 2017,
respectively. All equipment is used for selling, general and
administrative purposes and accordingly all depreciation is
classified in selling, general and administrative
expenses.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Property and equipment as of September 30, 2018 was comprised of
the following:&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0px auto 0px 0px; width: 80%; font-size: inherit; font-family: inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Estimated</font></div>
</td>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:45%;">
<div><font style="text-align: left; padding-bottom:2px;width:3%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">September
30, 2018</font> <font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:3%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Useful
Lives</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Purchased</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Capital
Leases</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Total</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Machinery
and equipment</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2-10
years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">332,305</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">42,681</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">374,986</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Leasehold
improvements</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2-3
years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">276,112</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">276,112</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Furniture
and fixtures</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2-3
years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">58,051</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">95,020</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">153,071</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Software
and websites</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">3-
7 years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">35,830</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">35,830</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Less:
accumulated depreciation</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(532,966</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(137,700</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(670,666</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="2" style="vertical-align: bottom; width: 42%;">
<div style="margin-left:0px;padding-bottom:4px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">169,332</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">169,333</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">8.&#xA0;</font>&#xA0;<font style="color: #000000">INTANGIBLE ASSETS</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Intangible assets as of September 30, 2018 and September 30, 2017
consisted of the following:&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0px auto 0px 0px; width: 60%; font-size: inherit; font-family: inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:35%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Estimated</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30,</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30,</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:35%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Useful
Lives</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">2018</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">2017</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:35%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:35%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Technology</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">3
years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">520,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:35%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Less:
accumulated amortization</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(72,222</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:35%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;Intangible
assets, net</font></div>
</td>
<td style="vertical-align: bottom; width: 15%;">
<div style="margin-left:0px;padding-bottom:4px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">447,778</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Total amortization expense was $72,222 and $0 for the years ended
September 30, 2018 and 2017, respectively.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Merger with RAAI Lighting, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company entered into an Agreement and Plan
of Merger with 500 Union Corporation, a Delaware corporation and a
wholly owned subsidiary of the Company, and RAAI Lighting, Inc., a
Delaware corporation. Pursuant to the Merger Agreement, we have
acquired all the outstanding shares of RAAI&#x2019;s capital stock
through a merger of Merger Sub with and into RAAI (the
&#x201C;Merger&#x201D;), with RAAI surviving the Merger as a wholly
owned subsidiary of the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Under the terms of the Merger Agreement, each share of RAAI common
stock issued and outstanding immediately before the Merger (1,000
shares) were cancelled and we issued 2,000,000 shares of our common
stock. As a result, we issued 2,000,000 shares of its common stock
to Phillip A. Bosua, formerly the sole stockholder of RAAI. The
consideration for the Merger was determined through arms-length
bargaining by the Company and RAAI. The Merger was structured to
qualify as a tax-free reorganization for U.S. federal income tax
purposes. As a result of the Merger, the Company received certain
intellectual property, related to RAAI.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-12</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Merger with Know Labs, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, Know Labs, Inc., a Nevada corporation incorporated
on April 3, 2018, and our wholly-owned subsidiary, merged with and
into the Company pursuant to an Agreement and Plan of Merger dated
May 1, 2018. In connection with the merger, our Articles of
Incorporation were effectively amended to change our name to Know
Labs, Inc. by and through the filing of Articles of Merger. This
parent-subsidiary merger was approved by us, the parent, in
accordance with Nevada Revised Statutes Section 92A.180.
Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1,
2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
RAAI had no outstanding indebtedness or assets at the closing of
the Merger. The 2,000,000 shares of the Company&#x2019;s common
stock issued for RAAI&#x2019;s shares were recorded at the fair
value at the date of the merger at $520,000 and the value assigned
to the patent acquired with RAAI.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The fair value of the intellectual property associated with the
assets acquired was $520,000 estimated by using a discounted cash
flow approach based on future economic benefits. In summary, the
estimate was based on a projected income approach and related
discounted cash flows over five years, with applicable risk factors
assigned to assumptions in the forecasted results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">9.&#xA0;</font>&#xA0;<font style="color: #000000">GOODWILL</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company&#x2019;s TransTech business is very capital intensive.
The Company reviewed TransTech&#x2019;s operations based on its
overall financial constraints and determined the value has been
impaired. The company recorded an impairment of goodwill associated
with TransTech of $983,645 during the year ended September 30,
2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
10. ACCOUNTS PAYABLE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Accounts payable were $1,512,618 and $2,154,646 as
of&#xA0;September 30, 2018 and 2017, respectively. Such liabilities
consisted of amounts due to vendors for inventory purchases and
technology development, external audit, legal and other expenses
incurred by the Company. The Company had two vendors (13.2% and
10.2%) with accounts payable in excess of 10% of its accounts
payable as of September 30, 2018. The Company does expect to have
vendors with accounts payable balances of 10% of total accounts
payable in the foreseeable future.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">11.</font>&#xA0;&#xA0;<font style="color: #000000">DERIVATIVE INSTRUMENTS</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
April 2008, the FASB issued a pronouncement that provides guidance
on determining what types of instruments or embedded features in an
instrument held by a reporting entity can be considered indexed to
its own stock for the purpose of evaluating the first criteria of
the scope exception in the pronouncement on accounting for
derivatives. This pronouncement was effective for financial
statements issued for fiscal years beginning after December 15,
2008. The adoption of these requirements can affect the accounting
for warrants and many convertible instruments with provisions that
protect holders from a decline in the stock price (or
&#x201C;down-round&#x201D; provisions). For example, warrants or
conversion features with such provisions are no longer recorded in
equity. Down-round provisions reduce the exercise price of a
warrant or convertible instrument if a company either issues equity
shares for a price that is lower than the exercise price of those
instruments or issues new warrants or convertible instruments that
have a lower exercise price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">There
was no derivative liability as of <font style="color: #000000">September 30, 2018 and 2017.</font> For the year
ended September 30, 2017, the Company recorded non-cash loss of
$217,828 related to the &#x201C;change in fair value of
derivative&#x201D; expense related to its derivative instruments.
The Company early adopted ASU 2017-11 and has reclassified its
financial instrument with down round features to equity in the
amount of $410,524.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
12. CONVERTIBLE NOTES PAYABLE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Convertible notes payable as of September 30, 2018 and September
30, 2017 consisted of the following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Convertible Promissory Note dated September 30, 2016</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On September 30, 2016, the Company entered into a $210,000
Convertible Promissory Note with Clayton A. Struve, an accredited
investor of the Company, to fund short-term working capital. The
Convertible Promissory Note accrued interest at a rate of 10% per
annum and was due on March 30, 2017. The Note holder can convert
the Note into common stock at $0.70 per share. During the year
ended September 30, 2017, the Company recorded interest of $21,000
related to the convertible note. This note was extended in the
Securities Purchase Agreement, General Security Agreement and
Subordination Agreement dated August 14, 2017 with a maturity date
of August 13, 2018. Also, the conversion price of the Debenture was
adjusted to $0.25 per share, subject to certain adjustments. The
balance was increased $75,000 during the year ended September 30,
2018.</font> On November 16, 2018, we signed Amendment 1 to Senior
Secured Convertible Redeemable Notes dated September 30,
2016extending the due dates of the Note to February 27, 2019. On
September 24, 2018, Mr. Struve converted $200,000 of the Note into
800,000 shares of our common stock. <font style="color: #000000">The Company recorded accrued interest of $54,671
as of September 30, 2018.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-13</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Securities Purchase Agreement dated August 14, 2017</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 14, 2017, the Company issued a senior convertible
exchangeable debenture with a principal amount of $360,000 and a
common stock purchase warrant to purchase 1,440,000 shares of
common stock in a private placement to Clayton Struve for gross
proceeds of $300,000 pursuant to a Securities Purchase Agreement
dated August 14, 2017. The debenture accrues interest at 20% per
annum and matures August 13, 2018. The convertible debenture
contains a beneficial conversion valued at $110,629. The warrants
were valued at $111,429. Because the note is immediately
convertible, the warrants and beneficial conversion were expensed
as interest.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On the same date, the Company entered into a General Security
Agreement with the Mr. Struve, pursuant to which the Company has
agreed to grant a security interest to the investor in
substantially all of our assets, effective upon the filing of a
UCC-3 termination statement to terminate the security interest held
by Capital Source Business Finance Group in the assets of the
Company. In addition, an entity affiliated with Ronald P. Erickson,
out then Chief Executive Officer, entered into a Subordination
Agreement with the investor pursuant to which all debt owed by us
to such entity is subordinated to amounts owed by us to Mr. Struve
under the Debenture (including amounts that become owing under any
Debentures issued to the investor in the future).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The initial conversion price of the Debenture is $0.25 per share,
subject to certain adjustments. The initial exercise price of the
Warrant is $0.25 per share, also subject to certain
adjustments.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As part of the Purchase Agreement, the Company granted the investor
&#x201C;piggyback&#x201D; registration rights to register the shares
of common stock issuable upon the conversion of the Debenture and
the exercise of the Warrant with the Securities and Exchange
Commission for resale or other disposition.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Debenture and the Warrant were issued in a transaction that was
not registered under the Securities Act of 1933, as amended in
reliance upon applicable exemptions from registration under Section
4(a)(2) of the Act and Rule 506 of SEC Regulation D under the Act.
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Under the terms of the Purchase Agreement, Mr. Struve may purchase
up to an aggregate of $1,000,000 principal amount of Debentures
(before a 20% original issue discount) (and Warrants to purchase up
to an aggregate of 250,000 shares of common stock). These
securities are being offered on a &#x201C;best efforts&#x201D; basis
by the placement agent.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the year ended September 30, 2017, $156,941 was recorded as
interest expense related to debt discounts, beneficial conversions
and warrants associated with Convertible Promissory
Notes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 12, 2017, the Company closed an additional $250,000 and
issued a senior convertible exchangeable debenture with a principal
amount of $300,000 and a common stock purchase warrant to purchase
1,200,000 shares of common stock in a private placement dated
December 12, 2017 with Mr. Struve pursuant to a Securities Purchase
Agreement dated August 14, 2017. The convertible debenture contains
a beneficial conversion valued at $93,174. The warrants were valued
at $123,600. Because the note is immediately convertible, the
warrants and beneficial conversion were expensed as
interest.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 2, 2018, the Company received gross proceeds of $280,000
in exchange for issuing a senior convertible redeemable debenture
with a principal amount of $336,000 and a warrant to purchase
1,344,000 shares of common stock in a private placement dated
February 28, 2018 with Mr. Struve pursuant to a Securities Purchase
Agreement dated August 14, 2017. The convertible debenture contains
a beneficial conversion valued at $252,932. The warrants were
valued at $348,096. Because the note is immediately convertible,
the warrants and beneficial conversion were expensed as
interest.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In connection with the February 28, 2018 private placement, the
placement agent for the debenture and the warrant received a cash
fee of $28,000 and the Company issued warrants to purchase shares
of the Company&#x2019;s common stock to the placement agent or its
affiliates based on 10% of proceeds.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 16, 2018, the Company signed Amendment 1 to Senior Secured
Convertible Redeemable Notes dated August 14, 2017 and December 12,
2017, extending the due dates of the Notes to February 27,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Convertible Redeemable Promissory Notes with Ronald P. Erickson and
J3E2A2Z</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 16, 2018, the Company entered into a Note and Account Payable
Conversion Agreement pursuant to which (a) all $664,233 currently
owing under the J3E2A2Z Notes was converted to a Convertible
Redeemable Promissory Note in the principal amount of $664,233, and
(b) all $519,833 of the J3E2A2Z Account Payable was converted into
a Convertible Redeemable Promissory Note in the principal amount of
$519,833 together with a warrant to purchase up to 1,039,666 shares
of common stock of the Company for a period of five years.
<font style="color: #000000">The initial exercise price of the
warrants described above is $0.50 per share, also subject to
certain adjustments. The warrants were valued at $110,545. Because
the note is immediately convertible, the warrants and beneficial
conversion were expensed as interest. The Company recorded accrued
interest of $23,649 as of September 30, 2018.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-14</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times\ New\ Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 2%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
12.</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
NOTES PAYABLE, CAPITALIZED LEASES AND LONG-TERM DEBT</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Notes payable, capitalized leases and long-term debt as of
September 30, 2018 and 2017 consisted of the
following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:70%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30,</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">September
30,</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">2018</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">2017</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Capital
Source Business Finance Group</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">145,186</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">365,725</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Note
payable to Umpqua Bank</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">199,935</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Secured
note payable to J3E2A2Z LP - related party</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">600,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
debt</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">145,186</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,165,660</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Less
current portion of long term debt</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(145,186</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(1,165,660</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Long
term debt</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Capital Source Business Finance Group</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Know
Labs, Inc. (the &#x201C;Company&#x201D;) finances its TransTech
operations from operations and a Secured Credit Facility with
Capital Source Business Finance Group. On June 15, 2018, TransTech
entered into a Fifth Modification to the Loan and Security
Agreement related to the $500,000 secured credit facility with
Capital Source to fund its operations. The Modification extended
the maturity to December 12, 2018. The secured credit facility
provides for a prime rate interest floor for prime interest of 4.5%
plus 2.5%. The eligible borrowing is based on 80% of eligible trade
accounts receivable, not to exceed $500,000. The secured credit
facility is collateralized by the assets of TransTech, with a
guarantee by Know Labs, including a security interest in all assets
of Know Labs. The remaining balance on the accounts receivable must
be repaid by the time the secured credit facility expires on
December 12, 2018, unless we renew by automatic extension for the
next successive term. TransTech has $24,000 available as of
September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
December 6, 2018, Capital Source notified TransTech that the Loan
and Security Agreement and Capital Source Credit Facility would be
cancelled as of March 12, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Effective
December 12, 2018, TransTech entered into the Sixth Modification to
the Loan and Security Agreement which reduced the secured credit
facility to $200,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">

<br></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Note Payable to Umpqua Bank</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On July 9, 2018, the Company repaid a $199,935 Business Loan
Agreement with Umpqua Bank from funds previously provided by</font>
an entity affiliated with Ronald P. Erickson, our Chairman of the
Board. The Company paid $27,041 and <font style="color: #000000">issued 800,000 shares of common stock in exchange
for the conversion of this debt. Mr. Erickson is an accredited
investor. These shares were issued in transactions that were not
registered under the Act in reliance upon applicable exemptions
from registration under Section 4(a)(2) of the Act and/or Rule 506
of SEC Regulation D under the Act.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Note Payables to Ronald P. Erickson or J3E2A2Z LP</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
January 25, 2018, the Company entered into amendments to two demand
promissory notes, totaling $600,000 with Mr. Erickson, the
Company&#x2019;s Chief Executive Officer and/or entities in which
Mr. Erickson has a beneficial interest. On March 16, 2018, the
demand promissory notes and accrued interest were converted into
convertible notes payable. <font style="color: #000000">See Note 11
for additional details.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
13.&#xA0; EQUITY</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Authorized Capital Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company authorized 105,000,000 shares of capital stock, of which
100,000,000 are shares of voting common stock, par value $0.001 per
share, and 5,000,000 are shares preferred stock, par value $0.001
per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company has authorized to issue up to 100,000,000 shares of
common stock with a par value of $0.001. As of September 30, 2018,
we had 17,531,502 shares of common stock issued and outstanding,
held by 122 shareholders of record. The number of shareholders,
including beneficial owners holding shares through nominee names,
is approximately 2,300. Each share of common stock entitles its
holder to one vote on each matter submitted to the shareholders for
a vote, and no cumulative voting for directors is
permitted.&#xA0;&#xA0;Shareholders do not have any preemptive
rights to acquire additional securities issued by us.&#xA0;&#xA0;As
of September 30, 2018, there were options outstanding for the
purchase of 2,182,668 common shares, warrants for the purchase of
15,473,398 common shares and 4,914,071&#xA0;shares of our common
stock issuable upon the conversion of Series A, Series C and Series
D Convertible Preferred Stock. We have Convertible Note Payable of
$2,255,066 (9,020,264 common shares at the current price of $0.25
per share). All of which could potentially dilute future earnings
per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-15</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Voting Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company is authorized to issue up to 5,000,000 shares of
preferred stock with a par value of $0.001.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Series A Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In July
2015, the Company sold Series A Preferred Stock to two investors
for a total of $350,000. <font style="color: #000000">As of
December 21, 2018, the Company had 20,000 Series A Preferred Stock
issued and outstanding.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Each
holder of outstanding shares of Series A Preferred is entitled to
the number of votes equal to the number of whole shares of common
stock into which the shares of Series A Preferred held by such
holder are then convertible as of the applicable record date. The
Series A Preferred may not be redeemed without the consent of the
holder. The Company cannot amend, alter or repeal any preferences,
rights, or other terms of the Series A Preferred so as to adversely
affect the Series A Preferred, without the written consent or
affirmative vote of the holders of at least 66% of the then
outstanding shares of Series A Preferred, voting as a separate
voting group, given by written consent or by vote at a meeting
called for such purpose for which notice shall have been duly given
to the holders of the Series A Preferred.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
connection with the issuance of the Series A Preferred, the Company
also issued (i) a Series C five-year Warrant for 2 shares of common
stock and (ii) a Series D five-year Warrant for 23,334 shares of
common stock. The Series A Preferred Stock and Series C and D
Warrants currently have no registration rights.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On August 14, 2017, the price of the Series A Preferred Stock and
Series C and D Warrants were adjusted to $0.25 per share pursuant
to the documents governing such
instruments.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
September 23, 2018, a holder of Series A Preferred Stock converted
3,334 shares into 3,334 shares of common stock. In addition, the
holder exercised Series C and D Warrants for 6,668 shares of common
stock at $0.25 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Series C and D Preferred Stock and Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
August 5, 2016, the Company closed a Series C Preferred Stock and
Warrant Purchase Agreement with Clayton A. Struve, an accredited
investor for the purchase of $1,250,000 of preferred stock with a
conversion price of $0.70 per share. The preferred stock has a
yield of 8% and an ownership blocker of 4.99%. In addition, Mr.
Struve received a five-year warrant to acquire 1,785,714 shares of
common stock at $0.70 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">To
determine the effective conversion price, a portion of the proceeds
received by the Company upon issuance of the Series C Preferred
Stock was first allocated to the freestanding warrants issued as
part of this transaction. Given that the warrants will not
subsequently be measured at fair value, the Company determined that
the warrants should receive an allocation of the proceeds based on
their relative fair value. This is based on the understanding that
the FASB staff and the SEC staff believe that a freestanding
instrument issued in a basket transaction should be initially
measured at fair value if it is required to be subsequently
measured at fair value pursuant to US generally accepted accounting
principles (&#x201C;GAAP&#x201D;), with the residual proceeds from
the transaction allocated to any remaining instruments based on
their relative fair values. As such, the warrants were allocated a
fair value of approximately $514,706 upon issuance, with the
remaining $735,294 of proceeds allocated to the Series C Preferred
Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Proportionately,
this allocation resulted in approximately 59% of the face amount of
the Series C Preferred Stock issuance remaining, which applied to
the stated conversion price of $0.70 resulted in an effective
conversion price of approximately $0.41.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Having
determined the effective conversion price, the Company then
compared this to the fair value of the underlying Common Stock as
of the commitment date, which was approximately $1.06 per share,
and concluded that the conversion feature did have an intrinsic
value of $0.65 per share. As such, the Company concluded that the
Series C Preferred Stock did contain a beneficial conversion
feature and an accounting entry and additional financial statement
disclosure was required.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Because
our preferred stock is perpetual, with no stated maturity date, and
the conversions may occur any time from inception, the dividend is
recognized immediately when a beneficial conversion exists at
issuance. During the year ending September 30, 2016, the Company
recognized preferred stock dividends of $1.16 million on Series C
preferred stock related to the beneficial conversion feature
arising from a common stock effective conversion rate of $0.41
versus a current market price of $1.06 per common
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 14, 2016, the Company issued 187,500 shares of Series D
Convertible Preferred Stock and a warrant to purchase 187,500
shares of common stock in a private placement to certain accredited
investors for gross proceeds of $150,000 pursuant to a Series D
Preferred Stock and Warrant Purchase Agreement dated November 10,
2016.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-16</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
warrants associated with the November 14, 2016 issuance were
allocated a fair value of approximately $56,539 upon issuance, with
the remaining $63,539 of net proceeds allocated to the Series D
Preferred Stock. Proportionately, this allocation resulted in
approximately 53% of the amount of the Series D Preferred Stock
issuance remaining, which applied to the stated conversion price of
$0.80 resulted in an effective conversion price of approximately
$0.34. Having determined the effective conversion price, the
Company then compared this to the fair value of the underlying
Common Stock as of the commitment date, which was approximately
$1.14 per share, and concluded that the conversion feature did have
an intrinsic value of $0.80 per share. As such, the Company
concluded that the Series D Preferred Stock did contain a
beneficial conversion feature of $150,211 which was recorded as a
beneficial conversion in stockholders&#x2019; equity.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
December 19, 2016, the Company issued 187,500 shares of Series D
Convertible Preferred Stock and a warrant to purchase 187,500
shares of common stock in a private placement to an accredited
investor for gross proceeds of $150,000 pursuant to a Series D
Preferred Stock and Warrant Purchase Agreement dated December 14,
2016.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
warrants associated with the December 19, 2016 issuance were
allocated a fair value of approximately $60,357 upon issuance, with
the remaining $69,643 of net proceeds allocated to the Series D
Preferred Stock. Proportionately, this allocation resulted in
approximately 54% of the amount of the Series D Preferred Stock
issuance remaining, which applied to the stated conversion price of
$0.80 resulted in an effective conversion price of approximately
$0.37. Having determined the effective conversion price, the
Company then compared this to the fair value of the underlying
Common Stock as of the commitment date, which was approximately
$0.81 per share, and concluded that the conversion feature did have
an intrinsic value of $0.44 per share. As such, the Company
concluded that the Series C Preferred Stock did contain a
beneficial conversion feature of $82,232 which was recorded as a
beneficial conversion in stockholders&#x2019; equity.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Because
the Company&#x2019;s preferred stock is perpetual, with no stated
maturity date, and the conversions may occur any time from
inception, the dividend is recognized immediately when a beneficial
conversion exists at issuance. During the year ending September 30,
2017, the Company recognized preferred stock dividends of $2.3
million on Series D preferred stock related to the beneficial
conversion feature arising from a common stock effective conversion
rate of $0.34 and $0.37 versus the original market price of $1.14
and $1.06 per common share, respectively.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2017, the Company issued 357,143 shares of Series D
Convertible Preferred Stock and a warrant to purchase 357,143
shares of common stock in a private placement to an accredited
investor for gross proceeds of $250,000 pursuant to a Series D
Preferred Stock and Warrant Purchase Agreement dated May 1,
2016.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The initial conversion price of the Series D Shares is $0.70 per
share, subject to certain adjustments. The initial exercise price
of the warrant is $0.70 per share, also subject to certain
adjustments. The Company also amended and restated the Certificate
of Designations, resulting in an adjustment to the conversion price
of all currently outstanding Series D Shares to $0.70 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On August 14, 2017,</font> the price of the <font style="color: #000000">Series C and D Preferred Stock</font> were
adjusted to $0.25 per share <font style="color: #000000">pursuant
to the documents governing such instruments. After adjustment there
were 3,108,356 shares of</font> Series D preferred stock
authorized.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On July
17, 2018, the Company filed with the State of Nevada a second
Amended and Restated Certificate of Designation of Preferences,
Powers, and Rights of the Series D Convertible Preferred Stock. The
Amended Certificate restates the prior Certificate of Designation
filed on May 8, 2017 to decrease the number of authorized Series D
shares from 3,906,250 shares to 1,016,014 shares. No other
amendments were made to the preferences and rights of the Series D
Convertible Preferred Stock. The filing of the Amended Certificate
was unanimously approved by the Board of Directors and the
shareholders of Series D Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Series F Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 1, 2018, the Company filed with the State of Nevada a
Certificate of Designation establishing the Designations,
Preferences, Limitations and Relative Rights of Series F Preferred
Stock (the &#x201C;Designation&#x201D;). The Designation authorized
500 shares of Series F Preferred Stock. The Series F Preferred
Stock shall only be issued to the current Board of Directors on the
date of the Designation&#x2019;s filing and is not convertible into
common stock. As set forth in the Designation, the Series F
Preferred Stock has no rights to dividends or liquidation
preference and carries rights to vote 100,000 shares of common
stock per share of Series F upon a Trigger Event, as defined in the
Designation. A Trigger Event includes certain unsolicited bids,
tender offers, proxy contests, and significant share purchases, all
as described in the Designation. Unless and until a Trigger Event,
the Series F shall have no right to vote. The Series F Preferred
Stock shall remain issued and outstanding until the date which is
731 days after the issuance of Series F Preferred Stock
(&#x201C;Explosion Date&#x201D;), unless a Trigger Event occurs, in
which case the Explosion Date shall be extended by 183
days.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Securities Subject to Price Adjustments</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
August 14, 2017, a private placement triggered a provision in the
documents governing 23,334 outstanding shares of Series A Preferred
Stock, 1,785,715 outstanding shares of Series C Preferred Stock and
1,016,004 outstanding shares Series D preferred Stock, which
adjusted the conversion price of such Preferred Stock to $0.25 per
share. In addition, the conversion price of a Convertible Note
Payables of $2,390,066 and the exercise price of outstanding
warrants to purchase 9,548,741 shares of common stock were adjusted
to $0.25 per share pursuant to the documents governing such
instruments.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-17</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">
As of December 21, 2018, there were outstanding warrants for the
purchase of 15,473,398 shares of common stock.</font> <font style="font-size: 13px">In the future, if we sell our common stock at a
price below $0.25 per share, the exercise price</font> <font style="color: #000000; font-size: 13px">of 20,000 outstanding shares of
Series A Preferred Stock, 1,785,715 outstanding shares of Series C
Preferred Stock, 1,016,004 outstanding shares Series D Preferred
Stock that adjust below $0.25 per share pursuant to the documents
governing such instruments. In addition, the conversion price of a
Convertible Note Payable of $2,255,066 (9,020,264 common shares at
the current price of $0.25 per share) and the exercise price of
additional outstanding warrants to purchase 13,865,286 shares of
common stock would adjust below $0.25 per share pursuant to the
documents governing such
instruments.</font>&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Common Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
All of the offerings and sales described below were deemed to be
exempt under Rule 506 of Regulation D and/or Section 4(a)(2) of the
Securities Act. No advertising or general solicitation was employed
in offering the securities, the offerings and sales were made to a
limited number of persons, all of whom were accredited investors
and transfer was restricted by the company in accordance with the
requirements of Regulation D and the Securities Act. All issuances
to accredited and non-accredited investors were structured to
comply with the requirements of the safe harbor afforded by Rule
506 of Regulation D, including limiting the number of
non-accredited investors to no more than 35 investors who have
sufficient knowledge and experience in financial and business
matters to make them capable of evaluating the merits and risks of
an investment in our securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following equity issuances occurred during the year ended
September 30, 2018:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company issued 779,676 shares of common stock to Names
Executive Officers, directors, employees and consultants and for
services during the year ended September 30, 2018. The Company
expensed $273,068.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
April 10, 2018, the Company issued 2,000,000 shares of our common
stock to Phillip A. Bosua under the terms of the Merger Agreement
with RAAI common stock. The shares were valued at the fair market
value of $520,000 or $0.26 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On June 25, 2018, the Company closed a private placement and
received gross proceeds of $1,750,000 ($1,710,000 as of June 30,
2018) in exchange for issuing 7,000,000 (6,840,000 as of June 30,
2018) shares of common stock and warrants to purchase 3,500,000
(3,420,000 as of June 30, 2018) shares of common stock in a private
placement to accredited investors pursuant to a series of
substantially identical subscription agreements. The initial
exercise price of the warrants described above is $0.25 per share,
subject to certain adjustments, and they expired five years after
their issuance. The shares and the warrants described above were
issued in transactions that were not registered under the
Securities Act of 1933, as amended (the &#x201C;Act&#x201D;) in
reliance upon applicable exemptions from registration under Section
4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the
Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On June
25, 2018, the Company issued 500,000 shares of our common stock to
Phillip A. Bosua under the terms of an Employment agreement dated
April 10, 2018. The shares were valued at the fair market value of
$165,000 or $0.33 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company closed debt conversions and issued 1,600,000 shares of
common stock in exchange for the conversion of $464,000, 230,000
shares in exchange for $48,300 in legal services and 605,000 shares
in for $199.935 in preexisting debt owed by the Company to certain
service providers, all of whom are accredited investors. These
shares were issued in transactions that were not registered under
the Act in reliance upon applicable exemptions from registration
under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation
D under the Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the year ended September 30, 2018, the Company issued
158,000 shares of our common stock related to warrant exercises
that were valued at $80,128.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 23, 2018, the Company issued 3,334 shares of our
common stock related to the conversion of Series A Preferred Stock
for $834.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following equity issuances occurred during the year ended
September 30, 2017:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On October 21, 2015, the Company entered into a Public Relations
Agreement with Financial Genetics LLC for public relation services.
On October 18, 2016, the Company entered into an Amendment to
Public Relations Agreement with Financial Genetics LLC. Under the
Agreements, Financial Genetics was issued 359,386 shares of our
common stock during the year ended September 30, 2017. The Company
expensed $271,309 during the year ended September 30,
2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On October 6, 2016, the Company entered into a Services Agreement
with Redwood Investment Group LLC for financial services. Under the
Agreement, Redwood was issued 200,000 shares of our common stock.
The Company expensed $140,000 during the year ended September 30,
2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company entered into Convertible Promissory Notes totaling
$710,000 with accredited investors during September 2015 to
February 2016 to fund short-term working capital. The Notes accrued
interest at a rate of 8% per annum and became due September 2016 to
February 2017 and were convertible into common stock as part of our
next financing. On November 30, 2016, the Company converted
$695,000 of the /Convertible Promissory Notes and interest of
$54,078 into 936,348 shares of comment stock. The Company also
issued warrants to purchase 936,348 shares of the Company&#x2019;s
common stock. The five-year warrants are exercisable at $1.00 per
share, subject to adjustment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-18</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 22, 2016, a supplier converted accounts payable
totaling $6,880 into 8,600 shares of common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On the year ended September 30, 2017, the Company issued 795,000
shares of restricted common stock to two Names Executive Officers
employees, two directors and six employees and consultants and for
services during 2015-2017. The shares were issued in accordance
with the 2011 Stock Incentive Plan and were valued at $0.17 per
share, the market price of our common stock. The Company expensed
$135,150 during the year ended September 30, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Warrants to Purchase Common Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following warrants were issued during the year ended September
30, 2018:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 15, 2017, the Company received $250,000 and issued a
senior convertible exchangeable debenture with a principal amount
of $300,000 and a five year common stock purchase warrant to
purchase 1,200,000 shares of common stock in a private placement
dated December 12, 2017 to an accredited investor pursuant to a
Securities Purchase Agreement dated August 14, 2017. See Note 12
for additional details. The initial exercise price of the warrants
described above is $0.25 per share, also subject to certain
adjustments. The warrants were valued at $123,600 and the
beneficial conversion feature was valued at $93,174.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 2, 2018, the Company received gross proceeds of $280,000
in exchange for issuing a senior convertible redeemable debenture
with a principal amount of $336,000 and a five year warrant to
purchase 1,344,000 shares of common stock in a private placement
dated February 28, 2018 to an accredited investor pursuant to a
Securities Purchase Agreement dated August 14, 2017 See Note 9 for
additional details. The initial exercise price of the warrants
described above is $0.25 per share, also subject to certain
adjustments. The warrants had an estimated fair value of $348,096
and the beneficial conversion feature was value at
$252,932.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company entered into a Note and Account Payable Conversion
Agreement pursuant to which (a) all $664,233 currently owing under
the J3E2A2Z Notes was converted to a Convertible Redeemable
Promissory Note in the principal amount of $664,233, and (b) all
$519,833 of the J3E2A2Z Account Payable was converted into a
Convertible Redeemable Promissory Note in the principal amount of
$519,833 together with a warrant to purchase up to 1,039,666 shares
of common stock of the Company for a period of five years.
<font style="color: #000000">The initial exercise price of the
warrants described above is $0.50 per share, also subject to
certain adjustments. See Note 9 for additional details. The
warrants had an estimated value of $60,820.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
addition, effective as of January 31, 2018, Mr. Erickson was issued
a warrant to purchase up to 855,000 shares of common stock of the
Company for a period of five years. <font style="color: #000000">The initial exercise price of the warrants
described above is $0.50 per share, also subject to certain
adjustments. See Note 12 for additional details. The warrants had
an estimated value of $49,726.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
During the year ended September 30, 2018, The Company issued
placement agent warrants related to the issuance of senior
convertible redeemable debentures and Series D Preferred Stock to
purchase up to 538,400 shares of common stock</font> for a period
of five years. <font style="color: #000000">The initial exercise
price of the warrants described above is $0.25 per share, also
subject to certain adjustments. The estimated fair value was
$134,600.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On June 25, 2018, the Company closed a private placement and
received gross proceeds of $1,750,000 ($1,710,000 as of June 30,
2018) in exchange for issuing 7,000,000 (6,840,000 as of June 30,
2018) shares of common stock and warrants to purchase 3,500,000
(3,420,000 as of June 30, 2018) shares of common stock in a private
placement to accredited investors pursuant to a series of
substantially identical subscription agreements. The initial
exercise price of the warrants described above is $0.25 per share,
subject to certain adjustments, and they expired five years after
their issuance. The shares and the warrants described above were
issued in transactions that were not registered under the
Securities Act of 1933, as amended (the &#x201C;Act&#x201D;) in
reliance upon applicable exemptions from registration under Section
4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the
Act. &#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company issued warrants to purchase 1,229,000 shares of common
stock to Named Executive Officers, directors, employees and
consultants and for services during the year ended September 30,
2018. The Company expensed $121,710.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the year ended September 30, 2018, the Company issued
158,000 shares of our common stock related to warrant exercises
that were valued at $80,128.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the year ended September 30, 2018, warrants for the purchase
of 544,998 shares of common stock valued at $136,250
expired.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following warrants were issued during the year ended September
30, 2017:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company entered into Convertible Promissory Notes totaling
$710,000 with accredited investors during September 2015 to
February 2016 to fund short-term working capital. The Notes accrued
interest at a rate of 8% per annum and became due September 2016 to
February 2017 and were convertible into common stock as part of our
next financing. On November 30, 2016, the Company converted
$695,000 of the /Convertible Promissory Notes and interest of
$54,078 into 936,348 shares of comment stock. The Company also
issued warrants to purchase 936,348 shares of the Company&#x2019;s
common stock. The five-year warrants are exercisable at $1.00 per
share, subject to adjustment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-19</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 14, 2016, the Company issued 187,500 shares of Series D
Convertible Preferred Stock and a warrant to purchase 187,500
shares of common stock in a private placement to certain accredited
investors for gross proceeds of $150,000 pursuant to a Series D
Preferred Stock and Warrant Purchase Agreement dated November 10,
2016. The warrant was valued at $189,938.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
December 19, 2016, the Company issued 187,500 shares of Series D
Convertible Preferred Stock and a warrant to purchase 187,500
shares of common stock in a private placement to an accredited
investor for gross proceeds of $150,000 pursuant to a Series D
Preferred Stock and Warrant Purchase Agreement dated December 14,
2016. The warrant was valued at $131,250.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
February 24, 2017, the Company issued 283,861 shares of Series D
Convertible Preferred Stock and a warrant to purchase 283,861
shares of common stock in a private placement to an accredited
investor for conversion of a $220,000 Promissory Note and accrued
interest of $7,089 pursuant to a Series D Preferred Stock and
Warrant Purchase Agreement dated February 28, 2017. The warrant was
valued at $198,703.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">During
the year ended September 30, 2017, the Company revised five year
placement agent warrants to purchase 312,500 shares of common
stock. The price was reduced from $1.00 to $0.70 per share and the
exercise price is now subject to adjustment. The Company recorded
250,000 shares during the year ended September 30, 2016 the fair
value of these warrants is $218,751 as of June 30,
2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On May 1, 2017, the Company issued 357,143 shares of Series D
Convertible Preferred Stock and a warrant to purchase 357,143
shares of common stock in a private placement to an accredited
investor for gross proceeds of $250,000 pursuant to a Series D
Preferred Stock and Warrant Purchase Agreement dated May 1,
2017.</font> The warrant was valued at $5,357.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 14, 2017, the Company issued a common stock purchase
warrant to purchase 1,440,000 shares of common stock in a private
placement to Clayton Struve for gross proceeds of $300,000 pursuant
to a Securities Purchase Agreement dated August 14, 2017. The
initial exercise price of the Warrant is $0.25 per share, also
subject to certain adjustments. The warrants were valued at
$111,429.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Warrants to acquire 7,668 shares of common stock at $30.00 per
share expired.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
conversion price of the Series A, C and D Shares and related
warrants is currently $0.250 per share, subject to certain
adjustments.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
A summary of the warrants issued as of September 30, 2018 were as
follows:</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:70%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:40%;">
<div><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">September
30, 2018</font> <font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Weighted</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Average</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exercise</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Shares</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Price</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Outstanding
at beginning of period</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">6,900,356</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.428</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issued</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">9,276,066</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Exercised</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(158,026</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.507</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Forfeited</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Expired</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(544,998</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Outstanding
at end of period</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15,473,398</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.326</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Exerciseable
at end of period</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15,473,398</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
A summary of the status of the warrants outstanding as of September
30, 2018 is presented below:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0px auto 0px 0px; width: 80%; font-size: inherit; font-family: inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="4" rowspan="1" style="vertical-align:bottom;width:56%;">
<div><font style="text-align: left; padding-bottom:2px;width:2%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:96%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times\ New\ Roman;color:#000;">September
30, 2018</font> <font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font>
<font style="font-size:13px;font-family:Times\ New\ Roman;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:2%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Weighted</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Weighted</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Weighted</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Average</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Average</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Average</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Number
of</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Remaining</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exercise</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Shares</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exercise</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Warrants</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Life (
In Years)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Price</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exerciseable</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Price</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13,870,286</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.04</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13,870,286</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">714,286</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2.83</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.700</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">714,286</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.700</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">882,159</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3.12</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">882,159</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">6,667</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.25</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">30.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">6,667</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">30.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15,473,398</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">3.61</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.326</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15,473,398</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.326</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-20</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The significant weighted average assumptions relating to the
valuation of the Company&#x2019;s warrants for the year ended
September 30, 2018 were as follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 45%; font-family: Times\ New\ Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 60%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Dividend yield</font></div>
</td>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
0%</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 60%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Expected life</font></div>
</td>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
1-2 years</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 60%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Expected volatility</font></div>
</td>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
125%-145%</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 60%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Risk free interest rate</font></div>
</td>
<td style="vertical-align: top; width: 30%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
..0202-.0214%</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
At September 30, 2018, vested warrants totaling 15,466,731 shares
had an&#xA0;aggregate intrinsic value of $13,870,286.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times\ New\ Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 2%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
14.</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
STOCK OPTIONS</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 21, 2013, an amendment to the Stock Option Plan was approved
by the stockholders of the Company, increasing the number of shares
reserved for issuance under the Plan to 93,333 shares.<font style="font-weight: bold">&#xA0;</font>On April 10, 2018, the Board
approved an amendment to its 2011 Stock Incentive Plan increasing
the number of shares of common stock reserved under the Incentive
Plan from 93,333 to 1,200,000. On August 7, 2018, the Board
approved an amendment to its 2011 Stock Incentive Plan increasing
the number of shares of common stock reserved under the Incentive
Plan from 1,200,000 to 2,000,000 to common
shares.<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Determining Fair Value under ASC 505</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company records compensation expense associated with stock
options and other equity-based compensation using the
Black-Scholes-Merton option valuation model for estimating fair
value of stock options granted under our plan. The Company
amortizes the fair value of stock options on a ratable basis over
the requisite service periods, which are generally the vesting
periods. The expected life of awards granted represents the period
of time that they are expected to be outstanding.&#xA0;&#xA0;The
Company estimates the volatility of our common stock based on the
historical volatility of its own common stock over the most recent
period corresponding with the estimated expected life of the award.
The Company bases the risk-free interest rate used in the Black
Scholes-Merton option valuation model on the implied yield
currently available on U.S. Treasury zero-coupon issues with an
equivalent remaining term equal to the expected life of the award.
The Company has not paid any cash dividends on our common stock and
does not anticipate paying any cash dividends in the foreseeable
future. Consequently, the Company uses an expected dividend yield
of zero in the Black-Scholes-Merton option valuation model and
adjusts share-based compensation for changes to the estimate of
expected equity award forfeitures based on actual forfeiture
experience. The effect of adjusting the forfeiture rate is
recognized in the period the forfeiture estimate is
changed.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Stock Option Activity</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company had the following stock option transactions during the
year ended September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
A former employee forfeited stock option grants for 10,668 shares
of common stock at $14.719 per share.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
During the year ended September 30, 2018, four employee and two
consultants were granted options to purchase 1,180,000 shares of
common stock</font> at an exercise price of $2.024 per share. The
stock option grants vest quarterly over four years (none during the
first six months) and are exercisable for 5 years. The stock option
grants were valued at an average of $2.38 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On July 30, 2018, Mr. Bosua was awarded a stock option grant for
1,000,000 shares of common stock that was awarded at $1.28 per
share and was valued at the black scholes value of $1.22 per
share.&#xA0;&#xA0;</font>The stock option grant vests quarterly
over four years and is exercisable for 5 years.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company had the following stock option transactions during the
year ended September 30, 2017:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
During the year ended September 30, 2017, employees forfeited stock
option grants for 35,504 shares of common stock at $19.51 per
share.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
There are currently 534,736 options to purchase common stock at an
average exercise price of $1.698 per share outstanding as of
September 30, 2018 under the 2011 Stock Incentive Plan. The Company
recorded $50,899 and $37,848 of compensation expense, net of
related tax effects, relative to stock options for the year ended
September 30, 2018 and in accordance with ASC 505. Net loss per
share (basic and diluted) associated with this expense was
approximately ($0.006) and ($0.01) per share, respectively. As of
September 30, 2018, there is approximately $1,789,384, net of
forfeitures, of total unrecognized costs related to employee
granted stock options that are not vested. These costs are expected
to be recognized over a period of approximately 4.94
years.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-21</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Stock option activity for the years ended September 30, 2018 and
2017 was as follows:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:70%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td colspan="1" rowspan="1" style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Weighted
Average&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align: bottom; width: 40%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; margin-left: 0px; padding-bottom: 2px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Options&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">
Exercise Price&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-size: 13px; font-family: Times\ New\ Roman; color: rgb(0, 0, 0);">&#xA0;
$</font></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Outstanding
as of September 30, 2016</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50,908</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">18.045</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">918,627</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Granted</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Exercised</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Forfeitures</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(35,504</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(19.507</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(692,568</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Outstanding
as of September 30, 2017</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">15,404</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">14.675</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">226,059</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Granted</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,180,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.683</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,668,500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Exercised</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Forfeitures</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(12,736</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">14.764</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(188,040</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:40%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Outstanding
as of September 30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,182,668</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1.698</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">3,706,519</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following table summarizes information about stock options
outstanding and exercisable as of September 30, 2018:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0px auto 0px 0px; width: 80%; font-size: inherit; font-family: inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Weighted</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Weighted</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Weighted</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Average</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Average</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Average</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Range
of</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Number</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Remaining
Life</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exercise
Price</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Number</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exercise
Price</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exercise
Prices</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Outstanding</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">In
Years</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exerciseable</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exerciseable</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Exerciseable</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.25</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">530,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.98</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.28</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,150,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.96</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.28</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.08-4.20</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">500,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.98</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13.500</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.44</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13.50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13.50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">15.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15.00</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15.00</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,182,668</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">4.94</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1.698</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">13.50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
There were stock option grants of 1,680,000 shares as of September
30, 2018 with an aggregate intrinsic value of
$4,964,300.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times\ New\ Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 2%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
15.</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Related Party Transactions with Ronald P. Erickson</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
See Notes 11, 12 and 13 for related party transactions with Ronald
P. Erickson.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 7, 2017 Mr. Erickson was issued 200,000 of restricted
common stock to at the grant date market value of $0.17 per
share.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On January 16, 2018 Mr. Erickson was issued 100,000 of restricted
common stock on to at the grant date market value of $0.21 per
share.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
January 25, 2018, the Company entered into amendments to two demand
promissory notes, totaling $600,000 with Mr. Erickson, our Chief
Executive Officer and/or entities in which Mr. Erickson has a
beneficial interest. The amendments extend the due date from
December 31, 2017 to September 30, 2018 and continue to provide for
interest of 3% per annum and a third lien on company assets if not
repaid by September 30, 2018 or converted into convertible
debentures or equity on terms acceptable to the Holder. On March
16, 2018, the demand promissory notes and accrued interest were
converted into convertible notes payable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 16, 2018, the Company entered into a Note and Account Payable
Conversion Agreement pursuant to which (a) all $664,233 currently
owing under the J3E2A2Z Notes was converted to a Convertible
Redeemable Promissory Note in the principal amount of $664,233, and
(b) all $519,833 of the J3E2A2Z Account Payable was converted into
a Convertible Redeemable Promissory Note in the principal amount of
$519,833 together with a warrant to purchase up to 1,039,666 shares
of our common stock for a period of five years. <font style="color: #000000">The initial exercise price of the warrants
described above is $0.50 per share, also subject to certain
adjustments. The warrants had an estimated value of $0.12 per
share.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On July 9, 2018, the Company repaid a $199,935 Business Loan
Agreement with Umpqua Bank from funds previously provided by</font>
an entity affiliated with Ronald P. Erickson, our Chairman of the
Board. The Company paid $27,041 and <font style="color: #000000">issued 800,000 shares of common stock in exchange
for the conversion of this debt. Mr. Erickson is an accredited
investor. These shares were issued in transactions that were not
registered under the Act in reliance upon applicable exemptions
from registration under Section 4(a)(2) of the Act and/or Rule 506
of SEC Regulation D under the Act.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-22</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Erickson and/or entities with which he is affiliated also have
accrued compensation, travel and interest of approximately $513,149
as of September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Related Party Transaction with Phillip A. Bosua</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On July
14, 2017, the Company issued 50,000 shares of our common stock to
Phillip A. Bosua under the terms of a consulting agreement dated
July 6, 2017. The fair value of the stock was $8,500.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
February 7, 2018, the Company issued 50,000 shares of our common
stock to Phillip A. Bosua under the terms of a consulting agreement
dated July 6, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
April 10, 2018, the Company issued 2,000,000 shares of our common
stock to Phillip A. Bosua under the terms of the Merger Agreement
with RAAI common stock. The fair value of the stock was
$520,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On June
25, 2018, the Company issued 500,000 shares of our common stock to
Phillip A. Bosua under the terms of an Employment agreement dated
April 10, 2018. The fair value of the stock was
$165,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On June
25, 2018, the Company <font style="color: #000000">closed a debt
conversion with an entity controlled by Phillip A. Bosua and issued
255,000 shares of common stock in exchange for the conversion of
$63,750 in preexisting debt owed by the Company to this
entity.&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On July 30, 2018, Mr. Bosua was awarded a stock option grant for
1,000,000 shares of our common stock that was awarded at $1.28 per
share and was valued at the black scholes value of $1.22 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stock Issuances to Named Executive Officers and
Directors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 7, 2017, the Company issued 400,000 shares of
restricted common stock to one Named Executive Officer and two
directors for services during 2015-2017. The shares were issued in
accordance with the 2011 Stock Incentive Plan and were valued at
$0.17 per share, the market price of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During January to May 2018, the Company issued 275,000 shares of
restricted common stock to one Named Executive Officer and two
directors for services during 2018. The shares were issued in
accordance with the 2011 Stock Incentive Plan and were valued at
$0.246 per share, the market price of our common
stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stock Option Grant Cancellations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the year ended September 30, 2017, two Named Executive
Officers forfeited stock option grants for 35,366 shares of common
stock at $19.53 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
16.&#xA0; COMMITMENTS, CONTINGENCIES AND LEGAL
PROCEEDINGS</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Legal Proceedings</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company may from time to time become a party to various legal
proceedings arising in the ordinary course of our business. The
Company is currently not a party to any pending legal proceeding
that is not ordinary routine litigation incidental to our
business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Employment Agreement with Phillip A. Bosua, Chief Executive
Officer</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company appointed Mr. Bosua as Chief
Executive Officer of the Company, replacing Ronald P. Erickson, who
remains Chairman of the Company. Mr. Erickson has been a director
and officer of Know Labs since April 2003. He was appointed as our
CEO and President in November 2009 and as Chairman of the Board in
February 2015. Previously, Mr. Erickson was our President and Chief
Executive Officer from September 2003 through August 2003 and was
Chairman of the Board from August 2004 until May 2011.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Phillip A. Bosua was appointed the Company&#x2019;s CEO on April 10,
2018. Previously, Mr. Bosua served as the Company&#x2019;s Chief
Product Officer since August 2017. The Company entered into a
Consulting Agreement with Mr. Bosua&#x2019;s company, Blaze Clinical
on July 7, 2017. From September 2012 to February 2015, Mr. Bosua
was the founder and Chief Executive Officer of LIFX Inc. (where he
developed and marketed an innovative &#x201C;smart&#x201D; light
bulb) and from August 2015 until February 2016 was Vice President
Consumer Products at Soraa (which markets specialty LED light
bulbs). From February 2016 to July 2017, Mr. Bosua was the founder
and CEO of RAAI, Inc. (where he continued the development of his
smart lighting technology). From May 2008 to February 2013 he was
the Founder and CEO of LimeMouse Apps, a leading developer of
applications for the Apple App Store.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-23</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company entered into an Employment Agreement
with Mr. Bosua reflecting his appointment as Chief Executive
Officer. The Employment Agreement is for an initial term of 12
months (subject to earlier termination) and will be automatically
extended for additional 12-month terms unless either party notifies
the other party of its intention to terminate the Employment
Agreement. Mr. Bosua will be paid a base salary of $225,000 per
year, received 500,000 shares of common stock valued at $0.33 per
share and may be entitled to bonuses and equity awards at the
discretion of the Board or a committee of the Board. The Employment
Agreement provides for severance pay equal to 12 months of base
salary if Mr. Bosua is terminated without &#x201C;cause&#x201D; or
voluntarily terminates his employment for &#x201C;good
reason.&#x201D;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Employment Agreement with Ronald P. Erickson, Chairman of the Board
and Interim Chief Financial Officer</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
August 4, 2017, the Board of Directors approved an Employment
Agreement with Ronald P. Erickson pursuant to which the Company
engaged Mr. Erickson as our Chief Executive Officer through
September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Mr.
Erickson&#x2019;s annual compensation is $180,000. Mr. Erickson is
also entitled to receive an annual bonus and equity awards
compensation as approved by the Board. The bonus should be paid no
later than 30 days following earning of the bonus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Mr.
Erickson will be entitled to participate in all group employment
benefits that are offered by the Company to our senior executives
and management employees from time to time, subject to the terms
and conditions of such benefit plans, including any eligibility
requirements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
If the Company terminates Mr. Erickson&#x2019;s employment at any
time prior to the expiration of the Term without Cause, as defined
in the Employment Agreement, or if Mr. Erickson terminates his
employment at any time for &#x201C;Good Reason&#x201D; or due to a
&#x201C;Disability&#x201D;, Mr. Erickson will be entitled to receive
(i) his Base Salary amount for one year; and (ii) medical benefits
for eighteen months.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company entered into an Amended Employment
Agreement for Ronald P. Erickson which amends the Employment
Agreement dated July 1, 2017. The Agreement expires March 21,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Properties and Operating Leases</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company is obligated under the following non-cancelable
operating leases for its various facilities and certain
equipment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0px auto 0px 0px; width: 35%; font-size: inherit; font-family: inherit;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Years
Ended September 30,</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">Total</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2019</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">118,190</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2020</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">85,914</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2021</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">23,498</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2022</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2023</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Beyond</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align: bottom; width: 30%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">227,602</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Corporate Offices</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 13, 2017, the Company leased its executive office located
at 500 Union Street, Suite 810, Seattle, Washington, USA, 98101.
The Company leases 943 square feet and the net monthly payment is
$2,672. The monthly payment increases approximately 3% each year
and the lease expires on May 31, 2022.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Lab Facilities and Executive Offices</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, the Company leased its lab facilities and executive
offices located at 304 Alaskan Way South, Suite 102, Seattle,
Washington, USA, 98101. The Company leases 2,800 square feet and
the net monthly payment is $4,000. The lease expires on April 30,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
TransTech Facilities</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
TransTech is located at 12142 NE Sky Lane, Suite 130, Aurora, OR
97002. TransTech leases a total of approximately 6,340 square feet
of office and warehouse space for its administrative offices,
product inventory and shipping operations. Effective December 1,
2017, TransTech leases this office from December 1, 2017 at $4,465
per month. The monthly payment increases approximately 3% each year
and the lease expires on January 31, 2020. Until December 1, 2017,
TransTech leased this office on a month to month basis at $6,942
per month.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-24</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
17.&#xA0; INCOME TAXES</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company has incurred losses since inception, which have generated
net operating loss carryforwards.&#xA0;&#xA0;The net operating loss
carryforwards arise from United States
sources.&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pretax
losses arising from United States operations were approximately
$3,258,000 for the year ended September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pretax
losses arising from United States operations were approximately
$3,901,000 for the year ended September 30, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company has net operating loss carryforwards of approximately
$27,352,000, which expire in 2022-2036. Because it is not more
likely than not that sufficient tax earnings will be generated to
utilize the net operating loss carryforwards, a corresponding
valuation allowance of approximately $5,744,000 was established as
of September 30, 2018. Additionally, under the Tax Reform Act of
1986, the amounts of, and benefits from, net operating losses may
be limited in certain circumstances, including a change in
control.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Section&#xA0;382
of the Internal Revenue Code generally imposes an annual limitation
on the amount of net operating loss carryforwards that may be used
to offset taxable income when a corporation has undergone
significant changes in its stock ownership. There can be no
assurance that the Company will be able to utilize any net
operating loss carryforwards in the future. The Company is subject
to possible tax examination for the years 2012 through
2018&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
For the year ended September 30, 2018, the Company&#x2019;s
effective tax rate differs from the federal statutory rate
principally due to net operating losses and warrants issued for
services.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic">
U.S. Tax Reform</font>&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
December 22, 2017, the U.S. government enacted comprehensive tax
legislation commonly referred to as the Tax Cuts and Jobs Act (the
Tax Reform Act). The Tax Reform Act significantly revises the
future ongoing federal income tax by, among other things, lowering
U.S. corporate income tax rates effective January 1, 2018. The
Company has calculated a blended U.S. federal income tax rate of
approximately 21% for the fiscal year ending September 30, 2018 and
21.0% for subsequent fiscal years. Remeasurement of the
Company&#x2019;s deferred tax balance under the Tax Reform Act
resulted in a non-cash tax benefit reduction of approximately $2.3
million for the year ended September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
changes included in the Tax Reform Act are broad and complex. The
final transition impacts of the Tax Reform Act may differ from the
above estimate due to, among other things, changes in
interpretations of the Tax Reform Act, any legislative action to
address questions that arise because of the Tax Reform Act and any
changes in accounting standards for income taxes or related
interpretations in response to the Tax Reform Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The principal components of the Company&#x2019;s deferred tax assets
at September 30, 2018 and 2017 are as follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:70%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">2018</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">2017</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">U.S.
operations loss carry forward at statutory rate of 21%</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(5,743,840</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(5,804,285</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Non-U.S.
operations loss carry forward at statutory rate of
20.5%</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(5,743,840</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(5,804,285</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Less
Valuation Allowance</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,743,840</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,804,285</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Net
Deferred Tax Assets</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Change
in Valuation allowance</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">60,445</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(1,036,276</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
A reconciliation of the United States Federal Statutory rate to the
Company&#x2019;s effective tax rate for the years ended September
30, 2018 and 2017 are as follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0px auto 0px 0px; width: 60%; font-size: inherit; font-family: inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:60%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">2018</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">2017</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Federal
Statutory Rate</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-21.0</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-21.0</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Increase
in Income Taxes Resulting from:</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;Change
in Valuation allowance</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">21.0</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">21.0</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">%</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:60%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Effective
Tax Rate</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.0</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">%</font></div>
</td>
<td style="vertical-align:bottom;width:20%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.0</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">%</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 4%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
18.</font></div>
</td>
<td style="vertical-align: top; width: 96%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SUBSEQUENT EVENTS</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company evaluated subsequent events, for the purpose of
adjustment or disclosure, up through the date the financial
statements were issued.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-25</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
October 31, 2018, the Board awarded stock option grants to two
directors to acquire 50,000 shares each of the Company&#x2019;s
common stock. The grants were valued at $3.03 per share and expire
on October 31, 2013. The grants vested immediately.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times\ New\ Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
October 31, 2018, the Board awarded Phillip A. Bosua a stock option
grant to acquire 100,000 shares of the Company&#x2019;s Common stock
for each $1,000,000 raised by the Company in revenue generated in a
planned Kickstarter campaign. In addition, Mr. Bosua was granted a
stock option grant to acquire 1,000,000 shares of the
Company&#x2019;s common which vests upon approval of the
Company&#x2019;s blood glucose measurement technology by the U.S.
Food and Drug Administration. The grants were valued at $3.03 per
share and expire on October 31, 2023.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
October 31, 2018, the Board awarded Ronald P Erickson a stock
option grant to acquire 1,000,000 shares of the Company&#x2019;s
common which vests upon the Company&#x2019;s successful listing of
its Common Stock on Nasdaq or the New York Stock Exchange
(including the NYSE American Market). The grant was valued at $3.03
per share and expires on October 31, 2023.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On November 16, 2018, the Company signed Amendment 1 to Senior
Secured Convertible Redeemable Notes dated September 30, 2016,
August 14, 2017 and December 12, 2017, extending the due dates of
the Notes to February 27, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 21, 2018, the Company&#x2019;s Board of Directors amended
the Company&#x2019;s Audit, Compensation and Nominating and
Corporate Governance Committee Charters. In addition, on November
21, 2018, the Company&#x2019;s Board of Directors amended the
Company&#x2019;s Code of Ethics Policy.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: center; width: 100%"><font style="font-family: Times New Roman; font-size: 11px"><font style="font-size: 13px">&#xA0;F-26</font></font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">

<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INC. AND SUBSIDIARIES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
CONSOLIDATED BALANCE SHEETS</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2019</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">September
30,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2018</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">ASSETS</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;(Audited)</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">CURRENT
ASSETS:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Cash
and cash equivalents</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,061,901</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">934,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Accounts
receivable, net of allowance of $60,000 and $60,000,
respectively</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">193,372</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">320,538</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Prepaid
expenses</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">12,844</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">20,140</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Inventories,
net</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100,989</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">203,582</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total current
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,369,106</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,478,667</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">EQUIPMENT,
NET</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">197,536</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">169,333</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">OTHER
ASSETS</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Intangible
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">361,112</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">447,778</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Other
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">15,867</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,170</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; padding-bottom:2px;margin-left:0px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; padding-bottom:2px;margin-left:0px;">
<div style="text-align: left; margin-left: 0px"><font style="font-family: Times New Roman; font-size: 13px">TOTAL
ASSETS</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:solid 2px #000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:solid 2px #000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,943,621</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000;">2,102,948</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">LIABILITIES
AND STOCKHOLDERS' (DEFICIT)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">CURRENT
LIABILITIES:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Accounts payable -
trade</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,298,278</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,512,617</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Accounts payable -
related parties</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,395</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">12,019</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Accrued
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">81,339</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">72,140</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Accrued expenses -
related parties</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">644,099</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">657,551</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Deferred
revenue</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">55,959</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Convertible notes
payable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,255,065</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,255,066</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; padding-bottom:2px;margin-left:0px;">
<font style="font-family: Times New Roman; font-size: 13px">Notes
payable - current portion of long term debt</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">145,186</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; padding-bottom:2px;margin-left:0px;">
<font style="font-family: Times New Roman; font-size: 13px">Total
current liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">4,286,176</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">4,710,538</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">COMMITMENTS AND
CONTINGENCIES</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">STOCKHOLDERS'
DEFICIT</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Preferred
stock - $0.001 par value, 5,000,000 shares authorized, 0 shares
issued and</font> <font style="font-family: Times New Roman; font-size: 13px">outstanding at
3/31/2019 and 9/30/2018, respectively</font></div>
</div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Series A
Convertible Preferred stock - $0.001 par value, 23,334 shares
authorized, 0 shares and</font> <font style="font-family: Times New Roman; font-size: 13px">20,000 shares
issued and outstanding at 3/31/2019 and 9/30/2018,
respectively</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">11</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Series
C Convertible Preferred stock - $0.001 par value, 1,785,715 shares
authorized, 1,785,715 shares issued and outstanding at 3/31/2019
and 9/30/2018, respectively</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,790</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,790</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Series D
Convertible Preferred stock - $0.001 par value, 1,016,014 shares
authorized,</font> <font style="font-family: Times New Roman; font-size: 13px">1,016,004 shares
issued and outstanding at 3/31/2019 and 9/30/2018,
respectively</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,015</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,015</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Common stock -
$0.001 par value, 100,000,000 shares authorized, 22,002,904 and
17,531,502 shares</font> <font style="font-family: Times New Roman; font-size: 13px">issued and
outstanding at 3/31/2019 and 9/30/2018, respectively</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">22,003</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">17,532</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Additional paid in
capital</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">36,917,782</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">32,163,386</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; padding-bottom:2px;margin-left:0px;">
<font style="font-family: Times New Roman; font-size: 13px">Accumulated
deficit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(37,285,145</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(34,791,324</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; padding-bottom:2px;margin-left:0px;">
<font style="font-family: Times New Roman; font-size: 13px">Total
stockholders' deficit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(342,555</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(2,607,590</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; padding-bottom:4px;margin-left:0px;">
<div style="text-align: left; margin-left: 0px"><font style="font-family: Times New Roman; font-size: 13px">TOTAL LIABILITIES
AND STOCKHOLDERS' DEFICIT</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,943,621</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,102,948</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying notes are an integral part of these consolidated
financial statements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-27</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INC. AND SUBSIDIARIES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
STATEMENTS OF OPERATIONS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:90%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">Three Months
Ended,</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:90%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">Six Months
Ended,</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2019</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2018</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2019</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2018</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">REVENUE</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">593,712</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,092,228</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,195,921</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,325,085</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">COST OF
SALES</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">454,839</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">865,571</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">927,125</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">1,850,594</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">GROSS
PROFIT</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">138,873</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">226,657</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">268,796</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">474,491</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">RESEARCH AND
DEVELOPMENT EXPENSES</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">184,024</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">153,300</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">391,014</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">241,020</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">SELLING, GENERAL
AND ADMINISTRATIVE EXPENSES</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">1,678,335</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">578,097</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">2,367,781</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">992,462</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">OPERATING
LOSS</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,723,486</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(504,740</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(2,489,999</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(758,991</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">OTHER INCOME
(EXPENSE):</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="font-family: Times New Roman; font-size: 13px">Interest
expense</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(7,750</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(793,837</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(16,876</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,087,039</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="font-family: Times New Roman; font-size: 13px">Other
income</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">6,618</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(577</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">13,054</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">18,611</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; padding-bottom:2px;margin-left:12px;">
<font style="font-size: 13px; font-family: Times New Roman">Total
other income (expense)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,132</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(794,414</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(3,822</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,068,428</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">(LOSS) BEFORE
INCOME TAXES</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,724,618</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,299,154</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,493,821</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,827,419</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Income taxes -
current provision</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">NET
(LOSS)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1,724,618</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1,299,154</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">(2,493,821</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(1,827,419</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="2" style="vertical-align:bottom;width:64%;">
<div style="text-align: left; margin-left:0px;"><font style="text-align: left; display:inline-block;vertical-align:bottom;">&#xA0;</font><font style="text-align: center; display:inline-block;vertical-align:bottom;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Basic
and diluted loss per common share attributable to Know
Labs,</font></div>
</font><font style="text-align: left; display:inline-block;vertical-align:bottom;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="font-family: Times New Roman; font-size: 13px">Inc. and
subsidiaries common shareholders-</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:12px;"><font style="font-family: Times New Roman; font-size: 13px">Basic and diluted
loss per share</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.09</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.25</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">(0.14</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.37</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:12px;"><font style="font-family: Times New Roman; font-size: 13px">Weighted average
shares of common stock outstanding- basic and diluted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">19,297,126</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">5,128,144</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">18,424,608</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,889,218</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying notes are an integral part of these consolidated
financial statements.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-28</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INC. AND SUBSIDIARIES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:90%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">Six Months
Ended,</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:5%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2019</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font><font style="text-align: center; border-bottom:solid 2px #000;font-weight:bold;vertical-align:bottom;display:inline-block;width:80%;font-size:11px;">
<div><font style="font-family:Times New Roman;font-weight:bold;">March
31,</font></div>
<div><font style="font-family:Times New Roman;font-weight:bold;">2018</font></div>
</font><font style="text-align: left; font-weight:bold;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:11px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">CASH FLOWS FROM
OPERATING ACTIVITIES:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">Net
loss</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,493,821</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,827,419</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">Adjustments to
reconcile net loss to net cash (used in)</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:60px;"><font style="font-family: Times New Roman; font-size: 13px">operating
activities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Depreciation and
amortization</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">133,019</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,462</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Issuance of capital
stock for services and expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">348,900</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">70,641</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Stock based
compensation- warrants</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">336,835</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Conversion of
interest</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,233</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Stock based
compensation- stock option grans</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">263,147</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,334</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Amortization of
debt discount</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">475,174</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Conversion of
accrued liabilities- related parties to notes payable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">491,802</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Provision on loss
on accounts receivable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">8,728</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">21,406</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:132px;"><font style="font-family: Times New Roman; font-size: 13px">Impairment of
goodwill</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">110,545</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">Changes in
operating assets and liabilities:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:60px;"><font style="font-family: Times New Roman; font-size: 13px">Accounts
receivable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">118,438</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">114,918</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:60px;"><font style="font-family: Times New Roman; font-size: 13px">Prepaid
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,296</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,292</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:60px;"><font style="font-family: Times New Roman; font-size: 13px">Inventory</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">102,593</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">21,616</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:60px;"><font style="font-family: Times New Roman; font-size: 13px">Other
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(8,697</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(2,100</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:60px;"><font style="font-family: Times New Roman; font-size: 13px">Accounts payable -
trade and accrued expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(223,216</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">33,193</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:60px;"><font style="font-family: Times New Roman; font-size: 13px">Deferred
revenue</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(55,959</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(58,615</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;NET CASH
(USED IN) OPERATING ACTIVITIES</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,462,737</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(442,518</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">CASH FLOWS FROM
INVESTING ACTIVITIES:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; padding-bottom:2px;margin-left:0px;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; margin-left: 24px"><font style="font-family: Times New Roman; font-size: 13px">Investment in
research and development equipment</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000;">(74,556</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">NET CASH (USED IN)
BY INVESTING ACTIVITIES:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(74,556</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">CASH FLOWS FROM
FINANCING ACTIVITIES:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">Issuance of common
stock for cash</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,809,975</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">(Repayments) from
line of credit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(145,188</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(190,663</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">Proceeds from
convertible notes payable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">530,000</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">NET CASH PROVIDED
BY FINANCING ACTIVITIES</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">3,664,787</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">339,337</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">NET INCREASE
(DECREASE) IN CASH AND CASH EQUIVALENTS</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,127,494</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(103,181</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">CASH AND CASH
EQUIVALENTS, beginning of period</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">934,407</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">103,181</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">CASH AND CASH
EQUIVALENTS, end of period</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,061,901</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Supplemental
disclosures of cash flow information:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">Interest
paid</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,750</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">20,243</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">Taxes
paid</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Non-cash investing
and financing activities:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;Beneficial
conversion feature</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">348,096</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:24px;"><font style="font-family: Times New Roman; font-size: 13px">Conversion of
accrued liabilities- related parties to notes payable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">482,014</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying notes are an integral part of these consolidated
financial statements.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-29</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INC. AND SUBSIDIARIES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
accompanying unaudited consolidated condensed financial statements
have been prepared by Know Labs, Inc, formerly Visualant,
Incorporated (&#x201C;the Company&#x201D;, &#x201C;us,&#x201D;
&#x201C;we,&#x201D; or &#x201C;our&#x201D;) in accordance with U.S.
generally accepted accounting principles (&#x201C;GAAP&#x201D;) for
interim financial reporting and rules and regulations of the
Securities and Exchange Commission. Accordingly, certain
information and footnote disclosures normally included in financial
statements prepared in accordance with GAAP have been condensed or
omitted. In the opinion of our management, all adjustments,
consisting of only normal recurring accruals, necessary for a fair
presentation of the financial position, results of operations, and
cash flows for the fiscal periods presented have been
included.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">These
financial statements should be read in conjunction with the audited
financial statements and related notes included in our Annual
Report filed on Form 10-K for the year ended September 30, 2018,
filed with the Securities and Exchange Commission
(&#x201C;SEC&#x201D;) on December 21, 2018. The results of operations
for the six months ended March 31, 2019 are not necessarily
indicative of the results expected for the full fiscal year, or for
any other fiscal period.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 21px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
1.</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
ORGANIZATION</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Know Labs, Inc. (the &#x201C;Company&#x201D;) was incorporated under
the laws of the State of Nevada in 1998.</font> The Company has
authorized 105,000,000 shares of capital stock, of which
100,000,000 are shares of voting common stock, par value $0.001 per
share, and 5,000,000 are shares preferred stock, par value $0.001
per share.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company is <font style="color: #000000">focused on the development,
marketing and sales of a proprietary technologies which are capable
of uniquely authenticating or diagnosing almost any substance or
material using electromagnetic energy to create, record and detect
the unique &#x201C;signature&#x201D; of the substance. The
Company&#x2019;s call these our &#x201C;ChromaID&#x2122;&#x201D; and
&#x201C;Bio-RFID&#x2122;&#x201D; technologies.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Overview</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Historically, the Company focused on the development of our
proprietary ChromaID technology. Using light from low-cost LEDs
(light emitting diodes) the Company&#x2019;s map the color of
substances, fluids and materials and with our proprietary processes
we can authenticate, identify and diagnose based upon the color
that is present. The color is both visible to us as humans but also
outside of the humanly visible color spectrum in the near infra-red
and near ultra-violet and beyond. The Company&#x2019;s ChromaID
scanner sees what we like to call &#x201C;Nature&#x2019;s Color
Fingerprint.&#x201D; Everything in nature has a unique color
identifier and with ChromaID the Company can see it, and identify,
authenticate and diagnose based upon the color that is present. The
Company&#x2019;s ChromaID scanner is capable of uniquely identifying
and authenticating almost any substance or liquid using light to
create, record and detect its unique color signature. The Company
will continue to develop and enhance its ChromaID technology and
extend its capacity. More recently, the Company has focused upon
extensions and new inventions that are derived from and extend
beyond our ChromaID technology. The Company&#x2019;s call this
technology Bio-RFID. The rapid advances made with our Bio-RFID
technology in our laboratory have caused us to move quickly in to
the commercialization phase of our Company as we work to create
revenue generating products for the marketplace. The Company will
also, as resources permit, pursue licensing opportunities with
third parties who have ready applications for our
technologies.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In 2010, the Company acquired TransTech Systems, Inc. as an adjunct
to its business. TransTech is a distributor of products for
employee and personnel identification. TransTech has provided all
of the Company&#x2019;s revenues.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The Company is in the process of commercializing its technology. To
date, the Company has entered into License Agreements with Sumitomo
Precision Products Co., Ltd. In addition, it has a technology
license agreement with Allied Inventors</font>, formerly Xinova
<font style="color: #000000">and Invention Development Management
Company, a subsidiary of Intellectual Ventures.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company believes that its commercialization success is
dependent upon its ability to significantly increase the number of
customers that are purchasing and using its products. To date the
Company has generated minimal revenue from sales of its ChromaID
and Bio-RFID products. The Company is currently not profitable.
Even if the Company succeeds in introducing the ChromaID and
Bio-RFID technology and related products to its target markets, the
Company may not be able to generate sufficient revenue to achieve
or sustain profitability.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
ChromaID was invented by scientists under contract with the
Company. Bio-RFID was invented by individuals working for the
Company. The Company actively pursues a robust intellectual
property strategy and has been granted twelve patents. The Company
also has 20 patents pending. The Company possesses all right, title
and interest to the issued patents. Ten of the pending patents are
licensed exclusively to the Company in perpetuity by the
Company&#x2019;s strategic partner, Allied
Inventors.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Merger with RAAI Lighting, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company entered into an Agreement and Plan
of Merger with 500 Union Corporation, a Delaware corporation and a
wholly owned subsidiary of the Company, and RAAI Lighting, Inc., a
Delaware corporation. Pursuant to the Merger Agreement, we have
acquired all the outstanding shares of RAAI&#x2019;s capital stock
through a merger of Merger Sub with and into RAAI (the
&#x201C;Merger&#x201D;), with RAAI surviving the Merger as a wholly
owned subsidiary of the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-30</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Under the terms of the Merger Agreement, each share of RAAI common
stock issued and outstanding immediately before the Merger (1,000
shares) were cancelled and we issued 2,000,000 shares of our common
stock. As a result, we issued 2,000,000 shares of its common stock
to Phillip A. Bosua, formerly the sole stockholder of RAAI. The
consideration for the Merger was determined through arms-length
bargaining by the Company and RAAI. The Merger was structured to
qualify as a tax-free reorganization for U.S. federal income tax
purposes. As a result of the Merger, the Company received certain
intellectual property, related to RAAI.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Merger with Know Labs, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, Know Labs, Inc., a Nevada corporation incorporated
on April 3, 2018, and our wholly-owned subsidiary, merged with and
into the Company pursuant to an Agreement and Plan of Merger dated
May 1, 2018. In connection with the merger, our Articles of
Incorporation were effectively amended to change our name to Know
Labs, Inc. by and through the filing of Articles of Merger. This
parent-subsidiary merger was approved by us, the parent, in
accordance with Nevada Revised Statutes Section 92A.180.
Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1,
2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Corporate Name Change and Symbol Change</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On May
24, 2018, the Financial Industry Regulatory Authority
(&#x201C;FINRA&#x201D;) announced the effectiveness of a change in
our name from Visualant Incorporated to Know Labs, Inc. and a
change in our ticker symbol from VSUL to the new trading symbol
KNWN which became effective on the opening of trading as of May 25,
2018. In addition, in connection with the name change and symbol
change, we were assigned the CUSIP number of
499238103.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
2.</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
GOING CONCERN</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
accompanying financial statements have been prepared on a going
concern basis, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. The
Company incurred net losses of $2,493,821, $3,257,597 and
$3,901,232 for the six months ended March 31, 2019 and the years
ended September 30, 2018 and 2017, respectively. Net cash used in
operating activities was $1,462,737, $1,117,131 and $1,264,324 for
the three months ended March 31, 2019 and for the years ended
September 30, 2018 and 2017, respectively.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company anticipates that it will record losses from operations for
the foreseeable future. As of March 31, 2019, the Company&#x2019;s
accumulated deficit was $37,285,145.&#xA0;&#xA0;The Company has
limited capital resources, and operations to date have been funded
with the proceeds from private equity and debt financings and loans
from Ronald P. Erickson, the Company&#x2019;s Chief Executive
Officer, or entities with which he is affiliated. These conditions
raise substantial doubt about our ability to continue as a going
concern. The audit report prepared by the Company&#x2019;s
independent registered public accounting firm relating to our
financial statements for the year ended September 30, 2018 includes
an explanatory paragraph expressing the substantial doubt about the
Company&#x2019;s ability to continue as a going
concern.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company believe that its cash on hand will be sufficient to fund
our operations until December 31, 2019. <font style="color: #000000">We need additional financing to implement our
business plan and to service our ongoing operations and pay our
current debts. There can be no assurance that we will be able to
secure any needed funding, or that if such funding is available,
the terms or conditions would be acceptable to us. If we are unable
to obtain additional financing when it is needed, we will need to
restructure our operations, and divest all or a portion of our
business.</font> <font style="color: #000000; background-color: #FFFFFF">We may seek additional
capital through a combination of private and public equity
offerings, debt financings and strategic collaborations. Debt
financing, if obtained, may involve agreements that include
covenants limiting or restricting our ability to take specific
actions, such as incurring additional debt, and could increase our
expenses and require that our assets secure such debt. Equity
financing, if obtained, could result in dilution to the
Company&#x2019;s then-existing stockholders and/or require such
stockholders to waive certain rights and preferences. If such
financing is not available on satisfactory terms, or is not
available at all, the Company may be required to delay, scale back,
eliminate the development of business opportunities or file for
bankruptcy and our operations and financial condition may be
materially adversely affected.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 66px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
3.&#xA0;&#xA0;</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING
STANDARDS</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Basis of Presentation</font> <font style="color: #000000">&#x2013;</font> The accompanying unaudited
consolidated financial statements include the accounts of the
Company. Intercompany accounts and transactions have been
eliminated. The preparation of these unaudited condensed
consolidated financial statements were prepared in conformity with
U.S. generally accepted accounting principles
(&#x201C;GAAP&#x201D;).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Principles of Consolidation</font> <font style="color: #000000">&#x2013; The consolidated financial statements
include the accounts of the Company and its wholly owned and
majority-owned subsidiaries, TransTech Systems, Inc and RAAI
Lighting, Inc. Inter-Company items and transactions have been
eliminated in consolidation.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Cash and Cash Equivalents</font> <font style="color: #000000">&#x2013;&#xA0;The Company classifies highly liquid
temporary investments with an original maturity of three months or
less when purchased as cash equivalents. The Company maintains cash
balances at various financial institutions. Balances at US banks
are insured by the Federal Deposit Insurance Corporation up to
$250,000. The Company has not experienced any losses in such
accounts and believes it is not exposed to any significant risk for
cash on deposit.&#xA0;&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-31</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Accounts Receivable and Allowance for Doubtful Accounts</font>
<font style="color: #000000">&#x2013; Accounts receivable consist
primarily of amounts due to the Company from normal business
activities. The Company maintains an allowance for doubtful
accounts to reflect the expected non-collection of accounts
receivable based on past collection history and specific risks
identified within the portfolio. If the financial condition of the
customers were to deteriorate resulting in an impairment of their
ability to make payments, or if payments from customers are
significantly delayed, additional allowances might be
required.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Inventories</font> <font style="color: #000000">&#x2013; Inventories
consist primarily of printers and consumable supplies, including
ribbons and cards, badge accessories, capture devices, and access
control components held for resale and are stated at the lower of
cost or market on the&#xA0;first-in, first-out (&#x201C;FIFO&#x201D;)
method.&#xA0;&#xA0;Inventories are considered available for resale
when drop shipped and invoiced directly to a customer from a
vendor, or when physically received by TransTech at a warehouse
location.&#xA0;&#xA0;The Company records a provision for excess and
obsolete inventory whenever an impairment has been identified.
There is a $35,000 reserve for impaired inventory as of March 31,
2019 and September 30, 2018, respectively.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Equipment</font> <font style="color: #000000">&#x2013; Equipment
consists of machinery, leasehold improvements, furniture and
fixtures and software, which are stated at cost less accumulated
depreciation and amortization. Depreciation is computed by the
straight-line method over the estimated useful lives or lease
period of the relevant asset, generally 2-10 years, except for
leasehold improvements which are depreciated over 2-3
years.&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Long-Lived Assets</font> <font style="color: #000000">&#x2013; The
Company reviews its long-lived assets for impairment annually or
when changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. Long-lived assets under certain
circumstances are reported at the lower of carrying amount or fair
value. Assets to be disposed of and assets not expected to provide
any future service potential to the Company are recorded at the
lower of carrying amount or fair value (less the projected cost
associated with selling the asset). To the extent carrying values
exceed fair values, an impairment loss is recognized in operating
results.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Intangible Assets</font> &#x2013; Intangible assets are capitalized
and amortized on a straight-line basis over their estimated useful
life, if the life is determinable. If the life is not determinable,
amortization is not recorded. We regularly perform reviews to
determine if facts and circumstances exist which indicate that the
useful lives of our intangible assets are shorter than originally
estimated or the carrying amount of these assets may not be
recoverable. When an indication exists that the carrying amount of
intangible assets may not be recoverable, we assess the
recoverability of our assets by comparing the projected
undiscounted net cash flows associated with the related asset or
group of assets over their remaining lives against their respective
carrying amounts. Such impairment test is based on the lowest level
for which identifiable cash flows are largely independent of the
cash flows of other groups of assets and liabilities. Impairment,
if any, is based on the excess of the carrying amount over the
estimated fair value of those assets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Research, Development and Engineering Expenses</font> &#x2013;
Research, development and engineering expenses consist of the cost
of employees, consultants and contractors who design, engineer and
develop new products and processes as well as materials, supplies
and facilities used in producing prototypes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company&#x2019;s research and development efforts are primarily
focused improving the core foundational ChromaID technology and
developing new and unique applications for the technology. As part
of this effort, the Company typically conduct testing to ensure
that ChromaID application methods are compatible with the
customer&#x2019;s requirements, and that they can be implemented in
a cost effective manner. The Company is also actively involved in
identifying new application methods. Know Lab&#x2019;s team has
considerable experience working with the application of light-based
technologies and their application to various industries. The
Company believes that its continued development of new and enhanced
technologies relating to our core business is essential to its
future success. The Company spent $391,014, $570,514 and $79,405
during the six months ended March 31, 2019 and the years ended
September 30, 2018 and 2017, respectively, on research and
development activities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; font-style: italic">
Fair Value Measurements and Financial Instruments</font>
<font style="color: #000000">&#x2013;</font><font style="font-weight: bold">&#xA0;</font>ASC Topic 820, <font style="font-style: italic">Fair Value Measurement and Disclosures</font>,
defines fair value as the exchange price that would be received for
an asset or paid to transfer a liability (an exit price) in the
principal or most advantageous market for the asset or liability in
an orderly transaction between market participants on the
measurement date.&#xA0;&#xA0;This topic also establishes a fair
value hierarchy, which requires classification based on observable
and unobservable inputs when measuring fair value.&#xA0;&#xA0;The
fair value hierarchy distinguishes between assumptions based on
market data (observable inputs) and an entity&#x2019;s own
assumptions (unobservable inputs).&#xA0;&#xA0;The hierarchy
consists of three levels:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Level 1
&#x2013; Quoted prices in active markets for identical assets and
liabilities;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Level 2
&#x2013; Inputs other than level one inputs that are either directly
or indirectly observable; and.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Level&#xA0;3
- Inputs to the valuation methodology are unobservable and
significant to the fair value measurement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
recorded value of other financial assets and liabilities, which
consist primarily of cash and cash equivalents, accounts
receivable, other current assets, and accounts payable and accrued
expenses approximate the fair value of the respective assets and
liabilities as of March 31, 2019 and September 30, 2018 are based
upon the short-term nature of the assets and
liabilities.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-32</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
Derivative Financial Instruments -</font>The Company evaluates all
of its financial instruments to determine if such instruments are
derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are
accounted for as liabilities, the derivative instrument is
initially recorded at its fair value and is then re-valued at each
reporting date, with changes in the fair value reported in the
consolidated statements of operations. For stock-based derivative
financial instruments, the Company uses a Black-Scholes-Merton
option pricing model to value the derivative instruments at
inception and on subsequent valuation dates. The classification of
derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is evaluated at the end of
each reporting period. Derivative instrument liabilities are
classified in the balance sheet as current or non-current based on
whether or not net-cash settlement of the derivative instrument
could be required within twelve months of the balance sheet
date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Revenue Recognition</font> <font style="color: #000000">&#x2013;
Know Lab and TransTech revenue are derived from products and
services. Revenue is considered realized when the products or
services have been provided to the customer, the work has been
accepted by the customer and collectability is&#xA0;reasonably
assured. Furthermore, if an actual measurement of revenue cannot be
determined, the Company defers all revenue recognition until such
time that an actual measurement can be determined. If during the
course of a contract management determines that losses are expected
to be incurred, such costs are charged to operations in the period
such losses are determined. Revenues are deferred when cash has
been received from the customer but the revenue has not been
earned.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Stock Based Compensation</font> <font style="color: #000000">&#x2013; The Company has share-based compensation
plans under which employees, consultants, suppliers and directors
may be granted restricted stock, as well as options to purchase
shares of Company common stock at the fair market value at the time
of grant. Stock-based compensation cost is measured by the Company
at the grant date, based on the fair value of the award, over the
requisite service period. For options issued to employees, the
Company recognizes stock compensation costs utilizing the fair
value methodology over the related period of
benefit.&#xA0;&#xA0;Grants of stock options and stock to
non-employees and other parties are accounted for in accordance
with the ASC 505.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Convertible Securities</font> <font style="color: #000000">&#x2013;</font> Based upon ASC 815-15, we have
adopted a sequencing approach regarding the application of ASC
815-40 to convertible securities. We will evaluate our contracts
based upon the earliest issuance date. In the event partial
reclassification of contracts subject to ASC 815-40-25 is
necessary, due to our inability to demonstrate we have sufficient
shares authorized and unissued, shares will be allocated on the
basis of issuance date, with the earliest issuance date receiving
first allocation of shares. If a reclassification of an instrument
were required, it would result in the instrument issued latest
being reclassified first.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Net Loss per Share</font> <font style="color: #000000">&#x2013;
Under the provisions of ASC 260, &#x201C;Earnings Per Share,&#x201D;
basic loss per common share is computed by dividing net loss
available to common stockholders by the weighted average number of
shares of common stock outstanding for the periods presented.
Diluted net loss per share reflects the potential dilution that
could occur if securities or other contracts to issue common stock
were exercised or converted into common stock or resulted in the
issuance of common stock that would then share in the income of the
Company, subject to anti-dilution limitations.</font> <a name="_Hlk8544289"></a><font style="color: #000000">As
of March 31, 2019, there were options outstanding for the purchase
of 2,282,668 common shares, warrants for the purchase of 17,572,583
common shares, and 4,894,071&#xA0;shares of the Company&#x2019;s
common stock issuable upon the conversion of Series A, Series C and
Series D Convertible Preferred Stock. In addition, the Company has
an unknown number of shares (9,020,264 common shares at the current
price of $0.25 per share) are issuable upon conversion of
convertible debentures of $2,255,065. All of which could
potentially dilute future earnings per share.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As of March 31, 2018, there were options outstanding for the
purchase of 4,736 common shares, warrants for the purchase of
11,837,422 common shares, 2,825,053 shares of the Company&#x2019;s
common stock issuable upon the conversion of Series A, Series C and
Series D Convertible Preferred Stock. In addition, the Company has
an unknown number of shares issuable upon conversion of convertible
debentures of $2,390,066. All of which could potentially dilute
future earnings per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Dividend Policy</font> <font style="color: #000000">&#x2013; The
Company has never paid any cash dividends and intends, for the
foreseeable future, to retain any future earnings for the
development of our business. Our future dividend policy will be
determined by the board of directors on the basis of various
factors, including our results of operations, financial condition,
capital requirements and investment
opportunities.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; color: #000000">
Use of Estimates</font> <font style="color: #000000">&#x2013; The
preparation of financial statements in conformity with accounting
principles generally accepted in the United States requires
management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during
the reporting period. Actual results could differ from those
estimates.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Recent Accounting Pronouncements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
A variety of proposed or otherwise potential accounting standards
are currently under study by standard setting organizations and
various regulatory agencies. Due to the tentative and preliminary
nature of those proposed standards, management has not determined
whether implementation of such proposed standards would be material
to the Company&#x2019;s consolidated financial
statements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-33</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">4.&#xA0;</font>&#xA0;<font style="color: #000000">ACCOUNTS RECEIVABLE/CUSTOMER
CONCENTRATION</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Accounts receivable were $193,372 and $320,538, net of allowance,
as of March 31, 2019 and September 30, 2018, respectively. The
Company had two customers in excess of 10% (14.8% and 10.1%) of the
Company&#x2019;s consolidated revenues for the three months ended
March 31, 2019. The Company had two customers in excess of 10%
(21.7%,and 20.7%) with accounts receivable in excess of 10% as of
March 31, 2019. The Company has a total allowance for bad debt in
the amount of $60,000 as of March 31, 2019.</font>&#xA0;The
decrease in accounts receivable related to lower sales and
purchases at TransTech.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">5.&#xA0;</font>&#xA0;<font style="color: #000000">INVENTORIES</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Inventories were and $100,989 and $203,582 as of March 31, 2019 and
September 30, 2018, respectively. Inventories consist primarily of
printers and consumable supplies, including ribbons and cards,
badge accessories, capture devices, and access control components
held for resale. There was a $35,000 reserve for impaired inventory
as of September 30, 2018 and 2017, respectively.</font> The
decrease in inventory related to lower sales at
TransTech.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
6.&#xA0;FIXED ASSETS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Fixed assets, net of accumulated depreciation, was $197,536 and
$169,333 as of March 31, 2019 and September 30, 2018, respectively.
Accumulated depreciation was $717,019 and $670,666 as of March 31,
2019 and September 30, 2018, respectively. Total depreciation
expense was $46,354 and $30,462 for the six months ended March 31,
2019 and 2017, respectively. All equipment is used for selling,
general and administrative purposes and accordingly all
depreciation is classified in selling, general and administrative
expenses.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Property and equipment as of March 31, 2019 was comprised of the
following:&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:27%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-weight: bold; font-size: 11px;"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-weight: bold;">
Estimated</font></font></div>
</td>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:45%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 3%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 94%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
March 31, 2019</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 3%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:27%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; display: inline-block; vertical-align: bottom; width: 10%; padding-bottom: 2px; font-weight: bold;">&#xA0;</font><font style="text-align: center; display: inline-block; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold;">
<div style="text-align: center; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-weight: bold;">
Useful Lives</font></div>
</font><font style="text-align: left; display: inline-block; vertical-align: bottom; width: 10%; padding-bottom: 2px; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Purchased</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Capital Leases</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Total</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Machinery
and equipment</font></div>
</td>
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2-10
years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">406,861</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">42,681</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">449,542</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Leasehold
improvements</font></div>
</td>
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2-3
years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">276,112</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">276,112</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Furniture
and fixtures</font></div>
</td>
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">2-3
years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">58,051</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">95,020</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">153,071</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Software
and websites</font></div>
</td>
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">3-
7 years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">35,830</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">35,830</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="2" style="vertical-align:bottom;width:54%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Less:
accumulated depreciation</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(579,318</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(137,701</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(717,019</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="2" style="vertical-align:bottom;width:54%;">
<div style="margin-left:0px;padding-bottom:4px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">197,536</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">197,536</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">7.&#xA0;</font>&#xA0;<font style="color: #000000">INTANGIBLE ASSETS</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Intangible assets as of March 31, 2019 and September 30, 2018
consisted of the following:&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:27%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; font-size: 11px;"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-weight: bold;">
Estimated</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
March 31,</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
September 30,</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:27%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; display: inline-block; vertical-align: bottom; width: 10%; padding-bottom: 2px; font-weight: bold;">&#xA0;</font><font style="text-align: center; display: inline-block; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: bold;">
<div style="text-align: center; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-weight: bold;">
Useful Lives</font></div>
</font><font style="text-align: left; display: inline-block; vertical-align: bottom; width: 10%; padding-bottom: 2px; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
2019</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
2018</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align:bottom;width:54%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Technology</font></div>
</td>
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">3
years</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">520,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">520,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align:bottom;width:54%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Less:
accumulated amortization</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(158,888</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(72,222</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(86,666</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:27%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;Intangible
assets, net</font></div>
</td>
<td style="vertical-align:bottom;width:27%;">
<div style="margin-left:0px;padding-bottom:4px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">361,112</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">447,778</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family: Times New Roman; vertical-align: bottom; font-size: 13px; display: inline-block; width: 5%; padding-bottom: 4px;">&#xA0;</font><font style="text-align: right; font-family: Times New Roman; vertical-align: bottom; font-size: 13px; display: inline-block; width: 75%; padding-bottom: 4px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Total amortization expense was $86,666 and $0 for the six months
ended March 31, 2019 and 2018, respectively.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Merger with RAAI Lighting, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 10, 2018, the Company entered into an Agreement and Plan
of Merger with 500 Union Corporation, a Delaware corporation and a
wholly owned subsidiary of the Company, and RAAI Lighting, Inc., a
Delaware corporation. Pursuant to the Merger Agreement, we have
acquired all the outstanding shares of RAAI&#x2019;s capital stock
through a merger of Merger Sub with and into RAAI (the
&#x201C;Merger&#x201D;), with RAAI surviving the Merger as a wholly
owned subsidiary of the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Under the terms of the Merger Agreement, each share of RAAI common
stock issued and outstanding immediately before the Merger (1,000
shares) were cancelled and converted into the right to receive
2,000 shares of the Company&#x2019;s common stock. As a result, the
Company issued 2,000,000 shares of its common stock to Phillip A.
Bosua, formerly the sole stockholder of RAAI. The consideration for
the Merger was determined through arms-length bargaining by the
Company and RAAI. The Merger was structured to qualify as a
tax-free reorganization for U.S. federal income tax purposes. As a
result of the Merger, the Company received certain intellectual
property, related to RAAI.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-34</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Merger with Know Labs, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, Know Labs, Inc., a Nevada corporation incorporated
on April 3, 2018, and our wholly-owned subsidiary, merged with and
into the Company pursuant to an Agreement and Plan of Merger dated
May 1, 2018. In connection with the merger, our Articles of
Incorporation were effectively amended to change our name to Know
Labs, Inc. by and through the filing of Articles of Merger. This
parent-subsidiary merger was approved by us, the parent, in
accordance with Nevada Revised Statutes Section 92A.180.
Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1,
2018.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
RAAI had no outstanding indebtedness or assets at the closing of
the Merger. The 2,000,000 shares of the Company&#x2019;s common
stock issued for RAAI&#x2019;s shares were recorded at the fair
value at the date of the merger at $520,000 and the value assigned
to the patent acquired with RAAI.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The fair value of the intellectual property associated with the
assets acquired was $520,000 estimated by using a discounted cash
flow approach based on future economic benefits. In summary, the
estimate was based on a projected income approach and related
discounted cash flows over five years, with applicable risk factors
assigned to assumptions in the forecasted results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
8. ACCOUNTS PAYABLE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Accounts payable were $1,298,278 and $1,517,617 as of&#xA0;March
31, 2019 and September 30, 2018, respectively. Such liabilities
consisted of amounts due to vendors for inventory purchases and
technology development, external audit, legal and other expenses
incurred by the Company. The Company had two vendors (12.3% and
10.0%) with accounts payable in excess of 10% of its accounts
payable as of March 31, 2019. The Company does expect to have
vendors with accounts payable balances of 10% of total accounts
payable in the foreseeable future.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">9.</font>&#xA0;&#xA0;<font style="color: #000000">DERIVATIVE INSTRUMENTS</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
April 2008, the FASB issued a pronouncement that provides guidance
on determining what types of instruments or embedded features in an
instrument held by a reporting entity can be considered indexed to
its own stock for the purpose of evaluating the first criteria of
the scope exception in the pronouncement on accounting for
derivatives. This pronouncement was effective for financial
statements issued for fiscal years beginning after December 15,
2008. The adoption of these requirements can affect the accounting
for warrants and many convertible instruments with provisions that
protect holders from a decline in the stock price (or
&#x201C;down-round&#x201D; provisions). For example, warrants or
conversion features with such provisions are no longer recorded in
equity. Down-round provisions reduce the exercise price of a
warrant or convertible instrument if a company either issues equity
shares for a price that is lower than the exercise price of those
instruments or issues new warrants or convertible instruments that
have a lower exercise price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">There
was no derivative liability as of March 31, 2019 and <font style="color: #000000">September 30, 2018.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
10. CONVERTIBLE NOTES PAYABLE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Convertible notes payable as of March 31, 2019 and September 30,
2018 consisted of the following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Convertible Promissory Notes with Clayton A. Struve</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
As of March 31, 2019, the Company owes Clayton A. Struve $1,071,000
under convertible promissory or OID notes. The Company recorded
accrued interest of $58,411 as of March 31, 2019.</font> On May 8,
2019, the Company signed Amendment 2 to the convertible promissory
or OID notes, extending the due dates to September 30,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Convertible Redeemable Promissory Notes with Ronald P. Erickson and
J3E2A2Z</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 16, 2018, the Company entered into a Note and Account Payable
Conversion Agreement pursuant to which (a) all $664,233 currently
owing under the J3E2A2Z Notes was converted to a Convertible
Redeemable Promissory Note in the principal amount of $664,233, and
(b) all $519,833 of the J3E2A2Z Account Payable was converted into
a Convertible Redeemable Promissory Note in the principal amount of
$519,833 together with a warrant to purchase up to 1,039,666 shares
of common stock of the Company for a period of five years.
<font style="color: #000000">The initial exercise price of the
warrants described above is $0.50 per share, also subject to
certain adjustments. The warrants were valued at $110,545. Because
the note is immediately convertible, the warrants and beneficial
conversion were expensed as interest.</font> <font style="color: #000000">The Company recorded accrued interest of $41,361
as of March 31, 2019.</font> On May 8, 2019, the Company signed
Amendment 1 to the convertible redeemable promissory notes,
extending the due dates to September 30, 2019 and increasing the
interest rate to 6%.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-35</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
11.</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Notes payable, capitalized leases and long-term debt as of March
31, 2019 and September 30, 2018 consisted of the
following:</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">March
31,</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">September
30,</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">2019</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">2018</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Capital Source
Business Finance Group</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">145,186</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total
debt</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">145,186</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Less current
portion of long term debt</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(145,186</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Long term
debt</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Capital Source Business Finance Group</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 12, 2019, Capital Source cancelled the Loan and Security
Agreement and Capital Source Credit Facility with TransTech.
TransTech repaid the remaining $15,165 due on the Secured Credit
Facility. On March 27, 2019, the Company received notice that the
UCC Financing Statement filed by Capital Source to secure a parent
Company guarantee was terminated and cancelled by the State of
Nevada.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
12. EQUITY</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Authorized Capital Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company authorized 105,000,000 shares of capital stock, of which
100,000,000 are shares of voting common stock, par value $0.001 per
share, and 5,000,000 are shares preferred stock, par value $0.001
per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As of March 31, 2019, the Company had 22,002,904 shares of common
stock issued and outstanding, held by 122 stockholders of record.
The number of stockholders, including beneficial owners holding
shares through nominee names, is approximately 2,300. Each share of
common stock entitles its holder to one vote on each matter
submitted to the stockholders for a vote, and no cumulative voting
for directors is permitted.&#xA0;&#xA0;Stockholders do not have any
preemptive rights to acquire additional securities issued by
us.&#xA0;&#xA0;As of March 31, 2019, there were options outstanding
for the purchase of 2,282,668 common shares, warrants for the
purchase of 17,572,583 common shares, and 4,894,071&#xA0;shares of
the Company&#x2019;s common stock issuable upon the conversion of
Series A, Series C and Series D Convertible Preferred Stock. In
addition, the Company has an unknown number of shares (9,020,264
common shares at the current price of $0.25 per share) are issuable
upon conversion of convertible debentures of $2,255,066. All of
which could potentially dilute future earnings per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Voting Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company is authorized to issue up to 5,000,000 shares of
preferred stock with a par value of $0.001.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Series A Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
January 29, 2019, a holder of Series A Preferred Stock converted
20,000 shares into 80,000 shares of common stock. There are no
Series A Preferred Stock outstanding as of March 31,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Series C and D Preferred Stock and Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
August 5, 2016, the Company closed a Series C Preferred Stock and
Warrant Purchase Agreement with Clayton A. Struve, an accredited
investor for the purchase of $1,250,000 of preferred stock with a
conversion price of $0.70 per share. The preferred stock has a
yield of 8% and an ownership blocker of 4.99%. In addition, Mr.
Struve received a five-year warrant to acquire 1,785,714 shares of
common stock at $0.70 per share. <font style="color: #000000">On
August 14, 2017,</font> the price of the <font style="color: #000000">Series C Stock</font> were adjusted to $0.25 per
share <font style="color: #000000">pursuant to the documents
governing such instruments.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
As of March 31, 2019, the Company has 3,108,356 of</font> Series D
Preferred Stock outstanding with Clayton A. Struve, an accredited
investor, outstanding. <font style="color: #000000">On August 14,
2017,</font> the price of the <font style="color: #000000">Series D
Stock</font> were adjusted to $0.25 per share <font style="color: #000000">pursuant to the documents governing such
instruments.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-36</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Series F Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 1, 2018, the Company filed with the State of Nevada a
Certificate of Designation establishing the Designations,
Preferences, Limitations and Relative Rights of Series F Preferred
Stock. The Designation authorized 500 shares of Series F Preferred
Stock. The Series F Preferred Stock shall only be issued to the
current Board of Directors on the date of the Designation&#x2019;s
filing and is not convertible into common stock. As set forth in
the Designation, the Series F Preferred Stock has no rights to
dividends or liquidation preference and carries rights to vote
100,000 shares of common stock per share of Series F upon a Trigger
Event, as defined in the Designation. A Trigger Event includes
certain unsolicited bids, tender offers, proxy contests, and
significant share purchases, all as described in the Designation.
Unless and until a Trigger Event, the Series F shall have no right
to vote. The Series F Preferred Stock shall remain issued and
outstanding until the date which is 731 days after the issuance of
Series F Preferred Stock (&#x201C;Explosion Date&#x201D;), unless a
Trigger Event occurs, in which case the Explosion Date shall be
extended by 183 days.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Securities Subject to Price Adjustments</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px">
In the future, if we sell our common stock at a price below $0.25
per share, the exercise price</font> <font style="color: #000000; font-size: 13px">of 1,785,715 outstanding shares
of Series C Preferred Stock, 1,016,004 outstanding shares Series D
Preferred Stock that adjust below $0.25 per share pursuant to the
documents governing such instruments. In addition, the conversion
price of a Convertible Note Payable of $2,255,066 (9,020,264 common
shares at the current price of $0.25 per share) and the exercise
price of additional outstanding warrants to purchase 12,664,385
shares of common stock would adjust below $0.25 per share pursuant
to the documents governing such instruments.</font>
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Common Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
All of the offerings and sales described below were deemed to be
exempt under Rule 506 of Regulation D and/or Section 4(a)(2) of the
Securities Act. No advertising or general solicitation was employed
in offering the securities, the offerings and sales were made to a
limited number of persons, all of whom were accredited investors
and transfer was restricted by the company in accordance with the
requirements of Regulation D and the Securities Act. All issuances
to accredited and non-accredited investors were structured to
comply with the requirements of the safe harbor afforded by Rule
506 of Regulation D, including limiting the number of
non-accredited investors to no more than 35 investors who have
sufficient knowledge and experience in financial and business
matters to make them capable of evaluating the merits and risks of
an investment in our securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following equity issuances occurred during the six months ended
March 31, 2019:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the six months ended March 31, 2019, the Company issued
336,427 shares of common stock and cancelled warrants to purchase
26,573 shares of common stock at $0.25 per share to two consultants
and two investors related to the cashless exercise of
warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the six months ended March 31, 2019, the Company issued
145,000 shares of common stock for services provided by two
consultants. The shares were valued at $246,900 or $1.703 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On January 2, 2019, the Company issued 100,000 shares of common
stock for services provided to Ronald P. Erickson. The shares were
valued at $102,000 or $1.02 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
January 29, 2019, a holder of Series A Preferred Stock converted
20,000 shares into 80,000 shares of common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Private Placements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 4, 2019, the Company closed rounds one and two of a
private placement and received gross proceeds of $2,409,975 in
exchange for issuing Subordinated Convertible Notes and Warrants in
a private placement to 26 accredited investors, pursuant to a
series of substantially identical Securities Purchase Agreements,
Common Stock Warrants, and related documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 18, 2019, Company closed round three of a private
placement and received gross proceeds of $1,400,000 in exchange for
issuing Subordinated Convertible Notes and Warrants in a private
placement to 8 accredited investors, pursuant to a series of
substantially identical Securities Purchase Agreements, Common
Stock Warrants, and related documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Convertible Notes have a principal amount of $3,809,975 and
bear annual interest of 8%. Both the principal amount of and the
interest are payable on a payment-in-kind basis in shares of Common
Stock of the Company. They are due and payable in common stock on
the earlier of (a) mandatory and automatic conversion of the
Convertible Notes into a financing that yields gross proceeds of at
least $10,000,000 or (b) on the one-year anniversary of the
Convertible Notes. Investors will be required to convert their
Convertible Notes into Common Stock in any $10,000,000 financing at
a conversion price per share equal to the lower of (i) $1.00 per
share or (ii) a 25% discount to the price per share paid by
investors in the $10,000,000 Financing. If the Convertible Notes
have not been paid or converted prior to the Maturity Date, the
outstanding principal amount of the Convertible Notes will be
automatically converted into shares of Common Stock at the lesser
of (a) $1.00 per share or (b) any adjusted price resulting from the
application of a &#x201C;most favored nations&#x201D; provision,
which requires the issuance of additional shares of Common Stock to
investors if the Company issues certain securities at less than the
then-current conversion price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-37</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Warrants were granted on a 1:0.5 basis (one-half Warrant for each
full share of Common Stock into which the Convertible Notes are
convertible). The Warrants have a five-year term and an exercise
price equal to 120% of the per share conversion price of the
Qualified Financing or other mandatory conversion.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Convertible Notes are initially convertible into 3,809,975 shares
of Common Stock, subject to certain adjustments, and the Warrants
are initially exercisable for 1,904,988 shares of Common Stock at
an exercise price of $1.20 per share of Common Stock, also subject
to certain adjustments.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
connection with the private placement, the placement agent for the
Convertible Notes and the Warrants received a cash fee of $324,798
and warrants to purchase 487,197 shares of the Company&#x2019;s
common stock, all based on 8% of gross proceeds to the Company. The
placement agent has also received a $25,000 advisory
fee.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">As part
of the Purchase Agreement, the Company entered into a Registration
Rights Agreement, which grants the investors &#x201C;demand&#x201D;
and &#x201C;piggyback&#x201D; registration rights to register the
shares of Common Stock issuable upon the conversion of the
Convertible Notes and the exercise of the Warrants with the
Securities and Exchange Commission for resale or other disposition.
In addition, the Convertible Notes are subordinated to certain
senior debt of the Company pursuant to a Subordination Agreement
executed by the investors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Convertible Notes and Warrants were issued in transactions that
were not registered under the Securities Act of 1933, as amended
(the &#x201C;Act&#x201D;) in reliance upon applicable exemptions from
registration under Section 4(a)(2) of the Act and/or Rule 506 of
SEC Regulation D under the Act. &#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company expects to continue offering additional Convertible Notes
and Warrants on substantially the same terms until April 15, 2019
(unless extended at the discretion of the Company) or until the
Company has raised a maximum of $5 million in gross proceeds (or
such other amount determined by the Company in its discretion). The
offering was extended until May 31, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Warrants to Purchase Common Stock</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following warrants were issued during the six months ended
March 31, 2019:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company issued 336,427 shares of common stock and cancelled
warrants to purchase 26,573 shares of common stock at $0.25 per
share to two consultants and two investors related to the cashless
exercise of warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company issued warrants to purchase 70,000 shares of common
stock at $1.61 to$2.72 per share to three consultants. The warrants
were valued at $30,325 or 0.79 to $1.11 per share. The warrants
expire during the first quarter of 2024.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Private Placements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Warrants issued for the private placements discussed above were
granted on a 1:0.5 basis (one-half Warrant for each full share of
Common Stock into which the Convertible Notes are convertible). The
Warrants have a five-year term and an exercise price equal to 120%
of the per share conversion price of the Qualified Financing or
other mandatory conversion.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Warrants are initially exercisable for 1,904,988 shares of Common
Stock at an exercise price of $1.20 per share of Common Stock, also
subject to certain adjustments.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
connection with the private placement, the placement agent for the
Convertible Notes and the Warrants received warrants to purchase
487,197 shares of the Company&#x2019;s common stock, all based on 8%
of gross proceeds to the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-38</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">A
summary of the warrants outstanding as of <font style="color: #000000">March 31, 2019</font> were as
follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:30%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 5%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
March 31, 2019</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 5%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Weighted</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Average</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exercise</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:70%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Shares</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Price</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Outstanding
at beginning of period</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">15,473,398</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.326</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issued</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,462,185</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.222</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Exercised</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(336,427</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Forfeited</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Expired</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(26,573</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Outstanding
at end of period</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">17,572,583</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.453</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:70%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Exerciseable
at end of period</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">17,572,583</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">A
summary of the status of the warrants outstanding as of
<font style="color: #000000">March 31, 2019</font> is presented
below:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 14%;">
<div style="padding-bottom: 2px;"><font style="font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font></div>
</td>
<td colspan="4" rowspan="1" style="vertical-align:bottom;width:56%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 2%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 96%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
March 31, 2019</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 2%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Weighted</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Weighted</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Weighted</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Average</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Average</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Average</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Number of</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Remaining</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exercise</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Shares</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exercise</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Warrants</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Life ( In Years)</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Price</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exerciseable</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Price</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13,507,286</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3.50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13,507,286</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">714,286</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2.33</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.700</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">714,286</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.700</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">882,159</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2.62</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">882,159</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,442,185</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.93</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.20-1.50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,442,185</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.20-1.50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">20,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.92</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2.34-4.08</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">20,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2.34-4.08</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">6,667</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">30.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">6,667</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">30.000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">17,572,583</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">3.78</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.453</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">17,572,583</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.453</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
significant weighted average assumptions relating to the valuation
of the Company&#x2019;s warrants for the six months ended
<font style="color: #000000">March 31, 2019</font> were as
follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Assumptions</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Dividend yield</font></div>
</td>
<td style="vertical-align: bottom; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
0%</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Expected life</font></div>
</td>
<td style="vertical-align: bottom; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
1 yr</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Expected volatility</font></div>
</td>
<td style="vertical-align: bottom; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
125%</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Risk free interest rate</font></div>
</td>
<td style="vertical-align: bottom; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
2.0%</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
There were vested warrants of 16,613,757 as of March 31, 2019 with
an aggregate intrinsic value of $14,664,327.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
13.</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
STOCK OPTIONS</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 21, 2013, an amendment to the Stock Option Plan was approved
by the stockholders of the Company, increasing the number of shares
reserved for issuance under the Plan to 93,333 shares.<font style="font-weight: bold">&#xA0;</font>On April 10, 2018, the Board
approved an amendment to its 2011 Stock Incentive Plan increasing
the number of shares of common stock reserved under the Incentive
Plan from 93,333 to 1,200,000. On August 7, 2018, the Board
approved an amendment to its 2011 Stock Incentive Plan increasing
the number of shares of common stock reserved under the Incentive
Plan from 1,200,000 to 2,000,000 to common
shares.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Determining Fair Value under ASC 505</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company records compensation expense associated with stock
options and other equity-based compensation using the
Black-Scholes-Merton option valuation model for estimating fair
value of stock options granted under our plan. The Company
amortizes the fair value of stock options on a ratable basis over
the requisite service periods, which are generally the vesting
periods. The expected life of awards granted represents the period
of time that they are expected to be outstanding.&#xA0;&#xA0;The
Company estimates the volatility of our common stock based on the
historical volatility of its own common stock over the most recent
period corresponding with the estimated expected life of the award.
The Company bases the risk-free interest rate used in the Black
Scholes-Merton option valuation model on the implied yield
currently available on U.S. Treasury zero-coupon issues with an
equivalent remaining term equal to the expected life of the award.
The Company has not paid any cash dividends on our common stock and
does not anticipate paying any cash dividends in the foreseeable
future. Consequently, the Company uses an expected dividend yield
of zero in the Black-Scholes-Merton option valuation model and
adjusts share-based compensation for changes to the estimate of
expected equity award forfeitures based on actual forfeiture
experience. The effect of adjusting the forfeiture rate is
recognized in the period the forfeiture estimate is
changed.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-39</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stock Option Activity</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company had the following stock option transactions during the
six months ended March 31, 2019:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
October 31, 2018, the Board awarded stock option grants to two
directors to acquire 50,000 shares each of the Company&#x2019;s
common stock. The grants were valued at $3.03 per share and expire
on October 31, 2013. The grants vested immediately.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
October 31, 2018, the Board awarded Phillip A. Bosua a stock option
grant to acquire 100,000 shares of the Company&#x2019;s Common stock
for each $1,000,000 raised by the Company in revenue generated in a
planned Kickstarter campaign. In addition, Mr. Bosua was granted a
stock option grant to acquire 1,000,000 shares of the
Company&#x2019;s common which vests upon approval of the
Company&#x2019;s blood glucose measurement technology by the U.S.
Food and Drug Administration. The grants were valued at $3.03 per
share and expire on October 31, 2023.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
October 31, 2018, the Board awarded Ronald P Erickson a stock
option grant to acquire 1,000,000 shares of the Company&#x2019;s
common which vests upon the Company&#x2019;s successful listing of
its Common Stock on Nasdaq or the New York Stock Exchange
(including the NYSE American Market). The grant was valued at $3.03
per share and expires on October 31, 2023.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 26, 2019, the Board awarded an employee a stock option grant
to acquire 10,000 shares of the Company&#x2019;s Common stock for
each $1,000,000 raised by the Company in revenue generated in a
planned Kickstarter campaign. In addition, the employee was granted
a stock option grant to acquire 130,000 shares of the
Company&#x2019;s common which vests upon approval of the
Company&#x2019;s blood glucose measurement technology by the U.S.
Food and Drug Administration. The grants were valued at $1.50 per
share and expire on March 26, 2024.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 26, 2019, the Board awarded an employee a stock option grant
to acquire 10,000 shares of the Company&#x2019;s Common stock for
each $1,000,000 raised by the Company in revenue generated in a
planned Kickstarter campaign. In addition, the employee was granted
a stock option grant to acquire 130,000 shares of the
Company&#x2019;s common which vests upon approval of the
Company&#x2019;s blood glucose measurement technology by the U.S.
Food and Drug Administration. The grants were valued at $1.50 per
share and expire on March 26, 2024.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
There are currently 2,282,668 options to purchase common stock at
an average exercise price of $1.757 per share outstanding as of
March 31, 2019 under the 2011 Stock Incentive Plan. The Company
recorded $263,145 and $7,334 of compensation expense, net of
related tax effects, relative to stock options for the six months
ended March 31, 2019 and 2018 and in accordance with ASC 505. Net
loss per share (basic and diluted) associated with this expense was
approximately ($0.010) and ($0.000) per share, respectively. As of
March 31, 2019, there is approximately $1,606,089, net of
forfeitures, of total unrecognized costs related to employee
granted stock options that are not vested. These costs are expected
to be recognized over a period of approximately 4.69
years.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Stock option activity for the three months ended March 31, 2019 was
as follows:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:55%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; padding-bottom: 2px; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;Weighted
Average</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:55%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;Options</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;Exercise
Price</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold; font-size: 11px;">
<div><font style="font-family: Times New Roman; font-weight: bold;">$</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:55%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Outstanding as of
September 30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">2,182,668</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.698</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3,706,519</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:55%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Granted</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3.030</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">303,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:55%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Exercised</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:55%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Forfeitures</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td colspan="1" style="vertical-align:bottom;width:55%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Outstanding as of
March 31, 2019</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:double 4px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:double 4px #000000;">2,282,668</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.757</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4,009,519</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-40</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following table summarizes information about stock options
outstanding and exercisable as of March 31, 2019:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="font-size: 11px; font-family: Times New Roman; font-weight: bold;">
&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Weighted</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Weighted</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Weighted</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-size: 11px; font-family: Times New Roman; font-weight: bold;">
&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Average</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Average</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; font-weight: bold;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Average</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:14%;">
<div style="text-align: center"><font style="font-weight: bold; font-size: 11px;"><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Range of</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Number</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Remaining Life</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exercise Price</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Number</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exercise Price</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 14%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: center"><font style="font-weight: bold; font-size: 11px;"><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exercise Prices</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Outstanding</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
In Years</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exerciseable</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exerciseable</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="font-weight: bold; font-size: 11px;"><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-weight: bold;">
<div><font style="font-family: Times New Roman; color: rgb(0, 0, 0); font-weight: bold;">
Exerciseable</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font></font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div style="text-align: center"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">
</font><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">0.25</font><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">530,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.61</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">99,375</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.25</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div style="text-align: center"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">
1.28</font><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,150,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.71</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.28</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">143,750</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1.28</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div style="text-align: center"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">
3.03</font><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.71</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3.03</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">3.03</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:14%;">
<div style="text-align: center"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">
4.08-4.20</font><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">500,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.73</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.08-4.20</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">31,250</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4.08-4.20</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:14%;">
<div style="text-align: center"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">
13.500</font><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">0.38</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13.50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13.50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align: bottom; width: 14%;">
<div style="text-align: center; padding-bottom: 2px;">
<div style="text-align: center"><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">
15.000</font><font style="color: rgb(0, 0, 0); font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,334</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15.00</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15.00</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align: bottom; width: 14%;">
<div style="text-align: center; padding-bottom: 4px;">
<div style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,282,668</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">4.69</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1.757</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">375,709</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:14%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1.755</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
There were stock option grants of 530,000 shares as of March 31,
2019 with an aggregate intrinsic value of $535,300.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
14.</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Related Party Transactions with Ronald P. Erickson</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
See Notes 10 and 13 for related party transactions with Ronald P.
Erickson.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Mr. Erickson and/or entities with which he is affiliated also have
accrued compensation, travel and interest of approximately $478,861
as of March 31, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Related Party Transaction with Phillip A. Bosua</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
See Note 13 for related party transactions with Phillip A.
Bosua.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stock Option Grants to Directors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
See Note 13 for related party transactions with
Directors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
15.</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Legal Proceedings</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company may from time to time become a party to various legal
proceedings arising in the ordinary course of our business. The
Company is currently not a party to any pending legal proceeding
that is not ordinary routine litigation incidental to our
business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Properties and Operating Leases</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company is obligated under the following non-cancelable
operating leases for its various facilities and certain
equipment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:85%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Years Ended March
31,</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;"><font style="font-weight: bold"><font style="font-size: 11px">Total</font></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:85%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">2020</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">187,652</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:85%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">2021</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">196,526</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:85%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">2022</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">5,816</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:85%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">2023</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:85%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">2024</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:85%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Beyond</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:85%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total</font></div>
</td>
<td style="vertical-align:bottom;width:15%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">389,994</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">F-41</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Corporate Offices</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On April 13, 2017, the Company leased its executive office located
at 500 Union Street, Suite 810, Seattle, Washington, USA, 98101.
The Company leases 943 square feet and the net monthly payment is
$2,672. The monthly payment increases approximately 3% each year
and the lease expires on May 31, 2022.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-style: italic; font-family: Times New Roman; font-size: 13px">
Lab Facilities and Executive Offices</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 1, 2018, the Company leased its lab facilities and executive
offices located at 304 Alaskan Way South, Suite 102, Seattle,
Washington, USA, 98101. The Company leases 2,800 square feet and
the net monthly payment is $4,000. The lease expired on April 30,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
February 1, 2019, the Company leased its lab facilities and
executive offices located at 915 E Pine Street, Suite 212, Seattle,
WA 98122. The Company leases 2,642 square feet and the net monthly
payment is $8,256. The monthly payment increases approximately 3%
on July 1, 2019 and annually thereafter. The lease expires on June
30, 2021 and can be extended.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
TransTech Facilities</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
TransTech is located at 12142 NE Sky Lane, Suite 130, Aurora, OR
97002. TransTech leases a total of approximately 6,340 square feet
of office and warehouse space for its administrative offices,
product inventory and shipping operations. Effective December 1,
2017, TransTech leases this office from December 1, 2017 at $4,465
per month. The monthly payment increases approximately 3% each year
and the lease expires on January 31, 2020. Until December 1, 2017,
TransTech leased this office on a month to month basis at $6,942
per month. TransTech terminated this lease effective May 31,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">16.</font>&#xA0;&#xA0;&#xA0;<font style="color: #000000">SUBSEQUENT EVENTS</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company evaluates subsequent events, for the purpose of
adjustment or disclosure, up through the date the financial
statements are available. Subsequent to March 31, 2019, there were
the following material transactions that require
disclosure:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Convertible Promissory Notes with Clayton A. Struve</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
As of March 31, 2019, the Company owes Clayton A. Struve $1,071,000
under convertible promissory or OID notes. The Company recorded
accrued interest of $58,411 as of March 31, 2019.</font> On May 8,
2019, the Company signed Amendment 2 to the convertible promissory
or OID notes, extending the due dates to September 30,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Convertible Redeemable Promissory Notes with Ronald P. Erickson and
J3E2A2Z</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
March 16, 2018, the Company entered into a Note and Account Payable
Conversion Agreement pursuant to which (a) all $664,233 currently
owing under the J3E2A2Z Notes was converted to a Convertible
Redeemable Promissory Note in the principal amount of $664,233, and
(b) all $519,833 of the J3E2A2Z Account Payable was converted into
a Convertible Redeemable Promissory Note in the principal amount of
$519,833 together with a warrant to purchase up to 1,039,666 shares
of common stock of the Company for a period of five years.
<font style="color: #000000">The initial exercise price of the
warrants described above is $0.50 per share, also subject to
certain adjustments. The warrants were valued at $110,545. Because
the note is immediately convertible, the warrants and beneficial
conversion were expensed as interest. The Company recorded accrued
interest of $41,361 as of March 31, 2019.</font> On May 8, 2019,
the Company signed Amendment 1 to the convertible redeemable
promissory notes, extending the due dates to September 30, 2019 and
increasing the interest rate to 6%.</font></div>
<br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: center; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;<font style="font-size: 13px">F-42</font></font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
PROSPECTUS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INC.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
500 Union Street, Suite 810</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Seattle, WA 98101</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
4,242,515 shares of common stock issuable upon conversion of the
Principal of the Notes;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
339,401 shares of common stock issuable upon
conversion of Interest on the Notes;</font> </div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
&#xA0;2,121,258 shares of common stock issuable upon exercise of
Investor Warrants;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
542,102 shares of common stock issuable upon exercise of Placement
Agent Warrants;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
3,108,356 shares of common stock issuable upon conversion of Series
D Preferred Stock; and</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
3,984,000 shares of common stock issuable upon exercise of Series F
Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
DEALER PROSPECTUS DELIVERY OBLIGATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Until _______________, 2019, all dealers that effect transactions
in these securities, whether or not participating in this offering,
may be required to deliver a prospectus. This is in addition to the
dealers' obligation to deliver a prospectus when acting as
underwriters and with respect to their unsold allotments or
subscriptions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
____________________, 2019</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">71</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
PART II&#x2014;INFORMATION NOT REQUIRED IN PROSPECTUS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ITEM 13.&#xA0;&#xA0;&#xA0;&#xA0;OTHER EXPENSES OF ISSUANCE AND
DISTRIBUTION.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The expenses payable by us in connection with the issuance and
distribution of the securities being registered other than
underwriting discounts and commissions, if any are set forth below.
Each item listed is estimated as follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family:inherit;margin-right:0px;margin-left:0px;width:100%;font-size:inherit;">
<tr style="background-color:#cceeff;">
<td rowspan="1" style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Securities
and Exchange Commission registration fee</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,157</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accountant's
fees and expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Legal
fees and expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">15,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Blue
Sky fees and expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Transfer
agent's fees and expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Miscellaneous</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">7,843</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">35,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ITEM 14.&#xA0;&#xA0;&#xA0;&#xA0;INDEMNIFICATION OF DIRECTORS AND
OFFICERS.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Nevada
Revised Statutes, or NRS, Sections&#xA0;78.7502 and 78.751 provide
us with the power to indemnify any of our directors and officers.
The director or officer must have conducted himself/herself in good
faith and reasonably believe that his/her conduct was in, or not
opposed to, our best interests. In a criminal action, the director,
officer, employee or agent must not have had reasonable cause to
believe his/her conduct was unlawful.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Under
NRS Section&#xA0;78.751, advances for expenses may be made by
agreement if the director or officer affirms in writing that he/she
believes he/she has met the standards and will personally repay the
expenses if it is determined such officer or director did not meet
the standards.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
articles of incorporation include an indemnification provision
under which we have the power to indemnify our directors, officers,
employees and other agents of the company to the fullest extent
permitted by applicable law.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have a directors&#x2019; and officers&#x2019; liability insurance
policy in place pursuant to which its directors and officers are
insured against certain liabilities, including certain liabilities
under the Securities Act of 1933, as amended and the Securities and
Exchange Act of 1934, as amended.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
underwriting agreement we will enter into in connection with the
offering of common stock and warrants being registered hereby
provides that the underwriters will indemnify, under certain
conditions, our directors and officers (as well as certain other
persons) against certain liabilities arising in connection with
such offering.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ITEM 15.&#xA0;&#xA0;&#xA0;&#xA0;RECENT SALES OF UNREGISTERED
SECURITIES.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In the three years preceding the filing of this Registration
Statement, we have issued the following securities that were not
registered under the Securities Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
All of the offerings and sales described below were deemed to be
exempt under Rule 506 of Regulation D and/or Section 4(a)(2) of the
Securities Act. No advertising or general solicitation was employed
in offering the securities, the offerings and sales were made to a
limited number of persons, all of whom were accredited investors
and transfer was restricted by the company in accordance with the
requirements of Regulation D and the Securities Act. All issuances
to accredited and non-accredited investors were structured to
comply with the requirements of the safe harbor afforded by Rule
506 of Regulation D, including limiting the number of
non-accredited investors to no more than 35 investors who have
sufficient knowledge and experience in financial and business
matters to make them capable of evaluating the merits and risks of
an investment in our securities. We have not employed any
underwriters in connection with any of the below transactions, and
the individuals and entities to whom we issued securities are not
affiliated with us. Except as noted below, none of the holders of
the securities have any contractual rights to have such securities
registered with the Securities and Exchange
Commission.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">72</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Year Ended September 30, 2017</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On October 21, 2015, we entered into a Public Relations Agreement
with Financial Genetics LLC for public relation</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
services. On October 18, 2016, we entered into an Amendment to
Public Relations Agreement with Financial Genetics LLC. Under the
Agreements, Financial Genetics was issued 359,386 shares of our
common stock during the year ended September 30, 2017. We expensed
$271,309 during the year ended September 30, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On October 6, 2016, we entered into a Services Agreement with
Redwood Investment Group LLC for financial services. Under the
Agreement, Redwood was issued 200,000 shares of our common stock.
We expensed $140,000 during the year ended September 30,
2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We entered into Convertible Promissory Notes totaling $710,000 with
accredited investors during September 2015 to February 2016 to fund
short-term working capital. The Notes accrued interest at a rate of
8% per annum and became due September 2016 to February 2017 and
were convertible into common stock as part of our next financing.
On November 30, 2016, we converted $695,000 of the /Convertible
Promissory Notes and interest of $54,078 into 936,348 shares of
comment stock. We also issued warrants to purchase 936,348 shares
of our common stock. The five-year warrants are exercisable at
$1.00 per share, subject to adjustment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 22, 2016, a supplier converted accounts payable
totaling $6,880 into 8,600 shares of common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On the year ended September 30, 2017, we issued 795,000 shares of
restricted common stock to two Named Executive Officers employees,
two directors and six employees and consultants and for services
during 2015-2017. The shares were issued in accordance with the
2011 Stock Incentive Plan and were valued at $0.17 per share, the
market price of our common stock. We expensed $135,150 during the
year ended September 30, 2017.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Year Ended September 30, 2018</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We issued 779,676 shares of common stock to Names Executive
Officers, directors, employees and consultants and for services
during the year ended September 30, 2018. We expensed
$273,068.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
April 10, 2018, we issued 2,000,000 shares of our common stock to
Phillip A. Bosua under the terms of the Merger Agreement with RAAI
common stock. The shares were valued at the fair market value of
$520,000 or $0.26 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On June 25, 2018, we closed a private placement and received gross
proceeds of $1,750,000 ($1,710,000 as of June 30, 2018) in exchange
for issuing 7,000,000 (6,840,000 as of June 30, 2018) shares of
common stock and warrants to purchase 3,500,000 (3,420,000 as of
June 30, 2018) shares of common stock in a private placement to
accredited investors pursuant to a series of substantially
identical subscription agreements. The initial exercise price of
the warrants described above is $0.25 per share, subject to certain
adjustments, and they expired five years after their issuance. The
shares and the warrants described above were issued in transactions
that were not registered under the Securities Act of 1933, as
amended (the &#x201C;Act&#x201D;) in reliance upon applicable
exemptions from registration under Section 4(a)(2) of the Act
and/or Rule 506 of SEC Regulation D under the Act.
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On June
25, 2018, we issued 500,000 shares of our common stock to Phillip
A. Bosua under the terms of an Employment agreement dated April 10,
2018. The shares were valued at the fair market value of $165,000
or $0.33 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We closed debt conversions and issued 1,600,000 shares of common
stock in exchange for the conversion of $464,000, 230,000 shares in
exchange for $48,300 in legal services and 605,000 shares in for
$199.935 in preexisting debt owed by the Company to certain service
providers, all of whom are accredited investors. These shares were
issued in transactions that were not registered under the Act in
reliance upon applicable exemptions from registration under Section
4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the
Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">73</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the year ended September 30, 2018, we issued 158,000 shares
of our common stock related to warrant exercises that were valued
at $80,128.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 23, 2018, we issued 3,334 shares of our common stock
related to the conversion of Series A Preferred Stock for
$834.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Subsequent to the Year Ended September 30, 2018</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the six months ended March 31, 2019, we issued 336,427
shares of common stock and cancelled warrants to purchase 26,573
shares of common stock at $0.25 per share to two consultants and
two investors related to the cashless exercise of
warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the six months ended March 31, 2019, we issued 145,000
shares of common stock for services provided by two consultants.
The shares were valued at $246,900 or $1.703 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On January 2, 2019, we issued 100,000 shares of common stock for
services provided to Ronald P. Erickson. The shares were valued at
$102,000 or $1.02 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
January 29, 2019, a holder of Series A Preferred Stock converted
20,000 shares into 80,000 shares of common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Private Placement</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 4, 2019, the we closed rounds one and two of a private
placement and received gross proceeds of $2,409,975 in exchange for
issuing Subordinated Convertible Notes and Warrants in a private
placement to 26 accredited investors, pursuant to a series of
substantially identical Securities Purchase Agreements, Common
Stock Warrants, and related documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On March 18, 2019, we closed round three of a private placement and
received gross proceeds of $1,400,000 in exchange for issuing
Subordinated Convertible Notes and Warrants in a private placement
to 8 accredited investors, pursuant to a series of substantially
identical Securities Purchase Agreements, Common Stock Warrants,
and related documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 15, 2019, we closed rounds four, five and six of a private
placement and received gross proceeds of $407,490 in exchange for
issuing Subordinated Convertible Notes and Warrants in a private
placement to 2 accredited investors, pursuant to a series of
substantially identical Securities Purchase Agreements, Common
Stock Warrants, and related documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On May 28, 2019, we closed round seven of a private placement and
received gross proceeds of $25,000 in exchange for issuing
Subordinated Convertible Notes and Warrants in a private placement
to one accredited investor, pursuant to a series of substantially
identical Securities Purchase Agreements, Common Stock Warrants,
and related documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Convertible Notes have a principal amount of $4,242,515 and
bear annual interest of 8%. Both the principal amount of and the
interest are payable on a payment-in-kind basis in shares of Common
Stock of the Company. They are due and payable in common stock on
the earlier of (a) mandatory and automatic conversion of the
Convertible Notes into a financing that yields gross proceeds of at
least $10,000,000 or (b) on the one-year anniversary of the
Convertible Notes. Investors will be required to convert their
Convertible Notes into Common Stock in any $10,000,000 financing at
a conversion price per share equal to the lower of (i) $1.00 per
share or (ii) a 25% discount to the price per share paid by
investors in the $10,000,000 Financing. If the Convertible Notes
have not been paid or converted prior to the Maturity Date, the
outstanding principal amount of the Convertible Notes will be
automatically converted into shares of Common Stock at the lesser
of (a) $1.00 per share or (b) any adjusted price resulting from the
application of a &#x201C;most favored nations&#x201D; provision,
which requires the issuance of additional shares of Common Stock to
investors if the Company issues certain securities at less than the
then-current conversion price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Warrants were granted on a 1:0.5 basis (one-half Warrant for each
full share of Common Stock into which the Convertible Notes are
convertible). The Warrants have a five-year term and an exercise
price equal to 120% of the per share conversion price of the
Qualified Financing or other mandatory conversion.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">74</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Convertible Notes are initially convertible into 4,242,515 shares
of Common Stock, subject to certain adjustments, and the Warrants
are initially exercisable for 2,121,258 shares of Common Stock at
an exercise price of $1.20 per share of Common Stock, also subject
to certain adjustments.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
connection with the private placement, the placement agent for the
Convertible Notes and the Warrants received a cash fee of $361,401
and warrants to purchase 542,102 shares of the Company&#x2019;s
common stock, all based on 8% of gross proceeds to the Company. The
placement agent has also received a $25,000 advisory
fee.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ITEM 16.&#xA0;&#xA0;&#xA0;&#xA0;EXHIBITS AND FINANCIAL STATEMENT
SCHEDULES.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
exhibits to the Registration Statement are listed in the Exhibit
Index attached hereto and incorporated by reference
herein.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ITEM 17.&#xA0;&#xA0;&#xA0;&#xA0;UNDERTAKINGS.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The undersigned registrant hereby undertakes:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(1)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;To file, during
any period in which offers or sales are being made, a
post-effective amendment to this Registration
Statement:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(i)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;To
include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(ii)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;To
reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form
of prospectus filed with the Commission pursuant to Rule 424(b) if,
in the aggregate, the changes in volume and price represent no more
than 20% change in the maximum aggregate offering price set forth
in the &#x201C;Calculation of Registration Fee&#x201D; table in the
effective registration statement;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(iii)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;To
include any material information with respect to the plan of
distribution not previously disclosed in the registration statement
or any material change to such information in the registration
statement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(2)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;That, for the
purpose of determining any liability under the Securities Act of
1933, each such post-effective amendment shall be deemed to be a
new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(3)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;To remove from
registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination
of the offering.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
(4)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;That, for the
purpose of determining liability of the registrant under the
Securities Act of 1933 to any purchaser in the initial distribution
of the securities: The undersigned registrant undertakes that in a
primary offering of securities of the undersigned registrant
pursuant to this registration statement, regardless of the
underwriting method used to sell the securities to the purchaser,
if the securities are offered or sold to such purchaser by means of
any of the following communications, the undersigned registrant
will be a seller to the purchaser and will be considered to offer
or sell such securities to such purchaser:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(i)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Any
preliminary prospectus or prospectus of the undersigned registrant
relating to the offering required to be filed pursuant to Rule
424;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">75</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(ii)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Any
free writing prospectus relating to the offering prepared by or on
behalf of the undersigned registrant or used or referred to by the
undersigned registrant;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(iii)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;
The portion of any other free writing prospectus relating to the
offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the
undersigned registrant; and</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(iv)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;
Any other communication that is an offer in the offering made by
the undersigned registrant to the purchaser.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that, in
the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the
Securities Act of 1933and is, therefore, unenforceable. In the
event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or
paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in
connection with the securities being registered, the Registrant
will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act of 1933
and will be governed by the final adjudication of such
issue.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
(5)</font>&#xA0;&#xA0;&#xA0; &#xA0;&#xA0;&#xA0; For purposes of
determining any liability under the Securities Act of 1933, the
information omitted from the form of prospectus filed as part of
this registration statement in reliance upon Rule 430A and
contained in a form of prospectus filed by the registrant pursuant
to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall
be deemed to be part of this registration statement as of the time
it was declared effective.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
(6)</font>&#xA0;&#xA0;&#xA0; &#xA0;&#xA0;&#xA0; For the purpose of
determining any liability under the Securities Act of 1933, each
post-effective amendment that contains a form of prospectus shall
be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering
thereof.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">76</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SIGNATURES</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Pursuant to the requirements of the Securities Act of 1933, as
amended, the registrant certifies that it has reasonable grounds to
believe that it meets all of the requirements for filing on Form
S-1/A and has duly caused this Registration Statement
to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Seattle, State of Washington, on
September 19, 2019.</font> </div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: middle; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: middle; width: 49%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
KNOW LABS, INC.</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 41%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
By:</font></div>
</td>
<td style="vertical-align: top; width: 41%; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
/s/ Ronald P. Erickson</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 41%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Ronald P. Erickson</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Chairman of the Board</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 41%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
By:</font></div>
</td>
<td style="vertical-align: top; width: 41%; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
/s/ Ronald P. Erickson</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 41%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Interim Chief Financial Officer</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;<br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Pursuant to the requirements of the Securities Act of 1933, as
amended, this registration statement has been signed by the
following persons in the capacities and on the dates
indicated.</font><br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;<br>
</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit; margin: 0px auto 0px 0px; width: 100%;">
<tr>
<td rowspan="1" style="vertical-align: top; padding-bottom: 2px; width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Signature</font></div>
</td>
<td rowspan="1" style="vertical-align: top; padding-bottom: 2px; width: 1%;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: top; padding-bottom: 2px; width: 58%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Title</font></div>
</td>
<td rowspan="1" style="vertical-align: top; padding-bottom: 2px; width: 1%;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align: top; width: 15%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Date</font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 25%; border-bottom: 2px solid black;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">/s/&#xA0;
<font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua</font></font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Chief
Executive Officer and Director</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 15%; white-space: nowrap;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">September
19, 2019<br></font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">(Principal
Executive Officer)<br></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 25%; border-bottom: 2px solid black;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">/s/&#xA0;
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ronald
P. Erickson</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Chairman
of the Board and Interim Chief Financial Officer <br>
</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 15%; white-space: nowrap;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman">September
19</font>, 2019</font></font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ronald
P. Erickson</font></font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">(Principal
Financial/Accounting Officer)</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 25%; border-bottom: 2px solid black;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">/s/&#xA0;
<font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Jon
Pepper</font></font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Director</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 15%; white-space: nowrap;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman">September
19</font>, 2019</font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Jon
Pepper</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit; margin: 0px auto 0px 0px; width: 100%;">
<tr>
<td style="width: 25%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 25%; border-bottom: 2px solid black;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">/s/&#xA0;
<font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ichiro
Takesako</font></font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Director</font></font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 15%; white-space: nowrap;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman">September
19</font>, 2019</font></font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ichiro
Takesako</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 25%; border-bottom: 2px solid black;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">/s/&#xA0;
<font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">William
A. Owens</font></font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Director</font></font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 15%; white-space: nowrap;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-size: 13px; font-family: Times New Roman">September
19</font>, 2019</font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">William
A. Owens</font></font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="width: 25%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 58%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 1%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 15%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: center; width: 100%"><font style="font-family: Times New Roman; font-size: 11px"><font style="font-size: 13px"><br></font></font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">77</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit Index</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman"><br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; padding-top: 0px; padding-bottom: 0px; margin-left: 0px; margin-right: auto; width: 100%;">
<tr>
<td style="vertical-align: top; width: 10%; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Exhibit
No.</font></div>
</td>
<td style="vertical-align: top; width: 90%; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Description</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169713000682/ex_3-1.htm">
<font style="vertical-align: bottom">3.1&#xA0;</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169713000682/ex_3-1.htm">
<font style="vertical-align: bottom">Restatement of the Articles of
Incorporation dated September 13, 2013 (incorporated by reference
to the Company&#x2019;s Current Report on Form 8-K/A2, filed
September 17, 2013)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169712000639/ex_3-1.htm">
<font style="vertical-align: bottom">3.2&#xA0;</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169712000639/ex_3-1.htm">
<font style="vertical-align: bottom">Amended and Restated Bylaws
(incorporated by reference to the Company&#x2019;s Form 8-K, filed
August 17, 2012)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000119983515000262/exhibit_3-1.htm">
<font style="vertical-align: bottom">3.3</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000119983515000262/exhibit_3-1.htm">
<font style="vertical-align: bottom">Certificate of Amendment to
the Restatement of the Articles of Incorporation dated June 11,
2015 (incorporated by reference to the Company&#x2019;s Current
Report on Form 8-K, filed June 17, 2015)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169715000318/ex_3-1.htm">
<font style="vertical-align: bottom">3.4&#xA0;</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169715000318/ex_3-1.htm">
<font style="vertical-align: bottom">Amended and Restated
Certificate of Designations, Preferences and Rights of the
Company&#x2019;s Series A Convertible Preferred Stock dated July 21,
2015 (incorporated by reference to the Company&#x2019;s Current
Report on Form 8-K, filed July 29, 2015)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169716000728/ex_3-1.htm">
<font style="vertical-align: bottom">3.5</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169716000728/ex_3-1.htm">
<font style="vertical-align: bottom">Correction to Amended and
Restated Certificate of Designations, Preferences and Rights of its
Series A Convertible Preferred Stock dated March 8, 2016
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed March 15, 2016)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169716000728/ex_3-2.htm">
<font style="vertical-align: bottom">3.6</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169716000728/ex_3-2.htm">
<font style="vertical-align: bottom">Amendment 2 of Series A
Preferred Stock Terms dated February 19, 2016 (incorporated by
reference to the Company&#x2019;s Current Report on Form 8-K, filed
March 15, 2016)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169716001036/ex_10-4.htm">
<font style="vertical-align: bottom">3.7</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169716001036/ex_10-4.htm">
<font style="vertical-align: bottom">Certificate of Designations,
Preferences and Rights of Series C Convertible Preferred Stock
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed August 11, 2016)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495416001959/exhibit_3-11.htm">
<font style="vertical-align: bottom">3.8</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495416001959/exhibit_3-11.htm">
<font style="vertical-align: bottom">Form of Series C Convertible
Preferred Stock 2016 (incorporated by reference to the
Company&#x2019;s Registration Statement on Form S-1, filed September
1, 2016)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000028/ex_10-4.htm">
<font style="vertical-align: bottom">3.9</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000028/ex_10-4.htm">
<font style="vertical-align: bottom">Certificate of Correction and
Certificate of Designations, Preferences and Rights of Series C
Convertible Preferred Stock (incorporated by reference to the
Company&#x2019;s Amended Current Report on Form 8-K/A, filed January
9, 2017)</font></a></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: center; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0; <font style="font-family: Times New Roman; font-size: 11px"><font style="font-size: 13px"><br></font></font></font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">78</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; padding-top: 0px; padding-bottom: 0px; margin-left: 0px; margin-right: auto; width: 100%;">
<tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000098/ex_3-1.htm">
<font style="vertical-align: bottom">3.10</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000098/ex_3-1.htm">
<font style="vertical-align: bottom">Certificate of Designations,
Preferences and Rights of Series D Convertible Preferred Stock
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed on February 10, 2017)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417004136/exhibit_10-4.htm">
<font style="vertical-align: bottom">3.11</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417004136/exhibit_10-4.htm">
<font style="vertical-align: bottom">Amended and Restated
Certificate of Designations, Preferences and Rights of Series D
Convertible Preferred Stock. (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed May 5,
2017)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000377/ex_10-1.htm">
<font style="vertical-align: bottom">3.12</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000377/ex_10-1.htm">
<font style="vertical-align: bottom">Second Amended and Restated
Certificate of Designations, Preferences and Rights of Series D
Convertible Preferred Stock&#xA0;(incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed July 19,
2018)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000234/ex_3-1.htm">
<font style="vertical-align: bottom">3.13</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000234/ex_3-1.htm">
<font style="vertical-align: bottom">Articles of Merger
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed May 3, 2018)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000377/ex_10-1.htm">
<font style="vertical-align: bottom">3.14</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000377/ex_10-1.htm">
<font style="vertical-align: bottom">Second Amended and Restated
Certificate of Designations, Preferences and Rights of Series D
Convertible Preferred Stock (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed July 20,
2018)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000395/ex_10-1.htm">
<font style="vertical-align: bottom">3.15</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000395/ex_10-1.htm">
<font style="vertical-align: bottom">Certificate of Designation of
Series F Preferred Stock (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed August 3,
2018)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000119983513000014/visualant_def14a-15407.htm">
<font style="vertical-align: bottom">4.1&#xA0;</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000119983513000014/visualant_def14a-15407.htm">
<font style="vertical-align: bottom">2011 Stock Incentive Plan
(incorporated by reference to the Company&#x2019;s Definitive Proxy
Statement on Schedule 14A, filed January 11, 2013)</font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="knwn_ex51.htm"><font style="vertical-align: bottom">5.1<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="knwn_ex51.htm"><font style="vertical-align: bottom"><font style="vertical-align: bottom">Opinion of Horowitz + Armstrong, A
Professional Law Corporation (filed
herewith)</font><br></font></a></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom"><font style="vertical-align: bottom">&#xA0;</font> &#xA0;<br></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417004136/exhibit_10-1.htm">
<font style="vertical-align: bottom">10.1&#xA0;<br></font></a></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417004136/exhibit_10-1.htm">
<font style="vertical-align: bottom"><font style="vertical-align: bottom"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">Form of Preferred Stock and Warrant Purchase
Agreement</font> <font style="font-size: 13px;">by and between
Visualant, Incorporated and Clayton A. Struve</font> <font style="font-size: 13px">(incorporated by reference to the Company&#x2019;s
Current Report on Form 8-K, filed May 5,
2017</font></font>&#xA0;</font><br></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom"><font style="vertical-align: bottom">&#xA0;</font> &#xA0;<br></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417004136/exhibit_10-2.htm">
<font style="vertical-align: bottom">10.2&#xA0;<br></font></a></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417004136/exhibit_10-2.htm">
<font style="vertical-align: bottom"><font style="vertical-align: bottom"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">Form of
Amended and Restated Registration Rights Agreement. by and between
Visualant, Incorporated and Clayton A. Struve (incorporated by
reference to the Companys Current Report on Form 8-K, filed May 5,
2017)</font></font>&#xA0;</font><br></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom"><font style="vertical-align: bottom">&#xA0;</font> &#xA0;<br></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417004136/exhibit_10-3.htm">
<font style="vertical-align: bottom">10.3&#xA0;<br></font></a></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417004136/exhibit_10-3.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">Form of Series F Warrant to Purchase Common
Stock</font><font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">by and between Visualant, Incorporated and
<font style="font-family: Times New Roman; font-size: 13px">Clayton
A. Struve (incorporated by reference to the Company&#x2019;s Current
Report on Form 8-K, filed&#xA0; <font style="font-family: Times New Roman; font-size: 13px">May 5,
2017)</font></font></font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="color: #000000; font-size: 13px">&#xA0; <font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">&#xA0;</font> &#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000373/ex_10-1.htm">
<font style="vertical-align: bottom">10.4&#xA0;<br></font></a></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000373/ex_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Securities
Purchase Agreement dated August 14, 2017 by and between Visualant,
Incorporated and <font style="font-family: Times New Roman; font-size: 13px">accredited investor
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K,&#xA0; <font style="font-family: Times New Roman; font-size: 13px">filed August 18,
2017</font></font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000562/ex_10-2.htm">
<font style="vertical-align: bottom">10.5&#xA0;<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000562/ex_10-2.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px">Senior Secured
Convertible Redeemable Debenture dated December 12, 2017 by and
between Visualant, Incorporated and accredited investor.
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed December 22, 2017)</font>&#xA0;</font><font style="font-size: 13px;"><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000373/ex_10-3.htm">
<font style="vertical-align: bottom">10.6&#xA0;<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000373/ex_10-3.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px">General Security
Agreement dated December 12, 2017 by and between Visualant,
Incorporated and accredited investor (incorporated by reference to
the Company&#x2019;s Current Report on Form 8-K, filed August 18,
2017)</font></font><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000562/ex_10-4.htm">
<font style="vertical-align: bottom">10.7&#xA0;<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000562/ex_10-4.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
Purchase Warrant dated December 12, 2017 issued by Visualant,
Incorporated to accredited investor. (incorporated by reference to
the Company&#x2019;s Current Report on Form 8-K, filed December 22,
2017)</font></font> <font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000562/ex_10-5.htm">
<font style="vertical-align: bottom">10.8&#xA0;<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169717000562/ex_10-5.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px">Schedule A to
Subordination Agreement dated December 12, 2017 by and between an
entity affiliated with Ronald P. Erickson and accredited investor.
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed December 22, 2017)</font></font><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000114/ex_10-2.htm">
<font style="vertical-align: bottom">10.9&#xA0;<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000114/ex_10-2.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px">Senior Secured
Convertible Redeemable Debenture dated February 28, 2018 by and
between Visualant, Incorporated and accredited investor.
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed March 7, 2018)</font></font> <font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000114/ex_10-4.htm">
<font style="vertical-align: bottom">10.10&#xA0;<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000114/ex_10-4.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
Purchase Warrant dated February 28, 2018 issued by Visualant,
Incorporated to accredited investor. (incorporated by reference to
the Company&#x2019;s Current Report on Form 8-K, filed March 7,
2018)</font></font> <font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417011929/exhibit_10-23.htm">
<font style="vertical-align: bottom">10.11&#xA0;<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495417011929/exhibit_10-23.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">C<font style="font-family: Times New Roman; font-size: 13px">onsulting and
Services Agreement dated July 6, 2017 amongst Visualant,
Incorporated, Blaze, Inc. and Phillip A. Bosua (incorporated by
reference to the Company&#x2019;s Form 10-K filed on December 29,
2017)</font></font><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-1.htm">
<font style="vertical-align: bottom">10.12&#xA0;<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px">Note and Account
Payable Conversion Agreement dated January 31, 2018 by and between
Visualant, Incorporated and J3E2A2Z LP (incorporated by reference
to the Company&#x2019;s Current Report on Form 8-K, filed March 21,
2018)</font></font><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="vertical-align: bottom">&#xA0;<br></font></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;">
&#xA0;</font> <font style="font-size: 13px">&#xA0;</font><font style="font-size: 13px;">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0; &#xA0;
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></font></font></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-2.htm">
<font style="vertical-align: bottom">10.13<br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-2.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px">Convertible
Redeemable Promissory Note dated January 31, 2018 by and between
Visualant, Incorporated and J3E2A2Z LP (incorporated by reference
to the Company&#x2019;s Current Report on Form 8-K, filed March 21,
2018)</font></font><font style="font-size: 13px;"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-3.htm">
<font style="vertical-align: bottom"><br></font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-3.htm">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px"></font><font style="color: #000000; font-size: 13px"><font style="font-family: Times New Roman; font-size: 13px"></font><br>
</font></font></a></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-3.htm">
<font style="vertical-align: bottom">10.14</font></a></div>
</td>
<td style="vertical-align: top; width: 90%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-3.htm">
<font style="vertical-align: bottom"><font style="font-family: Times New Roman; font-size: 13px">Convertible
Redeemable Promissory Note for Accounts Payable dated January 31,
2018 by and between Visualant, Incorporated and J3E2A2Z LP
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed March 21, 2018)</font><br></font></a></div>
</td>
</tr></table>
</div>
<div style="margin-left: 0px; margin-right: 0px;">
<font>&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: center; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0; <font style="font-family: Times New Roman; font-size: 11px"><font style="font-size: 13px"><br></font></font></font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">79</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="margin-left: 0px; margin-right: 0px;"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-5.htm">
<font>10.15<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-5.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Common
Stock Purchase Warrant dated January 31, 2018 by and between
Visualant, Incorporated and Ronald P. Erickson (incorporated by
reference to the Company&#x2019;s Current Report on Form 8-K, filed
March 21, 2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-4.htm">
<font>10.16<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000142/ex_10-4.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Common
Stock Purchase Warrant dated January 31, 2018 by and between
Visualant, Incorporated and J3E2A2ZLP (incorporated by reference to
the Company&#x2019;s Current Report on Form 8-K, filed March 21,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495418014237/exhibit_10-20.htm">
<font>10.17<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495418014237/exhibit_10-20.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Employment
Agreement dated April 10, 2018 by and between Visualant,
Incorporated and Phillip A. Bosua. (incorporated by reference to
the Company&#x2019;s Annual Report on Form 10-K, filed December 21,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495418014237/exhibit_10-21.htm">
<font>10.18<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495418014237/exhibit_10-21.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amended Employment
Agreement dated April 10, 2018 by and between Visualant,
Incorporated and Ronald P. Erickson. (incorporated by reference to
the Company&#x2019;s Annual Report on Form 10-K, filed December 21,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000195/ex_10-1.htm">
<font>10.19<br></font></a></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000195/ex_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Agreement and Plan
of Merger, dated as of April 10, 2018, by and among Visualant,
Incorporated, 500 Union Corporation, and RAAI Lighting, Inc.
(incorporated by reference to the Company&#x2019;s Annual Report on
Form 10-K, filed December 21, 2018)</font></a></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000195/ex_10-2.htm">
<font>10.20<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000195/ex_10-2.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Certificate
of Merger, dated as of April 10, 2018, by 500 Union Corporation
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed April 17, 2018)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000337/ex_10-1.htm">
<font>10.21<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000337/ex_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Fifth
Modification of Loan and Security Agreement dated June 6, 2017 by
and between TransTech Systems, Inc. and Capital Source Business
Finance Group (incorporated by reference to the Company&#x2019;s
Current Report on Form 8-K, filed June 26,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000339/ex_10-1.htm">
<font>10.22<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000339/ex_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Form
of subscription agreement (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed June 29,
2018)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000339/ex_10-2.htm">
<font>10.23<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000339/ex_10-2.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Form
of common stock purchase warrant (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed June 29,
2018)</font>&#xA0; </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000550/ex_10-1.htm">
<font>10.24<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000550/ex_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 1 dated
November 16, 2018 to Senior Secured Convertible Redeemable Note
dated September 30, 2016 by and between Know Labs, Inc. and Clayton
A. Struve (incorporated by reference to the Company&#x2019;s Current
Report on Form 8-K, filed November 16,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000550/ex_10-2.htm">
<font>10.25<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000550/ex_10-2.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 1 dated
November 16, 2018 to Senior Secured Convertible Redeemable Note
dated August 14, 2017 by and between Know Labs, Inc. and Clayton A.
Struve (incorporated by reference to the Company&#x2019;s Current
Report on Form 8-K, filed November 16,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000550/ex_10-3.htm">
<font>10.26<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000550/ex_10-3.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 1 dated
November 16, 2018 to Senior Secured Convertible Redeemable Note
dated December 12, 2017 by and between Know Labs, Inc. and Clayton
A. Struve (incorporated by reference to the Company&#x2019;s Current
Report on Form 8-K, filed November 16,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000607/ex_10-1.htm">
<font>10.27<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000607/ex_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Sixth
Modification of Loan and Security Agreement effective December 12,
2018 by and between TransTech Systems, Inc. and Capital Source
Business Finance Group (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed December 20,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-1.htm">
<font>10.28<br></font></a></font></div>
</td>
<td colspan="22" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Form
of Securities Purchase Agreement (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed March 6,
2019</font>&#xA0; </a></font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">80</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-2.htm">
<font>10.29<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-2.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Form
of Subscription Agreement (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed March 6,
2019)</font>&#xA0; </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;"><br></td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-3.htm">
<font>10.30<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-3.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Form
of Subordinated Convertible Note (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed March 6,
2019)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-4.htm">
<font>10.31<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-4.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Form
of Common Stock Purchase Warrant (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed March 6,
2019)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-5.htm">
<font>10.32<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-5.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Form
of Subordination Agreement (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed March 6,
2019)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-6.htm">
<font>10.33<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419002340/exhibit_10-6.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Form
of Registration Rights Agreement (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed March 6,
2019)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-1.htm">
<font>10.34<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 2 dated
April 30, 2019 to Senior Secured Convertible Redeemable Note
dated</font> <font style="font-family: Times New Roman; font-size: 13px;">September 30, 2016
by and between Know Labs, Inc. and Clayton A. Struve. (incorporated
by reference to the Company&#x2019;s Current Report on Form 8-K,
filed May 22, 2019)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-2.htm">
<font>10.35<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-2.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 2 dated
April 30, 2019 to Senior Secured Convertible Redeemable Note dated
August 14, 2017 by and between Know Labs, Inc. and Clayton A.
Struve. (incorporated by reference to the Company&#x2019;s Current
Report on Form 8-K, filed May 22, 2019)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-3.htm">
<font>10.36<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-3.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 2 dated
April 30, 2019 to Senior Secured Convertible Redeemable Note
dated</font>&#xA0; <font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px;">December 12, 2017
by and between Know Labs, Inc. and Clayton A. Struve. (incorporated
by reference to the Company&#x2019;s Current Report on Form 8-K,
filed May 22, 2019)</font>&#xA0; </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-4.htm">
<font>10.37<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-4.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 1 dated
April 30, 2019 to Senior Secured Convertible Redeemable Note dated
February 28, 2018 by and between Know Labs, Inc. and Clayton A.
Struve. (incorporated by reference to the Company&#x2019;s Current
Report on Form 8-K, filed May 22, 2019)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-5.htm">
<font>10.38<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-5.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 1 dated
April 30, 2019 to Convertible Redeemable Promissory Note
dated</font> <font style="font-family: Times New Roman; font-size: 13px"><font style="font-family: Times New Roman; font-size: 13px;">January 31, 2018
by and between Know Labs, Inc. and J3E2A2Z LP. (incorporated by
reference to the Company&#x2019;s Current Report on Form 8-K, filed
May 22, 2019)</font> </font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-6.htm">
<font>10.39<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169719000212/ex_10-6.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Amendment 1 dated
April 30, 2019 to Convertible Redeemable Promissory Note
dated</font> <font style="font-family: Times New Roman; font-size: 13px"><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;January 31,
2018 by and between Know Labs, Inc. and J3E2A2Z LP. (incorporated
by</font> <font style="font-family: Times New Roman; font-size: 13px;">reference to the
Company&#x2019;s Current Report on Form 8-K, filed May 22,
2019)</font></font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><br></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><a href="knwn_ex1040.htm">10.40</a></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<a href="knwn_ex1040.htm"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">The Offering Engagement Agreement
between Company and Boustead Securities, LLC</font><font style="color: #000000">&#xA0;</font><font style="font-size: 13px">dated
November 6, 2018 (Filed herewith)</font></font></a></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><br></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000556/ex_14-1.htm">
<font>14.1<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000556/ex_14-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Code
of Ethics dated November 2018 (incorporated by reference to the
Company&#x2019;s Current Report on Form 8-K, filed November 27,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419006742/knwn_ex211.htm">
<font>21.1<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419006742/knwn_ex211.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Subsidiaries of
the Registrant (filed
previously)</font>
</a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419006742/knwn_ex231.htm">
<font>23.1<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000165495419006742/knwn_ex231.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Consent
of SD Mayer &amp; Associates, LLP, independent registered public
accounting firm (filed previously)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="knwn_ex51.htm"><font>23.2<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="knwn_ex51.htm"><font style="font-family: Times New Roman; font-size: 13px;">Consent
of Horwitz + Armstrong, A Professional Law Corporation (included in
Exhibit 5.1) (filed herewith)</font> </a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000556/ex_99-1.htm">
<font>99.1<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000556/ex_99-1.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Audit
Committee Charter dated November 2018 (incorporated by reference to
the Company&#x2019;s Current Report on Form 8-K, filed November 27,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000556/ex_99-2.htm">
<font>99.2<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000556/ex_99-2.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Compensation
Committee Charter dated November 2018 (incorporated by reference to
the Company&#x2019;s Current Report on Form 8-K, filed November 27,
2018)</font></a></font></div>
</td>
</tr><tr>
<td style="width: 10%;">
<div><font>&#xA0;</font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="width: 10%;">
<div><font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000556/ex_99-3.htm">
<font>99.3<br></font></a></font></div>
</td>
<td colspan="26" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: rgb(0, 0, 0);"><a href="http://www.sec.gov/Archives/edgar/data/1074828/000116169718000556/ex_99-3.htm">
<font style="font-family: Times New Roman; font-size: 13px;">Nominations and
Corporate Governance Committee Charter dated November 2018
(incorporated by reference to the Company&#x2019;s Current Report on
Form 8-K, filed November 27, 2018)</font></a></font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">81</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>knwn_ex51.htm
<DESCRIPTION>OPINION ON LEGALITY
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2019 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #002060; font-family: Times New Roman; font-size: 13px">
<font style="color: rgb(0, 0, 0);">Exhibit 5.1</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #002060; font-family: Times New Roman; font-size: 13px">
Horwitz + Armstrong</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #002060; font-family: Times New Roman; font-size: 13px">
A Professional Law Corporation</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 80%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
14 Orchard, Suite 200</font></div>
</td>
<td style="vertical-align: top; width: 20%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
North San Diego Office</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 80%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Lake Forest, California 92630</font></div>
</td>
<td style="vertical-align: top; width: 20%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
804 N. The Strand #9</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 80%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
T: (949) 540-6540</font></div>
</td>
<td style="vertical-align: top; width: 20%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Oceanside, CA 92054</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 80%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
F: (949) 540-6578</font></div>
</td>
<td style="vertical-align: top; width: 20%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
September 19, 2019</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Know Labs, Inc.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
500 Union Street, Suite 420</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Seattle, WA 98101</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Re:&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font><font style="text-decoration: underline; color: #000000">Registration
Statement on Form S-1</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Gentleman:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
This law firm has represented Know Labs, Inc., formerly known as
Visualant, Incorporated, a Nevada corporation (the
&#x201C;Company&#x201D;), in connection with the preparation and
filing with the Securities and Exchange Commission of a
Registration Statement on Form S-1 (the &#x201C;Registration
Statement&#x201D;) under the Securities Act of 1933, as amended (the
&#x201C;Securities Act&#x201D;) of up to 14,337,632
shares of the Company&#x2019;s common stock, consisting
of:</font> </div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(i)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 4,242,515 shares of common stock underlying the principal amount
of registrants 8% Unsubordinated Convertible Notes
(&#x201C;Principal Shares&#x201D;)</font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(ii)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 339,401 shares of common
stock</font> issuable by the registrant upon the conversion of
interest accrued under the <font style="color: #000000">8%
Unsubordinated Convertible Notes (&#x201C;Interest
Shares&#x201D;)</font></font> </div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(iii)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">up
to 2,121,258 shares (the "Investor Warrant Shares") of common stock
issuable upon the exercise of outstanding investor's warrants at an
exercise price of $1.20 that were previously issued to the Selling
Shareholders in connection with 8% Unsubordinated Convertible Notes
offering that closed in a series of closings between February 15,
2019 and May 28, 2019.</font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px">(iv)</font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">542,102
shares of our common stock issuable upon the exercise of
outstanding placement agent warrants (the &#x201C;Placement Agent
Warrants&#x201D;) at an exercise price of $1.20 per share that were
previously issued to Boustead Securities, LLC and its
assigns.</font></div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(v</font><font style="font-family: Times New Roman; font-size: 13px">)&#xA0;<font style="font-family: Times New Roman; font-size: 13px"></font></font></font> </div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">up to 3,108,356 shares of common stock underlying
the outstanding Series D</font> <font style="color: #000000">Convertible Preferred Stock which is convertible
at any time at an initial conversion price of $0.25 per share of
our common stock subject to adjustment for certain events
(&#x201C;Series D Shares&#x201D;). There are currently 3,108,356
common shares estimated to underlying the 1,016,004 issued and
outstanding Series D
Shares.</font></font></font></font> </div>
</div>
</div>
<div style="display: table;">
<div style="display: table-row;">
<div style="text-align: left; display: table-cell; width: 36px;">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">(vi)</font></font></div>
<div style="text-align: justify; display: table-cell; margin-left: 0px; text-indent: 0px; margin-right: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">up to 3,984,000 shares <font style="color: #000000">of common stock issuable upon conversion of
outstanding Series F Warrants at an exercise price of $0.25 per
share that were previously issued to one of the Selling
Shareholders in connection with Preferred Stock and Warrant
Purchase Agreement dated November 10, 2016 (&#x201C;Series F Warrant
Shares&#x201D;).</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">(collectively,
the &#x201C;Shares&#x201D; and &#x201C;Warrant
Shares&#x201D;)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
This opinion is being delivered in accordance with the requirements
of Item 601(b)(5) of Regulation S-K under the Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In rendering this opinion, we have examined (i) the Registration
Statement and the exhibits thereto, (ii) the Company&#x2019;s
Amended and Restated Certificate of Incorporation, and all
amendments thereto, including preferred stock designations, (iii)
the Bylaws of the Company and all amendments thereto, (iv) certain
resolutions of the board of directors of the Company, relating to
the issuance and sale of the Shares and the Series D Convertible
Preferred Stock, (v) Series F Warrants, (vi) the Principal and
Interest Shares, Investor Warrant Shares, and Placement Agent
Warrants and (vii) certificates of officers of the Company and of
public officials and other such records, instruments and documents
as we have deemed advisable in order to render this opinion. In
such examination, we have assumed the genuineness of all
signatures, the legal capacity of all natural persons, the
authenticity of all documents submitted to us as originals, the
conformity to original documents of all documents submitted to us
as certified and conformed copies and the authenticity of the
originals of such documents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Based on the foregoing, we are of the opinion that the Shares
covered by the Registration Statement are, upon issuance, validly
issued, fully paid and non-assessable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We express no opinion as to the effect or application of any laws
or regulations other than those of the Nevada General Corporation
Law (including the statutory provisions and all applicable
provisions of the Nevada Constitution and the reported judicial
cases interpreting those laws currently in effect) and the federal
laws of the United States, in each case as currently in
effect.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The information set forth herein is as of the date hereof. We
assume no obligation to supplement this opinion letter if any
applicable law changes after the date hereof or if we become aware
of any fact that might change the opinion expressed herein after
the date hereof. Our opinion is expressly limited to the matters
set forth above, and we render no opinion, whether by implication
or otherwise, as to any other matters relating to the Company, the
Shares or Warrant Shares, the Registration Statement or the
prospectus included therein.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We hereby consent to the filing of this opinion as an exhibit to
the Registration Statement and being named in the prospectus
included in the Registration Statement under the heading
&#x201C;Legal Matters&#x201D;. In giving this consent, we do not
thereby admit that we are within the category of persons whose
consent is required under Section 7 of the Act or the rules and
regulations of the Commission promulgated thereunder.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: middle; width: 62%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 38%; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Very
truly yours,</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
/s/ Horwitz + Armstrong</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Horwitz
+ Armstrong, A Professional Law</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Corporation</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.40
<SEQUENCE>3
<FILENAME>knwn_ex1040.htm
<DESCRIPTION>OFFERING ENGAGEMENT AGREEMENT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2019 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit 10.40</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="knwn_ex1040000.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
CONFIDENTIAL</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">November
6, 2018</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Ronald P. Erickson</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Founder and Chairman</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Phillip A. Bosua</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
CEO</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Know Labs, Inc.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
500 Union Street, Suite 810</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Seattle, WA 98101</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 14px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dear
Ron and Phil:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We are
pleased to submit the following agreement with respect to certain
financing transactions, strategic corporate transactions and other
activities described herein by and for Know Labs, Inc. and its
consolidated subsidiaries (the &#x201C;Company&#x201D;).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Boustead
Securities, LLC (&#x201C;Boustead&#x201D;) is pleased to act as
exclusive financial advisor to the Company, subject to the terms
and conditions outlined below, in connection with the
Company&#x2019;s intention to pursue the activities described in
Section 2 below. The exclusive best efforts, engagement outlined in
this letter has the objective of providing growth capital for the
Company&#x2019;s future expansion and IP development
plans.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 2px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
letter agreement (&#x201C;Agreement&#x201D;) states certain
conditions and assumptions upon which the proposed services by
Boustead will be based. The final terms of any transaction will be
dictated by investor interest, market conditions and the financial
performance of the Company and its consolidated
subsidiaries.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
Agreement will confirm the understanding and agreement between
Boustead and the Company as follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">1.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Advisory
Services</font>: Boustead will provide advisory services to the
Company in the areas of strategic corporate development, financing
and/or capital placement transactions. Boustead will also introduce
strategic corporate investors / partners to the Company as
appropriate during the normal course of business and act as
coordinator for all activities within its purview. It is also
understood that Boustead is acting as an advisor only, and shall
have no authority to enter into any commitments on the
Company&#x2019;s behalf, or to negotiate the terms of any
transaction, or to hold any funds or securities in connection with
any transaction or to perform any other acts on behalf of the
Company without the Company&#x2019;s express written
consent.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 51%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Boustead
Securities, LLC</font></div>
</td>
<td style="vertical-align: top; width: 15%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Direct
phone:</font></div>
</td>
<td style="vertical-align: top; width: 34%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">+1 310
383 7874</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">6
Venture, Suite 265</font></div>
</td>
<td style="vertical-align: top; width: 15%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Email:</font></div>
</td>
<td style="vertical-align: top; width: 34%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;pete@boustead1828.com</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 51%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Irvine,
CA 92618 USA</font></div>
</td>
<td style="vertical-align: top; width: 15%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Web:</font></div>
</td>
<td style="vertical-align: top; width: 34%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">www.boustead1828.com</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">1</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Boustead will serve
as exclusive financial advisor to the Company to:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 72px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">(a)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Secure financing on
a best efforts basis, related to the sale of up to USD$5,000,000,
or more at the discretion of the Company, of the Company&#x2019;s
securities (the &#x201C;<font style="text-decoration: underline">Financing</font>&#x201D;) based upon
reasonably acceptable terms from qualified investors. The Financing
will be completed pursuant to a securities purchase agreement and
other customary documents containing terms and conditions that are
customary for a financing of the proposed size and
nature.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">2.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Fees and
Expenses</font>: In connection with the services to be rendered
hereunder, the Company agrees to pay Boustead the following fees
and expenses:</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">a)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Success
Fees</font>:</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 72px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Financing</font><font style="font-weight: bold">:</font>
For any equity investment into the Company, including preferred
stock, common stock, convertible debentures, convertible debt,
subordinated debt with warrants or any other securities convertible
into common or preferred stock, or any other form of debt
instrument involving any other form of equity participation,
Boustead shall receive upon closing: (i) a success fee, payable in
cash, equal to eight percent (8%) of the gross amount to be
disbursed to the Company from such equity closing, plus (ii)
placement agent warrants in the same equity as issued by the
Company equal to eight percent (8%) of the gross issuance of
securities by the Company from such equity closing. Any shares of
stock issued to Boustead hereunder shall be subject to the rights,
restrictions and obligations set forth in the Company&#x2019;s stock
purchase and investor rights agreements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 72px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">For any
equity investment into the Company, including preferred stock,
common stock, convertible debentures, convertible debt,
subordinated debt with warrants or any other securities convertible
into common or preferred stock, or any other form of debt
instrument involving any other form of equity participation from
any accredited investor introduced by Ronald Erickson or Philip
Bosua (the &#x201C;Company Investors&#x201D;), Boustead shall receive
upon closing: (i) a success fee, payable in cash, equal to two
percent (2%) of the gross amount to be disbursed to the Company
from such equity closing, plus (ii) placement agent warrants in the
same equity as issued by the Company equal to two percent (2%) of
the gross issuance of securities by the Company from such equity
closing. Any shares of stock issued to Boustead hereunder shall be
subject to the rights, restrictions and obligations set forth in
the Company&#x2019;s stock purchase and investor rights
agreements.</font></div>
<div style="text-align: justify; margin-left: 72px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">2</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 72px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Payment of Success Fees:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 72px">
<div style="display: table-row">
<div style="display: table-cell; width: 42px"><font style="font-family: Times New Roman; font-size: 13px">(i)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Cash Fee:</font>
The cash portion of the Success Fee will be due and payable upon
the closing of each Financing as the case may be and will be
payable directly to Boustead from the escrow or clearing account
established for such closing or in such other manner as may be
acceptable to Boustead. Immediately prior to closing of a
Financing, the Company will sign a payment authorization letter, in
a form to be prepared at the sole discretion of Boustead,
irrevocably instructing the Escrow or Closing Agent to deduct the
Success Fees due to Boustead from the Financing and remit those
Success Fees directly to Boustead.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 72px">
<div style="display: table-row">
<div style="display: table-cell; width: 42px"><font style="font-family: Times New Roman; font-size: 13px">(ii)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Warrants:</font>
The Boustead Warrants will be due and payable upon the closing of
each Financing and issued to Boustead in conjunction with the
issuance of the other securities pursuant to the Financing. The
Boustead Warrants will have a five (5) year term (or such longer
term as is provided in any warrants issued in the Financing) and
will provide for cashless exercise (even if the Investors do not
have such a right). The shares underlying the Boustead Warrants
will be included in the first registration statement filed by the
Company covering the securities issued in the Financing (or
securities issuable upon conversion or exercise thereof). The
Boustead Warrants will be transferable within Boustead&#x2019;s
organization, at Boustead&#x2019;s discretion. The Boustead Warrants
will contain such other terms and conditions no less favorable to
Boustead than the term and conditions of any warrants, if any,
issued to the Investors in the Financing, including any callable
provisions.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">b)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Expenses</font><font style="font-weight: bold">:</font>
The Company also agrees to reimburse Boustead, at the close of the
Financing upon presentation of an invoice, for all of its
reasonable out-of-pocket expenses (including reasonable fees and
expenses of its legal counsel) in connection with the performance
of its services hereunder. Any expense exceeding USD$1,500 shall be
pre-approved in writing by the Company. <font style="color: #000000">In the event the any fee becomes delinquent,
Boustead employs the same prudent collection procedures as other
businesses and, if it becomes necessary to file suit or to engage a
collection agency for the collection of any fees and/or expenses,
the Company shall pay all related costs and expenses of such
collection efforts, including reasonable attorney
fees.</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">c)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Advisory
Fee:</font> Upon execution of this Agreement and presentation of an
invoice, the <font style="font-family: Times New Roman; font-size: 13px">Company shall pay
Boustead an Advisory Fee of USD$25,000 which amount shall be
deducted from the cash fee at closing of the contemplated
financing.</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 72px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">3.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Indemnification</font>:
The Company agrees to indemnify Boustead as set forth in Schedule A
annexed hereto and made a part hereof.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">4.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Successors:</font><font style="font-weight: bold">&#xA0;</font>This
Agreement shall be binding upon any and all successors and assigns
of the Company (including any entity surviving any merger to which
the Company is a party). Boustead shall be permitted to assign its
rights or delegate its obligations hereunder by operation of law,
including as a result of the partial or total merger or
consolidation of Boustead with another entity.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">3</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">5.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Term:</font> The
term of this Agreement (the &#x201C;Engagement Period&#x201D;) will
expire upon the earlier to occur of (i) six (6) months from the
date Boustead receives an executed copy of this Agreement from the
Company or (ii) the mutual written agreement of the Company and
Boustead, or (iii) the closing of the Financing. The Engagement
Period may be extended for additional six (6) month periods under
the same terms and conditions as described herein by mutual written
agreement of the Company and Boustead.<font style="font-weight: bold">&#xA0;</font>In addition, Boustead shall be
entitled to a success fee(s), as defined above, if the Company
completes a Financing with any party who has made an investment in
the Company during Boustead&#x2019;s engagement hereunder
(collectively, the &#x201C;Identified Party (ies)&#x201D;) during the
twelve (12) month period following the termination of this
Agreement.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">6.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Governing Law;
Dispute Resolution:</font><font style="font-weight: bold">&#xA0;</font>This Agreement shall be deemed to
have been made in the State of California and shall be construed,
and the rights and liabilities determined, in accordance with the
law of the State of California, without regard to the conflicts of
laws rules of such jurisdiction. Any controversy or claim relating
to or arising from this Agreement (an "Arbitrable Dispute") shall
be settled by arbitration in accordance with the Financial Industry
Regulation Authority (&#x201C;FINRA&#x201D;) as such rules may be
modified herein or as otherwise agreed by the parties in
controversy. The forum for arbitration shall be Orange County,
California. Following thirty (30) days&#x2019; notice by any party
of intention to invoke arbitration, any Arbitrable Dispute arising
under this Agreement and not mutually resolved within such thirty
(30) day period shall be determined by a single arbitrator upon
which the parties agree.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">7.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">USA Patriot
Act:</font> Boustead is committed to complying with U.S. statutory
and regulatory requirements designed to combat money laundering and
terrorist financing. The USA Patriot Act requires that all
financial institutions obtain certain identification documents or
other information in order to comply with their customer
identification procedures.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">8.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Confidentiality:</font>
All non-public information concerning the Company and its
subsidiaries which is given to Boustead will be used by Boustead
solely in the course of the performance of its services hereunder
and will be treated confidentially by Boustead and any retained
advisors and agents for as long as such information remains
non-public. Except as otherwise required by law, Boustead will not
use such information or disclose such information to a third party,
other than its Representatives (as herein defined) who have a need
to know such information in connection with the transaction
contemplated by this Agreement and who agree to keep such
information confidential.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
Agreement is for confidential use of the Company and Boustead only
and may not be disclosed by the Company to any person other than
its attorneys, accountants and financial advisors, and only on a
confidential basis in connection with the proposed transaction or
financing, except where disclosure is required by law or is
mutually consented to in writing by Boustead and the
Company.</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">4</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">9.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Access to
Information:</font> In connection with Boustead activities on the
Company&#x2019;s behalf, the Company agrees that it will furnish
Boustead with all information concerning the Company and the
Financing that Boustead reasonably deems appropriate and that the
Company will provide Boustead with reasonable access to its
officers, accountants, attorneys and other professional advisors.
The Company represents that all information made available to
Boustead will be complete and correct in all material respects and
will not contain any untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements
therein not misleading in light of the circumstances under which
such statements are made. In rendering its services hereunder,
Boustead will be utilizing and relying on the information without
independent verification thereof or independent appraisal of any of
the Company&#x2019;s assets.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Disclosure:</font>
During the Engagement Period and for sixty (60) days thereafter,
the Company agrees not to issue any press releases or
communications to the public relating to the Financing without
Boustead prior approval or unless otherwise required by law, which
will not be unreasonably withheld or delayed, and the Company
agrees that such press release will state that the transaction
and/or financing was arranged by Boustead, unless we mutually agree
otherwise or unless otherwise required by law. The Company further
agrees that Boustead may, at its own expense, publicize its
services to the Company hereunder, including, without limitation,
issuing press releases, placing advertisements and referring to the
Financing on Boustead website.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">10.</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold; text-decoration: underline">Modification:</font><font style="font-weight: bold">&#xA0;</font>This
Agreement may not be modified or amended except in writing duly
executed by the parties hereto.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">5</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
&#xA0;&#xA0; <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Please
confirm that the foregoing is in accordance with our understanding
by signing and returning one copy of this Agreement to <font style="font-size: 13px">Boustead</font> to indicate the Company&#x2019;s
acceptance of the terms set forth herein.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Very
truly yours,</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Accepted
as of the date first above written:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Know Labs, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 8%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/
Ronald P. Erickson</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Name:</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ronald
P. Erickson</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Title:</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Founder
and Chairman</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 52%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Boustead Securities, LLC</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/
Phillip A. Bosua</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Name:</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Phillip
A. Bosua</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Title:</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">CEO</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/
Keith Moore</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Keith
Moore</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">CEO</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/
Peter Conley</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Peter
Conley</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Managing
Director</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 8%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 40%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 49%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Head of
IP Banking</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">6</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr"><br></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Schedule A</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
Company agrees that it shall indemnify and hold harmless, Boustead
Securities, LLC (&#x201C;BSL&#x201D;), its members, managers,
officers, employees, agents, affiliates and controlling persons
within the meaning of Section 20 of the Securities Exchange Act of
1934 and Section 15 of the Securities Act of 1933, each as amended
(any and all of whom are referred to as an "Indemnified Party"),
from and against any and all losses, claims, damages, liabilities,
or expenses, and all actions in respect thereof (including, but not
limited to, all legal or other expenses reasonably incurred by an
Indemnified Party in connection with the investigation,
preparation, defense or settlement of any claim, action or
proceeding, whether or not resulting in any liability), incurred by
an Indemnified Party with respect to, caused by, or otherwise
arising out of any transaction contemplated by this Agreement or
BSL's performing the services contemplated hereunder; provided,
however, the Company will not be liable to the extent, and only to
the extent, that any loss, claim, damage, liability or expense is
finally judicially determined to have resulted primarily from BSL's
gross negligence or bad faith in performing such
services.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">If
the indemnification provided for herein is conclusively determined
(by an entry of final judgment by a court of competent jurisdiction
and the expiration of the time or denial of the right to appeal) to
be unavailable or insufficient to hold any Indemnified Party
harmless in respect to any losses, claims, damages, liabilities or
expenses referred to herein, then the Company shall contribute to
the amounts paid or payable by such Indemnified Party in such
proportion as is appropriate and equitable under all circumstances
taking into account the relative benefits received by the Company
on the one hand and BSL on the other, from the transaction or
proposed transaction under the Agreement or, if allocation on that
basis is not permitted under applicable law, in such proportion as
is appropriate to reflect not only the relative benefits received
by the Company on the one hand and BSL on the other, but also the
relative fault of the Company and BSL; provided, however, in no
event shall the aggregate contribution of BSL and/or any
Indemnified Party be in excess of the net compensation actually
received by BSL and/or such Indemnified Party pursuant to this
Agreement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; text-indent: 48px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
Company shall not settle or compromise or consent to the entry of
any judgment in or otherwise seek to terminate any pending or
threatened action, claim, suit or proceeding in which any
Indemnified Party is or could be a party and as to which
indemnification or contribution could have been sought by such
Indemnified Party hereunder (whether or not such Indemnified Party
is a party thereto), unless such consent or termination includes an
express unconditional release of such Indemnified Party, reasonably
satisfactory in form and substance to such Indemnified Party, from
all losses, claims, damages, liabilities or expenses arising out of
such action, claim, suit or proceeding.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">In
the event any Indemnified Party shall incur any expenses covered by
this Exhibit A, the Company shall reimburse the Indemnified Party
for such covered expenses within ten (10) business days of the
Indemnified Party's delivery to the Company of an invoice therefor,
with receipts attached. Such obligation of the Company to so
advance funds may be</font>
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
conditioned upon the Company's receipt of a written undertaking
from the Indemnified Party to repay such amounts within ten (10)
business days after a final, non-appealable judicial determination
that such Indemnified Party was not entitled to indemnification
hereunder.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px;">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; text-indent: 48px; margin-right: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
foregoing indemnification and contribution provisions are not in
lieu of, but in addition to, any rights which any Indemnified Party
may have at common law hereunder or otherwise, and shall remain in
full force and effect following the expiration or termination of
BSL's engagement and shall be binding on any successors or assigns
of the Company and successors or assigns to all or substantially
all of the Company's business or assets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">7</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>knwn_ex1040000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_ex1040000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  C 3$# 2(  A$! Q$!_\0
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04 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>knwn_s1000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M=WG_ #YP?F:/^$[O/^?.#\S1_:N&[_@']D8K^7\3O:*X+_A.[S_GS@_,T?\
M"=WG_/G!^9H_M7#=_P  _LC%?R_B=[17!?\ "=WG_/G!^9H_X3N\_P"?.#\S
M1_:N&[_@']D8K^7\3O:*X+_A.[S_ )\X/S-'_"=WG_/G!^9H_M7#=_P#^R,5
M_+^)WM%<%_PG=Y_SYP?F:/\ A.[S_GS@_,T?VKAN_P" ?V1BOY?Q.]HK@O\
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M1_PB.A_\^9_[^O\ XT?V/7[K\?\ (/[;P_9_A_F>:45Z7_PB.A_\^9_[^O\
MXT?\(CH?_/F?^_K_ .-']CU^Z_'_ "#^V\/V?X?YGFE;GA#_ )&2W^C_ /H)
MKK_^$1T/_GS/_?U_\:L67A[2["Y6XMK<I*N<-YC'K]36M#*JU.K&;:T?]=#'
M$9Q0J4I02=VO+_,U:***^@/G HHHH **** "BBB@#S_PSJC0:YK,UY=2&WA5
MV.]R0HW]A^E&E?VAXMUV2^EEG@TV)L"-)"H([+QW[D^_TKGXM+O=6UG4+6S
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MX;T)+"25)9?,:221!@,2?\ !^%8G_"5:E_TQ_P"^/_KU?T;7KV^U..";RMC
MD[5P>!]:3H22N3/ 581<G;0ZFBBBL3B"N(\6?\AA/^N*_P S7;UQ'BS_ )#"
M?]<1_,UMA_C.[+_X_P F8=%%%=Y[P4444 %%%% !1110 4444 %%%% !6OX:
M_P"0Y#]&_E616OX:_P"0Y#]&_E45/@9CB?X,O1G>4445YI\R%<1XL_Y#"?\
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M_P"?Y?\ OU_]>C_A#I/^?Y?^_7_UZZRBCV\^X?7J_P#-^1R?_"'/_P _R_\
M?K_Z]'_"'2?\_P O_?K_ .O7644>VGW#Z]7_ )OR.3_X0V3_ )_E_P"_7_UZ
IN:7X;;3K]+DW0DV@_+Y>.HQZUT%%)UIM6;%+&5I)Q;T84445F<I__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>knwn_s1001.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "M X\# 2(  A$! Q$!_\0
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M_GA'_P!\"I:* (OLT'_/"/\ [X%1+;P_:9!Y,> JX&T>]6JA3_C[E_W5_K0
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MB@!?LT'_ #PC_P"^!1]F@_YX1_\ ? J6B@"+[-!_SPC_ .^!1]F@_P">$?\
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M5#]D@_YY+1]D@_YY+0!-14/V2#_GDM'V2#_GDM $U%0_9(/^>2T?9(/^>2T
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M3\0:[XW\-:SI=M9R6^C2><RS71C:4EE)4?*<?=Z^]>A_9(/^>2T?9(/^>2T
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M^$ \,_\ 0/D_\"IO_BZ/^$ \,_\ 0/D_\"IO_BZZ6B@#FO\ A /#/_0/D_\
M J;_ .+H_P"$ \,_] ^3_P "IO\ XNNEHH YK_A /#/_ $#Y/_ J;_XNC_A
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MG_@5-_\ %UTM% '-?\(!X9_Z!\G_ (%3?_%T?\(!X9_Z!\G_ (%3?_%UTM%
M'-?\(!X9_P"@?)_X%3?_ !='_" >&?\ H'R?^!4W_P 772T4 <U_P@'AG_H'
MR?\ @5-_\71_P@'AG_H'R?\ @5-_\772T4 <U_P@'AG_ *!\G_@5-_\ %T?\
M(!X9_P"@?)_X%3?_ !=:'B378?#7A^\UBXM[B>*UC+M' FYB/Z#U)Z5R.O\
MQ<TS08[1CI6HW9FL(]0F$" BWB<@*7)..IQQ_6@#>_X0#PS_ - ^3_P*F_\
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M%TT@7<<TDVJSI#!%&!D;L?,<]AD4 2?\(!X9_P"@?)_X%3?_ !='_" >&?\
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M ._C?XT $7_'S/\ \!_E7C_CWP_XRUCXJZ)<Z-8)9QVX.W5(7X*9!(EXX(Y
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M6:3$WV4SWDL)AAD!&7&'W, #D%1_A7IOV:+_ &_^_C?XTOV:/_;_ ._C?XT
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M;_&C[-%_M_\ ?QO\: /-]3\07/C_ ,/:UH>F>&7O'B<VKW%U)$(%D_OCY]Q
MZY7FN?/P>\0:5<:.]CK,>H3)=*\]S=0 O;J(RHPS/N9!G[H^M>T_9H_]O_OX
MW^-)]FB_V_\ OXW^- 'DG@7P9XOL/$^@-K%E9VVF:!9SVT,D<X=K@R$Y; Y'
M4'! P![UZV?^/Q?^N9_F*/LT7^W_ -_&_P :B-O']K4?-C83]\^H]Z /,OC7
MHWB77;;1[70M(%P5NU=+R&3$UN^".>/E0Y!W9X*\]J]+T>"]MM$L8-2N%N+Z
M.!$N)EZ22 #<PZ=3FI_LT7^W_P!_&_QH^S1?[?\ W\;_ !H FHJ'[-%_M_\
M?QO\:/LT7^W_ -_&_P : )J*A^S1?[?_ '\;_&C[-%_M_P#?QO\ &@":BH?L
MT7^W_P!_&_QH^S1?[?\ W\;_ !H FHJ'[-%_M_\ ?QO\:/LT7^W_ -_&_P :
M )J*A^S1?[?_ '\;_&C[-%_M_P#?QO\ &@ NTN);25+6=8)V7"2O'O"GU*Y&
M?S%0Z;#?V]ILU&]BO)]Q/FQP>2,=AMW-^>:F^S1?[?\ W\;_ !H^S1?[?_?Q
MO\: )JAF^_%_O'^1H^S1?[?_ '\;_&F/"D<D17=G<>K$]CZT >7^+M4U"_\
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M1110 4444 %%%% !4*?\?<O^ZO\ 6IJA3_C[E_W5_K0!-1110 4444 %%%%
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MYB@ ^SK_ 'Y?^_AH^SK_ 'Y?^_AJ:B@"'[.O]^7_ +^&C[.O]^7_ +^&IJ*
M(?LZ_P!^7_OX:/LZ_P!^7_OX:FHH A^SK_?E_P"_AH^SK_?E_P"_AJ:B@"'[
M.O\ ?E_[^&C[.O\ ?E_[^&IJ* (?LZ_WY?\ OX:/LZ_WY?\ OX:FHH @%I$&
M+#>&/4ASDTOV=?[\O_?PU-6%XJ\6Z5X.TM-0U9Y!')*L,:1)N9W/8#Z G\*
M-<VR$$%I"#U!<\T@M8U&%,BCT#D"L$>.-,G\42^'["WO-0NX-OVF2UC#16^3
MC#N2 ".X&3U]#AFJ>.M-TWQ.GAR.VO+[5'@^T>1:!&*KD]=SCG SCKCF@#HO
MLZ_WY?\ OX:/LZ_WY?\ OX:XQ?BKH<=U90ZA9ZGIBWGF&*6_A6)<("6)!;<!
MP0..3TS6WX9\56WBJU-Y96&H0V9&8KBZA$:3#.,IR21QU(% &G' IN)AODXV
M_P 9]*E^SK_?E_[^&B+_ (^9_P#@/\JFH A^SK_?E_[^&C[.O]^7_OX:FHH
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MBTB&STLN%"S$LKR<]=P93C./O5H?"CP_JVBZAJKS:5>:3I$D426]E=W7G,)
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MG6=W;?:KBXM2!,X"O\@)^Z/DZ^_M4%YXRN_A99SQ:[>WGB837;&*X5T4VZ8
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M'RS$&_Y91)G+ ?Q&IHO#?CBWTC4;6X\'!GUFP@M(%M8U6.V"-]Z0=G[Y/UH
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MA5'))KE;SXG^$K#P_I^MW.IE++4&86Q\ER\FTD,=F,X!'7'<>M %O_A$I_\
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M8[>*&%I7D8#. %!-1W7C'1;&?2[>\N)+:YU,D6T$T++(<=2RD94#U.* (/\
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M=2VOA^6POH)VU_6+L D>5<3(4/RGJ @/ZUT%0S??B_WC_(T +;?\>L/^XO\
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MZ )Z*@S-_?3_ +X_^O1F;^^G_?'_ ->@">BH,S?WT_[X_P#KT9F_OI_WQ_\
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MBRMHM0MK,6:6\";TDAEW9ED9%4CYNA8DD 5ZU_PCFH_]#=K?_?%K_P#&:/\
MA'-1_P"ANUO_ +XM?_C- 'D'Q@>7QM)9#0=$N=2N]+F:"^>"*0F%R,^64P"5
M.,[O;WJ%/"&O7LEII%MIUUIZZR]O)K%NNG;;6R\HAE:.0D DJ!\N3SNR<UZW
M9^"6TXS&Q\0ZE:F9M\IA@M$\QO5L0\FK7_".:C_T-VM_]\6O_P 9H P?!B7"
M?$?QO/+8WL,%Y-;O;S36SHDHC0HV&(P>3^(Y'%=TW_'W'_N-_,5A_P#".:C_
M -#=K?\ WQ:__&:3_A&M0W!O^$NUO(&!\MM_\9H \\^/2O'%H=S8:/<OJ\=V
MAM-2AB#!""2(CSDDMM(!&.N.]>K:%)J4V@6$FL1)%J3P(;F-.BR8^8#D]_>L
M[_A'-1_Z&[6O^^+7_P",TG_".:C_ -#=K?\ WQ:__&: .BHKG?\ A'-1_P"A
MNUO_ +XM?_C-'_".:C_T-VM_]\6O_P 9H Z*BN=_X1S4?^ANUO\ [XM?_C-'
M_".:C_T-VM_]\6O_ ,9H Z*BN=_X1S4?^ANUO_OBU_\ C-'_  CFH_\ 0W:W
M_P!\6O\ \9H Z*BN=_X1S4?^ANUO_OBU_P#C-'_".:C_ -#=K?\ WQ:__&:
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M_OBU_P#C- '145SO_".:C_T-VM_]\6O_ ,9H_P"$<U'_ *&[6_\ OBU_^,T
M=%17._\ ".:C_P!#=K?_ 'Q:_P#QFC_A'-1_Z&[6_P#OBU_^,T =%17._P#"
M.:C_ -#=K?\ WQ:__&:/^$<U'_H;M;_[XM?_ (S0!N71N5M9#9QQ27 7]VLK
ME$)]R 2!^!J+3GU%[7.IP6T-QN/RVTS2)CMRRJ<_A61_PCFH_P#0W:W_ -\6
MO_QFC_A'-1_Z&[6_^^+7_P",T =%4,WWXO\ >/\ (UA_\(YJ/_0W:W_WQ:__
@ !FI[/0[RVNXYYO$6J7B)G]S.L 1L@CG;&#W]: /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>knwn_s1002.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #B!/\# 2(  A$! Q$!_\0
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M14@MH,#]Q'_WP*+G_CUE_P!P_P JD'04 1_9H/\ GA'_ -\"C[-!_P \(_\
MO@5+10!%]F@_YX1_]\"C[-!_SPC_ .^!4M% $7V:#_GA'_WP*/LT'_/"/_O@
M5+10!%]F@_YX1_\ ? H^S0?\\(_^^!4M% $7V:#_ )X1_P#? H^S0?\ /"/_
M +X%2T4 1?9H/^>$?_? H^S0?\\(_P#O@5+10!%]F@_YX1_]\"C[-!_SPC_[
MX%2T4 1?9H/^>$?_ 'P*/LT'_/"/_O@5+10!%]F@_P">$?\ WP*/LT'_ #PC
M_P"^!4M% $7V:#_GA'_WP*/LT'_/"/\ [X%2T4 1?9H/^>$?_? H^S0?\\(_
M^^!4M% $7V:#_GA'_P!\"C[-!_SPC_[X%2T4 1?9H/\ GA'_ -\"C[-!_P \
M(_\ O@5+10!%]F@_YX1_]\"C[-!_SPC_ .^!4M% $7V:#_GA'_WP*/LT'_/"
M/_O@5+10!%]F@_YX1_\ ? H^S0?\\(_^^!4M% $7V:#_ )X1_P#? H^S0?\
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M%'V:#_GA'_WP*EHH B^S0?\ /"/_ +X%'V:#_GA'_P!\"I:* (OLT'_/"/\
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M\"C[-!_SPC_[X%2T4 1?9H/^>$?_ 'P*/LT'_/"/_O@5+10!%]F@_P">$?\
MWP*/LT'_ #PC_P"^!4M% $7V:#_GA'_WP*/LT'_/"/\ [X%2T4 1?9H/^>$?
M_? H^S0?\\(_^^!4M% $7V:#_GA'_P!\"C[-!_SPC_[X%2T4 54MX3<RCR8\
M!5P-H]ZE^S0?\\(_^^!2)_Q]3?[J_P!:FH B^S0?\\(_^^!1]F@_YX1_]\"I
M:* (OLT'_/"/_O@4?9H/^>$?_? J6B@"+[-!_P \(_\ O@4?9H/^>$?_ 'P*
MEHH B^S0?\\(_P#O@4?9H/\ GA'_ -\"I:* (OLT'_/"/_O@4?9H/^>$?_?
MJ6B@"+[-!_SPC_[X%0_9X?M>WR8\>7G&T>M6ZA_Y??\ MG_6@!?LT'_/"/\
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M[.O_ #TE_P"_AH^SK_STE_[^&IJ* (?LZ_\ /27_ +^&C[.O_/27_OX:FHH
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M +^&IJ* (?LZ_P#/27_OX:/LZ_\ /27_ +^&IJ* (?LZ_P#/27_OX:/LZ_\
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MZ=XCEL=7EU[3["1Q+ L:R1123;E&) %YR,>@P#F@#Z3^SK_STE_[^&C[.O\
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M)?\ OX:/LZ_\])?^_AJ:B@"'[.O_ #TE_P"_AH^SK_STE_[^&IJ* (?LZ_\
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MC_QP4>5/_P _'_C@J:B@"'RI_P#GX_\ '!1Y4_\ S\?^."IJ* (?*G_Y^/\
MQP4>5/\ \_'_ (X*FHH A\J?_GX_\<%'E3_\_'_C@J:B@"'RI_\ GX_\<%'E
M3_\ /Q_XX*FHH A\J?\ Y^/_ !P4>5/_ ,_'_C@J:B@"'RI_^?C_ ,<%'E3_
M //Q_P"."IJ* (?*G_Y^/_'!1Y4__/Q_XX*FHH A\J?_ )^/_'!1Y4__ #\?
M^."IJ* (?*G_ .?C_P <%'E3_P#/Q_XX*FHH A\J?_GX_P#'!1Y4_P#S\?\
MC@J:B@"'RI_^?C_QP4>5/_S\?^."IJ* (?*G_P"?C_QP4>5/_P _'_C@J:B@
M"'RI_P#GX_\ '!1Y4_\ S\?^."IJ* (?*G_Y^/\ QP4>5/\ \_'_ (X*FHH
MA\J?_GX_\<%'E3_\_'_C@J:B@"'RI_\ GX_\<%'E3_\ /Q_XX*FHH A\J?\
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M/IT% 'UIY4__ #\?^."CRI_^?C_QP5\ZZ'\9O&.L^(=-T*>XTZQDFN3!/<F
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M2>_UHM_BEXWFTR[N)KZTM+BUN%L6MYM.):6[;>?+4@X'" $MC!- 'T#Y4_\
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M2S-YH\YL[NVE@\QG3/R.K9Y '4]* /<M \.P^&]'ATK3[JX-I#D1K.WF%1Z
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M!#:K=V&I1C[0@V80NORE<E< @G/O7UL"" 000>010!%Y4_\ S\?^."CRI_\
MGX_\<%344 0^5/\ \_'_ (X*8R2+)$7EWC<>-H'8U9J&;[\7^\?Y&@".W-Q]
MFBVB+&P8R3Z5)FY_NQ?F?\*6V_X]8?\ <7^52T 0YN?[L7YG_"C-S_=B_,_X
M5-10!#FY_NQ?F?\ "C-S_=B_,_X5-10!#FY_NQ?F?\*,W/\ =B_,_P"%344
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M (<W/]V+\S_A45P;CR?F$6-R]"?45;J&Z_U'_ E_]"% !FY_NQ?F?\*,W/\
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M\*,W/]V+\S_A4U% $.;G^[%^9_PJ*(W'FS86+.X9Y/H*MU##_KI_]\?^@B@
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MF?\ "C-S_=B_,_X5-10!#FY_NQ?F?\*BS<?:^D6[R_4^M6ZA_P"7W_MG_6@
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M5VU% '._\)#K'_0G:K_X$6O_ ,=H_P"$AUC_ *$[5?\ P(M?_CM=%10!SO\
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M!%K_ /':Z*B@#G?^$AUC_H3M5_\  BU_^.T?\)#K'_0G:K_X$6O_ ,=KHJ*
M.=_X2'6/^A.U7_P(M?\ X[1_PD.L?]"=JO\ X$6O_P =KHJ* .=_X2'6/^A.
MU7_P(M?_ ([1_P )#K'_ $)VJ_\ @1:__':Z*B@#G?\ A(=8_P"A.U7_ ,"+
M7_X[1_PD.L?]"=JO_@1:_P#QVNBHH YW_A(=8_Z$[5?_  (M?_CM'_"0ZQ_T
M)VJ_^!%K_P#':Z*B@#G?^$AUC_H3M5_\"+7_ ..T?\)#K'_0G:K_ .!%K_\
M':Z*B@#@M=M!XE>%M6\"ZS<>208U&HQ1JI!R#A9P,CUZU6U71+36]1BU#4?
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M#'%$/N1KNEZ#Z>U>IT4 <[_PD.L?]"=JO_@1:_\ QVC_ (2'6/\ H3M5_P#
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MRT2\O_[0UC_383+=2=U \W 4X&>?< 8Y]AHH YM->U:.-43P;J@50 !]HM>
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M[PK?T?XEZ=_PC6F7WB?_ (D^HWB.39O'(7^0D,P4 L%XSSV[G% '+P_ 3PM
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MS;A5>/#$KANF6 POT)&*K2?%3PDU@UQ9:HMPQ8Q0_N)@DDN,B/<$/)].3[4
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MN%SE"I(P<X^8$CVJ.'XIW2[);WQ'X2@MC'$7*Q3R2)(Z[O+VAN0!GY@2,\$
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M5Q<1F' W_>7^ ^H]JMU#<_ZC_@2_^A"@ ^TQ?[?_ '[;_"C[3%_M_P#?MO\
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M3%_M_P#?MO\ "IJ* (?M,7^W_P!^V_PH^TQ?[?\ W[;_  J:B@"'[3%_M_\
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M  H^TQ?[?_?MO\*FHH A^TQ?[?\ W[;_  H^TQ?[?_?MO\*FHH A^TQ?[?\
MW[;_  H^TQ?[?_?MO\*FHH A^TQ?[?\ W[;_  H^TQ?[?_?MO\*FHH A^TQ?
M[?\ W[;_  J+[1']LW?-CR\?</K]*MU#_P OO_;/^M !]IB_V_\ OVW^%'VF
M+_;_ ._;?X5YW\7?&7B+PEI]@=#M$5+B8++?RJ&2'D84@]-WJ?YUWVDSW=SI
M-K/?1P1W4D8:1;>7S(\^JM@9!ZCZT 3?:8O]O_OVW^%'VF+_ &_^_;?X5-10
M!#]IB_V_^_;?X4?:8O\ ;_[]M_A4U% $/VF+_;_[]M_A1]IB_P!O_OVW^%34
M4 0_:8O]O_OVW^%'VF+_ &_^_;?X5-10!#]IB_V_^_;?X4?:8O\ ;_[]M_A4
MU% %1[B/[3$?GP W\!]O:I?M,7^W_P!^V_PH?_CZA_W6_I7G'Q9\:^)/"KZ3
M#HEK%'#=3*LM_. 8E.[ C/\ =!ZECVZ4 >C_ &F+_;_[]M_A1]IB_P!O_OVW
M^%,T^6YGTZWEO(HHKAXP9$ADWH#_ ++8&1^%6: (?M,7^W_W[;_"C[3%_M_]
M^V_PJ:B@"'[3%_M_]^V_PH^TQ?[?_?MO\*FJ&\-RME<&S6-KH1L85E)"%\?*
M&QSC.,T 'VF+_;_[]M_A1]IB_P!O_OVW^%>/:O\ %?Q9X?\ $,WAZ]T;3;C4
M&%LD<]N9%@ADEQ@2$DDCG QCH:N)\4O$4>A32WNB64.I6>LQZ;=KYK;%#D8*
MCJ3SZ^_M0!ZK]IB_V_\ OVW^%'VF+_;_ ._;?X5R_COQ1JGAY-*M=%LK:YU'
M4[K[-"+IRL:G!/..><8KS>'XU^*[ZVOC9^'+ 7&CPM+JB2RMT#[28P#QCODF
M@#W#[3%_M_\ ?MO\*8\R221!=V=QZJ1V/K7DNA?%_7M8U32+LZ#:1^'M3U'^
MSD<3$SQ2X'WCT/7/ Z UZ[-]^+_>/\C0!YCXK^&DGC#Q79ZQ=:CIZV4-F+3[
M-)"6?:5;+9W8W@N2O& 0,YK.F^%FO3WNE7<WB;3)I=+L'T^%GMVR\3*Z@OA_
MO .?K@9KUZVC0VL)*+]P=O:I/*C_ +B_E0!X)IWP%OM-2]6/Q)IL@N[5K5C)
M;-\@8J=P^;K\OZTES\!=1N[&VM;CQ592_9OEA=H6^1/[@&[&,\YZU[YY4?\
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MKTSRH_[B_E1Y4?\ <7\J /"+SX$7<VFPZ7#XELEL[:ZFN(6> F0^8$&&PV.
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MUO?"?C237WU;29(YX#!+;VUIY"A3@Y0!L Y4=O7O7J7E1_W%_*CRH_[B_E0
MGGP_\]4_[Z%'GP_\]4_[Z%+Y4?\ <7\J/*C_ +B_E0 GGP_\]4_[Z%'GP_\
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M_E1Y4?\ <7\J *UA%!864=JMW),J9Q)<3F1SDYY8\FK'GP_\]4_[Z%+Y4?\
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M5-&N]-MX;.UM1E-2@<C"9!(D[[NH Y!S7K$%M$PDRIXD8?>-2_98?[I_[Z-
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MD TR>Z\06[PWI,NW[.&?<V.QR,].E?0)MHB "&P.@WG_ !I/LL/]T_\ ?1H
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M7V73/$5K>7 4OY5O<1NVT=3@=N15NUO["]O;FSM=56:YMCB>))%+1G_:&.*
M-*BL;4=;T?2+J&UU'7;>TN)_]5'/.B,_.. >O-4I?&GA6":2*7Q78))&2KJU
MW&"I'7/I0!TU%5H@L\,<T-V\D4BAT=64A@>00<=*?Y#?\_$OZ?X4 345#Y#?
M\_$OZ?X52U'4+#2+?S]1U5;6+<$WS2*HR>@Y'L: -.BH%B+*&6XE((R""/\
M"E\AO^?B7]/\* )J*PK[Q'H.F7_V&^\16MM=G'[F6XC5^>G!]:;J/B;P_H]W
M]DU+Q):6EQM#>5/<QHV#T.#0!OT5B:5X@T37)WATG7[:^EC7>Z6TZ2%1G&3B
MM7R&_P"?B7]/\* )J*A\AO\ GXE_3_"CR&_Y^)?T_P * )J*A\AO^?B7]/\
M"CR&_P"?B7]/\* )J*A\AO\ GXE_3_"CR&_Y^)?T_P * )J*A\AO^?B7]/\
M"CR&_P"?B7]/\* )J*A\AO\ GXE_3_"CR&_Y^)?T_P * )J*A\AO^?B7]/\
M"CR&_P"?B7]/\* )J*A\AO\ GXE_3_"CR&_Y^)?T_P * )J*A\AO^?B7]/\
M"CR&_P"?B7]/\* )J*A\AO\ GXE_3_"CR&_Y^)?T_P * )J*A\AO^?B7]/\
M"CR&_P"?B7]/\* )J*A\AO\ GXE_3_"CR&_Y^)?T_P * )J*A\AO^?B7]/\
M"CR&_P"?B7]/\* )J*A\AO\ GXE_3_"CR&_Y^)?T_P * )J*A\AO^?B7]/\
M"CR&_P"?B7]/\* )J*A\AO\ GXE_3_"CR&_Y^)?T_P * )JANO\ 4?\  E_]
M"%'D-_S\2_I_A45Q"PASY\I^9>N/4>U %NBH?(;_ )^)?T_PH\AO^?B7]/\
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MO&_BFP77/$%MXBDBU.YF@69)(4=K@$/R-PX"8Q@#'S#VKZ[\F4XR8..G[O\
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MQ JK%L*/G*Y*G=GOT-=%J_CWQ;;ZO;Z;I?CNWN; "9GUBXTX0Q,Z#+1<*P;
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MV#@'G@5[CY,N,9@QZ>7_ /7I?+FW;MT.[U\LY_G0!\Y_L_);)XTOE&E7+3K
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MBO-]6DB?X&^'!IT5N^IZE;6FC)>J</"&QN4N 3MRI!7W->R%)V&"\1'H4/\
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M",&2+_O@_P"- 'S1)<^(]7\%:OH=@[ZKX+TR-F&HV]HEJ[E(]ZKM8C*JX!;
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M\3_:_OQ[O+_N'U^M 'AWQT;1],\4Z'J\5I]IUM)%\RUN(F:"XA&< Y&UCGC
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M_P"_G_UJ )J*A\R?_G@O_?S_ .M1YD__ #P7_OY_]:@":BH?,G_YX+_W\_\
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MD+')9CP"&/8UZS6?9V$.GR7,EIIT$#W4IFG:,@&1SU9N.35KS)_^>"_]_/\
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MYD__ #P7_OY_]:CS)_\ G@O_ '\_^M0!-4,/^NG_ -\?^@BCS)_^>"_]_/\
MZU11/-YLV(5/S#/S].![4 >"^(!I&@?M VM]>ZA<ZHEZXV^1<XDLIB^U4)4\
MJ,8VG'#<YQS]"US4G@_1I?%*>)7T6W.JHFT3;_\ QXC&"V.,]<5O^9/_ ,\%
M_P"_G_UJ )J*A\R?_G@O_?S_ .M1YD__ #P7_OY_]:@":BH?,G_YX+_W\_\
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MS?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\
M?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $
MU%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_
M:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\
MIC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_
MWS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]
MH_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8
MS?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\
M?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $U%0_:/\ IC-_WS1]H_Z8S?\ ?- $
MU%0_:/\ IC-_WS1]H_Z8S?\ ?- $U0W7^H_X$O\ Z$*/M'_3&;_OFHKB?=#C
MRI1\R]5]Q0!;HJ'[1_TQF_[YH^T?],9O^^: )J*A^T?],9O^^:/M'_3&;_OF
M@":BH?M'_3&;_OFC[1_TQF_[YH FHJ'[1_TQF_[YH^T?],9O^^: )J*A^T?]
M,9O^^:/M'_3&;_OF@":H;7_CW7ZG^9H^T?\ 3&;_ +YJ&VGVP >5*>3T7W-
M%RBH?M'_ $QF_P"^:/M'_3&;_OF@":BH?M'_ $QF_P"^:/M'_3&;_OF@":BH
M?M'_ $QF_P"^:/M'_3&;_OF@":BH?M'_ $QF_P"^:/M'_3&;_OF@":BH?M'_
M $QF_P"^:/M'_3&;_OF@":BH?M'_ $QF_P"^:/M'_3&;_OF@ M^DG_71JFJG
M!/@2?NI3F0GA:F^T?],9O^^: )J*A^T?],9O^^:/M'_3&;_OF@":BH?M'_3&
M;_OFC[1_TQF_[YH FHJ'[1_TQF_[YH^T?],9O^^: )J*A^T?],9O^^:/M'_3
M&;_OF@":BH?M'_3&;_OFC[1_TQF_[YH FJ&'_73_ .^/_011]H_Z8S?]\U%%
M/B68^5+RP_A]A0!;HJ'[1_TQF_[YH^T?],9O^^: )J*A^T?],9O^^:/M'_3&
M;_OF@":BH?M'_3&;_OFC[1_TQF_[YH FHJ'[1_TQF_[YH^T?],9O^^: )J*A
M^T?],9O^^:/M'_3&;_OF@":BH?M'_3&;_OFC[1_TQF_[YH $_P"/J;_=7^M3
M542?_29#Y4O*KQM^M2_:/^F,W_?- $U%0_:/^F,W_?-'VC_IC-_WS0!-14/V
MC_IC-_WS1]H_Z8S?]\T 345#]H_Z8S?]\T?:/^F,W_?- $U%0_:/^F,W_?-'
MVC_IC-_WS0!-14/VC_IC-_WS1]H_Z8S?]\T 35#_ ,OO_;/^M'VC_IC-_P!\
MU#Y_^E[O*E_U>,;?>@"Y14/VC_IC-_WS1]H_Z8S?]\T 345#]H_Z8S?]\T?:
M/^F,W_?- $U%0_:/^F,W_?-'VC_IC-_WS0!-14/VC_IC-_WS1]H_Z8S?]\T
M345#]H_Z8S?]\T?:/^F,W_?- $U%0_:/^F,W_?-'VC_IC-_WS0 /_P ?4/\
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M/;1F3<1]WS2"=N23@ ?6M#QKX(T7QO<Z5/>W30O83>9NC^\Z=2F>P) .<=J
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M=IN,*6/8G(&/:J%W\(4NH<#QC=0.;=K,B"V1(Q:E@PA50> &!.<DG//OO0^
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MJRLAX.1RI!_6@#0HJA81Z?IEE'9VC[((\[5:1G(R<]6))Z^M6?M<'_/5?SH
M'_X^H?\ =;^E>8_&/Q)XJ\/KI+:-+'9:;+.JW.H'YO+?=PK#LF.2>_2O27N8
M3<Q'S5P V>?I7$_$OP;/XZTZVM+37OL<22J9H'4-'( ?O=,[AVYP: .UTJ:>
MXTFUFN9;::9XPSR6I)B8^JY[5<K(T"PL/#V@V6D6LY:"TB$2,YRQ [FM'[7!
M_P ]5_.@":BH?M<'_/5?SH^UP?\ /5?SH FHJ'[7!_SU7\Z/M<'_ #U7\Z *
M&OQ:Q-IZKHM]:V5P)5,DUS%YBB/G=@9'/3K7C,'Q-\:7=PMM'?:5;6\[7+V=
M[=P@&98?E,9520&)!(YKVO4EMM1TN[L6N @N87A+CG;N4C./QKB+[X=6MYX/
MTWPNFM10Z=:QA)BMDADF(/)#$_(3W(&?>@#*\4_$KQ#8?"C1/$^FV4 N+[;]
MID*ET@SQT]SQ^-9]U\5O$MMX-TQGM;3^W9Y8WNC&N](+9W"H[@'"LQ( 4GWK
M3UWP1J'BQKCP_?72:=X;LA&=,E@V;F8<$.@;YACH2!SS1%\%/"L'AD:9%=N+
MXR*\FH<[G 8-MV!@,<8]NM #=+^)]SK/Q*N-(EO(]*TZ&\^Q01/:&1KN56(8
M&3.U,XP!UY%>JS??B_WC_(UYS9?##3['7;>YC\0W9TFVU'^TH=,8 JL^/O&0
M_,>?7MQ[UZ&\T4DD01PQW'@?0T 26W_'K#_N+_*I:AMB/LL/(^XO\JER/44
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MYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH
M/)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?
M(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?
M]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8
MO^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/
M)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(
MHHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_G
MFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O
M^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR***
M #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_
MWR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GF
MG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \
MF+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\B
MCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_W
MR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /*C_
M .>:?]\BCRHO^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/
M)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(
MHHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_G
MFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O
M^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR***
M #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\J/_GFG_?(HHH /)B_YYI_
MWR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GF
MG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \
MF+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\B
MCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_W
MR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_
MYYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F
M+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BB
MB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #RH_P#G
FFG_?-'DQ?\\T_P"^1110 >3%_P \T_[Y%.2-%;(10?4"BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>knwn_s1003.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #B!)T# 2(  A$! Q$!_\0
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M=HJ3[-!_SPC_ .^!1;?\>L7^X/Y5+0!%]F@_YX1_]\"C[-!_SPC_ .^!4M%
M$7V:#_GA'_WP*/LT'_/"/_O@5+10!%]F@_YX1_\ ? H^S0?\\(_^^!4M% $7
MV:#_ )X1_P#? H^S0?\ /"/_ +X%2T4 1?9H/^>$?_? J&.WA-Q,##'@;<#:
M/2K=0Q_\?4__  '^5 "_9H/^>$?_ 'P*/LT'_/"/_O@5+10!%]F@_P">$?\
MWP*/LT'_ #PC_P"^!4M% $7V:#_GA'_WP*/LT'_/"/\ [X%2T4 1?9H/^>$?
M_? H^S0?\\(_^^!4M% $7V:#_GA'_P!\"C[-!_SPC_[X%2T4 59;>$20@0QC
M+X/RCT-2_9H/^>$?_? I)O\ 60?[_P#0U-0!%]F@_P">$?\ WP*/LT'_ #PC
M_P"^!4M% $7V:#_GA'_WP*/LT'_/"/\ [X%2T4 1?9H/^>$?_? H^S0?\\(_
M^^!4M% $7V:#_GA'_P!\"C[-!_SPC_[X%2T4 1?9H/\ GA'_ -\"FR6\ B<B
M&/A3_ *GIDO^I?\ W30!%#;P&",F&,DJ,_(/2G_9H/\ GA'_ -\"E@_X]X_]
MT?RJ2@"+[-!_SPC_ .^!1]F@_P">$?\ WP*EHH B^S0?\\(_^^!1]F@_YX1_
M]\"I:* (OLT'_/"/_O@4?9H/^>$?_? J6B@"+[-!_P \(_\ O@4?9H/^>$?_
M 'P*EHH B^S0?\\(_P#O@5%';PF68&&/ 88^4>@JU4,7^NG_ -X?^@B@!?LT
M'_/"/_O@4?9H/^>$?_? J6B@"+[-!_SPC_[X%'V:#_GA'_WP*EHH B^S0?\
M/"/_ +X%'V:#_GA'_P!\"I:* (OLT'_/"/\ [X%'V:#_ )X1_P#? J6B@"+[
M-!_SPC_[X%'V:#_GA'_WP*EHH JR6\(GA ACP2<_*.>*E^S0?\\(_P#O@4DO
M_'Q!]6_E4U $7V:#_GA'_P!\"C[-!_SPC_[X%2T4 1?9H/\ GA'_ -\"C[-!
M_P \(_\ O@5+10!%]F@_YX1_]\"C[-!_SPC_ .^!4M% $7V:#_GA'_WP*/LT
M'_/"/_O@5+10!%]F@_YX1_\ ? J.>W@%O*1#&"$)!VCTJS45Q_Q[2_[A_E0
MBVT&T?N(^G]P4OV:#_GA'_WP*D7[B_2EH B^S0?\\(_^^!1]F@_YX1_]\"I:
M* (OLT'_ #PC_P"^!1]F@_YX1_\ ? J6B@"+[-!_SPC_ .^!1]F@_P">$?\
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M/_O@5+10!%]F@_YX1_\ ? H^S0?\\(_^^!4M% $7V:#_ )X1_P#? H^S0?\
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M ,])?^_AJ:B@"'[.O_/27_OX:/LZ_P#/27_OX:FHH A^SK_STE_[^&C[.O\
MSTE_[^&IJ* (?LZ_\])?^_AH^SK_ ,])?^_AJ:B@"'[.O_/27_OX:/LZ_P#/
M27_OX:FHH J6T :W0[Y1]'-2_9U_YZ2_]_#1:?\ 'JG^>]34 0_9U_YZ2_\
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M GY&W)V#GBKE0Q_\?4__  '^5 !Y4_\ S\?^."CRI_\ GX_\<%344 0^5/\
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M_/Q_XX*/*G_Y^/\ QP5\L:-\3/%MO;^(_$J:JDMVTULKV\L6]-K>9RHS\@7
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MJGKOQ#\3ZOX\LM"FUV)+2SUA(TN+>,(KXD"AW ;# #G&<=: /IP13 8^T?\
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M@8]^#P>M 'T-+HEE/###-I.F210@B)'@4K'GD[1CC\*B_P"$;TK_ * 6D?\
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M $/FR?\ /O)^:_XT>;)_S[R?FO\ C4U% $/FR?\ /O)^:_XT>;)_S[R?FO\
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M '[;_"EMO^/6'_<7^52T 0_:8O\ ;_[]M_A1]IB_V_\ OVW^%344 0_:8O\
M;_[]M_A1]IB_V_\ OVW^%344 0_:8O\ ;_[]M_A1]IB_V_\ OVW^%344 0_:
M8O\ ;_[]M_A1]IB_V_\ OVW^%344 0_:8O\ ;_[]M_A1]IB_V_\ OVW^%344
M 0_:8O\ ;_[]M_A1]IB_V_\ OVW^%344 0_:8O\ ;_[]M_A1]IB_V_\ OVW^
M%344 0_:8O\ ;_[]M_A1]IB_V_\ OVW^%344 0_:8O\ ;_[]M_A1]IB_V_\
MOVW^%344 0_:8O\ ;_[]M_A0;F+!^_\ ]^V_PJ:D/0T 5K>XC%M$#OR%'\!_
MPJ3[3%_M_P#?MO\ "EMO^/6+_<'\JEH A^TQ?[?_ '[;_"C[3%_M_P#?MO\
M"IJBNKA+2TFN9,^7#&TC;1DX R: $^TQ?[?_ '[;_"C[3%_M_P#?MO\ "O((
M_BQXDU#38];TZPT5=-GO&BB@NKC9.(5^](<NH/T4'K78-\6_ JQ)*VOQ"-R0
MKF"7#8ZX.WG&1^= '7_:8O\ ;_[]M_A1]IB_V_\ OVW^%<E/\6/ MM+Y4OB.
MUW;5;Y5=A@@$<A2.AI/!WQ)TKQKKFK:?IL,OE6.TQW# [9U.02!CY0".,G)!
MSCK@ Z[[3%_M_P#?MO\ "C[3%_M_]^V_PJ:B@"'[3%_M_P#?MO\ "L:[\3Z9
MINHS07)O?,PK?NK">48QZHA%;]0Q_P#'S/\ \!_E0!A_\)OHGKJ7_@JNO_C=
M'_";Z)ZZE_X*KK_XW715P?Q!\3>*/"EI<:K86^DR:5"D2_Z0)#*TKR!",*0
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MAA@MT.!QUYK5B^(F@6$T6E:_K6G6VN1QC[7!"S&.-PN6 8C'X$Y_&@#S:_\
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M<]&Z =.Q[T =%_PF^B>NI?\ @JNO_C='_";Z)ZZE_P""JZ_^-UE?\+?\ _\
M0QV__?J3_P")I[?%KP*B1N_B")4D!9&:&4!@#C(^7GD$?A0!I?\ ";Z)ZZE_
MX*KK_P"-T?\ ";Z)ZZE_X*KK_P"-U2L/BCX)U*^ALK3Q!;/<3-LC0JZ[CZ9(
M KKZ .=_X3?1/74O_!5=?_&ZO:5J]GJ,$UQ;^?Y9E(_>6TD9S@=F4']*U*A@
M.6F_ZZ'^0H /M,7^W_W[;_"L#Q;X=LO%VG6UI/?7]D;:Y6ZBFL\I(KJ"!R5/
MKG\*\UU/XQ>*5\2ZQINF:)II&GSF,6UP[BXD0<%U&0&S@$ <_,N >M=;X?\
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MFN;^"XTB59;2YC):12,?>W@ALE5)R">/K4)^+7@41+*?$$0C<E5<P2[6(QD
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M/^^A7)?$#P_>^+]".CV6HV%K;RLKRO,C.^4=67;A@.W.:Z[RH_[B_E1Y4?\
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ML-!T:[U2^VI;6L32R$ 9( Z#U)["O.Y_C3I5IIUI=W.CL&N('N##%<Q2/"G
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MKNU-O=I=Q><C\ *R\C!&U>.AVCU.>XN(T"+A%^^O;W%2^5'_ '%_*@#YDOO
ML/ASXA:-I&G7'G226;Q7]_/;2/ L\RR+T7@##+C!X.,GK740? 9M.@F2Q\16
MKM=V)M;@W,&[:Q96+1X88^Z ,YZFO=0H P ,>F*Y/QEXRM/"1LH$TR;4K^]9
MA#:6^T.55=S-S[#\: /+[7X$:A:Z1J&FIXFTXPWYB,C&W;<OEDD8^?'.><U)
M;? W4+73(K%/$6EE8[Y;T2&V;<65<;?O?=KJ_ WQ2'BM-6N[O0GL=-LMS+=
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M'/(R"/PJV&MC;B<-$82N\2 C;MQG.>F,=Z /./'O@'5/'"6JS:[901I;!)8
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M^,O_ (&3?_%T =+17-?\(!X:_P"?&7_P,F_^+H_X0#PU_P ^,O\ X&3?_%T
M=+3).8G _NFN=_X0#PU_SXR_^!DW_P 739/ /AH1L?L,O /_ "^3?_%T =)#
MQ!&#_='\J?7+Q> ?#;0H?L,O*@_\?DW_ ,73_P#A /#7_/C+_P"!DW_Q= '2
MT5S7_" >&O\ GQE_\#)O_BZ/^$ \-?\ /C+_ .!DW_Q= %?XG:9=:O\ #;7+
M*SC\RX> ,J>NU@QQ[X4XKR[Q3;Z]\0;3PG>>%;2V@LH "MY#+MDLI HWK+C[
MH7&1BO6?^$ \-_\ /C-_X&3?_%U!%\,_!\$<D<.C)%')]](YY5#_ % ;G\:
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M-_\ %T?\(!X:_P"?&7_P,F_^+H WY ?/@.#@$Y_*IJY63P%X;$T*_8)>2?\
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MO_BZ .EJ.XYMI0/[A_E7/?\ " >&O^?&7_P,F_\ BZCG\ ^&U@D86,N0I/\
MQ^3>G^_0!U"_<'TI:YE? /AHJ#]AEZ?\_DW_ ,72_P#" >&O^?&7_P #)O\
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M'AK_ )\9?_ R;_XNC_A /#7_ #XR_P#@9-_\70!TM0P AILC&9#_ "%8'_"
M>&O^?&7_ ,#)O_BZBA\!>&V:7-A+P^/^/R;T'^W0!U5%<U_P@'AK_GQE_P#
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MYX6FC:.737DC889'NIF!'N"_-$7P[\+01+%#IC11K]U([J957Z /@4 >5?\
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M]Q:2,\@KU&PC) S[_0G:N;_X0#PU_P ^,O\ X&3?_%U<TO0=-T66=-/@>)9
MI?=,[YQG'WF./PH U+;_ (]8?]Q?Y5+7-W'BGP[I<BV>H>([.TNDC4M!+<(C
M*" 1P>>E;%K)#?6L5U:7QGMY5#QRQNK*ZGH00.10!<HJ'R&_Y^)?T_PIDJK!
M$\LMVZ1H"S.S* H'<G% %FBL>'6M(N=)DU:'78)-.CSONEG0QKCKENE5[CQ1
MX>M;2VNKCQ):16]TI:"5[F,+( <$J>AYH Z"BLS3-0T_6K9KC3-62\A5BC/!
M*C@,.Q('7FLVX\8>%[2YEMKCQ38Q3PL5DC>ZC#(1U!';% '2T5DW&KZ7::9#
MJ=QK,45C-M,5PTJ"-]PR,-C!R*GO+JTT^Q>]O=2%O:H S32R*J 'U)&* +]%
M4[22"_M(KNTOC/;RJ&CEC=65P>X('(J;R&_Y^)?T_P * )J*A\AO^?B7]/\
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MHDVD[548 SGT% %^BH=MQ_STB_[X/^-&VX_YZ1?]\'_&@":BH=MQ_P ](O\
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MWNI_+/2M&H=MQ_STB_[X/^-&VX_YZ1?]\'_&@":H8O\ 73_[P_\ 011MN/\
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MK%@0,XY'M7O'E3$ %H<#H/+_ /KUF6/AFST[5]0U6VC47NH%3<RNSOOVYV@
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MQQQ;511T  / J7;<?\](O^^#_C0!-14.VX_YZ1?]\'_&C;<?\](O^^#_ (T
M35SWCN":Z\ >((+>)Y9I-/F5(XU)9B4.  .IK;VW'_/2+_O@_P"-&VX_YZ1?
M]\'_ !H \$^&6K>'+;QT-1L_+T^PCT""TN[B8>3%)>93< 3QDA3Z9VL?>NN\
M+Q:-??%CQ_I[16,]O<+:,UN55DE95/F$KT)#D9]S7I?DRXQF#'IY?_UZ413
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MG_YX+_W\_P#K4>9/_P \%_[^?_6H FHJ'S)_^>"_]_/_ *U'F3_\\%_[^?\
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M2^#[&.XB@2+%LTA)VN#N4L>I&ZLW0/A]$D=MJVI#4M/\0&U2VN&L+LE J *
MI[ A5)QW)H I>!EU[0OBCJ&@:E<A[:ZTF+43'YGF#S_DCD<$]"SB0GUX->KU
MYSX7\*ZG8?$G7?$VHQW*PS6\=I9(\HF9T4*&=CV)* X_VCWKT#[1_P!,9O\
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M_M.NZ7J6N75QJL%Q(;BRE^= 0VTR(YY.3D$=.17JL\<%_ICV=S;S/!-%Y;@
MC((]0<US'@GX?Z-X'N+ZZLDO+BZNV.Z><998\Y"#\>2>IH [BBH?M'_3&;_O
MFC[1_P!,9O\ OF@":BH?M'_3&;_OFC[1_P!,9O\ OF@":BH?M'_3&;_OFC[1
M_P!,9O\ OF@"*[U/3[!XTO;ZVMFD^X)IE0M],GFK=4+F"RO&1KK3EG9/NF6
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M^FS0:I+>/K%]/')G%I)Y?E)D]L(&X[98T :5,E_U+_[IIV1ZBFRD>2_(^Z:
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M>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR***
M#R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_W
MR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG
M_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F
M+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BC
MR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR
M*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_Y
MYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+
M_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB
M@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?
M]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YY
MI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /
M)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(
MH\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O^>:?]\BCR8O^>:?]
M\BBB@ \F+_GFG_?(H\F+_GFG_?(HHH /)B_YYI_WR*/)B_YYI_WR*** #R8O
M^>:?]\BCR8O^>:?]\BBB@ \F+_GFG_?(H\J/_GFG_?-%% !Y,7_/-/\ OD4>
M3%_SS3_OD444 'DQ?\\T_P"^11Y,7_/-/^^1110 >3%_SS3_ +Y%'DQ?\\T_
M[Y%%% !Y,7_/-/\ OD4>3%_SS3_OD444 'DQ?\\T_P"^11Y,7_/-/^^1110
M>3%_SS3_ +Y%'DQ?\\T_[Y%%% !Y,7_/-/\ OD4>3%_SS3_OD444 'DQ?\\T
M_P"^11Y,7_/-/^^1110 >3%_SS3_ +Y%'DQ?\\T_[Y%%% !Y,7_/-/\ OD4>
M3%_SS3_OD444 'DQ?\\T_P"^11Y,7_/-/^^1110 >3%_SS3_ +Y%'DQ?\\T_
M[Y%%% !Y,7_/-/\ OD4>3%_SS3_OD444 'DQ?\\T_P"^11Y,7_/-/^^1110
M>3%_SS3_ +Y%'DQ?\\T_[Y%%% !Y,7_/-/\ OD4>3%_SS3_OD444 'DQ?\\T
M_P"^11Y,7_/-/^^1110 >5'_ ,\T_P"^11Y,7_/-/^^1110 >3%_SS3_ +Y%
-21HJ@[5 ^@HHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>knwn_s1004.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #S @L# 2(  A$! Q$!_\0
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MOLT'_/"/_O@4?9H/^>$?_? J6B@"+[-!_P \(_\ O@4?9H/^>$?_ 'P*EHH
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M(('R\#.>E 'TM]GM_P#GC%_WR*S=>U/3?#NAW>K7MN7M[6,NZPP[W(]A_4X
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M* (OLT'_ #PC_P"^!1]F@_YX1_\ ? J6B@"+[-!_SPC_ .^!1]F@_P">$?\
MWP*EHH B^S0?\\(_^^!1]F@_YX1_]\"I:* (OLT'_/"/_O@4?9H/^>$?_? J
M6B@"+[-!_P \(_\ O@5'" (\   ,< ?4U9JO%]P_[S?S- #;> &VB.^490='
M/I4GV=?^>DO_ '\-+;?\>L/^XO\ *I: (?LZ_P#/27_OX:/LZ_\ /27_ +^&
MIJ* (?LZ_P#/27_OX:/LZ_\ /27_ +^&IJ* (?LZ_P#/27_OX:/LZ_\ /27_
M +^&IJ* (?LZ_P#/27_OX:/LZ_\ /27_ +^&IJ* (?LZ_P#/27_OX:/LZ_\
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MJCE\(6R!,:OX@Y<#_D+3_P#Q5=/4-QTB_P"NBT 87_"&VO\ T%]?_P#!M/\
M_%4?\(;:_P#07U__ ,&T_P#\571T4 <Y_P (;:_]!?7_ /P;3_\ Q5'_  AM
MK_T%]?\ _!M/_P#%5T=% '.?\(;:_P#07U__ ,&T_P#\51_PAMK_ -!?7_\
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M4U% $/E3?\_!_P"^!1Y4W_/P?^^!4U% $/E3?\_!_P"^!1Y4W_/P?^^!4U%
M$/E3?\_!_P"^!1Y4W_/P?^^!4U% $/E3?\_!_P"^!1Y4W_/P?^^!4U% $/E3
M?\_!_P"^!1Y4W_/P?^^!4U% $/E3?\_!_P"^!1Y4W_/P?^^!4U% $/E3?\_!
M_P"^!45O'*8>)R!N;^ >IJW4-K_J/^!-_P"A&@ \J;_GX/\ WP*I0ZE9W$RP
MP:S:RRL<!$D1F/X TWQ.8!X4U@W5Q+;6_P!BF\V>$9>-=ARRCU Y%?+NFZA9
M>![VUOK"RM=9O8K-[C3M2M)&4*&RI,\7JN7'..B]J /K'RIO^?@_]\"CRIO^
M?@_]\"O!;#XI>-9TTNSN]1\/VTFI2JRWY^<6RLFY4E5>%+<=3GFHKOXI>++3
M4M4M5\1:1=Q6=BUU%<V]H/+G<%1L!8\]3TSTH ]YN9DLH3-=ZA%!$#@O+M5<
M_4TR>[AM8XY+C4X(4E($;2,JAR>F">M?-7_"X/&&K:)J-S=7&BR169B)MY[-
M6,I=L?*">W4UEZ;\0/$5AI=UK,MYIU\)]117MKR$2,IV$AD!X1<#;Q[4 ?67
ME3?\_!_[X%'E3?\ /P?^^!7@>C?%KQCJ-E=ZA-?^&[2WF65;5+J78\;KC' R
M2,D*"V!S7HOPS\2ZMXBBU,:O="2XM3$C0_9?*,+$$L"P)5\\$8/ QGDT =OY
M4W_/P?\ O@5%!'*4;$Y'SM_ /4U;J&V_U;?[[?S- !Y4W_/P?^^!1Y4W_/P?
M^^!4U% &=<:A:VDOE7.KVT,@&=DCHIQ]":M*DKJ&6YRI&00HP17S3X_L]$A\
M9>(-5EFAUF$7B17MA([0W5NQ/!A;^)>W'XUI:?\ %SQ>B7ES:VNF1:799@@T
MZY;;<8"?* /O,0!D\8H ^A?*F_Y^#_WP*0QS 9-SQ_N"O!=6^)GBW3-/TRZB
M\5:#?->F,R0VUKEX$;C<_.  >.>]9O\ PM_QG+XQDT"+5=*$1OFM$NI;9=I4
M.5#G!Q@]: /H2&\@N+5[J#5();>/.^5&1D7 R<D<# J2WD%W L]M?QS0M]V2
M/:RGZ$5\G6'C_P 1:KXA@N%O=.LQ9VMS(MN(%2V?$3%@T8X9F P,^U=)X<^,
M/C"_F@M+(:!9P6D7FSK*JP1RCS ,#T)WJ,*,]Z /I+RIO^?@_P#? H\J;_GX
M/_? KR;PQX]\0ZIXWMK&]U33WL;FXE^S_8;?S8KB(+GY9,[E*GKN [5Z_0!#
MY4W_ #\'_O@5%/'*!'F<G]X/X!5NH;CI%_UT6@ \J;_GX/\ WP*/*F_Y^#_W
MP*FHH A\J;_GX/\ WP*/*F_Y^#_WP*FHH A\J;_GX/\ WP*/*F_Y^#_WP*FH
MH A\J;_GX/\ WP*AN8Y1;N3.2,=-@JY4-W_QZR?2@ \J;_GX/_? H\J;_GX/
M_? J:B@"'RIO^?@_]\"CRIO^?@_]\"IJ* (?*F_Y^#_WP*/*F_Y^#_WP*FHH
M A\J;_GX/_? H\J;_GX/_? J:B@"'RIO^?@_]\"CRIO^?@_]\"IJ* (?*F_Y
M^#_WP*9#D1X)R=QR?7DU9JO%]P_[S?S- #;?[1]FBVB+&P8R3Z5)FY](?S-+
M;?\ 'K#_ +B_RJ6@"'-SZ0_F:,W/I#^9J:B@"'-SZ0_F:,W/I#^9J:B@"'-S
MZ0_F:,W/I#^9J:B@"'-SZ0_F:,W/I#^9J:B@"'-SZ0_F:,W/I#^9J:B@"'-S
MZ0_F:,W/I#^9J:B@"'-SZ0_F:,W/I#^9J:B@"'-SZ0_F:,W/I#^9J:B@"'-S
MZ0_F:,W/I#^9J:B@"'-SZ0_F:,W/I#^9J:B@"'-SZ0_F:BM_M'D_*(L;FZD^
MIJW4-K_J/^!-_P"A&@!LB32QM')' \;@JRMD@@]01BJ<&C6EJTC6^EZ;"9$*
M.8X0NY3U!P.1[5YMXD@N(OV@O#<;27D>FWMNTC)]HD6*6:-7/3=C(Q'Q]/6N
M8L?&-[X0\3:E#9Z/-J=Q=:_<Z;:/<ZDX2-08]L05B>A8')'?KUH ]P&BV8M&
MM1I>FBV9][0B$;"WKC&,^]-?0K"2..-](TMHXL^6I@4A,G)P,<<UX_<_&F;Q
M+I#:+:6(L-8N%N8IV^TE5@5$+!D<*<DX(QP<_7-8WP^^+NL6.D6.A6NAWNNW
M:&2:YE:<M)L+YRO7( (ZD<T >[?\([IG_0$TG_P&7_XFC_A'=,SG^Q-)SZ_9
ME_\ B:\!\5_$37_%L6F:A902Z;';ZL+,6T=ZRF9^& ?  'IU/4\5T=U\9]1O
M[34-/E\/6CW-NL_VRR6]DC>..,?,V\* >G\)S0!Z\NA6")(B:1I:K* )%$"@
M. <C/'/-6;2S%A#Y-G:6=M%G.R%-BY]< 5X3I'QWOX='G-GX4A%CIT:-*6U!
MF959PHY8$L<L*Z*U^,^HZKK<=CI_A^*/SKNWMHX[N=A*!*N1*RJI 0<=_P"(
M4 >MYN?2'\S44'VC8VT1??;J3ZFK=0VW^K;_ 'V_F: #-SZ0_F:,W/I#^9J:
MO,_CFE['\/S?:>]U%<6MPC&6VE="B'(8G:1QTZT =O)HMG+<_:9-*TUYRV[S
M6A!;/KG&<U*--A6\:\%A8"Z<$-,(QO8'KEL9KQSQ?>#P_KVAWL%M=WUM!H#7
M4ELNH2(CLA7#L=W.,^Y/O4@^/L]G$QU?P^EJ\]@+NR\NX,@ESG:K87Y<X//:
M@#UE-"L(XY(TTC2U24 2*L"@/@Y&1CGFF?\ ".:9C']B:1C_ *]E_P#B:^?;
M7XGZKX3\=Z[=W:3ZG-=QQ"WM!>,\,9?8^ 2.P.!A>O'O71>(OBKX@U>SO?#K
M:!/HE\^FS7$LKW+))'L5V.S"YP0N.<<YZ=: /8/^$=TP]=$TG_P&7_XFG1Z#
M812I+'H^EI)&P9'6W4%2.A!QP:\-\,?&#5O#/A?3;#4[&&3?9O<6UW=7,CM=
M_O6 7A6VG((Y.  /45-:?&'4=-\676E6_A")=6NKP6TJ-JCNIFW$8&X%5&2>
MF!0![C;:3;65PT]KINGP3,,-)%$%8CT) S5S-SZ0_F:\7@^/5U=0VRIX>C@G
M:2>.66>X/DAXUW!5*J26(P.@Y(KU7PKJUWKOABPU6]M8[6:[B$ODHQ;8IY )
M(!SCKQ0!IYN?2'\S44_VC$>1%_K!C!-6ZAN.D7_71: #-SZ0_F:,W/I#^9J:
MB@"'-SZ0_F:,W/I#^9J:B@"'-SZ0_F:,W/I#^9J:B@"'-SZ0_F:AN?M'V=]P
MBQCL35RH;O\ X]9/I0 9N?2'\S1FY](?S-344 0YN?2'\S1FY](?S-344 0Y
MN?2'\S1FY](?S-344 0YN?2'\S1FY](?S-344 0YN?2'\S1FY](?S-344 0Y
MN?2'\S3(<^7SC.XYQ]35FJ\7W#_O-_,T -MY)!;1 0.1L'.X>GUJ3S9?^?=_
M^^E_QI;;_CUA_P!Q?Y5+0!#YLO\ S[O_ -]+_C1YLO\ S[O_ -]+_C4U% $/
MFR_\^[_]]+_C1YLO_/N__?2_XU-10!#YLO\ S[O_ -]+_C1YLO\ S[O_ -]+
M_C4U% $/FR_\^[_]]+_C1YLO_/N__?2_XU-10!#YLO\ S[O_ -]+_C1YLO\
MS[O_ -]+_C4U% $/FR_\^[_]]+_C1YLO_/N__?2_XU-10!#YLO\ S[O_ -]+
M_C1YLO\ S[O_ -]+_C4U% $/FR_\^[_]]+_C1YLO_/N__?2_XU-10!#YLO\
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M_P#/N_\ WTO^-344 0^;+_S[O_WTO^-'FR_\^[_]]+_C4U% $/FR_P#/N_\
MWTO^-'FR_P#/N_\ WTO^-344 0^;+_S[O_WTO^-'FR_\^[_]]+_C4U% $/FR
M_P#/N_\ WTO^-,AYCR1@[CQZ<FK-5XON'_>;^9H ;;W"+;1 A\A!T0^GTJ3[
M3'Z2?]^V_P *6V_X]8?]Q?Y5+0!#]IC])/\ OVW^%'VF/TD_[]M_A4U% $/V
MF/TD_P"_;?X4?:8_23_OVW^%344 0_:8_23_ +]M_A1]IC])/^_;?X5-10!#
M]IC])/\ OVW^%'VF/TD_[]M_A4U% $/VF/TD_P"_;?X4?:8_23_OVW^%344
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MYBHJD!,G: ,D8 ';GH*Z*#X1^')WCU:6;68=:>[6_:[D*^<DGWMI4*8\!N>
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MO<T /^T0_P#/:/\ [Z%'VB'_ )[1_P#?0KC-9\=-I'C_ $WPH-$\Z34%#PW
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MGZFC[)!_<_4T 345#]D@_N?J:SM;OK+0=,DU"XM+J:&+)D%M&9&50"2Q /0
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M_P"_\7_QN@#I**YO_A$Y_P#H:O$'_?\ B_\ C='_  B<_P#T-7B#_O\ Q?\
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M868"4Y.PNQ3\-I7'MBNUKF4\'RQQK''XHUY$4!559H@ !T 'E]*=_P (G/\
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M]_\ UZ )J*@'G%=PGBQZ[/\ Z](6D&,W,(ST^7K^M %BBH%\YAE9XR/4)_\
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M^_G_ -:HH&G\ML1(?G;^/W/M0!;HJ'?<?\\4_P"_G_UJ-]Q_SQ3_ +^?_6H
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M(H^SP_\ /&/_ +Y%244 1_9X?^>,?_?(J*$ 1X P QP!]35FJ\7W#_O-_,T
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FJ_\ WV?\:/*7U?\ [[/^-%% !Y2^K_\ ?9_QJ1$54  XHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>knwn_s1005.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $' I(# 2(  A$! Q$!_\0
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M_P \(_\ O@4?9H/^>$?_ 'P*EHH B^S0?\\(_P#O@4?9H/\ GA'_ -\"I:*
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M?"5%1+H,74D;BVS!VGY>IZ=Z .\\)^([#Q?IIU&STFYMK,DK'+=1QCS"&*L
M%8G@J>N*N_VQH)\1?V )[8ZIY/GFW5,D)ZDXP.HX)S7A2_#OQA%H_AJ*ZT>:
MZMK2TO8IK%)T/ES.9=CX+!>=T9R#GY?:KWPP^&GB3PKX[L=3US2UF@EM&Q*D
MBN;:4XQOR0<@ C*YZT >B3^/;.#4M0T\>$]9ENM/C66XCA@A=@C?=( DRV?0
M<UV4$=O/!'+]F5-ZAMCQ@,N1G!'K7E[^#[KQ/\2]2U+4M.U?3M/=;62WF$T:
MAGA/(=5=L@]LC\JX36OA_P"//.OY+?2[J;56U5[A-1BN4&Z H0%#%PW4],4
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M41XAC&9 #\HJ7[-!_P \(_\ O@4EQTB_ZZ+4U $7V:#_ )X1_P#? H^S0?\
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M_GI+_P!_#4U% $/V=?\ GI+_ -_#430+]IC&^7E6_C/M5NH7_P"/N+_<;^E
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M#_J(_P#='\J* &6\<IMHB)R!L&!M''%2^5-_S\'_ +X%+;?\>L/^XO\ *I:
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MF4?>0D'<C]R2-HYYZ4 >E_VMIYD>/^W+/?&&+KYL>5V]<C/&,<U-:7D%_O\
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ME'IG'6M?0/B_XDEOO[*2;2;!2UQ*]U#:(H;9$648R!R4QGJ=WL* /I;RIO\
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M>5<MM"/DX;*YR!Z9KK_!_P 0-3\5:CK>AWFDII^J65N)4,4XD4[E&WG'7D4
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MM4 5+?[1Y7RB+&YNI/J:=)'--$T4L=N\;@JRMDA@>H(I]M_J/^!-_P"A&IJ
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M3P[IIV\ZX0$ 1JP[Y^8@8&%->D?!2\-Y\/XV;69]4E2X99&F5@8&(5C&"W+
M;LY]2<< 4 =]_I([0_F:C'VC[6W$6[8.Y]35NH1_Q^M_US'\S0 ?Z3Z0_F:H
M2:+9RW#7$FEZ:\S-O,C0 L6]<XSFM6N8\?>+AX(\*3ZS]E-TZ.L:1;MH+,>,
MGTH TYM%L[B=IY]+TV65_O2/ &8_4D5'_P (_IPZ:-I7_@,O^%>3ZE\=M3TS
M5&T=_#UM+J(FC0%+HB(AU!')7.<L.V.M=-HOC36O''A/Q5:V>G_V=K^G&2U0
M13!E\W# ;6/<%3[=* .R_P"$?T[_ * ^E?\ @.O^%'_"/Z=_T!M*_P# 9?\
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M?7(^;F@#Z._TGTA_,TA^TXZ0_F:GI#T- $$/^HC_ -T?RHHA_P!1'_NC^5%
M&!!KVNBWB \'WQ 08/VRV]/^NE2?V]KW_0G7_P#X&6W_ ,<KB/%NI7VI?%3P
MGX0-[<6VDSVOVN=;25HI)6"R84N#G;\@X&.I]L3W^LWWPN-AI"ZA-X@_M?4/
M)L4O7VM:@L 0\OS,XRZX^7U]A0!V']O:]_T)U_\ ^!EM_P#'*/[>U[_H3K__
M ,#+;_XY7F47Q^O;R_CTZQ\++-??O1*C7NU 4W$[25Y&U<\XYXJ/_AH2Z@L;
M>\O/"HC@NXI&M6CO0V]D;:01M&T9SS^E 'J/]O:]_P!"=?\ _@9;?_'*/[>U
M[_H3K_\ \#+;_P".5YQ<?'>\TO3+:]U;PHT":A;&?3S%>+()<''S\ H/P)]J
MCN/C]-;W*V:Z!#/</-&B2Q7A,#*Z@_>V9R"0,8['F@#TO^WM>_Z$Z_\ _ RV
M_P#CE']O:]_T)U__ .!EM_\ '*X#_A=]S]IDL&\.K'=0ZD;&>YDN2+.+&0&,
MFS(Y4G!4< G-:%]\5M2LM%M-1ET72XDEAFE+2:U"4D\OHL.S<SD].@P2/K0!
MU_\ ;VO?]"=?_P#@9;?_ !RN9U;PY9ZYJ5QJ.H_#>[GN[A0DTG]HPKYB@  $
M+, 1\H_(5YG;_&'7-;U'7KZYM1)HL5BLITL7;0F/YXTRLJ*'SN.<9 P371V/
MQX$>D-=6_ATC3;!K:WF\R]9ILR!L[<J=V-C<LP)X]Z -S6?"J75M>3:?\,Q'
MJ$L6R-GO8$B#;2JL460J2H)(^4\_G6)X,^'UUI.@&Q\2> /[2N@'C6=-0B8&
M-CG&UI $.>ZU<TCXZ3:@^GSS^'TBL;S43IX9+HM*K84AMI4#'SKW]:]<LFO6
MM\W\4$<^X_+!(77;GCDJ#G'M0!YD_@;1I)_/?X87;39!\QM4C+9'0Y\[-++X
M'T:< 3?#&[D 8L ^IQL 3U/,W4]_6O5:* /*'\":'($$GPNN7"+M0-J41VCK
M@?ON!R?SH?P)H<K[Y/A=<NV -S:E&3@# &?.[  ?A7J]% 'GVB:6OAR^N+W2
M?A]?6UQ<#$SC4H6\SG.6W2G)SWZ\GUK>_M[7O^A.O_\ P,MO_CE='10!SG]O
M:]_T)U__ .!EM_\ '*/[>U[_ *$Z_P#_  ,MO_CE='10!SG]O:]_T)U__P"!
MEM_\<H_M[7O^A.O_ /P,MO\ XY71T4 <Y_;VO?\ 0G7_ /X&6W_QRC^WM>_Z
M$Z__ / RV_\ CE='10!SG]O:]_T)U_\ ^!EM_P#'*C;7==^T1G_A#[[(5L#[
M9;>W_32NGJ%_^/N+_<;^E &%_;VO?]"=?_\ @9;?_'*@O-2U74;*:SO/ ]W/
M;3*4DCDN[8JP/8_O*ZJB@#RA_ FAR[?,^%UR^U0J[M2C. .@&9N![5HZ7H4&
MBZA)?Z=\/+^"ZDC,;RC4XB64C&#F8Y_I7HU% 'FT'ARSMW:1?AM=,[3+.[RZ
MA#(7=?NEBTI+ >AR.AQQ5Z2UEGUI-7F\!7\M[&_F(\NI0NJ-C;N5#+M!QW K
MNZ* /+1X,T8:C]O'PLD^T>;YV?ML&W=G/W?-VXSVQBMC4+:;5=7L]5O? 5_)
M?67_ ![2_P!HPKY?.> )0.>_'/0\5W5% 'G6GZ':Z3K;ZS8_#26#4'+$S+=V
M_!;J0/,POX 5T7]O:]_T)U__ .!EM_\ '*Z.B@#E[C7==,#!O!]\!Q_R^6WK
M_P!=*E_M[7O^A.O_ /P,MO\ XY6[=_\ 'L_X?SJ:@#G/[>U[_H3K_P#\#+;_
M ..5RE_X3TS4[N>YN_AE<227$GFRXU"%5=\8W%1*!GD\X[GUKTZB@#RJ/P1H
M\)A,?PRO$,+^9%MU2,;&X^8?ON#P.1Z"M2_TM=4U9=4OOA]?7%XH(2234H3Y
M>5VDJ/-PIP!R #D ]>:]!HH \^GTL7&D6VE-\/[]+"V0I'!#J44:X/4';,-V
M>^<]_6JVJ^&=/UN:&74/AA+*\$0AC(O+=-J#HORRC@5Z510!P$FG"3PXOA\_
M#RZ725QBV2^@13CU(E!/XGFJ=[X8T_43:&\^&=Q.UI&(X6DOH"0HZ GS<L![
MYKTNB@#FDUO6XT5$\&7JHHPJK=VP 'H/WE._M[7O^A.O_P#P,MO_ (Y71T4
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M2+(I>?4(90 _WPJO*0H/0X XXZ5WM% 'F&G>$-*TG48=0LOA=+%=0MOC?[=
MVT^H!E(_PK3GLGNM>_MR?P!?2:CY?E>:VH0D%,8*[?-V[<=L8[UWE% 'GFA:
M-!X:O)KO1_AM/:7$HVO(EY;DXZX&93@?2N@_M[7O^A.O_P#P,MO_ (Y71T4
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M$<8Z#OS6/K?QC>Z\:>'[+1I[NUMTO7M]5LY+57E.UE&!MW9S\P&TY_2NDO\
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M5_NC\J (_M$'_/:/_OH5$T\/VJ,^:F K<[A[59VK_='Y5"RK]KB^4?<;M]*
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M=UR1;B( #:(0H Z<\].*]DGUO1K<PAM4+^=+Y*&%S(-_'!*@XZCKBM7[./\
MGK-_WV: /%)OA?XON+:32K(Z?H^ER1SK- MR]S Y8Y!CC<9C/N#Q67<?!/7]
M3T**UGM;&&^M+18XKN6_EF9V5B=BK@*B8/H<<^M>_P#V<?\ /6;_ +[-1SB&
MUMY)[BZ>*&-2SN\F H'4DT ><_#_ ,$Z_HGCK4]=U:&UA@NK"*V1(KCS&#(L
M:\_*.#L)_&N/M_@[XJB^)@U\_8/L0U9KSB<[]AD+=-O7%>GM\0O!:"-CXFA*
MR()%(D8@*3M!) ^7D8YQ6YINHZ9K'VC^SM1-Q]FE,4P20Y1O0_S!Z'M0!X?X
M3^$'C+PGX@M->CBTN[GA\]3:M<%5^:,JI+;>1ECD8Z#WXT]6^%_BC4/$M]K5
MS8Z5<C4K%(I[.VO)+6)'!3Y6(!+K\F>HR<>E>V?9Q_SUF_[[-'V<?\]9O^^S
M0!\_O\$O$L.D>(+"U73E2\NK>2V5;A]H2,R9!W G^(=<U%9?!;Q7_9%GH][!
M8&V35/MD\B7AYC*JK*!MZX4\Y[U]"_9Q_P ]9O\ OLT?9Q_SUF_[[- 'S[)\
M#?$KL+TWL;7%G=HMG!]I./LJG*@/MRK#MUKU7X>^%9_#5OJ<ES86]G-?7/FL
MD5U)<,W7YG=^K'/8"NM^SC_GK-_WV:/LX_YZS?\ ?9H FHJ'[./^>LW_ 'V:
M/LX_YZS?]]F@":H7_P"/N+_<;^E'V<?\]9O^^S430#[3&/,EY5N=_P!* +=%
M4KQ[;3[.:[O+QH+>%2\DDDF%4#N:R-#\5^&_$ES);Z/KL=Y-&NYHXY3NQZX/
M6@#I**A^SC_GK-_WV:/LX_YZS?\ ?9H FHJ'[./^>LW_ 'V:/LX_YZS?]]F@
M":BH?LX_YZS?]]FC[./^>LW_ 'V: )J*A^SC_GK-_P!]FC[./^>LW_?9H +O
M_CV?\/YU-5.Y@"V['S)3TZO[U-]G'_/6;_OLT 345RDOC?PE#K']DR>)(%OA
M((C$9CPY[9Z9_&NE^SC_ )ZS?]]F@":BH?LX_P">LW_?9H^SC_GK-_WV: )J
M*A^SC_GK-_WV:/LX_P">LW_?9H FHJ'[./\ GK-_WV:/LX_YZS?]]F@":BH?
MLX_YZS?]]FC[./\ GK-_WV: "V_U'_ F_P#0C4U5+> &+/F2CYFZ/[FL/6?&
M/A;P]??8=6\016MUM#^4\I) /3..E '3T56B2*>%)H;EY(G4,CI+E6!Z$$=1
M3_LX_P">LW_?9H FHJ'[./\ GK-_WV:IZG>6&BZ?)?ZEJ!M;6(?/+++@"@#2
MHK TCQ'H.O)<-IFL"Y^S#=,%<AD!&<D$ XQ5C1=5TKQ%8?;M(U(W=L',?F1N
M<;AC(Y^HH UZ*YJT\6>&[[63I%KK0DU /)'Y 9L[DR7'3&1CFH[#QKX5U3[0
M;+7UF%M;O=2E78;85.&?D<@'N* .IJ$?\?K?]<Q_,UCZ'XAT+Q(TZZ/JQNV@
M"M*$9@5#9*GD#@@'%:8@'VMAYDOW <[_ '- %NBL;6]8TCPY9K=ZQJHLX&;8
MK2R'D^@'4TNBZOI'B*S-WH^J"\@#;"\4I.#Z$=10!L45#]G'_/6;_OLT?9Q_
MSUF_[[- $U%0&W &3-+C_?KG;3QIX5OM573+7Q#%+=O(T2(LIPSKU4-T)^A[
MCUH ZFBL:+6-(GU^?0HM3+:I!&)9;4.=RKP<G_OI?SJKK7BGP]X=N5MM7UG[
M),T?FA'9B=F<;N!P,\4 ='17-7GB[PUI^IKIMUK8BO&,8$19LY?[G; SGBE'
MBOPX=<_L4:UG4?-,'D;FSY@&=N<8SCWH WKCI%_UT6IJJ3P "/\ >2G,@'+U
M(8% ),TH ZDO0!/17*V7C;PGJ.KKI5IXC@FOF<QK"LQRS#J >AZ=JZ3[./\
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MR1QUKZ!N[!+]56\L[*Y53E1-'O ^F14-UI=DT"&[L-,,4"X0RQ+MC7T&1P*
M/F)?'_C>_P!+UO4YO$M_;36*P%8(U"*=[!3QCCCFGZYX_P#&.D:U)HP\5WK0
M*\$AN'"^8 T:D\XZ#>>/85]-C3K.Z1Y!8Z;,LX&YO+#"3'3)QSBN;\9_#BT\
M90V:.UO8/;7"S&2"!2TF!@*>G'^% 'C5SX]\2Q^*8M#L?$]WJ6A_;T1-1#K
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MC4 !% [85?\ OD4 =?14/^D^D/YFC_2?2'\S0!-14/\ I/I#^9H_TGTA_,T
M345#_I/I#^9H_P!)](?S- $U%0_Z3Z0_F:/])](?S- $U0O_ ,?<7^XW]*/]
M)](?S-1-]H^TQ\19VMCD^U &-X_BTN?P)J\>M&X73FA_?-;H6D4;A@@#K@X/
MT%>+_L^ZUY7B&\T**QBEAD$ER+UD_>(!M4+[ XSCUKZ#D\XQ.)5MS&5.X,3C
M'?/M6-X=T71=&6X3P_::9 )6#S?9FR2>V?\ "@#HJ*A_TGTA_,T?Z3Z0_F:
M)J*A_P!)](?S-'^D^D/YF@":JU_-<V]E)+9VGVNX4#9!Y@CW\_WCP..:?_I/
MI#^9H_TGTA_,T 1Z=/=W-DDM[9?8[@D[H/-$FWGCYAP<CFK50_Z3Z0_F:/\
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MVEMF]@>WGE0;9&1EVD;L9Z57M/#.GVFF66G_ -GV4\-E"L$!N4$C*BC &2*
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M #[M_P!]+_C1YLO_ #[M_P!]+_C0!-14/FR_\^[?]]+_ (T>;+_S[M_WTO\
MC0!-14/FR_\ /NW_ 'TO^-'FR_\ /NW_ 'TO^- $U%0^;+_S[M_WTO\ C1YL
MO_/NW_?2_P"- $U%0^;+_P ^[?\ ?2_XT>;+_P ^[?\ ?2_XT 35"_\ Q]Q?
M[C?TH\V7_GW;_OI?\:B:23[3&?(;.UN-P]O>@#'\>VD%_P"!M6M+G5$TN&6'
M:UX[86/D8R?0G /UKQ?]GV^TJV\07NEM:,^JR"1X[V-_W?DKM!7&><GD<=Z]
M]OK:+4[&:RO=/$]M.A22*0J58'\:YKPA\/=!\$S7$^DZ?.;B?@S3RJ[*O]U3
MV% '9T5#YLO_ #[M_P!]+_C1YLO_ #[M_P!]+_C0!-14/FR_\^[?]]+_ (T>
M;+_S[M_WTO\ C0!-5>^O%L+*2Z:&>98\9CMXC(YYQPHY-.\V7_GW;_OI?\:/
M-E_Y]V_[Z7_&@"/3[Y=1LDN4@N8%8D>7<PF)Q@XY4\BK50^;+_S[M_WTO^-'
MFR_\^[?]]+_C0 7?_'L_X?SJ:JES)(;=@8& XYW#U^M2^;+_ ,^[?]]+_C0!
M\KWC:%X;^,\MU?W \06+3M)O@D^=)68@*3D89&QWZ8KZNKA)OA?X7G\7#Q(^
MCN;L-YAAWKY#/_?*>O?T]J[7S9?^?=O^^E_QH FHJ'S9?^?=O^^E_P :/-E_
MY]V_[Z7_ !H FHJ'S9?^?=O^^E_QH\V7_GW;_OI?\: )JS=.UJ/4KJ:!++4(
M#%U>YM7B1N<?*2,'\*N>;+_S[M_WTO\ C1YLO_/NW_?2_P"- $U%0^;+_P ^
M[?\ ?2_XT>;+_P ^[?\ ?2_XT %M_J/^!-_Z$:^?_P!HNPMFU33=0_M:)KE(
MA$=,9OG"%F/FJ/0D%2?85[W;R2"'B!C\S?Q#U/O7-^,? 6B>.$M_[7T^830'
MY)X)%23;W4GG*]\?EWH F^'6I:5JW@?3[O1;*6RT\[UBMY'W%-KE3SD\9!QS
M74UG:;96^CZ=!I^GZ<+>T@79'$A4 #\^OOWJWYLO_/NW_?2_XT 345#YLO\
MS[M_WTO^-'FR_P#/NW_?2_XT 345#YLO_/NW_?2_XT>;+_S[M_WTO^- %.ZU
MF.TU2&P:RU"1I=N)H;5WB7)Q\S@8'OGI6E4/FR_\^[?]]+_C1YLO_/NW_?2_
MXT 35"/^/UO^N8_F:/-E_P"?=O\ OI?\:B$DGVMCY#9V#C</4^] ''?&"QM]
M1^'EY!<:O%I@#JZ22MA96&2(S]?Y@5Q'[.VHZ4]C?:=!8R1:I$OFW%SN^25"
MQVC&>H^E>NZWI-IXBTF?3-4T[S[68892RY![$'/!'K67X0\%:1X(LY;?1["4
M-,VZ2>:16D?T!/' ]* .JHJ'S9?^?=O^^E_QH\V7_GW;_OI?\: )J*A\V7_G
MW;_OI?\ &CS9?^?=O^^E_P : )JIZGJ*:7:BX>VN[@%@NRU@:5^>^U><>]3>
M;+_S[M_WTO\ C1YLO_/NW_?2_P"- !:W N[2*X6.6,2*&"3(4=<]BIY!]JFJ
M'S9?^?=O^^E_QH\V7_GW;_OI?\: "XZ1?]=%I;D!K68-)Y:E""_]WCK4,\DA
M$>8&'[P?Q#_&I#)(RE6MF((P067G]: /ESX?OHGA[XP"UN91KBRW"0V&H6\A
MQYKLI$A.1G@D$<\YZU]55PNE?##PSH_BJ3Q#::1(+MF+1Q-(IBA8]61>QZ_3
M/&*[3S9?^?=O^^E_QH FHJ'S9?\ GW;_ +Z7_&CS9?\ GW;_ +Z7_&@":BH?
M-E_Y]V_[Z7_&CS9?^?=O^^E_QH D=MD;.0QV@G"C)/T%4-*U>/5DD=+._MO+
M(!%Y;-"6SZ;AS5OS9?\ GW;_ +Z7_&CS9?\ GW;_ +Z7_&@":D/0U%YLO_/N
MW_?2_P"-(99<'_1V_P"^E_QH 2'_ %$?^Z/Y440_ZB/_ '1_*B@!]M_QZP_[
MB_RJ6JMO<(MM$"LG"#HA]/I4GVE/[LG_ '[;_"@":BH?M*?W9/\ OVW^%'VE
M/[LG_?MO\* )J*A^TI_=D_[]M_A1]I3^[)_W[;_"@":BH?M*?W9/^_;?X4?:
M4_NR?]^V_P * )J*A^TI_=D_[]M_A1]I3^[)_P!^V_PH FHJ'[2G]V3_ +]M
M_A1]I3^[)_W[;_"@":BH?M*?W9/^_;?X4?:4_NR?]^V_PH FHJ'[2G]V3_OV
MW^%'VE/[LG_?MO\ "@":BH?M*?W9/^_;?X4?:4_NR?\ ?MO\* )J*A^TI_=D
M_P"_;?X4?:4_NR?]^V_PH FHJ'[2G]V3_OVW^%'VE/[LG_?MO\* )J*A^TI_
M=D_[]M_A1]I3^[)_W[;_  H FJ%_^/N+_<;^E'VE/[LG_?MO\*B:X3[5&<2<
M*W\!]O:@"W14/VE/[LG_ '[;_"C[2G]V3_OVW^% $U%0_:4_NR?]^V_PH^TI
M_=D_[]M_A0!-14/VE/[LG_?MO\*/M*?W9/\ OVW^% $U%0_:4_NR?]^V_P *
M/M*?W9/^_;?X4 345#]I3^[)_P!^V_PH^TI_=D_[]M_A0 7?_'L_X?SJ:JES
M.C6[ "3MU0^OTJ7[2G]V3_OVW^% $U%0_:4_NR?]^V_PH^TI_=D_[]M_A0!-
M14/VE/[LG_?MO\*/M*?W9/\ OVW^% $U%0_:4_NR?]^V_P */M*?W9/^_;?X
M4 345#]I3^[)_P!^V_PH^TI_=D_[]M_A0!-14/VE/[LG_?MO\*/M*?W9/^_;
M?X4 %M_J/^!-_P"A&IJJ6]P@AQMD^\W1#ZGVJ7[2G]V3_OVW^% $U%0_:4_N
MR?\ ?MO\*/M*?W9/^_;?X4 345#]I3^[)_W[;_"C[2G]V3_OVW^% $U%0_:4
M_NR?]^V_PH^TI_=D_P"_;?X4 345#]I3^[)_W[;_  H^TI_=D_[]M_A0!-4(
M_P"/UO\ KF/YFC[2G]V3_OVW^%1"X3[6QQ)]P#[A]3[4 6Z*A^TI_=D_[]M_
MA1]I3^[)_P!^V_PH FHJ'[2G]V3_ +]M_A1]I3^[)_W[;_"@":BH?M*?W9/^
M_;?X4?:4_NR?]^V_PH FHJ'[2G]V3_OVW^%'VE/[LG_?MO\ "@":BH?M*?W9
M/^_;?X4?:4_NR?\ ?MO\* "XZ1?]=%J:JD\Z$1_+)Q(#]P_X5+]I3^[)_P!^
MV_PH FHJ'[2G]V3_ +]M_A1]I3^[)_W[;_"@":BH?M*?W9/^_;?X4?:4_NR?
M]^V_PH FHJ'[2G]V3_OVW^%'VE/[LG_?MO\ "@":BH?M*?W9/^_;?X4?:4_N
MR?\ ?MO\* )J0]#47VE/[LG_ '[;_"@W*8/RR?\ ?MO\* &P_P"HC_W1_*BB
M'_41_P"Z/Y44 >5^+_%NKZ;\3?#^@PZM=66E76GB6<6EHL\N[]Y@J-C'^%>@
MZ9JIX<^*\FGZCJUIKE]+J:MJOV'2X%@6.\?MET(157E1DX.2WIQTNL^#+K4?
M'&C>+=/UFSMKC3[,0+;W$!D5B0^22'4]'_2N6O?@A%J.L7&N77B&V?5)]0^V
M,GV;_1BN=Q0IOW')[[NGYT ;T/QR\,W5U%9VMEJL]XXD+0+"@:/9DL"2X'12
M>">/?BG+\<O"L\/F64.I792V:ZG2*%08$! .[<P!(R/NYK)@^#PCURRU5]>T
M])88IHY(K73XX$;>KJ" A'0,.N2<=:S=-^ Z:2R3P>(=/N+@PO$_VVP6:,$G
MAE0OC('KF@#'?XZ2W?B749Y;_4K32 @_L^"TM8"S-_TUWY.#WVFNP\*?&?[?
MH>GR:UIDS:IJ%V\%K!I\8VRA<9(WOQ@D Y/<8KG]2_9]2]U*:YB\4VL*2,&$
M8LE4+QS@*P4<^@%;VF_"N[TWPU;:,-?TFZAM[IYPMUIJR*^X8.<ON4CL5([T
M >BZ9XB@U/P^VL?8M1M8T5B]O<VCI.NWJ-F"3[8SFN-O_C9X?TD[-5TO6K"9
MH!/%#<6RJ\BEMO W\'@GYL<#Z9T]!\(S:#\.[CPS%XDEDNY(Y5COF;F$N.-@
MSD =<9ZD\UYS=_L_O>1VRMXIL8V@A\DNEF=TOS,VYR9.6^;'T H [*;XY>%+
M6.?[9#J5M<1QQ2QV\D*EYED 92NUB/ND$Y(Z^M)\-O%^M>)/&/B^SU.206MC
M<*MK;21HK0*6?Y25ZG '<]*YO5O@1#JUZ;J3Q/&C+9V\$06 8#Q(B;C\W((4
M\<=1SQSVG@CP8_A77M>U:[UBUNYM7D61DBB\M8R"Q.,LV1\WZ4 >:6'Q&UZY
M\$^(M6NO&0M]6L;DQV=GY=L/-7*_PE-S=3T]*[/3?C5ID6DQ'6;._%Y;1P#4
MI(K<+';R2<8(9@W4'. :V_A]X)M_!.GZA;3:C;W[7=VUR'\H)L! &WDG/2L'
M4OA/#=>*M5UBWU?3MFI2I+(E[8)<M%@Y81ECM&?=3B@"TGQQ\.30B>#3M7FM
MWNA9QRK%& \IY &7!Y'/(%/L?C;X<OO$":(MCJL5XTS0$21)M5QG()#GT/2L
M.#X*QV^D/:1^)(?.35%U&W<VX"K@8V,H;GCT(KE/!7P[U#6/$>JZW/=_V;J-
MEJCO']IM6\F=6W9*J2#C/0Y/% '71_'?PI/JOVLW>O00)"Q^R-:P^4[ ''(R
M^X\8Y Z9Q6CXB^*^G6^CQ7,]OXFTA6DC,4L=E$PG5T+##-N0C&,X.[]:YS0_
M@3+HE\UU%XMM6?R)(@K6".IWJ1\RNQ!7GD8_$5)J/P.EU..XW^*K:V\V6*3[
M-:VNRV&Q"I/E[^&.<Y! &6XYX -'PE\;/MVB03Z]ILGVZ[U V=G%81C$QPO]
M]^""PSD@?,,=\:]K\;/#.H26MOI]KJEY?W'F?Z%% OFIL!)SE@IR 2 I)_&N
M:M?@@;?3+&TD\164YL;XWD0DM,QR;@N])%W\@^6O0C^+KD8UI?A;.^DPV@UO
M1"?WQE0Z- L89UVAH]A#(P&.=QR5'TH ]!TG7?[8CM9HM+U&"&>$R%[J$1&)
M@<>6RD[MWT!'O6O7+^$M&NO#&D:?I+ZU%?6EM 4>2<'S6?.1M.[ 0#@+@GIS
M72?:(/\ GM'_ -]"@"2BH_M$'_/:/_OH4?:(/^>T?_?0H DHJ/[1!_SVC_[Z
M%'VB#_GM'_WT* )*A?\ X^XO]QOZ4[[1!_SVC_[Z%0M/#]JC/FI@*W.X>U %
MJBH_M$'_ #VC_P"^A1]H@_Y[1_\ ?0H DHJ/[1!_SVC_ .^A1]H@_P">T?\
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M'_/:/_OH4?:(/^>T?_?0H DHJ/[1!_SVC_[Z%'VB#_GM'_WT* )**C^T0?\
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M%Q)(Y^U&2158,.3M&XC/XUN>"_A3K&B:GHXU.SM)X]-NI)DNS?RG:"01Y<(
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M ,UKEF/SL2%!&!D@=*ZZ*X?P9H7AG1X-):9IWBLG^S [+=BOS2-Q]W=GTZT
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MKV+:O]T?E7S[HOPX\<7'QA&LZP(HXH+I+B>^BPD=R$VX"JO=@!G/OG/?Z#H
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M!_SS%'V2#_GF*FHH KO8VLB,CP(Z,,%6&01[@TOV*VV[?)3;C&W'&/3%3T4
M58M.LH$V06L,2==L:!1^0J3[)!_SS%344 0_9(/^>8J)K:'[3&OEC!5OZ5;J
M%_\ C[B_W&_I0!E>)-3T_P ,>';W6KR!G@M(][+']YB2  /J2*YCP!\0+;Q[
M+<>1X>O+2WAX^T.X>/=P2I(Z'!!KJ_%*W3^%]06RTV#4[@PD+9SG"3#NI_#.
M/?%>)_ 73_$UOXBOW>VN;/0P',L$@*)YQQMP#R2 ,?E0![[]D@_YYBC[)!_S
MS%344 0_9(/^>8H^R0?\\Q4U% $/V2#_ )YBC[)!_P \Q4U5K^&YN+*2*SN_
MLEPP&R?RQ)LY_NG@\<4 /^R0?\\Q1]D@_P">8J/3H+NVLDBO;W[9< G=-Y0C
MW<\?*.!@<5:H IW-M"MNQ$8!X_G4WV2#_GF*+O\ X]G_  _G4U 'E%K\7M,U
M'QD_A[3O#=_=LD[1&6-USA3AFVGL.>_:O4?LD'_/,5\UZ[IWC"7XU>9I&B-I
M6H.X42VF?+DCR<RER,<KU^GK7TU0!#]D@_YYBC[)!_SS%344 0_9(/\ GF*/
MLD'_ #S%344 0_9(/^>8H^R0?\\Q4U9FG66J6UU/)?:Q]MA?_5Q?9EC\OGU'
M)XXH N_9(/\ GF*/LD'_ #S%344 5+>VA:+)C&=S?S-><^*/BOI?A[QC_P (
MQ;Z#=:C?!HXSY4@3,C@%5&>O!7\Z]+MO]1_P)O\ T(U\^_&NS\0S>/M+FTW0
M&2=&4V6HV:EI)V^7 ?'"E6SC/8T >^VT<%S:Q3FUDA,B!O+E&'3(Z$9X-2_9
M(/\ GF*I^'HM0@\.:;#JTGF:BEM&MT^[=ND"C<<]^<UI4 0_9(/^>8J*Y6QL
M[:2YN3'%#$I9Y'; 4#N35NN6\?>'M4\4^'6TC3;R"U2=Q]I:7=\\8Y*#;Z]Z
M .3M/BYIFH:7=WEAX>O;HPWRV<20MN\TG)WDX^5<#//K72>#O&%AXLCU95T^
M6TN=+G-O<PE]XR,_=8?>^Z:\N\(Z;XZ\":!XBATWPY*T]W>".V(4L8E /[P
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M(?\ P+7_ .(H_P"$/?\ Z&?Q#_X%K_\ $5TM% '-?\(>_P#T,_B'_P "U_\
MB*/^$/?_ *&?Q#_X%K_\172T4 <U_P (>_\ T,_B'_P+7_XBC_A#W_Z&?Q#_
M .!:_P#Q%=+10!S7_"'O_P!#/XA_\"U_^(H_X0]_^AG\0_\ @6O_ ,172T4
M<U_PA[_]#/XA_P# M?\ XBC_ (0]_P#H9_$/_@6O_P 172T4 <K/X2=(6;_A
M)O$1QC_E\7U_W*E_X0]_^AG\0_\ @6O_ ,16_=_\>S_A_.IJ .:_X0]_^AG\
M0_\ @6O_ ,11_P (>_\ T,_B'_P+7_XBNEHH YK_ (0]_P#H9_$/_@6O_P 1
M1_PA[_\ 0S^(?_ M?_B*Z6B@#FO^$/?_ *&?Q#_X%K_\11_PA[_]#/XA_P#
MM?\ XBNEHH YK_A#W_Z&?Q#_ .!:_P#Q%'_"'O\ ]#/XA_\  M?_ (BNEHH
MYK_A#W_Z&?Q#_P"!:_\ Q%'_  A[_P#0S^(?_ M?_B*Z6B@#EH?"+M'G_A)O
M$(^9O^7Q?4_[%2?\(>__ $,_B'_P+7_XBM^V_P!1_P ";_T(U-0!S7_"'O\
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M(/C_ )&?Q#_X%K_\1734AZ&@"G:0^5901^;+)LC5=\C99L#J3W-%2P_ZB/\
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M $.RX_Y[+_W[_P#KT;+C_GLO_?O_ .O4U% $.RX_Y[+_ -^__KT;+C_GLO\
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M\]E_[]__ %Z-EQ_SV7_OW_\ 7J:B@"'9<?\ /9?^_?\ ]>C9<?\ /9?^_?\
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M_P Q_C1YS?\ /%_S'^-%% !YS?\ /%_S'^-'G-_SQ?\ ,?XT44 'G-_SQ?\
M,?XT><W_ #Q?\Q_C110 ><W_ #Q?\Q_C1YS?\\7_ #'^-%% !YS?\\7_ #'^
M-'G-_P \7_,?XT44 'G-_P \7_,?XT><W_/%_P Q_C110 ><W_/%_P Q_C1Y
MS?\ /%_S'^-%% !YS?\ /%_S'^-'G-_SQ?\ ,?XT44 'G-_SQ?\ ,?XUGZE+
MK DA?2[&SF(#"07=RT6,XQC:CYZ'KBBB@#GM<T35?$L5O'K/A;P]>+;R"6(2
M:E+\K?A#T]1T/>M1;GQ<BA5T;0U4#  U*4 #_OQ110 [[7XP_P"@/HG_ (,Y
M?_C%'VOQA_T!]$_\&<O_ ,8HHH /M?C#_H#Z)_X,Y?\ XQ1]K\8?] ?1/_!G
M+_\ &*** #[7XP_Z ^B?^#.7_P",4?:_&'_0'T3_ ,&<O_QBBB@ ^U^,/^@/
MHG_@SE_^,4?:_&'_ $!]$_\ !G+_ /&*** &2S^,)(RG]D:(,_\ 42E_^,5'
M>#Q/J%G-9WF@Z#/;S*4DBDU&0JP/8CR*** *VBZ=KOAW3(].TCPWH-I:1DE8
MTU.4\GJ23#DGW-:'VOQA_P! ?1/_  9R_P#QBBB@ ^U^,/\ H#Z)_P"#.7_X
MQ1]K\8?] ?1/_!G+_P#&*** #[7XP_Z ^B?^#.7_ .,4?:_&'_0'T3_P9R__
M !BBB@ ^U^,/^@/HG_@SE_\ C%'VOQA_T!]$_P#!G+_\8HHH /M?C#_H#Z)_
MX,Y?_C%'VOQA_P! ?1/_  9R_P#QBBB@!D<_C"--O]D:(>2?^0E+W.?^>%9?
M]A:I_P ))_PD7_"*^'?[7\OROM7]HR[MOT\C&<<;L9QQG%%% &O]K\8?] ?1
M/_!G+_\ &*/M?C#_ * ^B?\ @SE_^,444 'VOQA_T!]$_P#!G+_\8JM?0^(]
M4MC;:AX<\.W=N2"8I[]W4D=#@P8HHH S_P#A'+O[,;;_ (0CPAY!?S#'YYVE
ML8SC[/UQQFITTG5X;PWL/A+PO%=[=@N$NV$@&W;C=]GSTX^E%% &+HO@2\T;
M3C9-X9\/Z@GVA[E6OKPR%'?&[;_HP"CY1P!6U-I.K7%])?3>$?"TEW(I1YWN
MV+LI7:06^SY(V\?2BB@";3[77])@:#3?#/ANSB9M[);WKQJ6]2!!UXJSY_C#
MSC)_9&B<J%Q_:4O_ ,8HHH S-<T75O$L$,.L^%_#]Y'!()8Q)J4ORL/<0]/4
M=#WK42X\6QHJ)HNAJBC"JNI2@ >G^HHHH =]K\8?] ?1/_!G+_\ &*/M?C#_
M * ^B?\ @SE_^,444 (;KQ>00='T0@]1_:4O_P 8K'A\.7=NY>'P/X0C<JRE
MDG()##!'_'OT()!HHH #X<NS;K;GP1X0,*L76/SSM#' )Q]GZG _(53F\(:O
M=>*I_$%UH>BSS3VGV1[:6_)A,>5/*_9LL<J.I/\ *BB@"^^A:A)916<G@SPF
MUK"Q:*%KABB$]2%^SX!-30:;K-MJ#:A!X4\,17K##7"7C"0C_>%OFBB@"[)/
MXP?;_P 2C1!M8-_R$I>W_;"JFK66OZ]IDVG:IX=T&ZLYAAXGU*7!^A$&0?<<
MT44 2:?#XDTG3X+"P\/Z#;VL"!(XH]2E 4?]^/UJU]K\8?\ 0'T3_P &<O\
M\8HHH /M?C#_ * ^B?\ @SE_^,4?:_&'_0'T3_P9R_\ QBBB@ ^U^,/^@/HG
M_@SE_P#C%'VOQA_T!]$_\&<O_P 8HHH /M?C#_H#Z)_X,Y?_ (Q1]K\8?] ?
M1/\ P9R__&*** #[7XP_Z ^B?^#.7_XQ2?:O&'_0'T3_ ,&<O_QBBB@#8MEN
9!:PB=(EF"#>J.64-CD D#(SWP**** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>knwn_s1006.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $' I(# 2(  A$! Q$!_\0
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M_P \(_\ O@4?9H/^>$?_ 'P*EHH B^S0?\\(_P#O@4?9H/\ GA'_ -\"I:*
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M?"5%1+H,74D;BVS!VGY>IZ=Z .\\)^([#Q?IIU&STFYMK,DK'+=1QCS"&*L
M%8G@J>N*N_VQH)\1?V )[8ZIY/GFW5,D)ZDXP.HX)S7A2_#OQA%H_AJ*ZT>:
MZMK2TO8IK%)T/ES.9=CX+!>=T9R#GY?:KWPP^&GB3PKX[L=3US2UF@EM&Q*D
MBN;:4XQOR0<@ C*YZT >B3^/;.#4M0T\>$]9ENM/C66XCA@A=@C?=( DRV?0
M<UV4$=O/!'+]F5-ZAMCQ@,N1G!'K7E[^#[KQ/\2]2U+4M.U?3M/=;62WF$T:
MAGA/(=5=L@]LC\JX36OA_P"//.OY+?2[J;56U5[A-1BN4&Z H0%#%PW4],4
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M41XAC&9 #\HJ7[-!_P \(_\ O@4EQTB_ZZ+4U $7V:#_ )X1_P#? H^S0?\
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M_GI+_P!_#4U% $/V=?\ GI+_ -_#430+]IC&^7E6_C/M5NH7_P"/N+_<;^E
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M#_J(_P#='\J* &6\<IMHB)R!L&!M''%2^5-_S\'_ +X%+;?\>L/^XO\ *I:
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MF4?>0D'<C]R2-HYYZ4 >E_VMIYD>/^W+/?&&+KYL>5V]<C/&,<U-:7D%_O\
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ME'IG'6M?0/B_XDEOO[*2;2;!2UQ*]U#:(H;9$648R!R4QGJ=WL* /I;RIO\
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M>5<MM"/DX;*YR!Z9KK_!_P 0-3\5:CK>AWFDII^J65N)4,4XD4[E&WG'7D4
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MM4 5+?[1Y7RB+&YNI/J:=)'--$T4L=N\;@JRMDA@>H(I]M_J/^!-_P"A&IJ
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M3P[IIV\ZX0$ 1JP[Y^8@8&%->D?!2\-Y\/XV;69]4E2X99&F5@8&(5C&"W+
M;LY]2<< 4 =]_I([0_F:C'VC[6W$6[8.Y]35NH1_Q^M_US'\S0 ?Z3Z0_F:H
M2:+9RW#7$FEZ:\S-O,C0 L6]<XSFM6N8\?>+AX(\*3ZS]E-TZ.L:1;MH+,>,
MGTH TYM%L[B=IY]+TV65_O2/ &8_4D5'_P (_IPZ:-I7_@,O^%>3ZE\=M3TS
M5&T=_#UM+J(FC0%+HB(AU!')7.<L.V.M=-HOC36O''A/Q5:V>G_V=K^G&2U0
M13!E\W# ;6/<%3[=* .R_P"$?T[_ * ^E?\ @.O^%'_"/Z=_T!M*_P# 9?\
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M?7(^;F@#Z._TGTA_,TA^TXZ0_F:GI#T- $$/^HC_ -T?RHHA_P!1'_NC^5%
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MYKTNB@#FDUO6XT5$\&7JHHPJK=VP 'H/WE._M[7O^A.O_P#P,MO_ (Y71T4
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M2+(I>?4(90 _WPJO*0H/0X XXZ5WM% 'F&G>$-*TG48=0LOA=+%=0MOC?[=
MVT^H!E(_PK3GLGNM>_MR?P!?2:CY?E>:VH0D%,8*[?-V[<=L8[UWE% 'GFA:
M-!X:O)KO1_AM/:7$HVO(EY;DXZX&93@?2N@_M[7O^A.O_P#P,MO_ (Y71T4
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M$<8Z#OS6/K?QC>Z\:>'[+1I[NUMTO7M]5LY+57E.UE&!MW9S\P&TY_2NDO\
MXV>']).S5=+UJPF: 3Q0W%LJO(I;;P-_!X)^;' ^F0"A;_ WPK:0W44&H:ZD
M=U%Y,PW(=Z;@V/\ 5^JJ?PJ=/@KX1BB:W275ULY'A>>VW_),T8(!8[-W.YLX
M(^\<8XK2MOC#X;EAU%[F*_LWL;..]:.>%=TD3A=I7:Q&3O3J1]X>^.ST?4X=
M:T:RU2V618+R!)XUD&&"L,C('?F@#@+3X/\ A:SM[."*;5O+M-0_M",%@?WF
M%&#\GW?D'O[UWUEFUM_+ENKNZ;<6\R:,;L$]/E4# Z=*\]C\:^(=6\<>*[70
MXEN8-"MQ##ISHJ&YN"V"YD)X (/'&1Z&N/TCXE>,_P#A ]2\175P;JZTS5DB
MFMU@0(82OS*Q5<@ ]&S]<T >]?:4_NR?]^V_PH^TI_=D_P"_;?X4EE<?;+"W
MN=NSSHEDVYSC(SBIZ (?M*?W9/\ OVW^%'VE/[LG_?MO\*FHH A^TI_=D_[]
MM_A1]I3^[)_W[;_"IJ* (?M*?W9/^_;?X4?:4_NR?]^V_P *FHH A^TI_=D_
M[]M_A1]I3^[)_P!^V_PJ:B@"'[2G]V3_ +]M_A1]I3^[)_W[;_"IJ* (?M*?
MW9/^_;?X5$UPGVJ,XDX5OX#[>U6ZA?\ X^XO]QOZ4 'VE/[LG_?MO\*/M*?W
M9/\ OVW^%97BZYUBS\):E<:! )]4CA)MXRN[)R,X'<@9('<CO7G/P8\8^(/%
M,]\VN^(;:=XF,::>\"1S< $N-N#CG!R#TZB@#UO[2G]V3_OVW^%'VE/[LG_?
MMO\ "IJ* (?M*?W9/^_;?X4?:4_NR?\ ?MO\*FHH A^TI_=D_P"_;?X4?:4_
MNR?]^V_PJ:CIUH A^TI_=D_[]M_A1]I3^[)_W[;_  J;.>E% %2YG1K=@!)V
MZH?7Z5+]I3^[)_W[;_"B[_X]G_#^=34 0_:4_NR?]^V_PH^TI_=D_P"_;?X5
MX5#XZ\<'XMR:%J^LVNB6:S.Z1W-M'Y31C[@W$@G>!U#=3^%>]T 0_:4_NR?]
M^V_PH^TI_=D_[]M_A4U% $/VE/[LG_?MO\*/M*?W9/\ OVW^%344 0_:4_NR
M?]^V_P */M*?W9/^_;?X5-29!Z$4 1?:4_NR?]^V_P */M*?W9/^_;?X5-10
M!4M[A!#C;)]YNB'U/M4OVE/[LG_?MO\ "BV_U/\ P)O_ $(UY!\:O&?C/PGJ
M.G-HLGV32I8\-="!9-TV3\I+ XPH!'3.3UQP >O_ &E/[LG_ '[;_"C[2G]V
M3_OVW^%9_AJXEN?#UG+/JUKJTI3#7MJH5)2#C. 2 ?7!ZYZ=*UJ (?M*?W9/
M^_;?X4?:4_NR?]^V_P *K:VNJ-HMVNBM;IJ1C(MVN<^6K>IQ7CB:]\2W\87'
MA+3=;L+Z^2P1[JZFA4Q6LW5MK(@P>P#@T >V?:4_NR?]^V_PH^TI_=D_[]M_
MA7SYJGQ2\4:/?:SI!U66[6.Z@M[74HK6-PLGRF5,JNT\;L#:3Q7L'A36;+4-
M/O[BR\0W.L_9W*2+<Q)$\+*#E2H1",^X[4 =']I3^[)_W[;_  H^TI_=D_[]
MM_A7SK#\9O$=C'IWB"ZF>[L;R[O(SII6- B*$\L!PF[(,G)[X%0_\+C\5:+8
M6=S>7K:@VIZ3))&K1Q1BWG\UT5QA/F "#Y3U)- 'TA]I3^[)_P!^V_PJ(7"?
M:V.)/N ?</J?:O+_ (;>-M<U/QG-H6KWKWR2Z3;7\<K1QH8F9$9UPJC()DXS
MTV^]>JC_ (_6_P"N8_F: #[2G]V3_OVW^%'VE/[LG_?MO\*Y?XEZGX@T?P3=
MWOAJ+??1LI9A&',<?\3!3U(^A[\5@?!OQ/K'BC0Y[S6=?M;^X9SBU6%$E@ .
M,G:1\I[97\: /1_M*?W9/^_;?X4?:4_NR?\ ?MO\*FHH A^TI_=D_P"_;?X4
M?:4_NR?]^V_PKQSQQXA^(/A.]CNCJUC-+>ZHL6GZ5;Q*XD@PV=P*[\Y" E3U
M8^U5M=\9>.?!&NZ0-;U2VU"2YFGFN].L(5=8K50I!7Y5<$?O#DG'RC)X- 'M
MGVE/[LG_ '[;_"C[2G]V3_OVW^%>7?#'QDWB*/3?[6\5W;:Q<+++_9TEM'%%
M*@=E&UO+!;@ _*W4'T-9?Q#\?^(+#QAKFEZ3?O80Z3I*W0VQQR>=(7CY.Y20
M,28P#VS0![+]I3^[)_W[;_"C[2G]V3_OVW^%?.LGQE\2:C;ZEKEK</9VMA)9
MJ+$+$XD#EA)ERF>=O&.F:MV/Q<\17=S:ZV;EUL+C6Q9_V;MCVK$4! W[-V03
MUH ]ZGG0B/Y9.) ?N'_"I?M*?W9/^_;?X47'2+_KHM/F,BP2&)0T@4E0>YQQ
M0 S[2G]V3_OVW^%'VE/[LG_?MO\ "O#? 'CGQIJWQ&GTCQ+K=MIWV=B7T^XM
MHU\QBP B0\-G#9!RV<#K7O% $/VE/[LG_?MO\*/M*?W9/^_;?X5-10!#]I3^
M[)_W[;_"C[2G]V3_ +]M_A4U% $/VE/[LG_?MO\ "C[2G]V3_OVW^%34@(/0
MYH B^TI_=D_[]M_A0;E,'Y9/^_;?X5-2'H: ((?]1'_NC^5%$/\ J(_]T?RH
MH X36?!EUJ/CC1O%NGZU9VUQI]GY"V]Q 9%8D/DDAU/1^GM7-77P;NKO5[G5
MG\5VXN+S4/MMU;"W/V:7!W*A3S,D EQR>C5T.M^,M9LOB'H?A'2X-."ZA9>>
M;BZC=RA <D85AQA/UJOH'Q6MO[8U[2?%+6-G-IEX+6*6W5\7!)8 +'\S9RIZ
M9ZC\0#(T_P"#DVG:9+9IXATN>.6XDF:*XTU'1=Z!<H=V]&'7(;L./6.+X)_9
M9[>ZC\36U[<I9_9G.J6BW**>Q12P  ' #;J[6Z^*?@V&S\V#5H;F9XI'AMXH
MW+R%<Y7 7*G(/4>_2N:\&_&73-6L9;OQ!?Z=8O\ ,5M(+:9I(E!^\[<@C&.@
M% '8W?A]9? X\/6NIVD#K"(Q*UI"T9]08<;=I]!BO/[GX-7<ZW/E^+H;5+B>
M.62RMK<I:,$'0QB3KD9ZXY/%=Q-\3_!$$DR/KMN?)QYC)$[JN>F652.<^M0K
M\6_ #,%'B*UR3@9BD'_LM 'G;? 2X75GU*U\7VUG,9VGC%M:%!"2<@)^\R .
MU-N_V?WO$ME;Q38QM!#Y)=+,[I?F9MSDR<M\V/H!7J4GQ&\&1WYLVUVT\T2+
M$6 )C#L,@>8!L_7L?2F67Q*\%:A/%#;Z[:[I2PC:1&C1BHRPW, N0,=^X]:
M/-/&OA&/5=?\(^'-/GN#+%:+IVK7D<<D<1MXPCKEB"F3AB!D\X!Z5[E'+;QQ
MJBS1[5  ^85S-M\3/!=T'$>OVH5(6G_>*T89%."5W ;N0>!D\'TJ]H?C#PYX
MDN9+;2=1BN)XT61H]C(VQNC , 2.G(]1ZT <9X2TV;P[\8?%7VA)7MM81;NW
MNE0>4,,2R%L\,"V/?!-<UXA\'7WA'X?ZKHFF:C_:%UK^IJ<16IPD9^\&(W8
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MR.-8B!)8W,Y$!QG$@ !^?DCIT],<^FVRKY/W1]YNW^T:FVK_ '1^5 '.>"M
MM/!WA*QT..^6X^SJQ:5B!N9F+-@=ADG'M6_]H@_Y[1_]]"I-J_W1^5&U?[H_
M*@#,UM)[_1;NTTW58["\EC*176 _E$]\9]*\_LOA[K6E^%+C0=,\3:79FZ):
MYOXK-S<S$]2S&4\GIQT[5ZGM7^Z/RHVK_='Y4 >?:7X3UG1/#T.DZ1K^CZ<E
MNRLCP:?N\TY^8R;W;)/J,'WQQ5+0_"VJ>"9Y&L);;5GUS51)JKX\M+> [B2@
MWYR"QZD_2O3MJ_W1^5&U?[H_*@#QVV^">F_:[:WO]5MKC0[6XN9HK-49'Q*
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M$]/66ZMM.U:VMM(NWMGGMG1G<^5G.'W\;MQ[<5/;_!RQMM3A2/5;8:)#J?\
M:"66QO,!"A0GF;^G .<5ZYM7^Z/RHVK_ '1^5 %:>>$B/$J'$BG[PI\DT,D3
M)]H5=P(W*XR/<47"KB/Y1_K%[5-M7^Z/RH \/T3X.ZC;?$M=>U;Q%'>V=K<+
M<0S/*6N)V7&P29X&,8)!.<<8SQ[9]H@_Y[1_]]"I-J_W1^5&U?[H_*@"/[1!
M_P ]H_\ OH4?:(/^>T?_ 'T*DVK_ '1^5&U?[H_*@"/[1!_SVC_[Z%'VB#_G
MM'_WT*DVK_='Y4;5_NC\J (GEMI$9'DB96&&!88(JEIFF:)HJ2)IEK96:R$%
MQ JH&(Z9Q6EM7^Z/RHVK_='Y4 1_:(/^>T?_ 'T*#<08/[Z/_OH5)M7^Z/RI
M"JX/RC\J (8?]1'_ +H_E11#_J(_]T?RHH \ZU[X?W7B+XF^']=N+>UGT6UL
M?)N(Y7.XMB3&%QSRR]ZB\<_"Q;X:'+X6L[2S-A??:IXHF\AI<[<D2 $AODX.
M.^>U>D6\ -M$?,E&4' ?VJ3[./\ GK-_WV: /"[+X/:[:^)[+5H++3K*,0W
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M  1_O)3F0#EZD,"@$F:4 =27H GHKE;+QMX3U'5UTJT\1P37S.8UA68Y9AU
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MJMO<(MM$"LG"#HA]/I4GVE/[LG_?MO\ "@":BH?M*?W9/^_;?X4?:4_NR?\
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M1]I3^[)_W[;_  H FHJ'[2G]V3_OVW^%'VE/[LG_ '[;_"@":BH?M*?W9/\
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M**C^T0?\]H_^^A1]H@_Y[1_]]"@"2BH_M$'_ #VC_P"^A1]H@_Y[1_\ ?0H
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MY!-#%"DP4 'RX5/.,=3]>] 'M'A#QKI7BV;7%BL_LL.DS^2\\DP*2#+?,".
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MM#]IC7RQ@JW]*MU"_P#Q]Q?[C?TH RO$FIZ?X8\.WNM7D#/!:1[V6/[S$D
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MOQJ\S2-$;2M0=PHEM,^7)'DYE+D8Y7K]/6OIJ@"'[)!_SS%'V2#_ )YBIJ*
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M?Q#_ .!:_P#Q%'_"'O\ ]#/XA_\  M?_ (BNEHH YK_A#W_Z&?Q#_P"!:_\
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M_$/_ (%K_P#$4?\ "'O_ -#/XA_\"U_^(KI:* .:_P"$/?\ Z&?Q#_X%K_\
M$4?\(>__ $,_B'_P+7_XBNEHH YK_A#W_P"AG\0_^!:__$4?\(>__0S^(?\
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MVO?)7"?:(4D"G SC=TZ"HY/#VA36<-I+X>L'MH"QAA:VC*1D\G:.@SWQ110
M7'A[0;M(4N?#MA,L$8CA$EM$PC0?PKGH/85!_P (AX7_ .A4TK_P"A_PHHH
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M'VOQA_T!]$_\&<O_ ,8HHH /M?C#_H#Z)_X,Y?\ XQ1]K\8?] ?1/_!G+_\
M&*** #[7XP_Z ^B?^#.7_P",4?:_&'_0'T3_ ,&<O_QBBB@ ^U^,/^@/HG_@
MSE_^,4?:_&'_ $!]$_\ !G+_ /&*** #[7XP_P"@/HG_ (,Y?_C%'VOQA_T!
M]$_\&<O_ ,8HHH 9'/XPC3;_ &1HAY)_Y"4O<Y_YX5E_V%JG_"2?\)%_PBOA
MW^U_+\K[5_:,N[;]/(QG'&[&<<9Q110!K_:_&'_0'T3_ ,&<O_QBC[7XP_Z
M^B?^#.7_ .,444 'VOQA_P! ?1/_  9R_P#QBH;D^*+VVDMKK0= G@D&UXI=
M0D96'H08,&BB@"HFEZO%I_V"/PEX72SWB3[.MVPCW YW;?L^,Y[TMSINM7E\
ME_<>%?#$MZ@ 2Y>[9I$QTPQM\C&:** .?T3X>3:+:2P'PIX<OVEF:9I;ZZ\Q
MP6QE1BV "\< #'-;T.DZM;WR7L/A'PM'=QJ$2=+I@ZJ%V@!A;Y V\8].***
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52S!!O5'+*&QR 2!D9[X%%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>knwn_s1007.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ![ FX# 2(  A$! Q$!_\0
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MN*[2]8VXN1!:0&1PF0/FXPA!/(8BNIT._P!/U_0[/5K2W"V]W$)461%# 'U
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M?Y5+0!#]G7^_+_W\-'V=?[\O_?PU-10!#]G7^_+_ -_#1]G7^_+_ -_#4U%
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MK]G$: .'0KY;0X'4$,>!USD ]X^SK_?E_P"_AH^SK_?E_P"_AJ:B@"'[.O\
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M7&T4 ?27V=?[\O\ W\-'V=?[\O\ W\-344 5! OVMAOD_P!6#]\^IJ7[.O\
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M/B#_ *'&\_\  *W_ /B*Z2B@#F_[!\0?]#C>?^ 5O_\ $4?V#X@_Z'&\_P#
M*W_^(KI** .;_L'Q!_T.-Y_X!6__ ,11_8/B#_H<;S_P"M__ (BNDHH YO\
ML'Q!_P!#C>?^ 5O_ /$4?V#X@_Z'&\_\ K?_ .(KI** .;_L'Q!_T.-Y_P"
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M2B@#F_[!\0?]#C>?^ 5O_P#$4?V#X@_Z'&\_\ K?_P"(KI** .;_ +!\0?\
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M1Y3!I:ZH7CED*O&P4[0<=?F'/3BM;Q7XBO/%?A3PC;:>SZ>OB:X5)760AHT
MW,H(]<$4 >G_ .D^L/Y&C_2?6'\C7AVL^";"X^(FE^&]'OM0AM((GDU*>2\D
M.YFY1-^[[W' %>@?"K4K^_\ !S6^I2^?<Z;>36#3DDF41G 8Y^N/PH ['_2?
M6'\C1_I/K#^1J:B@"'_2?6'\C1_I/K#^1J:B@"'_ $GUA_(T?Z3ZP_D:FHH
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MFHH A_TGUA_(T?Z3ZP_D:F[5F:5X@TO6VF73KKSS#CS/W;+C.<=0/0T 7?\
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M4U% $/FS?\^Y_P"^Q1YLW_/N?^^Q4U% $/FS?\^Y_P"^Q1YLW_/N?^^Q4U%
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M%<O^%'_"90?] 3Q!_P""N7_"NDHH YO_ (3*#_H">(/_  5R_P"%'_"90?\
M0$\0?^"N7_"NDHH YO\ X3*#_H">(/\ P5R_X4?\)E!_T!/$'_@KE_PKI**
M.;_X3*#_ * GB#_P5R_X5'/XN@GMY(AI/B2(NA7S(],E#+D=1QU%=110!Y5:
MZ;I%CX;_ + M(O'$.GDR;D6S?++)]Y23'T/)^K&H4CNK;68H=-_X2;2O#4-L
M(X["RTV0.)!CYLM&0 ><\DD\UZW10!X[>^$/!=[I]O:'P]XJ@,*NK3P6,J2S
M!CEO,;;\V3STIB^"O T=_;7,?AKQ3'' R2"U6SF\EW7HS+CD^IS7LM% '+3>
M,(&5?^)+X@X=3_R"Y?7Z5+_PF4'_ $!/$'_@KE_PK>N/NQ_]=%_G4U '-_\
M"90?] 3Q!_X*Y?\ "C_A,H/^@)X@_P#!7+_A7244 <W_ ,)E!_T!/$'_ (*Y
M?\*/^$R@_P"@)X@_\%<O^%=)10!S?_"90?\ 0$\0?^"N7_"C_A,H/^@)X@_\
M%<O^%=)10!S?_"90?] 3Q!_X*Y?\*/\ A,H/^@)X@_\ !7+_ (5TE% '-_\
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MK4HEBOO#&L74:MN"3Z,[@'UP5ZUUM% ',1>+;."%(8= UZ.)%"HB:3* H'0
M <"G_P#"90?] 3Q!_P""N7_"NDHH Y8>,(/M+-_8OB#[@'_(+E]3[5+_ ,)E
M!_T!/$'_ (*Y?\*WA_Q^M_US'\S4U '-_P#"90?] 3Q!_P""N7_"C_A,H/\
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M)^=35'<7$-I;R7%Q*D4,2EY)';"JHZDGL* &_:H/^>R?G1]J@_Y[)^=>4_\
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M\<9)^I[3SX?^>J?]]"L7_A"O"O\ T+>D?^ 4?^%'_"%>%?\ H6](_P# */\
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,+=$)'7&0.G H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>knwn_s1008.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 knwn_s1008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #M VH# 2(  A$! Q$!_\0
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M_?(J6B@"+[/!_P \8_\ OD4?9X/^>,?_ 'R*EHH B^SP?\\8_P#OD4?9X/\
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MO_AGKL>GKKEKI(CNM4U27.F[&D^R6LP(&\*0 4Z\<@D<\8H ^AOL\'_/&/\
M[Y%'V>#_ )XQ_P#?(KYTM/A]J;Z18W.MZ7J3W"ZK#9O':0.A6RC!#R$+U+Y!
MW')/.*KZ/X2\4SSO9:S::W%X<W7,=O$MJ\SVQ8AE<(3D9 P&&<'.>IR >Z>+
MO$NE^#-(34M0L9IH7F6'%O"K$%NA.2 !6_\ 9X/^>,?_ 'R*^:=8\'^)+FSU
M&"]T;Q#J-[#):KI-Q<(7*VRYW(VQB@;D9SGH><U],1,7A1F1HV902C8ROL<<
M?E0 W[/!_P \8_\ OD4?9X/^>,?_ 'R*EHH B^SP?\\8_P#OD53!(4 8''I6
MC6<.@H L01,;:(^=(/D' QZ?2I/*;_GM)^G^%%O_ ,>L/^X/Y5+0!%Y3?\]I
M/T_PH\IO^>TGZ?X5+10!%Y3?\]I/T_PH\IO^>TGZ?X5+10!%Y3?\]I/T_P *
M/*;_ )[2?I_A4M% $7E-_P ]I/T_PH\IO^>TGZ?X5+10!%Y3?\]I/T_PH\IO
M^>TGZ?X5+10!%Y3?\]I/T_PJ.*)BTO[Z0?/[>@]JLU%#]Z;_ '_Z"@ \IO\
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MB EIYH.X.5).W)7!))/Z5LZ5\3-+MVOC<ZEJ6IO+JLEI;0?V>L+1D#=L'(R
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M4_[ZH^T0_P#/5/\ OJI:* (OM$/_ #U3_OJC[1#_ ,]4_P"^JEHH B^T0_\
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MYIU[2O+W;-YO(\;NN,YZUDW?Q"T"V\3:/HD=Q#<-JB.\=S#-&T2!<_>.>Y!
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M%_"VFZIH5_I/C33+>321*_[_ &2FXEE&)))#YB\GC '3%>P;1Z#\J-H]!^5
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M: ):*B^SQ_[7_?9_QH^SQ_[7_?9_QH EHJ+[/'_M?]]G_&C[/'_M?]]G_&@
M_P"7L?\ 7/\ K4M5O(3[5CYON?WSZ_6I/L\?^U_WV?\ &@"6BHOL\?\ M?\
M?9_QH^SQ_P"U_P!]G_&@"6BHOL\?^U_WV?\ &C[/'_M?]]G_ !H EHJ+[/'_
M +7_ 'V?\:/L\?\ M?\ ?9_QH EHJ+[/'_M?]]G_ !H^SQ_[7_?9_P : ):*
MB^SQ_P"U_P!]G_&C[/'_ +7_ 'V?\: ):*B^SQ_[7_?9_P :/L\?^U_WV?\
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MZ\=1\0:Y<+8F(VRRR/'#/E2)<QE=N V.!@BO6=DW_/8?]\?_ %Z-DW_/8?\
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M 2T5%LF_Y[#_ +X_^O1LF_Y[#_OC_P"O0!+146R;_GL/^^/_ *]&R;_GL/\
MOC_Z] $M%1;)O^>P_P"^/_KT;)O^>P_[X_\ KT 2T5%LF_Y[#_OC_P"O1LF_
MY[#_ +X_^O0!+146R;_GL/\ OC_Z]&R;_GL/^^/_ *] !/\ ZK_@2_S%2U6F
M27R^90?F7^#W'O4FR;_GL/\ OC_Z] $M%1;)O^>P_P"^/_KT;)O^>P_[X_\
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MR;_GL/\ OC_Z]1;)?M/^M&=G79[_ %H M4AZ&H]DW_/8?]\?_7I"DV/]</\
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M\/\ Q\4 2T5%YDO_ #P_\?%'F2_\\/\ Q\4 2T5%YDO_ #P_\?%'F2_\\/\
MQ\4 2T5%YDO_ #P_\?%'F2_\\/\ Q\4 2T5%YDO_ #P_\?%'F2_\\/\ Q\4
M2T5%YDO_ #P_\?%'F2_\\/\ Q\4 2T5%YDO_ #P_\?%'F2_\\/\ Q\4 2U%;
M_P"J_P"!-_,T>9+_ ,\/_'Q4<+RB/B'/S-_$/4T 6:*B\R7_ )X?^/BCS)?^
M>'_CXH EHJ+S)?\ GA_X^*/,E_YX?^/B@"6BHO,E_P">'_CXH\R7_GA_X^*
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M4MKFEWT]G97Z6UJL$48,.XL KG<,DX!'6MZ^^&6FZA/J:W&MZF^G:E>B]N;
MJAC+[LX4[=RYZ$@@D=ZK:A\)=)OIM3V:WJ5O;ZA<)<RVZ(A563[FW*$C&<=:
M ))_C%9VMAJMS<^']3A;2KB*WNH':/>K2;MN,-@_=_6JX^.&CK:)=7&E7T$)
M\T2 O&TD)0@$2(&RA+$ 9QDU;\0?"_3?$%]?7,NN:E;+?F%KJ&W1%25XAA7(
MV=>I_&E_X5-X49]>:4W,O]LJHD+$YB(.[<IQU+88YSR* -7P_P#$73_$"ZTL
M=G<0S:0GF3(71U==I(*.K%3G![USECXC\1WOPOUCQQ'J*1SSI-<6EM)&'CMX
M(RX5 !C+Y'+'/0<5VFG:1]FL;FTO]9O=1CGA$!$R*@5-I!P$4?,<\FN;T3PE
M=6W@S4_!-[<E=*)DCL[V AI#;NQ)1E*\. 3DXQ\W'2@"IJOB76[/X8:%XX2]
M)G@@MYK^VP!'=1N5#@#'RMDC!'3FO2+*Y6]L;>[12JSQ+(H;J PSS^=>?ZQX
M/O;GP=I_@JTO&ETG=&EU>3A5=+:,KB-%5>7..&QV.>M=[;?9K2TAMHBPCA18
MT!!)P!@4 6J*B^T1?WC_ -\FC[1%_>/_ 'R: ):*B^T1?WC_ -\FC[1%_>/_
M 'R: ):*B^T1?WC_ -\FC[1%_>/_ 'R: ):*B^T1?WC_ -\FC[1%_>/_ 'R:
M ):*B^T1?WC_ -\FC[1%_>/_ 'R: #_E['_7/^M2U5\^/[5G<<;,?=/K4OVB
M+^\?^^30!+147VB+^\?^^31]HB_O'_ODT 2T5%]HB_O'_ODT?:(O[Q_[Y- $
MM%1?:(O[Q_[Y-'VB+^\?^^30!+147VB+^\?^^31]HB_O'_ODT 2T5%]HB_O'
M_ODT?:(O[Q_[Y- $M%1?:(O[Q_[Y-'VB+^\?^^30!+147VB+^\?^^31]HB_O
M'_ODT 2T5%]HB_O'_ODT?:(O[Q_[Y- $M%1?:(O[Q_[Y-'VB+^\?^^30!+14
M7VB+^\?^^31]HB_O'_ODT 2T5%]HB_O'_ODT?:(O[Q_[Y- !/_JO^!+_ #%2
MU6FN(S'@,?O+_"?45)]HB_O'_ODT 2T5%]HB_O'_ +Y-'VB+^\?^^30!+147
MVB+^\?\ ODT?:(O[Q_[Y- '$?\)%K<7QGC\.374#Z7+IC7:QI!M8'>0,L223
MQVP/:N6\/?$37]0^)G]@W-_:L!?W$4MNL2")8%4;"DF=S29SE>>AZ8KM[KPI
M;W/CJ/Q6NJW4=REN+40+$IC,6<E>5SDG/.<\UDCX;Z7;-"8]0U&>UL;F2^L;
M!]I6*=N00Q&6PW(#-C)YH F^(M[XFT73K_7+#7K;3M/L[=2EO]D6:2XE)/!+
M$!>J@ 9[US6H_$?5K._CT:XN+FW.D6L<VO:E;V*SD2,H_=HH&U5RWWB.WL<]
M8GA^]\1Z+IL?BR\E%S9ZA]L"6V%#JK'RUDVC!QP3CC(INL_#_2]6U+4[N+4K
M^Q35HTBU*&W VW(4\9W*2IQQD8X)H P-4\4Z_H^NZ'$_BBRFCU.^011-:!(&
MM"N0S3[<>8W'"\9;C KM/%L>O&V6?2M;M=(M;:.26ZGEMQ,S #( 5B !U).:
MH77@NPU"/3[*]OYI='T^9)K73Q"J(FP$(I8#<0 >YYQS44FCZMXET;7M(\1W
MTT%A=RHEJ80BSB(8+AB@*X8@CUV]: .(L/'OBF8Z#8ZIKEOI?]I6$VH#4I;6
M,K)RPBB ^XN%4,V23SC(XJOX?^*7B7QI97QL[F+2YM(T>2\N"+=91<S*>/O?
M=4@#@<Y)]J]-USPS#KFG1:4^KWMMI*QI%+:0(H\Y%_A+E=P!& <$51U;P!I%
M].9=.O;G1_,T\Z;,EE&@66W[*0RG!'(R.<4 ;WA+7?\ A)?">F:R8O*:[@#N
MG8-T./;(.*U;?_5?\";^9JKIMO8Z3IEMIUDGEVUM&L4:!3P ,>G6IH9XUCP2
M0=Q_A/J: +-%1?:(O[Q_[Y-'VB+^\?\ ODT 2T5%]HB_O'_ODT?:(O[Q_P"^
M30!+147VB+^\?^^31]HB_O'_ +Y- $M%1?:(O[Q_[Y-'VB+^\?\ ODT 9/BK
MQ''X:T=KD0FYO)&\JTLU;#W$IZ*/YD]@":XGPMKOBSQGX L=7BUVPTJ;SKA[
MRY:V60*BL0JA"0 ,=6)SQWYKT#4+/2]5A$5_:07*KDH)H ^TD8R,@X-<MIOP
M\T72O EWX5M+NZCBNU99KQ459V!;."0O/!(Y[$T 0^$O%E_#\,)O%GB6Y>Z0
M"2X0QPHC&$'"_*O )QW)Z]:Y _$;Q5>Z)>7=H]Q'KEQ ;S3](_L\;/LVX+N5
MR-TK!26X].F!7I5[X>M+W28=%:[E71DM1:R6?E ^:@&!E\;@<8Y![5FZ+X%L
M-)U&UU"75KZ_NK"S^Q6#W"+_ *+'@C@*HW'!QDYXH X?1_BGK<EAIMIXCN5T
M6YCNBVHW\]N%Q%@E(A&0?WC?0;5&<<\^R6US!>F&ZM9DF@FA#QR(<JRGD$&N
M!U?X2^&M7\/VVF2W5]'+%<-<R7BG,UQ*XPS.2""3Q],<5V6D6=EHEA9Z9:%_
MLUI;+#'OR6PO SQ0!KTAZ&H_M$7]X_\ ?)I#<18/S'_ODT .@_X]X_\ <'\J
MDJM#<1"",%CPH_A/I4GVB+^\?^^30!+147VB+^\?^^31]HB_O'_ODT <O\2=
M7U;P_P"!M0U;2+B&"XM55R98?,R"P&!R #SU(/TKE?'/CO5_#^A>$[U;U+:#
M4(2U[-%"DLQ?R@R[(VXV[CR>W'(S7<>*M&M?%?AVYT6>[GMH+G D>% 6(!!P
M,@CJ!61-X)@E729H]=U"'4=+@:V@O(XTR8F&-I0J5Z8YQGB@"SHU]X@\0?#C
M3[R"ZL8-:N[=&-PHWQ(2>6VC()Q_#TSQQ7#R>/\ 7O"O_"1SZKJ0UZ*PN(M.
MLUAM$A$UVZEB"%)("@8Z]<C&<5UGA_0;WPKJ>G:5HSE/#4$,ANOM 5GEE(&"
MI'S9+$ELX'  I!\.]"/A'^P)+J]DQ=F^6]9LS+<$Y\P'&,\XY% &'IOB37+^
MPFW^*'MKO3F!UB.;20)8,@E1#$ 2020-S9X&1BNC^'^O:KXD^'Z:C+>65YJ+
MF58Y4^1203L\Q0/D;&,@9_6DL/!XTR]OM2MM?O/[5OW#75[+!&[2*H 5 NW:
MJC'857M?#]]X732M/\+2E;5KPW&J37"H1*&.9&/&[>0 %VC [T <QJGB7QMX
M7UF_MYM:AUPZ=I)O[F"*Q2(*[-L1?E)8@<L?N\ >M8>I_&/5_#T$$:ZK:ZX^
MHZ6D\4RP(GV.Y)(*LJ]1['GI^/K-CX<MM,O-=OK/4;I;[6)EEDGD4/Y04855
M!&, 9Z^OM68?A[H-QI>L6VHS7%]>:N<W-_,H\WCE0F%PH7 P * &^&/$&JIX
M]U3PGJ]\-0:&RBO8+H6ZQ$ X#J0IQU((_'-=LW_'S'_NM_2N=\/^&K71-4O=
M5GU&ZU'4KN..)[FY10PC08"@*H '<^I^E;S3QF=&R<!6R=I]J +-%1?:(O[Q
M_P"^31]HB_O'_ODT 2T5%]HB_O'_ +Y-'VB+^\?^^30!+147VB+^\?\ ODT?
M:(O[Q_[Y- $M%1?:(O[Q_P"^31]HB_O'_ODT >;^-OB->:7XKT71=&2-H)-1
M@MM0O3AEC+-S"/\ ;V\D]@1W-,U3Q)XBT;QOI&GW?B&Q/]H7[@V;6GEPK;8^
M0"8C)DY' ZDXXQSO^)/ OAWQ+=V%U<0)!+:WBW;M#;J#<$?PR$KEE/>GWOA.
MUU6]L)-4U&6ZL]/N1<VMF+=(TC=00G*J"0H/3/89H K_ !"U/6=%L)-3M=8C
MT[3[>V<G99&XEEG_ (0>"%3 Z\5P>L?$/Q[8W/AV[M8(+G2);&&>]N[:W\V&
M1L_O29. F .G&#QS7I5WHVHWMI/:S>*+KR9T:-P+.(':PP>=OH:AF\$Z%+H6
MDZ"#,NC:=()#9C.VX(R0)#C+#<2Q'0GK0!G>"O'</B'7;Z&\U.*"XG?-CH[J
MHEBA51\SG'+MRVW/RC\:ZX=!7(Z?\,_#VG?$"7Q?#<WANWDDE6 G]VCN,,1Q
MGH3QG S[5UPY4$>E %RW_P"/6'_<'\JEJ*W_ ./6'_<'\JEH **** "BBB@
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MKOASX;U/PIX.M]*U:]6ZNDD=]R.S*BDY"@MS@?0=: .LHHHH **** "BBB@
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MX4'@')SBN4N_A18QZ!I.@Z7';Q0Q.?MNI2H&NS&<EA&2#M+D]01M&< YK/\
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M_GFOY5'#!$T>3&I^8]O<U9J*W_U7_ F_F: #[-#_ ,\U_*C[-#_SS7\JEHH
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MD9$[D'V7_"CRW_Y[O^2_X5Q'P<U2]U?X9:9<7TQFE0O"KD '8C%5'X "N\H
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MO^%'EO\ \]W_ "7_  J6B@"+RW_Y[O\ DO\ A1Y;_P#/=_R7_"I:* (O+?\
MY[O^2_X4>6__ #W?\E_PJ6B@"+RW_P">[_DO^%'EO_SW?\E_PJ6B@"+RW_Y[
MO^2_X4>6_P#SW?\ )?\ "I:* (O+?_GN_P"2_P"%'EO_ ,]W_)?\*EHH B\M
M_P#GN_Y+_A1Y;_\ /=_R7_"I:* *TT;^7_KG/S+V'J/:I/+?_GN_Y+_A1/\
MZK_@2_S%2T 1>6__ #W?\E_PH\M_^>[_ )+_ (5+10!%Y;_\]W_)?\*/+?\
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M, P8 GH!QQ7H7Q>T26ZM(O$;7FG7-GI$+.=*OHR8IRQP6W*P.[&T*,=>_)H
M].".1D3L0>APO^%1P1OY7^N<?,W8>I]JAT1E?0-.9;3[&IM8B+8_\L1M'R<^
MG3\*M6_^J_X$W\S0 >6__/=_R7_"CRW_ .>[_DO^%2T4 1>6_P#SW?\ )?\
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MB/\ ?./E'8>GTI_EO_SW?\E_PI8/^/>/_<'\JDH B\M_^>[_ )+_ (4>6_\
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M_P"^S_A4M% $69_[D?\ WV?\*,S_ -R/_OL_X5+10!%F?^Y'_P!]G_"C,_\
M<C_[[/\ A4M% %;,WVK[B9V?WCZ_2I,S_P!R/_OL_P"%'_+V/^N?]:EH BS/
M_<C_ .^S_A1F?^Y'_P!]G_"I:* (LS_W(_\ OL_X49G_ +D?_?9_PJ6B@"+,
M_P#<C_[[/^%&9_[D?_?9_P *EHH BS/_ '(_^^S_ (49G_N1_P#?9_PJ6B@"
M+,_]R/\ [[/^%&9_[D?_ 'V?\*EHH BS/_<C_P"^S_A1F?\ N1_]]G_"I:*
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MD@>5@;GY!Z UKM\2?":Q1/\ VH6DDDDC$"6\C3!HQEP8PNY< 9Y% '3>>O\
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M!6\X?:L[)/N?W#ZU)YZ_W)/^^#1_R]C_ *Y_UJ6@"+SU_N2?]\&CSU_N2?\
M?!J6B@"+SU_N2?\ ?!H\]?[DG_?!J6B@"+SU_N2?]\&CSU_N2?\ ?!J6B@"+
MSU_N2?\ ?!H\]?[DG_?!J6B@"+SU_N2?]\&CSU_N2?\ ?!J6B@"+SU_N2?\
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MOJ-_%9M*\Q4H7)Z*!SP,YS67X@^(U]8:KK\&E:?:7-MX?MXYK]IYF1V+\[4
M7&0H)R?I0!Z!YZ_W)/\ O@T>>O\ <D_[X-><W'Q2:[\56FCZ+'IWE3013"?4
MIW@$N\ [(ODPS!64XSW]C70>*/%=SI6NZ+H&EV]O/JFJN^S[2[)''&BEF8D
MDGC % '3>>O]R3_O@T>>O]R3_O@UYCIOQ8N_$%S:Z3HUA9'6UCN'OXKB9Q%
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MT_[Y%'DQ?\\T_P"^10 N]/[R_G1O3^\OYTGDQ?\ /-/^^11Y,7_/-/\ OD4
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MLO\ WU1Y'_367_OJ@"6BHO(_Z:R_]]4>1_TUE_[ZH EHJ+R/^FLO_?5'D?\
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M[>^TZ\NI+6VU2*>XBSYD45PK.F#@Y Y'/%6&A_TB,>;)RK?Q?2@"S147D?\
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M%5/M,GHOY4?:9/1?RH MT54^TR>B_E1]ID]%_*@"W153[3)Z+^5'VF3T7\J
M+=%5/M,GHOY4?:9/1?RH F_Y>Q_US_K4M4O.?S/,^7.,8Q3OM,GHOY4 6Z*J
M?:9/1?RH^TR>B_E0!;HJI]ID]%_*C[3)Z+^5 %NBJGVF3T7\J/M,GHOY4 6Z
M*J?:9/1?RH^TR>B_E0!;HJI]ID]%_*C[3)Z+^5 %NBJGVF3T7\J/M,GHOY4
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MX2)8HH5 #,",AW5<*HQ][/0\^OZ/H6FZ'8?8[2UC9#(\KO*H9W=B2Q)]R>P
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83Q)B4RB.(2$8+[>2/K3U@RH.[MZ4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>14
<FILENAME>knwn-20190331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.26a -->
    <!-- Field: Doc-Info; Name: Source; Value: 189473 03312019 S1.xfr; Date: 2019%2D05%2D30T16:40:16Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x8014001D -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:KNWN="http://knowlabs.co/20190331">
    <link:schemaRef xlink:href="knwn-20190331.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_PurchasedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">KNWN:PurchasedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_CapitalLeaseObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_us-gaap_MinimumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_us-gaap_MaximumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_TechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">KNWN:TechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_TechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">KNWN:TechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_WarrantsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">KNWN:WarrantsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_WarrantsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">KNWN:WarrantsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_WarrantsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">KNWN:WarrantsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_StockIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">KNWN:StockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_RangeofExercisePrices1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_RangeofExercisePrices2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_RangeofExercisePrices3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_RangeofExercisePrices4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_RangeofExercisePrices5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_RangeofExercisePrices1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_RangeofExercisePrices2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_RangeofExercisePrices3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_RangeofExercisePrices4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_RangeofExercisePrices5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_Warrant2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:Warrant2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_Warrant3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:Warrant3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_Warrant2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:Warrant2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_Warrant3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:Warrant3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember108656942">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember108668237">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember109244239">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember109256907">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-09-30_us-gaap_SeriesDPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_SeriesDPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember18674396">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember18691134">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_Warrant4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:Warrant4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_Warrant4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:Warrant4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_SeriesDPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_PurchasedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">KNWN:PurchasedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_CapitalLeaseObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_TechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">KNWN:TechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">KNWN:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_ConvertibleRedeemablePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">KNWN:ConvertibleRedeemablePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">KNWN:WarrantsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantsOutstandingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">KNWN:WarrantsOutstandingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_WarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_WarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_WarrantThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_WarrantFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_WarrantFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantFourMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantFourMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantFiveMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantFiveMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantFiveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_WarrantSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_WarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_WarrantOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_WarrantSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:WarrantSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePrices5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePrices4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePrices3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePrices3Member_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePrices3Member_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePrices1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePrices2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePrices5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePrices4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePrices3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePrices3Member_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePrices3Member_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePrices1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePricesTotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePricesTotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePrices2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_RangeofExercisePrices6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePrices6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePrices6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_RangeofExercisePricesTotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">KNWN:RangeofExercisePricesTotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_StockIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001074828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">KNWN:StockIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="USDPShares" decimals="INF">.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-03-31_us-gaap_SeriesAPreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-03-31_us-gaap_SeriesCPreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-03-31_us-gaap_SeriesDPreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-09-30" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">23334</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">23334</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016014</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016014</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-03-31_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">23334</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-03-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-03-31_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016014</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-09-30" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">934407</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">188309</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">103181</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-03-31" unitRef="USD" decimals="0">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">3061901</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">320538</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">693320</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">193372</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">20140</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">27687</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">12844</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">203582</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">225909</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">100989</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">1478667</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1050097</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">3369106</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">169333</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2018-09-30_custom_PurchasedMember" unitRef="USD" decimals="0">169332</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2018-09-30_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">1</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">133204</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">197536</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-03-31_custom_PurchasedMember" unitRef="USD" decimals="0">197536</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-03-31_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">447778</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2018-09-30_custom_TechnologyMember" unitRef="USD" decimals="0">447778</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2017-09-30_TechnologyMember" unitRef="USD" decimals="0">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">361112</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2019-03-31_custom_TechnologyMember" unitRef="USD" decimals="0">361112</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">7170</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">5070</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">15867</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">2102948</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1188371</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">3943621</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">1512617</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">2156646</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">1298278</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">12019</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">2905</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">7395</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">72140</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">24000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">81339</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">657551</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1166049</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">644099</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DeferredRevenue contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">55959</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">63902</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:DeferredRevenue>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">2255066</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">570000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">2255065</us-gaap:ConvertibleNotesPayable>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">145186</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1165660</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">4710538</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">5149162</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">4286176</us-gaap:LiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2017-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">11</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">23</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">1790</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">1790</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="USD" decimals="0">1015</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="USD" decimals="0">1015</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-03-31_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-03-31_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">1790</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-03-31_us-gaap_SeriesDPreferredStockMember" unitRef="USD" decimals="0">1015</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">17532</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">4655</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">22003</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">32163386</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">27565453</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">36917782</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">-34791324</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">-31533727</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">-37285145</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">-2607590</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30" unitRef="USD" decimals="0">-2809494</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">-3960791</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2356</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">4655</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">17532</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">24259702</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">27565453</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">32163386</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-27073365</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-31533727</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-34791324</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">23</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember108656942" unitRef="USD" decimals="0">23</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="0">1790</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember108668237" unitRef="USD" decimals="0">1790</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember109244239" unitRef="USD" decimals="0">11</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember109256907" unitRef="USD" decimals="0">1790</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember18674396" unitRef="USD" decimals="0">1015</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember18691134" unitRef="USD" decimals="0">1015</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">-342555</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">2102948</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1188371</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">3943621</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">20000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">23334</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016004</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016004</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-03-31_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-03-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-03-31_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016014</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">20000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">23334</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016004</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016004</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-03-31_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-03-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-03-31_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016014</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:Revenues contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">4303296</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">4874359</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">1195921</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">593712</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">1092228</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">2325085</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">3481673</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">3966607</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">927125</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">454839</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">865571</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">1850594</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">821623</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">907752</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">268796</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">138873</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">226657</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">474491</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">570514</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">79405</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">391014</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">184024</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">153300</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">241020</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">2508846</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">3088178</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">2367781</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1678335</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">578097</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">992462</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GoodwillImpairmentLoss contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">983645</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">110545</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-2257737</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-3243476</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-2489999</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-1723486</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-504740</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-758991</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">1195329</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">376974</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">16876</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">7750</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">793837</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">1087039</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">25160</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-62954</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">13054</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">6618</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-577</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">18611</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-217828</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">170309</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-999860</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-657756</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-3822</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-1132</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-794414</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-1068428</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-3257597</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-3901232</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-2493821</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-1724618</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-1299154</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-1827419</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-3257597</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-3901232</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-10-01to2017-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-3901232</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-10-01to2018-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-3257597</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-2493821</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-1724618</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-1299154</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-1827419</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-10-01to2018-09-30" unitRef="USDPShares" decimals="INF">-0.38</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-10-01to2017-09-30" unitRef="USDPShares" decimals="INF">-1.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-10-01to2019-03-31" unitRef="USDPShares" decimals="INF">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-01-01to2018-03-31" unitRef="USDPShares" decimals="INF">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="USDPShares" decimals="INF">-0.25</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-10-01to2018-03-31" unitRef="USDPShares" decimals="INF">-0.37</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-10-01to2018-09-30" unitRef="Shares" decimals="INF">8630891</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-10-01to2017-09-30" unitRef="Shares" decimals="INF">3844840</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2018-10-01to2019-03-31" unitRef="Shares" decimals="INF">18424608</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2018-01-01to2018-03-31" unitRef="Shares" decimals="INF">19297126</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="Shares" decimals="INF">5128144</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-10-01to2018-03-31" unitRef="Shares" decimals="INF">4889218</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesIssued contextRef="AsOf2016-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2356152</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2017-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">4655486</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2018-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">17531502</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2016-09-30_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2017-09-30_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2016-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">23334</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2017-09-30_us-gaap_SeriesAPreferredStockMember108656942" unitRef="Shares" decimals="INF">23334</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2016-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">1785715</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2017-09-30_us-gaap_SeriesCPreferredStockMember108668237" unitRef="Shares" decimals="INF">1785715</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2018-09-30_us-gaap_SeriesAPreferredStockMember109244239" unitRef="Shares" decimals="INF">20000</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2018-09-30_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember109256907" unitRef="Shares" decimals="INF">1785715</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2016-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2017-09-30_us-gaap_SeriesDPreferredStockMember18674396" unitRef="Shares" decimals="INF">1016004</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2018-09-30_us-gaap_SeriesDPreferredStockMember18691134" unitRef="Shares" decimals="INF">1016004</us-gaap:SharesIssued>
    <KNWN:StockCompensationExpenseEmployeeOptions contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">50899</KNWN:StockCompensationExpenseEmployeeOptions>
    <KNWN:StockCompensationExpenseEmployeeOptions contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">37848</KNWN:StockCompensationExpenseEmployeeOptions>
    <KNWN:StockCompensationExpenseEmployeeOptions contextRef="From2016-10-01to2017-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">37848</KNWN:StockCompensationExpenseEmployeeOptions>
    <KNWN:StockCompensationExpenseEmployeeOptions contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">50899</KNWN:StockCompensationExpenseEmployeeOptions>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">440319</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">546456</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2016-10-01to2017-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1353</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1280</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2016-10-01to2017-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">545103</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">439039</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2016-10-01to2017-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1354386</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1279676</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">817802</KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues>
    <KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">999147</KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues>
    <KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues contextRef="From2016-10-01to2017-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">998132</KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues>
    <KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">817802</KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues>
    <KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues contextRef="From2016-10-01to2017-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="USD" decimals="0">1015</KNWN:SeriesDStockIssuedDuringPeriodValueNewIssues>
    <KNWN:SeriesDStockIssuedDuringPeriodSharesNewIssues contextRef="From2016-10-01to2017-09-30_us-gaap_SeriesDPreferredStockMember" unitRef="Shares" decimals="INF">1016004</KNWN:SeriesDStockIssuedDuringPeriodSharesNewIssues>
    <KNWN:BeneficialConversionFeature contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:BeneficialConversionFeature>
    <KNWN:BeneficialConversionFeature contextRef="From2016-10-01to2017-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">559130</KNWN:BeneficialConversionFeature>
    <KNWN:BeneficialConversionFeature contextRef="From2016-10-01to2017-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-559130</KNWN:BeneficialConversionFeature>
    <KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">711950</KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount>
    <KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">755960</KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount>
    <KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount contextRef="From2016-10-01to2017-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">946</KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount>
    <KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2435</KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount>
    <KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount contextRef="From2016-10-01to2017-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">755014</KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount>
    <KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">709515</KNWN:IssuanceOfCommonStockForAccruedLiabilitiesAmount>
    <KNWN:IssuanceOfCommonStockForAccruedLiabilitiesShares contextRef="From2016-10-01to2017-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">944948</KNWN:IssuanceOfCommonStockForAccruedLiabilitiesShares>
    <KNWN:IssuanceOfCommonStockForAccruedLiabilitiesShares contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2435000</KNWN:IssuanceOfCommonStockForAccruedLiabilitiesShares>
    <KNWN:WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">410524</KNWN:WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital>
    <KNWN:WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital contextRef="From2016-10-01to2017-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">410524</KNWN:WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">132615</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">81283</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">133019</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">30462</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">440319</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">547838</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">348900</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">70641</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <KNWN:ConversionOfInterest contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">64233</KNWN:ConversionOfInterest>
    <KNWN:ConversionOfInterest contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">68043</KNWN:ConversionOfInterest>
    <KNWN:ConversionOfInterest contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</KNWN:ConversionOfInterest>
    <KNWN:ConversionOfInterest contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">64233</KNWN:ConversionOfInterest>
    <us-gaap:ShareBasedCompensation contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">50899</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">37848</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">263147</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">7334</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-113244</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">145282</us-gaap:DerivativeGainLossOnDerivativeNet>
    <KNWN:ReclassificationOfDerivativeLiability contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</KNWN:ReclassificationOfDerivativeLiability>
    <KNWN:ReclassificationOfDerivativeLiability contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">410324</KNWN:ReclassificationOfDerivativeLiability>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">475174</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">158941</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">475174</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">136217</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">10747</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">8728</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">21406</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-362035</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">20582</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-118438</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-114918</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-7547</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">7204</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-7296</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-4292</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-22327</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-69309</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-102593</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-21616</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-176495</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">134382</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-223216</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">33193</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-7943</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">63902</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-55959</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-58615</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-1117131</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-1264324</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-1462737</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-442518</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">260000</us-gaap:PaymentsToAcquireInvestments>
    <KNWN:RepaymentFromInvestment contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</KNWN:RepaymentFromInvestment>
    <KNWN:RepaymentFromInvestment contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">290000</KNWN:RepaymentFromInvestment>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">97251</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-2441</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">1434</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-97251</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">33875</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-74556</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-220539</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">30321</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-145188</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-190663</us-gaap:ProceedsFromLinesOfCredit>
    <KNWN:ProceedsFromConvertibleNotesPayable contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">636000</KNWN:ProceedsFromConvertibleNotesPayable>
    <KNWN:ProceedsFromConvertibleNotesPayable contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">690000</KNWN:ProceedsFromConvertibleNotesPayable>
    <KNWN:ProceedsFromConvertibleNotesPayable contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</KNWN:ProceedsFromConvertibleNotesPayable>
    <KNWN:ProceedsFromConvertibleNotesPayable contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">530000</KNWN:ProceedsFromConvertibleNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">1750000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">550000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">3809975</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromRepaymentsOfDebt contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfDebt contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-125000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">2045608</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">1145321</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">3664787</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">339337</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">831226</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-85128</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">2127494</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-103181</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:InterestPaidNet contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">64228</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">47789</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">7750</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">20243</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">695000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">482014</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">559130</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">220000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">3</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">9</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2017-10-01to2018-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="0">-12</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">35000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">35000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">35000</us-gaap:InventoryValuationReserves>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2017-10-01to2018-09-30_MinimumMember">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2017-10-01to2018-09-30_MaximumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2017-10-01to2018-09-30_us-gaap_MinimumMember_us-gaap_LeaseholdImprovementsMember">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2017-10-01to2018-09-30_us-gaap_MaximumMember_us-gaap_LeaseholdImprovementsMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2018-10-01to2019-03-31_srt_MinimumMember">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2018-10-01to2019-03-31_srt_MaximumMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2019-01-01to2019-03-31_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2019-01-01to2019-03-31_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">670666</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2018-09-30_custom_PurchasedMember" unitRef="USD" decimals="0">532966</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2018-09-30_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">137700</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">662855</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">717019</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2019-03-31_custom_PurchasedMember" unitRef="USD" decimals="0">579318</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2019-03-31_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">137701</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:Depreciation contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">60393</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">38031</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">46354</us-gaap:Depreciation>
    <us-gaap:InterestExpenseDebt contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">156941</us-gaap:InterestExpenseDebt>
    <us-gaap:LineOfCredit contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">145186</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">365725</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:LineOfCredit>
    <us-gaap:NotesPayableToBank contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:NotesPayableToBank>
    <us-gaap:NotesPayableToBank contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">199935</us-gaap:NotesPayableToBank>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">600000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">145186</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">1165660</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-09-30_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">6900356</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-09-30_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">15473398</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">50908</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">15404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">2182668</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-03-31_custom_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">17572583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">2282668</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-10-01to2018-09-30_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">9276066</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-10-01to2018-09-30_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">2180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-10-01to2019-03-31" unitRef="Shares" decimals="INF">2462185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">2462185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2017-10-01to2018-09-30_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">-158026</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">-336427</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2017-10-01to2018-09-30_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2017-10-01to2018-09-30_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">12736</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">35504</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-09-30_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-09-30_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.326</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">18.045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">14.675</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.698</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-03-31_custom_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.453</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.757</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.683</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">0.000</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">1.222</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">3.030</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.507</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">0.000</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.250</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">0.000</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">-14.764</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">19.507</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.000</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">0.000</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2016-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">918627</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">226059</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">3706519</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">14664327</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">4009519</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue contextRef="From2017-10-01to2018-09-30_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">3668500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">303000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue contextRef="From2017-10-01to2018-09-30_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">188040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue contextRef="From2016-10-01to2017-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">692568</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue contextRef="From2018-10-01to2019-03-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">50899</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">37848</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">263145</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">7334</us-gaap:StockOptionPlanExpense>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">5743840</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">5804285</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">5743840</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">5804285</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">-5743840</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">-5804285</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">60445</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">-1036276</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2017-10-01to2018-09-30" unitRef="Pure" decimals="INF">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2016-10-01to2017-09-30" unitRef="Pure" decimals="INF">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2017-10-01to2018-09-30" unitRef="Pure" decimals="INF">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2016-10-01to2017-09-30" unitRef="Pure" decimals="INF">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2017-10-01to2018-09-30" unitRef="Pure" decimals="INF">0.0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2016-10-01to2017-09-30" unitRef="Pure" decimals="INF">0.0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">60000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">60000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">60000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">17531502</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-09-30" unitRef="Shares" decimals="INF">4655486</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">22002904</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">17531502</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-09-30" unitRef="Shares" decimals="INF">4655486</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">22002904</us-gaap:CommonStockSharesOutstanding>
    <KNWN:StockIssuedDuringPeriodSharesCash contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">7000000</KNWN:StockIssuedDuringPeriodSharesCash>
    <KNWN:StockIssuedDuringPeriodValueCash contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">1750000</KNWN:StockIssuedDuringPeriodValueCash>
    <KNWN:StockIssuedDuringPeriodValueCash contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">7000</KNWN:StockIssuedDuringPeriodValueCash>
    <KNWN:StockIssuedDuringPeriodValueCash contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1743000</KNWN:StockIssuedDuringPeriodValueCash>
    <KNWN:StockCompensationExpenseWarrants contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">239680</KNWN:StockCompensationExpenseWarrants>
    <KNWN:StockCompensationExpenseWarrants contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">5000</KNWN:StockCompensationExpenseWarrants>
    <KNWN:StockCompensationExpenseWarrants contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">239680</KNWN:StockCompensationExpenseWarrants>
    <KNWN:StockIssuedDuringPeriodSharesPatents contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2000000</KNWN:StockIssuedDuringPeriodSharesPatents>
    <KNWN:StockIssuedDuringPeriodValuePatents contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">520000</KNWN:StockIssuedDuringPeriodValuePatents>
    <KNWN:StockIssuedDuringPeriodValuePatents contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2000</KNWN:StockIssuedDuringPeriodValuePatents>
    <KNWN:StockIssuedDuringPeriodValuePatents contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">518000</KNWN:StockIssuedDuringPeriodValuePatents>
    <KNWN:StockIssuedDuringPeriodSharesWarrantExercise contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">158006</KNWN:StockIssuedDuringPeriodSharesWarrantExercise>
    <KNWN:StockIssuedDuringPeriodValueWarrantExercise contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-80147</KNWN:StockIssuedDuringPeriodValueWarrantExercise>
    <KNWN:StockIssuedDuringPeriodValueWarrantExercise contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:StockIssuedDuringPeriodValueWarrantExercise>
    <KNWN:StockIssuedDuringPeriodValueWarrantExercise contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">158</KNWN:StockIssuedDuringPeriodValueWarrantExercise>
    <KNWN:StockIssuedDuringPeriodValueWarrantExercise contextRef="From2017-10-01to2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">79989</KNWN:StockIssuedDuringPeriodValueWarrantExercise>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="From2017-10-01to2018-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">3334</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="From2017-10-01to2018-09-30_us-gaap_SeriesAPreferredStockMember" unitRef="Shares" decimals="INF">-3334</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-2100</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-8697</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-2100</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <KNWN:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1 contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">348096</KNWN:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1>
    <KNWN:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1 contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1>
    <KNWN:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1 contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</KNWN:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1>
    <KNWN:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1 contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">482014</KNWN:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1>
    <KNWN:AcquisitionOfPatents contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">520000</KNWN:AcquisitionOfPatents>
    <KNWN:AcquisitionOfPatents contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:AcquisitionOfPatents>
    <KNWN:RelatedPartyAccountsConvertedToNotes contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">1184066</KNWN:RelatedPartyAccountsConvertedToNotes>
    <KNWN:RelatedPartyAccountsConvertedToNotes contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:RelatedPartyAccountsConvertedToNotes>
    <KNWN:PenaltyOnNotesPayable contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">75000</KNWN:PenaltyOnNotesPayable>
    <KNWN:PenaltyOnNotesPayable contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:PenaltyOnNotesPayable>
    <KNWN:IssuanceOfCommonStockForConversionOfLiabilities contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">199935</KNWN:IssuanceOfCommonStockForConversionOfLiabilities>
    <KNWN:IssuanceOfCommonStockForConversionOfLiabilities contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:IssuanceOfCommonStockForConversionOfLiabilities>
    <KNWN:ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">491802</KNWN:ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable>
    <KNWN:ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable>
    <KNWN:ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">0</KNWN:ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable>
    <KNWN:ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">491802</KNWN:ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable>
    <KNWN:NoncashGainOnAccountsPayable contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">-170309</KNWN:NoncashGainOnAccountsPayable>
    <KNWN:NoncashGainOnAccountsPayable contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</KNWN:NoncashGainOnAccountsPayable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Know Labs, Inc. (the &amp;#8220;Company&amp;#8221;)&#13;was incorporated under the laws of the State of Nevada in 1998. The Company has authorized 105,000,000 shares of capital stock,&#13;of which 100,000,000 are shares of voting common stock, par value $0.001 per share, and 5,000,000 are shares preferred stock, par&#13;value $0.001 per share.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is focused on the development, marketing&#13;and sales of a proprietary technologies which are capable of uniquely authenticating or diagnosing almost any substance or material&#13;using electromagnetic energy to create, record and detect the unique &amp;#8220;signature&amp;#8221; of the substance. The Company&amp;#8217;s&#13;call these our &amp;#8220;ChromaID&amp;#8482;&amp;#8221; and &amp;#8220;Bio-RFID&amp;#8482;&amp;#8221; technologies.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Overview&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Historically, the Company focused on the development&#13;of our proprietary ChromaID technology. Using light from low-cost LEDs (light emitting diodes) the Company&amp;#8217;s map the color&#13;of substances, fluids and materials and with our proprietary processes we can authenticate, identify and diagnose based upon the&#13;color that is present. The color is both visible to us as humans but also outside of the humanly visible color spectrum in the&#13;near infra-red and near ultra-violet and beyond. The Company&amp;#8217;s ChromaID scanner sees what we like to call &amp;#8220;Nature&amp;#8217;s&#13;Color Fingerprint.&amp;#8221; Everything in nature has a unique color identifier and with ChromaID the Company can see it, and identify,&#13;authenticate and diagnose based upon the color that is present. The Company&amp;#8217;s ChromaID scanner is capable of uniquely identifying&#13;and authenticating almost any substance or liquid using light to create, record and detect its unique color signature. The Company&#13;will continue to develop and enhance its ChromaID technology and extend its capacity. More recently, the Company has focused upon&#13;extensions and new inventions that are derived from and extend beyond our ChromaID technology. The Company&amp;#8217;s call this technology&#13;Bio-RFID. The rapid advances made with our Bio-RFID technology in our laboratory have caused us to move quickly in to the commercialization&#13;phase of our Company as we work to create revenue generating products for the marketplace. The Company will also, as resources&#13;permit, pursue licensing opportunities with third parties who have ready applications for our technologies.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In 2010, the Company acquired TransTech Systems,&#13;Inc. as an adjunct to its business. TransTech is a distributor of products for employee and personnel identification. TransTech&#13;currently provides substantially all of the Company&amp;#8217;s revenues.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is in the process of commercializing&#13;its ChromaID&amp;#8482; and Bio-RFID&amp;#8482; technology. To date, the Company has entered into License Agreements with Sumitomo Precision&#13;Products Co., Ltd. In addition, it has a technology license agreement with Allied Inventors, formerly Xinova and Invention Development&#13;Management Company, a subsidiary of Intellectual Ventures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company believes that its commercialization&#13;success is dependent upon its ability to significantly increase the number of customers that are purchasing and using its products.&#13;To date the Company has generated minimal revenue from sales of its ChromaID and Bio-RFID products. The Company is currently not&#13;profitable. Even if the Company succeeds in introducing the ChromaID and Bio-RFID technology and related products to its target&#13;markets, the Company may not be able to generate sufficient revenue to achieve or sustain profitability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ChromaID was invented by scientists under contract&#13;with the Company. Bio-RFID was invented by individuals working for the Company. The Company actively pursues a robust intellectual&#13;property strategy and has been granted twelve patents. The Company also has 20 patents pending. The Company possesses all right,&#13;title and interest to the issued patents. Ten of the pending patents are licensed exclusively to the Company in perpetuity by the&#13;Company&amp;#8217;s strategic partner, Allied Inventors.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Merger with RAAI Lighting, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company entered into&#13;an Agreement and Plan of Merger with 500 Union Corporation, a Delaware corporation and a wholly owned subsidiary of the Company,&#13;and RAAI Lighting, Inc., a Delaware corporation. Pursuant to the Merger Agreement, we have acquired all the outstanding shares&#13;of RAAI&amp;#8217;s capital stock through a merger of Merger Sub with and into RAAI (the &amp;#8220;Merger&amp;#8221;), with RAAI surviving&#13;the Merger as a wholly owned subsidiary of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the terms of the Merger Agreement, each&#13;share of RAAI common stock issued and outstanding immediately before the Merger (1,000 shares) were cancelled and we issued 2,000,000&#13;shares of our common stock. As a result, we issued 2,000,000 shares of its common stock to Phillip A. Bosua, formerly the sole&#13;stockholder of RAAI. The consideration for the Merger was determined through arms-length bargaining by the Company and RAAI. The&#13;Merger was structured to qualify as a tax-free reorganization for U.S. federal income tax purposes. As a result of the Merger,&#13;the Company received certain intellectual property, related to RAAI.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Appointment of Director&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Board increased the size&#13;of the Board from three to four members and Phillip A. Bosua was appointed as a member of the Board. Mr. Bosua&amp;#8217;s term of&#13;office expires at the next annual meeting of our stockholders. On May 24, 2018, the Board of Directors increased the size of the&#13;Board from four to five members and appointed (Ret.) Admiral William Owens as a member of the Board. Admiral Owen&amp;#8217;s term&#13;of office expires at the next annual meeting of our stockholders.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Appointment of Officer&lt;/b&gt; &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company appointed Mr.&#13;Bosua as Chief Executive Officer of the Company, replacing Ronald P. Erickson, who remains Chairman of the Company. Previously,&#13;Mr. Bosua served as the Company&amp;#8217;s Chief Product Officer since August 2017. The Company entered into a Consulting Agreement&#13;with Mr. Bosua&amp;#8217;s company, Blaze Clinical on July 7, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company entered into&#13;an Employment Agreement with Mr. Bosua reflecting Mr. Bosua&amp;#8217;s appointment as Chief Executive Officer. The Employment Agreement&#13;is for an initial term of 12 months (subject to earlier termination) and will be automatically extended for additional 12-month&#13;terms unless either party notifies the other party of its intention to terminate the Employment Agreement. Mr. Bosua will be paid&#13;a base salary of $225,000 per year, received 500,000 shares of common stock valued at $0.33 per share and may be entitled to bonuses&#13;and equity awards at the discretion of the Board or a committee of the Board. The Employment Agreement provides for severance pay&#13;equal to 12 months of base salary if Mr. Bosua is terminated without &amp;#8220;cause&amp;#8221; or voluntarily terminates his employment&#13;for &amp;#8220;good reason.&amp;#8221;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company entered into&#13;an Amended Employment Agreement for Ronald P. Erickson which amends the Employment Agreement dated July 1, 2017. The Agreement&#13;expires March 21, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Merger with Know Labs, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2018, Know Labs, Inc., a Nevada corporation&#13;incorporated on April 3, 2018, and our wholly-owned subsidiary, merged with and into the Company pursuant to an Agreement and Plan&#13;of Merger dated May 1, 2018. In connection with the merger, our Articles of Incorporation were effectively amended to change our&#13;name to Know Labs, Inc. by and through the filing of Articles of Merger. This parent-subsidiary merger was approved by us, the&#13;parent, in accordance with Nevada Revised Statutes Section 92A.180. Stockholder approval was not required. This amendment was filed&#13;with the Nevada Secretary of State and became effective on May 1, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Corporate Name Change and Symbol Change&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 24, 2018, the Financial Industry Regulatory&#13;Authority (&amp;#8220;FINRA&amp;#8221;) announced the effectiveness of a change in our name from Visualant Incorporated to Know Labs, Inc.&#13;and a change in our ticker symbol from VSUL to the new trading symbol KNWN which became effective on the opening of trading as&#13;of May 25, 2018. In addition, in connection with the name change and symbol change, we were assigned the CUSIP number of 499238103.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Closing of Financing on June 25, 2018&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 25, 2018, the Company closed a private&#13;placement and received gross proceeds of $1,750,000 in exchange for issuing 7,000,000 shares of common stock and warrants to purchase&#13;3,500,000 shares of common stock in a private placement to accredited investors pursuant to a series of substantially identical&#13;subscription agreements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The initial exercise price of the warrants described&#13;above is $0.25 per share, subject to certain adjustments, and the warrants expire five years after their issuance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The shares and the warrants described above&#13;were issued in transactions that were not registered under the Securities Act of 1933, as amended (the &amp;#8220;Act&amp;#8221;) in reliance&#13;upon applicable exemptions from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act.&#13;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Know Labs, Inc. (the &amp;#8220;Company&amp;#8221;)&#13;was incorporated under the laws of the State of Nevada in 1998. The Company has authorized 105,000,000 shares of capital stock,&#13;of which 100,000,000 are shares of voting common stock, par value $0.001 per share, and 5,000,000 are shares preferred stock, par&#13;value $0.001 per share.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is focused on the development, marketing&#13;and sales of a proprietary technologies which are capable of uniquely authenticating or diagnosing almost any substance or material&#13;using electromagnetic energy to create, record and detect the unique &amp;#8220;signature&amp;#8221; of the substance. The Company&amp;#8217;s&#13;call these our &amp;#8220;ChromaID&amp;#8482;&amp;#8221; and &amp;#8220;Bio-RFID&amp;#8482;&amp;#8221; technologies.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Overview&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Historically, the Company focused on the development&#13;of our proprietary ChromaID technology. Using light from low-cost LEDs (light emitting diodes) the Company&amp;#8217;s map the color&#13;of substances, fluids and materials and with our proprietary processes we can authenticate, identify and diagnose based upon the&#13;color that is present. The color is both visible to us as humans but also outside of the humanly visible color spectrum in the&#13;near infra-red and near ultra-violet and beyond. The Company&amp;#8217;s ChromaID scanner sees what we like to call &amp;#8220;Nature&amp;#8217;s&#13;Color Fingerprint.&amp;#8221; Everything in nature has a unique color identifier and with ChromaID the Company can see it, and identify,&#13;authenticate and diagnose based upon the color that is present. The Company&amp;#8217;s ChromaID scanner is capable of uniquely identifying&#13;and authenticating almost any substance or liquid using light to create, record and detect its unique color signature. The Company&#13;will continue to develop and enhance its ChromaID technology and extend its capacity. More recently, the Company has focused upon&#13;extensions and new inventions that are derived from and extend beyond our ChromaID technology. The Company&amp;#8217;s call this technology&#13;Bio-RFID. The rapid advances made with our Bio-RFID technology in our laboratory have caused us to move quickly in to the commercialization&#13;phase of our Company as we work to create revenue generating products for the marketplace. The Company will also, as resources&#13;permit, pursue licensing opportunities with third parties who have ready applications for our technologies.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In 2010, the Company acquired TransTech Systems,&#13;Inc. as an adjunct to its business. TransTech is a distributor of products for employee and personnel identification. TransTech&#13;has provided all of the Company&amp;#8217;s revenues.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is in the process of commercializing&#13;its technology. To date, the Company has entered into License Agreements with Sumitomo Precision Products Co., Ltd. In addition,&#13;it has a technology license agreement with Allied Inventors, formerly Xinova and Invention Development Management Company, a subsidiary&#13;of Intellectual Ventures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company believes that its commercialization&#13;success is dependent upon its ability to significantly increase the number of customers that are purchasing and using its products.&#13;To date the Company has generated minimal revenue from sales of its ChromaID and Bio-RFID products. The Company is currently not&#13;profitable. Even if the Company succeeds in introducing the ChromaID and Bio-RFID technology and related products to its target&#13;markets, the Company may not be able to generate sufficient revenue to achieve or sustain profitability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ChromaID was invented by scientists under contract&#13;with the Company. Bio-RFID was invented by individuals working for the Company. The Company actively pursues a robust intellectual&#13;property strategy and has been granted twelve patents. The Company also has 20 patents pending. The Company possesses all right,&#13;title and interest to the issued patents. Ten of the pending patents are licensed exclusively to the Company in perpetuity by the&#13;Company&amp;#8217;s strategic partner, Allied Inventors.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Merger with RAAI Lighting, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company entered into&#13;an Agreement and Plan of Merger with 500 Union Corporation, a Delaware corporation and a wholly owned subsidiary of the Company,&#13;and RAAI Lighting, Inc., a Delaware corporation. Pursuant to the Merger Agreement, we have acquired all the outstanding shares&#13;of RAAI&amp;#8217;s capital stock through a merger of Merger Sub with and into RAAI (the &amp;#8220;Merger&amp;#8221;), with RAAI surviving&#13;the Merger as a wholly owned subsidiary of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the terms of the Merger Agreement, each&#13;share of RAAI common stock issued and outstanding immediately before the Merger (1,000 shares) were cancelled and we issued 2,000,000&#13;shares of our common stock. As a result, we issued 2,000,000 shares of its common stock to Phillip A. Bosua, formerly the sole&#13;stockholder of RAAI. The consideration for the Merger was determined through arms-length bargaining by the Company and RAAI. The&#13;Merger was structured to qualify as a tax-free reorganization for U.S. federal income tax purposes. As a result of the Merger,&#13;the Company received certain intellectual property, related to RAAI.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Merger with Know Labs, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2018, Know Labs, Inc., a Nevada corporation&#13;incorporated on April 3, 2018, and our wholly-owned subsidiary, merged with and into the Company pursuant to an Agreement and Plan&#13;of Merger dated May 1, 2018. In connection with the merger, our Articles of Incorporation were effectively amended to change our&#13;name to Know Labs, Inc. by and through the filing of Articles of Merger. This parent-subsidiary merger was approved by us, the&#13;parent, in accordance with Nevada Revised Statutes Section 92A.180. Stockholder approval was not required. This amendment was filed&#13;with the Nevada Secretary of State and became effective on May 1, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Corporate Name Change and Symbol Change&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 24, 2018, the Financial Industry Regulatory&#13;Authority (&amp;#8220;FINRA&amp;#8221;) announced the effectiveness of a change in our name from Visualant Incorporated to Know Labs, Inc.&#13;and a change in our ticker symbol from VSUL to the new trading symbol KNWN which became effective on the opening of trading as&#13;of May 25, 2018. In addition, in connection with the name change and symbol change, we were assigned the CUSIP number of 499238103.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying financial statements&#13;have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in&#13;the normal course of business. The Company incurred net losses of $3,257,597 and $3,901,232 for the years ended September 30, 2018&#13;and 2017, respectively. Net cash used in operating activities was $1,117,131 and $1,264,324 for the years ended September 30, 2018&#13;and 2017, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company anticipates that it will&#13;record losses from operations for the foreseeable future. As of September 30, 2018, the Company&amp;#8217;s accumulated deficit was&#13;$34,791,324.&amp;#160;&amp;#160;The Company has limited capital resources, and operations to date have been funded with the proceeds from&#13;private equity and debt financings and loans from Ronald P. Erickson, the Company&amp;#8217;s Chief Executive Officer, or entities&#13;with which he is affiliated. These conditions raise substantial doubt about our ability to continue as a going concern. The audit&#13;report prepared by the Company&amp;#8217;s independent registered public accounting firm relating to our financial statements for the&#13;year ended September 30, 2018 includes an explanatory paragraph expressing the substantial doubt about the Company&amp;#8217;s ability&#13;to continue as a going concern.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company believe that its cash on&#13;hand will be sufficient to fund our operations until March 31, 2019. We need additional financing to implement our business plan&#13;and to service our ongoing operations and pay our current debts. There can be no assurance that we will be able to secure any needed&#13;funding, or that if such funding is available, the terms or conditions would be acceptable to us. If we are unable to obtain additional&#13;financing when it is needed, we will need to restructure our operations, and divest all or a portion of our business. &lt;font style="background-color: white"&gt;We&#13;may seek additional capital through a combination of private and public equity offerings, debt financings and strategic collaborations.&#13;Debt financing, if obtained, may involve agreements that include covenants limiting or restricting our ability to take specific&#13;actions, such as incurring additional debt, and could increase our expenses and require that our assets secure such debt. Equity&#13;financing, if obtained, could result in dilution to the Company&amp;#8217;s then-existing stockholders and/or require such stockholders&#13;to waive certain rights and preferences. If such financing is not available on satisfactory terms, or is not available at all,&#13;the Company may be required to delay, scale back, eliminate the development of business opportunities or file for bankruptcy and&#13;our operations and financial condition may be materially adversely affected.&lt;/font&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying financial statements have been&#13;prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal&#13;course of business. The Company incurred net losses of $2,493,821, $3,257,597 and $3,901,232 for the six months ended March 31,&#13;2019 and the years ended September 30, 2018 and 2017, respectively. Net cash used in operating activities was $1,462,737, $1,117,131&#13;and $1,264,324 for the three months ended March 31, 2019 and for the years ended September 30, 2018 and 2017, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company anticipates that it will record&#13;losses from operations for the foreseeable future. As of March 31, 2019, the Company&amp;#8217;s accumulated deficit was $37,285,145.&amp;#160;&amp;#160;The&#13;Company has limited capital resources, and operations to date have been funded with the proceeds from private equity and debt financings&#13;and loans from Ronald P. Erickson, the Company&amp;#8217;s Chief Executive Officer, or entities with which he is affiliated. These&#13;conditions raise substantial doubt about our ability to continue as a going concern. The audit report prepared by the Company&amp;#8217;s&#13;independent registered public accounting firm relating to our financial statements for the year ended September 30, 2018 includes&#13;an explanatory paragraph expressing the substantial doubt about the Company&amp;#8217;s ability to continue as a going concern.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company believe that its cash on hand will&#13;be sufficient to fund our operations until December 31, 2019. We need additional financing to implement our business plan and to&#13;service our ongoing operations and pay our current debts. There can be no assurance that we will be able to secure any needed funding,&#13;or that if such funding is available, the terms or conditions would be acceptable to us. If we are unable to obtain additional&#13;financing when it is needed, we will need to restructure our operations, and divest all or a portion of our business. &lt;font style="background-color: white"&gt;We&#13;may seek additional capital through a combination of private and public equity offerings, debt financings and strategic collaborations.&#13;Debt financing, if obtained, may involve agreements that include covenants limiting or restricting our ability to take specific&#13;actions, such as incurring additional debt, and could increase our expenses and require that our assets secure such debt. Equity&#13;financing, if obtained, could result in dilution to the Company&amp;#8217;s then-existing stockholders and/or require such stockholders&#13;to waive certain rights and preferences. If such financing is not available on satisfactory terms, or is not available at all,&#13;the Company may be required to delay, scale back, eliminate the development of business opportunities or file for bankruptcy and&#13;our operations and financial condition may be materially adversely affected.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt; &amp;#8211; The accompanying&#13;unaudited consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been&#13;eliminated. The preparation of these unaudited condensed consolidated financial statements were prepared in conformity with U.S.&#13;generally accepted accounting principles (&amp;#8220;GAAP&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt; &amp;#8211; The&#13;consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries, TransTech&#13;Systems, Inc and RAAI Lighting, Inc. Inter-Company items and transactions have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt; &amp;#8211;&amp;#160;The&#13;Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash&#13;equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal&#13;Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not&#13;exposed to any significant risk for cash on deposit.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Accounts Receivable and Allowance for Doubtful&#13;Accounts&lt;/b&gt; &amp;#8211; Accounts receivable consist primarily of amounts due to the Company from normal business activities. The Company&#13;maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection&#13;history and specific risks identified within the portfolio. If the financial condition of the customers were to deteriorate resulting&#13;in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances&#13;might be required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Inventories&lt;/b&gt; &amp;#8211; Inventories consist&#13;primarily of printers and consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control&#13;components held for resale and are stated at the lower of cost or market on the&amp;#160;first-in, first-out (&amp;#8220;FIFO&amp;#8221;) method.&amp;#160;&amp;#160;Inventories&#13;are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received&#13;by TransTech at a warehouse location.&amp;#160;&amp;#160;The Company records a provision for excess and obsolete inventory whenever an&#13;impairment has been identified. There is a $35,000 reserve for impaired inventory as of September 30, 2018 and 2017, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Equipment&lt;/b&gt; &amp;#8211; Equipment consists&#13;of machinery, leasehold improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation&#13;and amortization. Depreciation is computed by the straight-line method over the estimated useful lives or lease period of the relevant&#13;asset, generally 2-10 years, except for leasehold improvements which are depreciated over 2-3 years.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Long-Lived Assets&lt;/b&gt; &amp;#8211; The Company&#13;reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an&#13;asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair&#13;value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at&#13;the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying&#13;values exceed fair values, an impairment loss is recognized in operating results.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Intangible Assets&lt;/b&gt; &amp;#8211; Intangible&#13;assets are capitalized and amortized on a straight-line basis over their estimated useful life, if the life is determinable. If&#13;the life is not determinable, amortization is not recorded. We regularly perform reviews to determine if facts and circumstances&#13;exist which indicate that the useful lives of our intangible assets are shorter than originally estimated or the carrying amount&#13;of these assets may not be recoverable. When an indication exists that the carrying amount of intangible assets may not be recoverable,&#13;we assess the recoverability of our assets by comparing the projected undiscounted net cash flows associated with the related asset&#13;or group of assets over their remaining lives against their respective carrying amounts. Such impairment test is based on the lowest&#13;level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Impairment,&#13;if any, is based on the excess of the carrying amount over the estimated fair value of those assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Research, Development and Engineering Expenses&lt;/b&gt;&#13;&amp;#8211; Research, development and engineering expenses consist of the cost of employees, consultants and contractors who design,&#13;engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#8217;s research and development&#13;efforts are primarily focused improving the core foundational ChromaID technology and developing new and unique applications for&#13;the technology. As part of this effort, the Company typically conduct testing to ensure that ChromaID application methods are compatible&#13;with the customer&amp;#8217;s requirements, and that they can be implemented in a cost effective manner. The Company is also actively&#13;involved in identifying new application methods. Know Lab&amp;#8217;s team has considerable experience working with the application&#13;of light-based technologies and their application to various industries. The Company believes that its continued development of&#13;new and enhanced technologies relating to our core business is essential to its future success. The Company spent $570,514 and&#13;$79,405 during the years ended September 30, 2018 and 2017, respectively, on research and development activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurements and Financial&#13;Instruments&lt;/i&gt;&lt;/b&gt; &amp;#8211;&lt;b&gt;&amp;#160;&lt;/b&gt;ASC Topic 820, &lt;i&gt;Fair Value Measurement and Disclosures&lt;/i&gt;, defines fair value as the&#13;exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous&#13;market for the asset or liability in an orderly transaction between market participants on the measurement date.&amp;#160;&amp;#160;This&#13;topic also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring&#13;fair value.&amp;#160;&amp;#160;The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and&#13;an entity&amp;#8217;s own assumptions (unobservable inputs).&amp;#160;&amp;#160;The hierarchy consists of three levels:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 100%; font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 8pt"&gt;Level 1 &amp;#8211; Quoted prices in active markets for identical assets and liabilities;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 100%"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Level 2 &amp;#8211; Inputs other than level one inputs that are either&#13;        directly or indirectly observable; and.&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level&amp;#160;3 - Inputs to the valuation methodology&#13;        are unobservable and significant to the fair value measurement.&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The recorded value of other financial assets&#13;and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts&#13;payable and accrued expenses approximate the fair value of the respective assets and liabilities as of September 30, 2018 and 2017&#13;are based upon the short-term nature of the assets and liabilities.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Derivative Financial Instruments -&lt;/b&gt;The&#13;Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify&#13;as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument&#13;is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in&#13;the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton&#13;option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of&#13;derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the&#13;end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based&#13;on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet&#13;date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt; &amp;#8211; Know Lab&#13;and TransTech revenue are derived from products and services. Revenue is considered realized when the products or services have&#13;been provided to the customer, the work has been accepted by the customer and collectability is&amp;#160;reasonably assured. Furthermore,&#13;if an actual measurement of revenue cannot be determined, the Company defers all revenue recognition until such time that an actual&#13;measurement can be determined. If during the course of a contract management determines that losses are expected to be incurred,&#13;such costs are charged to operations in the period such losses are determined. Revenues are deferred when cash has been received&#13;from the customer but the revenue has not been earned.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Stock Based Compensation&lt;/b&gt; &amp;#8211; The&#13;Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted&#13;stock, as well as options to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based&#13;compensation cost is measured by the Company at the grant date, based on the fair value of the award, over the requisite service&#13;period. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over&#13;the related period of benefit.&amp;#160;&amp;#160;Grants of stock options and stock to non-employees and other parties are accounted for&#13;in accordance with the ASC 505.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Convertible Securities&lt;/b&gt; &amp;#8211; Based&#13;upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will&#13;evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC&#13;815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated&#13;on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an&#13;instrument were required, it would result in the instrument issued latest being reclassified first.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Net Loss per Share&lt;/b&gt; &amp;#8211; Under the&#13;provisions of ASC 260, &amp;#8220;Earnings Per Share,&amp;#8221; basic loss per common share is computed by dividing net loss available&#13;to common stockholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted&#13;net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were&#13;exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the&#13;Company, subject to anti-dilution limitations. The common stock equivalents have not been included as they are anti-dilutive. As&#13;of September 30, 2018, there were options outstanding for the purchase of 2,182,668 common shares, warrants for the purchase of&#13;15,473,398 common shares, 4,914,071 shares of the Company&amp;#8217;s common stock issuable upon the conversion of Series A, Series&#13;C and Series D Convertible Preferred Stock. In addition, we have an unknown number of shares (9,020,264 common shares at the current&#13;price of $0.25 per share) are issuable upon conversion of convertible debentures of $2,255,066. All of which could potentially&#13;dilute future earnings per share. &amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of September 30, 2017, there were options&#13;outstanding for the purchase of 15,404 common shares, warrants for the purchase of 6,900,356 common shares, 2,825,053&amp;#160;shares&#13;of the Company&amp;#8217;s common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock&#13;and up to 332,940 shares of the Company&amp;#8217;s common stock issuable upon the exercise of placement agent warrants. In addition,&#13;the Company has an unknown number of shares are issuable upon conversion of convertible debentures of $570,000. All of which could&#13;potentially dilute future earnings per share. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Dividend Policy&lt;/b&gt; &amp;#8211; The Company has&#13;never paid any cash dividends and intends, for the foreseeable future, to retain any future earnings for the development of our&#13;business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our&#13;results of operations, financial condition, capital requirements and investment opportunities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt; &amp;#8211; The preparation&#13;of financial statements in conformity with accounting principles generally accepted in the United States requires management to&#13;make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and&#13;liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#13;Actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In July 2015, the Financial Accounting Standards&#13;Board (FASB) issued Accounting Standards Update (ASU) 2015-11, &amp;#8220;Simplifying the Measurement of Inventory,&amp;#8221; Topic 330,&#13;&amp;#8220;Inventory&amp;#8221; (ASU 2015-11). The amendments in ASU 2015-11, which apply to inventory that is measured using any method&#13;other than the last-in, first-out (LIFO) or retail inventory method, require that entities measure inventory at the lower of cost&#13;and net realizable value. The amendments in ASU 2015-11 should be applied on a prospective basis. ASU 2015-11 is effective for&#13;fiscal years beginning after December 15, 2016 and interim periods within those years. The Company adopted the amendments of ASU&#13;2015-11 effective October 1, 2017. The adoption of this standard did not have a material impact on the Company&amp;#8217;s consolidated&#13;financial statements for the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In March 2016, the FASB issued ASU 2016-09,&#13;&amp;#8220;Improvements to Employee Share-Based Payment Accounting,&amp;#8221; Topic 718, &amp;#8220;Compensation-Stock Compensation&amp;#8221;&#13;(ASU 2016-09). ASU 2016-09 includes provisions intended to simplify various aspects related to how share-based payments are accounted&#13;for and presented in the Company&amp;#8217;s financial statements, including income tax consequences, forfeitures and classification&#13;on the statement of cash flows. Under previous guidance, excess tax benefits and deficiencies from share-based compensation arrangements&#13;were recorded in equity when the awards vested or were settled. ASU 2016-09 requires prospective recognition of excess tax benefits&#13;and deficiencies in income tax expense, rather than paid-in-capital. The Company adopted the amendments of ASU 2016-09 effective&#13;October 1, 2017.The adoption of this standard did not have a material impact on the Company&amp;#8217;s consolidated statements of&#13;income for the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition, under ASU 2016-09, excess tax income&#13;tax benefits from share-based compensation arrangements are classified as cash flow from operations, rather than as cash flow from&#13;financing activities. For the year ended September 30, 2018, there were no excess income tax benefits.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has elected to continue to estimate&#13;the number of share-based awards expected to vest, as permitted by ASU 2016-09, rather than electing to account for forfeitures&#13;as they occur.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2016-09 requires excess tax benefits and&#13;deficiencies to be prospectively excluded from assumed future proceeds in the calculation of diluted shares, resulting in an immaterial&#13;decrease in diluted weighted average shares outstanding for the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In January 2017, the FASB issued ASU 2017-04,&#13;&amp;#8220;Simplifying the Test for Goodwill Impairment,&amp;#8221; Topic 350, &amp;#8220;Intangibles &amp;#8211; Goodwill and Other&amp;#8221; (ASU&#13;2017-04). The amendments in ASU 2017-04 simplify the accounting for goodwill impairment for all entities by requiring impairment&#13;charges to be based on the first step in the current two-step impairment test. An impairment charge for the amount by which the&#13;carrying amount exceeds the reporting unit&amp;#8217;s fair value should be recognized; however, the loss recognized should not exceed&#13;the total amount of goodwill allocated to that reporting unit. The amendments should be applied on a prospective basis. Early adoption&#13;is permitted for annual and interim goodwill impairment testing dates after January 1, 2017, and the ASU is effective for the Company&amp;#8217;s&#13;first quarter of the fiscal year ending September 30, 2020. The Company is currently evaluating the impact that the adoption of&#13;these provisions will have on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2016, the FASB issued ASU 2016-02,&#13;&amp;#8220;Leases,&amp;#8221; Topic 842, &amp;#8220;Leases&amp;#8221; (ASU 2016-02). ASU No. 2016-02 requires lessees to recognize a right-of-use&#13;asset and corresponding lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation&#13;of expenses will depend on classification as a finance or operating lease. ASU 2016-02 also requires certain quantitative and qualitative&#13;disclosures. The provisions of ASU 2016-02 are effective for the Company&amp;#8217;s first quarter of the fiscal year ending September&#13;30, 2020, with early adoption permitted. The Company will apply the transition provisions of ASU 2016-02 at its adoption date,&#13;rather than the earliest comparative period presented in the financial statements, as permitted by ASU 2018-11, &amp;#8220;Leases,&amp;#8221;&#13;Topic 842, &amp;#8220;Targeted Improvements,&amp;#8221; released in July 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The adoption of ASU 2016-02 may result in a&#13;material increase to the Company&amp;#8217;s consolidated balance sheets for lease liabilities and right-of-use assets. The Company&#13;is also performing a comprehensive review of its current processes to determine and implement changes required to support the adoption&#13;of this standard. The Company is currently evaluating the other effects the adoption of ASU 2016-02 will have on its consolidated&#13;financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In January 2018, the FASB issued ASU 2018-01,&#13;&amp;#8220;Leases,&amp;#8221; Topic 842, &amp;#8220;Land Easement Practical Expedient for Transition to Topic 842&amp;#8221; (ASU 2018-01). ASU&#13;2018-01 permits an entity to elect a transition practical expedient to not assess, under Accounting Standards Codification (ASC)&#13;842, land easements that exist or expired before the standard&amp;#8217;s effective date that were not previously accounted for as&#13;leases under ASC 840. The Company plans to elect this practical expedient in implementing ASU 2016-02.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In May 2014, the FASB issued ASU 2014-09, &amp;#8220;Revenue&#13;from Contracts with Customers,&amp;#8221; Topic 606, &amp;#8220;Revenue from Contracts with Customers&amp;#8221; (ASU 2014-09). ASU 2014-09&#13;provides guidance for revenue recognition and will replace most existing revenue recognition guidance in GAAP when it becomes effective.&#13;ASU 2014-09&amp;#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers&#13;in an amount that reflects the consideration to which the company expects to be entitled for the transfer of those goods or services.&#13;ASU 2014-09 permits the use of either the retrospective or cumulative effect transition method. Additionally, the amendments in&#13;this ASU provide a practical expedient for entities to recognize the incremental costs of obtaining a contract as an expense when&#13;incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less, The Company&#13;plans to elect this practical expedient upon adoption.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In July 2015, the FASB issued ASU 2015-14, &amp;#8220;Revenue&#13;from Contracts with Customers &amp;#8211; Deferral of the Effective Date.&amp;#8221; The FASB approved the deferral of ASU 2014-09, by&#13;extending the new revenue recognition standard&amp;#8217;s mandatory effective date by one year and permitting public companies to&#13;apply the new revenue standard to annual reporting periods beginning after December 15, 2017. The guidance in ASU 2014-09 will&#13;be effective for the Company in the first quarter of the fiscal year ending September 30, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further to ASU 2014-09 and ASU 2015-14, the&#13;FASB issued ASU 2016-08, &amp;#8220;Revenue from Contracts with Customers,&amp;#8221; Topic 606, &amp;#8220;Principal versus Agent Considerations&#13;(Reporting Revenue Gross versus Net)&amp;#8221; (ASU 2016-08) in March 2016, ASU 2016-12, &amp;#8220;Revenue from Contracts with Customers,&amp;#8221;&#13;Topic 606, &amp;#8220;Narrow-Scope Improvements and Practical Expedients&amp;#8221; (ASU 2016-12) in May 2016 and ASU 2016-20, &amp;#8220;Revenue&#13;from Contracts with Customers,&amp;#8221; Topic 606, &amp;#8220;Technical Corrections and Improvements&amp;#8221; (ASU 2016-20) in December&#13;2016. The amendments in ASU 2016-08 clarify the implementation guidance on principal versus agent considerations, including indicators&#13;to assist an entity in determining whether it controls a specified good or service before it is transferred to the customers. ASU&#13;2016-12 addresses narrow-scope improvements to the guidance on collectability, non-cash consideration, and completed contracts&#13;at transition. Additionally, the amendments in this ASU provide a practical expedient for contract modifications at transition&#13;and an accounting policy election related to the presentation of sales taxes and other similar taxes collected from customers.&#13;The Company plans to make such election. The Company also plans to elect the practical expedient in ASU 2016-20 that provides entities&#13;do not need to disclose the transaction price allocated to performance obligations when the related contracts have a duration of&#13;one year or less. This includes loyalty rewards, which can be redeemed in the month subsequent to the quarter earned, and marketing&#13;promotions that cross accounting periods. Both of these classes of transactions are currently immaterial to the Company. The effective&#13;date and transition requirements for ASU 2016-08, ASU 2016-12 and ASU 2016-20 are the same as for ASU 2014-09.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company does not plan to early adopt the&#13;new revenue recognition guidance; adoption will be on the modified retrospective basis beginning in fiscal year 2019. The Company&#13;has substantially concluded its assessment of the impact of the adoption of this standard on its consolidated financial statements.&#13;Most of the Company&amp;#8217;s revenue is expected to continue to be generated from point-of-sale transactions, which ASU 2014-09&#13;treats generally consistent with current accounting standards. The Company does not expect this standard will have a material impact&#13;on the accounting for point-of-sale transactions or related areas including the right of return and customer incentives. Although&#13;the impact on the consolidated financial statements is not expected to be material, additional disclosures will be required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In June 2018, the FASB issued ASU 2018-07, &amp;#8220;Compensation-Stock&#13;Compensation,&amp;#8221; Topic 718, &amp;#8220;Improvements to Nonemployee Share-Based Payment Accounting&amp;#8221; (ASU 2018-07) as part&#13;of its Simplification Initiative to reduce complexity when accounting for share-based payments to non-employees. ASU 2018-07 expands&#13;the scope of Topic 718 to more closely align share-based payment transactions for acquiring goods and services from non-employees&#13;with the accounting for share-based payments to employees, with certain exceptions. The provisions of ASU 2018-07 are effective&#13;for the Company&amp;#8217;s first quarter of the fiscal year ending September 30, 2020, with early adoption permitted.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt; &amp;#8211; The accompanying&#13;unaudited consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been&#13;eliminated. The preparation of these unaudited condensed consolidated financial statements were prepared in conformity with U.S.&#13;generally accepted accounting principles (&amp;#8220;GAAP&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt; &amp;#8211; The&#13;consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries, TransTech&#13;Systems, Inc and RAAI Lighting, Inc. Inter-Company items and transactions have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt; &amp;#8211;&amp;#160;The&#13;Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash&#13;equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal&#13;Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not&#13;exposed to any significant risk for cash on deposit.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Accounts Receivable and Allowance for Doubtful&#13;Accounts&lt;/b&gt; &amp;#8211; Accounts receivable consist primarily of amounts due to the Company from normal business activities. The Company&#13;maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection&#13;history and specific risks identified within the portfolio. If the financial condition of the customers were to deteriorate resulting&#13;in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances&#13;might be required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Inventories&lt;/b&gt; &amp;#8211; Inventories consist&#13;primarily of printers and consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control&#13;components held for resale and are stated at the lower of cost or market on the&amp;#160;first-in, first-out (&amp;#8220;FIFO&amp;#8221;) method.&amp;#160;&amp;#160;Inventories&#13;are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received&#13;by TransTech at a warehouse location.&amp;#160;&amp;#160;The Company records a provision for excess and obsolete inventory whenever an&#13;impairment has been identified. There is a $35,000 reserve for impaired inventory as of March 31, 2019 and September 30, 2018,&#13;respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Equipment&lt;/b&gt; &amp;#8211; Equipment consists&#13;of machinery, leasehold improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation&#13;and amortization. Depreciation is computed by the straight-line method over the estimated useful lives or lease period of the relevant&#13;asset, generally 2-10 years, except for leasehold improvements which are depreciated over 2-3 years.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Long-Lived Assets&lt;/b&gt; &amp;#8211; The Company&#13;reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an&#13;asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair&#13;value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at&#13;the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying&#13;values exceed fair values, an impairment loss is recognized in operating results.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Intangible Assets&lt;/b&gt; &amp;#8211; Intangible&#13;assets are capitalized and amortized on a straight-line basis over their estimated useful life, if the life is determinable. If&#13;the life is not determinable, amortization is not recorded. We regularly perform reviews to determine if facts and circumstances&#13;exist which indicate that the useful lives of our intangible assets are shorter than originally estimated or the carrying amount&#13;of these assets may not be recoverable. When an indication exists that the carrying amount of intangible assets may not be recoverable,&#13;we assess the recoverability of our assets by comparing the projected undiscounted net cash flows associated with the related asset&#13;or group of assets over their remaining lives against their respective carrying amounts. Such impairment test is based on the lowest&#13;level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Impairment,&#13;if any, is based on the excess of the carrying amount over the estimated fair value of those assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Research, Development and Engineering Expenses&lt;/b&gt;&#13;&amp;#8211; Research, development and engineering expenses consist of the cost of employees, consultants and contractors who design,&#13;engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#8217;s research and development&#13;efforts are primarily focused improving the core foundational ChromaID technology and developing new and unique applications for&#13;the technology. As part of this effort, the Company typically conduct testing to ensure that ChromaID application methods are compatible&#13;with the customer&amp;#8217;s requirements, and that they can be implemented in a cost effective manner. The Company is also actively&#13;involved in identifying new application methods. Know Lab&amp;#8217;s team has considerable experience working with the application&#13;of light-based technologies and their application to various industries. The Company believes that its continued development of&#13;new and enhanced technologies relating to our core business is essential to its future success. The Company spent $391,014, $570,514&#13;and $79,405 during the six months ended March 31, 2019 and the years ended September 30, 2018 and 2017, respectively, on research&#13;and development activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Fair Value Measurements and Financial Instruments&#13;&lt;/b&gt;&amp;#8211;&lt;b&gt;&amp;#160;&lt;/b&gt;ASC Topic 820, &lt;i&gt;Fair Value Measurement and Disclosures&lt;/i&gt;, defines fair value as the exchange price&#13;that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market&#13;for the asset or liability in an orderly transaction between market participants on the measurement date.&amp;#160;&amp;#160;This topic&#13;also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring&#13;fair value.&amp;#160;&amp;#160;The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and&#13;an entity&amp;#8217;s own assumptions (unobservable inputs).&amp;#160;&amp;#160;The hierarchy consists of three levels:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Level 1 &amp;#8211; Quoted prices in active markets for identical assets&#13;and liabilities;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Level 2 &amp;#8211; Inputs other than level one inputs that are either&#13;directly or indirectly observable; and.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level&amp;#160;3 - Inputs to the valuation methodology&#13;are unobservable and significant to the fair value measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The recorded value of other financial assets&#13;and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts&#13;payable and accrued expenses approximate the fair value of the respective assets and liabilities as of March 31, 2019 and September&#13;30, 2018 are based upon the short-term nature of the assets and liabilities.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Derivative Financial Instruments -&lt;/b&gt;The&#13;Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify&#13;as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument&#13;is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in&#13;the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton&#13;option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of&#13;derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the&#13;end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based&#13;on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet&#13;date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt; &amp;#8211; Know Lab&#13;and TransTech revenue are derived from products and services. Revenue is considered realized when the products or services have&#13;been provided to the customer, the work has been accepted by the customer and collectability is&amp;#160;reasonably assured. Furthermore,&#13;if an actual measurement of revenue cannot be determined, the Company defers all revenue recognition until such time that an actual&#13;measurement can be determined. If during the course of a contract management determines that losses are expected to be incurred,&#13;such costs are charged to operations in the period such losses are determined. Revenues are deferred when cash has been received&#13;from the customer but the revenue has not been earned.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Stock Based Compensation&lt;/b&gt; &amp;#8211; The&#13;Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted&#13;stock, as well as options to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based&#13;compensation cost is measured by the Company at the grant date, based on the fair value of the award, over the requisite service&#13;period. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over&#13;the related period of benefit.&amp;#160;&amp;#160;Grants of stock options and stock to non-employees and other parties are accounted for&#13;in accordance with the ASC 505.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Convertible Securities&lt;/b&gt; &amp;#8211; Based&#13;upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will&#13;evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC&#13;815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated&#13;on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an&#13;instrument were required, it would result in the instrument issued latest being reclassified first.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Net Loss per Share&lt;/b&gt; &amp;#8211; Under the&#13;provisions of ASC 260, &amp;#8220;Earnings Per Share,&amp;#8221; basic loss per common share is computed by dividing net loss available&#13;to common stockholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted&#13;net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were&#13;exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the&#13;Company, subject to anti-dilution limitations. As of March 31, 2019, there were options outstanding for the purchase of 2,282,668&#13;common shares, warrants for the purchase of 17,572,583 common shares, and 4,894,071&amp;#160;shares of the Company&amp;#8217;s common stock&#13;issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, the Company has an unknown&#13;number of shares (9,020,264 common shares at the current price of $0.25 per share) are issuable upon conversion of convertible&#13;debentures of $2,255,065. All of which could potentially dilute future earnings per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2018, there were options outstanding&#13;for the purchase of 4,736 common shares, warrants for the purchase of 11,837,422 common shares, 2,825,053 shares of the Company&amp;#8217;s&#13;common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, the Company&#13;has an unknown number of shares issuable upon conversion of convertible debentures of $2,390,066. All of which could potentially&#13;dilute future earnings per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Dividend Policy&lt;/b&gt; &amp;#8211; The Company has&#13;never paid any cash dividends and intends, for the foreseeable future, to retain any future earnings for the development of our&#13;business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our&#13;results of operations, financial condition, capital requirements and investment opportunities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt; &amp;#8211; The preparation&#13;of financial statements in conformity with accounting principles generally accepted in the United States requires management to&#13;make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and&#13;liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#13;Actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A variety of proposed or otherwise potential&#13;accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative&#13;and preliminary nature of those proposed standards, management has not determined whether implementation of such proposed standards&#13;would be material to the Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivable were $320,538 and $693,320,&#13;net of allowance, as of September 30, 2018 and 2017, respectively. The Company had one customer in excess of 10% (25.4%) of the&#13;Company&amp;#8217;s consolidated revenues for the year ended September 30, 2018. The Company had four customers in excess of 10% (13.9%,&#13;12.9%, 12.5% and 11.2%) with accounts receivable in excess of 10% as of September 30, 2018. The Company has a total allowance for&#13;bad debt in the amount of $60,000 as of September 30, 2018.&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivable were $193,372 and $320,538,&#13;net of allowance, as of March 31, 2019 and September 30, 2018, respectively. The Company had two customers in excess of 10% (14.8%&#13;and 10.1%) of the Company&amp;#8217;s consolidated revenues for the three months ended March 31, 2019. The Company had two customers&#13;in excess of 10% (21.7%,and 20.7%) with accounts receivable in excess of 10% as of March 31, 2019. The Company has a total allowance&#13;for bad debt in the amount of $60,000 as of March 31, 2019.&amp;#160;The decrease in accounts receivable related to lower sales and&#13;purchases at TransTech.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories were $203,582 and $225,909 as of&#13;September 30, 2018 and 2017, respectively. Inventories consist primarily of printers and consumable supplies, including ribbons&#13;and cards, badge accessories, capture devices, and access control components held for resale. There was a $35,000 reserve for impaired&#13;inventory as of September 30, 2018 and 2017, respectively.&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories were and $100,989 and $203,582 as&#13;of March 31, 2019 and September 30, 2018, respectively. Inventories consist primarily of printers and consumable supplies, including&#13;ribbons and cards, badge accessories, capture devices, and access control components held for resale. There was a $35,000 reserve&#13;for impaired inventory as of September 30, 2018 and 2017, respectively. The decrease in inventory related to lower sales at TransTech.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 1, 2016, the Company purchased an&#13;Original Issue Discount Convertible Promissory Note from BioMedx, Inc. The Company paid $260,000 for the Note with a principal&#13;amount of $286,000. The Note matured one year from issuance and bears interest at 5%. The principal and interest was convertible&#13;into BioMedx common stock at the option of the Company. The Company received 150,000 shares of BioMedx common stock as partial&#13;consideration for purchasing the Note. In addition, if BioMedx does not repay the Promissory Note, the Company would have the right&#13;to convert the Promissory Note into 51% of the ownership of BioMedx.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition, the Company and BioMedx agreed&#13;to negotiate in good faith to enter into a joint development agreement and subsequent merger transaction prior to December 31,&#13;2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Due to the uncertainty involved with a start-up&#13;company, The Company&amp;#8217;s management determined that the value of the Promissory Note and BioMedx common stock was zero at December&#13;31, 2016 and recorded an impairment reserve for the full value as of December 31, 2016. During the three months ended March 31,&#13;2017, BioMedx paid the Company $290,608 in full satisfaction of the Note. The Company recorded the gain as a reduction in SG&amp;#38;A&#13;expense during the three months ended March 31, 2017. In addition, the Company has not valued the 150,000 shares of BioMedx common&#13;stock.&lt;/p&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Fixed assets, net of accumulated depreciation,&#13;was $169,333 and $133,204 as of September 30, 2018 and 2017, respectively. Accumulated depreciation was $670,666 and $662,855 as&#13;of September 30, 2018 and 2017, respectively. Total depreciation expense was $60,393 and 38,031 for the years ended September 30,&#13;2018 and 2017, respectively. All equipment is used for selling, general and administrative purposes and accordingly all depreciation&#13;is classified in selling, general and administrative expenses.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Property and equipment as of September 30, 2018 was comprised of&#13;the following:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Estimated&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30, 2018 &amp;#160; &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid"&gt;Useful Lives&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Purchased&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Capital Leases&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 32%"&gt;&lt;font style="font-size: 8pt"&gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2-10 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;332,305&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;42,681&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;374,986&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 4%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2-3 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;276,112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;276,112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2-3 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;58,051&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;95,020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;153,071&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Software and websites&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;3- 7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;35,830&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;35,830&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Less: accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(532,966&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(137,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(670,666&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;169,332&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;169,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Fixed assets, net of accumulated depreciation,&#13;was $197,536 and $169,333 as of March 31, 2019 and September 30, 2018, respectively. Accumulated depreciation was $717,019 and&#13;$670,666 as of March 31, 2019 and September 30, 2018, respectively. Total depreciation expense was $46,354 and $30,462 for the&#13;six months ended March 31, 2019 and 2017, respectively. All equipment is used for selling, general and administrative purposes&#13;and accordingly all depreciation is classified in selling, general and administrative expenses.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Property and equipment as of March 31, 2019 was comprised of the&#13;following:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;March 31, 2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Estimated Useful Lives&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Purchased&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Capital Leases&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 18%; text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: center"&gt;2-10 years&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;406,861&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;42,681&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;449,542&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;2-3 years&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;2-3 years&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,051&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,020&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;153,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Software and websites&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;3- 7 years&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,830&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,830&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less:&amp;#160;accumulated&amp;#160;depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(579,318&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(137,701&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(717,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;197,536&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;197,536&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Intangible assets as of September 30, 2018 and September 30, 2017&#13;consisted of the following:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Estimated&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid"&gt;Useful Lives&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 47%"&gt;&lt;font style="font-size: 8pt"&gt;Technology&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 19%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;3 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;520,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Less: accumulated amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(72,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Intangible assets, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;447,778&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Total amortization expense was $72,222 and $0&#13;for the years ended September 30, 2018 and 2017, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Merger with RAAI Lighting, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company entered into&#13;an Agreement and Plan of Merger with 500 Union Corporation, a Delaware corporation and a wholly owned subsidiary of the Company,&#13;and RAAI Lighting, Inc., a Delaware corporation. Pursuant to the Merger Agreement, we have acquired all the outstanding shares&#13;of RAAI&amp;#8217;s capital stock through a merger of Merger Sub with and into RAAI (the &amp;#8220;Merger&amp;#8221;), with RAAI surviving&#13;the Merger as a wholly owned subsidiary of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the terms of the Merger Agreement, each&#13;share of RAAI common stock issued and outstanding immediately before the Merger (1,000 shares) were cancelled and we issued 2,000,000&#13;shares of our common stock. As a result, we issued 2,000,000 shares of its common stock to Phillip A. Bosua, formerly the sole&#13;stockholder of RAAI. The consideration for the Merger was determined through arms-length bargaining by the Company and RAAI. The&#13;Merger was structured to qualify as a tax-free reorganization for U.S. federal income tax purposes. As a result of the Merger,&#13;the Company received certain intellectual property, related to RAAI.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Merger with Know Labs, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2018, Know Labs, Inc., a Nevada corporation&#13;incorporated on April 3, 2018, and our wholly-owned subsidiary, merged with and into the Company pursuant to an Agreement and Plan&#13;of Merger dated May 1, 2018. In connection with the merger, our Articles of Incorporation were effectively amended to change our&#13;name to Know Labs, Inc. by and through the filing of Articles of Merger. This parent-subsidiary merger was approved by us, the&#13;parent, in accordance with Nevada Revised Statutes Section 92A.180. Stockholder approval was not required. This amendment was filed&#13;with the Nevada Secretary of State and became effective on May 1, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;RAAI had no outstanding indebtedness or assets&#13;at the closing of the Merger. The 2,000,000 shares of the Company&amp;#8217;s common stock issued for RAAI&amp;#8217;s shares were recorded&#13;at the fair value at the date of the merger at $520,000 and the value assigned to the patent acquired with RAAI.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the intellectual property&#13;associated with the assets acquired was $520,000 estimated by using a discounted cash flow approach based on future economic benefits.&#13;In summary, the estimate was based on a projected income approach and related discounted cash flows over five years, with applicable&#13;risk factors assigned to assumptions in the forecasted results.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Intangible assets as of March 31, 2019 and September 30, 2018 consisted&#13;of the following:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center"&gt;Estimated&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;March 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Useful Lives&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 22%"&gt;Technology&lt;/td&gt;&lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: center"&gt;3 years&lt;/td&gt;&lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 19%; text-align: right"&gt;520,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 19%; text-align: right"&gt;520,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(158,888&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(72,222&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Intangible assets, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;361,112&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;447,778&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Total amortization expense was $86,666 and $0&#13;for the six months ended March 31, 2019 and 2018, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Merger with RAAI Lighting, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company entered into&#13;an Agreement and Plan of Merger with 500 Union Corporation, a Delaware corporation and a wholly owned subsidiary of the Company,&#13;and RAAI Lighting, Inc., a Delaware corporation. Pursuant to the Merger Agreement, we have acquired all the outstanding shares&#13;of RAAI&amp;#8217;s capital stock through a merger of Merger Sub with and into RAAI (the &amp;#8220;Merger&amp;#8221;), with RAAI surviving&#13;the Merger as a wholly owned subsidiary of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the terms of the Merger Agreement, each&#13;share of RAAI common stock issued and outstanding immediately before the Merger (1,000 shares) were cancelled and converted into&#13;the right to receive 2,000 shares of the Company&amp;#8217;s common stock. As a result, the Company issued 2,000,000 shares of its&#13;common stock to Phillip A. Bosua, formerly the sole stockholder of RAAI. The consideration for the Merger was determined through&#13;arms-length bargaining by the Company and RAAI. The Merger was structured to qualify as a tax-free reorganization for U.S. federal&#13;income tax purposes. As a result of the Merger, the Company received certain intellectual property, related to RAAI.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Merger with Know Labs, Inc.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2018, Know Labs, Inc., a Nevada corporation&#13;incorporated on April 3, 2018, and our wholly-owned subsidiary, merged with and into the Company pursuant to an Agreement and Plan&#13;of Merger dated May 1, 2018. In connection with the merger, our Articles of Incorporation were effectively amended to change our&#13;name to Know Labs, Inc. by and through the filing of Articles of Merger. This parent-subsidiary merger was approved by us, the&#13;parent, in accordance with Nevada Revised Statutes Section 92A.180. Stockholder approval was not required. This amendment was filed&#13;with the Nevada Secretary of State and became effective on May 1, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;RAAI had no outstanding indebtedness or assets at the closing of&#13;the Merger. The 2,000,000 shares of the Company&amp;#8217;s common stock issued for RAAI&amp;#8217;s shares were recorded at the fair value&#13;at the date of the merger at $520,000 and the value assigned to the patent acquired with RAAI.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the intellectual property&#13;associated with the assets acquired was $520,000 estimated by using a discounted cash flow approach based on future economic benefits.&#13;In summary, the estimate was based on a projected income approach and related discounted cash flows over five years, with applicable&#13;risk factors assigned to assumptions in the forecasted results.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#8217;s TransTech business is very&#13;capital intensive. The Company reviewed TransTech&amp;#8217;s operations based on its overall financial constraints and determined&#13;the value has been impaired. The company recorded an impairment of goodwill associated with TransTech of $983,645 during the year&#13;ended September 30, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts payable were $1,512,618 and $2,154,646&#13;as of&amp;#160;September 30, 2018 and 2017, respectively. Such liabilities consisted of amounts due to vendors for inventory purchases&#13;and technology development, external audit, legal and other expenses incurred by the Company. The Company had two vendors (13.2%&#13;and 10.2%) with accounts payable in excess of 10% of its accounts payable as of September 30, 2018. The Company does expect to&#13;have vendors with accounts payable balances of 10% of total accounts payable in the foreseeable future.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts payable were $1,298,278 and $1,517,617&#13;as of&amp;#160;March 31, 2019 and September 30, 2018, respectively. Such liabilities consisted of amounts due to vendors for inventory&#13;purchases and technology development, external audit, legal and other expenses incurred by the Company. The Company had two vendors&#13;(12.3% and 10.0%) with accounts payable in excess of 10% of its accounts payable as of March 31, 2019. The Company does expect&#13;to have vendors with accounts payable balances of 10% of total accounts payable in the foreseeable future.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In April 2008, the FASB issued a pronouncement&#13;that provides guidance on determining what types of instruments or embedded features in an instrument held by a reporting entity&#13;can be considered indexed to its own stock for the purpose of evaluating the first criteria of the scope exception in the pronouncement&#13;on accounting for derivatives. This pronouncement was effective for financial statements issued for fiscal years beginning after&#13;December 15, 2008. The adoption of these requirements can affect the accounting for warrants and many convertible instruments with&#13;provisions that protect holders from a decline in the stock price (or &amp;#8220;down-round&amp;#8221; provisions). For example, warrants&#13;or conversion features with such provisions are no longer recorded in equity. Down-round provisions reduce the exercise price of&#13;a warrant or convertible instrument if a company either issues equity shares for a price that is lower than the exercise price&#13;of those instruments or issues new warrants or convertible instruments that have a lower exercise price.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There was no derivative liability as of September&#13;30, 2018 and 2017. For the year ended September 30, 2017, the Company recorded non-cash loss of $217,828 related to the &amp;#8220;change&#13;in fair value of derivative&amp;#8221; expense related to its derivative instruments. The Company early adopted ASU 2017-11 and has&#13;reclassified its financial instrument with down round features to equity in the amount of $410,524.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In April 2008, the FASB issued a pronouncement&#13;that provides guidance on determining what types of instruments or embedded features in an instrument held by a reporting entity&#13;can be considered indexed to its own stock for the purpose of evaluating the first criteria of the scope exception in the pronouncement&#13;on accounting for derivatives. This pronouncement was effective for financial statements issued for fiscal years beginning after&#13;December 15, 2008. The adoption of these requirements can affect the accounting for warrants and many convertible instruments with&#13;provisions that protect holders from a decline in the stock price (or &amp;#8220;down-round&amp;#8221; provisions). For example, warrants&#13;or conversion features with such provisions are no longer recorded in equity. Down-round provisions reduce the exercise price of&#13;a warrant or convertible instrument if a company either issues equity shares for a price that is lower than the exercise price&#13;of those instruments or issues new warrants or convertible instruments that have a lower exercise price.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There was no derivative liability as of March&#13;31, 2019 and September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <KNWN:ConvertibleNotesPayableDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Convertible notes payable as of September 30, 2018 and September&#13;30, 2017 consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Convertible Promissory Note dated September&#13;30, 2016&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 30, 2016, the Company entered into&#13;a $210,000 Convertible Promissory Note with Clayton A. Struve, an accredited investor of the Company, to fund short-term working&#13;capital. The Convertible Promissory Note accrued interest at a rate of 10% per annum and was due on March 30, 2017. The Note holder&#13;can convert the Note into common stock at $0.70 per share. During the year ended September 30, 2017, the Company recorded interest&#13;of $21,000 related to the convertible note. This note was extended in the Securities Purchase Agreement, General Security Agreement&#13;and Subordination Agreement dated August 14, 2017 with a maturity date of August 13, 2018. Also, the conversion price of the Debenture&#13;was adjusted to $0.25 per share, subject to certain adjustments. The balance was increased $75,000 during the year ended September&#13;30, 2018. On November 16, 2018, we signed Amendment 1 to Senior Secured Convertible Redeemable Notes dated September 30, 2016extending&#13;the due dates of the Note to February 27, 2019. On September 24, 2018, Mr. Struve converted $200,000 of the Note into 800,000 shares&#13;of our common stock. The Company recorded accrued interest of $54,671 as of September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Securities Purchase Agreement dated August&#13;14, 2017&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 14, 2017, the Company issued a senior&#13;convertible exchangeable debenture with a principal amount of $360,000 and a common stock purchase warrant to purchase 1,440,000&#13;shares of common stock in a private placement to Clayton Struve for gross proceeds of $300,000 pursuant to a Securities Purchase&#13;Agreement dated August 14, 2017. The debenture accrues interest at 20% per annum and matures August 13, 2018. The convertible debenture&#13;contains a beneficial conversion valued at $110,629. The warrants were valued at $111,429. Because the note is immediately convertible,&#13;the warrants and beneficial conversion were expensed as interest.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On the same date, the Company entered into a&#13;General Security Agreement with the Mr. Struve, pursuant to which the Company has agreed to grant a security interest to the investor&#13;in substantially all of our assets, effective upon the filing of a UCC-3 termination statement to terminate the security interest&#13;held by Capital Source Business Finance Group in the assets of the Company. In addition, an entity affiliated with Ronald P. Erickson,&#13;out then Chief Executive Officer, entered into a Subordination Agreement with the investor pursuant to which all debt owed by us&#13;to such entity is subordinated to amounts owed by us to Mr. Struve under the Debenture (including amounts that become owing under&#13;any Debentures issued to the investor in the future).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The initial conversion price of the Debenture&#13;is $0.25 per share, subject to certain adjustments. The initial exercise price of the Warrant is $0.25 per share, also subject&#13;to certain adjustments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As part of the Purchase Agreement, the Company&#13;granted the investor &amp;#8220;piggyback&amp;#8221; registration rights to register the shares of common stock issuable upon the conversion&#13;of the Debenture and the exercise of the Warrant with the Securities and Exchange Commission for resale or other disposition.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Debenture and the Warrant were issued in&#13;a transaction that was not registered under the Securities Act of 1933, as amended in reliance upon applicable exemptions from&#13;registration under Section 4(a)(2) of the Act and Rule 506 of SEC Regulation D under the Act. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the terms of the Purchase Agreement, Mr.&#13;Struve may purchase up to an aggregate of $1,000,000 principal amount of Debentures (before a 20% original issue discount) (and&#13;Warrants to purchase up to an aggregate of 250,000 shares of common stock). These securities are being offered on a &amp;#8220;best&#13;efforts&amp;#8221; basis by the placement agent.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2017, $156,941&#13;was recorded as interest expense related to debt discounts, beneficial conversions and warrants associated with Convertible Promissory&#13;Notes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 12, 2017, the Company closed an&#13;additional $250,000 and issued a senior convertible exchangeable debenture with a principal amount of $300,000 and a common stock&#13;purchase warrant to purchase 1,200,000 shares of common stock in a private placement dated December 12, 2017 with Mr. Struve pursuant&#13;to a Securities Purchase Agreement dated August 14, 2017. The convertible debenture contains a beneficial conversion valued at&#13;$93,174. The warrants were valued at $123,600. Because the note is immediately convertible, the warrants and beneficial conversion&#13;were expensed as interest.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 2, 2018, the Company received gross&#13;proceeds of $280,000 in exchange for issuing a senior convertible redeemable debenture with a principal amount of $336,000 and&#13;a warrant to purchase 1,344,000 shares of common stock in a private placement dated February 28, 2018 with Mr. Struve pursuant&#13;to a Securities Purchase Agreement dated August 14, 2017. The convertible debenture contains a beneficial conversion valued at&#13;$252,932. The warrants were valued at $348,096. Because the note is immediately convertible, the warrants and beneficial conversion&#13;were expensed as interest.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the February 28, 2018 private&#13;placement, the placement agent for the debenture and the warrant received a cash fee of $28,000 and the Company issued warrants&#13;to purchase shares of the Company&amp;#8217;s common stock to the placement agent or its affiliates based on 10% of proceeds.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 16, 2018, the Company signed Amendment&#13;1 to Senior Secured Convertible Redeemable Notes dated August 14, 2017 and December 12, 2017, extending the due dates of the Notes&#13;to February 27, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Convertible Redeemable Promissory Notes with&#13;Ronald P. Erickson and J3E2A2Z&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 16, 2018, the Company entered into&#13;a Note and Account Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was&#13;converted to a Convertible Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z&#13;Account Payable was converted into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a&#13;warrant to purchase up to 1,039,666 shares of common stock of the Company for a period of five years. The initial exercise price&#13;of the warrants described above is $0.50 per share, also subject to certain adjustments. The warrants were valued at $110,545.&#13;Because the note is immediately convertible, the warrants and beneficial conversion were expensed as interest. The Company recorded&#13;accrued interest of $23,649 as of September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</KNWN:ConvertibleNotesPayableDisclosureTextBlock>
    <KNWN:ConvertibleNotesPayableDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Convertible notes payable as of March 31, 2019 and September 30,&#13;2018 consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Convertible Promissory Notes with Clayton&#13;A. Struve&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2019, the Company owes Clayton&#13;A. Struve $1,071,000 under convertible promissory or OID notes. The Company recorded accrued interest of $58,411 as of March 31,&#13;2019. On May 8, 2019, the Company signed Amendment 2 to the convertible promissory or OID notes, extending the due dates to September&#13;30, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Convertible Redeemable Promissory Notes with&#13;Ronald P. Erickson and J3E2A2Z&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 16, 2018, the Company entered into&#13;a Note and Account Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was&#13;converted to a Convertible Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z&#13;Account Payable was converted into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a&#13;warrant to purchase up to 1,039,666 shares of common stock of the Company for a period of five years. The initial exercise price&#13;of the warrants described above is $0.50 per share, also subject to certain adjustments. The warrants were valued at $110,545.&#13;Because the note is immediately convertible, the warrants and beneficial conversion were expensed as interest. The Company recorded&#13;accrued interest of $41,361 as of March 31, 2019. On May 8, 2019, the Company signed Amendment 1 to the convertible redeemable&#13;promissory notes, extending the due dates to September 30, 2019 and increasing the interest rate to 6%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</KNWN:ConvertibleNotesPayableDisclosureTextBlock>
    <us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Notes payable, capitalized leases and long-term debt as of September&#13;30, 2018 and 2017 consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;Capital Source Business Finance Group&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;145,186&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;365,725&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Note payable to Umpqua Bank&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;199,935&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Secured note payable to J3E2A2Z LP - related party&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;600,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Total debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;145,186&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,165,660&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Less current portion of long term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(145,186&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,165,660&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Long term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Capital Source Business Finance Group&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Know Labs, Inc. (the &amp;#8220;Company&amp;#8221;)&#13;finances its TransTech operations from operations and a Secured Credit Facility with Capital Source Business Finance Group. On&#13;June 15, 2018, TransTech entered into a Fifth Modification to the Loan and Security Agreement related to the $500,000 secured credit&#13;facility with Capital Source to fund its operations. The Modification extended the maturity to December 12, 2018. The secured credit&#13;facility provides for a prime rate interest floor for prime interest of 4.5% plus 2.5%. The eligible borrowing is based on 80%&#13;of eligible trade accounts receivable, not to exceed $500,000. The secured credit facility is collateralized by the assets of TransTech,&#13;with a guarantee by Know Labs, including a security interest in all assets of Know Labs. The remaining balance on the accounts&#13;receivable must be repaid by the time the secured credit facility expires on December 12, 2018, unless we renew by automatic extension&#13;for the next successive term. TransTech has $24,000 available as of September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 6, 2018, Capital Source notified&#13;TransTech that the Loan and Security Agreement and Capital Source Credit Facility would be cancelled as of March 12, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Effective December 12, 2018, TransTech&#13;entered into the Sixth Modification to the Loan and Security Agreement which reduced the secured credit facility to $200,000.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note Payable to Umpqua Bank&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 9, 2018, the Company repaid a $199,935&#13;Business Loan Agreement with Umpqua Bank from funds previously provided by an entity affiliated with Ronald P. Erickson, our Chairman&#13;of the Board. The Company paid $27,041 and issued 800,000 shares of common stock in exchange for the conversion of this debt. Mr.&#13;Erickson is an accredited investor. These shares were issued in transactions that were not registered under the Act in reliance&#13;upon applicable exemptions from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note Payables to Ronald P. Erickson or J3E2A2Z&#13;LP&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 25, 2018, the Company entered into&#13;amendments to two demand promissory notes, totaling $600,000 with Mr. Erickson, the Company&amp;#8217;s Chief Executive Officer and/or&#13;entities in which Mr. Erickson has a beneficial interest. On March 16, 2018, the demand promissory notes and accrued interest were&#13;converted into convertible notes payable. See Note 11 for additional details.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock>
    <us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Notes payable, capitalized leases and long-term debt as of March&#13;31, 2019 and September 30, 2018 consisted of the following:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"&gt;March 31,&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 56%; font-size: 8pt; text-align: left; padding-bottom: 1pt"&gt;Capital Source Business Finance Group&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;145,186&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;Total debt&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;145,186&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt"&gt;Less current portion of long term debt&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(145,186&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Long term debt&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Capital Source Business Finance Group&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 12, 2019, Capital Source cancelled&#13;the Loan and Security Agreement and Capital Source Credit Facility with TransTech. TransTech repaid the remaining $15,165 due on&#13;the Secured Credit Facility. On March 27, 2019, the Company received notice that the UCC Financing Statement filed by Capital Source&#13;to secure a parent Company guarantee was terminated and cancelled by the State of Nevada.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Authorized Capital Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company authorized 105,000,000 shares of&#13;capital stock, of which 100,000,000 are shares of voting common stock, par value $0.001 per share, and 5,000,000 are shares preferred&#13;stock, par value $0.001 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has authorized to issue up to 100,000,000&#13;shares of common stock with a par value of $0.001. As of September 30, 2018, we had 17,531,502 shares of common stock issued and&#13;outstanding, held by 122 shareholders of record. The number of shareholders, including beneficial owners holding shares through&#13;nominee names, is approximately 2,300. Each share of common stock entitles its holder to one vote on each matter submitted to the&#13;shareholders for a vote, and no cumulative voting for directors is permitted.&amp;#160;&amp;#160;Shareholders do not have any preemptive&#13;rights to acquire additional securities issued by us.&amp;#160;&amp;#160;As of September 30, 2018, there were options outstanding for the&#13;purchase of 2,182,668 common shares, warrants for the purchase of 15,473,398 common shares and 4,914,071&amp;#160;shares of our common&#13;stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. We have Convertible Note Payable&#13;of $2,255,066 (9,020,264 common shares at the current price of $0.25 per share). All of which could potentially dilute future earnings&#13;per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Voting Preferred Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is authorized to issue up to 5,000,000&#13;shares of preferred stock with a par value of $0.001.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Series A Preferred Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In July 2015, the Company sold Series A Preferred&#13;Stock to two investors for a total of $350,000. As of December 21, 2018, the Company had 20,000 Series A Preferred Stock issued&#13;and outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Each holder of outstanding shares of Series&#13;A Preferred is entitled to the number of votes equal to the number of whole shares of common stock into which the shares of Series&#13;A Preferred held by such holder are then convertible as of the applicable record date. The Series A Preferred may not be redeemed&#13;without the consent of the holder. The Company cannot amend, alter or repeal any preferences, rights, or other terms of the Series&#13;A Preferred so as to adversely affect the Series A Preferred, without the written consent or affirmative vote of the holders of&#13;at least 66% of the then outstanding shares of Series A Preferred, voting as a separate voting group, given by written consent&#13;or by vote at a meeting called for such purpose for which notice shall have been duly given to the holders of the Series A Preferred.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the issuance of the Series&#13;A Preferred, the Company also issued (i) a Series C five-year Warrant for 2 shares of common stock and (ii) a Series D five-year&#13;Warrant for 23,334 shares of common stock. The Series A Preferred Stock and Series C and D Warrants currently have no registration&#13;rights.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 14, 2017, the price of the Series&#13;A Preferred Stock and Series C and D Warrants were adjusted to $0.25 per share pursuant to the documents governing such instruments.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 23, 2018, a holder of Series A&#13;Preferred Stock converted 3,334 shares into 3,334 shares of common stock. In addition, the holder exercised Series C and D Warrants&#13;for 6,668 shares of common stock at $0.25 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Series C and D Preferred Stock and Warrants&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 5, 2016, the Company closed a Series&#13;C Preferred Stock and Warrant Purchase Agreement with Clayton A. Struve, an accredited investor for the purchase of $1,250,000&#13;of preferred stock with a conversion price of $0.70 per share. The preferred stock has a yield of 8% and an ownership blocker of&#13;4.99%. In addition, Mr. Struve received a five-year warrant to acquire 1,785,714 shares of common stock at $0.70 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;To determine the effective conversion price,&#13;a portion of the proceeds received by the Company upon issuance of the Series C Preferred Stock was first allocated to the freestanding&#13;warrants issued as part of this transaction. Given that the warrants will not subsequently be measured at fair value, the Company&#13;determined that the warrants should receive an allocation of the proceeds based on their relative fair value. This is based on&#13;the understanding that the FASB staff and the SEC staff believe that a freestanding instrument issued in a basket transaction should&#13;be initially measured at fair value if it is required to be subsequently measured at fair value pursuant to US generally accepted&#13;accounting principles (&amp;#8220;GAAP&amp;#8221;), with the residual proceeds from the transaction allocated to any remaining instruments&#13;based on their relative fair values. As such, the warrants were allocated a fair value of approximately $514,706 upon issuance,&#13;with the remaining $735,294 of proceeds allocated to the Series C Preferred Stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Proportionately, this allocation resulted in&#13;approximately 59% of the face amount of the Series C Preferred Stock issuance remaining, which applied to the stated conversion&#13;price of $0.70 resulted in an effective conversion price of approximately $0.41.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Having determined the effective conversion price,&#13;the Company then compared this to the fair value of the underlying Common Stock as of the commitment date, which was approximately&#13;$1.06 per share, and concluded that the conversion feature did have an intrinsic value of $0.65 per share. As such, the Company&#13;concluded that the Series C Preferred Stock did contain a beneficial conversion feature and an accounting entry and additional&#13;financial statement disclosure was required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Because our preferred stock is perpetual, with&#13;no stated maturity date, and the conversions may occur any time from inception, the dividend is recognized immediately when a beneficial&#13;conversion exists at issuance. During the year ending September 30, 2016, the Company recognized preferred stock dividends of $1.16&#13;million on Series C preferred stock related to the beneficial conversion feature arising from a common stock effective conversion&#13;rate of $0.41 versus a current market price of $1.06 per common share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 14, 2016, the Company issued 187,500&#13;shares of Series D Convertible Preferred Stock and a warrant to purchase 187,500 shares of common stock in a private placement&#13;to certain accredited investors for gross proceeds of $150,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement&#13;dated November 10, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The warrants associated with the November 14,&#13;2016 issuance were allocated a fair value of approximately $56,539 upon issuance, with the remaining $63,539 of net proceeds allocated&#13;to the Series D Preferred Stock. Proportionately, this allocation resulted in approximately 53% of the amount of the Series D Preferred&#13;Stock issuance remaining, which applied to the stated conversion price of $0.80 resulted in an effective conversion price of approximately&#13;$0.34. Having determined the effective conversion price, the Company then compared this to the fair value of the underlying Common&#13;Stock as of the commitment date, which was approximately $1.14 per share, and concluded that the conversion feature did have an&#13;intrinsic value of $0.80 per share. As such, the Company concluded that the Series D Preferred Stock did contain a beneficial conversion&#13;feature of $150,211 which was recorded as a beneficial conversion in stockholders&amp;#8217; equity.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 19, 2016, the Company issued 187,500&#13;shares of Series D Convertible Preferred Stock and a warrant to purchase 187,500 shares of common stock in a private placement&#13;to an accredited investor for gross proceeds of $150,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement&#13;dated December 14, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The warrants associated with the December 19,&#13;2016 issuance were allocated a fair value of approximately $60,357 upon issuance, with the remaining $69,643 of net proceeds allocated&#13;to the Series D Preferred Stock. Proportionately, this allocation resulted in approximately 54% of the amount of the Series D Preferred&#13;Stock issuance remaining, which applied to the stated conversion price of $0.80 resulted in an effective conversion price of approximately&#13;$0.37. Having determined the effective conversion price, the Company then compared this to the fair value of the underlying Common&#13;Stock as of the commitment date, which was approximately $0.81 per share, and concluded that the conversion feature did have an&#13;intrinsic value of $0.44 per share. As such, the Company concluded that the Series C Preferred Stock did contain a beneficial conversion&#13;feature of $82,232 which was recorded as a beneficial conversion in stockholders&amp;#8217; equity.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Because the Company&amp;#8217;s preferred stock&#13;is perpetual, with no stated maturity date, and the conversions may occur any time from inception, the dividend is recognized immediately&#13;when a beneficial conversion exists at issuance. During the year ending September 30, 2017, the Company recognized preferred stock&#13;dividends of $2.3 million on Series D preferred stock related to the beneficial conversion feature arising from a common stock&#13;effective conversion rate of $0.34 and $0.37 versus the original market price of $1.14 and $1.06 per common share, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2017, the Company issued 357,143 shares&#13;of Series D Convertible Preferred Stock and a warrant to purchase 357,143 shares of common stock in a private placement to an accredited&#13;investor for gross proceeds of $250,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement dated May 1, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The initial conversion price of the Series D&#13;Shares is $0.70 per share, subject to certain adjustments. The initial exercise price of the warrant is $0.70 per share, also subject&#13;to certain adjustments. The Company also amended and restated the Certificate of Designations, resulting in an adjustment to the&#13;conversion price of all currently outstanding Series D Shares to $0.70 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 14, 2017, the price of the Series&#13;C and D Preferred Stock were adjusted to $0.25 per share pursuant to the documents governing such instruments. After adjustment&#13;there were 3,108,356 shares of Series D preferred stock authorized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 17, 2018, the Company filed with the&#13;State of Nevada a second Amended and Restated Certificate of Designation of Preferences, Powers, and Rights of the Series D Convertible&#13;Preferred Stock. The Amended Certificate restates the prior Certificate of Designation filed on May 8, 2017 to decrease the number&#13;of authorized Series D shares from 3,906,250 shares to 1,016,014 shares. No other amendments were made to the preferences and rights&#13;of the Series D Convertible Preferred Stock. The filing of the Amended Certificate was unanimously approved by the Board of Directors&#13;and the shareholders of Series D Convertible Preferred Stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Series F Preferred Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 1, 2018, the Company filed with the&#13;State of Nevada a Certificate of Designation establishing the Designations, Preferences, Limitations and Relative Rights of Series&#13;F Preferred Stock (the &amp;#8220;Designation&amp;#8221;). The Designation authorized 500 shares of Series F Preferred Stock. The Series&#13;F Preferred Stock shall only be issued to the current Board of Directors on the date of the Designation&amp;#8217;s filing and is not&#13;convertible into common stock. As set forth in the Designation, the Series F Preferred Stock has no rights to dividends or liquidation&#13;preference and carries rights to vote 100,000 shares of common stock per share of Series F upon a Trigger Event, as defined in&#13;the Designation. A Trigger Event includes certain unsolicited bids, tender offers, proxy contests, and significant share purchases,&#13;all as described in the Designation. Unless and until a Trigger Event, the Series F shall have no right to vote. The Series F Preferred&#13;Stock shall remain issued and outstanding until the date which is 731 days after the issuance of Series F Preferred Stock (&amp;#8220;Explosion&#13;Date&amp;#8221;), unless a Trigger Event occurs, in which case the Explosion Date shall be extended by 183 days.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Securities Subject to Price Adjustments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 14, 2017, a private placement triggered&#13;a provision in the documents governing 23,334 outstanding shares of Series A Preferred Stock, 1,785,715 outstanding shares of Series&#13;C Preferred Stock and 1,016,004 outstanding shares Series D preferred Stock, which adjusted the conversion price of such Preferred&#13;Stock to $0.25 per share. In addition, the conversion price of a Convertible Note Payables of $2,390,066 and the exercise price&#13;of outstanding warrants to purchase 9,548,741 shares of common stock were adjusted to $0.25 per share pursuant to the documents&#13;governing such instruments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 21, 2018, there were outstanding&#13;warrants for the purchase of 15,473,398 shares of common stock. In the future, if we sell our common stock at a price below $0.25&#13;per share, the exercise price of 20,000 outstanding shares of Series A Preferred Stock, 1,785,715 outstanding shares of Series&#13;C Preferred Stock, 1,016,004 outstanding shares Series D Preferred Stock that adjust below $0.25 per share pursuant to the documents&#13;governing such instruments. In addition, the conversion price of a Convertible Note Payable of $2,255,066 (9,020,264 common shares&#13;at the current price of $0.25 per share) and the exercise price of additional outstanding warrants to purchase 13,865,286 shares&#13;of common stock would adjust below $0.25 per share pursuant to the documents governing such instruments.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Common Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the offerings and sales described below&#13;were deemed to be exempt under Rule 506 of Regulation D and/or Section 4(a)(2) of the Securities Act. No advertising or general&#13;solicitation was employed in offering the securities, the offerings and sales were made to a limited number of persons, all of&#13;whom were accredited investors and transfer was restricted by the company in accordance with the requirements of Regulation D and&#13;the Securities Act. All issuances to accredited and non-accredited investors were structured to comply with the requirements of&#13;the safe harbor afforded by Rule 506 of Regulation D, including limiting the number of non-accredited investors to no more than&#13;35 investors who have sufficient knowledge and experience in financial and business matters to make them capable of evaluating&#13;the merits and risks of an investment in our securities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following equity issuances occurred during&#13;the year ended September 30, 2018:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company issued 779,676 shares of common&#13;stock to Names Executive Officers, directors, employees and consultants and for services during the year ended September 30, 2018.&#13;The Company expensed $273,068.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company issued 2,000,000&#13;shares of our common stock to Phillip A. Bosua under the terms of the Merger Agreement with RAAI common stock. The shares were&#13;valued at the fair market value of $520,000 or $0.26 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 25, 2018, the Company closed a private&#13;placement and received gross proceeds of $1,750,000 ($1,710,000 as of June 30, 2018) in exchange for issuing 7,000,000 (6,840,000&#13;as of June 30, 2018) shares of common stock and warrants to purchase 3,500,000 (3,420,000 as of June 30, 2018) shares of common&#13;stock in a private placement to accredited investors pursuant to a series of substantially identical subscription agreements. The&#13;initial exercise price of the warrants described above is $0.25 per share, subject to certain adjustments, and they expired five&#13;years after their issuance. The shares and the warrants described above were issued in transactions that were not registered under&#13;the Securities Act of 1933, as amended (the &amp;#8220;Act&amp;#8221;) in reliance upon applicable exemptions from registration under Section&#13;4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 25, 2018, the Company issued 500,000&#13;shares of our common stock to Phillip A. Bosua under the terms of an Employment agreement dated April 10, 2018. The shares were&#13;valued at the fair market value of $165,000 or $0.33 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company closed debt conversions and issued&#13;1,600,000 shares of common stock in exchange for the conversion of $464,000, 230,000 shares in exchange for $48,300 in legal services&#13;and 605,000 shares in for $199.935 in preexisting debt owed by the Company to certain service providers, all of whom are accredited&#13;investors. These shares were issued in transactions that were not registered under the Act in reliance upon applicable exemptions&#13;from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2018, the&#13;Company issued 158,000 shares of our common stock related to warrant exercises that were valued at $80,128.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 23, 2018, the Company issued 3,334&#13;shares of our common stock related to the conversion of Series A Preferred Stock for $834.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following equity issuances occurred during&#13;the year ended September 30, 2017:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 21, 2015, the Company entered into&#13;a Public Relations Agreement with Financial Genetics LLC for public relation services. On October 18, 2016, the Company entered&#13;into an Amendment to Public Relations Agreement with Financial Genetics LLC. Under the Agreements, Financial Genetics was issued&#13;359,386 shares of our common stock during the year ended September 30, 2017. The Company expensed $271,309 during the year ended&#13;September 30, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 6, 2016, the Company entered into&#13;a Services Agreement with Redwood Investment Group LLC for financial services. Under the Agreement, Redwood was issued 200,000&#13;shares of our common stock. The Company expensed $140,000 during the year ended September 30, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company entered into Convertible Promissory&#13;Notes totaling $710,000 with accredited investors during September 2015 to February 2016 to fund short-term working capital. The&#13;Notes accrued interest at a rate of 8% per annum and became due September 2016 to February 2017 and were convertible into common&#13;stock as part of our next financing. On November 30, 2016, the Company converted $695,000 of the /Convertible Promissory Notes&#13;and interest of $54,078 into 936,348 shares of comment stock. The Company also issued warrants to purchase 936,348 shares of the&#13;Company&amp;#8217;s common stock. The five-year warrants are exercisable at $1.00 per share, subject to adjustment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 22, 2016, a supplier converted accounts&#13;payable totaling $6,880 into 8,600 shares of common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On the year ended September 30, 2017, the Company&#13;issued 795,000 shares of restricted common stock to two Names Executive Officers employees, two directors and six employees and&#13;consultants and for services during 2015-2017. The shares were issued in accordance with the 2011 Stock Incentive Plan and were&#13;valued at $0.17 per share, the market price of our common stock. The Company expensed $135,150 during the year ended September&#13;30, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Warrants to Purchase Common Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following warrants were issued during the&#13;year ended September 30, 2018:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 15, 2017, the Company received $250,000&#13;and issued a senior convertible exchangeable debenture with a principal amount of $300,000 and a five year common stock purchase&#13;warrant to purchase 1,200,000 shares of common stock in a private placement dated December 12, 2017 to an accredited investor pursuant&#13;to a Securities Purchase Agreement dated August 14, 2017. See Note 12 for additional details. The initial exercise price of the&#13;warrants described above is $0.25 per share, also subject to certain adjustments. The warrants were valued at $123,600 and the&#13;beneficial conversion feature was valued at $93,174.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 2, 2018, the Company received gross&#13;proceeds of $280,000 in exchange for issuing a senior convertible redeemable debenture with a principal amount of $336,000 and&#13;a five year warrant to purchase 1,344,000 shares of common stock in a private placement dated February 28, 2018 to an accredited&#13;investor pursuant to a Securities Purchase Agreement dated August 14, 2017 See Note 9 for additional details. The initial exercise&#13;price of the warrants described above is $0.25 per share, also subject to certain adjustments. The warrants had an estimated fair&#13;value of $348,096 and the beneficial conversion feature was value at $252,932.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company entered into a Note and Account&#13;Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was converted to a Convertible&#13;Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z Account Payable was converted&#13;into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a warrant to purchase up to 1,039,666&#13;shares of common stock of the Company for a period of five years. The initial exercise price of the warrants described above is&#13;$0.50 per share, also subject to certain adjustments. See Note 9 for additional details. The warrants had an estimated value of&#13;$60,820.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition, effective as of January 31, 2018,&#13;Mr. Erickson was issued a warrant to purchase up to 855,000 shares of common stock of the Company for a period of five years. The&#13;initial exercise price of the warrants described above is $0.50 per share, also subject to certain adjustments. See Note 12 for&#13;additional details. The warrants had an estimated value of $49,726.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2018, The&#13;Company issued placement agent warrants related to the issuance of senior convertible redeemable debentures and Series D Preferred&#13;Stock to purchase up to 538,400 shares of common stock for a period of five years. The initial exercise price of the warrants described&#13;above is $0.25 per share, also subject to certain adjustments. The estimated fair value was $134,600.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 25, 2018, the Company closed a private&#13;placement and received gross proceeds of $1,750,000 ($1,710,000 as of June 30, 2018) in exchange for issuing 7,000,000 (6,840,000&#13;as of June 30, 2018) shares of common stock and warrants to purchase 3,500,000 (3,420,000 as of June 30, 2018) shares of common&#13;stock in a private placement to accredited investors pursuant to a series of substantially identical subscription agreements. The&#13;initial exercise price of the warrants described above is $0.25 per share, subject to certain adjustments, and they expired five&#13;years after their issuance. The shares and the warrants described above were issued in transactions that were not registered under&#13;the Securities Act of 1933, as amended (the &amp;#8220;Act&amp;#8221;) in reliance upon applicable exemptions from registration under Section&#13;4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company issued warrants to purchase 1,229,000&#13;shares of common stock to Named Executive Officers, directors, employees and consultants and for services during the year ended&#13;September 30, 2018. The Company expensed $121,710.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2018, the&#13;Company issued 158,000 shares of our common stock related to warrant exercises that were valued at $80,128.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2018, warrants&#13;for the purchase of 544,998 shares of common stock valued at $136,250 expired.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following warrants were issued during the&#13;year ended September 30, 2017:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company entered into Convertible Promissory&#13;Notes totaling $710,000 with accredited investors during September 2015 to February 2016 to fund short-term working capital. The&#13;Notes accrued interest at a rate of 8% per annum and became due September 2016 to February 2017 and were convertible into common&#13;stock as part of our next financing. On November 30, 2016, the Company converted $695,000 of the /Convertible Promissory Notes&#13;and interest of $54,078 into 936,348 shares of comment stock. The Company also issued warrants to purchase 936,348 shares of the&#13;Company&amp;#8217;s common stock. The five-year warrants are exercisable at $1.00 per share, subject to adjustment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 14, 2016, the Company issued 187,500&#13;shares of Series D Convertible Preferred Stock and a warrant to purchase 187,500 shares of common stock in a private placement&#13;to certain accredited investors for gross proceeds of $150,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement&#13;dated November 10, 2016. The warrant was valued at $189,938.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 19, 2016, the Company issued 187,500&#13;shares of Series D Convertible Preferred Stock and a warrant to purchase 187,500 shares of common stock in a private placement&#13;to an accredited investor for gross proceeds of $150,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement&#13;dated December 14, 2016. The warrant was valued at $131,250.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 24, 2017, the Company issued 283,861&#13;shares of Series D Convertible Preferred Stock and a warrant to purchase 283,861 shares of common stock in a private placement&#13;to an accredited investor for conversion of a $220,000 Promissory Note and accrued interest of $7,089 pursuant to a Series D Preferred&#13;Stock and Warrant Purchase Agreement dated February 28, 2017. The warrant was valued at $198,703.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2017, the&#13;Company revised five year placement agent warrants to purchase 312,500 shares of common stock. The price was reduced from $1.00&#13;to $0.70 per share and the exercise price is now subject to adjustment. The Company recorded 250,000 shares during the year ended&#13;September 30, 2016 the fair value of these warrants is $218,751 as of June 30, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2017, the Company issued 357,143 shares&#13;of Series D Convertible Preferred Stock and a warrant to purchase 357,143 shares of common stock in a private placement to an accredited&#13;investor for gross proceeds of $250,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement dated May 1, 2017.&#13;The warrant was valued at $5,357.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 14, 2017, the Company issued a common&#13;stock purchase warrant to purchase 1,440,000 shares of common stock in a private placement to Clayton Struve for gross proceeds&#13;of $300,000 pursuant to a Securities Purchase Agreement dated August 14, 2017. The initial exercise price of the Warrant is $0.25&#13;per share, also subject to certain adjustments. The warrants were valued at $111,429.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Warrants to acquire 7,668 shares of common stock&#13;at $30.00 per share expired.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The conversion price of the Series A, C and&#13;D Shares and related warrants is currently $0.250 per share, subject to certain adjustments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A summary of the warrants issued as of September&#13;30, 2018 were as follows:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30, 2018 &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at beginning of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,900,356&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,276,066&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(158,026&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.507&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(544,998&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at end of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable at end of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A summary of the status of the warrants outstanding&#13;as of September 30, 2018 is presented below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30, 2018 &amp;#160; &amp;#160; &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Number of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Remaining&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Life ( In Years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13,870,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.04&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13,870,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;714,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;714,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;882,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;882,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The significant weighted average assumptions&#13;relating to the valuation of the Company&amp;#8217;s warrants for the year ended September 30, 2018 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 67%"&gt;&lt;font style="font-size: 8pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 33%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expected life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;1-2 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;125%-145%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;.0202-.0214%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;At September 30, 2018, vested warrants totaling 15,466,731 shares&#13;had an&amp;#160;aggregate intrinsic value of $13,870,286.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Authorized Capital Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company authorized 105,000,000 shares of&#13;capital stock, of which 100,000,000 are shares of voting common stock, par value $0.001 per share, and 5,000,000 are shares preferred&#13;stock, par value $0.001 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2019, the Company had 22,002,904&#13;shares of common stock issued and outstanding, held by 122 stockholders of record. The number of stockholders, including beneficial&#13;owners holding shares through nominee names, is approximately 2,300. Each share of common stock entitles its holder to one vote&#13;on each matter submitted to the stockholders for a vote, and no cumulative voting for directors is permitted.&amp;#160;&amp;#160;Stockholders&#13;do not have any preemptive rights to acquire additional securities issued by us.&amp;#160;&amp;#160;As of March 31, 2019, there were options&#13;outstanding for the purchase of 2,282,668 common shares, warrants for the purchase of 17,572,583 common shares, and 4,894,071&amp;#160;shares&#13;of the Company&amp;#8217;s common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock.&#13;In addition, the Company has an unknown number of shares (9,020,264 common shares at the current price of $0.25 per share) are&#13;issuable upon conversion of convertible debentures of $2,255,066. All of which could potentially dilute future earnings per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Voting Preferred Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is authorized to issue up to 5,000,000&#13;shares of preferred stock with a par value of $0.001.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Series A Preferred Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 29, 2019, a holder of Series A Preferred&#13;Stock converted 20,000 shares into 80,000 shares of common stock. There are no Series A Preferred Stock outstanding as of March&#13;31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Series C and D Preferred Stock and Warrants&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 5, 2016, the Company closed a Series&#13;C Preferred Stock and Warrant Purchase Agreement with Clayton A. Struve, an accredited investor for the purchase of $1,250,000&#13;of preferred stock with a conversion price of $0.70 per share. The preferred stock has a yield of 8% and an ownership blocker of&#13;4.99%. In addition, Mr. Struve received a five-year warrant to acquire 1,785,714 shares of common stock at $0.70 per share. On&#13;August 14, 2017, the price of the Series C Stock were adjusted to $0.25 per share pursuant to the documents governing such instruments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2019, the Company has 3,108,356&#13;of Series D Preferred Stock outstanding with Clayton A. Struve, an accredited investor, outstanding. On August 14, 2017, the price&#13;of the Series D Stock were adjusted to $0.25 per share pursuant to the documents governing such instruments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Series F Preferred Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 1, 2018, the Company filed with the&#13;State of Nevada a Certificate of Designation establishing the Designations, Preferences, Limitations and Relative Rights of Series&#13;F Preferred Stock. The Designation authorized 500 shares of Series F Preferred Stock. The Series F Preferred Stock shall only be&#13;issued to the current Board of Directors on the date of the Designation&amp;#8217;s filing and is not convertible into common stock.&#13;As set forth in the Designation, the Series F Preferred Stock has no rights to dividends or liquidation preference and carries&#13;rights to vote 100,000 shares of common stock per share of Series F upon a Trigger Event, as defined in the Designation. A Trigger&#13;Event includes certain unsolicited bids, tender offers, proxy contests, and significant share purchases, all as described in the&#13;Designation. Unless and until a Trigger Event, the Series F shall have no right to vote. The Series F Preferred Stock shall remain&#13;issued and outstanding until the date which is 731 days after the issuance of Series F Preferred Stock (&amp;#8220;Explosion Date&amp;#8221;),&#13;unless a Trigger Event occurs, in which case the Explosion Date shall be extended by 183 days.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Securities Subject to Price Adjustments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In the future, if we sell our common stock at&#13;a price below $0.25 per share, the exercise price of 1,785,715 outstanding shares of Series C Preferred Stock, 1,016,004 outstanding&#13;shares Series D Preferred Stock that adjust below $0.25 per share pursuant to the documents governing such instruments. In addition,&#13;the conversion price of a Convertible Note Payable of $2,255,066 (9,020,264 common shares at the current price of $0.25 per share)&#13;and the exercise price of additional outstanding warrants to purchase 12,664,385 shares of common stock would adjust below $0.25&#13;per share pursuant to the documents governing such instruments. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Common Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the offerings and sales described below&#13;were deemed to be exempt under Rule 506 of Regulation D and/or Section 4(a)(2) of the Securities Act. No advertising or general&#13;solicitation was employed in offering the securities, the offerings and sales were made to a limited number of persons, all of&#13;whom were accredited investors and transfer was restricted by the company in accordance with the requirements of Regulation D and&#13;the Securities Act. All issuances to accredited and non-accredited investors were structured to comply with the requirements of&#13;the safe harbor afforded by Rule 506 of Regulation D, including limiting the number of non-accredited investors to no more than&#13;35 investors who have sufficient knowledge and experience in financial and business matters to make them capable of evaluating&#13;the merits and risks of an investment in our securities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following equity issuances occurred during&#13;the six months ended March 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the six months ended March 31, 2019,&#13;the Company issued 336,427 shares of common stock and cancelled warrants to purchase 26,573 shares of common stock at $0.25 per&#13;share to two consultants and two investors related to the cashless exercise of warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the six months ended March 31, 2019,&#13;the Company issued 145,000 shares of common stock for services provided by two consultants. The shares were valued at $246,900&#13;or $1.703 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 2, 2019, the Company issued 100,000&#13;shares of common stock for services provided to Ronald P. Erickson. The shares were valued at $102,000 or $1.02 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 29, 2019, a holder of Series A Preferred&#13;Stock converted 20,000 shares into 80,000 shares of common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Private Placements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 4, 2019, the Company closed rounds&#13;one and two of a private placement and received gross proceeds of $2,409,975 in exchange for issuing Subordinated Convertible Notes&#13;and Warrants in a private placement to 26 accredited investors, pursuant to a series of substantially identical Securities Purchase&#13;Agreements, Common Stock Warrants, and related documents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 18, 2019, Company closed round three&#13;of a private placement and received gross proceeds of $1,400,000 in exchange for issuing Subordinated Convertible Notes and Warrants&#13;in a private placement to 8 accredited investors, pursuant to a series of substantially identical Securities Purchase Agreements,&#13;Common Stock Warrants, and related documents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Convertible Notes have a principal amount&#13;of $3,809,975 and bear annual interest of 8%. Both the principal amount of and the interest are payable on a payment-in-kind basis&#13;in shares of Common Stock of the Company. They are due and payable in common stock on the earlier of (a) mandatory and automatic&#13;conversion of the Convertible Notes into a financing that yields gross proceeds of at least $10,000,000 or (b) on the one-year&#13;anniversary of the Convertible Notes. Investors will be required to convert their Convertible Notes into Common Stock in any $10,000,000&#13;financing at a conversion price per share equal to the lower of (i) $1.00 per share or (ii) a 25% discount to the price per share&#13;paid by investors in the $10,000,000 Financing. If the Convertible Notes have not been paid or converted prior to the Maturity&#13;Date, the outstanding principal amount of the Convertible Notes will be automatically converted into shares of Common Stock at&#13;the lesser of (a) $1.00 per share or (b) any adjusted price resulting from the application of a &amp;#8220;most favored nations&amp;#8221;&#13;provision, which requires the issuance of additional shares of Common Stock to investors if the Company issues certain securities&#13;at less than the then-current conversion price.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Warrants were granted on a 1:0.5 basis (one-half&#13;Warrant for each full share of Common Stock into which the Convertible Notes are convertible). The Warrants have a five-year term&#13;and an exercise price equal to 120% of the per share conversion price of the Qualified Financing or other mandatory conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Convertible Notes are initially convertible&#13;into 3,809,975 shares of Common Stock, subject to certain adjustments, and the Warrants are initially exercisable for 1,904,988&#13;shares of Common Stock at an exercise price of $1.20 per share of Common Stock, also subject to certain adjustments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the private placement, the&#13;placement agent for the Convertible Notes and the Warrants received a cash fee of $324,798 and warrants to purchase 487,197 shares&#13;of the Company&amp;#8217;s common stock, all based on 8% of gross proceeds to the Company. The placement agent has also received a&#13;$25,000 advisory fee.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As part of the Purchase Agreement, the Company&#13;entered into a Registration Rights Agreement, which grants the investors &amp;#8220;demand&amp;#8221; and &amp;#8220;piggyback&amp;#8221; registration&#13;rights to register the shares of Common Stock issuable upon the conversion of the Convertible Notes and the exercise of the Warrants&#13;with the Securities and Exchange Commission for resale or other disposition. In addition, the Convertible Notes are subordinated&#13;to certain senior debt of the Company pursuant to a Subordination Agreement executed by the investors.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Convertible Notes and Warrants were issued&#13;in transactions that were not registered under the Securities Act of 1933, as amended (the &amp;#8220;Act&amp;#8221;) in reliance upon&#13;applicable exemptions from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company expects to continue offering additional&#13;Convertible Notes and Warrants on substantially the same terms until April 15, 2019 (unless extended at the discretion of the Company)&#13;or until the Company has raised a maximum of $5 million in gross proceeds (or such other amount determined by the Company in its&#13;discretion). The offering was extended until May 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Warrants to Purchase Common Stock&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following warrants were issued during the&#13;six months ended March 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company issued 336,427 shares of common&#13;stock and cancelled warrants to purchase 26,573 shares of common stock at $0.25 per share to two consultants and two investors&#13;related to the cashless exercise of warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company issued warrants to purchase 70,000&#13;shares of common stock at $1.61 to$2.72 per share to three consultants. The warrants were valued at $30,325 or 0.79 to $1.11 per&#13;share. The warrants expire during the first quarter of 2024.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Private Placements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Warrants issued for the private placements&#13;discussed above were granted on a 1:0.5 basis (one-half Warrant for each full share of Common Stock into which the Convertible&#13;Notes are convertible). The Warrants have a five-year term and an exercise price equal to 120% of the per share conversion price&#13;of the Qualified Financing or other mandatory conversion.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Warrants are initially exercisable for 1,904,988&#13;shares of Common Stock at an exercise price of $1.20 per share of Common Stock, also subject to certain adjustments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the private placement, the&#13;placement agent for the Convertible Notes and the Warrants received warrants to purchase 487,197 shares of the Company&amp;#8217;s&#13;common stock, all based on 8% of gross proceeds to the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;A summary of the warrants outstanding as of March 31, 2019 were as&#13;follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;March 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 70%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at beginning of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,462,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(336,427&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(26,573&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at end of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,572,583&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.453&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at end of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,572,583&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;A summary of the status of the warrants outstanding as of March 31,&#13;2019 is presented below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="17" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;March 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Life ( In Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 23%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13,507,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13,507,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;714,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;714,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;882,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;882,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,442,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.93&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.20-1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,442,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.20-1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.34-4.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.34-4.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,572,583&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.78&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.453&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,572,583&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.453&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;The significant weighted average assumptions relating to the valuation&#13;of the Company&amp;#8217;s warrants for the six months ended March 31, 2019 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;u&gt;Assumptions&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 8pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 23%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expected life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;1 yr&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;125%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2.0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;There were vested warrants of 16,613,757 as of March 31, 2019 with&#13;an aggregate intrinsic value of $14,664,327.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 21, 2013, an amendment to the Stock&#13;Option Plan was approved by the stockholders of the Company, increasing the number of shares reserved for issuance under the Plan&#13;to 93,333 shares. On April 10, 2018, the Board approved an amendment to its 2011 Stock Incentive Plan increasing the number of&#13;shares of common stock reserved under the Incentive Plan from 93,333 to 1,200,000. On August 7, 2018, the Board approved an amendment&#13;to its 2011 Stock Incentive Plan increasing the number of shares of common stock reserved under the Incentive Plan from 1,200,000&#13;to 2,000,000 to common shares.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"&gt;&lt;b&gt;Determining Fair Value under ASC&#13;505&lt;/b&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company records compensation expense associated&#13;with stock options and other equity-based compensation using the Black-Scholes-Merton option valuation model for estimating fair&#13;value of stock options granted under our plan. The Company amortizes the fair value of stock options on a ratable basis over the&#13;requisite service periods, which are generally the vesting periods. The expected life of awards granted represents the period of&#13;time that they are expected to be outstanding.&amp;#160;&amp;#160;The Company estimates the volatility of our common stock based on the&#13;historical volatility of its own common stock over the most recent period corresponding with the estimated expected life of the&#13;award. The Company bases the risk-free interest rate used in the Black Scholes-Merton option valuation model on the implied yield&#13;currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award.&#13;The Company has not paid any cash dividends on our common stock and does not anticipate paying any cash dividends in the foreseeable&#13;future. Consequently, the Company uses an expected dividend yield of zero in the Black-Scholes-Merton option valuation model and&#13;adjusts share-based compensation for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience.&#13;The effect of adjusting the forfeiture rate is recognized in the period the forfeiture estimate is changed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Stock Option Activity&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company had the following stock option transactions&#13;during the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A former employee forfeited stock option grants&#13;for 10,668 shares of common stock at $14.719 per share.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2018, four&#13;employee and two consultants were granted options to purchase 1,180,000 shares of common stock at an exercise price of $2.024 per&#13;share. The stock option grants vest quarterly over four years (none during the first six months) and are exercisable for 5 years.&#13;The stock option grants were valued at an average of $2.38 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 30, 2018, Mr. Bosua was awarded a stock&#13;option grant for 1,000,000 shares of common stock that was awarded at $1.28 per share and was valued at the black scholes value&#13;of $1.22 per share.&amp;#160;&amp;#160;The stock option grant vests quarterly over four years and is exercisable for 5 years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company had the following stock option transactions&#13;during the year ended September 30, 2017:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2017, employees&#13;forfeited stock option grants for 35,504 shares of common stock at $19.51 per share.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There are currently 534,736 options to purchase&#13;common stock at an average exercise price of $1.698 per share outstanding as of September 30, 2018 under the 2011 Stock Incentive&#13;Plan. The Company recorded $50,899 and $37,848 of compensation expense, net of related tax effects, relative to stock options for&#13;the year ended September 30, 2018 and in accordance with ASC 505. Net loss per share (basic and diluted) associated with this expense&#13;was approximately ($0.006) and ($0.01) per share, respectively. As of September 30, 2018, there is approximately $1,789,384, net&#13;of forfeitures, of total unrecognized costs related to employee granted stock options that are not vested. These costs are expected&#13;to be recognized over a period of approximately 4.94 years.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Stock option activity for the years ended September 30, 2018 and&#13;2017 was as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted Average&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Options&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise Price&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160; $&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 46%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of September 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;50,908&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;18.045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;918,627&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Forfeitures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(35,504&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(19.507&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(692,568&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,404&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;14.675&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;226,059&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,180,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.683&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,668,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Forfeitures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(12,736&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;14.764&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(188,040&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,182,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.698&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,706,519&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes information about&#13;stock options outstanding and exercisable as of September 30, 2018:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Range of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Number&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Remaining Life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Number&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise Prices&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;In Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;530,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.08-4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,182,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.94&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.698&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;There were stock option grants of 1,680,000 shares as of September&#13;30, 2018 with an aggregate intrinsic value of $4,964,300.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 21, 2013, an amendment to the Stock&#13;Option Plan was approved by the stockholders of the Company, increasing the number of shares reserved for issuance under the Plan&#13;to 93,333 shares.&lt;b&gt;&amp;#160;&lt;/b&gt;On April 10, 2018, the Board approved an amendment to its 2011 Stock Incentive Plan increasing the&#13;number of shares of common stock reserved under the Incentive Plan from 93,333 to 1,200,000. On August 7, 2018, the Board approved&#13;an amendment to its 2011 Stock Incentive Plan increasing the number of shares of common stock reserved under the Incentive Plan&#13;from 1,200,000 to 2,000,000 to common shares.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Determining Fair Value under ASC 505&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company records compensation expense associated&#13;with stock options and other equity-based compensation using the Black-Scholes-Merton option valuation model for estimating fair&#13;value of stock options granted under our plan. The Company amortizes the fair value of stock options on a ratable basis over the&#13;requisite service periods, which are generally the vesting periods. The expected life of awards granted represents the period of&#13;time that they are expected to be outstanding.&amp;#160;&amp;#160;The Company estimates the volatility of our common stock based on the&#13;historical volatility of its own common stock over the most recent period corresponding with the estimated expected life of the&#13;award. The Company bases the risk-free interest rate used in the Black Scholes-Merton option valuation model on the implied yield&#13;currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award.&#13;The Company has not paid any cash dividends on our common stock and does not anticipate paying any cash dividends in the foreseeable&#13;future. Consequently, the Company uses an expected dividend yield of zero in the Black-Scholes-Merton option valuation model and&#13;adjusts share-based compensation for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience.&#13;The effect of adjusting the forfeiture rate is recognized in the period the forfeiture estimate is changed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Stock Option Activity&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company had the following stock option transactions&#13;during the six months ended March 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 31, 2018, the Board awarded stock&#13;option grants to two directors to acquire 50,000 shares each of the Company&amp;#8217;s common stock. The grants were valued at $3.03&#13;per share and expire on October 31, 2013. The grants vested immediately.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 31, 2018, the Board awarded Phillip&#13;A. Bosua a stock option grant to acquire 100,000 shares of the Company&amp;#8217;s Common stock for each $1,000,000 raised by the Company&#13;in revenue generated in a planned Kickstarter campaign. In addition, Mr. Bosua was granted a stock option grant to acquire 1,000,000&#13;shares of the Company&amp;#8217;s common which vests upon approval of the Company&amp;#8217;s blood glucose measurement technology by the&#13;U.S. Food and Drug Administration. The grants were valued at $3.03 per share and expire on October 31, 2023.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 31, 2018, the Board awarded Ronald&#13;P Erickson a stock option grant to acquire 1,000,000 shares of the Company&amp;#8217;s common which vests upon the Company&amp;#8217;s&#13;successful listing of its Common Stock on Nasdaq or the New York Stock Exchange (including the NYSE American Market). The grant&#13;was valued at $3.03 per share and expires on October 31, 2023.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 26, 2019, the Board awarded an employee&#13;a stock option grant to acquire 10,000 shares of the Company&amp;#8217;s Common stock for each $1,000,000 raised by the Company in&#13;revenue generated in a planned Kickstarter campaign. In addition, the employee was granted a stock option grant to acquire 130,000&#13;shares of the Company&amp;#8217;s common which vests upon approval of the Company&amp;#8217;s blood glucose measurement technology by the&#13;U.S. Food and Drug Administration. The grants were valued at $1.50 per share and expire on March 26, 2024.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 26, 2019, the Board awarded an employee&#13;a stock option grant to acquire 10,000 shares of the Company&amp;#8217;s Common stock for each $1,000,000 raised by the Company in&#13;revenue generated in a planned Kickstarter campaign. In addition, the employee was granted a stock option grant to acquire 130,000&#13;shares of the Company&amp;#8217;s common which vests upon approval of the Company&amp;#8217;s blood glucose measurement technology by the&#13;U.S. Food and Drug Administration. The grants were valued at $1.50 per share and expire on March 26, 2024.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There are currently 2,282,668 options to purchase&#13;common stock at an average exercise price of $1.757 per share outstanding as of March 31, 2019 under the 2011 Stock Incentive Plan.&#13;The Company recorded $263,145 and $7,334 of compensation expense, net of related tax effects, relative to stock options for the&#13;six months ended March 31, 2019 and 2018 and in accordance with ASC 505. Net loss per share (basic and diluted) associated with&#13;this expense was approximately ($0.010) and ($0.000) per share, respectively. As of March 31, 2019, there is approximately $1,606,089,&#13;net of forfeitures, of total unrecognized costs related to employee granted stock options that are not vested. These costs are&#13;expected to be recognized over a period of approximately 4.69 years.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock option activity for the three months ended&#13;March 31, 2019 was as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 58%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,182,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.698&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,706,519&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.030&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;303,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;Forfeitures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,282,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,009,519&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes information about&#13;stock options outstanding and exercisable as of March 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Range of&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise Prices&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;In Years&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 20%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;0.25&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;530,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;99,375&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;143,750&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;3.03&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;4.08-4.20&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.08-4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;31,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.08-4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;13.500&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;15.000&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,282,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;375,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.755&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;There were stock option grants of 530,000 shares as of March 31,&#13;2019 with an aggregate intrinsic value of $535,300.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Related Party Transactions with Ronald P.&#13;Erickson&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;See Notes 11, 12 and 13 for related party transactions&#13;with Ronald P. Erickson.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 7, 2017 Mr. Erickson was issued&#13;200,000 of restricted common stock to at the grant date market value of $0.17 per share.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 16, 2018 Mr. Erickson was issued&#13;100,000 of restricted common stock on to at the grant date market value of $0.21 per share.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 25, 2018, the Company entered into&#13;amendments to two demand promissory notes, totaling $600,000 with Mr. Erickson, our Chief Executive Officer and/or entities in&#13;which Mr. Erickson has a beneficial interest. The amendments extend the due date from December 31, 2017 to September 30, 2018 and&#13;continue to provide for interest of 3% per annum and a third lien on company assets if not repaid by September 30, 2018 or converted&#13;into convertible debentures or equity on terms acceptable to the Holder. On March 16, 2018, the demand promissory notes and accrued&#13;interest were converted into convertible notes payable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 16, 2018, the Company entered into&#13;a Note and Account Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was&#13;converted to a Convertible Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z&#13;Account Payable was converted into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a&#13;warrant to purchase up to 1,039,666 shares of our common stock for a period of five years. The initial exercise price of the warrants&#13;described above is $0.50 per share, also subject to certain adjustments. The warrants had an estimated value of $0.12 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 9, 2018, the Company repaid a $199,935&#13;Business Loan Agreement with Umpqua Bank from funds previously provided by an entity affiliated with Ronald P. Erickson, our Chairman&#13;of the Board. The Company paid $27,041 and issued 800,000 shares of common stock in exchange for the conversion of this debt. Mr.&#13;Erickson is an accredited investor. These shares were issued in transactions that were not registered under the Act in reliance&#13;upon applicable exemptions from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Mr. Erickson and/or entities with which he is&#13;affiliated also have accrued compensation, travel and interest of approximately $513,149 as of September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Related Party Transaction with Phillip A. Bosua&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 14, 2017, the Company issued 50,000&#13;shares of our common stock to Phillip A. Bosua under the terms of a consulting agreement dated July 6, 2017. The fair value of&#13;the stock was $8,500.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 7, 2018, the Company issued 50,000&#13;shares of our common stock to Phillip A. Bosua under the terms of a consulting agreement dated July 6, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company issued 2,000,000&#13;shares of our common stock to Phillip A. Bosua under the terms of the Merger Agreement with RAAI common stock. The fair value of&#13;the stock was $520,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 25, 2018, the Company issued 500,000&#13;shares of our common stock to Phillip A. Bosua under the terms of an Employment agreement dated April 10, 2018. The fair value&#13;of the stock was $165,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 25, 2018, the Company closed a debt&#13;conversion with an entity controlled by Phillip A. Bosua and issued 255,000 shares of common stock in exchange for the conversion&#13;of $63,750 in preexisting debt owed by the Company to this entity.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 30, 2018, Mr. Bosua was awarded a stock&#13;option grant for 1,000,000 shares of our common stock that was awarded at $1.28 per share and was valued at the black scholes value&#13;of $1.22 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Stock Issuances to Named Executive Officers&#13;and Directors&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 7, 2017, the Company issued 400,000&#13;shares of restricted common stock to one Named Executive Officer and two directors for services during 2015-2017. The shares were&#13;issued in accordance with the 2011 Stock Incentive Plan and were valued at $0.17 per share, the market price of our common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During January to May 2018, the Company issued&#13;275,000 shares of restricted common stock to one Named Executive Officer and two directors for services during 2018. The shares&#13;were issued in accordance with the 2011 Stock Incentive Plan and were valued at $0.246 per share, the market price of our common&#13;stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Stock Option Grant Cancellations&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended September 30, 2017, two&#13;Named Executive Officers forfeited stock option grants for 35,366 shares of common stock at $19.53 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Related Party Transactions with Ronald&#13;P. Erickson&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;See Notes 10 and 13 for related party&#13;transactions with Ronald P. Erickson.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Mr. Erickson and/or entities with which&#13;he is affiliated also have accrued compensation, travel and interest of approximately $478,861 as of March 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Related Party Transaction with Phillip A. Bosua&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;See Note 13 for related party transactions with Phillip A.&#13;Bosua.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Stock Option Grants to Directors&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;See Note 13 for related party transactions with Directors.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Legal Proceedings&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company may from time to time become a party&#13;to various legal proceedings arising in the ordinary course of our business. The Company is currently not a party to any pending&#13;legal proceeding that is not ordinary routine litigation incidental to our business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Employment Agreement with Phillip A. Bosua,&#13;Chief Executive Officer&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company appointed Mr.&#13;Bosua as Chief Executive Officer of the Company, replacing Ronald P. Erickson, who remains Chairman of the Company. Mr. Erickson&#13;has been a director and officer of Know Labs since April 2003. He was appointed as our CEO and President in November 2009 and as&#13;Chairman of the Board in February 2015. Previously, Mr. Erickson was our President and Chief Executive Officer from September 2003&#13;through August 2003 and was Chairman of the Board from August 2004 until May 2011.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Phillip A. Bosua was appointed the Company&amp;#8217;s&#13;CEO on April 10, 2018. Previously, Mr. Bosua served as the Company&amp;#8217;s Chief Product Officer since August 2017. The Company&#13;entered into a Consulting Agreement with Mr. Bosua&amp;#8217;s company, Blaze Clinical on July 7, 2017. From September 2012 to February&#13;2015, Mr. Bosua was the founder and Chief Executive Officer of LIFX Inc. (where he developed and marketed an innovative &amp;#8220;smart&amp;#8221;&#13;light bulb) and from August 2015 until February 2016 was Vice President Consumer Products at Soraa (which markets specialty LED&#13;light bulbs). From February 2016 to July 2017, Mr. Bosua was the founder and CEO of RAAI, Inc. (where he continued the development&#13;of his smart lighting technology). From May 2008 to February 2013 he was the Founder and CEO of LimeMouse Apps, a leading developer&#13;of applications for the Apple App Store.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company entered into&#13;an Employment Agreement with Mr. Bosua reflecting his appointment as Chief Executive Officer. The Employment Agreement is for an&#13;initial term of 12 months (subject to earlier termination) and will be automatically extended for additional 12-month terms unless&#13;either party notifies the other party of its intention to terminate the Employment Agreement. Mr. Bosua will be paid a base salary&#13;of $225,000 per year, received 500,000 shares of common stock valued at $0.33 per share and may be entitled to bonuses and equity&#13;awards at the discretion of the Board or a committee of the Board. The Employment Agreement provides for severance pay equal to&#13;12 months of base salary if Mr. Bosua is terminated without &amp;#8220;cause&amp;#8221; or voluntarily terminates his employment for &amp;#8220;good&#13;reason.&amp;#8221;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Employment Agreement with Ronald P. Erickson, Chairman of the&#13;Board and Interim Chief Financial Officer&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 4, 2017, the Board of Directors approved&#13;an Employment Agreement with Ronald P. Erickson pursuant to which the Company engaged Mr. Erickson as our Chief Executive Officer&#13;through September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Mr. Erickson&amp;#8217;s annual compensation is&#13;$180,000. Mr. Erickson is also entitled to receive an annual bonus and equity awards compensation as approved by the Board. The&#13;bonus should be paid no later than 30 days following earning of the bonus.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Mr. Erickson will be entitled to participate&#13;in all group employment benefits that are offered by the Company to our senior executives and management employees from time to&#13;time, subject to the terms and conditions of such benefit plans, including any eligibility requirements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;If the Company terminates Mr. Erickson&amp;#8217;s&#13;employment at any time prior to the expiration of the Term without Cause, as defined in the Employment Agreement, or if Mr. Erickson&#13;terminates his employment at any time for &amp;#8220;Good Reason&amp;#8221; or due to a &amp;#8220;Disability&amp;#8221;, Mr. Erickson will be&#13;entitled to receive (i) his Base Salary amount for one year; and (ii) medical benefits for eighteen months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 10, 2018, the Company entered into&#13;an Amended Employment Agreement for Ronald P. Erickson which amends the Employment Agreement dated July 1, 2017. The Agreement&#13;expires March 21, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Properties and Operating Leases&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is obligated under the following&#13;non-cancelable operating leases for its various facilities and certain equipment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid"&gt;Years Ended&#13;        September 30,&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 63%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;118,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;85,914&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;23,498&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Beyond&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;227,602&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Corporate Offices&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 13, 2017, the Company leased its executive&#13;office located at 500 Union Street, Suite 810, Seattle, Washington, USA, 98101. The Company leases 943 square feet and the net&#13;monthly payment is $2,672. The monthly payment increases approximately 3% each year and the lease expires on May 31, 2022.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Lab Facilities and Executive Offices&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2018, the Company leased its lab facilities&#13;and executive offices located at 304 Alaskan Way South, Suite 102, Seattle, Washington, USA, 98101. The Company leases 2,800 square&#13;feet and the net monthly payment is $4,000. The lease expires on April 30, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;TransTech Facilities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;TransTech is located at 12142 NE Sky Lane, Suite&#13;130, Aurora, OR 97002. TransTech leases a total of approximately 6,340 square feet of office and warehouse space for its administrative&#13;offices, product inventory and shipping operations. Effective December 1, 2017, TransTech leases this office from December 1, 2017&#13;at $4,465 per month. The monthly payment increases approximately 3% each year and the lease expires on January 31, 2020. Until&#13;December 1, 2017, TransTech leased this office on a month to month basis at $6,942 per month.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Legal Proceedings&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company may from time to time become a party&#13;to various legal proceedings arising in the ordinary course of our business. The Company is currently not a party to any pending&#13;legal proceeding that is not ordinary routine litigation incidental to our business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Properties and Operating Leases&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is obligated under the following&#13;non-cancelable operating leases for its various facilities and certain equipment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Years Ended March 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 86%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;187,652&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;196,526&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,816&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Beyond&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;389,994&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Corporate Offices&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 13, 2017, the Company leased its executive&#13;office located at 500 Union Street, Suite 810, Seattle, Washington, USA, 98101. The Company leases 943 square feet and the net&#13;monthly payment is $2,672. The monthly payment increases approximately 3% each year and the lease expires on May 31, 2022.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Lab Facilities and Executive Offices&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 1, 2018, the Company leased its&#13;lab facilities and executive offices located at 304 Alaskan Way South, Suite 102, Seattle, Washington, USA, 98101. The Company&#13;leases 2,800 square feet and the net monthly payment is $4,000. The lease expired on April 30, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"&gt;On February 1, 2019, the Company&#13;leased its lab facilities and executive offices located at 915 E Pine Street, Suite 212, Seattle, WA 98122. The Company leases&#13;2,642 square feet and the net monthly payment is $8,256. The monthly payment increases approximately 3% on July 1, 2019 and annually&#13;thereafter. The lease expires on June 30, 2021 and can be extended.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;TransTech Facilities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;TransTech is located at 12142 NE Sky&#13;Lane, Suite 130, Aurora, OR 97002. TransTech leases a total of approximately 6,340 square feet of office and warehouse space for&#13;its administrative offices, product inventory and shipping operations. Effective December 1, 2017, TransTech leases this office&#13;from December 1, 2017 at $4,465 per month. The monthly payment increases approximately 3% each year and the lease expires on January&#13;31, 2020. Until December 1, 2017, TransTech leased this office on a month to month basis at $6,942 per month. TransTech terminated&#13;this lease effective May 31, 2019.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has incurred losses since inception,&#13;which have generated net operating loss carryforwards.&amp;#160;&amp;#160;The net operating loss carryforwards arise from United States&#13;sources.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pretax losses arising from United States operations&#13;were approximately $3,258,000 for the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pretax losses arising from United States operations&#13;were approximately $3,901,000 for the year ended September 30, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has net operating loss carryforwards&#13;of approximately $27,352,000, which expire in 2022-2036. Because it is not more likely than not that sufficient tax earnings will&#13;be generated to utilize the net operating loss carryforwards, a corresponding valuation allowance of approximately $5,744,000 was&#13;established as of September 30, 2018. Additionally, under the Tax Reform Act of 1986, the amounts of, and benefits from, net operating&#13;losses may be limited in certain circumstances, including a change in control.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Section&amp;#160;382 of the Internal Revenue Code&#13;generally imposes an annual limitation on the amount of net operating loss carryforwards that may be used to offset taxable income&#13;when a corporation has undergone significant changes in its stock ownership. There can be no assurance that the Company will be&#13;able to utilize any net operating loss carryforwards in the future. The Company is subject to possible tax examination for the&#13;years 2012 through 2018&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the year ended September 30, 2018, the Company&amp;#8217;s&#13;effective tax rate differs from the federal statutory rate principally due to net operating losses and warrants issued for services.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;U.S. Tax Reform&lt;/i&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 22, 2017, the U.S. government enacted&#13;comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the Tax Reform Act). The Tax Reform Act significantly&#13;revises the future ongoing federal income tax by, among other things, lowering U.S. corporate income tax rates effective January&#13;1, 2018. The Company has calculated a blended U.S. federal income tax rate of approximately 21% for the fiscal year ending September&#13;30, 2018 and 21.0% for subsequent fiscal years. Remeasurement of the Company&amp;#8217;s deferred tax balance under the Tax Reform&#13;Act resulted in a non-cash tax benefit reduction of approximately $2.3 million for the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The changes included in the Tax Reform Act are&#13;broad and complex. The final transition impacts of the Tax Reform Act may differ from the above estimate due to, among other things,&#13;changes in interpretations of the Tax Reform Act, any legislative action to address questions that arise because of the Tax Reform&#13;Act and any changes in accounting standards for income taxes or related interpretations in response to the Tax Reform Act.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;The principal components of the Company&amp;#8217;s deferred tax assets&#13;at September 30, 2018 and 2017 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;U.S. operations loss carry forward at statutory rate of 21%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(5,743,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(5,804,285&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Non-U.S. operations loss carry forward at statutory rate of 20.5%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(5,743,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(5,804,285&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Less Valuation Allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,743,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,804,285&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Net Deferred Tax Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Change in Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;60,445&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,036,276&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A reconciliation of the United States Federal&#13;Statutory rate to the Company&amp;#8217;s effective tax rate for the years ended September 30, 2018 and 2017 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;Federal Statutory Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Increase in Income Taxes Resulting from:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Change in Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Effective Tax Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluated subsequent events, for&#13;the purpose of adjustment or disclosure, up through the date the financial statements were issued.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 31, 2018, the Board awarded stock&#13;option grants to two directors to acquire 50,000 shares each of the Company&amp;#8217;s common stock. The grants were valued at $3.03&#13;per share and expire on October 31, 2013. The grants vested immediately.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 31, 2018, the Board awarded Phillip&#13;A. Bosua a stock option grant to acquire 100,000 shares of the Company&amp;#8217;s Common stock for each $1,000,000 raised by the Company&#13;in revenue generated in a planned Kickstarter campaign. In addition, Mr. Bosua was granted a stock option grant to acquire 1,000,000&#13;shares of the Company&amp;#8217;s common which vests upon approval of the Company&amp;#8217;s blood glucose measurement technology by the&#13;U.S. Food and Drug Administration. The grants were valued at $3.03 per share and expire on October 31, 2023.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 31, 2018, the Board awarded Ronald&#13;P Erickson a stock option grant to acquire 1,000,000 shares of the Company&amp;#8217;s common which vests upon the Company&amp;#8217;s&#13;successful listing of its Common Stock on Nasdaq or the New York Stock Exchange (including the NYSE American Market). The grant&#13;was valued at $3.03 per share and expires on October 31, 2023.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 16, 2018, the Company signed Amendment&#13;1 to Senior Secured Convertible Redeemable Notes dated September 30, 2016, August 14, 2017 and December 12, 2017, extending the&#13;due dates of the Notes to February 27, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 21, 2018, the Company&amp;#8217;s Board&#13;of Directors amended the Company&amp;#8217;s Audit, Compensation and Nominating and Corporate Governance Committee Charters. In addition,&#13;on November 21, 2018, the Company&amp;#8217;s Board of Directors amended the Company&amp;#8217;s Code of Ethics Policy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluates subsequent events, for&#13;the purpose of adjustment or disclosure, up through the date the financial statements are available. Subsequent to March 31, 2019,&#13;there were the following material transactions that require disclosure:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Convertible Promissory Notes with Clayton&#13;A. Struve&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2019, the Company owes Clayton&#13;A. Struve $1,071,000 under convertible promissory or OID notes. The Company recorded accrued interest of $58,411 as of March 31,&#13;2019. On May 8, 2019, the Company signed Amendment 2 to the convertible promissory or OID notes, extending the due dates to September&#13;30, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Convertible Redeemable Promissory Notes with&#13;Ronald P. Erickson and J3E2A2Z&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 16, 2018, the Company entered into&#13;a Note and Account Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was&#13;converted to a Convertible Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z&#13;Account Payable was converted into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a&#13;warrant to purchase up to 1,039,666 shares of common stock of the Company for a period of five years. The initial exercise price&#13;of the warrants described above is $0.50 per share, also subject to certain adjustments. The warrants were valued at $110,545.&#13;Because the note is immediately convertible, the warrants and beneficial conversion were expensed as interest. The Company recorded&#13;accrued interest of $41,361 as of March 31, 2019. On May 8, 2019, the Company signed Amendment 1 to the convertible redeemable&#13;promissory notes, extending the due dates to September 30, 2019 and increasing the interest rate to 6%.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="margin: 0"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;The accompanying unaudited consolidated&#13;financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation&#13;of these unaudited condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting&#13;principles (&amp;#8220;GAAP&amp;#8221;).&lt;/font&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt; &amp;#8211; The accompanying&#13;unaudited consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been&#13;eliminated. The preparation of these unaudited condensed consolidated financial statements were prepared in conformity with U.S.&#13;generally accepted accounting principles (&amp;#8220;GAAP&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements include&#13;the accounts of the Company and its wholly owned and majority-owned subsidiaries, TransTech Systems, Inc and RAAI Lighting, Inc.&#13;Inter-Company items and transactions have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt; &amp;#8211; The&#13;consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries, TransTech&#13;Systems, Inc and RAAI Lighting, Inc. Inter-Company items and transactions have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company classifies highly liquid temporary&#13;investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances&#13;at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000.&#13;The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on&#13;deposit.&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt; &amp;#8211;&amp;#160;The&#13;Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash&#13;equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal&#13;Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not&#13;exposed to any significant risk for cash on deposit.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivable consist primarily of amounts&#13;due to the Company from normal business activities. The Company maintains an allowance for doubtful accounts to reflect the expected&#13;non-collection of accounts receivable based on past collection history and specific risks identified within the portfolio. If&#13;the financial condition of the customers were to deteriorate resulting in an impairment of their ability to make payments, or&#13;if payments from customers are significantly delayed, additional allowances might be required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Accounts Receivable and Allowance for Doubtful&#13;Accounts&lt;/b&gt; &amp;#8211; Accounts receivable consist primarily of amounts due to the Company from normal business activities. The Company&#13;maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection&#13;history and specific risks identified within the portfolio. If the financial condition of the customers were to deteriorate resulting&#13;in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances&#13;might be required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories consist primarily of printers and&#13;consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control components held for resale&#13;and are stated at the lower of cost or market on the&amp;#160;first-in, first-out (&amp;#8220;FIFO&amp;#8221;) method.&amp;#160;&amp;#160;Inventories&#13;are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received&#13;by TransTech at a warehouse location.&amp;#160;&amp;#160;The Company records a provision for excess and obsolete inventory whenever an&#13;impairment has been identified. There is a $35,000 reserve for impaired inventory as of September 30, 2018 and 2017, respectively.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Inventories&lt;/b&gt; &amp;#8211; Inventories consist&#13;primarily of printers and consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control&#13;components held for resale and are stated at the lower of cost or market on the&amp;#160;first-in, first-out (&amp;#8220;FIFO&amp;#8221;) method.&amp;#160;&amp;#160;Inventories&#13;are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received&#13;by TransTech at a warehouse location.&amp;#160;&amp;#160;The Company records a provision for excess and obsolete inventory whenever an&#13;impairment has been identified. There is a $35,000 reserve for impaired inventory as of March 31, 2019 and September 30, 2018,&#13;respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Equipment consists of machinery, leasehold&#13;improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation and amortization. Depreciation&#13;is computed by the straight-line method over the estimated useful lives or lease period of the relevant asset, generally 2-10&#13;years, except for leasehold improvements which are depreciated over 2-3 years.&amp;#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Equipment&lt;/b&gt; &amp;#8211; Equipment consists&#13;of machinery, leasehold improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation&#13;and amortization. Depreciation is computed by the straight-line method over the estimated useful lives or lease period of the relevant&#13;asset, generally 2-10 years, except for leasehold improvements which are depreciated over 2-3 years.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company reviews its long-lived assets for&#13;impairment annually or when changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived&#13;assets under certain circumstances are reported at the lower of carrying amount or fair value. Assets to be disposed of and assets&#13;not expected to provide any future service potential to the Company are recorded at the lower of carrying amount or fair value&#13;(less the projected cost associated with selling the asset). To the extent carrying values exceed fair values, an impairment loss&#13;is recognized in operating results.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Long-Lived Assets&lt;/b&gt; &amp;#8211; The Company&#13;reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an&#13;asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair&#13;value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at&#13;the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying&#13;values exceed fair values, an impairment loss is recognized in operating results.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Intangible assets are capitalized and amortized&#13;on a straight-line basis over their estimated useful life, if the life is determinable. If the life is not determinable, amortization&#13;is not recorded. We regularly perform reviews to determine if facts and circumstances exist which indicate that the useful lives&#13;of our intangible assets are shorter than originally estimated or the carrying amount of these assets may not be recoverable.&#13;When an indication exists that the carrying amount of intangible assets may not be recoverable, we assess the recoverability of&#13;our assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their&#13;remaining lives against their respective carrying amounts. Such impairment test is based on the lowest level for which identifiable&#13;cash flows are largely independent of the cash flows of other groups of assets and liabilities. Impairment, if any, is based on&#13;the excess of the carrying amount over the estimated fair value of those assets.&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Intangible Assets&lt;/b&gt; &amp;#8211; Intangible&#13;assets are capitalized and amortized on a straight-line basis over their estimated useful life, if the life is determinable. If&#13;the life is not determinable, amortization is not recorded. We regularly perform reviews to determine if facts and circumstances&#13;exist which indicate that the useful lives of our intangible assets are shorter than originally estimated or the carrying amount&#13;of these assets may not be recoverable. When an indication exists that the carrying amount of intangible assets may not be recoverable,&#13;we assess the recoverability of our assets by comparing the projected undiscounted net cash flows associated with the related asset&#13;or group of assets over their remaining lives against their respective carrying amounts. Such impairment test is based on the lowest&#13;level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Impairment,&#13;if any, is based on the excess of the carrying amount over the estimated fair value of those assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Research, development and engineering expenses&#13;consist of the cost of employees, consultants and contractors who design, engineer and develop new products and processes as well&#13;as materials, supplies and facilities used in producing prototypes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#8217;s research and development&#13;efforts are primarily focused improving the core foundational ChromaID technology and developing new and unique applications for&#13;the technology. As part of this effort, the Company typically conduct testing to ensure that ChromaID application methods are compatible&#13;with the customer&amp;#8217;s requirements, and that they can be implemented in a cost effective manner. The Company is also actively&#13;involved in identifying new application methods. Know Lab&amp;#8217;s team has considerable experience working with the application&#13;of light-based technologies and their application to various industries. The Company believes that its continued development of&#13;new and enhanced technologies relating to our core business is essential to its future success. The Company spent $570,514 and&#13;$79,405 during the years ended September 30, 2018 and 2017, respectively, on research and development activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Research, Development and Engineering Expenses&lt;/b&gt;&#13;&amp;#8211; Research, development and engineering expenses consist of the cost of employees, consultants and contractors who design,&#13;engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#8217;s research and development&#13;efforts are primarily focused improving the core foundational ChromaID technology and developing new and unique applications for&#13;the technology. As part of this effort, the Company typically conduct testing to ensure that ChromaID application methods are compatible&#13;with the customer&amp;#8217;s requirements, and that they can be implemented in a cost effective manner. The Company is also actively&#13;involved in identifying new application methods. Know Lab&amp;#8217;s team has considerable experience working with the application&#13;of light-based technologies and their application to various industries. The Company believes that its continued development of&#13;new and enhanced technologies relating to our core business is essential to its future success. The Company spent $391,014, $570,514&#13;and $79,405 during the six months ended March 31, 2019 and the years ended September 30, 2018 and 2017, respectively, on research&#13;and development activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC Topic 820, &lt;i&gt;Fair Value Measurement and&#13;Disclosures&lt;/i&gt;, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability&#13;(an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market&#13;participants on the measurement date.&amp;#160;&amp;#160;This topic also establishes a fair value hierarchy, which requires classification&#13;based on observable and unobservable inputs when measuring fair value.&amp;#160;&amp;#160;The fair value hierarchy distinguishes between&#13;assumptions based on market data (observable inputs) and an entity&amp;#8217;s own assumptions (unobservable inputs).&amp;#160;&amp;#160;The&#13;hierarchy consists of three levels:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 100%; font: 12pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 8pt"&gt;Level 1 &amp;#8211; Quoted prices in active markets for identical assets and liabilities;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 100%"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Level 2 &amp;#8211; Inputs other than level one inputs that are either&#13;        directly or indirectly observable; and.&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level&amp;#160;3 - Inputs to the valuation methodology&#13;        are unobservable and significant to the fair value measurement.&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The recorded value of other financial assets&#13;and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts&#13;payable and accrued expenses approximate the fair value of the respective assets and liabilities as of September 30, 2018 and 2017&#13;are based upon the short-term nature of the assets and liabilities.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Fair Value Measurements and Financial Instruments&lt;/b&gt;&#13;&amp;#8211;&lt;b&gt;&amp;#160;&lt;/b&gt;ASC Topic 820, &lt;i&gt;Fair Value Measurement and Disclosures&lt;/i&gt;, defines fair value as the exchange price that&#13;would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for&#13;the asset or liability in an orderly transaction between market participants on the measurement date.&amp;#160;&amp;#160;This topic also&#13;establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring fair&#13;value.&amp;#160;&amp;#160;The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and an entity&amp;#8217;s&#13;own assumptions (unobservable inputs).&amp;#160;&amp;#160;The hierarchy consists of three levels:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Level 1 &amp;#8211; Quoted prices in active markets for identical assets&#13;and liabilities;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Level 2 &amp;#8211; Inputs other than level one inputs that are either&#13;directly or indirectly observable; and.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level&amp;#160;3 - Inputs to the valuation methodology&#13;are unobservable and significant to the fair value measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The recorded value of other financial assets&#13;and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts&#13;payable and accrued expenses approximate the fair value of the respective assets and liabilities as of March 31, 2019 and September&#13;30, 2018 are based upon the short-term nature of the assets and liabilities.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesMethodsOfAccountingHedgeEffectiveness contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluates all of its financial&#13;instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative&#13;financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value&#13;and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations.&#13;For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative&#13;instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such&#13;instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument&#13;liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative&#13;instrument could be required within twelve months of the balance sheet date.&lt;/p&gt;</us-gaap:DerivativesMethodsOfAccountingHedgeEffectiveness>
    <us-gaap:DerivativesMethodsOfAccountingHedgeEffectiveness contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Derivative Financial Instruments -&lt;/b&gt;The&#13;Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify&#13;as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument&#13;is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in&#13;the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton&#13;option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of&#13;derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the&#13;end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based&#13;on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet&#13;date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DerivativesMethodsOfAccountingHedgeEffectiveness>
    <us-gaap:RevenueRecognitionSalesOfServices contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Know Lab and TransTech revenue are derived&#13;from products and services. Revenue is considered realized when the products or services have been provided to the customer, the&#13;work has been accepted by the customer and collectability is&amp;#160;reasonably assured. Furthermore, if an actual measurement of&#13;revenue cannot be determined, the Company defers all revenue recognition until such time that an actual measurement can be determined.&#13;If during the course of a contract management determines that losses are expected to be incurred, such costs are charged to operations&#13;in the period such losses are determined. Revenues are deferred when cash has been received from the customer but the revenue&#13;has not been earned.&lt;/p&gt;</us-gaap:RevenueRecognitionSalesOfServices>
    <us-gaap:RevenueRecognitionSalesOfServices contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt; &amp;#8211; Know Lab&#13;and TransTech revenue are derived from products and services. Revenue is considered realized when the products or services have&#13;been provided to the customer, the work has been accepted by the customer and collectability is&amp;#160;reasonably assured. Furthermore,&#13;if an actual measurement of revenue cannot be determined, the Company defers all revenue recognition until such time that an actual&#13;measurement can be determined. If during the course of a contract management determines that losses are expected to be incurred,&#13;such costs are charged to operations in the period such losses are determined. Revenues are deferred when cash has been received&#13;from the customer but the revenue has not been earned.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:RevenueRecognitionSalesOfServices>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has share-based compensation plans&#13;under which employees, consultants, suppliers and directors may be granted restricted stock, as well as options to purchase shares&#13;of Company common stock at the fair market value at the time of grant. Stock-based compensation cost is measured by the Company&#13;at the grant date, based on the fair value of the award, over the requisite service period. For options issued to employees, the&#13;Company recognizes stock compensation costs utilizing the fair value methodology over the related period of benefit.&amp;#160;&amp;#160;Grants&#13;of stock options and stock to non-employees and other parties are accounted for in accordance with the ASC 505.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Stock Based Compensation&lt;/b&gt; &amp;#8211; The&#13;Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted&#13;stock, as well as options to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based&#13;compensation cost is measured by the Company at the grant date, based on the fair value of the award, over the requisite service&#13;period. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over&#13;the related period of benefit.&amp;#160;&amp;#160;Grants of stock options and stock to non-employees and other parties are accounted for&#13;in accordance with the ASC 505.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Based upon ASC 815-15, we have adopted a sequencing&#13;approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest&#13;issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability&#13;to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with&#13;the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would&#13;result in the instrument issued latest being reclassified first.&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Convertible Securities&lt;/b&gt; &amp;#8211; Based&#13;upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will&#13;evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC&#13;815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated&#13;on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an&#13;instrument were required, it would result in the instrument issued latest being reclassified first.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Under the provisions of ASC 260, &amp;#8220;Earnings&#13;Per Share,&amp;#8221; basic loss per common share is computed by dividing net loss available to common stockholders by the weighted&#13;average number of shares of common stock outstanding for the periods presented. Diluted net loss per share reflects the potential&#13;dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock&#13;or resulted in the issuance of common stock that would then share in the income of the Company, subject to anti-dilution limitations.&#13;The common stock equivalents have not been included as they are anti-dilutive. As of September 30, 2018, there were options outstanding&#13;for the purchase of 2,182,668 common shares, warrants for the purchase of 15,473,398 common shares, 4,914,071 shares of the Company&amp;#8217;s&#13;common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, we have&#13;an unknown number of shares (9,020,264 common shares at the current price of $0.25 per share) are issuable upon conversion of&#13;convertible debentures of $2,255,066. All of which could potentially dilute future earnings per share. &amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of September 30, 2017, there were options&#13;outstanding for the purchase of 15,404 common shares, warrants for the purchase of 6,900,356 common shares, 2,825,053&amp;#160;shares&#13;of the Company&amp;#8217;s common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock&#13;and up to 332,940 shares of the Company&amp;#8217;s common stock issuable upon the exercise of placement agent warrants. In addition,&#13;the Company has an unknown number of shares are issuable upon conversion of convertible debentures of $570,000. All of which could&#13;potentially dilute future earnings per share. &amp;#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Net Loss per Share&lt;/b&gt; &amp;#8211; Under the&#13;provisions of ASC 260, &amp;#8220;Earnings Per Share,&amp;#8221; basic loss per common share is computed by dividing net loss available&#13;to common stockholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted&#13;net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were&#13;exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the&#13;Company, subject to anti-dilution limitations. As of March 31, 2019, there were options outstanding for the purchase of 2,282,668&#13;common shares, warrants for the purchase of 17,572,583 common shares, and 4,894,071&amp;#160;shares of the Company&amp;#8217;s common stock&#13;issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, the Company has an unknown&#13;number of shares (9,020,264 common shares at the current price of $0.25 per share) are issuable upon conversion of convertible&#13;debentures of $2,255,065. All of which could potentially dilute future earnings per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2018, there were options outstanding&#13;for the purchase of 4,736 common shares, warrants for the purchase of 11,837,422 common shares, 2,825,053 shares of the Company&amp;#8217;s&#13;common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, the Company&#13;has an unknown number of shares issuable upon conversion of convertible debentures of $2,390,066. All of which could potentially&#13;dilute future earnings per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <KNWN:DividendPolicy contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has never paid any cash dividends&#13;and intends, for the foreseeable future, to retain any future earnings for the development of our business. Our future dividend&#13;policy will be determined by the board of directors on the basis of various factors, including our results of operations, financial&#13;condition, capital requirements and investment opportunities.&lt;/p&gt;</KNWN:DividendPolicy>
    <KNWN:DividendPolicy contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Dividend Policy&lt;/b&gt; &amp;#8211; The Company has&#13;never paid any cash dividends and intends, for the foreseeable future, to retain any future earnings for the development of our&#13;business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our&#13;results of operations, financial condition, capital requirements and investment opportunities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</KNWN:DividendPolicy>
    <us-gaap:UseOfEstimates contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of financial statements in&#13;conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions&#13;that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of&#13;the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ&#13;from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:UseOfEstimates contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt; &amp;#8211; The preparation&#13;of financial statements in conformity with accounting principles generally accepted in the United States requires management to&#13;make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and&#13;liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#13;Actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2017-10-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In July 2015, the Financial Accounting Standards&#13;Board (FASB) issued Accounting Standards Update (ASU) 2015-11, &amp;#8220;Simplifying the Measurement of Inventory,&amp;#8221; Topic 330,&#13;&amp;#8220;Inventory&amp;#8221; (ASU 2015-11). The amendments in ASU 2015-11, which apply to inventory that is measured using any method&#13;other than the last-in, first-out (LIFO) or retail inventory method, require that entities measure inventory at the lower of cost&#13;and net realizable value. The amendments in ASU 2015-11 should be applied on a prospective basis. ASU 2015-11 is effective for&#13;fiscal years beginning after December 15, 2016 and interim periods within those years. The Company adopted the amendments of ASU&#13;2015-11 effective October 1, 2017. The adoption of this standard did not have a material impact on the Company&amp;#8217;s consolidated&#13;financial statements for the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In March 2016, the FASB issued ASU 2016-09,&#13;&amp;#8220;Improvements to Employee Share-Based Payment Accounting,&amp;#8221; Topic 718, &amp;#8220;Compensation-Stock Compensation&amp;#8221;&#13;(ASU 2016-09). ASU 2016-09 includes provisions intended to simplify various aspects related to how share-based payments are accounted&#13;for and presented in the Company&amp;#8217;s financial statements, including income tax consequences, forfeitures and classification&#13;on the statement of cash flows. Under previous guidance, excess tax benefits and deficiencies from share-based compensation arrangements&#13;were recorded in equity when the awards vested or were settled. ASU 2016-09 requires prospective recognition of excess tax benefits&#13;and deficiencies in income tax expense, rather than paid-in-capital. The Company adopted the amendments of ASU 2016-09 effective&#13;October 1, 2017.The adoption of this standard did not have a material impact on the Company&amp;#8217;s consolidated statements of&#13;income for the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition, under ASU 2016-09, excess tax income&#13;tax benefits from share-based compensation arrangements are classified as cash flow from operations, rather than as cash flow from&#13;financing activities. For the year ended September 30, 2018, there were no excess income tax benefits.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has elected to continue to estimate&#13;the number of share-based awards expected to vest, as permitted by ASU 2016-09, rather than electing to account for forfeitures&#13;as they occur.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2016-09 requires excess tax benefits and&#13;deficiencies to be prospectively excluded from assumed future proceeds in the calculation of diluted shares, resulting in an immaterial&#13;decrease in diluted weighted average shares outstanding for the year ended September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In January 2017, the FASB issued ASU 2017-04,&#13;&amp;#8220;Simplifying the Test for Goodwill Impairment,&amp;#8221; Topic 350, &amp;#8220;Intangibles &amp;#8211; Goodwill and Other&amp;#8221; (ASU&#13;2017-04). The amendments in ASU 2017-04 simplify the accounting for goodwill impairment for all entities by requiring impairment&#13;charges to be based on the first step in the current two-step impairment test. An impairment charge for the amount by which the&#13;carrying amount exceeds the reporting unit&amp;#8217;s fair value should be recognized; however, the loss recognized should not exceed&#13;the total amount of goodwill allocated to that reporting unit. The amendments should be applied on a prospective basis. Early adoption&#13;is permitted for annual and interim goodwill impairment testing dates after January 1, 2017, and the ASU is effective for the Company&amp;#8217;s&#13;first quarter of the fiscal year ending September 30, 2020. The Company is currently evaluating the impact that the adoption of&#13;these provisions will have on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2016, the FASB issued ASU 2016-02,&#13;&amp;#8220;Leases,&amp;#8221; Topic 842, &amp;#8220;Leases&amp;#8221; (ASU 2016-02). ASU No. 2016-02 requires lessees to recognize a right-of-use&#13;asset and corresponding lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation&#13;of expenses will depend on classification as a finance or operating lease. ASU 2016-02 also requires certain quantitative and qualitative&#13;disclosures. The provisions of ASU 2016-02 are effective for the Company&amp;#8217;s first quarter of the fiscal year ending September&#13;30, 2020, with early adoption permitted. The Company will apply the transition provisions of ASU 2016-02 at its adoption date,&#13;rather than the earliest comparative period presented in the financial statements, as permitted by ASU 2018-11, &amp;#8220;Leases,&amp;#8221;&#13;Topic 842, &amp;#8220;Targeted Improvements,&amp;#8221; released in July 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The adoption of ASU 2016-02 may result in a&#13;material increase to the Company&amp;#8217;s consolidated balance sheets for lease liabilities and right-of-use assets. The Company&#13;is also performing a comprehensive review of its current processes to determine and implement changes required to support the adoption&#13;of this standard. The Company is currently evaluating the other effects the adoption of ASU 2016-02 will have on its consolidated&#13;financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In January 2018, the FASB issued ASU 2018-01,&#13;&amp;#8220;Leases,&amp;#8221; Topic 842, &amp;#8220;Land Easement Practical Expedient for Transition to Topic 842&amp;#8221; (ASU 2018-01). ASU&#13;2018-01 permits an entity to elect a transition practical expedient to not assess, under Accounting Standards Codification (ASC)&#13;842, land easements that exist or expired before the standard&amp;#8217;s effective date that were not previously accounted for as&#13;leases under ASC 840. The Company plans to elect this practical expedient in implementing ASU 2016-02.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In May 2014, the FASB issued ASU 2014-09, &amp;#8220;Revenue&#13;from Contracts with Customers,&amp;#8221; Topic 606, &amp;#8220;Revenue from Contracts with Customers&amp;#8221; (ASU 2014-09). ASU 2014-09&#13;provides guidance for revenue recognition and will replace most existing revenue recognition guidance in GAAP when it becomes effective.&#13;ASU 2014-09&amp;#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers&#13;in an amount that reflects the consideration to which the company expects to be entitled for the transfer of those goods or services.&#13;ASU 2014-09 permits the use of either the retrospective or cumulative effect transition method. Additionally, the amendments in&#13;this ASU provide a practical expedient for entities to recognize the incremental costs of obtaining a contract as an expense when&#13;incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less, The Company&#13;plans to elect this practical expedient upon adoption.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In July 2015, the FASB issued ASU 2015-14, &amp;#8220;Revenue&#13;from Contracts with Customers &amp;#8211; Deferral of the Effective Date.&amp;#8221; The FASB approved the deferral of ASU 2014-09, by&#13;extending the new revenue recognition standard&amp;#8217;s mandatory effective date by one year and permitting public companies to&#13;apply the new revenue standard to annual reporting periods beginning after December 15, 2017. The guidance in ASU 2014-09 will&#13;be effective for the Company in the first quarter of the fiscal year ending September 30, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further to ASU 2014-09 and ASU 2015-14, the&#13;FASB issued ASU 2016-08, &amp;#8220;Revenue from Contracts with Customers,&amp;#8221; Topic 606, &amp;#8220;Principal versus Agent Considerations&#13;(Reporting Revenue Gross versus Net)&amp;#8221; (ASU 2016-08) in March 2016, ASU 2016-12, &amp;#8220;Revenue from Contracts with Customers,&amp;#8221;&#13;Topic 606, &amp;#8220;Narrow-Scope Improvements and Practical Expedients&amp;#8221; (ASU 2016-12) in May 2016 and ASU 2016-20, &amp;#8220;Revenue&#13;from Contracts with Customers,&amp;#8221; Topic 606, &amp;#8220;Technical Corrections and Improvements&amp;#8221; (ASU 2016-20) in December&#13;2016. The amendments in ASU 2016-08 clarify the implementation guidance on principal versus agent considerations, including indicators&#13;to assist an entity in determining whether it controls a specified good or service before it is transferred to the customers. ASU&#13;2016-12 addresses narrow-scope improvements to the guidance on collectability, non-cash consideration, and completed contracts&#13;at transition. Additionally, the amendments in this ASU provide a practical expedient for contract modifications at transition&#13;and an accounting policy election related to the presentation of sales taxes and other similar taxes collected from customers.&#13;The Company plans to make such election. The Company also plans to elect the practical expedient in ASU 2016-20 that provides entities&#13;do not need to disclose the transaction price allocated to performance obligations when the related contracts have a duration of&#13;one year or less. This includes loyalty rewards, which can be redeemed in the month subsequent to the quarter earned, and marketing&#13;promotions that cross accounting periods. Both of these classes of transactions are currently immaterial to the Company. The effective&#13;date and transition requirements for ASU 2016-08, ASU 2016-12 and ASU 2016-20 are the same as for ASU 2014-09.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company does not plan to early adopt the&#13;new revenue recognition guidance; adoption will be on the modified retrospective basis beginning in fiscal year 2019. The Company&#13;has substantially concluded its assessment of the impact of the adoption of this standard on its consolidated financial statements.&#13;Most of the Company&amp;#8217;s revenue is expected to continue to be generated from point-of-sale transactions, which ASU 2014-09&#13;treats generally consistent with current accounting standards. The Company does not expect this standard will have a material impact&#13;on the accounting for point-of-sale transactions or related areas including the right of return and customer incentives. Although&#13;the impact on the consolidated financial statements is not expected to be material, additional disclosures will be required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In June 2018, the FASB issued ASU 2018-07, &amp;#8220;Compensation-Stock&#13;Compensation,&amp;#8221; Topic 718, &amp;#8220;Improvements to Nonemployee Share-Based Payment Accounting&amp;#8221; (ASU 2018-07) as part&#13;of its Simplification Initiative to reduce complexity when accounting for share-based payments to non-employees. ASU 2018-07 expands&#13;the scope of Topic 718 to more closely align share-based payment transactions for acquiring goods and services from non-employees&#13;with the accounting for share-based payments to employees, with certain exceptions. The provisions of ASU 2018-07 are effective&#13;for the Company&amp;#8217;s first quarter of the fiscal year ending September 30, 2020, with early adoption permitted.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A variety of proposed or otherwise potential&#13;accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative&#13;and preliminary nature of those proposed standards, management has not determined whether implementation of such proposed standards&#13;would be material to the Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Estimated&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30, 2018 &amp;#160; &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid"&gt;Useful Lives&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Purchased&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Capital Leases&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 32%"&gt;&lt;font style="font-size: 8pt"&gt;Machinery and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 17%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2-10 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;332,305&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;42,681&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;374,986&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 4%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2-3 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;276,112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;276,112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2-3 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;58,051&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;95,020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;153,071&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Software and websites&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;3- 7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;35,830&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;35,830&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Less: accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(532,966&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(137,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(670,666&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;169,332&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;169,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;March 31, 2019&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Estimated Useful Lives&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Purchased&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Capital Leases&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 18%; text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: center"&gt;2-10 years&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;406,861&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;42,681&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;449,542&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;2-3 years&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;2-3 years&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,051&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,020&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;153,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;Software and websites&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;3- 7 years&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,830&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,830&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less:&amp;#160;accumulated&amp;#160;depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(579,318&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(137,701&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(717,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;197,536&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;197,536&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Estimated&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid"&gt;Useful Lives&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 47%"&gt;&lt;font style="font-size: 8pt"&gt;Technology&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 19%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;3 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;520,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Less: accumulated amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(72,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Intangible assets, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;447,778&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center"&gt;Estimated&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;March 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;Useful Lives&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 22%"&gt;Technology&lt;/td&gt;&lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: center"&gt;3 years&lt;/td&gt;&lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 19%; text-align: right"&gt;520,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 19%; text-align: right"&gt;520,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(158,888&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(72,222&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Intangible assets, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;361,112&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;447,778&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;Capital Source Business Finance Group&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;145,186&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;365,725&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Note payable to Umpqua Bank&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;199,935&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Secured note payable to J3E2A2Z LP - related party&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;600,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Total debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;145,186&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,165,660&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Less current portion of long term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(145,186&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,165,660&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Long term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"&gt;March 31,&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2019&lt;/td&gt;&lt;td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"&gt;2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 56%; font-size: 8pt; text-align: left; padding-bottom: 1pt"&gt;Capital Source Business Finance Group&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;145,186&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;Total debt&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: right"&gt;145,186&lt;/td&gt;&lt;td style="font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 1pt"&gt;Less current portion of long term debt&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"&gt;(145,186&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt"&gt;Long term debt&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 8pt; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <KNWN:SummaryOfWarrantsIssuedTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30, 2018 &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at beginning of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,900,356&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;9,276,066&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(158,026&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.507&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(544,998&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at end of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable at end of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</KNWN:SummaryOfWarrantsIssuedTableTextBlock>
    <KNWN:SummaryOfWarrantsIssuedTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;March 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 70%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at beginning of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,462,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(336,427&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(26,573&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at end of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,572,583&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.453&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at end of period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,572,583&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</KNWN:SummaryOfWarrantsIssuedTableTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30, 2018 &amp;#160; &amp;#160; &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Number of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Remaining&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Life ( In Years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13,870,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.04&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13,870,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 7%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;714,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;714,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;882,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.12&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;882,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,473,398&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="17" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;March 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Life ( In Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 23%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13,507,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13,507,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;714,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.33&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;714,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;882,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;882,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,442,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.93&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.20-1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,442,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.20-1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.34-4.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2.34-4.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;6,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;30.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,572,583&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.78&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.453&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;17,572,583&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.453&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <KNWN:WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 67%"&gt;&lt;font style="font-size: 8pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 33%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expected life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;1-2 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;125%-145%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;.0202-.0214%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</KNWN:WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock>
    <KNWN:WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 8pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 23%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expected life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;1 yr&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;125%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2.0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</KNWN:WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted Average&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Options&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise Price&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160; $&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 46%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of September 30, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;50,908&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;18.045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;918,627&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Forfeitures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(35,504&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(19.507&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(692,568&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of September 30, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15,404&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;14.675&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;226,059&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,180,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.683&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,668,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Forfeitures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(12,736&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;14.764&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(188,040&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,182,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.698&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,706,519&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;&amp;#160;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 58%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,182,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.698&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1pt solid"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,706,519&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.030&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;303,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-size: 8pt"&gt;Forfeitures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding as of March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,282,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4,009,519&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Range of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Number&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Remaining Life&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Number&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exercise Prices&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;In Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Exerciseable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 17%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;530,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.08-4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,182,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.94&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.698&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Range of&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercise Prices&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;In Years&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 20%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;0.25&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;530,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;99,375&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,150,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;143,750&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;3.03&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;4.08-4.20&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.08-4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;31,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.08-4.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;13.500&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;13.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;15.000&lt;/font&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,334&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;15.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;2,282,668&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.757&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;375,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1.755&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid"&gt;Years Ended&#13;        September 30,&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 63%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;118,190&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;85,914&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;23,498&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Beyond&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;227,602&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Years Ended March 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 86%; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;187,652&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;196,526&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,816&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Beyond&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;389,994&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;U.S. operations loss carry forward at statutory rate of 21%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(5,743,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(5,804,285&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Non-U.S. operations loss carry forward at statutory rate of 20.5%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(5,743,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(5,804,285&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Less Valuation Allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,743,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;5,804,285&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Net Deferred Tax Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Change in Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;60,445&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,036,276&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2017-10-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 64%"&gt;&lt;font style="font-size: 8pt"&gt;Federal Statutory Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Increase in Income Taxes Resulting from:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Change in Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 8pt"&gt;Effective Tax Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt double; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 3pt"&gt;&lt;font style="font-size: 8pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:AllowanceForLoanAndLeaseLossRecoveryOfBadDebts contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">60000</us-gaap:AllowanceForLoanAndLeaseLossRecoveryOfBadDebts>
    <us-gaap:AllowanceForLoanAndLeaseLossRecoveryOfBadDebts contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">60000</us-gaap:AllowanceForLoanAndLeaseLossRecoveryOfBadDebts>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">35830</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2018-09-30_custom_PurchasedMember" unitRef="USD" decimals="0">35830</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2018-09-30_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">0</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">35830</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2019-03-31_custom_PurchasedMember" unitRef="USD" decimals="0">35830</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="AsOf2019-03-31_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">0</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">153071</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2018-09-30_custom_PurchasedMember" unitRef="USD" decimals="0">58051</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2018-09-30_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">95020</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">153071</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2019-03-31_custom_PurchasedMember" unitRef="USD" decimals="0">58051</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="AsOf2019-03-31_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">95020</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">276112</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="AsOf2018-09-30_custom_PurchasedMember" unitRef="USD" decimals="0">276112</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="AsOf2018-09-30_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">0</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">276112</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="AsOf2019-03-31_custom_PurchasedMember" unitRef="USD" decimals="0">276112</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="AsOf2019-03-31_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">0</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">374986</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="AsOf2018-09-30_custom_PurchasedMember" unitRef="USD" decimals="0">332305</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="AsOf2018-09-30_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">42681</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">449542</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="AsOf2019-03-31_custom_PurchasedMember" unitRef="USD" decimals="0">406861</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="AsOf2019-03-31_us-gaap_CapitalLeaseObligationsMember" unitRef="USD" decimals="0">42681</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2018-09-30_custom_TechnologyMember" unitRef="USD" decimals="0">520000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2017-09-30_TechnologyMember" unitRef="USD" decimals="0">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2019-03-31_custom_TechnologyMember" unitRef="USD" decimals="0">520000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2018-09-30_custom_TechnologyMember" unitRef="USD" decimals="0">-72222</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2017-09-30_TechnologyMember" unitRef="USD" decimals="0">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2019-03-31_custom_TechnologyMember" unitRef="USD" decimals="0">-158888</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2017-10-01to2018-09-30_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">544998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">26573</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.250</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_custom_WarrantsOutstandingMember" unitRef="USDPShares" decimals="INF">0.250</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">15473398</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">2182668</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_StockIncentivePlanMember" unitRef="Shares" decimals="INF">534736</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices1Member" unitRef="Shares" decimals="INF">1334</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices2Member" unitRef="Shares" decimals="INF">1334</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices3Member" unitRef="Shares" decimals="INF">500000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices4Member" unitRef="Shares" decimals="INF">1150000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices5Member" unitRef="Shares" decimals="INF">530000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_Warrant2Member" unitRef="Shares" decimals="INF">714286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_Warrant3Member" unitRef="Shares" decimals="INF">882159</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_Warrant4Member" unitRef="Shares" decimals="INF">6667</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">17572583</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_WarrantOneMember" unitRef="Shares" decimals="INF">13507286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_WarrantTwoMember" unitRef="Shares" decimals="INF">714286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_WarrantThreeMember" unitRef="Shares" decimals="INF">882159</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_WarrantFourMember" unitRef="Shares" decimals="INF">2442185</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_WarrantFiveMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_WarrantSixMember" unitRef="Shares" decimals="INF">6667</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2018-09-30_custom_WarrantOneMember" unitRef="Shares" decimals="INF">13870286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices5Member" unitRef="Shares" decimals="INF">530000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices4Member" unitRef="Shares" decimals="INF">1150000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices3Member" unitRef="Shares" decimals="INF">500000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices1Member" unitRef="Shares" decimals="INF">1334</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePricesTotalMember" unitRef="Shares" decimals="INF">2282668</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices2Member" unitRef="Shares" decimals="INF">1334</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices6Member" unitRef="Shares" decimals="INF">100000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2019-03-31_custom_StockIncentivePlanMember" unitRef="Shares" decimals="INF">2282668</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30">P3Y7M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_EmployeeStockOptionMember">P4Y11M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_RangeofExercisePrices1Member">P5M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_RangeofExercisePrices2Member" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_RangeofExercisePrices3Member">P4Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_RangeofExercisePrices4Member">P4Y11M16D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_RangeofExercisePrices5Member">P4Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_Warrant2Member">P2Y9M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_Warrant3Member">P3Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_Warrant4Member">P3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31">P3Y9M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_WarrantOneMember">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_WarrantTwoMember">P2Y3M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_WarrantThreeMember">P2Y7M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_WarrantFourMember">P4Y11M5D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_WarrantFiveMember">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_WarrantOneMember">P4Y14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-10-01to2018-09-30_custom_WarrantSixMember">P3Y7M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices5Member">P4Y7M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices4Member">P4Y8M16D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices3Member">P4Y8M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices1Member">P4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices6Member">P4Y8M16D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePricesTotalMember">P4Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.326</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.698</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices1Member" unitRef="USDPShares" decimals="INF">13.5</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices2Member" unitRef="USDPShares" decimals="INF">15</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices4Member" unitRef="USDPShares" decimals="INF">1.28</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices5Member" unitRef="USDPShares" decimals="INF">0.25</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_custom_Warrant2Member" unitRef="USDPShares" decimals="INF">0.70</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_custom_Warrant3Member" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_custom_Warrant4Member" unitRef="USDPShares" decimals="INF">30.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">0.453</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_WarrantOneMember" unitRef="USDPShares" decimals="INF">0.250</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_WarrantTwoMember" unitRef="USDPShares" decimals="INF">0.700</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_WarrantThreeMember" unitRef="USDPShares" decimals="INF">1.000</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_WarrantFourMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.200</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_WarrantFourMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">1.500</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_WarrantFiveMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">2.340</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_WarrantFiveMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">4.080</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_WarrantSixMember" unitRef="USDPShares" decimals="INF">30.000</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2018-09-30_custom_WarrantOneMember" unitRef="USDPShares" decimals="INF">0.25</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices5Member" unitRef="USDPShares" decimals="INF">0.250</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices4Member" unitRef="USDPShares" decimals="INF">1.280</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices3Member_srt_MinimumMember" unitRef="USDPShares" decimals="INF">4.080</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices3Member_srt_MaximumMember" unitRef="USDPShares" decimals="INF">4.200</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices1Member" unitRef="USDPShares" decimals="INF">13.500</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_RangeofExercisePricesTotalMember" unitRef="USDPShares" decimals="INF">1.757</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices2Member" unitRef="USDPShares" decimals="INF">15.000</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices6Member" unitRef="USDPShares" decimals="INF">3.030</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">15473398</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">1334</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices1Member" unitRef="Shares" decimals="INF">1334</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices2Member" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices3Member" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices4Member" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_RangeofExercisePrices5Member" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_Warrant2Member" unitRef="Shares" decimals="INF">714286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_Warrant3Member" unitRef="Shares" decimals="INF">882159</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_Warrant4Member" unitRef="Shares" decimals="INF">6667</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">17572583</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_WarrantOneMember" unitRef="Shares" decimals="INF">13507286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_WarrantTwoMember" unitRef="Shares" decimals="INF">714286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_WarrantThreeMember" unitRef="Shares" decimals="INF">882159</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_WarrantFourMember" unitRef="Shares" decimals="INF">2442185</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_WarrantFiveMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_WarrantSixMember" unitRef="Shares" decimals="INF">6667</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2018-09-30_custom_WarrantOneMember" unitRef="Shares" decimals="INF">13870286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices5Member" unitRef="Shares" decimals="INF">99375</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices4Member" unitRef="Shares" decimals="INF">143750</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices3Member" unitRef="Shares" decimals="INF">31250</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices1Member" unitRef="Shares" decimals="INF">1334</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePricesTotalMember" unitRef="Shares" decimals="INF">375709</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices2Member" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2019-03-31_custom_RangeofExercisePrices6Member" unitRef="Shares" decimals="INF">100000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2018-09-30_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">13.5</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices1Member" unitRef="USDPShares" decimals="INF">13.5</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices2Member" unitRef="USDPShares" decimals="INF">15</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices3Member" unitRef="USDPShares" decimals="INF">0</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices4Member" unitRef="USDPShares" decimals="INF">0</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2018-09-30_custom_RangeofExercisePrices5Member" unitRef="USDPShares" decimals="INF">0</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices5Member" unitRef="USDPShares" decimals="INF">0.250</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices4Member" unitRef="USDPShares" decimals="INF">1.280</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices3Member_srt_MinimumMember" unitRef="USDPShares" decimals="INF">4.080</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices3Member_srt_MaximumMember" unitRef="USDPShares" decimals="INF">4.200</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices1Member" unitRef="USDPShares" decimals="INF">13.500</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2019-03-31_custom_RangeofExercisePricesTotalMember" unitRef="USDPShares" decimals="INF">1.755</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices2Member" unitRef="USDPShares" decimals="INF">15.00</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2 contextRef="AsOf2019-03-31_custom_RangeofExercisePrices6Member" unitRef="USDPShares" decimals="INF">3.030</KNWN:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2017-10-01to2018-09-30" unitRef="Pure" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2018-10-01to2019-03-31" unitRef="Pure" decimals="INF">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-10-01to2018-09-30_MinimumMember">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-10-01to2018-09-30_MaximumMember">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-10-01to2019-03-31">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2017-10-01to2018-09-30_MinimumMember" unitRef="Pure" decimals="INF">1.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2017-10-01to2018-09-30_MaximumMember" unitRef="Pure" decimals="INF">1.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2018-10-01to2019-03-31" unitRef="Pure" decimals="INF">1.2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2017-10-01to2018-09-30_MinimumMember" unitRef="Pure" decimals="INF">0.0202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2017-10-01to2018-09-30_MaximumMember" unitRef="Pure" decimals="INF">0.0214</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2018-10-01to2019-03-31" unitRef="Pure" decimals="INF">0.0200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.326</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2018-09-30_custom_StockIncentivePlanMember" unitRef="USDPShares" decimals="INF">1.698</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2018-09-30_custom_Warrant2Member" unitRef="USDPShares" decimals="INF">0.7</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2018-09-30_custom_Warrant3Member" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2018-09-30_custom_Warrant4Member" unitRef="USDPShares" decimals="INF">30.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">0.453</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_WarrantOneMember" unitRef="USDPShares" decimals="INF">0.250</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_WarrantTwoMember" unitRef="USDPShares" decimals="INF">0.700</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_WarrantThreeMember" unitRef="USDPShares" decimals="INF">1.000</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_WarrantFourMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.200</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_WarrantFourMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">1.500</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_WarrantFiveMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">2.340</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_WarrantFiveMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">4.080</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_WarrantSixMember" unitRef="USDPShares" decimals="INF">30.000</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2018-09-30_custom_WarrantOneMember" unitRef="USDPShares" decimals="INF">0.25</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2019-03-31_custom_StockIncentivePlanMember" unitRef="USDPShares" decimals="INF">1.757</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:DueToOtherRelatedPartiesClassifiedCurrent contextRef="AsOf2018-09-30_us-gaap_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">513149</us-gaap:DueToOtherRelatedPartiesClassifiedCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">118190</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">187652</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">85914</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">196526</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">23498</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">5816</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">227602</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">389994</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2017-10-01to2018-09-30" unitRef="USD" decimals="0">200000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2016-10-01to2017-09-30" unitRef="USD" decimals="0">0</us-gaap:RepaymentsOfNotesPayable>
    <dei:EntityRegistrantName contextRef="From2018-10-01to2019-03-31">KNOW LABS, INC.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2018-10-01to2019-03-31">0001074828</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2018-10-01to2019-03-31">S-1</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2018-10-01to2019-03-31">2019-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2018-10-01to2019-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2018-10-01to2019-03-31">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityCurrentReportingStatus contextRef="From2018-10-01to2019-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2018-10-01to2019-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2018-10-01to2019-03-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness contextRef="From2018-10-01to2019-03-31">true</dei:EntitySmallBusiness>
    <KNWN:ShareBasedCompensationWarrants contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">336835</KNWN:ShareBasedCompensationWarrants>
    <KNWN:ShareBasedCompensationWarrants contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">0</KNWN:ShareBasedCompensationWarrants>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">74556</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">86666</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2019-03-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">58411</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2019-03-31_custom_ConvertibleRedeemablePromissoryNoteMember" unitRef="USD" decimals="0">41361</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2018-09-30_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">15473398</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">17572583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-03-31_custom_WarrantsOutstandingMember" unitRef="Shares" decimals="INF">17572583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <KNWN:WarrantsVested contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">16613757</KNWN:WarrantsVested>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices5Member" unitRef="USDPShares" decimals="INF">0.250</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices4Member" unitRef="USDPShares" decimals="INF">1.280</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices3Member_srt_MinimumMember" unitRef="USDPShares" decimals="INF">4.080</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices3Member_srt_MaximumMember" unitRef="USDPShares" decimals="INF">4.200</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices1Member" unitRef="USDPShares" decimals="INF">13.500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices2Member" unitRef="USDPShares" decimals="INF">15.000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2018-10-01to2019-03-31_custom_RangeofExercisePrices6Member" unitRef="USDPShares" decimals="INF">3.030</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">1606089</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">535300</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2018-10-01to2019-03-31">P4Y8M8D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">478861</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>knwn-20190331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.26a -->
    <!-- Field: Doc-Info; Name: Source; Value: 189473 03312019 S1.xfr; Date: 2019%2D05%2D30T16:40:16Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x8014001D -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9aQ5w7xRiXgen8uOanNMSaaACcPtwZB6uYlBvml5fTkq/yQrTRk7Mi/az42mgcUF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:KNWN="http://knowlabs.co/20190331" elementFormDefault="qualified" targetNamespace="http://knowlabs.co/20190331">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://knowlabs.co/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/ConsolidatedStatementOfShareholdersEquity" id="ConsolidatedStatementOfShareholdersEquity">
	  <link:definition>00000005 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDER'S EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/Organization" id="Organization">
	  <link:definition>00000007 - Disclosure - 1. ORGANIZATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/GoingConcern" id="GoingConcern">
	  <link:definition>00000008 - Disclosure - 2. GOING CONCERN</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandards" id="SignificantAccountingPoliciesAdoptionOfAccountingStandards">
	  <link:definition>00000009 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/AccountsReceivablecustomerConcentration" id="AccountsReceivablecustomerConcentration">
	  <link:definition>00000010 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/Inventories" id="Inventories">
	  <link:definition>00000011 - Disclosure - 5. INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/NotesReceivableFromBiomedxInc" id="NotesReceivableFromBiomedxInc">
	  <link:definition>00000012 - Disclosure - 6. NOTES RECEIVABLE FROM BIOMEDX, INC</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/FixedAssets" id="FixedAssets">
	  <link:definition>00000013 - Disclosure - 7. FIXED ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/IntangibleAssets" id="IntangibleAssets">
	  <link:definition>00000014 - Disclosure - 8. INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/Goodwill" id="Goodwill">
	  <link:definition>00000015 - Disclosure - 9. GOODWILL</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/AccountsPayable" id="AccountsPayable">
	  <link:definition>00000016 - Disclosure - 10. ACCOUNTS PAYABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/DerivativeInstruments" id="DerivativeInstruments">
	  <link:definition>00000017 - Disclosure - 11. DERIVATIVE INSTRUMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/ConvertibleNotesPayable" id="ConvertibleNotesPayable">
	  <link:definition>00000018 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt" id="NotesPayableCapitalizedLeasesAndLongTermDebt">
	  <link:definition>00000019 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/Equity" id="Equity">
	  <link:definition>00000020 - Disclosure - 14. EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/StockOptions" id="StockOptions">
	  <link:definition>00000021 - Disclosure - 15. STOCK OPTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties" id="OtherSignificantTransactionsWithRelatedParties">
	  <link:definition>00000022 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings" id="CommitmentsContingenciesAndLegalProceedings">
	  <link:definition>00000023 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000024 - Disclosure - 18. INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000025 - Disclosure - 19. SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" id="SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies">
	  <link:definition>00000026 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/FixedAssetsTables" id="FixedAssetsTables">
	  <link:definition>00000027 - Disclosure - 7. FIXED ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
	  <link:definition>00000028 - Disclosure - 8. INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables" id="NotesPayableCapitalizedLeasesAndLongTermDebtTables">
	  <link:definition>00000029 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/EquityTables" id="EquityTables">
	  <link:definition>00000030 - Disclosure - 14. EQUITY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/StockOptionsTables" id="StockOptionsTables">
	  <link:definition>00000031 - Disclosure - 15. STOCK OPTIONS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables" id="CommitmentsContingenciesAndLegalProceedingsTables">
	  <link:definition>00000032 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000033 - Disclosure - 18. INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/GoingConcernDetailsNarrative" id="GoingConcernDetailsNarrative">
	  <link:definition>00000034 - Disclosure - 2. GOING CONCERN (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" id="SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative">
	  <link:definition>00000035 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/AccountsReceivablecustomerConcentrationDetailsNarrative" id="AccountsReceivablecustomerConcentrationDetailsNarrative">
	  <link:definition>00000036 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/InventoriesDetailsNarrative" id="InventoriesDetailsNarrative">
	  <link:definition>00000037 - Disclosure - 5. INVENTORIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/FixedAssetsDetails" id="FixedAssetsDetails">
	  <link:definition>00000038 - Disclosure - 7. FIXED ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/FixedAssetsDetailsNarrative" id="FixedAssetsDetailsNarrative">
	  <link:definition>00000039 - Disclosure - 7. FIXED ASSETS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/IntangibleAssetsDetails" id="IntangibleAssetsDetails">
	  <link:definition>00000040 - Disclosure - 8. INTANGIBLE ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
	  <link:definition>00000041 - Disclosure - 8. INTANGIBLE ASSETS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/GoodwillDetailsNarrative" id="GoodwillDetailsNarrative">
	  <link:definition>00000042 - Disclosure - 9. GOODWILL (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/AccountsPayableDetailsNarrative" id="AccountsPayableDetailsNarrative">
	  <link:definition>00000043 - Disclosure - 10. ACCOUNTS PAYABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/ConvertibleNotesPayableDetailsNarrative" id="ConvertibleNotesPayableDetailsNarrative">
	  <link:definition>00000044 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtDetails" id="NotesPayableCapitalizedLeasesAndLongTermDebtDetails">
	  <link:definition>00000045 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/EquityDetails" id="EquityDetails">
	  <link:definition>00000046 - Disclosure - 14. EQUITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/EquityDetails1" id="EquityDetails1">
	  <link:definition>00000047 - Disclosure - 12. EQUITY (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/EquityDetails2" id="EquityDetails2">
	  <link:definition>00000048 - Disclosure - 14. EQUITY (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/EquityDetailsNarrative" id="EquityDetailsNarrative">
	  <link:definition>00000049 - Disclosure - 14. EQUITY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/StockOptionsDetails" id="StockOptionsDetails">
	  <link:definition>00000050 - Disclosure - 15. STOCK OPTIONS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/StockOptionsDetails1" id="StockOptionsDetails1">
	  <link:definition>00000051 - Disclosure - 15. STOCK OPTIONS (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/StockOptionsDetailsNarrative" id="StockOptionsDetailsNarrative">
	  <link:definition>00000052 - Disclosure - 15. STOCK OPTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" id="OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative">
	  <link:definition>00000053 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsDetails" id="CommitmentsContingenciesAndLegalProceedingsDetails">
	  <link:definition>00000054 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
	  <link:definition>00000055 - Disclosure - 18. INCOME TAXES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://knowlabs.co/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
	  <link:definition>00000056 - Disclosure - 17. INCOME TAXES (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="knwn-20190331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="knwn-20190331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="knwn-20190331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="knwn-20190331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
    <element id="KNWN_StockCompensationExpenseEmployeeOptions" name="StockCompensationExpenseEmployeeOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues" name="SeriesDStockIssuedDuringPeriodValueNewIssues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues" name="SeriesDStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_BeneficialConversionFeature" name="BeneficialConversionFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount" name="IssuanceOfCommonStockForAccruedLiabilitiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares" name="IssuanceOfCommonStockForAccruedLiabilitiesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" name="WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ConversionOfInterest" name="ConversionOfInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ReclassificationOfDerivativeLiability" name="ReclassificationOfDerivativeLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RepaymentFromInvestment" name="RepaymentFromInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ProceedsFromConvertibleNotesPayable" name="ProceedsFromConvertibleNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_StockIssuedDuringPeriodSharesCash" name="StockIssuedDuringPeriodSharesCash" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_StockIssuedDuringPeriodValueCash" name="StockIssuedDuringPeriodValueCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_StockCompensationExpenseWarrants" name="StockCompensationExpenseWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_StockIssuedDuringPeriodSharesPatents" name="StockIssuedDuringPeriodSharesPatents" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_StockIssuedDuringPeriodValuePatents" name="StockIssuedDuringPeriodValuePatents" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_StockIssuedDuringPeriodSharesWarrantExercise" name="StockIssuedDuringPeriodSharesWarrantExercise" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_StockIssuedDuringPeriodValueWarrantExercise" name="StockIssuedDuringPeriodValueWarrantExercise" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1" name="AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_AcquisitionOfPatents" name="AcquisitionOfPatents" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RelatedPartyAccountsConvertedToNotes" name="RelatedPartyAccountsConvertedToNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_PenaltyOnNotesPayable" name="PenaltyOnNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IssuanceOfCommonStockForConversionOfLiabilities" name="IssuanceOfCommonStockForConversionOfLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" name="ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_NoncashGainOnAccountsPayable" name="NoncashGainOnAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ConvertibleNotesPayableDisclosureTextBlock" name="ConvertibleNotesPayableDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_DividendPolicy" name="DividendPolicy" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_SummaryOfWarrantsIssuedTableTextBlock" name="SummaryOfWarrantsIssuedTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" name="WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ShareBasedCompensationWarrants" name="ShareBasedCompensationWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantsVested" name="WarrantsVested" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_PurchasedMember" name="PurchasedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_TechnologyMember" name="TechnologyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_GeminiMember" name="GeminiMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_AscendiantMember" name="AscendiantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantOneMember" name="WarrantOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantTwoMember" name="WarrantTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantThreeMember" name="WarrantThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantFourMember" name="WarrantFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantFiveMember" name="WarrantFiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_SeasideMember" name="SeasideMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePricesMember" name="RangeofExercisePricesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePricesOneMember" name="RangeofExercisePricesOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePricesTwoMember" name="RangeofExercisePricesTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePricesThreeMember" name="RangeofExercisePricesThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePricesFourMember" name="RangeofExercisePricesFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePricesFiveMember" name="RangeofExercisePricesFiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_BfiFinanceCorpSecuredCreditFacilityMember" name="BfiFinanceCorpSecuredCreditFacilityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantsOutstandingMember" name="WarrantsOutstandingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ExercisePriceMember" name="ExercisePriceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ExercisePriceOneMember" name="ExercisePriceOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ExercisePriceTwoMember" name="ExercisePriceTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ExercisePriceThreeMember" name="ExercisePriceThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ExercisePriceFourMember" name="ExercisePriceFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ExercisePriceFiveMember" name="ExercisePriceFiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_StockIncentivePlanMember" name="StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantsJunePrivatePlacementMember" name="WarrantsJunePrivatePlacementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantsNovemberLicenseAgreementMember" name="WarrantsNovemberLicenseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePrices1Member" name="RangeofExercisePrices1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePrices2Member" name="RangeofExercisePrices2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePrices3Member" name="RangeofExercisePrices3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePrices4Member" name="RangeofExercisePrices4Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePrices5Member" name="RangeofExercisePrices5Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_Warrant1Member" name="Warrant1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_Warrant2Member" name="Warrant2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_Warrant3Member" name="Warrant3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantsJune2013PrivatePlacementMember" name="WarrantsJune2013PrivatePlacementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantNovember2013IdmcServicesAndLicenseAgreementMember" name="WarrantNovember2013IdmcServicesAndLicenseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ConvertibleNotePayableVisViresGroupIncMember" name="ConvertibleNotePayableVisViresGroupIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_Warrant4Member" name="Warrant4Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ConvertiblePromissoryNoteMember" name="ConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ConvertibleRedeemablePromissoryNoteMember" name="ConvertibleRedeemablePromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_WarrantSixMember" name="WarrantSixMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePricesTotalMember" name="RangeofExercisePricesTotalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_RangeofExercisePrices6Member" name="RangeofExercisePrices6Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IntangibleAssetsAbstract" name="IntangibleAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IntangibleAssetsTablesAbstract" name="IntangibleAssetsTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract" name="CommitmentsContingenciesAndLegalProceedingsTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_GoingConcernDetailsNarrativeAbstract" name="GoingConcernDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_SignificantAccountingPoliciesDetailsAbstract" name="SignificantAccountingPoliciesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_InventoriesDetailsNarrativeAbstract" name="InventoriesDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IntangibleAssetsDetailsAbstract" name="IntangibleAssetsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IntangibleAssetsDetailsNarrativeAbstract" name="IntangibleAssetsDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_GoodwillDetailsNarrativeAbstract" name="GoodwillDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_ConvertibleNotesPayableAbstract" name="ConvertibleNotesPayableAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" name="NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_EquityDetailsAbstract" name="EquityDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_AggregateIntrinsicValueAbstract" name="AggregateIntrinsicValueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract" name="CommitmentsContingenciesAndLegalProceedingsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IncomeTaxesDetailsAbstract" name="IncomeTaxesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract" name="IncomeTaxesEffectiveTaxRateDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="KNWN_IncreaseInIncomeTaxesResultingFromAbstract" name="IncreaseInIncomeTaxesResultingFromAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>knwn-20190331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.26a -->
    <!-- Field: Doc-Info; Name: Source; Value: 189473 03312019 S1.xfr; Date: 2019%2D05%2D30T16:40:16Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x8014001D -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://knowlabs.co/role/DocumentAndEntityInformation" xlink:href="knwn-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedBalanceSheets" xlink:href="knwn-20190331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="knwn-20190331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementsOfOperations" xlink:href="knwn-20190331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementOfShareholdersEquity" xlink:href="knwn-20190331.xsd#ConsolidatedStatementOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementsOfCashFlows" xlink:href="knwn-20190331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Organization" xlink:href="knwn-20190331.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoingConcern" xlink:href="knwn-20190331.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsReceivablecustomerConcentration" xlink:href="knwn-20190331.xsd#AccountsReceivablecustomerConcentration" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Inventories" xlink:href="knwn-20190331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesReceivableFromBiomedxInc" xlink:href="knwn-20190331.xsd#NotesReceivableFromBiomedxInc" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssets" xlink:href="knwn-20190331.xsd#FixedAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssets" xlink:href="knwn-20190331.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Goodwill" xlink:href="knwn-20190331.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsPayable" xlink:href="knwn-20190331.xsd#AccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/DerivativeInstruments" xlink:href="knwn-20190331.xsd#DerivativeInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConvertibleNotesPayable" xlink:href="knwn-20190331.xsd#ConvertibleNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Equity" xlink:href="knwn-20190331.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptions" xlink:href="knwn-20190331.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties" xlink:href="knwn-20190331.xsd#OtherSignificantTransactionsWithRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedings" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxes" xlink:href="knwn-20190331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SubsequentEvents" xlink:href="knwn-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsTables" xlink:href="knwn-20190331.xsd#FixedAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsTables" xlink:href="knwn-20190331.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityTables" xlink:href="knwn-20190331.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsTables" xlink:href="knwn-20190331.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedingsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesTables" xlink:href="knwn-20190331.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoingConcernDetailsNarrative" xlink:href="knwn-20190331.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:href="knwn-20190331.xsd#AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/InventoriesDetailsNarrative" xlink:href="knwn-20190331.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsDetails" xlink:href="knwn-20190331.xsd#FixedAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsDetailsNarrative" xlink:href="knwn-20190331.xsd#FixedAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsDetails" xlink:href="knwn-20190331.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsDetailsNarrative" xlink:href="knwn-20190331.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoodwillDetailsNarrative" xlink:href="knwn-20190331.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsPayableDetailsNarrative" xlink:href="knwn-20190331.xsd#AccountsPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConvertibleNotesPayableDetailsNarrative" xlink:href="knwn-20190331.xsd#ConvertibleNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails" xlink:href="knwn-20190331.xsd#EquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails1" xlink:href="knwn-20190331.xsd#EquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails2" xlink:href="knwn-20190331.xsd#EquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetailsNarrative" xlink:href="knwn-20190331.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetails" xlink:href="knwn-20190331.xsd#StockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetails1" xlink:href="knwn-20190331.xsd#StockOptionsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetailsNarrative" xlink:href="knwn-20190331.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:href="knwn-20190331.xsd#OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsDetails" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedingsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesDetails" xlink:href="knwn-20190331.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesDetails1" xlink:href="knwn-20190331.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementOfShareholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDER'S EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConversionOfInterest" xlink:label="loc_KNWNConversionOfInterest" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KNWNConversionOfInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ReclassificationOfDerivativeLiability" xlink:label="loc_KNWNReclassificationOfDerivativeLiability" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KNWNReclassificationOfDerivativeLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockCompensationExpenseWarrants" xlink:label="loc_KNWNStockCompensationExpenseWarrants" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KNWNStockCompensationExpenseWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForConversionOfLiabilities" xlink:label="loc_KNWNIssuanceOfCommonStockForConversionOfLiabilities" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KNWNIssuanceOfCommonStockForConversionOfLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" xlink:label="loc_KNWNConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KNWNConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NoncashGainOnAccountsPayable" xlink:label="loc_KNWNNoncashGainOnAccountsPayable" />
      <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KNWNNoncashGainOnAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ShareBasedCompensationWarrants" xlink:label="loc_KNWNShareBasedCompensationWarrants" />
      <link:calculationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_KNWNShareBasedCompensationWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RepaymentFromInvestment" xlink:label="loc_KNWNRepaymentFromInvestment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_KNWNRepaymentFromInvestment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ProceedsFromConvertibleNotesPayable" xlink:label="loc_KNWNProceedsFromConvertibleNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_KNWNProceedsFromConvertibleNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValueWarrantExercise" xlink:label="loc_KNWNStockIssuedDuringPeriodValueWarrantExercise" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_KNWNStockIssuedDuringPeriodValueWarrantExercise" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Organization" xlink:title="00000007 - Disclosure - 1. ORGANIZATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoingConcern" xlink:title="00000008 - Disclosure - 2. GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:title="00000009 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsReceivablecustomerConcentration" xlink:title="00000010 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Inventories" xlink:title="00000011 - Disclosure - 5. INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesReceivableFromBiomedxInc" xlink:title="00000012 - Disclosure - 6. NOTES RECEIVABLE FROM BIOMEDX, INC" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssets" xlink:title="00000013 - Disclosure - 7. FIXED ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssets" xlink:title="00000014 - Disclosure - 8. INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Goodwill" xlink:title="00000015 - Disclosure - 9. GOODWILL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsPayable" xlink:title="00000016 - Disclosure - 10. ACCOUNTS PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/DerivativeInstruments" xlink:title="00000017 - Disclosure - 11. DERIVATIVE INSTRUMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConvertibleNotesPayable" xlink:title="00000018 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:title="00000019 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Equity" xlink:title="00000020 - Disclosure - 14. EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptions" xlink:title="00000021 - Disclosure - 15. STOCK OPTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties" xlink:title="00000022 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings" xlink:title="00000023 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxes" xlink:title="00000024 - Disclosure - 18. INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SubsequentEvents" xlink:title="00000025 - Disclosure - 19. SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:title="00000026 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsTables" xlink:title="00000027 - Disclosure - 7. FIXED ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsTables" xlink:title="00000028 - Disclosure - 8. INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:title="00000029 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityTables" xlink:title="00000030 - Disclosure - 14. EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsTables" xlink:title="00000031 - Disclosure - 15. STOCK OPTIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables" xlink:title="00000032 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesTables" xlink:title="00000033 - Disclosure - 18. INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoingConcernDetailsNarrative" xlink:title="00000034 - Disclosure - 2. GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:title="00000035 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:title="00000036 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/InventoriesDetailsNarrative" xlink:title="00000037 - Disclosure - 5. INVENTORIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsDetails" xlink:title="00000038 - Disclosure - 7. FIXED ASSETS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsDetailsNarrative" xlink:title="00000039 - Disclosure - 7. FIXED ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsDetails" xlink:title="00000040 - Disclosure - 8. INTANGIBLE ASSETS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsDetailsNarrative" xlink:title="00000041 - Disclosure - 8. INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoodwillDetailsNarrative" xlink:title="00000042 - Disclosure - 9. GOODWILL (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsPayableDetailsNarrative" xlink:title="00000043 - Disclosure - 10. ACCOUNTS PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="00000044 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:title="00000045 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails" xlink:title="00000046 - Disclosure - 14. EQUITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails1" xlink:title="00000047 - Disclosure - 12. EQUITY (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails2" xlink:title="00000048 - Disclosure - 14. EQUITY (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetailsNarrative" xlink:title="00000049 - Disclosure - 14. EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetails" xlink:title="00000050 - Disclosure - 15. STOCK OPTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetails1" xlink:title="00000051 - Disclosure - 15. STOCK OPTIONS (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetailsNarrative" xlink:title="00000052 - Disclosure - 15. STOCK OPTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:title="00000053 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsDetails" xlink:title="00000054 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesDetails" xlink:title="00000055 - Disclosure - 18. INCOME TAXES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesDetails1" xlink:title="00000056 - Disclosure - 17. INCOME TAXES (Details 1)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>knwn-20190331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.26a -->
    <!-- Field: Doc-Info; Name: Source; Value: 189473 03312019 S1.xfr; Date: 2019%2D05%2D30T16:40:16Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x8014001D -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://knowlabs.co/role/DocumentAndEntityInformation" xlink:href="knwn-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedBalanceSheets" xlink:href="knwn-20190331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="knwn-20190331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementsOfOperations" xlink:href="knwn-20190331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementOfShareholdersEquity" xlink:href="knwn-20190331.xsd#ConsolidatedStatementOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementsOfCashFlows" xlink:href="knwn-20190331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Organization" xlink:href="knwn-20190331.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoingConcern" xlink:href="knwn-20190331.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsReceivablecustomerConcentration" xlink:href="knwn-20190331.xsd#AccountsReceivablecustomerConcentration" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Inventories" xlink:href="knwn-20190331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesReceivableFromBiomedxInc" xlink:href="knwn-20190331.xsd#NotesReceivableFromBiomedxInc" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssets" xlink:href="knwn-20190331.xsd#FixedAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssets" xlink:href="knwn-20190331.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Goodwill" xlink:href="knwn-20190331.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsPayable" xlink:href="knwn-20190331.xsd#AccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/DerivativeInstruments" xlink:href="knwn-20190331.xsd#DerivativeInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConvertibleNotesPayable" xlink:href="knwn-20190331.xsd#ConvertibleNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Equity" xlink:href="knwn-20190331.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptions" xlink:href="knwn-20190331.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties" xlink:href="knwn-20190331.xsd#OtherSignificantTransactionsWithRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedings" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxes" xlink:href="knwn-20190331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SubsequentEvents" xlink:href="knwn-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsTables" xlink:href="knwn-20190331.xsd#FixedAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsTables" xlink:href="knwn-20190331.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityTables" xlink:href="knwn-20190331.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsTables" xlink:href="knwn-20190331.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedingsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesTables" xlink:href="knwn-20190331.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoingConcernDetailsNarrative" xlink:href="knwn-20190331.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:href="knwn-20190331.xsd#AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/InventoriesDetailsNarrative" xlink:href="knwn-20190331.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsDetails" xlink:href="knwn-20190331.xsd#FixedAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsDetailsNarrative" xlink:href="knwn-20190331.xsd#FixedAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsDetails" xlink:href="knwn-20190331.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsDetailsNarrative" xlink:href="knwn-20190331.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoodwillDetailsNarrative" xlink:href="knwn-20190331.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsPayableDetailsNarrative" xlink:href="knwn-20190331.xsd#AccountsPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConvertibleNotesPayableDetailsNarrative" xlink:href="knwn-20190331.xsd#ConvertibleNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails" xlink:href="knwn-20190331.xsd#EquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails1" xlink:href="knwn-20190331.xsd#EquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails2" xlink:href="knwn-20190331.xsd#EquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetailsNarrative" xlink:href="knwn-20190331.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetails" xlink:href="knwn-20190331.xsd#StockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetails1" xlink:href="knwn-20190331.xsd#StockOptionsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetailsNarrative" xlink:href="knwn-20190331.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:href="knwn-20190331.xsd#OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsDetails" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedingsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesDetails" xlink:href="knwn-20190331.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesDetails1" xlink:href="knwn-20190331.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesDPreferredStockMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_130" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseCurrent_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryNet_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_130" xlink:to="loc_us-gaapOtherAssetsAbstract_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherAssetsAbstract_130" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherAssetsAbstract_130" xlink:to="loc_us-gaapOtherAssetsNoncurrent_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherAssetsAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableTradeCurrent_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenue_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapConvertibleNotesPayable_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapNotesPayableCurrent_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommitmentsAndContingencies_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="32" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesDPreferredStockMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementOfShareholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDER'S EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapSeriesDPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockCompensationExpenseEmployeeOptions" xlink:label="loc_KNWNStockCompensationExpenseEmployeeOptions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockCompensationExpenseEmployeeOptions_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_KNWNSeriesDStockIssuedDuringPeriodValueNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNSeriesDStockIssuedDuringPeriodValueNewIssues_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_KNWNSeriesDStockIssuedDuringPeriodSharesNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNSeriesDStockIssuedDuringPeriodSharesNewIssues_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_BeneficialConversionFeature" xlink:label="loc_KNWNBeneficialConversionFeature_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNBeneficialConversionFeature_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount" xlink:label="loc_KNWNIssuanceOfCommonStockForAccruedLiabilitiesAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNIssuanceOfCommonStockForAccruedLiabilitiesAmount_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares" xlink:label="loc_KNWNIssuanceOfCommonStockForAccruedLiabilitiesShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNIssuanceOfCommonStockForAccruedLiabilitiesShares_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValueCash" xlink:label="loc_KNWNStockIssuedDuringPeriodValueCash_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodValueCash_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesCash" xlink:label="loc_KNWNStockIssuedDuringPeriodSharesCash_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodSharesCash_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockCompensationExpenseWarrants" xlink:label="loc_KNWNStockCompensationExpenseWarrants_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockCompensationExpenseWarrants_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValuePatents" xlink:label="loc_KNWNStockIssuedDuringPeriodValuePatents_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodValuePatents_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesPatents" xlink:label="loc_KNWNStockIssuedDuringPeriodSharesPatents_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodSharesPatents_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValueWarrantExercise" xlink:label="loc_KNWNStockIssuedDuringPeriodValueWarrantExercise_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodValueWarrantExercise_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesWarrantExercise" xlink:label="loc_KNWNStockIssuedDuringPeriodSharesWarrantExercise_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodSharesWarrantExercise_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" xlink:label="loc_KNWNWriteOffOfDerivativeLiabilityToAdditionalPaidInCapital_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNWriteOffOfDerivativeLiabilityToAdditionalPaidInCapital_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Organization" xlink:title="00000007 - Disclosure - 1. ORGANIZATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoingConcern" xlink:title="00000008 - Disclosure - 2. GOING CONCERN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:title="00000009 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsReceivablecustomerConcentration" xlink:title="00000010 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Inventories" xlink:title="00000011 - Disclosure - 5. INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesReceivableFromBiomedxInc" xlink:title="00000012 - Disclosure - 6. NOTES RECEIVABLE FROM BIOMEDX, INC" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssets" xlink:title="00000013 - Disclosure - 7. FIXED ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssets" xlink:title="00000014 - Disclosure - 8. INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Goodwill" xlink:title="00000015 - Disclosure - 9. GOODWILL" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsPayable" xlink:title="00000016 - Disclosure - 10. ACCOUNTS PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/DerivativeInstruments" xlink:title="00000017 - Disclosure - 11. DERIVATIVE INSTRUMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConvertibleNotesPayable" xlink:title="00000018 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:title="00000019 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Equity" xlink:title="00000020 - Disclosure - 14. EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptions" xlink:title="00000021 - Disclosure - 15. STOCK OPTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties" xlink:title="00000022 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings" xlink:title="00000023 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxes" xlink:title="00000024 - Disclosure - 18. INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SubsequentEvents" xlink:title="00000025 - Disclosure - 19. SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:title="00000026 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsTables" xlink:title="00000027 - Disclosure - 7. FIXED ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsTables" xlink:title="00000028 - Disclosure - 8. INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:title="00000029 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityTables" xlink:title="00000030 - Disclosure - 14. EQUITY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsTables" xlink:title="00000031 - Disclosure - 15. STOCK OPTIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables" xlink:title="00000032 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesTables" xlink:title="00000033 - Disclosure - 18. INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoingConcernDetailsNarrative" xlink:title="00000034 - Disclosure - 2. GOING CONCERN (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:title="00000035 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryValuationReserves_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_140" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:title="00000036 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/InventoriesDetailsNarrative" xlink:title="00000037 - Disclosure - 5. INVENTORIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsDetails" xlink:title="00000038 - Disclosure - 7. FIXED ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_PurchasedMember" xlink:label="loc_KNWNPurchasedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_KNWNPurchasedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsMember" xlink:label="loc_us-gaapCapitalLeaseObligationsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapCapitalLeaseObligationsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="loc_us-gaapMachineryAndEquipmentGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMachineryAndEquipmentGross_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaapLeaseholdImprovementsGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseholdImprovementsGross_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaapFurnitureAndFixturesGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFurnitureAndFixturesGross_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsDetailsNarrative" xlink:title="00000039 - Disclosure - 7. FIXED ASSETS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsDetails" xlink:title="00000040 - Disclosure - 8. INTANGIBLE ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_TechnologyMember" xlink:label="loc_KNWNTechnologyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_KNWNTechnologyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsDetailsNarrative" xlink:title="00000041 - Disclosure - 8. INTANGIBLE ASSETS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoodwillDetailsNarrative" xlink:title="00000042 - Disclosure - 9. GOODWILL (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsPayableDetailsNarrative" xlink:title="00000043 - Disclosure - 10. ACCOUNTS PAYABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="00000044 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertiblePromissoryNoteMember" xlink:label="loc_KNWNConvertiblePromissoryNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_KNWNConvertiblePromissoryNoteMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertibleRedeemablePromissoryNoteMember" xlink:label="loc_KNWNConvertibleRedeemablePromissoryNoteMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_KNWNConvertibleRedeemablePromissoryNoteMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="loc_us-gaapDepositLiabilitiesAccruedInterest_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositLiabilitiesAccruedInterest_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:title="00000045 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails" xlink:title="00000046 - Disclosure - 14. EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantsOutstandingMember" xlink:label="loc_KNWNWarrantsOutstandingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_KNWNWarrantsOutstandingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails1" xlink:title="00000047 - Disclosure - 12. EQUITY (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantOneMember" xlink:label="loc_KNWNWarrantOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantTwoMember" xlink:label="loc_KNWNWarrantTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantThreeMember" xlink:label="loc_KNWNWarrantThreeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantThreeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantFourMember" xlink:label="loc_KNWNWarrantFourMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantFourMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantFiveMember" xlink:label="loc_KNWNWarrantFiveMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantFiveMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantSixMember" xlink:label="loc_KNWNWarrantSixMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantSixMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant2Member" xlink:label="loc_KNWNWarrant2Member_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrant2Member_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant3Member" xlink:label="loc_KNWNWarrant3Member_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrant3Member_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant4Member" xlink:label="loc_KNWNWarrant4Member_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrant4Member_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_300" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_300" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_300" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_300" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_300" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails2" xlink:title="00000048 - Disclosure - 14. EQUITY (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetailsNarrative" xlink:title="00000049 - Disclosure - 14. EQUITY (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetails" xlink:title="00000050 - Disclosure - 15. STOCK OPTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_AggregateIntrinsicValueAbstract" xlink:label="loc_KNWNAggregateIntrinsicValueAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNAggregateIntrinsicValueAbstract_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract_50" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_50" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetails1" xlink:title="00000051 - Disclosure - 15. STOCK OPTIONS (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices5Member" xlink:label="loc_KNWNRangeofExercisePrices5Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices5Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices4Member" xlink:label="loc_KNWNRangeofExercisePrices4Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices4Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices3Member" xlink:label="loc_KNWNRangeofExercisePrices3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices1Member" xlink:label="loc_KNWNRangeofExercisePrices1Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices1Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices2Member" xlink:label="loc_KNWNRangeofExercisePrices2Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices2Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices6Member" xlink:label="loc_KNWNRangeofExercisePrices6Member_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices6Member_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesTotalMember" xlink:label="loc_KNWNRangeofExercisePricesTotalMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePricesTotalMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_310" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_310" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_310" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_310" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_310" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" xlink:label="loc_KNWNSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2_310" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetailsNarrative" xlink:title="00000052 - Disclosure - 15. STOCK OPTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIncentivePlanMember" xlink:label="loc_KNWNStockIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_KNWNStockIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_80" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:title="00000053 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapDueToOtherRelatedPartiesClassifiedCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToOtherRelatedPartiesClassifiedCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsDetails" xlink:title="00000054 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesDetails" xlink:title="00000055 - Disclosure - 18. INCOME TAXES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesDetails1" xlink:title="00000056 - Disclosure - 17. INCOME TAXES (Details 1)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>knwn-20190331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.26a -->
    <!-- Field: Doc-Info; Name: Source; Value: 189473 03312019 S1.xfr; Date: 2019%2D05%2D30T16:40:16Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x8014001D -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_PurchasedMember" xlink:label="KNWN_PurchasedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_PurchasedMember" xlink:to="KNWN_PurchasedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_PurchasedMember_lbl" xml:lang="en-US">Purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsMember" xlink:label="us-gaap_CapitalLeaseObligationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsMember" xlink:to="us-gaap_CapitalLeaseObligationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsMember_lbl" xml:lang="en-US">Capital Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_TechnologyMember" xlink:label="KNWN_TechnologyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_TechnologyMember" xlink:to="KNWN_TechnologyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_TechnologyMember_lbl" xml:lang="en-US">Technology [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantsOutstandingMember" xlink:label="KNWN_WarrantsOutstandingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantsOutstandingMember" xlink:to="KNWN_WarrantsOutstandingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WarrantsOutstandingMember_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIncentivePlanMember" xlink:label="KNWN_StockIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIncentivePlanMember" xlink:to="KNWN_StockIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockIncentivePlanMember_lbl" xml:lang="en-US">2011 Stock Incentive Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices1Member" xlink:label="KNWN_RangeofExercisePrices1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePrices1Member" xlink:to="KNWN_RangeofExercisePrices1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RangeofExercisePrices1Member_lbl" xml:lang="en-US">Exercise Price 13.500</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices2Member" xlink:label="KNWN_RangeofExercisePrices2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePrices2Member" xlink:to="KNWN_RangeofExercisePrices2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RangeofExercisePrices2Member_lbl" xml:lang="en-US">Exercise Price 15.000</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices3Member" xlink:label="KNWN_RangeofExercisePrices3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePrices3Member" xlink:to="KNWN_RangeofExercisePrices3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RangeofExercisePrices3Member_lbl" xml:lang="en-US">Exercise Price 4.08-4.20</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices4Member" xlink:label="KNWN_RangeofExercisePrices4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePrices4Member" xlink:to="KNWN_RangeofExercisePrices4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RangeofExercisePrices4Member_lbl" xml:lang="en-US">Exercise Price 1.28</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices5Member" xlink:label="KNWN_RangeofExercisePrices5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePrices5Member" xlink:to="KNWN_RangeofExercisePrices5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RangeofExercisePrices5Member_lbl" xml:lang="en-US">Exercise Price 0.25</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant2Member" xlink:label="KNWN_Warrant2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_Warrant2Member" xlink:to="KNWN_Warrant2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_Warrant2Member_lbl" xml:lang="en-US">Warrant 2</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant3Member" xlink:label="KNWN_Warrant3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_Warrant3Member" xlink:to="KNWN_Warrant3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_Warrant3Member_lbl" xml:lang="en-US">Warrant 3</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Series C Convertible Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementEquityComponentsAxis_2_lbl" xml:lang="en-US">StatementEquityComponents [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="us-gaap_SeriesDPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesDPreferredStockMember" xlink:to="us-gaap_SeriesDPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesDPreferredStockMember_lbl" xml:lang="en-US">Series D Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant4Member" xlink:label="KNWN_Warrant4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_Warrant4Member" xlink:to="KNWN_Warrant4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_Warrant4Member_lbl" xml:lang="en-US">Warrant 4</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="us-gaap_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChiefExecutiveOfficerMember" xlink:to="us-gaap_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertiblePromissoryNoteMember" xlink:label="KNWN_ConvertiblePromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ConvertiblePromissoryNoteMember" xlink:to="KNWN_ConvertiblePromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_ConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Convertible Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertibleRedeemablePromissoryNoteMember" xlink:label="KNWN_ConvertibleRedeemablePromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ConvertibleRedeemablePromissoryNoteMember" xlink:to="KNWN_ConvertibleRedeemablePromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_ConvertibleRedeemablePromissoryNoteMember_lbl" xml:lang="en-US">Convertible Redeemable Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantOneMember" xlink:label="KNWN_WarrantOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantOneMember" xlink:to="KNWN_WarrantOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WarrantOneMember_lbl" xml:lang="en-US">Warrant One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantTwoMember" xlink:label="KNWN_WarrantTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantTwoMember" xlink:to="KNWN_WarrantTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WarrantTwoMember_lbl" xml:lang="en-US">Warrant Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantThreeMember" xlink:label="KNWN_WarrantThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantThreeMember" xlink:to="KNWN_WarrantThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WarrantThreeMember_lbl" xml:lang="en-US">Warrant Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantFourMember" xlink:label="KNWN_WarrantFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantFourMember" xlink:to="KNWN_WarrantFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WarrantFourMember_lbl" xml:lang="en-US">Warrant Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantFiveMember" xlink:label="KNWN_WarrantFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantFiveMember" xlink:to="KNWN_WarrantFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WarrantFiveMember_lbl" xml:lang="en-US">Warrant Five [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantSixMember" xlink:label="KNWN_WarrantSixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantSixMember" xlink:to="KNWN_WarrantSixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WarrantSixMember_lbl" xml:lang="en-US">Warrant Six [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesTotalMember" xlink:label="KNWN_RangeofExercisePricesTotalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePricesTotalMember" xlink:to="KNWN_RangeofExercisePricesTotalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RangeofExercisePricesTotalMember_lbl" xml:lang="en-US">Exercise Price Total</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices6Member" xlink:label="KNWN_RangeofExercisePrices6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePrices6Member" xlink:to="KNWN_RangeofExercisePrices6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RangeofExercisePrices6Member_lbl" xml:lang="en-US">Exercise Price 3.03</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_DocumentAndEntityInformationAbstract" xlink:label="KNWN_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_DocumentAndEntityInformationAbstract" xlink:to="KNWN_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net of allowance of $60,000 and $60,000, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="us-gaap_OtherAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">OTHER ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Accounts payable - trade</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xml:lang="en-US">Accounts payable - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Accrued expenses - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Convertible notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable - current portion of long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for Accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_2_lbl" xml:lang="en-US">EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">COST OF SALES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">GROSS PROFIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">RESEARCH AND DEVELOPMENT EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">SELLING, GENERAL AND ADMINISTRATIVE EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">IMPAIRMENT OF GOODWILL</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">OPERATING LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">OTHER INCOME (EXPENSE):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">(Loss) on change - derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on debt settlements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">(LOSS) BEFORE INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes - current provision</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET (LOSS)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Basic and diluted loss per common share attributable to Visualant, Inc. and subsidiaries common shareholders-</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average shares of common stock outstanding- basic and diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning Balance, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Beginning Balance, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockCompensationExpenseEmployeeOptions" xlink:label="KNWN_StockCompensationExpenseEmployeeOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockCompensationExpenseEmployeeOptions" xlink:to="KNWN_StockCompensationExpenseEmployeeOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockCompensationExpenseEmployeeOptions_lbl" xml:lang="en-US">Stock compensation expense - employee options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock for services, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock for services, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues" xlink:label="KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues" xlink:to="KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of Series D Convertible Preferred Stock, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues" xlink:label="KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues" xlink:to="KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of Series D Convertible Preferred Stock, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_BeneficialConversionFeature" xlink:label="KNWN_BeneficialConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_BeneficialConversionFeature" xlink:to="KNWN_BeneficialConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_BeneficialConversionFeature_lbl" xml:lang="en-US">Benefical conversion feature of Preferred Stock/dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount" xlink:label="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount" xlink:to="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount_lbl" xml:lang="en-US">Issuance of common stock for conversion of liabilities, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares" xlink:label="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares" xlink:to="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares_lbl" xml:lang="en-US">Issuance of common stock for conversion of liabilities, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValueCash" xlink:label="KNWN_StockIssuedDuringPeriodValueCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIssuedDuringPeriodValueCash" xlink:to="KNWN_StockIssuedDuringPeriodValueCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockIssuedDuringPeriodValueCash_lbl" xml:lang="en-US">Issuance of common stock for cash, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesCash" xlink:label="KNWN_StockIssuedDuringPeriodSharesCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIssuedDuringPeriodSharesCash" xlink:to="KNWN_StockIssuedDuringPeriodSharesCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockIssuedDuringPeriodSharesCash_lbl" xml:lang="en-US">Issuance of common stock for cash, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockCompensationExpenseWarrants" xlink:label="KNWN_StockCompensationExpenseWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockCompensationExpenseWarrants" xlink:to="KNWN_StockCompensationExpenseWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockCompensationExpenseWarrants_lbl" xml:lang="en-US">Stock based compensation- warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValuePatents" xlink:label="KNWN_StockIssuedDuringPeriodValuePatents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIssuedDuringPeriodValuePatents" xlink:to="KNWN_StockIssuedDuringPeriodValuePatents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockIssuedDuringPeriodValuePatents_lbl" xml:lang="en-US">Acquisition of patent, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesPatents" xlink:label="KNWN_StockIssuedDuringPeriodSharesPatents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIssuedDuringPeriodSharesPatents" xlink:to="KNWN_StockIssuedDuringPeriodSharesPatents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockIssuedDuringPeriodSharesPatents_lbl" xml:lang="en-US">Acquisition of patent, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValueWarrantExercise" xlink:label="KNWN_StockIssuedDuringPeriodValueWarrantExercise" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIssuedDuringPeriodValueWarrantExercise" xlink:to="KNWN_StockIssuedDuringPeriodValueWarrantExercise_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockIssuedDuringPeriodValueWarrantExercise_lbl" xml:lang="en-US">Issuance of common stock for warrant exercise, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesWarrantExercise" xlink:label="KNWN_StockIssuedDuringPeriodSharesWarrantExercise" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIssuedDuringPeriodSharesWarrantExercise" xlink:to="KNWN_StockIssuedDuringPeriodSharesWarrantExercise_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_StockIssuedDuringPeriodSharesWarrantExercise_lbl" xml:lang="en-US">Issuance of common stock for warrant exercise, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Conversion of Series A Convertible Preferred Stock, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Conversion of Series A Convertible Preferred Stock, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" xlink:label="KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" xlink:to="KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital_lbl" xml:lang="en-US">Write-off of derivative liability to additional paid in capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending Balance, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_2_lbl" xml:lang="en-US">Ending Balance, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash (used in) operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Issuance of capital stock for services and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ShareBasedCompensationWarrants" xlink:label="KNWN_ShareBasedCompensationWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ShareBasedCompensationWarrants" xlink:to="KNWN_ShareBasedCompensationWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="KNWN_ShareBasedCompensationWarrants_lbl" xml:lang="en-US">Stock based compensation- warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConversionOfInterest" xlink:label="KNWN_ConversionOfInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ConversionOfInterest" xlink:to="KNWN_ConversionOfInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_ConversionOfInterest_lbl" xml:lang="en-US">Conversion of interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation- stock option grants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">(Loss) on sale of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Loss on change - derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ReclassificationOfDerivativeLiability" xlink:label="KNWN_ReclassificationOfDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ReclassificationOfDerivativeLiability" xlink:to="KNWN_ReclassificationOfDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_ReclassificationOfDerivativeLiability_lbl" xml:lang="en-US">Reclassification of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" xlink:label="KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" xlink:to="KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable_lbl" xml:lang="en-US">Conversion of accrued liabilites- related parties to convertible notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_lbl" xml:lang="en-US">Provision on loss on accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForConversionOfLiabilities" xlink:label="KNWN_IssuanceOfCommonStockForConversionOfLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IssuanceOfCommonStockForConversionOfLiabilities" xlink:to="KNWN_IssuanceOfCommonStockForConversionOfLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_IssuanceOfCommonStockForConversionOfLiabilities_lbl" xml:lang="en-US">Issuance of common stock for conversion of liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NoncashGainOnAccountsPayable" xlink:label="KNWN_NoncashGainOnAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_NoncashGainOnAccountsPayable" xlink:to="KNWN_NoncashGainOnAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_NoncashGainOnAccountsPayable_lbl" xml:lang="en-US">Non-cash gain on accounts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillImpairmentLoss_2_lbl" xml:lang="en-US">Impairment of goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Bad debt expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable - trade and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH (USED IN) OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Investment in research and development equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Investment in BioMedx, Inc., net</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RepaymentFromInvestment" xlink:label="KNWN_RepaymentFromInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RepaymentFromInvestment" xlink:to="KNWN_RepaymentFromInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RepaymentFromInvestment_lbl" xml:lang="en-US">Proceeds from investment in BioMedx, Inc,</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">(Repayments) proceeds from line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ProceedsFromConvertibleNotesPayable" xlink:label="KNWN_ProceedsFromConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ProceedsFromConvertibleNotesPayable" xlink:to="KNWN_ProceedsFromConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_ProceedsFromConvertibleNotesPayable_lbl" xml:lang="en-US">Proceeds from convertible notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of common/preferred stock, net of costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIssuedDuringPeriodValueWarrantExercise" xlink:to="KNWN_StockIssuedDuringPeriodValueWarrantExercise_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="KNWN_StockIssuedDuringPeriodValueWarrantExercise_2_lbl" xml:lang="en-US">Issuance of common stock for warrant exercise</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xml:lang="en-US">Repayment of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1" xlink:label="KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1" xlink:to="KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1_lbl" xml:lang="en-US">Beneficial conversion feature</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Conversion of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xml:lang="en-US">Beneficial conversion feature</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockAmountConverted1_2_lbl" xml:lang="en-US">Conversion of convertible debt to preferred shares</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RelatedPartyAccountsConvertedToNotes" xlink:label="KNWN_RelatedPartyAccountsConvertedToNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RelatedPartyAccountsConvertedToNotes" xlink:to="KNWN_RelatedPartyAccountsConvertedToNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_RelatedPartyAccountsConvertedToNotes_lbl" xml:lang="en-US">Related party accounts converted to notes</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_AcquisitionOfPatents" xlink:label="KNWN_AcquisitionOfPatents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_AcquisitionOfPatents" xlink:to="KNWN_AcquisitionOfPatents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_AcquisitionOfPatents_lbl" xml:lang="en-US">Acquisition of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_PenaltyOnNotesPayable" xlink:label="KNWN_PenaltyOnNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_PenaltyOnNotesPayable" xlink:to="KNWN_PenaltyOnNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_PenaltyOnNotesPayable_lbl" xml:lang="en-US">Penalty on notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="KNWN_NotesToFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_NotesToFinancialStatementsAbstract" xlink:to="KNWN_NotesToFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_NotesToFinancialStatementsAbstract_lbl" xml:lang="en-US">Notes to Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">GOING CONCERN</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">NOTES RECEIVABLE FROM BIOMEDX, INC</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">FIXED ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IntangibleAssetsAbstract" xlink:label="KNWN_IntangibleAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IntangibleAssetsAbstract" xlink:to="KNWN_IntangibleAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_IntangibleAssetsAbstract_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US">GOODWILL</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertibleNotesPayableDisclosureTextBlock" xlink:label="KNWN_ConvertibleNotesPayableDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ConvertibleNotesPayableDisclosureTextBlock" xlink:to="KNWN_ConvertibleNotesPayableDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_ConvertibleNotesPayableDisclosureTextBlock_lbl" xml:lang="en-US">CONVERTIBLE NOTES PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:to="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_lbl" xml:lang="en-US">NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">STOCK OPTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">PRINCIPLES OF CONSOLIDATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">LONG-LIVED ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">RESEARCH, DEVELOPMENT, AND ENGINEERING EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness" xlink:label="us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness" xlink:to="us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness_lbl" xml:lang="en-US">DERIVATIVE FINANCIAL INSTRUMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionSalesOfServices" xlink:label="us-gaap_RevenueRecognitionSalesOfServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionSalesOfServices" xlink:to="us-gaap_RevenueRecognitionSalesOfServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionSalesOfServices_lbl" xml:lang="en-US">REVENUE RECOGNITION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">STOCK BASED COMPENSATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">CONVERTIBLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">NET LOSS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_DividendPolicy" xlink:label="KNWN_DividendPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_DividendPolicy" xlink:to="KNWN_DividendPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_DividendPolicy_lbl" xml:lang="en-US">DIVIDEND POLICY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">USE OF ESTIMATES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IntangibleAssetsTablesAbstract" xlink:label="KNWN_IntangibleAssetsTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IntangibleAssetsTablesAbstract" xlink:to="KNWN_IntangibleAssetsTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="KNWN_IntangibleAssetsTablesAbstract_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Notes payable, capitalized leases and long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SummaryOfWarrantsIssuedTableTextBlock" xlink:label="KNWN_SummaryOfWarrantsIssuedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_SummaryOfWarrantsIssuedTableTextBlock" xlink:to="KNWN_SummaryOfWarrantsIssuedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_SummaryOfWarrantsIssuedTableTextBlock_lbl" xml:lang="en-US">Summary of the warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Summary of the status of the warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" xlink:label="KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" xlink:to="KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock_lbl" xml:lang="en-US">Weighted average assumptions relating to the valuation of the Companys warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Stock option activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_lbl" xml:lang="en-US">Stock options outstanding and exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract" xlink:label="KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract" xlink:to="KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract_lbl" xml:lang="en-US">Commitments Contingencies And Legal Proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Future minimum lease payments under non-cancelable operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of components of the Company&#8217;s deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of effective tax rate reconciliation</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_GoingConcernDetailsNarrativeAbstract" xlink:label="KNWN_GoingConcernDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_GoingConcernDetailsNarrativeAbstract" xlink:to="KNWN_GoingConcernDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_GoingConcernDetailsNarrativeAbstract_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Reserve for impaired inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated useful lives of assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Accounts receivable, net of allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts" xlink:label="us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts" xlink:to="us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts_lbl" xml:lang="en-US">Allowance for bad debt</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_InventoriesDetailsNarrativeAbstract" xlink:label="KNWN_InventoriesDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_InventoriesDetailsNarrativeAbstract" xlink:to="KNWN_InventoriesDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_InventoriesDetailsNarrativeAbstract_lbl" xml:lang="en-US">Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="us-gaap_MachineryAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentGross" xlink:to="us-gaap_MachineryAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentGross_lbl" xml:lang="en-US">Machinery and equipment (2-10 years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="us-gaap_LeaseholdImprovementsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US">Leasehold improvements (5-20 years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="us-gaap_FurnitureAndFixturesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US">Furniture and fixtures (3-10 years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="us-gaap_CapitalizedComputerSoftwareGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareGross" xlink:to="us-gaap_CapitalizedComputerSoftwareGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareGross_lbl" xml:lang="en-US">Software and websites (3- 7 years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xml:lang="en-US">Loss on sale of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IntangibleAssetsDetailsNarrativeAbstract" xlink:label="KNWN_IntangibleAssetsDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IntangibleAssetsDetailsNarrativeAbstract" xlink:to="KNWN_IntangibleAssetsDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="KNWN_IntangibleAssetsDetailsNarrativeAbstract_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_GoodwillDetailsNarrativeAbstract" xlink:label="KNWN_GoodwillDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_GoodwillDetailsNarrativeAbstract" xlink:to="KNWN_GoodwillDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_GoodwillDetailsNarrativeAbstract_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableTradeCurrent_2_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:label="KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:to="KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract_lbl" xml:lang="en-US">Notes Payable Capitalized Leases And Long Term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Capital Source&#160;Business&#160;Finance&#160;Group</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableToBank" xlink:label="us-gaap_NotesPayableToBank" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableToBank" xlink:to="us-gaap_NotesPayableToBank_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableToBank_lbl" xml:lang="en-US">Note payable to Umpqua Bank</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Secured note payable to J3E2A2Z LP - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Total debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NotesPayableCurrent_2_lbl" xml:lang="en-US">Less current portion of long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exerciseable at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US">Weighted Average Exercise Price:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Outstanding at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Number of Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Life (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US">Weighted Average Exercise Price, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Shares Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Weighted Average Exercise Price, exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantsVested" xlink:label="KNWN_WarrantsVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantsVested" xlink:to="KNWN_WarrantsVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_WarrantsVested_lbl" xml:lang="en-US">Warrants vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2_lbl" xml:lang="en-US">Shares:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Shares granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Shares exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Shares forfeitures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Shares granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Shares exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Shares forfeitures</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_AggregateIntrinsicValueAbstract" xlink:label="KNWN_AggregateIntrinsicValueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_AggregateIntrinsicValueAbstract" xlink:to="KNWN_AggregateIntrinsicValueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_AggregateIntrinsicValueAbstract_lbl" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding, Forefeitures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding, End</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Range of Exercise Prices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_2_lbl" xml:lang="en-US">Number of Outstanding Stock Options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_2_lbl" xml:lang="en-US">Weighted Average Exercise Price Exerciseable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_2_lbl" xml:lang="en-US">Number Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" xlink:label="KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" xlink:to="KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2_lbl" xml:lang="en-US">Weighted Average Exercise Price Exerciseable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_3_lbl" xml:lang="en-US">Options to purchase common stock under 2011 Stock Incentive Plan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2_lbl" xml:lang="en-US">Average exercise price under 2011 Stock Incentive Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Period for recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Exercisable at end of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Stock options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xml:lang="en-US">Accrued liabilities related parties from advances</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:label="KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:to="KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract_lbl" xml:lang="en-US">Commitments Contingencies And Legal Proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xml:lang="en-US">Beyond</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IncomeTaxesDetailsAbstract" xlink:label="KNWN_IncomeTaxesDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IncomeTaxesDetailsAbstract" xlink:to="KNWN_IncomeTaxesDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_IncomeTaxesDetailsAbstract_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">U.S. operations loss carry forward at statutory rate of 34%</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Non-U.S. operations loss carry forward at statutory rate of 20.5%</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net Deferred Tax Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract" xlink:label="KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract" xlink:to="KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal Statutory Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IncreaseInIncomeTaxesResultingFromAbstract" xlink:label="KNWN_IncreaseInIncomeTaxesResultingFromAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IncreaseInIncomeTaxesResultingFromAbstract" xlink:to="KNWN_IncreaseInIncomeTaxesResultingFromAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_IncreaseInIncomeTaxesResultingFromAbstract_lbl" xml:lang="en-US">Increase in Income Taxes Resulting from:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective Tax Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_AggregateIntrinsicValueAbstract" xlink:to="KNWN_AggregateIntrinsicValueAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_AggregateIntrinsicValueAbstract_doc" xml:lang="en-US">Aggregate intrinsic value abstract</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_AscendiantMember" xlink:label="KNWN_AscendiantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_AscendiantMember" xlink:to="KNWN_AscendiantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_AscendiantMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_BeneficialConversionFeature" xlink:to="KNWN_BeneficialConversionFeature_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_BeneficialConversionFeature_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_BfiFinanceCorpSecuredCreditFacilityMember" xlink:label="KNWN_BfiFinanceCorpSecuredCreditFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_BfiFinanceCorpSecuredCreditFacilityMember" xlink:to="KNWN_BfiFinanceCorpSecuredCreditFacilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_BfiFinanceCorpSecuredCreditFacilityMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertibleNotePayableVisViresGroupIncMember" xlink:label="KNWN_ConvertibleNotePayableVisViresGroupIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ConvertibleNotePayableVisViresGroupIncMember" xlink:to="KNWN_ConvertibleNotePayableVisViresGroupIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_ConvertibleNotePayableVisViresGroupIncMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_DividendPolicy" xlink:to="KNWN_DividendPolicy_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_DividendPolicy_doc" xml:lang="en-US">Dividend policy.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ExercisePriceFiveMember" xlink:label="KNWN_ExercisePriceFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ExercisePriceFiveMember" xlink:to="KNWN_ExercisePriceFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_ExercisePriceFiveMember_doc" xml:lang="en-US">Exercise price five.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ExercisePriceFourMember" xlink:label="KNWN_ExercisePriceFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ExercisePriceFourMember" xlink:to="KNWN_ExercisePriceFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_ExercisePriceFourMember_doc" xml:lang="en-US">Exercise price four.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ExercisePriceMember" xlink:label="KNWN_ExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ExercisePriceMember" xlink:to="KNWN_ExercisePriceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_ExercisePriceMember_doc" xml:lang="en-US">Exercise Price.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ExercisePriceOneMember" xlink:label="KNWN_ExercisePriceOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ExercisePriceOneMember" xlink:to="KNWN_ExercisePriceOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_ExercisePriceOneMember_doc" xml:lang="en-US">Exercise price one.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ExercisePriceThreeMember" xlink:label="KNWN_ExercisePriceThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ExercisePriceThreeMember" xlink:to="KNWN_ExercisePriceThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_ExercisePriceThreeMember_doc" xml:lang="en-US">Exercise price three</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ExercisePriceTwoMember" xlink:label="KNWN_ExercisePriceTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ExercisePriceTwoMember" xlink:to="KNWN_ExercisePriceTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_ExercisePriceTwoMember_doc" xml:lang="en-US">Exercise price two.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_GeminiMember" xlink:label="KNWN_GeminiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_GeminiMember" xlink:to="KNWN_GeminiMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_GeminiMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount" xlink:to="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares" xlink:to="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_PurchasedMember" xlink:to="KNWN_PurchasedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_PurchasedMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesFiveMember" xlink:label="KNWN_RangeofExercisePricesFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePricesFiveMember" xlink:to="KNWN_RangeofExercisePricesFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_RangeofExercisePricesFiveMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesFourMember" xlink:label="KNWN_RangeofExercisePricesFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePricesFourMember" xlink:to="KNWN_RangeofExercisePricesFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_RangeofExercisePricesFourMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesMember" xlink:label="KNWN_RangeofExercisePricesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePricesMember" xlink:to="KNWN_RangeofExercisePricesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_RangeofExercisePricesMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesOneMember" xlink:label="KNWN_RangeofExercisePricesOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePricesOneMember" xlink:to="KNWN_RangeofExercisePricesOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_RangeofExercisePricesOneMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesThreeMember" xlink:label="KNWN_RangeofExercisePricesThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePricesThreeMember" xlink:to="KNWN_RangeofExercisePricesThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_RangeofExercisePricesThreeMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesTwoMember" xlink:label="KNWN_RangeofExercisePricesTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_RangeofExercisePricesTwoMember" xlink:to="KNWN_RangeofExercisePricesTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_RangeofExercisePricesTwoMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SeasideMember" xlink:label="KNWN_SeasideMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_SeasideMember" xlink:to="KNWN_SeasideMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_SeasideMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockCompensationExpenseEmployeeOptions" xlink:to="KNWN_StockCompensationExpenseEmployeeOptions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_StockCompensationExpenseEmployeeOptions_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_StockIncentivePlanMember" xlink:to="KNWN_StockIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_StockIncentivePlanMember_doc" xml:lang="en-US">Stock incentive plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_SummaryOfWarrantsIssuedTableTextBlock" xlink:to="KNWN_SummaryOfWarrantsIssuedTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_SummaryOfWarrantsIssuedTableTextBlock_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_TechnologyMember" xlink:to="KNWN_TechnologyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_TechnologyMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantFiveMember" xlink:to="KNWN_WarrantFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantFiveMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantFourMember" xlink:to="KNWN_WarrantFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantFourMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantNovember2013IdmcServicesAndLicenseAgreementMember" xlink:label="KNWN_WarrantNovember2013IdmcServicesAndLicenseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantNovember2013IdmcServicesAndLicenseAgreementMember" xlink:to="KNWN_WarrantNovember2013IdmcServicesAndLicenseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantNovember2013IdmcServicesAndLicenseAgreementMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantOneMember" xlink:to="KNWN_WarrantOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantOneMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantThreeMember" xlink:to="KNWN_WarrantThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantThreeMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantTwoMember" xlink:to="KNWN_WarrantTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantTwoMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantsJune2013PrivatePlacementMember" xlink:label="KNWN_WarrantsJune2013PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantsJune2013PrivatePlacementMember" xlink:to="KNWN_WarrantsJune2013PrivatePlacementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantsJune2013PrivatePlacementMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantsJunePrivatePlacementMember" xlink:label="KNWN_WarrantsJunePrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantsJunePrivatePlacementMember" xlink:to="KNWN_WarrantsJunePrivatePlacementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantsJunePrivatePlacementMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantsNovemberLicenseAgreementMember" xlink:label="KNWN_WarrantsNovemberLicenseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantsNovemberLicenseAgreementMember" xlink:to="KNWN_WarrantsNovemberLicenseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantsNovemberLicenseAgreementMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantsOutstandingMember" xlink:to="KNWN_WarrantsOutstandingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantsOutstandingMember_doc" xml:lang="en-US">Warrants outstanding member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" xlink:to="KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_WarrantsVested" xlink:to="KNWN_WarrantsVested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KNWN_WarrantsVested_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_3_lbl" xml:lang="en-US">Shares, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KNWN_ShareBasedCompensationWarrants" xlink:to="KNWN_ShareBasedCompensationWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KNWN_ShareBasedCompensationWarrants_2_lbl" xml:lang="en-US">ShareBasedCompensationWarrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_2_lbl" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_2_lbl" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_2_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_2_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>knwn-20190331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.26a -->
    <!-- Field: Doc-Info; Name: Source; Value: 189473 03312019 S1.xfr; Date: 2019%2D05%2D30T16:40:16Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x8014001D -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://knowlabs.co/role/DocumentAndEntityInformation" xlink:href="knwn-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedBalanceSheets" xlink:href="knwn-20190331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="knwn-20190331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementsOfOperations" xlink:href="knwn-20190331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementOfShareholdersEquity" xlink:href="knwn-20190331.xsd#ConsolidatedStatementOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConsolidatedStatementsOfCashFlows" xlink:href="knwn-20190331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Organization" xlink:href="knwn-20190331.xsd#Organization" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoingConcern" xlink:href="knwn-20190331.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsReceivablecustomerConcentration" xlink:href="knwn-20190331.xsd#AccountsReceivablecustomerConcentration" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Inventories" xlink:href="knwn-20190331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesReceivableFromBiomedxInc" xlink:href="knwn-20190331.xsd#NotesReceivableFromBiomedxInc" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssets" xlink:href="knwn-20190331.xsd#FixedAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssets" xlink:href="knwn-20190331.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Goodwill" xlink:href="knwn-20190331.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsPayable" xlink:href="knwn-20190331.xsd#AccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/DerivativeInstruments" xlink:href="knwn-20190331.xsd#DerivativeInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConvertibleNotesPayable" xlink:href="knwn-20190331.xsd#ConvertibleNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/Equity" xlink:href="knwn-20190331.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptions" xlink:href="knwn-20190331.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties" xlink:href="knwn-20190331.xsd#OtherSignificantTransactionsWithRelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedings" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxes" xlink:href="knwn-20190331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SubsequentEvents" xlink:href="knwn-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsTables" xlink:href="knwn-20190331.xsd#FixedAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsTables" xlink:href="knwn-20190331.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityTables" xlink:href="knwn-20190331.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsTables" xlink:href="knwn-20190331.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedingsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesTables" xlink:href="knwn-20190331.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoingConcernDetailsNarrative" xlink:href="knwn-20190331.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:href="knwn-20190331.xsd#SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:href="knwn-20190331.xsd#AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/InventoriesDetailsNarrative" xlink:href="knwn-20190331.xsd#InventoriesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsDetails" xlink:href="knwn-20190331.xsd#FixedAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/FixedAssetsDetailsNarrative" xlink:href="knwn-20190331.xsd#FixedAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsDetails" xlink:href="knwn-20190331.xsd#IntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IntangibleAssetsDetailsNarrative" xlink:href="knwn-20190331.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/GoodwillDetailsNarrative" xlink:href="knwn-20190331.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/AccountsPayableDetailsNarrative" xlink:href="knwn-20190331.xsd#AccountsPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/ConvertibleNotesPayableDetailsNarrative" xlink:href="knwn-20190331.xsd#ConvertibleNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:href="knwn-20190331.xsd#NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails" xlink:href="knwn-20190331.xsd#EquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails1" xlink:href="knwn-20190331.xsd#EquityDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetails2" xlink:href="knwn-20190331.xsd#EquityDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/EquityDetailsNarrative" xlink:href="knwn-20190331.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetails" xlink:href="knwn-20190331.xsd#StockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetails1" xlink:href="knwn-20190331.xsd#StockOptionsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/StockOptionsDetailsNarrative" xlink:href="knwn-20190331.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:href="knwn-20190331.xsd#OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsDetails" xlink:href="knwn-20190331.xsd#CommitmentsContingenciesAndLegalProceedingsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesDetails" xlink:href="knwn-20190331.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://knowlabs.co/role/IncomeTaxesDetails1" xlink:href="knwn-20190331.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_DocumentAndEntityInformationAbstract" xlink:label="loc_KNWNDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesDPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaapOtherAssetsAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesDPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementOfShareholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDER'S EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaapSeriesDPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapSeriesDPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockCompensationExpenseEmployeeOptions" xlink:label="loc_KNWNStockCompensationExpenseEmployeeOptions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockCompensationExpenseEmployeeOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_KNWNSeriesDStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNSeriesDStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_KNWNSeriesDStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNSeriesDStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_BeneficialConversionFeature" xlink:label="loc_KNWNBeneficialConversionFeature" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNBeneficialConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount" xlink:label="loc_KNWNIssuanceOfCommonStockForAccruedLiabilitiesAmount" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNIssuanceOfCommonStockForAccruedLiabilitiesAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares" xlink:label="loc_KNWNIssuanceOfCommonStockForAccruedLiabilitiesShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNIssuanceOfCommonStockForAccruedLiabilitiesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValueCash" xlink:label="loc_KNWNStockIssuedDuringPeriodValueCash" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodValueCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesCash" xlink:label="loc_KNWNStockIssuedDuringPeriodSharesCash" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodSharesCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockCompensationExpenseWarrants" xlink:label="loc_KNWNStockCompensationExpenseWarrants" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockCompensationExpenseWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValuePatents" xlink:label="loc_KNWNStockIssuedDuringPeriodValuePatents" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodValuePatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesPatents" xlink:label="loc_KNWNStockIssuedDuringPeriodSharesPatents" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodSharesPatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValueWarrantExercise" xlink:label="loc_KNWNStockIssuedDuringPeriodValueWarrantExercise" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodValueWarrantExercise" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodSharesWarrantExercise" xlink:label="loc_KNWNStockIssuedDuringPeriodSharesWarrantExercise" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNStockIssuedDuringPeriodSharesWarrantExercise" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" xlink:label="loc_KNWNWriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNWriteOffOfDerivativeLiabilityToAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ShareBasedCompensationWarrants" xlink:label="loc_KNWNShareBasedCompensationWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_KNWNShareBasedCompensationWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConversionOfInterest" xlink:label="loc_KNWNConversionOfInterest" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_KNWNConversionOfInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ReclassificationOfDerivativeLiability" xlink:label="loc_KNWNReclassificationOfDerivativeLiability" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_KNWNReclassificationOfDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" xlink:label="loc_KNWNConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_KNWNConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockCompensationExpenseWarrants" xlink:label="loc_KNWNStockCompensationExpenseWarrants" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_KNWNStockCompensationExpenseWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IssuanceOfCommonStockForConversionOfLiabilities" xlink:label="loc_KNWNIssuanceOfCommonStockForConversionOfLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_KNWNIssuanceOfCommonStockForConversionOfLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NoncashGainOnAccountsPayable" xlink:label="loc_KNWNNoncashGainOnAccountsPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_KNWNNoncashGainOnAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RepaymentFromInvestment" xlink:label="loc_KNWNRepaymentFromInvestment" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_KNWNRepaymentFromInvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ProceedsFromConvertibleNotesPayable" xlink:label="loc_KNWNProceedsFromConvertibleNotesPayable" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_KNWNProceedsFromConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIssuedDuringPeriodValueWarrantExercise" xlink:label="loc_KNWNStockIssuedDuringPeriodValueWarrantExercise" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_KNWNStockIssuedDuringPeriodValueWarrantExercise" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfDebt" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1" xlink:label="loc_KNWNAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_KNWNAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RelatedPartyAccountsConvertedToNotes" xlink:label="loc_KNWNRelatedPartyAccountsConvertedToNotes" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_KNWNRelatedPartyAccountsConvertedToNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_AcquisitionOfPatents" xlink:label="loc_KNWNAcquisitionOfPatents" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_KNWNAcquisitionOfPatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_PenaltyOnNotesPayable" xlink:label="loc_KNWNPenaltyOnNotesPayable" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_KNWNPenaltyOnNotesPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Organization" xlink:title="00000007 - Disclosure - 1. ORGANIZATION">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoingConcern" xlink:title="00000008 - Disclosure - 2. GOING CONCERN">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandards" xlink:title="00000009 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsReceivablecustomerConcentration" xlink:title="00000010 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Inventories" xlink:title="00000011 - Disclosure - 5. INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesReceivableFromBiomedxInc" xlink:title="00000012 - Disclosure - 6. NOTES RECEIVABLE FROM BIOMEDX, INC">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssets" xlink:title="00000013 - Disclosure - 7. FIXED ASSETS">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssets" xlink:title="00000014 - Disclosure - 8. INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IntangibleAssetsAbstract" xlink:label="loc_KNWNIntangibleAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIntangibleAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Goodwill" xlink:title="00000015 - Disclosure - 9. GOODWILL">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapGoodwillDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsPayable" xlink:title="00000016 - Disclosure - 10. ACCOUNTS PAYABLE">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/DerivativeInstruments" xlink:title="00000017 - Disclosure - 11. DERIVATIVE INSTRUMENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConvertibleNotesPayable" xlink:title="00000018 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertibleNotesPayableDisclosureTextBlock" xlink:label="loc_KNWNConvertibleNotesPayableDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_KNWNConvertibleNotesPayableDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt" xlink:title="00000019 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:label="loc_us-gaapDebtAndCapitalLeasesDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapDebtAndCapitalLeasesDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/Equity" xlink:title="00000020 - Disclosure - 14. EQUITY">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptions" xlink:title="00000021 - Disclosure - 15. STOCK OPTIONS">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties" xlink:title="00000022 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings" xlink:title="00000023 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxes" xlink:title="00000024 - Disclosure - 18. INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SubsequentEvents" xlink:title="00000025 - Disclosure - 19. SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies" xlink:title="00000026 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Policies)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapReceivablesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness" xlink:label="loc_us-gaapDerivativesMethodsOfAccountingHedgeEffectiveness" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapDerivativesMethodsOfAccountingHedgeEffectiveness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionSalesOfServices" xlink:label="loc_us-gaapRevenueRecognitionSalesOfServices" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapRevenueRecognitionSalesOfServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_DividendPolicy" xlink:label="loc_KNWNDividendPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_KNWNDividendPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsTables" xlink:title="00000027 - Disclosure - 7. FIXED ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsTables" xlink:title="00000028 - Disclosure - 8. INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IntangibleAssetsTablesAbstract" xlink:label="loc_KNWNIntangibleAssetsTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIntangibleAssetsTablesAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables" xlink:title="00000029 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Tables)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityTables" xlink:title="00000030 - Disclosure - 14. EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SummaryOfWarrantsIssuedTableTextBlock" xlink:label="loc_KNWNSummaryOfWarrantsIssuedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_KNWNSummaryOfWarrantsIssuedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" xlink:label="loc_KNWNWeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_KNWNWeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsTables" xlink:title="00000031 - Disclosure - 15. STOCK OPTIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables" xlink:title="00000032 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Tables)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract" xlink:label="loc_KNWNCommitmentsContingenciesAndLegalProceedingsTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNCommitmentsContingenciesAndLegalProceedingsTablesAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesTables" xlink:title="00000033 - Disclosure - 18. INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoingConcernDetailsNarrative" xlink:title="00000034 - Disclosure - 2. GOING CONCERN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_GoingConcernDetailsNarrativeAbstract" xlink:label="loc_KNWNGoingConcernDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNGoingConcernDetailsNarrativeAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNGoingConcernDetailsNarrativeAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNGoingConcernDetailsNarrativeAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative" xlink:title="00000035 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SignificantAccountingPoliciesDetailsAbstract" xlink:label="loc_KNWNSignificantAccountingPoliciesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNSignificantAccountingPoliciesDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsReceivablecustomerConcentrationDetailsNarrative" xlink:title="00000036 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts" xlink:label="loc_us-gaapAllowanceForLoanAndLeaseLossRecoveryOfBadDebts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapAllowanceForLoanAndLeaseLossRecoveryOfBadDebts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/InventoriesDetailsNarrative" xlink:title="00000037 - Disclosure - 5. INVENTORIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_InventoriesDetailsNarrativeAbstract" xlink:label="loc_KNWNInventoriesDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNInventoriesDetailsNarrativeAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNInventoriesDetailsNarrativeAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsDetails" xlink:title="00000038 - Disclosure - 7. FIXED ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_PurchasedMember" xlink:label="loc_KNWNPurchasedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_KNWNPurchasedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeaseObligationsMember" xlink:label="loc_us-gaapCapitalLeaseObligationsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapCapitalLeaseObligationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="loc_us-gaapMachineryAndEquipmentGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMachineryAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaapLeaseholdImprovementsGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseholdImprovementsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaapFurnitureAndFixturesGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFurnitureAndFixturesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/FixedAssetsDetailsNarrative" xlink:title="00000039 - Disclosure - 7. FIXED ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsDetails" xlink:title="00000040 - Disclosure - 8. INTANGIBLE ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IntangibleAssetsDetailsAbstract" xlink:label="loc_KNWNIntangibleAssetsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIntangibleAssetsDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_TechnologyMember" xlink:label="loc_KNWNTechnologyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_KNWNTechnologyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IntangibleAssetsDetailsNarrative" xlink:title="00000041 - Disclosure - 8. INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IntangibleAssetsDetailsNarrativeAbstract" xlink:label="loc_KNWNIntangibleAssetsDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIntangibleAssetsDetailsNarrativeAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/GoodwillDetailsNarrative" xlink:title="00000042 - Disclosure - 9. GOODWILL (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_GoodwillDetailsNarrativeAbstract" xlink:label="loc_KNWNGoodwillDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNGoodwillDetailsNarrativeAbstract" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/AccountsPayableDetailsNarrative" xlink:title="00000043 - Disclosure - 10. ACCOUNTS PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="00000044 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertibleNotesPayableAbstract" xlink:label="loc_KNWNConvertibleNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNConvertibleNotesPayableAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertiblePromissoryNoteMember" xlink:label="loc_KNWNConvertiblePromissoryNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_KNWNConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_ConvertibleRedeemablePromissoryNoteMember" xlink:label="loc_KNWNConvertibleRedeemablePromissoryNoteMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_KNWNConvertibleRedeemablePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="loc_us-gaapDepositLiabilitiesAccruedInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositLiabilitiesAccruedInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtDetails" xlink:title="00000045 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Details)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:label="loc_KNWNNotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableToBank" xlink:label="loc_us-gaapNotesPayableToBank" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:to="loc_us-gaapNotesPayableToBank" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:to="loc_us-gaapNotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails" xlink:title="00000046 - Disclosure - 14. EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_EquityDetailsAbstract" xlink:label="loc_KNWNEquityDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNEquityDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantsOutstandingMember" xlink:label="loc_KNWNWarrantsOutstandingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_KNWNWarrantsOutstandingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails1" xlink:title="00000047 - Disclosure - 12. EQUITY (Details 1)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantOneMember" xlink:label="loc_KNWNWarrantOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantTwoMember" xlink:label="loc_KNWNWarrantTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantThreeMember" xlink:label="loc_KNWNWarrantThreeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantFourMember" xlink:label="loc_KNWNWarrantFourMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantFiveMember" xlink:label="loc_KNWNWarrantFiveMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantSixMember" xlink:label="loc_KNWNWarrantSixMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrantSixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant2Member" xlink:label="loc_KNWNWarrant2Member" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrant2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant3Member" xlink:label="loc_KNWNWarrant3Member" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrant3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_Warrant4Member" xlink:label="loc_KNWNWarrant4Member" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNWarrant4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetails2" xlink:title="00000048 - Disclosure - 14. EQUITY (Details 2)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_EquityDetailsAbstract" xlink:label="loc_KNWNEquityDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNEquityDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/EquityDetailsNarrative" xlink:title="00000049 - Disclosure - 14. EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_WarrantsVested" xlink:label="loc_KNWNWarrantsVested" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_KNWNWarrantsVested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetails" xlink:title="00000050 - Disclosure - 15. STOCK OPTIONS (Details)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_AggregateIntrinsicValueAbstract" xlink:label="loc_KNWNAggregateIntrinsicValueAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNAggregateIntrinsicValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetails1" xlink:title="00000051 - Disclosure - 15. STOCK OPTIONS (Details 1)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices5Member" xlink:label="loc_KNWNRangeofExercisePrices5Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices4Member" xlink:label="loc_KNWNRangeofExercisePrices4Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices3Member" xlink:label="loc_KNWNRangeofExercisePrices3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices1Member" xlink:label="loc_KNWNRangeofExercisePrices1Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices2Member" xlink:label="loc_KNWNRangeofExercisePrices2Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePrices6Member" xlink:label="loc_KNWNRangeofExercisePrices6Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePrices6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_RangeofExercisePricesTotalMember" xlink:label="loc_KNWNRangeofExercisePricesTotalMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_KNWNRangeofExercisePricesTotalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" xlink:label="loc_KNWNSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_KNWNSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/StockOptionsDetailsNarrative" xlink:title="00000052 - Disclosure - 15. STOCK OPTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_StockIncentivePlanMember" xlink:label="loc_KNWNStockIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_KNWNStockIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative" xlink:title="00000053 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_NotesToFinancialStatementsAbstract" xlink:label="loc_KNWNNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapDueToOtherRelatedPartiesClassifiedCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToOtherRelatedPartiesClassifiedCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsDetails" xlink:title="00000054 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Details)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:label="loc_KNWNCommitmentsContingenciesAndLegalProceedingsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNCommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNCommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNCommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNCommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNCommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNCommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNCommitmentsContingenciesAndLegalProceedingsDetailsAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesDetails" xlink:title="00000055 - Disclosure - 18. INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IncomeTaxesDetailsAbstract" xlink:label="loc_KNWNIncomeTaxesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncomeTaxesDetailsAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://knowlabs.co/role/IncomeTaxesDetails1" xlink:title="00000056 - Disclosure - 17. INCOME TAXES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract" xlink:label="loc_KNWNIncomeTaxesEffectiveTaxRateDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncomeTaxesEffectiveTaxRateDetailsAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="knwn-20190331.xsd#KNWN_IncreaseInIncomeTaxesResultingFromAbstract" xlink:label="loc_KNWNIncreaseInIncomeTaxesResultingFromAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncomeTaxesEffectiveTaxRateDetailsAbstract" xlink:to="loc_KNWNIncreaseInIncomeTaxesResultingFromAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncreaseInIncomeTaxesResultingFromAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_KNWNIncreaseInIncomeTaxesResultingFromAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6812151936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. EQUITY (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issued</a></td>
<td class="nump">2,462,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exerciseable at end of period</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=KNWN_WarrantsOutstandingMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period</a></td>
<td class="nump">15,473,398<span></span>
</td>
<td class="nump">6,900,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issued</a></td>
<td class="nump">2,462,185<span></span>
</td>
<td class="nump">9,276,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(336,427)<span></span>
</td>
<td class="num">(158,026)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired</a></td>
<td class="num">(26,573)<span></span>
</td>
<td class="num">(544,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="nump">15,473,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exerciseable at end of period</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="nump">15,473,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period</a></td>
<td class="nump">$ 0.326<span></span>
</td>
<td class="nump">$ 0.428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Issued</a></td>
<td class="nump">1.222<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="num">(0.250)<span></span>
</td>
<td class="num">(0.507)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">0.000<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired</a></td>
<td class="num">(0.250)<span></span>
</td>
<td class="num">(0.250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period</a></td>
<td class="nump">$ 0.453<span></span>
</td>
<td class="nump">$ 0.326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=KNWN_WarrantsOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=KNWN_WarrantsOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6631931520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. GOODWILL (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_GoodwillDetailsNarrativeAbstract', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 110,545<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 983,645<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_GoodwillDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_GoodwillDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001654954-19-010948-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-19-010948-xbrl.zip
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MS=^'[4['[AMP55FL,0A[%2!T!H.V/=P7A*4\I0BAW78&SKX@')3QDP*$]KZ
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MV]:Q'A!HY5C;S(&U7;25PN;8@UZW-^RX.P>R'(&;6O/;16$I=(C"WL!M]_<
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MA/23HP4AVS;058+S32)@8(%FN'Q&QAM9VG$T,2#Y>0_/)HI9I3XJ$A;>*2G
MRNZ<)-"MG/(!V3TLG)6.06:K<;.5$# 9JZ&4TX&4*.MYI@:\F@1 D;O"Z0@D
M(A"XD?69[JFPSFYCP<X'OJ+7<[C-T32RKH!-^XEB-%>*/CY$IRWK<PJJP@42
M&X>N0"E*I8@VN%T@E_#4$KS"61#X ,4%\?$H1O4LB@$#0"+_[8?1O4>[O%!L
MWCHO*)F_>J''/3_4[H K$:WY(+J!IP).+V"K 5IJ<R^P_@&/@HQ[T91U(P"I
M]T+*1!*ZI0(CF8^([H 2QV(&,A+12"H._H9]A&3-HFI =YVNM"\S"(BFPCFF
MRA#I4K=@8!"9* 8Q, )*(+4E5+H)OEMQF%."0Q+I HU*\03T,?5#],1IP46R
M7?L!<IJ'>2NR=:S"S<L85!@Q)<&C$S]%C>P4M4[ 08X]680L,:9+"Y>&7HS;
MH6=*%R_H0#'[6C/N*KDRF!FW@F%@F9OD;^O4(R#A5"U/&@8*,0#4!([%QW-3
MJ(&OO=$=GC]JA0D<B@<0J]W1D;XTVM?H9R\C\@K \PV<&:$&A%LB_8VHP\;>
M*)5:+6DA&M.GV=$57^2'8Q_$V!Q-1=2E\."5HJ1__2TGI+&$$>4?:4+(#.,(
MY&^*M*.YD2(\$*MPT4 &PYE*:D'ZOQ% AK>8T0=0I \B@#.=<9"[L!K:A?@+
MUU8/6'B? <S\@[,(35FT9E$ QV@EL-*0^FG (MXGP9"D2M?TN3 L6Q=@DI);
M+J&7Q"LO^3QJW:, +CPA0;Y*W[\0%8F92.?(7P"]RD(M4P4D5OP1J8I ]ZT%
MH?$BG:=YW].O IA$S#+SZ]G9!8AL.#M /OOA7Y=+ZC*TSF:Q'UBH&F/8(\\P
M3=5&6M&99D,TCAV9D(A-K'9MV_HM1!WC@XQ2D"[C@<H1> _D2<X^I[=X:+2@
M,AL]A.CGSRD=!D M;<J7G-RR%4ZM*^0<</?5[9' ZIVTT+ CDTE;!-(#3"XB
M51+(\0CE"$,("M:M$2>!'\?1_/8.8)KR:AF2KN<WC"C))"+>33$ Q$^;\9^6
M0;7)/+X'1BH56V-7I"Y60^>KL/Q^T^$QH.6ICH\MTH#PI,E%YVS)(\Y%L!0+
M]\C[D5&&#SHA(#A%#GTC)NB-,=9XZQ@1M7= :Q1+"4<HO/A=#UHXN"H"ED&2
M*$>$"<FI=4:24"3S@.FW^ (C%J?T5KT-(+FK.Q]X_\PZ UD=P>TPS 6*E$0!
M"Q+Z 5#3F$D84:)\K2$Z3^4M5B)<\0$O(>]8#.HF2EQU&>  3@(1W@(5W\#1
M@3Z%Z&.YE<E@>;]I';9-LK>"$ .5;XYW%';Q+Q#]Y#,F&\G[?C*!XP2L1$:X
MF&#[[?3ZU)IP[Q$*GTX%/H]*!4AR,&),?.9II*5OF (PIF)YK/$&;<-C+3:S
MBY06TM)ZJKSAK^*Z:3E[-IM%@!>2%(#/<V"K(U QCO(5".E]Y,5C;?V-^<;Y
M_Q9*MF3/D'D&UT>0.3)!-C"ED@KVW!9O,5T1CS&/O"4A^:/L2OW:4^O76/XB
M)\+PPL*#$HP)SEP1V-,3M5R.MX:P45@Y1$*?"L%!7V9/!J> ZP0[_Q7,+;>S
MN&^#&I(2)$A(V3&<(8'VCCB FY?#0;;=MU]%>OK..AM/?;SFOR-NO*EU^2#"
M9 4NU//XW (Z= !N(W2\!EI?=O,O"7/&Q;=>HI&QMHZ=D2_<24GT>),]],3X
M8F)]_"Y&<[2!%2:+2C'(&0PN(.U]Q7QW8 NGUL?8'_V9H-Z-\8!83$%.X1L]
M/YYZ85$11+?DO1_-DT#JV)H_6(F([YF5+',Q,YC2E:F!3'P,99W-;]%4Q^RJ
MO/V<\YIZ%N9T@>3%/6B5+',ME'.KD=K_^\ #MO$A &UB!!<11/[_G8,>TV_Q
MND<B*S7DN(LTW=*SO"LY._Q83%"MP6,I/P//N.O+*9:/OFQ!=LMS?,1#1<K'
ML(821);C6J"UIG>)]1:LF#\$1V"$%P<8GV;]DI2\=S)8#68;>O?F*> QY50+
M&;7$."8NHLM"X.4G]'+6[\@XF(<!NG&%CX5<Y"8ACR&&PYG^(^,+J5GCY667
M.IJ7$B0V ,IV;,A>#>_,\\=\+!0=1W^LM-9^<%U*BJ/\MD?8>"O3/KN+J7JF
MDD_I<6.45#_8I^UVEB$G$S;05$'"0'\5Z:@W43A/I(%+T=Y_D5?)HU:T2N*-
M_00$-FTWIZ@@:FE]/TV%*$C89:>?Q;3P:!*!3<*1:\P\C@L+U.\1M(P.X,4F
MBOR)@4X_R?#/F0M@I)DF-46$<WEAL74?!?,P]>#N/&:_3BR,4@L-,D&#,!HO
MNXTB=$5[P&3-1(LCMREW&TWY#I:2 6)V472IU$/\9;+T/E' 8\P<WVD9DB;/
M8Y3B]JL7PSM=?G+X*F1#J>NSD'[\ZLPR-$X<1;P%9* G4:9-&WY$%E5FYG6D
MKD%;O<B3:3'L?SLI^M]:[ P<%]Q_YMV9&;[*4F^K,DCD83+U&[NA"/((4PM&
MQ*5U;(;]D"V"[RP&X2AC?A>AZ8XE[Y10G2,QOT!>7,QYH0Z>^ +.@O.F9)46
M,]EOV(6CG#ZX]L0/I&EDKLQ;P-N*F5\>AA%/#&?E-//Z@)H!DH(C2'..ZG'$
MAW[4PCB(-\*\+!(?M&5Y@%]!KT7KDAO.PKK7$B]#]^S4&=BGUK7AX>)U0.;@
MHA@JC 4[A"60A Q6E#"OR@?)F0^ R56OL20\E3*<4_$Y'7"$.-/H10HRC^XU
MW#W-C51P )"&2.'VL(2FZ\?I313(3UXE9\J[371)"]RO,3P,9/55W,X#RG4C
M>,ZXB .TM;>&AO+IXLO7,S. @*Z*: Y7A+TMF@Y#F3/CJ2LN,^KHAI/WY1\^
M<*4 ^=*%R0$7;W^6;%EX%US[/U$#Y;/EEU[_]EG%9# ',8T]#K3P,U@D)'6
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MA)+J9(LO'O^I% Y9QLM9I])2H8-4L1\><B\[9.?:7.?'&+#!I0UPR?Q)0WC
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MC!M8I)F(JII/^6ZP9$GC1\8U"I<L*X$2NEQK*5_ZG0)/H0(4,4/P)RM9WB+
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M' ?/0@BO@=5IP?@)%81_D()@-%UFLBP=9ZWA^M&(5W%L=%4,"PN49:4W%5;
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MR:J8/'C. ;F5U150H4SI7Z2 9.%DU3#W\S( \PPQWT7>5U/;C)9VE+<J.3<
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M=-Y2$SFJ\99=*"0C2E*X?R?SF<X;I12-;TMLOK(<[*QG1CY+M'AK3)K(9ZD
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M=)OT,3*;8+J+YX_+AGMR0]*8 E&()J5@;U#2+L+W"R-1(8&Y[% X%?C\G3<
MN"B%_E4DP_4ZX+][(37B$X^]Y']39TYW&=[+ =^1?+R\!HZE[C9[ /XSK);0
M5YQ6!EY->3U9KR.?<^11TVV01*:V)7*?I%-#OW_OW<-W0(]S51=6G@V1V1D9
M@'^[G>/?Q,J^_^.S*E5WRL]KH:M(;Q.F_!"XELZXK[IM0O5P-@4+07[# %G[
M+7H2#G%''F,\XQT4JA2Y5>5I%L)TYX4^R 4A&OZJ\_@W;P@X)1-!AJRLT)0D
M,W'U.GAD;7Q:E6,1P\+G/GKW<88U;W97G@X4E(/=DA#_&DMAUDJSKVQ1[*4O
M2W+0*U2!26Z=[HKY>Q633TDO,CJ>^7:M^E/)<U#<RL[-E->"S!% 4N[.SLR5
M]$YEK;]K)"1THK@_%S@(N"E11B(WE&I&ZBY00A F3_@&FLPU.9V\P- M&@-Y
MR*AB,) 2]3O+;+6JVL@62R2YH W=8@AS E>$\+".-+A"0#$T>X@Q'PC1X<#S
MAIP8=(1,%NJ5JU0_ 3%'A;/HYEAAF4T*%M>>LK-C$?=.Z?G?2T9K6-#JZ)B#
MIL9[!5P&*&N+I$6@]"75A%Y9X*5T;'',J6)).I N/ 4HQZ?>>@,W2SAJ)O,(
M9E*_NZ(!E3>6+:0CJB'BHFQ.FPX--T?,62BJ+R*;@J73R#[USJ7A$B3U'D9>
M:IJ;(+/ P\^/_N"Q\ $L)G-Q ?(!'DC<4,S%VHI'A;<DW5&9$<>"]A3> 9)B
MZCH(9$=G5]Q\SS-FV20*2^7RKO''NW<WCL$92/:'5"J-/BG^P$PW!177T(BD
MXSM1IW<'GP>/Y*VLY?M(63K/^'L<91.5].9:W-*--KQ<@#>;Q97#4"0O,=L&
M,.?U<M^BT(6/?FT8'\"_^I[ TVRW,W)R0^/=H^^-C \_ &#:^Q=88(#7$XKT
MK'4%%2&5^S]-140VEI\;T;.L&I9U"90F$["#D";J*Z+>5E1[Y"_B;S6W)5.W
MWI3+:%R##@\R*GN7[U-JZ=ZC8F&*H/E%X>B^Y"^KK&B)BU3- ]4YO#D+>?^=
M]N^G)24XPU$'"J[DF\NO3&4XZ1O_%+:U:G470@GY"<E359\Y!WK=TN4==3VO
M*N;3;VT@+*1%O6&1U;7T^,1_>'BY=P??]>QX[#WX6/]+FH#N;B9\>1-_+:2Q
MSML!X2+/2ZG8G+'R5+(NS/)6AV*-$E,H_:.Y//C.!^'GX78QBR!O.P)4+GP?
MTQ24!A_ZR21*2(^>!9/\7HE=A4UT<(0&]$.1(TJQYMKEVUJD2/-+64QQ>#C7
MPQH=;@?$C%;? 9?03=05-I#-V ,KA;:.&"&_?H%TEA<L\#!'G"-K#,=?DK?'
M6M?NFVO[C>0*_"+=C\U@J7:S0V'EAW<09C]@9RI\X[T&*SS>, ZVL^HNKXE7
M*0LPLP2+,+5C-Z^-!K*)BY'N [SP(#(]5Y:Z*58526E6]EI<'W<IGHA B_A8
MA4FLIV[NO#&N@9@$PS^E<ZX'6-5 V.WR735=!;TABY,H%XWT!0!R[[&G-R)V
MIFM&FAZ\ERX<.(E1G":Z.KQW$[!,HBPTC^#<!_C?LU IBV<_KZQVQ^RW+)75
MR[-#6I!949="WJ-D"P"N,CQ+1-97AG&EJR/5J64"A5)O9T$KB.'RHWR[*H&"
M!VAT)8>UOX@Q -%74K#HOG0QS6*LFV)IUJ58"K7<-6D6>^IVZB(I%LZ 3&&#
MX=1"#!G/2/>R,KLR+SD^(QEB+)X((1"N^HYI=5OS<B&V8W::S>5R(<9B>1 6
MWW//A?"9DEW53TAUP:"$G:Q<R9-V=H\9EFO^V4\=B8()OD];(59Q?E2PH% Y
M'2E4I4J1HO@XK=;*XI.?-?3$@?;!BX_=MLV^8\^1'Z?5,YO]SD5^ME886-4;
M8YJ=!..Q#$GF,ZM\+56)-YP*;R3?*[ETQ95PSQ/R6.@@4#I+*-1\Z:*S9#<$
MV8F@!#;*/7*+S-QIUV_%-1RI.\Z",ZK/5G6RE ]9^31LM8/6\ADVLD"%@Z1.
M7XW:DU?%'M/'K^= -M7<J ;II6(.K:9S.D5-5/B'\\&^M?_W#!LBH5M1S?D5
M!3Q<&0/X$O?=#%$*)Y@_*6;KIW/SU^X;RL]?=3HMTW8<@ZXYABEUU5.)<H)"
M4$32SY6=TV3A !GWQ<B?5SM7^"T"$N[B='TOX&M;?;,'\ F1D^Q!IYJEK6-D
M66PUMQG ) AI].!1\I"]+Q'-3KM6G)^PS*;3IZ:E-0Y6T7[(&ES@F8@J__)F
M);.2Y7KV5'D@0R\9Q/X]&KS[Z,D3&?1VLRZ#/C-)/^/8M6FV6VU.%FW!79IQ
M[%I9:L*2455N@C%1JW_ Y29_^6G)\M8-5L5N;2[6O*K8>;?$B0S%&5GG6Q$[
M96,K#:LL'F'U*&.Q\[*EMQ7,532GT3-\HA)3E,GN<A4F&T ]]ISD* ==_>73
M>V;KI0K?>F;+LLH"(#F=*_:P(UVO"NZI*D.[JD2T!LIZ9Y8<Z(J"QXL#>W%@
M+P[LQ8&].+![=V!;ENETILR&L8+)L*I,1IYBECEKR5I+F [I3O=%8UTJM9>O
MJ-W0M0UXK?-Z_]9E9:\[O]=VG]Z&0U'7]QFO%FA7V)+]7$;[37>U3=FVW_\W
ML$'@J<9(>"&5[^30&>M"S0V.R _/I]/JTVC+TVJ+_3'M^;!IPVKSF4WTO8U.
M:%SMN7P@HJVV5C,W$%_ 7>L8N$F 1WY6#3^G1ZOB0\J?60O24]A1L)DQ7PNC
MHFXHV7*#G"H06AK!=#]K>-IR"%>33>?C>4/;.TXD=;>,I!VSZC:D>X.?/3CP
M-D0>^8:P49W6ZT59<*%["4ORJ!IENK3PEMZ<#_[5BJ"U:^>T+O!1J]4VK5YG
M7U@Y.7PZG;;9M=M;P.<FM=_\?5 L+O/<$.?\,9[\F;G&6S?\OB\GJD)W+46:
MYIX W]D&K7[?[#N+\MZA<)JL=@A+'">S79^_&C>JEA8OB+SLQ1>;[3EM>+DU
M%-#-,7JJ1X;C3C.??WX<[N[\/?'@4DRB'*M^7\Z5.5XM;UK@8W0ZZYNSW3+8
M9W3%Q>&&03T+N>\>9O ,E<&[Z/89*+Q>S5N?@:3YWWQSH<A,BBPIC5NFR8Y%
M>I.BZVR237CH^K8BQ3F?W:/WM@H2+X38.2$JQ/0G.NHI_.J4"BMP82Y/63A)
M=S9%)XM_[*<PBL> O/6_61ZV6IYJ7KH-@F/-"2[NQ(Q]1E)]GILV?(UZ&&O_
MYCN1ZDX#M5LT/KH#[@;+U7Z+\ 06"! (_\A"3_1QQOJ<'(A2RY>/_@BO<D5#
M?P16CZ__<\W Y\@-19WF5&>?4M/"J[:\G"DVP/TB&1>S-B&[1E*W;84-,?1:
MATFU/<3/J>:#\'KY'H?H2#4+$-5W7#5"'GM<JJ *%T9!A VSL=$-_56OSV@U
MVJ^-29 EA@T_\><\X!TJK@!=&W-%DJ]=\>DU7\O*%_5D&KM#+Q^[P[>6^!0?
MVRY@7_P?>"%((;=J8X;:E(_%1 %2)1;G_^*RNJM:"RD>X!)$<:OP(7.I/XB'
M+V@,K_77J>B_A*4W/+E/+*[>9#!C;RP'FXN6C*(5B-PP@9!OVACC#9U[?''B
M^@KX%)&?SMBV]V/B4[72])5GX/HL#%!"GG%9;%"-O> SL#S 4P-F*7533]XK
M"^'7V+ (AS1A21,Z;@U-?+!!U97-=RG=)]</9D]<VX?66D5!;^[K^N5S51Y8
M$GM@<)H700#EN*6^(_-4#_ZZM-R4NHPR[,'E86MZK +A<BQ53"7X8YF*UU,A
MS@?5_JQ"6O*)H0A*P4Y0SQ?_QPJ6@NLWN<']<*8H8\]7<<F_FC*'Y&,<MQ]%
M3B,=7GVM/[PZ&\\2--8_LN#%Z%??\B=[Y!I7\N (85'.%[%^J5&>ADCV\]#%
MP8Z>WI,?94F@/! >3K),6S_J9?CN$8?HNH5>6F\C-QX6"TT)[BN[:S9;EM[.
MHS>WD4:A74&Q?Q?7 OH)Y3(:JGN0JHGWDYJ&X:HCCS817O6@TKM/B3Y^]$!M
M_REL :4UF"(8YC29,I9N,/433K1?O,?4.8A*I?*@RN"*^Q& /KW^_?/7\U,K
M;LB7Q-N+W9.0A=N$49PQ.@0WFD?%E&JT:6@GNM=7XI@M;\F1*XNZA@4U[4 %
MSTOKS\T[0,K8A.M+<YM6O0X^KW6ON1Q2LQ,.?,M5\"C\!$;I?D2Y.;ZJ?&X
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M/'! Z?9[?XB#/;R0[UB,R$IB)NZ%&^PDJ;":^ $2 )S-*OTI"IL241A,D_D
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M+(@0"\%RSLE5F 6NH@M)LJ2&\0G+0IA'EQ#B:$PPNI-)@'4-@M==0SOI'$?
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M1+]XZ-VGI6"L%-/G.00$+;][ ;L=9-I9N*+B64A)C;G5\W/DIO$!@@R&J9S
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MOVS<[O(7_O)3EMP\N.[D9YJ+\Q@%X(XF'_[,0+YQB,M[/QD$49+%WN\ ]]L
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MQ/@<N;I($@_],9[\F;G&6S?\SD9F!&('JB_VGOPH2^!+PG*0LD<ZH*F#G\
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M:*H)W8GCK.K@K-($M2I-T(RSLPA49 W6B9WIN$$BG:0E\>(G[!UI#+,8%1/
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M'?MRXA8PPH959>CM_L+WDWUX>NP-*8>@! N?\S#6Q&0=>X=GP:$K!':W8PZ
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M2SJNH;(Z/O[P+HHG48S% 'R.QID?7Z'B;') ><K2J;JA3HF=(25UU/F'*(!
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MTDR;#AD3:50AS(9::N^DQ62M6:)TU]>NJ00&.OZ).#Z/O%&*?7;98  89.$
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M+SQWP]9J\B )M?)=&^Q7UJ^P>F&)7B%$3*0LC;YNX7HH<,RR?WKQH1D/5W\
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M2&<IXGRRBFS&9PJP.]I=95&F\//V:@&M4@W "IT.:@&M'@T0M1&F:P&M)@V
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MM8KIO>A!TAOL8G9'@@=*+Z<OQ ]7D!/7EO02_/E$L8,#,8$31"F: 'F]+*+
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MTI6#3QT&L\TU I:;?3*,CN6.:M>(DC" R'''=D=A,:J-@(MDT%TD1R-2J9
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M;6;*,X ,I+A<NJBF1+I?QW?C%<,7QWVRC7N_;;J$](R,)QCX-EH@)QBZWF*
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MR ]MTBW)_2HEZM;FV*.Z'SKQ'7_P\7]02P,$%     @ \84S3]T1PS0'$@
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M6!C'L6R5#$.1;,<NH*I*]3^IS8Q$56U?6&W=&8NJ\ 5$ZW;(F^=4\,@YB88
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MYL>#O)9C^+OM+4OLFX0R^Y>.Q/<O*6\R]?VWG3U8);<,990YYBECF/#K4IN
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MSO*D6P=I9D%-Q!\F%I2WW'A!WS;O;,?V5[EL0?0O\O9,^DXC.H+ZP;=LG("
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M2KAE_@D%P1!/A:[.N$P6X508R& V"1X)9'KM$\OH4A6QR1(1N#(YRK^#X80
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MS$TJ]@;T57LG8#N\7"C[?/9YO%RS%5RZ(0K,,;E+6/X1=M%B2K,#E3I28RR
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MQ>[ZM!E\+4F65!X,TS1 <AE)EL05FRRF8T8RLM1<S:>3$226B5\?T:.;GBZ
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M_E-!7=*P<)X&Z/,=@3Z&DEY.#MK71LNQAGP;0S^#N(S%ZOL7G71,8FS;&2X
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M:4K^1?Z<_XG\'[J6)'_Y?U!+ P04    " #QA3-/M:R &)HS  "'F , %0
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M,W)Q6,U6%3'I=1R8Z\*H5P:C@D[:[OSE,.*2;A)&_3(8%732=\\I!Q*7=C-
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MI8'AT&P&*#('@0HG@'-EK^72D("V_D8:-3+Y3ZA/0#8%"F\5Y'2"HFOJ51C
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M&.V!"G7#M<\?55L.9]OK.>$=[U[%[:;=5U_B1@6@_[CL3Z&7YW^VGW87^4H
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M %;J-B7JPYZE9":WPTY&),7.6,29\Y5*ABTQF$GYWMAH%B; EF:9?BV3R3#
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M^?]02P$"% ,4    " #QA3-/O*3K!.H[ 0#T3@T $0              @ $
M    :VYW;BTR,#$Y,#,S,2YX;6Q02P$"% ,4    " #QA3-/7R+*7&,0   X
ML@  $0              @ $9/ $ :VYW;BTR,#$Y,#,S,2YX<V102P$"% ,4
M    " #QA3-/W1'#- <2  !4TP  %0              @ &K3 $ :VYW;BTR
M,#$Y,#,S,5]C86PN>&UL4$L! A0#%     @ \84S3ZB&#T;W'@  BRT" !4
M             ( !Y5X! &MN=VXM,C Q.3 S,S%?9&5F+GAM;%!+ 0(4 Q0
M   ( /&%,T];:ES^8$@  %0L!  5              "  0]^ 0!K;G=N+3(P
M,3DP,S,Q7VQA8BYX;6Q02P$"% ,4    " #QA3-/M:R &)HS  "'F , %0
M            @ &BQ@$ :VYW;BTR,#$Y,#,S,5]P<F4N>&UL4$L%!@     &
-  8 B@$  &_Z 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6592005792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis of Presentation</b> &#8211; The accompanying
unaudited consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been
eliminated. The preparation of these unaudited condensed consolidated financial statements were prepared in conformity with U.S.
generally accepted accounting principles (&#8220;GAAP&#8221;).</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Principles of Consolidation</b> &#8211; The
consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries, TransTech
Systems, Inc and RAAI Lighting, Inc. Inter-Company items and transactions have been eliminated in consolidation.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash and Cash Equivalents</b> &#8211;&#160;The
Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash
equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal
Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not
exposed to any significant risk for cash on deposit.&#160;&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounts Receivable and Allowance for Doubtful
Accounts</b> &#8211; Accounts receivable consist primarily of amounts due to the Company from normal business activities. The Company
maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection
history and specific risks identified within the portfolio. If the financial condition of the customers were to deteriorate resulting
in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances
might be required.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Inventories</b> &#8211; Inventories consist
primarily of printers and consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control
components held for resale and are stated at the lower of cost or market on the&#160;first-in, first-out (&#8220;FIFO&#8221;) method.&#160;&#160;Inventories
are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received
by TransTech at a warehouse location.&#160;&#160;The Company records a provision for excess and obsolete inventory whenever an
impairment has been identified. There is a $35,000 reserve for impaired inventory as of March 31, 2019 and September 30, 2018,
respectively.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Equipment</b> &#8211; Equipment consists
of machinery, leasehold improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation
and amortization. Depreciation is computed by the straight-line method over the estimated useful lives or lease period of the relevant
asset, generally 2-10 years, except for leasehold improvements which are depreciated over 2-3 years.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Long-Lived Assets</b> &#8211; The Company
reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an
asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair
value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at
the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying
values exceed fair values, an impairment loss is recognized in operating results.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Intangible Assets</b> &#8211; Intangible
assets are capitalized and amortized on a straight-line basis over their estimated useful life, if the life is determinable. If
the life is not determinable, amortization is not recorded. We regularly perform reviews to determine if facts and circumstances
exist which indicate that the useful lives of our intangible assets are shorter than originally estimated or the carrying amount
of these assets may not be recoverable. When an indication exists that the carrying amount of intangible assets may not be recoverable,
we assess the recoverability of our assets by comparing the projected undiscounted net cash flows associated with the related asset
or group of assets over their remaining lives against their respective carrying amounts. Such impairment test is based on the lowest
level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Impairment,
if any, is based on the excess of the carrying amount over the estimated fair value of those assets.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Research, Development and Engineering Expenses</b>
&#8211; Research, development and engineering expenses consist of the cost of employees, consultants and contractors who design,
engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s research and development
efforts are primarily focused improving the core foundational ChromaID technology and developing new and unique applications for
the technology. As part of this effort, the Company typically conduct testing to ensure that ChromaID application methods are compatible
with the customer&#8217;s requirements, and that they can be implemented in a cost effective manner. The Company is also actively
involved in identifying new application methods. Know Lab&#8217;s team has considerable experience working with the application
of light-based technologies and their application to various industries. The Company believes that its continued development of
new and enhanced technologies relating to our core business is essential to its future success. The Company spent $391,014, $570,514
and $79,405 during the six months ended March 31, 2019 and the years ended September 30, 2018 and 2017, respectively, on research
and development activities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Fair Value Measurements and Financial Instruments
</b>&#8211;<b>&#160;</b>ASC Topic 820, <i>Fair Value Measurement and Disclosures</i>, defines fair value as the exchange price
that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market
for the asset or liability in an orderly transaction between market participants on the measurement date.&#160;&#160;This topic
also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring
fair value.&#160;&#160;The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and
an entity&#8217;s own assumptions (unobservable inputs).&#160;&#160;The hierarchy consists of three levels:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Level 1 &#8211; Quoted prices in active markets for identical assets
and liabilities;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Level 2 &#8211; Inputs other than level one inputs that are either
directly or indirectly observable; and.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level&#160;3 - Inputs to the valuation methodology
are unobservable and significant to the fair value measurement.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The recorded value of other financial assets
and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts
payable and accrued expenses approximate the fair value of the respective assets and liabilities as of March 31, 2019 and September
30, 2018 are based upon the short-term nature of the assets and liabilities.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative Financial Instruments -</b>The
Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in
the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton
option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of
derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the
end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based
on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet
date.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Revenue Recognition</b> &#8211; Know Lab
and TransTech revenue are derived from products and services. Revenue is considered realized when the products or services have
been provided to the customer, the work has been accepted by the customer and collectability is&#160;reasonably assured. Furthermore,
if an actual measurement of revenue cannot be determined, the Company defers all revenue recognition until such time that an actual
measurement can be determined. If during the course of a contract management determines that losses are expected to be incurred,
such costs are charged to operations in the period such losses are determined. Revenues are deferred when cash has been received
from the customer but the revenue has not been earned.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock Based Compensation</b> &#8211; The
Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted
stock, as well as options to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based
compensation cost is measured by the Company at the grant date, based on the fair value of the award, over the requisite service
period. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over
the related period of benefit.&#160;&#160;Grants of stock options and stock to non-employees and other parties are accounted for
in accordance with the ASC 505.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Securities</b> &#8211; Based
upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will
evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC
815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated
on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an
instrument were required, it would result in the instrument issued latest being reclassified first.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Net Loss per Share</b> &#8211; Under the
provisions of ASC 260, &#8220;Earnings Per Share,&#8221; basic loss per common share is computed by dividing net loss available
to common stockholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted
net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were
exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the
Company, subject to anti-dilution limitations. As of March 31, 2019, there were options outstanding for the purchase of 2,282,668
common shares, warrants for the purchase of 17,572,583 common shares, and 4,894,071&#160;shares of the Company&#8217;s common stock
issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, the Company has an unknown
number of shares (9,020,264 common shares at the current price of $0.25 per share) are issuable upon conversion of convertible
debentures of $2,255,065. All of which could potentially dilute future earnings per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2018, there were options outstanding
for the purchase of 4,736 common shares, warrants for the purchase of 11,837,422 common shares, 2,825,053 shares of the Company&#8217;s
common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, the Company
has an unknown number of shares issuable upon conversion of convertible debentures of $2,390,066. All of which could potentially
dilute future earnings per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Dividend Policy</b> &#8211; The Company has
never paid any cash dividends and intends, for the foreseeable future, to retain any future earnings for the development of our
business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our
results of operations, financial condition, capital requirements and investment opportunities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b> &#8211; The preparation
of financial statements in conformity with accounting principles generally accepted in the United States requires management to
make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Recent Accounting Pronouncements</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A variety of proposed or otherwise potential
accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative
and preliminary nature of those proposed standards, management has not determined whether implementation of such proposed standards
would be material to the Company&#8217;s consolidated financial statements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis of Presentation</b> &#8211; The accompanying
unaudited consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been
eliminated. The preparation of these unaudited condensed consolidated financial statements were prepared in conformity with U.S.
generally accepted accounting principles (&#8220;GAAP&#8221;).</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Principles of Consolidation</b> &#8211; The
consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries, TransTech
Systems, Inc and RAAI Lighting, Inc. Inter-Company items and transactions have been eliminated in consolidation.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash and Cash Equivalents</b> &#8211;&#160;The
Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash
equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal
Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not
exposed to any significant risk for cash on deposit.&#160;&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounts Receivable and Allowance for Doubtful
Accounts</b> &#8211; Accounts receivable consist primarily of amounts due to the Company from normal business activities. The Company
maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection
history and specific risks identified within the portfolio. If the financial condition of the customers were to deteriorate resulting
in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances
might be required.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Inventories</b> &#8211; Inventories consist
primarily of printers and consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control
components held for resale and are stated at the lower of cost or market on the&#160;first-in, first-out (&#8220;FIFO&#8221;) method.&#160;&#160;Inventories
are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received
by TransTech at a warehouse location.&#160;&#160;The Company records a provision for excess and obsolete inventory whenever an
impairment has been identified. There is a $35,000 reserve for impaired inventory as of September 30, 2018 and 2017, respectively.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Equipment</b> &#8211; Equipment consists
of machinery, leasehold improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation
and amortization. Depreciation is computed by the straight-line method over the estimated useful lives or lease period of the relevant
asset, generally 2-10 years, except for leasehold improvements which are depreciated over 2-3 years.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Long-Lived Assets</b> &#8211; The Company
reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an
asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair
value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at
the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying
values exceed fair values, an impairment loss is recognized in operating results.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Intangible Assets</b> &#8211; Intangible
assets are capitalized and amortized on a straight-line basis over their estimated useful life, if the life is determinable. If
the life is not determinable, amortization is not recorded. We regularly perform reviews to determine if facts and circumstances
exist which indicate that the useful lives of our intangible assets are shorter than originally estimated or the carrying amount
of these assets may not be recoverable. When an indication exists that the carrying amount of intangible assets may not be recoverable,
we assess the recoverability of our assets by comparing the projected undiscounted net cash flows associated with the related asset
or group of assets over their remaining lives against their respective carrying amounts. Such impairment test is based on the lowest
level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Impairment,
if any, is based on the excess of the carrying amount over the estimated fair value of those assets.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Research, Development and Engineering Expenses</b>
&#8211; Research, development and engineering expenses consist of the cost of employees, consultants and contractors who design,
engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s research and development
efforts are primarily focused improving the core foundational ChromaID technology and developing new and unique applications for
the technology. As part of this effort, the Company typically conduct testing to ensure that ChromaID application methods are compatible
with the customer&#8217;s requirements, and that they can be implemented in a cost effective manner. The Company is also actively
involved in identifying new application methods. Know Lab&#8217;s team has considerable experience working with the application
of light-based technologies and their application to various industries. The Company believes that its continued development of
new and enhanced technologies relating to our core business is essential to its future success. The Company spent $570,514 and
$79,405 during the years ended September 30, 2018 and 2017, respectively, on research and development activities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Fair Value Measurements and Financial
Instruments</i></b> &#8211;<b>&#160;</b>ASC Topic 820, <i>Fair Value Measurement and Disclosures</i>, defines fair value as the
exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous
market for the asset or liability in an orderly transaction between market participants on the measurement date.&#160;&#160;This
topic also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring
fair value.&#160;&#160;The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and
an entity&#8217;s own assumptions (unobservable inputs).&#160;&#160;The hierarchy consists of three levels:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 100%; font: 12pt Times New Roman, Times, Serif"><font style="font-size: 8pt">Level 1 &#8211; Quoted prices in active markets for identical assets and liabilities;</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 100%">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Level 2 &#8211; Inputs other than level one inputs that are either
        directly or indirectly observable; and.</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level&#160;3 - Inputs to the valuation methodology
        are unobservable and significant to the fair value measurement.</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The recorded value of other financial assets
and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts
payable and accrued expenses approximate the fair value of the respective assets and liabilities as of September 30, 2018 and 2017
are based upon the short-term nature of the assets and liabilities.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative Financial Instruments -</b>The
Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in
the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton
option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of
derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the
end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based
on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet
date.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Revenue Recognition</b> &#8211; Know Lab
and TransTech revenue are derived from products and services. Revenue is considered realized when the products or services have
been provided to the customer, the work has been accepted by the customer and collectability is&#160;reasonably assured. Furthermore,
if an actual measurement of revenue cannot be determined, the Company defers all revenue recognition until such time that an actual
measurement can be determined. If during the course of a contract management determines that losses are expected to be incurred,
such costs are charged to operations in the period such losses are determined. Revenues are deferred when cash has been received
from the customer but the revenue has not been earned.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock Based Compensation</b> &#8211; The
Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted
stock, as well as options to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based
compensation cost is measured by the Company at the grant date, based on the fair value of the award, over the requisite service
period. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over
the related period of benefit.&#160;&#160;Grants of stock options and stock to non-employees and other parties are accounted for
in accordance with the ASC 505.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Securities</b> &#8211; Based
upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will
evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC
815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated
on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an
instrument were required, it would result in the instrument issued latest being reclassified first.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Net Loss per Share</b> &#8211; Under the
provisions of ASC 260, &#8220;Earnings Per Share,&#8221; basic loss per common share is computed by dividing net loss available
to common stockholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted
net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were
exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the
Company, subject to anti-dilution limitations. The common stock equivalents have not been included as they are anti-dilutive. As
of September 30, 2018, there were options outstanding for the purchase of 2,182,668 common shares, warrants for the purchase of
15,473,398 common shares, 4,914,071 shares of the Company&#8217;s common stock issuable upon the conversion of Series A, Series
C and Series D Convertible Preferred Stock. In addition, we have an unknown number of shares (9,020,264 common shares at the current
price of $0.25 per share) are issuable upon conversion of convertible debentures of $2,255,066. All of which could potentially
dilute future earnings per share. &#160;&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2017, there were options
outstanding for the purchase of 15,404 common shares, warrants for the purchase of 6,900,356 common shares, 2,825,053&#160;shares
of the Company&#8217;s common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock
and up to 332,940 shares of the Company&#8217;s common stock issuable upon the exercise of placement agent warrants. In addition,
the Company has an unknown number of shares are issuable upon conversion of convertible debentures of $570,000. All of which could
potentially dilute future earnings per share. &#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Dividend Policy</b> &#8211; The Company has
never paid any cash dividends and intends, for the foreseeable future, to retain any future earnings for the development of our
business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our
results of operations, financial condition, capital requirements and investment opportunities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b> &#8211; The preparation
of financial statements in conformity with accounting principles generally accepted in the United States requires management to
make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recent Accounting Pronouncements</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2015, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) 2015-11, &#8220;Simplifying the Measurement of Inventory,&#8221; Topic 330,
&#8220;Inventory&#8221; (ASU 2015-11). The amendments in ASU 2015-11, which apply to inventory that is measured using any method
other than the last-in, first-out (LIFO) or retail inventory method, require that entities measure inventory at the lower of cost
and net realizable value. The amendments in ASU 2015-11 should be applied on a prospective basis. ASU 2015-11 is effective for
fiscal years beginning after December 15, 2016 and interim periods within those years. The Company adopted the amendments of ASU
2015-11 effective October 1, 2017. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated
financial statements for the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU 2016-09,
&#8220;Improvements to Employee Share-Based Payment Accounting,&#8221; Topic 718, &#8220;Compensation-Stock Compensation&#8221;
(ASU 2016-09). ASU 2016-09 includes provisions intended to simplify various aspects related to how share-based payments are accounted
for and presented in the Company&#8217;s financial statements, including income tax consequences, forfeitures and classification
on the statement of cash flows. Under previous guidance, excess tax benefits and deficiencies from share-based compensation arrangements
were recorded in equity when the awards vested or were settled. ASU 2016-09 requires prospective recognition of excess tax benefits
and deficiencies in income tax expense, rather than paid-in-capital. The Company adopted the amendments of ASU 2016-09 effective
October 1, 2017.The adoption of this standard did not have a material impact on the Company&#8217;s consolidated statements of
income for the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, under ASU 2016-09, excess tax income
tax benefits from share-based compensation arrangements are classified as cash flow from operations, rather than as cash flow from
financing activities. For the year ended September 30, 2018, there were no excess income tax benefits.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has elected to continue to estimate
the number of share-based awards expected to vest, as permitted by ASU 2016-09, rather than electing to account for forfeitures
as they occur.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2016-09 requires excess tax benefits and
deficiencies to be prospectively excluded from assumed future proceeds in the calculation of diluted shares, resulting in an immaterial
decrease in diluted weighted average shares outstanding for the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2017, the FASB issued ASU 2017-04,
&#8220;Simplifying the Test for Goodwill Impairment,&#8221; Topic 350, &#8220;Intangibles &#8211; Goodwill and Other&#8221; (ASU
2017-04). The amendments in ASU 2017-04 simplify the accounting for goodwill impairment for all entities by requiring impairment
charges to be based on the first step in the current two-step impairment test. An impairment charge for the amount by which the
carrying amount exceeds the reporting unit&#8217;s fair value should be recognized; however, the loss recognized should not exceed
the total amount of goodwill allocated to that reporting unit. The amendments should be applied on a prospective basis. Early adoption
is permitted for annual and interim goodwill impairment testing dates after January 1, 2017, and the ASU is effective for the Company&#8217;s
first quarter of the fiscal year ending September 30, 2020. The Company is currently evaluating the impact that the adoption of
these provisions will have on its consolidated financial statements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,
&#8220;Leases,&#8221; Topic 842, &#8220;Leases&#8221; (ASU 2016-02). ASU No. 2016-02 requires lessees to recognize a right-of-use
asset and corresponding lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation
of expenses will depend on classification as a finance or operating lease. ASU 2016-02 also requires certain quantitative and qualitative
disclosures. The provisions of ASU 2016-02 are effective for the Company&#8217;s first quarter of the fiscal year ending September
30, 2020, with early adoption permitted. The Company will apply the transition provisions of ASU 2016-02 at its adoption date,
rather than the earliest comparative period presented in the financial statements, as permitted by ASU 2018-11, &#8220;Leases,&#8221;
Topic 842, &#8220;Targeted Improvements,&#8221; released in July 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The adoption of ASU 2016-02 may result in a
material increase to the Company&#8217;s consolidated balance sheets for lease liabilities and right-of-use assets. The Company
is also performing a comprehensive review of its current processes to determine and implement changes required to support the adoption
of this standard. The Company is currently evaluating the other effects the adoption of ASU 2016-02 will have on its consolidated
financial statements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2018, the FASB issued ASU 2018-01,
&#8220;Leases,&#8221; Topic 842, &#8220;Land Easement Practical Expedient for Transition to Topic 842&#8221; (ASU 2018-01). ASU
2018-01 permits an entity to elect a transition practical expedient to not assess, under Accounting Standards Codification (ASC)
842, land easements that exist or expired before the standard&#8217;s effective date that were not previously accounted for as
leases under ASC 840. The Company plans to elect this practical expedient in implementing ASU 2016-02.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued ASU 2014-09, &#8220;Revenue
from Contracts with Customers,&#8221; Topic 606, &#8220;Revenue from Contracts with Customers&#8221; (ASU 2014-09). ASU 2014-09
provides guidance for revenue recognition and will replace most existing revenue recognition guidance in GAAP when it becomes effective.
ASU 2014-09&#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers
in an amount that reflects the consideration to which the company expects to be entitled for the transfer of those goods or services.
ASU 2014-09 permits the use of either the retrospective or cumulative effect transition method. Additionally, the amendments in
this ASU provide a practical expedient for entities to recognize the incremental costs of obtaining a contract as an expense when
incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less, The Company
plans to elect this practical expedient upon adoption.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2015, the FASB issued ASU 2015-14, &#8220;Revenue
from Contracts with Customers &#8211; Deferral of the Effective Date.&#8221; The FASB approved the deferral of ASU 2014-09, by
extending the new revenue recognition standard&#8217;s mandatory effective date by one year and permitting public companies to
apply the new revenue standard to annual reporting periods beginning after December 15, 2017. The guidance in ASU 2014-09 will
be effective for the Company in the first quarter of the fiscal year ending September 30, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further to ASU 2014-09 and ASU 2015-14, the
FASB issued ASU 2016-08, &#8220;Revenue from Contracts with Customers,&#8221; Topic 606, &#8220;Principal versus Agent Considerations
(Reporting Revenue Gross versus Net)&#8221; (ASU 2016-08) in March 2016, ASU 2016-12, &#8220;Revenue from Contracts with Customers,&#8221;
Topic 606, &#8220;Narrow-Scope Improvements and Practical Expedients&#8221; (ASU 2016-12) in May 2016 and ASU 2016-20, &#8220;Revenue
from Contracts with Customers,&#8221; Topic 606, &#8220;Technical Corrections and Improvements&#8221; (ASU 2016-20) in December
2016. The amendments in ASU 2016-08 clarify the implementation guidance on principal versus agent considerations, including indicators
to assist an entity in determining whether it controls a specified good or service before it is transferred to the customers. ASU
2016-12 addresses narrow-scope improvements to the guidance on collectability, non-cash consideration, and completed contracts
at transition. Additionally, the amendments in this ASU provide a practical expedient for contract modifications at transition
and an accounting policy election related to the presentation of sales taxes and other similar taxes collected from customers.
The Company plans to make such election. The Company also plans to elect the practical expedient in ASU 2016-20 that provides entities
do not need to disclose the transaction price allocated to performance obligations when the related contracts have a duration of
one year or less. This includes loyalty rewards, which can be redeemed in the month subsequent to the quarter earned, and marketing
promotions that cross accounting periods. Both of these classes of transactions are currently immaterial to the Company. The effective
date and transition requirements for ASU 2016-08, ASU 2016-12 and ASU 2016-20 are the same as for ASU 2014-09.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not plan to early adopt the
new revenue recognition guidance; adoption will be on the modified retrospective basis beginning in fiscal year 2019. The Company
has substantially concluded its assessment of the impact of the adoption of this standard on its consolidated financial statements.
Most of the Company&#8217;s revenue is expected to continue to be generated from point-of-sale transactions, which ASU 2014-09
treats generally consistent with current accounting standards. The Company does not expect this standard will have a material impact
on the accounting for point-of-sale transactions or related areas including the right of return and customer incentives. Although
the impact on the consolidated financial statements is not expected to be material, additional disclosures will be required.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07, &#8220;Compensation-Stock
Compensation,&#8221; Topic 718, &#8220;Improvements to Nonemployee Share-Based Payment Accounting&#8221; (ASU 2018-07) as part
of its Simplification Initiative to reduce complexity when accounting for share-based payments to non-employees. ASU 2018-07 expands
the scope of Topic 718 to more closely align share-based payment transactions for acquiring goods and services from non-employees
with the accounting for share-based payments to employees, with certain exceptions. The provisions of ASU 2018-07 are effective
for the Company&#8217;s first quarter of the fiscal year ending September 30, 2020, with early adoption permitted.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6798160240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Legal Proceedings</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company may from time to time become a party
to various legal proceedings arising in the ordinary course of our business. The Company is currently not a party to any pending
legal proceeding that is not ordinary routine litigation incidental to our business.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Properties and Operating Leases</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is obligated under the following
non-cancelable operating leases for its various facilities and certain equipment.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Years Ended March 31,</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 86%; text-align: center"><font style="font-size: 8pt">2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 8pt">187,652</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2021</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">196,526</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2022</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">5,816</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2023</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2024</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Beyond</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">389,994</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b><i>Corporate Offices</i></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 13, 2017, the Company leased its executive
office located at 500 Union Street, Suite 810, Seattle, Washington, USA, 98101. The Company leases 943 square feet and the net
monthly payment is $2,672. The monthly payment increases approximately 3% each year and the lease expires on May 31, 2022.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Lab Facilities and Executive Offices</i></b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2018, the Company leased its
lab facilities and executive offices located at 304 Alaskan Way South, Suite 102, Seattle, Washington, USA, 98101. The Company
leases 2,800 square feet and the net monthly payment is $4,000. The lease expired on April 30, 2019.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">On February 1, 2019, the Company
leased its lab facilities and executive offices located at 915 E Pine Street, Suite 212, Seattle, WA 98122. The Company leases
2,642 square feet and the net monthly payment is $8,256. The monthly payment increases approximately 3% on July 1, 2019 and annually
thereafter. The lease expires on June 30, 2021 and can be extended.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>TransTech Facilities</i></b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">TransTech is located at 12142 NE Sky
Lane, Suite 130, Aurora, OR 97002. TransTech leases a total of approximately 6,340 square feet of office and warehouse space for
its administrative offices, product inventory and shipping operations. Effective December 1, 2017, TransTech leases this office
from December 1, 2017 at $4,465 per month. The monthly payment increases approximately 3% each year and the lease expires on January
31, 2020. Until December 1, 2017, TransTech leased this office on a month to month basis at $6,942 per month. TransTech terminated
this lease effective May 31, 2019.</p>



<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Legal Proceedings</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company may from time to time become a party
to various legal proceedings arising in the ordinary course of our business. The Company is currently not a party to any pending
legal proceeding that is not ordinary routine litigation incidental to our business.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Employment Agreement with Phillip A. Bosua,
Chief Executive Officer</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company appointed Mr.
Bosua as Chief Executive Officer of the Company, replacing Ronald P. Erickson, who remains Chairman of the Company. Mr. Erickson
has been a director and officer of Know Labs since April 2003. He was appointed as our CEO and President in November 2009 and as
Chairman of the Board in February 2015. Previously, Mr. Erickson was our President and Chief Executive Officer from September 2003
through August 2003 and was Chairman of the Board from August 2004 until May 2011.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Phillip A. Bosua was appointed the Company&#8217;s
CEO on April 10, 2018. Previously, Mr. Bosua served as the Company&#8217;s Chief Product Officer since August 2017. The Company
entered into a Consulting Agreement with Mr. Bosua&#8217;s company, Blaze Clinical on July 7, 2017. From September 2012 to February
2015, Mr. Bosua was the founder and Chief Executive Officer of LIFX Inc. (where he developed and marketed an innovative &#8220;smart&#8221;
light bulb) and from August 2015 until February 2016 was Vice President Consumer Products at Soraa (which markets specialty LED
light bulbs). From February 2016 to July 2017, Mr. Bosua was the founder and CEO of RAAI, Inc. (where he continued the development
of his smart lighting technology). From May 2008 to February 2013 he was the Founder and CEO of LimeMouse Apps, a leading developer
of applications for the Apple App Store.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company entered into
an Employment Agreement with Mr. Bosua reflecting his appointment as Chief Executive Officer. The Employment Agreement is for an
initial term of 12 months (subject to earlier termination) and will be automatically extended for additional 12-month terms unless
either party notifies the other party of its intention to terminate the Employment Agreement. Mr. Bosua will be paid a base salary
of $225,000 per year, received 500,000 shares of common stock valued at $0.33 per share and may be entitled to bonuses and equity
awards at the discretion of the Board or a committee of the Board. The Employment Agreement provides for severance pay equal to
12 months of base salary if Mr. Bosua is terminated without &#8220;cause&#8221; or voluntarily terminates his employment for &#8220;good
reason.&#8221;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Employment Agreement with Ronald P. Erickson, Chairman of the
Board and Interim Chief Financial Officer</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 4, 2017, the Board of Directors approved
an Employment Agreement with Ronald P. Erickson pursuant to which the Company engaged Mr. Erickson as our Chief Executive Officer
through September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Erickson&#8217;s annual compensation is
$180,000. Mr. Erickson is also entitled to receive an annual bonus and equity awards compensation as approved by the Board. The
bonus should be paid no later than 30 days following earning of the bonus.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Erickson will be entitled to participate
in all group employment benefits that are offered by the Company to our senior executives and management employees from time to
time, subject to the terms and conditions of such benefit plans, including any eligibility requirements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If the Company terminates Mr. Erickson&#8217;s
employment at any time prior to the expiration of the Term without Cause, as defined in the Employment Agreement, or if Mr. Erickson
terminates his employment at any time for &#8220;Good Reason&#8221; or due to a &#8220;Disability&#8221;, Mr. Erickson will be
entitled to receive (i) his Base Salary amount for one year; and (ii) medical benefits for eighteen months.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company entered into
an Amended Employment Agreement for Ronald P. Erickson which amends the Employment Agreement dated July 1, 2017. The Agreement
expires March 21, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Properties and Operating Leases</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is obligated under the following
non-cancelable operating leases for its various facilities and certain equipment.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid">Years Ended
        September 30,</p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 63%; text-align: center"><font style="font-size: 8pt">2019</font></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 30%; text-align: right"><font style="font-size: 8pt">118,190</font></td>
    <td style="width: 3%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">85,914</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2021</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">23,498</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2022</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2023</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Beyond</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Total</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">227,602</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b><i>Corporate Offices</i></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 13, 2017, the Company leased its executive
office located at 500 Union Street, Suite 810, Seattle, Washington, USA, 98101. The Company leases 943 square feet and the net
monthly payment is $2,672. The monthly payment increases approximately 3% each year and the lease expires on May 31, 2022.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Lab Facilities and Executive Offices</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2018, the Company leased its lab facilities
and executive offices located at 304 Alaskan Way South, Suite 102, Seattle, Washington, USA, 98101. The Company leases 2,800 square
feet and the net monthly payment is $4,000. The lease expires on April 30, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>TransTech Facilities</i></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">TransTech is located at 12142 NE Sky Lane, Suite
130, Aurora, OR 97002. TransTech leases a total of approximately 6,340 square feet of office and warehouse space for its administrative
offices, product inventory and shipping operations. Effective December 1, 2017, TransTech leases this office from December 1, 2017
at $4,465 per month. The monthly payment increases approximately 3% each year and the lease expires on January 31, 2020. Until
December 1, 2017, TransTech leased this office on a month to month basis at $6,942 per month.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6813865808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF SHAREHOLDER'S EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Series A Convertible Preferred Stock</div></th>
<th class="th"><div>Series B Convertible Preferred Stock</div></th>
<th class="th"><div>Series C Convertible Preferred Stock</div></th>
<th class="th"><div>Series D Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance, Amount at Sep. 30, 2016</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,790<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,356<span></span>
</td>
<td class="nump">$ 24,259,702<span></span>
</td>
<td class="num">$ (27,073,365)<span></span>
</td>
<td class="num">$ (2,809,494)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance, Shares at Sep. 30, 2016</a></td>
<td class="nump">23,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,356,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockCompensationExpenseEmployeeOptions', window );">Stock compensation expense - employee options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,353<span></span>
</td>
<td class="nump">545,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,354,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series D Convertible Preferred Stock, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series D Convertible Preferred Stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,016,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_BeneficialConversionFeature', window );">Benefical conversion feature of Preferred Stock/dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,130<span></span>
</td>
<td class="num">(559,130)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount', window );">Issuance of common stock for conversion of liabilities, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 946<span></span>
</td>
<td class="nump">755,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares', window );">Issuance of common stock for conversion of liabilities, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">944,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockCompensationExpenseWarrants', window );">Stock based compensation- warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockIssuedDuringPeriodValueWarrantExercise', window );">Issuance of common stock for warrant exercise, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of Series A Convertible Preferred Stock, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital', window );">Write-off of derivative liability to additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,901,232)<span></span>
</td>
<td class="num">(3,901,232)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, Amount at Sep. 30, 2017</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,790<span></span>
</td>
<td class="nump">$ 1,015<span></span>
</td>
<td class="nump">$ 4,655<span></span>
</td>
<td class="nump">27,565,453<span></span>
</td>
<td class="num">(31,533,727)<span></span>
</td>
<td class="num">(3,960,791)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance, Shares at Sep. 30, 2017</a></td>
<td class="nump">23,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">1,016,004<span></span>
</td>
<td class="nump">4,655,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockCompensationExpenseEmployeeOptions', window );">Stock compensation expense - employee options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,280<span></span>
</td>
<td class="nump">439,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,279,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series D Convertible Preferred Stock, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">817,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">817,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount', window );">Issuance of common stock for conversion of liabilities, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,435<span></span>
</td>
<td class="nump">709,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">711,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares', window );">Issuance of common stock for conversion of liabilities, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,435,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockIssuedDuringPeriodValueCash', window );">Issuance of common stock for cash, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">1,743,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockIssuedDuringPeriodSharesCash', window );">Issuance of common stock for cash, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockCompensationExpenseWarrants', window );">Stock based compensation- warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockIssuedDuringPeriodValuePatents', window );">Acquisition of patent, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">518,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockIssuedDuringPeriodSharesPatents', window );">Acquisition of patent, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockIssuedDuringPeriodValueWarrantExercise', window );">Issuance of common stock for warrant exercise, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">79,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,147)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockIssuedDuringPeriodSharesWarrantExercise', window );">Issuance of common stock for warrant exercise, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of Series A Convertible Preferred Stock, Amount</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Series A Convertible Preferred Stock, Shares</a></td>
<td class="num">(3,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,257,597)<span></span>
</td>
<td class="num">(3,257,597)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, Amount at Sep. 30, 2018</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,790<span></span>
</td>
<td class="nump">$ 1,015<span></span>
</td>
<td class="nump">$ 17,532<span></span>
</td>
<td class="nump">$ 32,163,386<span></span>
</td>
<td class="num">$ (34,791,324)<span></span>
</td>
<td class="num">(2,607,590)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance, Shares at Sep. 30, 2018</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">1,016,004<span></span>
</td>
<td class="nump">17,531,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,493,821)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance, Amount at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (342,555)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_BeneficialConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Custom Element.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_BeneficialConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Custom Element.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IssuanceOfCommonStockForAccruedLiabilitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Custom Element.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IssuanceOfCommonStockForAccruedLiabilitiesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_SeriesDStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_SeriesDStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockCompensationExpenseEmployeeOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Custom Element.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockCompensationExpenseEmployeeOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockCompensationExpenseWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockCompensationExpenseWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockIssuedDuringPeriodSharesCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockIssuedDuringPeriodSharesCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockIssuedDuringPeriodSharesPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockIssuedDuringPeriodSharesPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockIssuedDuringPeriodSharesWarrantExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockIssuedDuringPeriodSharesWarrantExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockIssuedDuringPeriodValueCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockIssuedDuringPeriodValueCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockIssuedDuringPeriodValuePatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockIssuedDuringPeriodValuePatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockIssuedDuringPeriodValueWarrantExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockIssuedDuringPeriodValueWarrantExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_WriteOffOfDerivativeLiabilityToAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6809649936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KNOW LABS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001074828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6813303008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. FIXED ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2019</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Estimated Useful Lives</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Purchased</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Capital Leases</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 18%; text-align: left">Machinery and equipment</td><td style="width: 3%">&#160;</td>
    <td style="width: 18%; text-align: center">2-10 years</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">406,861</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">42,681</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">449,542</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">2-3 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,112</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: center">2-3 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,051</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">153,071</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Software and websites</td><td>&#160;</td>
    <td style="text-align: center">3- 7 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,830</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,830</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Less:&#160;accumulated&#160;depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(579,318</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(137,701</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(717,019</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">197,536</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">197,536</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 8pt">Estimated</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">September 30, 2018 &#160; &#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid">Useful Lives</p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Purchased</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Capital Leases</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 32%"><font style="font-size: 8pt">Machinery and equipment</font></td>
    <td style="width: 17%; text-align: center"><font style="font-size: 8pt">2-10 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">332,305</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">42,681</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">374,986</font></td>
    <td style="width: 4%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Leasehold improvements</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">2-3 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">276,112</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">276,112</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Furniture and fixtures</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">2-3 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">58,051</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">95,020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">153,071</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Software and websites</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">3- 7 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">35,830</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">35,830</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Less: accumulated depreciation</font></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(532,966</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(137,700</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(670,666</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">169,332</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">169,333</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6802685120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories were and $100,989 and $203,582 as
of March 31, 2019 and September 30, 2018, respectively. Inventories consist primarily of printers and consumable supplies, including
ribbons and cards, badge accessories, capture devices, and access control components held for resale. There was a $35,000 reserve
for impaired inventory as of September 30, 2018 and 2017, respectively. The decrease in inventory related to lower sales at TransTech.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories were $203,582 and $225,909 as of
September 30, 2018 and 2017, respectively. Inventories consist primarily of printers and consumable supplies, including ribbons
and cards, badge accessories, capture devices, and access control components held for resale. There was a $35,000 reserve for impaired
inventory as of September 30, 2018 and 2017, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6631907344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. GOODWILL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">GOODWILL</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s TransTech business is very
capital intensive. The Company reviewed TransTech&#8217;s operations based on its overall financial constraints and determined
the value has been impaired. The company recorded an impairment of goodwill associated with TransTech of $983,645 during the year
ended September 30, 2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6632477584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock', window );">NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Notes payable, capitalized leases and long-term debt as of March
31, 2019 and September 30, 2018 consisted of the following:&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 8pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center">March 31,</td><td style="font-size: 8pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center">September 30,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 56%; font-size: 8pt; text-align: left; padding-bottom: 1pt">Capital Source Business Finance Group</td><td style="width: 8%; font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">$</td><td style="width: 12%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td><td style="width: 8%; font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">$</td><td style="width: 12%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">145,186</td><td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: left">Total debt</td><td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt; text-align: right">145,186</td><td style="font-size: 8pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: left; padding-bottom: 1pt">Less current portion of long term debt</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">(145,186</td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt">Long term debt</td><td style="font-size: 8pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Capital Source Business Finance Group</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 12, 2019, Capital Source cancelled
the Loan and Security Agreement and Capital Source Credit Facility with TransTech. TransTech repaid the remaining $15,165 due on
the Secured Credit Facility. On March 27, 2019, the Company received notice that the UCC Financing Statement filed by Capital Source
to secure a parent Company guarantee was terminated and cancelled by the State of Nevada.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Notes payable, capitalized leases and long-term debt as of September
30, 2018 and 2017 consisted of the following:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">September 30,</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">September 30,</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 64%"><font style="font-size: 8pt">Capital Source Business Finance Group</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">145,186</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">365,725</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Note payable to Umpqua Bank</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">199,935</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Secured note payable to J3E2A2Z LP - related party</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">600,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Total debt</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">145,186</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,165,660</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Less current portion of long term debt</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(145,186</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(1,165,660</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Long term debt</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Capital Source Business Finance Group</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Know Labs, Inc. (the &#8220;Company&#8221;)
finances its TransTech operations from operations and a Secured Credit Facility with Capital Source Business Finance Group. On
June 15, 2018, TransTech entered into a Fifth Modification to the Loan and Security Agreement related to the $500,000 secured credit
facility with Capital Source to fund its operations. The Modification extended the maturity to December 12, 2018. The secured credit
facility provides for a prime rate interest floor for prime interest of 4.5% plus 2.5%. The eligible borrowing is based on 80%
of eligible trade accounts receivable, not to exceed $500,000. The secured credit facility is collateralized by the assets of TransTech,
with a guarantee by Know Labs, including a security interest in all assets of Know Labs. The remaining balance on the accounts
receivable must be repaid by the time the secured credit facility expires on December 12, 2018, unless we renew by automatic extension
for the next successive term. TransTech has $24,000 available as of September 30, 2018.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 6, 2018, Capital Source notified
TransTech that the Loan and Security Agreement and Capital Source Credit Facility would be cancelled as of March 12, 2019.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective December 12, 2018, TransTech
entered into the Sixth Modification to the Loan and Security Agreement which reduced the secured credit facility to $200,000.</p>



<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note Payable to Umpqua Bank</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 9, 2018, the Company repaid a $199,935
Business Loan Agreement with Umpqua Bank from funds previously provided by an entity affiliated with Ronald P. Erickson, our Chairman
of the Board. The Company paid $27,041 and issued 800,000 shares of common stock in exchange for the conversion of this debt. Mr.
Erickson is an accredited investor. These shares were issued in transactions that were not registered under the Act in reliance
upon applicable exemptions from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note Payables to Ronald P. Erickson or J3E2A2Z
LP</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 25, 2018, the Company entered into
amendments to two demand promissory notes, totaling $600,000 with Mr. Erickson, the Company&#8217;s Chief Executive Officer and/or
entities in which Mr. Erickson has a beneficial interest. On March 16, 2018, the demand promissory notes and accrued interest were
converted into convertible notes payable. See Note 11 for additional details.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6599134480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance</a></td>
<td class="nump">$ 193,372<span></span>
</td>
<td class="nump">$ 320,538<span></span>
</td>
<td class="nump">$ 693,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts', window );">Allowance for bad debt</a></td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recovery of loans and lease receivables which had previously been fully or partially written-off as bad debts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForLoanAndLeaseLossRecoveryOfBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>133</ContextCount>
  <ElementCount>307</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDER'S EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/ConsolidatedStatementOfShareholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENT OF SHAREHOLDER'S EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - 1. ORGANIZATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/Organization</Role>
      <ShortName>1. ORGANIZATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - 2. GOING CONCERN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/GoingConcern</Role>
      <ShortName>2. GOING CONCERN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandards</Role>
      <ShortName>3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/AccountsReceivablecustomerConcentration</Role>
      <ShortName>4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - 5. INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/Inventories</Role>
      <ShortName>5. INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - 6. NOTES RECEIVABLE FROM BIOMEDX, INC</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://knowlabs.co/role/NotesReceivableFromBiomedxInc</Role>
      <ShortName>6. NOTES RECEIVABLE FROM BIOMEDX, INC</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - 7. FIXED ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/FixedAssets</Role>
      <ShortName>7. FIXED ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - 8. INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/IntangibleAssets</Role>
      <ShortName>8. INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - 9. GOODWILL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/Goodwill</Role>
      <ShortName>9. GOODWILL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - 10. ACCOUNTS PAYABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/AccountsPayable</Role>
      <ShortName>10. ACCOUNTS PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - 11. DERIVATIVE INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/DerivativeInstruments</Role>
      <ShortName>11. DERIVATIVE INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://knowlabs.co/role/ConvertibleNotesPayable</Role>
      <ShortName>12. CONVERTIBLE NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt</Role>
      <ShortName>13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - 14. EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/Equity</Role>
      <ShortName>14. EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - 15. STOCK OPTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/StockOptions</Role>
      <ShortName>15. STOCK OPTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties</Role>
      <ShortName>16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings</Role>
      <ShortName>17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - 18. INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/IncomeTaxes</Role>
      <ShortName>18. INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - 19. SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/SubsequentEvents</Role>
      <ShortName>19. SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies</Role>
      <ShortName>3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - 7. FIXED ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/FixedAssetsTables</Role>
      <ShortName>7. FIXED ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://knowlabs.co/role/FixedAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - 8. INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/IntangibleAssetsTables</Role>
      <ShortName>8. INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://knowlabs.co/role/IntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables</Role>
      <ShortName>13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebt</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - 14. EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/EquityTables</Role>
      <ShortName>14. EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://knowlabs.co/role/Equity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - 15. STOCK OPTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/StockOptionsTables</Role>
      <ShortName>15. STOCK OPTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://knowlabs.co/role/StockOptions</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables</Role>
      <ShortName>17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedings</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - 18. INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/IncomeTaxesTables</Role>
      <ShortName>18. INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://knowlabs.co/role/IncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - 2. GOING CONCERN (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/GoingConcernDetailsNarrative</Role>
      <ShortName>2. GOING CONCERN (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/GoingConcern</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - 3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsDetailsNarrative</Role>
      <ShortName>3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/SignificantAccountingPoliciesAdoptionOfAccountingStandardsPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - 4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/AccountsReceivablecustomerConcentrationDetailsNarrative</Role>
      <ShortName>4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/AccountsReceivablecustomerConcentration</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - 5. INVENTORIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/InventoriesDetailsNarrative</Role>
      <ShortName>5. INVENTORIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/Inventories</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - 7. FIXED ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/FixedAssetsDetails</Role>
      <ShortName>7. FIXED ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/FixedAssetsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - 7. FIXED ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/FixedAssetsDetailsNarrative</Role>
      <ShortName>7. FIXED ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/FixedAssetsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - 8. INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/IntangibleAssetsDetails</Role>
      <ShortName>8. INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/IntangibleAssetsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - 8. INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>8. INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/IntangibleAssetsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - 9. GOODWILL (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/GoodwillDetailsNarrative</Role>
      <ShortName>9. GOODWILL (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/Goodwill</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - 10. ACCOUNTS PAYABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/AccountsPayableDetailsNarrative</Role>
      <ShortName>10. ACCOUNTS PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/AccountsPayable</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - 12. CONVERTIBLE NOTES PAYABLE (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://knowlabs.co/role/ConvertibleNotesPayableDetailsNarrative</Role>
      <ShortName>12. CONVERTIBLE NOTES PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/ConvertibleNotesPayable</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - 13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtDetails</Role>
      <ShortName>13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/NotesPayableCapitalizedLeasesAndLongTermDebtTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - 14. EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/EquityDetails</Role>
      <ShortName>14. EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/EquityTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - 12. EQUITY (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/EquityDetails1</Role>
      <ShortName>12. EQUITY (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - 14. EQUITY (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/EquityDetails2</Role>
      <ShortName>14. EQUITY (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/EquityTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - 14. EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/EquityDetailsNarrative</Role>
      <ShortName>14. EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/EquityTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - 15. STOCK OPTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/StockOptionsDetails</Role>
      <ShortName>15. STOCK OPTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/StockOptionsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - 15. STOCK OPTIONS (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/StockOptionsDetails1</Role>
      <ShortName>15. STOCK OPTIONS (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/StockOptionsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - 15. STOCK OPTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/StockOptionsDetailsNarrative</Role>
      <ShortName>15. STOCK OPTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/StockOptionsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - 16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedPartiesDetailsNarrative</Role>
      <ShortName>16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/OtherSignificantTransactionsWithRelatedParties</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - 17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsDetails</Role>
      <ShortName>17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/CommitmentsContingenciesAndLegalProceedingsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - 18. INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/IncomeTaxesDetails</Role>
      <ShortName>18. INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://knowlabs.co/role/IncomeTaxesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="knwn-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - 17. INCOME TAXES (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://knowlabs.co/role/IncomeTaxesDetails1</Role>
      <ShortName>17. INCOME TAXES (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>knwn-20190331.xml</File>
    <File>knwn-20190331.xsd</File>
    <File>knwn-20190331_cal.xml</File>
    <File>knwn-20190331_def.xml</File>
    <File>knwn-20190331_lab.xml</File>
    <File>knwn-20190331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6636908144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract', window );"><strong>Commitments Contingencies And Legal Proceedings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Future minimum lease payments under non-cancelable operating leases</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Years Ended March 31,</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 86%; text-align: center"><font style="font-size: 8pt">2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 8pt">187,652</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2021</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">196,526</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2022</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">5,816</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2023</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2024</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Beyond</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">389,994</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid">Years Ended
        September 30,</p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 63%; text-align: center"><font style="font-size: 8pt">2019</font></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 30%; text-align: right"><font style="font-size: 8pt">118,190</font></td>
    <td style="width: 3%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">85,914</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2021</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">23,498</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2022</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">2023</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Beyond</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">Total</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">227,602</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_CommitmentsContingenciesAndLegalProceedingsTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6632316784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Accrued liabilities related parties from advances</a></td>
<td class="nump">$ 478,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToOtherRelatedPartiesClassifiedCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 513,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOtherRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToOtherRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6608114768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. CONVERTIBLE NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_ConvertibleNotesPayableDisclosureTextBlock', window );">CONVERTIBLE NOTES PAYABLE</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Convertible notes payable as of March 31, 2019 and September 30,
2018 consisted of the following:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Promissory Notes with Clayton
A. Struve</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2019, the Company owes Clayton
A. Struve $1,071,000 under convertible promissory or OID notes. The Company recorded accrued interest of $58,411 as of March 31,
2019. On May 8, 2019, the Company signed Amendment 2 to the convertible promissory or OID notes, extending the due dates to September
30, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Redeemable Promissory Notes with
Ronald P. Erickson and J3E2A2Z</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 16, 2018, the Company entered into
a Note and Account Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was
converted to a Convertible Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z
Account Payable was converted into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a
warrant to purchase up to 1,039,666 shares of common stock of the Company for a period of five years. The initial exercise price
of the warrants described above is $0.50 per share, also subject to certain adjustments. The warrants were valued at $110,545.
Because the note is immediately convertible, the warrants and beneficial conversion were expensed as interest. The Company recorded
accrued interest of $41,361 as of March 31, 2019. On May 8, 2019, the Company signed Amendment 1 to the convertible redeemable
promissory notes, extending the due dates to September 30, 2019 and increasing the interest rate to 6%.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Convertible notes payable as of September 30, 2018 and September
30, 2017 consisted of the following:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Convertible Promissory Note dated September
30, 2016</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 30, 2016, the Company entered into
a $210,000 Convertible Promissory Note with Clayton A. Struve, an accredited investor of the Company, to fund short-term working
capital. The Convertible Promissory Note accrued interest at a rate of 10% per annum and was due on March 30, 2017. The Note holder
can convert the Note into common stock at $0.70 per share. During the year ended September 30, 2017, the Company recorded interest
of $21,000 related to the convertible note. This note was extended in the Securities Purchase Agreement, General Security Agreement
and Subordination Agreement dated August 14, 2017 with a maturity date of August 13, 2018. Also, the conversion price of the Debenture
was adjusted to $0.25 per share, subject to certain adjustments. The balance was increased $75,000 during the year ended September
30, 2018. On November 16, 2018, we signed Amendment 1 to Senior Secured Convertible Redeemable Notes dated September 30, 2016extending
the due dates of the Note to February 27, 2019. On September 24, 2018, Mr. Struve converted $200,000 of the Note into 800,000 shares
of our common stock. The Company recorded accrued interest of $54,671 as of September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Securities Purchase Agreement dated August
14, 2017</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 14, 2017, the Company issued a senior
convertible exchangeable debenture with a principal amount of $360,000 and a common stock purchase warrant to purchase 1,440,000
shares of common stock in a private placement to Clayton Struve for gross proceeds of $300,000 pursuant to a Securities Purchase
Agreement dated August 14, 2017. The debenture accrues interest at 20% per annum and matures August 13, 2018. The convertible debenture
contains a beneficial conversion valued at $110,629. The warrants were valued at $111,429. Because the note is immediately convertible,
the warrants and beneficial conversion were expensed as interest.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On the same date, the Company entered into a
General Security Agreement with the Mr. Struve, pursuant to which the Company has agreed to grant a security interest to the investor
in substantially all of our assets, effective upon the filing of a UCC-3 termination statement to terminate the security interest
held by Capital Source Business Finance Group in the assets of the Company. In addition, an entity affiliated with Ronald P. Erickson,
out then Chief Executive Officer, entered into a Subordination Agreement with the investor pursuant to which all debt owed by us
to such entity is subordinated to amounts owed by us to Mr. Struve under the Debenture (including amounts that become owing under
any Debentures issued to the investor in the future).</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The initial conversion price of the Debenture
is $0.25 per share, subject to certain adjustments. The initial exercise price of the Warrant is $0.25 per share, also subject
to certain adjustments.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of the Purchase Agreement, the Company
granted the investor &#8220;piggyback&#8221; registration rights to register the shares of common stock issuable upon the conversion
of the Debenture and the exercise of the Warrant with the Securities and Exchange Commission for resale or other disposition.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Debenture and the Warrant were issued in
a transaction that was not registered under the Securities Act of 1933, as amended in reliance upon applicable exemptions from
registration under Section 4(a)(2) of the Act and Rule 506 of SEC Regulation D under the Act. &#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Purchase Agreement, Mr.
Struve may purchase up to an aggregate of $1,000,000 principal amount of Debentures (before a 20% original issue discount) (and
Warrants to purchase up to an aggregate of 250,000 shares of common stock). These securities are being offered on a &#8220;best
efforts&#8221; basis by the placement agent.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2017, $156,941
was recorded as interest expense related to debt discounts, beneficial conversions and warrants associated with Convertible Promissory
Notes.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 12, 2017, the Company closed an
additional $250,000 and issued a senior convertible exchangeable debenture with a principal amount of $300,000 and a common stock
purchase warrant to purchase 1,200,000 shares of common stock in a private placement dated December 12, 2017 with Mr. Struve pursuant
to a Securities Purchase Agreement dated August 14, 2017. The convertible debenture contains a beneficial conversion valued at
$93,174. The warrants were valued at $123,600. Because the note is immediately convertible, the warrants and beneficial conversion
were expensed as interest.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 2, 2018, the Company received gross
proceeds of $280,000 in exchange for issuing a senior convertible redeemable debenture with a principal amount of $336,000 and
a warrant to purchase 1,344,000 shares of common stock in a private placement dated February 28, 2018 with Mr. Struve pursuant
to a Securities Purchase Agreement dated August 14, 2017. The convertible debenture contains a beneficial conversion valued at
$252,932. The warrants were valued at $348,096. Because the note is immediately convertible, the warrants and beneficial conversion
were expensed as interest.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the February 28, 2018 private
placement, the placement agent for the debenture and the warrant received a cash fee of $28,000 and the Company issued warrants
to purchase shares of the Company&#8217;s common stock to the placement agent or its affiliates based on 10% of proceeds.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 16, 2018, the Company signed Amendment
1 to Senior Secured Convertible Redeemable Notes dated August 14, 2017 and December 12, 2017, extending the due dates of the Notes
to February 27, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Redeemable Promissory Notes with
Ronald P. Erickson and J3E2A2Z</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 16, 2018, the Company entered into
a Note and Account Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was
converted to a Convertible Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z
Account Payable was converted into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a
warrant to purchase up to 1,039,666 shares of common stock of the Company for a period of five years. The initial exercise price
of the warrants described above is $0.50 per share, also subject to certain adjustments. The warrants were valued at $110,545.
Because the note is immediately convertible, the warrants and beneficial conversion were expensed as interest. The Company recorded
accrued interest of $23,649 as of September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_ConvertibleNotesPayableDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_ConvertibleNotesPayableDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6636921584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">ACCOUNTS RECEIVABLE/CUSTOMER CONCENTRATION</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable were $193,372 and $320,538,
net of allowance, as of March 31, 2019 and September 30, 2018, respectively. The Company had two customers in excess of 10% (14.8%
and 10.1%) of the Company&#8217;s consolidated revenues for the three months ended March 31, 2019. The Company had two customers
in excess of 10% (21.7%,and 20.7%) with accounts receivable in excess of 10% as of March 31, 2019. The Company has a total allowance
for bad debt in the amount of $60,000 as of March 31, 2019.&#160;The decrease in accounts receivable related to lower sales and
purchases at TransTech.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable were $320,538 and $693,320,
net of allowance, as of September 30, 2018 and 2017, respectively. The Company had one customer in excess of 10% (25.4%) of the
Company&#8217;s consolidated revenues for the year ended September 30, 2018. The Company had four customers in excess of 10% (13.9%,
12.9%, 12.5% and 11.2%) with accounts receivable in excess of 10% as of September 30, 2018. The Company has a total allowance for
bad debt in the amount of $60,000 as of September 30, 2018.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6630659280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IntangibleAssetsAbstract', window );"><strong>Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Intangible assets as of March 31, 2019 and September 30, 2018 consisted
of the following:&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Estimated</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">September 30,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Useful Lives</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 22%">Technology</td><td style="width: 5%">&#160;</td>
    <td style="width: 21%; text-align: center">3 years</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 19%; text-align: right">520,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 19%; text-align: right">520,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(158,888</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(72,222</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;&#160;&#160;&#160;Intangible assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">361,112</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">447,778</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total amortization expense was $86,666 and $0
for the six months ended March 31, 2019 and 2018, respectively.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Merger with RAAI Lighting, Inc.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company entered into
an Agreement and Plan of Merger with 500 Union Corporation, a Delaware corporation and a wholly owned subsidiary of the Company,
and RAAI Lighting, Inc., a Delaware corporation. Pursuant to the Merger Agreement, we have acquired all the outstanding shares
of RAAI&#8217;s capital stock through a merger of Merger Sub with and into RAAI (the &#8220;Merger&#8221;), with RAAI surviving
the Merger as a wholly owned subsidiary of the Company.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Merger Agreement, each
share of RAAI common stock issued and outstanding immediately before the Merger (1,000 shares) were cancelled and converted into
the right to receive 2,000 shares of the Company&#8217;s common stock. As a result, the Company issued 2,000,000 shares of its
common stock to Phillip A. Bosua, formerly the sole stockholder of RAAI. The consideration for the Merger was determined through
arms-length bargaining by the Company and RAAI. The Merger was structured to qualify as a tax-free reorganization for U.S. federal
income tax purposes. As a result of the Merger, the Company received certain intellectual property, related to RAAI.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Merger with Know Labs, Inc.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2018, Know Labs, Inc., a Nevada corporation
incorporated on April 3, 2018, and our wholly-owned subsidiary, merged with and into the Company pursuant to an Agreement and Plan
of Merger dated May 1, 2018. In connection with the merger, our Articles of Incorporation were effectively amended to change our
name to Know Labs, Inc. by and through the filing of Articles of Merger. This parent-subsidiary merger was approved by us, the
parent, in accordance with Nevada Revised Statutes Section 92A.180. Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">RAAI had no outstanding indebtedness or assets at the closing of
the Merger. The 2,000,000 shares of the Company&#8217;s common stock issued for RAAI&#8217;s shares were recorded at the fair value
at the date of the merger at $520,000 and the value assigned to the patent acquired with RAAI.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the intellectual property
associated with the assets acquired was $520,000 estimated by using a discounted cash flow approach based on future economic benefits.
In summary, the estimate was based on a projected income approach and related discounted cash flows over five years, with applicable
risk factors assigned to assumptions in the forecasted results.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>



<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Intangible assets as of September 30, 2018 and September 30, 2017
consisted of the following:&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 8pt">Estimated</font></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">September 30,</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">September 30,</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid">Useful Lives</p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 47%"><font style="font-size: 8pt">Technology</font></td>
    <td style="width: 19%; text-align: center"><font style="font-size: 8pt">3 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 8pt">520,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Less: accumulated amortization</font></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(72,222</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">&#160;&#160;&#160;&#160;Intangible assets, net</font></td>
    <td>&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">447,778</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total amortization expense was $72,222 and $0
for the years ended September 30, 2018 and 2017, respectively.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Merger with RAAI Lighting, Inc.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company entered into
an Agreement and Plan of Merger with 500 Union Corporation, a Delaware corporation and a wholly owned subsidiary of the Company,
and RAAI Lighting, Inc., a Delaware corporation. Pursuant to the Merger Agreement, we have acquired all the outstanding shares
of RAAI&#8217;s capital stock through a merger of Merger Sub with and into RAAI (the &#8220;Merger&#8221;), with RAAI surviving
the Merger as a wholly owned subsidiary of the Company.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Merger Agreement, each
share of RAAI common stock issued and outstanding immediately before the Merger (1,000 shares) were cancelled and we issued 2,000,000
shares of our common stock. As a result, we issued 2,000,000 shares of its common stock to Phillip A. Bosua, formerly the sole
stockholder of RAAI. The consideration for the Merger was determined through arms-length bargaining by the Company and RAAI. The
Merger was structured to qualify as a tax-free reorganization for U.S. federal income tax purposes. As a result of the Merger,
the Company received certain intellectual property, related to RAAI.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Merger with Know Labs, Inc.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2018, Know Labs, Inc., a Nevada corporation
incorporated on April 3, 2018, and our wholly-owned subsidiary, merged with and into the Company pursuant to an Agreement and Plan
of Merger dated May 1, 2018. In connection with the merger, our Articles of Incorporation were effectively amended to change our
name to Know Labs, Inc. by and through the filing of Articles of Merger. This parent-subsidiary merger was approved by us, the
parent, in accordance with Nevada Revised Statutes Section 92A.180. Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">RAAI had no outstanding indebtedness or assets
at the closing of the Merger. The 2,000,000 shares of the Company&#8217;s common stock issued for RAAI&#8217;s shares were recorded
at the fair value at the date of the merger at $520,000 and the value assigned to the patent acquired with RAAI.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the intellectual property
associated with the assets acquired was $520,000 estimated by using a discounted cash flow approach based on future economic benefits.
In summary, the estimate was based on a projected income approach and related discounted cash flows over five years, with applicable
risk factors assigned to assumptions in the forecasted results.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6644023552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>5. INVENTORIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_InventoriesDetailsNarrativeAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 100,989<span></span>
</td>
<td class="nump">$ 203,582<span></span>
</td>
<td class="nump">$ 225,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserve for impaired inventory</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_InventoriesDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_InventoriesDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6631077648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>18. INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of components of the Company&#8217;s deferred tax assets</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 64%"><font style="font-size: 8pt">U.S. operations loss carry forward at statutory rate of 21%</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">(5,743,840</font></td>
    <td style="width: 1%"><font style="font-size: 8pt">)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">(5,804,285</font></td>
    <td style="width: 1%"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Non-U.S. operations loss carry forward at statutory rate of 20.5%</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Total</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(5,743,840</font></td>
    <td><font style="font-size: 8pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(5,804,285</font></td>
    <td><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Less Valuation Allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">5,743,840</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">5,804,285</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Net Deferred Tax Assets</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Change in Valuation allowance</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">60,445</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">(1,036,276</font></td>
    <td style="padding-bottom: 3pt"><font style="font-size: 8pt">)</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of effective tax rate reconciliation</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 64%"><font style="font-size: 8pt">Federal Statutory Rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">-21.0</font></td>
    <td style="width: 1%"><font style="font-size: 8pt">%</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">-21.0</font></td>
    <td style="width: 1%"><font style="font-size: 8pt">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Increase in Income Taxes Resulting from:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">&#160;&#160;&#160;&#160;Change in Valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">21.0</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">%</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">21.0</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Effective Tax Rate</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.0</font></td>
    <td style="padding-bottom: 3pt"><font style="font-size: 8pt">%</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.0</font></td>
    <td style="padding-bottom: 3pt"><font style="font-size: 8pt">%</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6801837520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. STOCK OPTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options to purchase common stock under 2011 Stock Incentive Plan</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,473,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Average exercise price under 2011 Stock Incentive Plan</a></td>
<td class="nump">$ 0.453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Compensation expense</a></td>
<td class="nump">$ 263,145<span></span>
</td>
<td class="nump">$ 7,334<span></span>
</td>
<td class="nump">$ 50,899<span></span>
</td>
<td class="nump">$ 37,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs</a></td>
<td class="nump">$ 1,606,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition</a></td>
<td class="text">4 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="nump">2,462,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 535,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=KNWN_StockIncentivePlanMember', window );">2011 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options to purchase common stock under 2011 Stock Incentive Plan</a></td>
<td class="nump">2,282,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Average exercise price under 2011 Stock Incentive Plan</a></td>
<td class="nump">$ 1.757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=KNWN_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=KNWN_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6801974912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. INCOME TAXES (Details 1)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract', window );"><strong>Income Taxes Effective Tax Rate Details Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal Statutory Rate</a></td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IncreaseInIncomeTaxesResultingFromAbstract', window );"><strong>Increase in Income Taxes Resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in Valuation allowance</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Tax Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IncomeTaxesEffectiveTaxRateDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IncreaseInIncomeTaxesResultingFromAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IncreaseInIncomeTaxesResultingFromAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6814707840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. EQUITY (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="nump">15,473,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">3 years 9 months 11 days<span></span>
</td>
<td class="text">3 years 7 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">$ 0.453<span></span>
</td>
<td class="nump">$ 0.326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="nump">15,473,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">$ 0.453<span></span>
</td>
<td class="nump">$ 0.326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantOneMember', window );">Warrant One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="nump">13,507,286<span></span>
</td>
<td class="nump">13,870,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">4 years 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">$ 0.250<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="nump">13,507,286<span></span>
</td>
<td class="nump">13,870,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">$ 0.250<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantTwoMember', window );">Warrant Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="nump">714,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">2 years 3 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">$ 0.700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="nump">714,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">$ 0.700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantThreeMember', window );">Warrant Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="nump">882,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">2 years 7 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">$ 1.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="nump">882,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">$ 1.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantFourMember', window );">Warrant Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="nump">2,442,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">4 years 11 months 5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="nump">2,442,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantFiveMember', window );">Warrant Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantSixMember', window );">Warrant Six [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 7 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">$ 30.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">$ 30.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant2Member', window );">Warrant 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">714,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">714,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant3Member', window );">Warrant 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 1 month 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">882,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant4Member', window );">Warrant 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Warrant Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">1.200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">1.200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Warrant Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">2.340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">2.340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Warrant Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">1.500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">1.500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Warrant Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price, outstanding</a></td>
<td class="nump">4.080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted Average Exercise Price, exercisable</a></td>
<td class="nump">$ 4.080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_WarrantSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_Warrant4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6630553488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>10. ACCOUNTS PAYABLE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 1,298,278<span></span>
</td>
<td class="nump">$ 1,512,617<span></span>
</td>
<td class="nump">$ 2,156,646<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>45
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+""
MWTG] E!+ P04    " #QA3-/T(-;:N\    K @  $0   &1O8U!R;W!S+V-O
M<F4N>&ULS9+!:L,P#(9?9?B>*&Y+(2;-I:.G#@8K;.QF;+4UBV-C:R1]^SE>
MFS*V!QCX8NGWIT_@1GFA7,#GX#P&,A@?1MOU42B_86<B+P"B.J.5L4R)/C6/
M+EA)Z1I.X*7ZD">$156MP2))+4G"!"S\3&1MHY50 26Y<,5K->/]9^@R3"O
M#BWV%(&7'%@[3?27L6O@#IA@A,'&[P+JF9BK?V)S!]@U.48SIX9A*(=ESJ4=
M.+P][5_RNH7I(\E>87H5C:"+QPV[37Y=;A\/.]8N*EX755WP^L#78I7.ZGUR
M_>%W%[9.FZ/YQ\8WP;:!7_^B_0)02P,$%     @ \84S3YE<G",0!@  G"<
M !,   !X;"]T:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T
M$W-I=MNTF83M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY
M\^XN8NB&B)3R>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2
MP]R"BPA+>!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?
M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA
M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M
M&N#C\7@XMLO2BW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_K
MFVB<"HU;3]-K=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K
M>A(5M>5 TR  6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T
M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)
MI#-ZG7TZSFN4?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R
M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MCR_SCP=]<SC]4%&<?RV9_P]02P,$%     @ \84S3V$Z60RC P  ;A0  !@
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M?MY3WMU%]#XQ5W_;'>PO=O^=N3RM.?JVX8M5]-:M,R(/ \*N$&83CP"1V(@
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M=V]R:W-H965T<R]S:&5E=#0N>&ULC9G;;MM&$(9?1=!]K)W9LV$;B Y4"[1
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MI5M&-@XA5IP 4-;0-GPQT9H3,6AG1M8?E&Q"%+\FLA3SGAF.],&JM,?I9I%
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M/7R-W??=Z5CCZ4?;O/9'-J<?YT;O_P]02P,$%     @ \84S3Z*6=6C/ 0
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MJ*R?[MU<CQTP!E9U4W.3^0^3_P-02P,$%     @ \84S3^-(2I#1 0  ;00
M !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q]5.V.G" 4?17" RR.NN-T
MHB8[L]FT29M,MFG[F]'K1Q;$ H[;MR^@:UV7](]P+^<<S@6NZ2CDBVH -'KE
MK%,9;K3NCX2HH@%.U9WHH3,KE9"<:A/*FJA> BT=B3,2!L&><-IV.$]=[B+S
M5 R:M1U<)%(#YU3^.0$38X9W^"WQW-:-M@F2ISVMX3OH'_U%FH@L*F7+H5.M
MZ)"$*L,/N^,YMG@'^-G"J%9S9"NY"O%B@R]EA@-K"!@4VBI0,]S@#(Q9(6/C
M]ZR)ERTM<3U_4W]RM9M:KE3!6;!?;:F;#!\P*J&B ]//8OP,<SWW&,W%?X4;
M, .W3LP>A6#*?5$Q*"WXK&*L</HZC6WGQG%:V7^::7Y".!/"A7 (_DN(9D*T
M(9#)F2OUD6J:IU*,2$Z7U5/[)G;'R!QF89/N[-R:J5:9["W?'>Y3<K-",^8T
M8<(UYCWB_!&1A N$& .+B]#GXA1^X(>;'3R(V+]#Y*TS<OQH74.2^ 5BKT#L
M!.)W![7?')0/DVP*\6$.&R-D=7L<9.T>ND*%&#K79*OLTDL/H;O]?_"I$;]1
M6;>=0E>AS1MR-UT)H<%8">[,ZVY,[R\!@TK;:6+F<NJ *="BGYN;+'^8_"]0
M2P,$%     @ \84S3Q.*? /0 0  ;00  !D   !X;"]W;W)K<VAE971S+W-H
M965T,3 N>&UL?53;;IPP$/T5RQ\0LT"SFQ4@9;>J6JF55JF:/GMAN"B^4-LL
MZ=_7-@ZE!/4%>\;GG+G80S9*]:); (->.1,ZQZTQ_9$07;; J;Z3/0A[4DO%
MJ;&F:HCN%=#*DS@C<13=$TX[@8O,^RZJR.1@6"?@HI >.*?J]PF8''.\PV^.
MIZYIC7.0(NMI ]_!_.@OREID5JDZ#D)W4B %=8X?=\=SZO >\-S!J!=[Y"JY
M2OGBC"]5CB.7$# HC5.@=KG!&1AS0C:-7T$3SR$=<;E_4__D:[>U7*F&LV0_
MN\JT.3Y@5$%-!V:>Y/@90CT?, K%?X4;, MWF=@8I63:?U$Y:"-Y4+&I</HZ
MK9WPZSB=I/>!MDV( R&>"8?HOX0D$)(5@4R9^5(_4D.+3,D1J>FR>NK>Q.Z8
MV&:6SNE[Y\]LM=IZ;\7N\)"1FQ,*F-.$B9>8?Q'G]XA]/$.(36#.(M[*XA2_
MX\>K"!N(=#M"LEEGXOG)LH;]?EL@W11(O4"Z%'B(5HW:PJQ;M859]XHL;H^#
M:OQ#UZB4@_!#MO#.L_08^]O_"Y\&\1M532<TNDICWY"_Z5I* S:5Z,Z^[M;.
M_FPPJ(W;[NU>31,P&4;V8;C)_(<I_@!02P,$%     @ \84S3Q\TND;/ 0
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M[Q,(->9XC^^)9]ZTUB=(D?6L@6]@O_<7[2*RJ%1<0F>XZI"&.L=/^^,Y]?@
M^,%A-*LY\DZN2KWXX'.5XYTO" 24UBLP-]S@#$)X(5?&KUD3+UMZXGI^5_\8
MO#LO5V;@K,1/7MDVQX\855"S0=AG-7Z"V<\[C&;S7^ &PL%])6Z/4@D3OJ@<
MC%5R5G&E2/8ZC;P+XSBM)'=:G$!G ET(C_\G)#,AV1#(5%FP^H%95F1:C4A/
ME]4S_R;VQ\0=9NF3X>S"FG-K7/964+K/R,T+S9C3A*$KS 9Q?HLXT 5"7 %+
M%316Q8F^X=/-#A%$&M\AB?I, C]9>S@<X@)I5" - ND_![4I\A3#)!LC,<S6
M"5G=G@3=A(=N4*F&+C39*KOTTA,-M_\7/C7B5Z8;WAET5=:]H7#3M5(67"F[
M!_>Z6]?[2R"@MGYZ<',]=< 46-7/S4V6/TSQ!U!+ P04    " #QA3-/H^K:
M@]$!  !M!   &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q]5.UNG# 0
M?!7+#Q!SA@NG$R#E+HI:J95.J=K^]L'RH=B8VN9(W[ZV(800U#_8NYX9S]I>
MDD&J%UT#&/0J>*M37!O3'0G1>0V"Z3O906M72JD$,S94%=&= E9XDN"$!L$]
M$:QI<9;XW$5EB>P-;UJX**1[(9CZ>P(NAQ3O\%OBN:EJXQ(D2SI6P0\P/[N+
MLA&958I&0*L;V2(%98H?=L=SY/ >\*N!02_FR%5RE?+%!5^+% ?.$'#(C5-@
M=KC!&3AW0M;&GTD3SULZXG+^IO[D:[>U7)F&L^2_F\+4*3Y@5$#)>FZ>Y? %
MIGKV&$W%?X,;< MW3NP>N>3:?U'>:R/%I&*M"/8ZCDWKQV%<V<<3;9M )P*=
M"8?@OX1P(H0K AF=^5(?F6%9HN2 U'A9'7-O8G<,[6'F+NG/SJ_9:K7-WC)*
M]PFY.:$)<QHQ=('9?42</R-B.D.(-3"[H%LN3O03GZYVV$!$VSN$FW6&GA\N
M:XCC;8%H4R#R M&'@[I?'=06)EX5LH4YK(R0Q>T)4)5_Z!KELF]]DRVR<R\]
M4'_[[_"Q$;\S536M1E=I[!OR-UU*:<!:">[LZZYM[\\!A]*X:6SG:NR ,3"R
MFYJ;S'^8[!]02P,$%     @ \84S3]] !J7. 0  ;00  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL?531CIP@%/T5P@<L#KJ=[41-=F;3M$F;3+;I
M]IG1JY(%L8#C]N\+Z%CKFKX(]W+.X5S@F@Y*OYH&P*(W*5J3X<;:[D"(*1J0
MS-RI#EJW4BDMF76AKHGI-+ RD*0@-(H^$,EXB_,TY,XZ3U5O!6_AK)'II63Z
M]Q&$&C*\P[?$,Z\;ZQ,D3SM6PW>P/[JS=A&954HNH35<M4A#E>''W>&4>'P
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M5.UNVR 4?17$ Q0'NTT5V9::3-,F;5+4:>MO8E]_J&!<P''W]@-,7=>U]B?
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M_<WH]2,%<0'']NT7T%IKS?X1[N6<P[G -1F$?%$U@$:OG+4JQ;76W8$0E=?
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M:&5E=#,Q+GAM;'U4VV[<(!#]%<0'!*\OV6AE6\IN5:52*ZT2M7UF[?%% >,
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MVVD5V9::3M,F;5+4:NMO8E]_J& \P''W]@7LN&Y*_QBXG'/NN<!U.DKUHAL
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M C#+ /& RQ"00IR"L5?> !#B#(VAUPSKD.(84@PRK]8!((*$DLSKT6T(F(T
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M;;<?S%X.'^80:-&-,P=/@R_] U!+ P04    " #QA3-/3&U"SCT#  !&#@
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MDS2R+6TNJU9JI6BKML_$F<36@O$"B;=_7\"LXSA6^F)@..=P9@R3MER\R1)
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M4/PZK5UOUG$ZB:\T.\&?"?Y"\.+_$H*9$+P10M/\Y,RT^H0ESE/.1H=/?]:
M]9WP]H'ZF*5.FF]GSE2W0F4O>;#S4G310C/F,&'\%2;Q%PA2\DL-WU;CX-_Q
M_>C?$H4%8J\06+L(##U<T;?!31,3)#*0WD"\*-Z%GKU,:"T3WI4)=N_XC*P"
MD47@QF@1W1F-MJ'WCL_86B:VE GM HE5(/F S^3.9^@%\:U/M+J(%'ACWJQP
M2G;NS;Q899>Q\.B;B_P&GV;*-\R;KA?.B4GU',REK1F3H,QL'I2/5HVQ)2!0
M2[U-U)Y/CWD*)!OF.86689G_!5!+ P04    " #QA3-/00,H&#0"  !M!P
M&0   'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6R-E5^OFC 8QK\*X7ZG_"UH
MD.2H6;9D2\Q9MEU7?15R"F5ME;-OO[9PF$+5XX6TY7F>_MX";=8R_BH* .F\
M5;06"[>0LIDC)'8%5$0\L09J=>? >$6DZO(C$@T'LC>FBJ+ \S"J2%F[>6;&
M-CS/V$G2LH8-=\2IJ@C_NP3*VH7KN^\#+^6QD'H Y5E#CO #Y,]FPU4/#2G[
MLH):E*QV.!P6[K,_7Z=:;P2_2FC%1=O1E6P9>]6=K_N%ZVD@H+"3.H&HRQE6
M0*D.4AA_^DQWF%(;+]OOZ9]-[:J6+1&P8O1WN9?%PDU=9P\'<J+RA;5?H*\G
M=IV^^&]P!JKDFD3-L6-4F']G=Q*257V*0JG(6W<M:W-MNSM)TMOLAJ W!(/!
MC^X:PMX0?M00]89H9$!=*69MUD22/..L=7CW=!NB7R)_'JG5W^E!L]CFGEH>
MH4;/>3B+,W360;UFV6F""TUPK5A9%-&U9&V1_)\'*<8!-+""!L8?7H%B>T!H
M#0A-0'05D(PJ[32QT=1&XXTJG2K\*/93/*IV*@MQG-RJ.+("1Q;@=(33:?!M
MX/54X<]FL_ &26PEB2TDLQ%)_)!DJL">_ME)L)4$3T@B;S3/$C\B64T5UH=H
MD?DXQO@&<6(E3BS$_H@X>4@\57RR(MMT]YA3*W-J81Y]\LOTX:?R4+&^I^@P
MT<4^I@^B[X0?RUHX6R;5EF@VK@-C$E2:]Z2""G7V#1T*!ZF;B6KS[@3H.I(U
M_>&&AA,V_P=02P,$%     @ \84S3TQ:!Z8B P  WPP  !D   !X;"]W;W)K
M<VAE971S+W-H965T-#8N>&ULC5=M;YLP$/XKB.\MV,:\5$FD-M.T29M4=>KV
MV4V<!!4P R?I_OV,<2G81](O8)OG[IXSOH=C<1;-:WO@7'IO95&U2_\@97T7
M!.WFP$O6WHJ:5^K)3C0EDVK:[(.V;CC;:J.R"' 8QD')\LI?+?3:8[-:B*,L
M\HH_-EY[+$O6_'O@A3@O?>2_+SSE^X/L%H+5HF9[_HO+Y_JQ4;-@\++-2UZU
MN:B\AN^6_CVZ6V-MH!&_<WYN1V.O2^5%B-=N\GV[],..$2_X1G8NF+J=^)H7
M1>=)\?AKG/I#S,YP/'[W_E4GKY)Y82U?B^)/OI6'I9_ZWI;OV+&03^+\C9N$
MJ.^9['_P$R\4O&.B8FQ$T>JKMSFV4I3&BZ)2LK?^GE?Z?NZ?$&K,8 -L#/!@
M@"X;$&- /@QBG7S/3*?ZA4FV6C3B[#7]VZI9=RC0'5&;N>D6]=[I9RK;5JV>
M5E%(%L&I<V0P#ST&CS!HBEB[B 0/D$ 1&%A@B,4#=NRQ%0% 1' $ N9)M#V9
MY#GC( (=1-I!-'% K8WJ,;'&5(9DC%%*X4 4#$2!0+$5B#J!4$(33%,"1XK!
M2#$0*8$=)*"#Y/.;FH(.4H!!:N6:NKG2*"$DLX!K%QAG84AH##/*0$;9)UYS
M=O4U]X1<7(:3.(QG"*$0KM 0H)39)1HZL6X(B2.<V)4* !%-0SQ':D8VD$L*
MA38IY,0*;3J7(%,BH'+<(PP00381[":-8YH0FPV HU&4C8[:E!.L-8@ G+#-
MB5RO8<,*0-H5,*4%*QB"),Q6%N1JV!PM 'F9%JQWB+HJ@F9T#,%"AB ELW7$
M@)+Q4;LE.+;3@F 1GLL)%D:4?$)&#"@;;^ MQO:7S\"ZPATQPC/?% 0++8*4
MUA&1U"%T,XED"($P.O?I0+#0(D!I705Q)=11D$N0:>L!ZRL&]-51$ .ZMC57
M85-"L+9B2%MM^3 @ZYA2NTA!&''$/ABUBR5O]KJS;KV-.%:ZK1^M#MW[/=;M
MY@>\;_U_LF:?5ZWW(J1J6G5KN1-"<L5&'1+?.ZB_C6%2\)WLAHD:-WW+W4^D
MJ,WO1##\TZS^ U!+ P04    " #QA3-/#VJFE1<%  "H'@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970T-RYX;6R5F6N/ZC80AO\*X@>0Q+>$%2 MJ:I6:J75
MJ7KZ.0OFHI,+3<)R^N^;BP\-]CO4^V4AV=?VS-C/C+%7MZK^UIRT;F??B[QL
MUO-3VUY>@J#9G721-8OJHLON/X>J+K*V>ZR/07.I=;8?&A5YP,)0!45V+N>;
MU?#NK=ZLJFN;GTO]5L^::U%D]3];G5>W]3R:_WCQY7P\M?V+8+.Z9$?]AV[_
MO+S5W5-P[V5_+G39G*MR5NO#>OX:O:1JV3<8%%_/^M9,OL]Z5]ZKZEO_\.M^
M/0][BW2N=VW?1=9]?.A4YWG?4V?'WZ;3^7W,ON'T^X_>?QZ<[YQYSQJ=5OE?
MYWU[6L^3^6RO#]DU;[]4MU^T<4C.9\;[W_2'SCMY;TDWQJ[*F^'O;'=MVJHP
MO72F%-GW\?-<#I^W\3]"FF:X 3,-V+T!>]Z FP;<:A",E@VN_I2UV6955[=9
M/<[6)>L71?3"NV#N^I=#[(;_==XVW=N/C8C$*OCH.S*:[:AA$TWTJ$A=1<SN
MDJ SX&X%0U9LF=.>62, A< C<.@G']J+!S^EY>>H48.F'/V,9<QDPBUC@%"*
MF/-E@DT2T"0!3%*624@36]8@#6&(A(9(T,'2,F34Q!.7PX60=F"0BC.%C5'0
M&.4:PT++&.4[44#X=*)B:%(,3+((V,9>\4$J,CX)-"8!QA"L+6$'2P\2EF[<
MN QCEECK,T7") ZGP@>3HA!GH="#!21B=H2AB,@4$9$2(P\>C.AQ*IFTK1E5
M":5Z- ?FQM>(>1!A1!XS!I5/IPPGU AD5(<*(_J_*/'/1 DGTPAD0;(+G 8C
ME =M,HQH&KXX$G3P<)*+0)9SUSM*A=0X.'-%('6Y2QEEI9@8!R>E"&4E9XTF
MGPL=3E\1R%_NNEOZN\1P2F(HD5!=X$3"4"*Q%Y013:.2)"R22V(HG"082!+.
M@D(B1E1"AJEG:!]E+R@CDM,40XR"868(9GLY&9%WX##T#$#O+"<C\G$(\\X0
MRI2A&&6&4'864^S$A(G.GX3(A SCS #.[FH"(AX2XV"6&6+9F6=WC_'4)XYY
MYH!G3LPBQSQS'YZYRW/WHSHD L,QSMP'9R3BQ%:0$[^*4!&W)X"[/W>>>821
MY@!ISHDN,*K<ISYSMSXKI8B\S3&MW*,ZIU!$)%..D>8^U=F(IKF'HHQCFKE/
M<>9N<7X2-XPS]RG-1N3CC\ D"T0RL<47F&3A07(J7)*?[5<$1EEXH)PB$2?R
MF\ H"X_*G JTTR8F61"G%AZU.15N;7X:.@R\\*C-J1%%D9=/&'@!6.:4K9AE
MX5&>4^&6YV=;%H%Y%A[5.44B3D4%XRS028&SHER<B:(J,<T2[;/M]61$OH&3
MF'H)J'?6DQ'Y.(2!EXAEZCP.LRP]3BM3Z99E.F-+#+/T.(-,D8A3D2=.&#V.
M&%/I[K*IRB QQ]+C\#"5[J'@D[AAVJ7'D6 J_2NWQ*1+ +&@NL 02P^(MT:T
MG*[Y!;&35!ACA3"V:[\1^8V#&5: 84$ JC"@"E5D.R1&-#65+:A=AL(8*Y\C
M,B/R' ACK "A@HHK)E3Y7 (8T>/\$=L411SO(T2=F*A/C(,)58!00?S>4)@^
MA>JL$Y+$,54L0B+=*\RH\MDW*_=("PP43.[]"ET?ARO29K:KKF7;7_--WMZO
M85_9<&_XGWR\P_T]JX_GLIF]5VU;%<,=X:&J6MT9$RZZA7#2V?[^D.M#VW^-
MN^_U>'<Z/K35Q=P+!_?+Z<V_4$L#!!0    ( /&%,T]5 TPN4 (  $H(   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;(U6[8Z;,!!\%<0#'-\AB0 I
MH:I:J96BJ]K^=L@FH#.8VDZXOGUMPW$)62[]<]AF=F9VC_4FZ1A_$26 M%YK
MVHC4+J5LUXXCBA)J(IY8"XUZ<V2\)E)M^<D1+0=R,$$U=7S773@UJ1H[2\S9
MCF<).TM:-;#CECC7->%_MT!9E]J>_7;P7)U*J0^<+&G)"7Z _-GNN-HY(\NA
MJJ$1%6LL#L?4WGCKW MU@$'\JJ 35VM+I[)G[$5OOAY2V]6.@$(A-051CPOD
M0*EF4C[^#*3VJ*D#K]=O[)]-\BJ9/1&0,_J[.L@RM9>V=8 C.5/YS+HO,"04
MV=:0_3>X %5P[41I%(P*\]<JSD*R>F!15FKRVC^KQCR[_HT?#F%X@#\$^&.
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MD3$)RHO[I-J[5(-]W% X2KV,U9KWTZW?2-8.D]L9?SYD_P!02P,$%     @
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M[VU.C9*ET:*IE-E;_\RK[GGNOS!BQ& !8@3(10"SJP*A$0@_!/A5 6H$Z(<
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MZ_[ZW ^4/)J?!H++[Q/+_U!+ P04    " #QA3-/PH;Q+V8%   N(   &0
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MY^,)/0XDZZ?+!\TW8/4?4$L#!!0    ( /&%,T^CUP>I2@(  "T'   9
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MKS?P'8]'-G;\ Q7A7R:GR/6#.!!Z,(ZNC<J(8ADY39_Q-B!Z\WN7F_M[MK_
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MU\C008.%G7Y!6L$[)0%C4< W<([3SW-Z ;YB+%LL4+A/YV+84/< )4(;VI9
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MFN479'W.#H@![08V4!N-^01#@HW]I Z,#*B'XF@DV:MO<Q5,3TFFM.#)@:'
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M1$U/479AIPYHNE)HC*=<\F:<J2D6 81.LN]+;5C$>B;*["1 F\2R0(J_87.
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MK-J,:>+$\(D'SHO5>U/4,$CV4FG4P68H5\%NZ$YK.H9T^M4&'N&1667)J=M
MM5.DTP99@ZW::<4.:S1>+"_)EMW*8?E'[[B[C)HJU1D1(J$!N*52O_.3!@$V
M85J5=_F]L[_F&A $?;U<*H4WPPF7V6V!BAE1-3+YWJ2DN13<"$LWN?L;JN!^
MZJS7P<FQBDF;HXJ!KR"WBEN[7+'7QZF+@'E7I/6L3=4^W5(*U>W5^F!SKTP+
MO:N 1.S41O!:>PH.><F75?BZ /+0!%'U']FJ0$PTAG[AJP.IV2?Y!JD77>K2
M,5*S-J#P\QJ8AE5+N0\0'";?>9L KYC.Z?7257=/>R\9M^-!>T2F+YRV6EG8
MXG3E!O%&R!Y/I2:Y[2CF]>.;\,WE^_^9+N[_.%':%SS;;<GBY6M$4%W,0GK?
MX4]/W6/N_%HC\##+NY/_.#X"]?CR^*HF>6WY+2QZO<N_4KH )P!K2=TK\'N/
M'>G9Y**XR/%X"%+^0*2TP3CN=KO?HD-.&J;CDLI#0 892^T-AG#T@\$W::PD
M&GOS&,\_SM<;Q-U^3W3F-K8N,65N=ZG8%9)=,-LS,Y4X\I(+27-_P?F<REN*
M;9)%C!GZL;@ISY?,],E5.CU[A3(,F7@J^\"8-)L# OB\R_ ZWA2[C$IK<PJ6
M,NL-PIIYW *H'P6MLZ)U4Z#" 1/^0?F/*YV7.L-$5;BT$58B*;$MMH@)AU)>
ME>/4^)!@D.D=4+E5=47)0:<M.8A[4:\]B$>##OZ5Q(,1_=$;Q_U>HF@PK./I
M^^22@ZZ\G0P'<:<CA0:2/^K/ZMUFM:2T#REW^963P^R+_5'<[G>B,0AU21ON
M<C=N#SOJLKA9/^A.E@_9=9EC5'CW(!K*:R $CKIM,QU_A&66Y1\:+UVTWQ_"
M%0,9\ TJD\-XV.[@G_I>O%%[D;Z1>V9H^]V/(P/ZYA,9Z';CI-U[OOJQ_?*;
M^TX&A4$2C_I]T0&?H^(\<>5!C.R.>2-=.-ANY^ER[6K[IK[+A8^>NO#J1U[X
M 'RKEYYLT<ZEM[<\4-K^NU]\K!70;??=B]\=]N+Q:+#[Q3_XK:[\P<Z7'2L@
M ,:;R][&/_4]H,M.]R[!*Q[I3]V:'H[I6&=7D[/W)ZC1A:6%6@6HNB%G^PA-
MYAPSK*[*L3N[-KZYF2Y+$40P.Y9_+3TLHVD(^:YLV:BN0:!^PB*8^2MP.%[<
MWWX'D& T(DH\3.(D2>! :KME^@G(..@0CB$_@H,<CH0.>4-Z= BT4T/LVL;-
ML:/441-TW$ZZ%Y/)"0 %5#&B#KJ;[K.:!=?:VM*9.I/T 9:?EEPDQ72HQ::\
M1]D\?> J6+9S+5$FZ;H;5;ON5G3AF&2?P"::1F\AA3&M*7$D6:C9!5609U?M
M5!(!D+R2]NED/MH**3B[-2$+U6(MRM:$%P71 N9R<UWI'$R[<#LW\I.Z>6/L
M'%BY67W)L2J:<G9 6LMN8-.YZ:2^Z RE,# RH+B*VW#+7NM55D@)G'G@R1>+
M;(8Z]OS1#9^7\?<[CHKSALV!4[2KS.<REA@%-)I9OS9'\Z+)(THJ>E+87637
M2J7=4LEH\7%:=I$$&JAB<KNW8UC!Q[L<V.E]-)&.WE0J (Y8 D7+ LV+3EMB
M@1SKG76SBP,9O.Z>%D\(I%(XHX-YMKP%#+A.5[<2JNPW](CT7>!YG!%-!P2R
MV5(VU\TC(\PZ_7IP@PKL*G.+.]*Z/K4N6]%-AFN=*R=76\LA'D!]%/+!:XQ4
MVL.+)C$*Y,+ V7N1-F+7L,S[>&WZ_=KT^Y^ZZ3<11'3W+0N?_BW1HY;-N*6"
M:6@A-KFIZ23M$'"^M2$2]!1AT^0+[ZS'C60(OSZ(K,$F;"OYAL+E9#HYPA0K
M%(HTI+.5M3%/-\V68,YTS8%2PC,-L^)MU>O !4D YMH64^J1Y%2(%-B9H5$D
MTJO*C.1'&,8)'#/Q)&0SIX8%H4F*G<=U/KTNHP47KECD4UN# F0WN/2+!=UX
M7(*>A>8V[U,"^=\X_DG(HYF$3:0BR >6 P?[A8K[Z<;2PM]M1V8%VM3GB#N"
ME!Z\J0R$5'_6*0# 86%L=EPC.=ZU,&V33-Z@1=>KUBDCET?;Y'+_Q>VR^8@'
M?D(V/WA2*M>B.#S:*(QK$1S&>U(,E_$J8O@+6PV_2N&O4O@_NQ3^D-4D8V79
M$M? ;92O R_[8G7T K%:?4^Q.GJ!6*V^KU@=/5.L]@I2OHK5KV+UJU@MF4^>
M6.U<F=](K%8UL3IZ%:O_7Q"K_S1N1>_/SX]^/3D]K?[4\'US/^8J.IIX.J_.
M/.SP46D9AZIK8NV3:E0#%D*!=9LAS*!.TSX#<V3'"#D4LKPN?N@=RG7^JF6A
MRJ(LQC!0-UX=MJ;Y<26\PH\3\<IY5;#3[AICL\:C;CSHU:KBJP:)>U@_H4[;
MB<K_./DKQK(UQMZ'?W\BX%G71)?P^C@9C^)D*/'.G;@/XO\ ZY:_/#KA$I,8
MW8HYGMK%H6P@XW!@T1> #6(W!1/J&$(WMGLY<QMF."%.6'H2SAB#\JB'<!S-
MLUMQ%TKU&EV&RE1"\,6E<(2]K$CM=Y)65^*<VZUV+<Y9 [(6Y"PB8^W!IV/L
M*4Z-\Y0P^HN4"@V@\.12L<B=6^*F \O49*+:.OO;$*C?20!C!(&2N-/OP1T8
MJ&=[T;\=;4S()L>9_"YH0\'RB4D/J8?'OQ!MGHJ9=U '2T'\3JCSITZG%1T=
M7YS\,KDZ^>4X.CF[O+KX].'XK.ZX=9H:N*T,$&Y_SF:W5!W(=J:W#3NB_S.Y
M+BFG^/_6AMQEXB;;DN@!2;L=R.TC/F\KSRL_H]K-C/=S^%&N>KP7-=+9)19]
M@<.<4;G4+&4_O90Z-8]Q-#:*Y$[!#JX6H"0'6FN2)'[,LJ\L'1"'?-"BH=-7
M 74V*G[CU_KBI+/I*J>,2"V><8*>27#36. #HJBE!<[,N>I\;N\-DI_\,B$-
M29M&H-U6L%U5"I6T W7BUI2P[653(_A2*>US5TL"-"TI.%5\^>CU0W#/$6^6
M<G+^-%ZL<63=GIGKX6*"PCQ?FMO$A\.Y]?LPJ=AP9G!P!ROL&Z7S..WP;[B$
M<?8UQ<1,VSI#<=T#W;_!(!3=>]U73"\QY;+&\V*)XGV]%#?<7[,$]SU)"B59
M6#>GX-47-RK5:XG,4JK PGAL6W1*RB_1*9>Z"+@H*S?<W)S&UOT,.'G#UC'T
M5J!,':C*'9/A,8'=G&GC N7T)/69)_3G<=,AEH6#Z4YE38?)JR?DIIW-WJ^D
MZ94TO9*F5]+T74A3J/NL2.2[5<@?U@(F^)A,#2"JF$VI2O#L*!E5B^D(.K$Y
M$M.8?=.07;M&,^W9<L9!.N)LT@&5+Q8[Z?"94[N]TZ%-@ZZ@8/U.^.G:[<'A
M8 CA*UZ B+'/(#)FXC"*U%-2>YUVW$]Z 2DY:6&2_"_'%U<4F,C9:PWJ_JX/
MAKF'FZ"V+-"2NDT=K7,JY0<TUAVGVU+@=(6O>?JX+I9J@E;;U>9+L&/PV$<K
MP/$R\"+HF^TA.X.X'*E[8>[M[(#'YR='O..&'!K=$,[DO.&1]4=Q#Y'#7Y]B
M55W\#:/0>L4V-S&6YL14WGIZA:R3VLJ!J.1R.788HW9A824NS"^H#E+:"'YU
M@:5-9M''5G0,I.)S*2[3?^L>)Y/D/WE7N%%,@'S*>VMSL<0>@ 5(:.Y#2^6M
MQ\-UA7!-F_WT#;E']P:#7IQTNTZQ),(G.59<@5Z@;"7%X#8=:D=9;[M!P4H'
M)M/1R1KG5;#;9_]:UM:'TQW!V@3992&JNF4G25( ]'T6I:=?%[=<!(X5>*49
M&1;@TDWRN.<<W(CNF )OK<_ \P_X/@3-QTP-4&N$YLN24SV8>9"9999A@80)
MHMDU7J;KX@O5/]IKM_IMV^4MYKIEY>;Z;VR9, [ =/:W3;EV2+89E0Q+DF:&
M[H<.DM%>OZ7>9M-T(P7*E@3$TO,;.S<M]A?*GIPEM3!A8['&57:8,8.AGC.:
M'(2IA@I2C5XG[@YJ5"-Z =7HA*C&RJ"1<@C(,RB'*:(I#DO*E#==%/1.5E05
MNH@&/^VHF3S%6YX*S-$$;?A2_B+NT]J  P1Z;?;!5L(&T@K[D[;-Y[*SR'"E
M6(H)PF@Y4P+LW5.L*K<N1N#>H/3@= "5)L.JTEBJ>0DU!*1BSBOQW*$A#R\?
M%GI=<&!$RD;30I-YZWS J6A,5@=(<W-3G&U><S7C&V[YL.WU<O0]'L^5'?5F
M%(N-4F; DQJG%603#8[H "EN7Z5UFU!6I[&ISM1QPU3>2W*1//9H?R/3[>7F
MFE*6V*MN&1HCW&1S"[0KPF*SA+Z2!$V)^#B6]J/JY[I:X9\ ,8R=[92VOJ+@
MRI'NMDD):DPD&0@ \Z3O4M9=B*KN:/# M==6W%=A;\B5'&;;3TU92X57+<'(
M"0]9 P6[S):84D[ S69-/)$9^RP0=(>WU1 VY1,V)SL:I[(-6H8.Q;7#)3V]
MV@\K(T9:KKV7B+/='99P?N1YX54PBN@9@F4O'@P[6XSY6_'5PSME\ X#[WQ4
M#.8*I%%)YZ'<.Y1]904L]7J\UDI/N'))=V#C %*?)AAY)"2C=.)>KQJ1Y4<O
ML"<=M;G,:7<+8VA:*^=&[:JH0J=I*$8+DZ/R(F]"$%5/W&1=2D9#@X_2KYR1
MU$CL0G3!VG6_JM M,S">!%Y8#)X*RR45^6>0C)^4D@#,^-1SI"3U[5+2N=B,
M,$J&FLXT,EF08)NIK@WVL-<T#N@/[N!4)XIJ9>#OMX1WB.LRMCDTX2":+:/)
MP:\FFG(K8[S?.N36V@%-3V8;"95&GPX/#[H1VU-37=5];=!6_R!E6*LK4MI\
MJC-'+V%JH-)O=>3$.VF*]'Y5;$SW-(F"J49F>A4;;#WI] ;7:R,5ZEI@C!V[
M<:QE='B79S?1\5=8*#>DA9>G&&WFGU\C6S2'9T2?^LEQYN_U&E5[B=51U+<&
M2QY+#6PJ\RHSB)8G?E_[$G[KD'*K+QK6&>W;,DGZ?3*@<<L,5]%4B$='ML.U
M4,P*QA@/*'D]W_@ZTM.<G-6BYS/OL!:FQ_]5*&UH=%?I4DU33+B^CBFX$I"2
M'$13=+^RF0\8L>7=Y[>WC]?I]+-MX70KV=I8R!@CK:6[!7XMY]7$#+9T:5=5
MV)J8-+=AN@L=@YD.-\!WCH7]X?90OM81KUSXBKJ1D>H]R\O[0M<IOPI.;:;*
M5B:..%^JU*NQP]UV3'@B@P$>M.CK+'#"I8L[8[),E":(,Z?"Y#F1!NZ986+%
M$  Z(HQ:H'HGP+/H&,K>?OIF/S%U*W$V"AS>P##]]H DE.-#D-1N=8O.(V>=
M\'AC.'@(A^"N*KFKV*6K8KE S>D6'KX5D7FO8\(?0S*(<U7W)4P\)8Y<Z )=
M=  FX.Y-M(]%5W[5+*YN.JDN(*D5M7&QD^]^:6@ZH=,*R^\S:[C)5CHR4*[&
M-=)[X":@\9D&!5( FZ-*K+Q#'02>HTOM=?J#>-SKD*Y@Y4]'7@F8SHD&:_A@
MU;@0QR]%=]22027L+:R@JC,VMYXOG?XA24@PI0J_5%C-*;Z\IT%/1@I?=(V^
M571M-XFNZ@G1-:D%X^XBNK)T68,"K]'A7II-JB:)]2G=<XN0&>TN9*J]<3?N
M#'M/R9A)-QY@[;D?8(E3VV5,Z882LE";W +2#)2G&20C/CV.MF**?R/N-XX4
M#N"7M;?MBEW=@<8NQ]_HXU&WUWLQ'ED==Z3+F/RSXE'23^)Q-WD"D;J]4=P>
M#WYS1&K(K:C#5TY"F9.(0[3:!##,:D*!1@*#G*E$?F>9(*874E_1V(W[W,6A
M9Z0#Z)#\RG(1\1%T6C5PHJHE E!?GB:+SS;CM7JAZ:=J34.8!/A'DZ';,=P0
MO (&H5=WV:N[[-5=]D_C+D,IHC=^1JGN3K?EAS[$T>'DX\G5Y/3D/X^/HM/C
MR27\-CF#/\_/WD=7QQ<?HJ/CMU?A*L'?-$;8$W;F>K]BG=1+31*E>2J"% .;
MV.M#,O@S0@6W.<A44QTI6SIJ-S.35WFOUX\[HX'29>=@N?I'_=,IU9#6;8LQ
M!I!CVG"7D=VE?FU?WHO>J%/_"7=>_==N*[:T.-'>U<J+)DF8+)VG1;H4"-?L
MC_AUY>5#<NA%[](I!U#Y&3\M)_D'ZPI+B=<54#".L03M+.X,^N)]4T;'1Z[H
MC^Q*N,.0G]A($7"/3>P9/O#I\%!@(DV$Q09).8YU"R,9W&@-2,\H"]/,<0M,
M$RT\3*B-!5.*')ED:]%:.4,2CIO3)W?T&'_#/=D2M[;U=FRKYF +..QZ0S02
M8VFT?CQ,^J3S&K\W@/?3XO[OFS1ZFRX_1^VH,QZ#.-Q7^N"7E:<UTS[]&!T8
M)1VM<H_P>2!Y[,XEU/-W$+. @[5WO8;V^F$RO;P<NHL']-]N\*BF#[O%"!SY
M%*L12"-P-+&NW61!)\./@E&=SZRK-UP9L4/LLDR\78H:-TDS4Q#9[ (J%NYW
M^0UJ5FX/;A&FMQ&/BJ]ZKZ^-!K)X#@U0-]L6KX,#*$3:0$$*9+GK,9YNG,KX
MG-WRW4(.Q0/5M @3)&ZB6A<9!Q(8;GTS+S#*&>WY]*O+QGO8!>1^OBDC[ <B
M#>WF.5<NN2ZPFR3E03M*QJC]$PI%YJGU*IUE-M_(=@Z)R4R*L95?41TQ  UM
M*#(;RKGI(C;V$J(BQ,IZ3LRYQTH4>DOVX&$'H1T70L"EA!(9IX/*P.9-7J+E
M MH#7WB]TRCN5+=)6:#Z0YW&B(O(HM<(\/66[7+/=^S!7#]Y[#"/+17110^4
M(7N@8/W-N@!\R:>,0J0L:PUV"5^A+P8STJ@-&) $E\.AKVTO81-&^B7-YT_D
MIKDV0*,H53 >F1F&W2H[C6%LW\JJJ8+_M5<EQ(G.TO)"R^W]7(>A69?RJ 3Q
MO_SK"^@$*W4<KS[;>K@8\)%HI"<>\S',8\ZE6?8X;!HCC$JQX#DS(D,B:9D5
M#YX[+E%C)$CH:\^^Y,6FG!N:P;D?S_$UDG/U\ YSJE/CQGE;I*M9L"O&,&[W
M.JXA>/2D&=:S[U5"; KI^X@\KD4>":/;YV5#]):Q]#LE%(QWQ^] Q\Z=C-(7
M&KP[Z&1QW#?J"?=-]&SWS<]8^N$9'AP7I\@O$K![P)!:F0<!!3$M7;)II?^T
M[<-V\,6+\8".!VQT'M5#&"GME"1FD7BL>=/B3\CFU>"V%G"H3#K=(N#YYKE#
M2ILI1\\-&)Q](T_##G21:U_317Q0%7M'-8C-R,(8_R/!1QTNW>UVI<S60' #
M]1PZ/=C.OW\ZN?IK]9?@MPV)W9OU7;$B=FF(*MTI]UJF]J%.NU^O4**\.E8Q
M(B!#O,-/,M]8N4;,+P5E-;G7.$;15S)!]MJM=KOCF48 ROW08+ 7;G:MGARE
MM4/J 69T)UB%)8G'[5YCS%*PCE5L,N,Z2>(65J4!V"S"!&^Y(68#W[I/N7*'
MQ4S%S60H3M/6$HMTF1ZL7;($],&J/CB"%-WY2@5+@&ACC7'@(L=8E<14YO(V
M0S=E+L*Y%-4!=,6.0G!,&>;285TOE#;1>U]NKKFKI.9YWD99G/Q"7740/$OL
M6DAE[_".RK%3/EZ.K=PQ0QU3\6RG2J>TC^E2S;E/R""08]W34#:N0"K#N)?&
M<=#*45'TR!8$6$E- T[/*Y5;S<?)5&1#(GJ*XV24@!HU,K"D8[');\&W.L.X
M/TSB_JA;?0UAU8M'XQZFN#AAAT]:^[=%3+!\1BW')K'^ZU#D$_IP5/'FREWB
M4Z!".,T-85+D39^7F!?EX#-CY_X8J\S'R:#G;]14%M4ZJPYJJ42QO,$KKOR]
M^?L*>JO$[Q<G?: 5@P$W,C#D:$IRX7V!I8HX]FN6SS?KS%0"2E<HM9<NQ?B%
M,;8"&8\\XI6S%!+STR@*@:W-AF8YI,20+-W$2+R+J9,(Q[2K98ZOM@*7(8\U
M(J>1+3E7?U/QFY8M)1XAE\#7+9*63C247,W&M;F7)V3H;/FX>%0; +\U81LV
MT+4?"N77X00RICK<-EK()?K,N/[0O<92.AR_H)K/-Q0K5HNEOR)'A_\^RRJ/
M.3(7>&?$=6FP<J9I,W8]AP?IW%6O-1[_5(D,=)S%CD\2/1D'%&7B>$LT->W$
MPU$_'G9Z35)W*!/@?*F",<E>[)HY>SX=;IC9'.ON.<9($"NFDAA[BZ6@2-&F
M0$(O$7075E]&W;C3'L7=_D#9&U-'1Q>?GX<ML?MNJS%FVW,9F67\4/C(+.]"
MA$6O,23GLW%9>\]5Q12,3CVDRJ079QRTA:YB,5X!)*[G.6"L.'*='X$'\DJR
M)?6J/,U!(G",@1>9R! 7S/C->:G:%G2LGIW8H<]]C[HU08&':(01#(",94GU
M2I4?-ZI9&^FW! $CZ0B#=BOM.:MT^H"30L0*, E ?F9X)2>GI0#7RXP"$M9W
MVEOJ#!R[:%7?##=W<P2J68YJ/BK_0.KF^=^QC(3T"M0')'Z!%1V ??,+Z3#;
MM76+N"[\626.KF LS/\__D)A%U0.]89JH=:W!7=</Z_H>1&?L7J4.$XWU"AY
M2E?R.L<VJ60]77&P'GQ$29F<H:".K44,PPD(@6%$<\.XM%0LAC_'F\OK4MZZ
M/K'Y#0?#\@WS^L:\ V%L(B%7GX,&YDYXR/9&%59*9 4&[U@4 KP:=COPS6/)
M!2LXLE>W#=UR,Z)]L?$??[W'.I9H7H!Q3>%A);;'RI:C8@H7@U0<+8VEXI[V
M!Y(]76?6U(T*%4C,N%@O5>;2>LH_$H.96#\Y\K^UB=JFAJ"8L)3AM:UD\F#H
MDJ[K<)UAK<A:2+479&R8F6:1_4"M9P>$-8$DQAB$#D:-]=PWM838R(;(TL2<
M(+S0%[("5U10%0W";-:/UO",DI[,_>VBOZJ%==M%6!7/X\FA"%^L3#?HQ=U1
MOXD2L9VX#E#UK0 ]Y%GXU$0%P;>)ZI"&072&NE%;2D(KX  V#(5ACG*MK8-B
MPG.M?)Z%3ZR #79"/[X<#8"P;SI-KD2[T@W7E!!,V\,.)I\7CTSI] ;<S!9J
M-=VT.]K- AT]Y&";(U-'3ZC1%P'4)3%_3L-1#W?%0D2>NC0E%2'1^GHC%8;1
MV@;8L;;^'EW*)5!?F%WT3KV= !!5"%QXAIHXBLW!+(ZM',N#X'II)W[];5S?
M_+%Q031_F=Y@P=+5-5I3,'Q<R&#3Z;N6(X*Q/B,+Z,8EKM'&$BVXZ'JZ5-V^
MN_X[J419;M"\FN/%194?9,!;%@(P'@CH%<(8J[F8^BD41J3]#6PZHKD6Z6<B
M^PL, -#DPQ9^HNTO8$2)1,(JN'1.Z5*6Q45[ED3&+0I*G6'M^C=U6<RA$?_!
M(^"\5P;S]LYD?W"C\9]XUJ]X+JP80X-[R;!1@_)B*X)$+!G$_6%WNPK&Q%/*
M[HNYG?K'S]<FH N_LZ=:S:Y.RSOBV6X>C5Y.ZUN!@+$'6\1!;BJYH@[UGH>I
ML@WQ_CK^&"?L+>D-XC$JWRM0Q4$G[?I*J;64A/1 O<Z:G6:'=09=)UN7VFES
M/S!>:CMI6NEO9]/Y*('G'W7 <&E=(+T0P,3B0L602H5V8HUB)"?4 ]FY&K8;
MJ.^G\"9QKSV.Q\-^8ZC^I9L96!5$N.*KL1<U)Q0G@R!7B2NYPR5#&:V97J8H
M*D7K?&I36,/9Q3">)P#HA<5^57 M2;@.)U,G) 3JB#IXJQ?"N ,PWIX.L1W&
MGDU.-<-X].- '#D@5L\#,=MKJUN2FFK5P&(J1-&-1X*3'!";<M*WXRED6QSV
M !%.'@I0UK*L32)?V1@P4GGA R[R(%\>?,YQ*LP/HS1E<U^]O593@&%KCS0J
MAAJ2A])6[O7CFJ5&7;J:YTQ.,, <G9HI%5 FHZ*.$E%5!WH(?A(V=6-B$$E#
M(4-E&<!!^ T#_8@(&E<>("#&DLOB@)B011)N]#+'^;UV-)7Y47,Q@DK.2J-N
M_A!9ARN^G*^:EN_!EDI=/KKK4W9S5&NEIAI972'#SBJ:IW*=/H1Q_H8(?=LU
M?,"><_@^C9+^3R8=SR1N^.,J'1=D^;?80EPPFCA0 $K3<8F%8<UE\&E8F_R$
MH8<K3-Z057R0V#)U9/+Z794KA.OA6?7)&-2BBU[QC3?@>KHFB0*%$XNQ(6AB
M-@)ZJK69E&'(O1#(A8=A%12"Q5$7.E#29&HN"HQX2[\4%*C)=D>Q:=A"FK&)
MX2$D*VM&$]<%&=[1VI7#\INZ(&*-5U:X571S2HHUX:.'_Y8'6I.NXB23NU^]
M' &=P$TDI_.'=JLOB:C[>.7NTOF-SI,EGD .WYO-?&Y-=96+4BG*4.,6*R^A
M[$UE34)YK0<"0\Z4N#4J>K^Y5YU$*I7?N=>N*07_WZG/$19VM#'2)K/;4CW[
M>A.7P$DDR<-/G% $!<LHPD?^5+I_7,TEK\XHX.#2Z["##D8FQ./12#7>F@ 4
M209H)6W?_NHO=*?\DX8TNIHP(-U^&I+FPO*%!X6F[+ENTHN'XY&?I.PJ3;W1
M,.Z,M=JUBQ>=S0\V5)70K,+ UD6-[]9R[,A3AT"T:\>L2(Y9F0$108R#?3R[
M_D(E4/G"#1 3AXC;DXXNYJU YBYS2(XNYTO!3#HE'2&Y2S$']60Q!Y](/!&:
ML!T/&HHZE.J[5G4(1#B$[K];F<2MJ2$)Q%S:Q*?FE7I$#<53,HI?L]8K<U*-
MU,A5=9RX1/6"N,0=JDZX4?WPC#;SUZI1J-\SG-&-QN V&*7(?\#\-]8RZ?!G
M]01DBVJ9(#;++73-"_:J2.?+ON1O[8OOPW@N=&LMD/!6V=I#>UKM&[186 >-
MZYE>I3F'-2S2K_EBL^!LQVB!K0<+JGI>H4]8K)M,T8SE(I8YW00K[0)SZJ:D
M[-J$1QM@>87U>)%8R](&<;B%-0P!\RB ;Y-["*"M4X9./6F.\Z-NMIK8U \P
ML46[F]C4\TQL@8T%USK<:J(B\U)K@)G8>TEKF%36C-:#ND6M.4V_'7=AWX!5
M[=9P3($'G5:G8VV-E?<Y(\$M*\CU^T%Z6ZU9>D_:6! [8&_R9$.GQ'Y0L&"<
MW91T/2B7=D<)-_H^$JYZN80;?1<)5WV;A/LJ9H;%S!UDR2@L2ZIOE24GNM^@
MGL"V!0B'TMFB[>PK*Q63V=+-",;?U:\9RFP@'TRP;=YMIH[EP-0E;XE<Y^K<
MG6?MM+-@'QWFO@.;ZPV[<7>,7:C;K6XR4">Z<6YOD,2=43^"HT\2,P6(#YH^
MOXGVD8QBUN&[8G63D7GP(#J 9^_)7K,O=-AYL+*F;#ES5V-#:7$UO7Y73\O)
M25N>KT$;R_=MRN? GO.KJ8E(5F9$=\A]VPC^J/:'/I"H\J\Z,SZ["Y-(IB$:
MR:&90S1H?)K?9-$^7IN_8FV"-Q(2X<*$3[K3C?OM89R,!E$7ZP\@]!#>SO?R
ME1IV>O0Y:76[R 5 B]%?T2<U&F'/MS$\,$@B-,NT(_T5?5* &3W&C%YKW$7T
M:!]T<%;[@_E.B>L"GDQPRMY!K]4>:8>&^4(-XL%@"+C3;=.$_)$_*.>4NZWA
M2*-& %O81^.$^CSH TKE/-P^F\3.B:_QS15_I2U*5]4N:V'@3P@W^AY'^AZ#
MAFBF5T<2D25!H.V?\-IPY]$YGGLG>ES9K[X4N%C*).LD_9_4!7421>[OE_M.
M6L!MKFSL.\HN+AU$?0"@"X@Q[ \;J \63?&JJ,$4( "4^=2)90:<H5",I-[T
M\C4MI=(0E4P(C>'DSM*;I,!MT>23AI1-:6//5!(.M]].ME5HY*@'U9SZ@J\^
MG?KB/!5.?8FVIKZH'Y[Z$CV1^J*\C7Y[ZHL[6G/JB_J6U)?0V:]KZ2]1(/U%
M^>DOG9>DOU@)HA(:1MDOXXZ;_8(OV% ]]>.S78 S,[B; MW4=PYT>V%ZBG(H
MQS]M>LJ)9"8#AO4KE<, P9L#&42YM@9+OE7<G)2LOWW)BV9\-HG;23!:G=+Y
MF#@W+E7L9Y6X6:$;-O9B6XRG<D?-2TU7C/IOB=X74D(\5Z']\0%F:RZ-ZRND
M6Y>@B3'9@V0+9 ; >L]N,'EJI%['?L?DFL*%O?AC=P:LYLJN1*F8"!!$1)&J
MTF1GR*Q;D-?@<SJ0NG $LC2BTD1& C37WF<4/_;HQ)L#96&J%UL-URL^&P!"
MB:W2B4IBI&.)','IK5??$[=@UQMX6"%57MJ-4"0>9K!K<I[YFR.1P[BX!P.C
MR!/0MT8(>XL01D$Y/V4&MPZE*OGR%DN:Q-$MK&")YUM9)%H3X5M:&WFK%UG&
M DU*]J\;;2+4/1>IJR"AE-06<D+1R4D\PSO,TPFV.FP]#,9&U=UUE(:/S+^[
M9"80'K9/WG)#TZU5Q37I-,HL5+ N=X<XLD-X?L\$N%.W*>6I\3+8-+-*7IO1
MSFSE/A/F7_>K/)$?M 75GU[ #\HB.O>Z;70U"0[%K*GJ<FT(@ =T<:IN.X::
MTT9FRXS=H0$,5/%D0'++SO;>UV3%_Z;)BE>%]8ZPQ]&4@ZGN/L8$$5M>BZ^D
MV/+,&BO^%9)0PS2OGA)"SA:VEP,!+J:N[P U=Y,C\E"QDJ>N'QDD#\<%V(K>
M,^'6976LJ1]#<I#WHHL+9!&F3-<8>)V6%*>>KIW&G+XKVO$HU4<N[TB(%9@0
M5O)V0I S-M(U!6BM=(:?G5GZ/#EEI"@>B-Q_AIV:55!G9/CZQH;=H>>0O[G.
MYGGV1:KGI1Y0W5Z?MLA+BG-^SM9>)7_>G[IV#>=AH&%P3TX-&MR0M.O,AWG#
MNRXQ_G2I<S-0@)EBVV.NK:E; TLH%JJQ.C?K_63RT61DN:D&93Y#R=,<@8F+
M<C?I82!7$M)V2(?XJZ>/C[5.Y!J5&J/,C<PT::4+K*_&[_6!&0[; _]&Q<K9
MEJFZ..SVXV3<8S5&]EB[4$V7$%U3A5QSFCKF.^6@,$>49=SCP5ME?VP$OIMT
MFE7"XAKOO2$09A,Z?(,$<KMH:C$S<TM=5^BRLS3RRS02LP"$VZT>*'-_3K\@
M$+T+OITJNO1.=(L%5I:<"3$2 N8=KKG \T><S7<I&;D2J7>^-B7+-5"H+YJ[
M=H71@(.J20Y62IF@#HFJ-Z(&]7JF[2M!LV6[-?#D  ^7-3D,3-5XV#BAU%-O
M+*>N%R=<T[GG  L=I6O#& )-RBG< .2,C;2$UO3'%EQ'LTJ5;[,IZCY; WU@
MDJ% 2A6L\YK;V8 UMV4$*H248T,4@^K7$7$!VL2-VJ6*DK9DY]RTXG9)9@FW
M-/$#(I(+'C<6.?L*4C.96/3-"?;,H'CV)WI .M-7@>%D0),_LS-0.O "<56?
M;_6UBM/_B0-><>Z=M&'W[9*!.Z=TFT>ZK1%^NT%12YN9%ND*N97KAI6+X5JG
M*K7=>R' Z(28T3#N>Y:A7<QH4KDSV >!!WQ>%P2O@U$H?ZVA+5RG'VX+UY!;
MNUWL5ERLWL)-$*H2 E'ME() =6&MJ#VI(?G/Y(*#N-\=5YA@%&*"@RX]"4,L
M"2&J?%#Y?+ &C.?QP<HZ^UW#!X,L\*AF\GLY"_14D]&WL$ % W1[+V"!T7=C
M@>JE+) (5.^;6: *L\!1^RD6&)JJ\9[MP *57IR^QDFGX^S=;774Q$3SI5>5
M3+RRDA1:Z5$T_B]! K?H][\1\;,0Z^U,_%PH?Q/Q&[3C;G^X$_$;QX->]_<B
M?KW_LL1O^%^5^,'F:R[Y[T7\>KUO('XODO\]XC=*XJ2;?%_:YS8&J0:M5.19
M5=<)HM]')U UG2#Z3CI!H"EY6"=0ODZ0M+I1724X^F$J@0I>0T<EZ/;H".@J
M:^4 9S2]$0/Z04?>"6H*,5*4>YYSKKM4/$I1L'"O:2#1<:>G8ZG5M[-+?\ =
MV65499?J*7:9?$]V*8VM+*P&N[6,U=/IN$QN$#3T&@1]>^-8#>70Z#LUCO4B
ML/ %G2G"F=="' @Y&@O!E;&3FLGLRLZA8VN";&L^=YM@.3Y56S1/8H2*4'7"
MW;UK3<Z>'U6MD&IP62 H)R;'U"BL.X[K],:&>K1,=?C.\$6%_$J@A4MI\2;G
M>Z'/=TN1/_CH%?+[B)G0DN5H:_=Y0I$;7!\LQ*?7X$XKN%;J(X2KO655O-N"
M:=A(FLUAK;L,J(2N1,:1&%1AP4;,F%4*](DX=^-Q>X!N-!.35NBB7L8)1566
M=#*.J8?N541:&P<: 4LJWB",:L4@MT8N(8QLA_)U \10@M@LTV6^X'K^)$@Y
MGJMZQ4)3BJL:T;?;LOX;UYCT$N,J11S1Z_*=:U &%N#5H*ST+O\!-2AU-?N&
M&I31;U2#4H5K4$:_40U*5=F64X,R^JUJ4*J&&I31;UR#4M5K4#84QO_Q-2B5
M5X,R^B>I01D2.(("*Z\2W;J1*3:A3S4D0$B8TJY!9;;LY"X%*QN"4H(U*_7+
M 7E$YA1CAI&8[L(&"1*) L&@M6"<6NS/\XI5ZH)3W7&;@GC#M295)=XSF!HV
MCON]43SL=9JHS,ME1?5T9>MPX*N)XW;*BNX:DKTEVHJL.#M54HT"E525HV/4
M84WAY%(+Z#?"YX8"K#5D_HX%6+>>Z#?B=+1;7+K:O??"]RG VHU'@SYEBUF#
MP$X%6+]9G7HMP/I:@+5\+<#Z3U^ 59MFLU#?XV"]A^%P' ^&]=[=DA\$^SO#
M;+!Z7S# <)-W%>L[)2IWM92#5^MS5K<D!Y?;4NYR39OLO038:WO 71&E7D@[
MI/3F.I>ZGI%3X[,H;=ZA]?D>8X#?%@!CIR:*EQCQ(5NA %R)(+Z83$X"L>U.
MS5)E2T$8'XZ8D*V'I)^8(GY(N <5:QOU70VWBS.!T"(-J^=4LAR*O78?_^Y(
M[B7]2#/J$WG36.IR:%(V]P?QJ,?P#HZP):,@R/0PB5I&[L:]9,O:&C!XBTT[
M1#R>6U83OP=V=\\F"5-/DXY?[60Z;FIE[U?,W['FF6YD.J/X;H47S%$&\Y7C
MT7'P4\LGC2MZ>;_& /<A,?FE=9%>UN91?9^Z2-NOH,"G_]W(#7"(8Z*K4HC#
M=XCXM.]E] 9;5UMZT^TV)5$+=:&R7*Y#,C4]154G'GQK5]&]WH!ZXL*.NI6J
MR_ZK>Z G=KGR[CR[I21=9BYD7QVT^Y67Z9W.>-P:DRQ N;_HXV3O/)8:>\AJ
M^09>53(:7I>I7AGI+B+I+O6$.^67'/M134^WW ;UVU0)"[B$@XR<*\I4(X'Z
MHPJRU&Z)X^K57C9-2%V .2661NVXDXP:LZA"'E:T^VR[JM6Z4\'LZ)IB2P@W
MP@"X[RS$#?^ FSL'J<LQ5502@OW.L=''S36@B-CB$=<JHLL[(^&^!XT)N%H9
MG9X><I]R?G4EKYIKUG(7(46V!\%%<$E/;(ZL/39<W.PE2T(;K$% ISAXX&E4
MI(0N=?OCN#L:;$.T'2728;TPGI9(.T".QN%Q5&@<!WR#+=#31WBI9>>JU)G-
M'HIB)F6;Z?OWF-%J#M")9C='%P!B;$:R@(N2)_E8$SPZ+ "^%*YN:4[?':8[
M!4O%,-OJ6 NMG&P7DNMD+0Y9@'N#N/@NNUYQAP ,IX,OL$TWYB6MU@=48NRA
M6'WFG%^J?L*2G=2^JK8I)GN=#B(9_43L%*N<+Z3H^10+'F)=<6\=@^HZABP/
M9WY%--=+I,OQV6PU/!SJ.W]C*U>[H>GAF'V;,[HW&(LLP$SAYS#HG08!;MWV
MO3Z6FACQ$L?=0=SM50V@B)T!M'&SDL-FX=IH#CL)5I_5_MM*@B,7:,O\HE:5
MXM>>H&T%;#_$-4DT*$%#V%!8H5OV6U),2G5OFLR;EMSQ:-26)A(H+S7:B,^7
M3U\;/V]&Z_/C:G<0QZ!4%4*Q,D23>F]5^I@;CAN/)_O3OOHZO]I%Y\<[=V!O
M?%@N"MFXX)V.*80Q1=WK"]4[7)J+XHB[(,G"#:K8R*O16CO3LFX_[O2?I&7*
MTK+O7<7S"9N.%WO=;XC!8]U?QV4I*[:3CDLE=UU"HX7MU&L&; J7!$K5[W5U
MR::E3BYF./EN8MW;(QC*'2=/*A A3;X:39W88)2&(&^MXRL)2]O2&$/K6K[7
MT6TPGS0VF+]Z*GA,/<L"L%.5QZN[+15(.R *#^2,</KMP9,H"C@OC[MQ9]AS
MFJLD(;':MS,I/RIPM+U?2A 5N1C*<Q"Q.]"(J%Q$#*-<M]=[,<I9CLT2\&A+
MH&0U$O+9*&<Q;OPLA%,O-SD]'^&P.E!*(4,433XCJX.RY@9@XW%[;)W$.R(@
MMZ3J)_&XFVR1%5.&#PX^81:LM$/OT(YNX>R>"7O5L1L&*O9[6%TOZ7;=V,@'
MCKO0LO._=8^32?*?NB='6CH" *W%C<&[L$A<D:1T4$(0E645;-RCEARXMGYG
M'(^Z77VD>B&R9>/#])8D:I@G3K]P47KZ=7&;H8-<7\;0_9(:>W&[.XX'@T%3
MA;W"+_3.%:JDS"C\9N[P<P)R0RB.>1G]Q@C=1A3?\>8UWP)] 12FW8R2=L5!
M;2/1Q:XM+<NZ.A!!804/W0S-5=&V07W4W]HF[GDP_S9+]K? G/FK>CG0H[W>
M.!XF@^?8JZ[J]JIJ060S<<5 Y(9;[<C.2K^D7B!HIW*T_>X(FX\U'>WWOC_J
M.[ (GR7(X2 F@X#=0Z'DU;_UZM]Z]6_]SOZM0'Q .!(I3I+QMIJY$C8P^]%A
M W7CZJA1D4_H[O\SNRUV7YD^%14*0>R#3C-NC#_T%,(NYUS(G:IZ*[[%,C'\
MPZM1]]6H^\]OU'TMW?(C2K=4C4>=T1B4]]%KI8@?4"FB!NLNU:,D6%OZTPM9
MAK6G;X21Q9WO!VL9\+O"VO>\I]%>(L)RU7A!RZK2<#P:$.)'XR</1NUR, T6
MP.'V@QF/XF&[NS.?'_H2R"K[0J58K4FS42?U%(Q.L@7O=<U1%-LY^GBVF>(D
M*&\2&57US-^F>'9*;'MH(K8N?S!U%W2FN*QN1R%O8$.:W#(8I2/AHXZ1@*@T
M['<"ZM3P-?W^Q>GW0P[,;4#R/M:5:4X-KT X]24? ZBPL;[7>XE_" 5.J>\K
M57#K8%.N"^N;;?6[F%DTP+4NK+ZOIZ<#T$HJ+05U<=_AEGK-BCO5^0VA/?7@
MB7(+DYCK.BM3.2!U.LB[U]/:UO>X8=(SZC(T]_>R97P+ISF'=L^.:FV! AKD
M=VSQ-8C'[3:5&J N2<E(=_@:Q\EP0-E%W!G*Z?!%*F8RX,9=_?:PN<.75O1V
M;O%5;SBFYVWH\65?>$&/+U4Y! /@8)^O+>?P._?ZROQF7Z-AFW*P>JUVSVWV
MI;^O-_L:;6_VU6UUPLV^N!,76<J"O;GLZ72Q2Z6<:>"8G]6;2S7VYJHX#9I[
M<VVU7M2OX)/=N X2ME\WMN0ZZ/2V].5JM9-V<@#_[_1^BB;KH$6EVJO+F"$0
MFH-!C)G5(@>(J^&)%ET&(6HMNO[4Z;>BRZOSP[]$YQ^O3L[/+JL/;/LQW.#+
M>N6927>Y@KT;=$E$FFC\.5MS*7[&% !SZE:XY:XJ9TYY65C@HYZ/)0Q%EC0S
M]G,V;1I#(\ZJR)X0=[M:% *96(JDX;CO4+#[A4#)[TTN#Z-^NQ\0(<E&@"8^
M*5;!YCZG=AY7M1:?U[TM3<%U1#@>]X K;WLC;<P.WX(D\?G@<HJ]9,J##\".
M\"8P".W56!2S;,Z-4-G5076G//>WOPC=7I5W2!6$ 3(5,\H"Z^;]0VJR^/*N
M/QH56@!D)U+%;5HQG9,4",K'*W-,P]=Q[$3>2Y-,CMU>34ETNO(9!\?+@^+#
M\2XE*F%P6V9V)ZM,B+J4D-$.*$6%RG0UMT<QV,A8G!'J]0GR[(;B-^(AG5L?
MLKRZ!=3578XB,ODP_-<P$:]X6%;<H0(L.$>D&MF4 @1X!X!G6+FKD-1<'9-F
M75HUP.#\!!Q_,[@^W@@F 1X$*-6FS$SU"<*[:#>\DR(D^8)+'!(=55; 2K^D
M^9Q3$Y?1I]8E+&M%A?(?HW]DJ^)@6IA"D!C,0/;6)5T.F @A8>M!DO74:[<4
MVCVCAI_!QR5) *II/HNX7U%YY]8E60;RW^&FSHJ,7T3O%(8CH'2?/G(UE=HH
M CRXB("*Q+D5)]IC$O/2- KPM9%-27*JW<K,YTBP*823=S([4@0*0R+1M61:
M%R(V9-\@KZ.I\:BQBY))];(D?8" BR^A4$@.9(/YZ11K"SJ_.>FL?!P<;4#7
MEY9EFDO;5P@5*[4#E^Z=KCQOUHI2/6T#F^]Q82*&R@3C&W#I/D+HD;3#P:5I
MGA-..8:!)[N:.\'U7:\<$E?O(>AEN@JA3'9KM"0_UM51FWQ+!;4Q;)"'Z@:6
MVX:6X*UV5_EF%>GZ7=3VT/5&$G'%*>G8VG7?DGFF3.99ZL/]MM8,IA:6&=KT
M834$@2"TUS&>\U5*^HV?9:7(__DE6VXT"](55XD=8I&@OV#<RYI[GD]3> OD
MV$"'&]X+BC.:'SVYKT!F\);C9%Z)@"^-IQ;$IG3>]-[U'#,J;N>;*;8&D\XD
M+(UET[ME,2]N'P4<BHCR.WR>RN2M-K?19(;BD/;W/HE'T6YXE'1W1I0+#+>9
MJ8\V]&AGB#Z!*TT0#3RKRLUTFI7ES68.#(;)E3!Q+Z8:_CA+RUGZ]TATD+/L
M(?IKL?HLOQ_KL(Y]6UB 'OOKY3$F)Z&D0#+TYVS]Q@&VJMBW&D%=-L):!'-.
M]!F'((VL1SSAZNG;^,,N(];C^O;+2-Q+=O.\^]C][W$;.U[ 6^4VNLB0]%[Q
MXQ4_MN/'%=6@PN>L.)_$B30+UNJ?8R=7M0)22V/EJ9NB83'8B]RIW^<:$ G(
ME0[E5I-O3,KQY7[CZ]E+!MVXT^MSC>0A5UR["2KP,16;I^0E":9)OXKD2K5N
MI:SDNJBHP;JU\E/-X7$%9(OBD(=:SI$8'%K 1=;1G#P%!D+[J%Y/636A?L*S
M-]5:_8JJM6MC1+W&^CZV^^VTN3 4?6C#!\?^[5>*G@3.05<GJS7IWL-$_ &Z
M.F,E0'0T!>K:SLU_-TM'O@>D]V-9S0W5M],'-%?NDI@X%D9UMCL/!;^IBI+O
M3$?JMANCZN^AUQJ,=<3JI4L34JU':$OC^@Z5:/>H5>6H"?J.L='8DK7)^%RV
M9,S$;/S=\VWI3:9LV[A[+^K LO'?+G97B_N=L7HOP-,B-$H/\/]VEPB9-?H?
MD&'_G:/1\3?U)51V9TD!3H]7>2_"C)8Q3E\)YV+C$)OQR:B4+P&,"ZFF>@TW
M7U6,2N[L1*6<*)O :O[P$HO]!4EE,):8[JW=GJSRE5.1A_QOE?^QC%RP::.^
M?H=6W_"W(EM[7XI/]+11'0W\XW'<'?;EH^JTDA%(NSK8H]<:=B+^KM?%:&/Z
MH$A6U$=/SWC?D/;7:[5'![U6TM9U0_#!;F2_YF@.^X4"31#]^1VBG^U6%R;%
M;^0+^EMU^N0NX*\.(OJH_U469^B>:<2![0'>ZL]]X3Q2[ZO*E^GT^WZ5C@I*
M*+Y^8DS:;BWO=_M8T*-F*O]O:NP^#U>N$J%/+["Z)]1YFA-AFY;:%*)KEFY7
M6QF18D!DY93&(_F9KG=_N./ZU8O7W^3MWW']9M6X E,++'+*+>_H@%"O#HA7
M!\2K ^+5 ?'J@/A_W &QO6IE-,&5+9"V:Q7JQH3O! 0I2N$ .: Y)HN-!B@_
MCMWZ;+MGB]P 6BNS&@K>?"B\;!N2\C09#1@54-8=;0V^8T-#P,"0M-H)=?U2
M3EVYD$"))#^">XVV(TRX1H*(*V=%,-I?%LO,#1#E[NY6TV=MNIH-@-#MBRZI
MFJ:N6&@<BPGO &3L:B%.6*$%L.]_,%:[@(N)UA,RD_OI4Y0EY Y%9J-D5#$;
M^;9I!,HUT>R2*0/_IMC,DR35XGX!:QO;RYH/0=I7- 'X1]^NX1^>$3MM<LO4
MUOM'&P#UH]_N;;U_XU:_4X%@S3#7[_;B87?P7<QR:$K89I8+V"*VF^;4QYIX
M9TUSH,B.QFP7V^L.XU%O] -,<T^7*/Y!]KC(M<>I!GM<>^#8XSI/FN,:$@8;
M3'+#$5:AZQ'PU.]GDC.<7#W?)#?N[6:28TJQ[8059</]4,/< -WUXS:9Q4:M
M=@\M-V,XHD$R-$:Y XFF;3;"[0M=>!/MX_W'6-QH?S!.XCXPZS>[K&-(\8,P
M!/#OP; ?)<D@;O>M83 Q?!5N_*@;=5$.H,2GK>OJ)$1GWN"PPT$/OAB-XG:O
M%@'\(JOECS<;!NI8_5<P'6:NO;#^H6H]E/A;M-X=P%\'=:OA>,!60SS?D"%P
MS#]5+'Z]WO,M?AUC\1OWS)GSPWLRVM/VODX\& 4L?J$H^YVL?KUX/.@%[7Y_
MPARW\ZL_'U]$ER?OST[>G1Q.SJZBJXO)V>7DD,)BHU]/KOX<71R?3JZ.CZ*/
MDXNKD^-:(.UW&.)""/!'D(E ?7 K W -3HF2<"JTZ.(E)<CUW.JG2]11TW+,
M[GU4ZX:A(F>H5N25?I&4?N3GE)!";Y$)1=TQW[G!/F/< !J32+@;KR3#N=P\
M1OGK"ZN'7I9<A7/UAB/*Y N9^UM1(VQX9;4:U[:J2P @41T@=@!% U24NO<F
M:,NV8WON%.;-UDZFY]VP 8Y0A; ! -=)&C'"%XD;,>+<+6X\%"[34"%(Z9)Z
MQ=8ZD*(\L Y '<5JE<+]FHJL!$F=HLY ;GW3(CI/+P(5@AW7D70:UA$N'..7
MTK5](W6H'_",)38G-DFD2SRKV"W:V7;J$+A[C,E>='B79S?U0A>URYHO%5L[
M/3#=53M/Z\O(DKJS8&Z=1GO#8@,$'C)QF_1@N9A4^K!!\L*N>#G&;Z!JPM7,
MV7?AD(!NM<1!BO+S"NUK&35GGFKK<%EFF')U(Y51R+!V_1B:NW *I"HI>6 S
M*)U22(6VB1-*4"5\H%\PH%12I?W_F=PU3O",1D'I?QT^4S<S6)D-NP49!$V\
MM?&K4LJU<<HPMM4*TD6_84$ZU5R0[J6UWYY3D$YM+4@7_?""=,$:HY6"=-O*
MN'R?*EKJNU5$N[K;K=I9&[/) M:J<;A<)QO#J3M"/.[VU5O=X>BT2)?5>N.?
M%O=_!S;^-EU^9M*#954HE^]+SBUPA:80&< %(O%[=,62!K:F26F:@V:QU,UZ
MR:'HFRQHO7O)$+2=CM-^(AI]:_,),A%@,PB2N2S[SLN&J@0_M+N#>GDMJ._4
MW6%'P3,BP5-]=\&SW\%8L7&CPOA\X5-?A*T)Z?WOUKM%V]=)"Z[DB],Z!FZR
MN.=:528N@4ODD4' K^<1[$#^.^ZA(:*A6FCD]^S%M17$TGCKOT"+'[L-326=
M;4@_GYV+*2*]4PX=-)Y7IMLH+:Z*^9SI>6T_#OE-ME<;W4Y^R4,QX,"I9W3G
M8:,NK?0'.67JI_K#'3-BM'=;,S95TJ-Z75;S#>F%0>SMU;!WBVJ(3K>&!1A/
MHDV7>E[1?V79Y<N*_KM1U2\K^B_N)*U"PH:QT$G3Q5?)\!G=%;X+Z+S&7NJ[
MM$KPH9;T!KN#30G8ZF:8Z!"7,=<-?9Y1XNBA4$T8OMUSKCUWW4&]?67%<^<U
M-JO9&@$S#\\_?#BY^G!\=G49PX>SJY.S]\=GAR?'E]'D["@Z/7X_.8T^7IP?
M'A\?P4\U*^&WOG]*;<P^<CD::CGK"KT+P$F2^CB0J>!_KS/8:X9*"ML3"SC8
M%<KATA3MWAD-?J!X,E&D &OR)2(\J&BKTARR;F]:K03JJ)T4!Z/M504%P(!L
M1^4^JK,RM<PY=L;,N"K@C.%FS$&2O&79$Y4Z+#C+(3W^0@ D]Z@@BOI^?H]9
M)V3BSRB8J;+0XGJ.HWJBM7%E*&P9.R4\Y5@D,]B<!R-+"(8B"!QOTBE&;>G)
MM5Z&!HI[*FJEQ#]0R3&X0MN12MI)F_Q/PWC03_!C)^J,!W$_&>"').K'HP[]
MV8T.\)\>_/,V>RQ@J@-%8Z!;!DOGC7NPR=5]08$Q?#M*1^;JAJ@][6E&^\GT
MS0*6@^]&\V+*LOH:99GHTS*G1#I@O.LXNMQ@J-X(Q8[++%VOYT 6?DW+.P#4
M&@7X3Y>3.!K#[QT?3P2(8RQPA2$$ 'D8SQ0+0\\G16J@FIBRP$-5NN+!4,KZ
MUW[FF-"LZE#M_L0)2T1:]/@TO9N,AY1<$O%@_-/T.GKGGV>5X)1^4;!1$SP5
MH$\5-PR(HT+&<F#<;?>BR3PM/P,5_A7&OX0[<*<!W6DGSP.T$D G\0A941C4
M=5B6Z' AX?"J BT*W&)4$KH\]K4--^?$7P7CUW/A,>[TH^/H(Y(!'^F2C@>+
M">X^24)HI@!M>LFS=C^*D_[@V8A6:+7121U"TRB&JBIR^%/YZ3I42W[5%)U+
MV%Z!::;4 WU-/+'%FNM5!NCLH*?],O<@UTDZL.NSX^CR\Z,Z39>9P2*<9+)9
M 8F(H_.+:#QLMQ-W<$&:5$(-:AHWUF/UL0F9 I,+J5Z>W0%1!%D$G2(4ST$]
MK9W$-WO:,?*!V8:,&E\ PFC)H[Y1=_G]/>7P,NT%6:$5'9L&"+;2I:9HM0V0
MU,^S*-_\K:W?R/1[<6_ ]<7IJ'\$>1&940F):6-GO35<H2?W,'/WP('3M#)D
M?OP'QT_C/@;QN)=X^S!C<;@ZA9C3>+)  TM+_N Z[^3<>A5"&H001T6OV!JJ
M.G&LFMQ!_W][W]:<R)6M^9Z_(B.F:D**2&A(KK(C'$$A5&:.2E(+J>R>$^<!
MB93$,0(=$JJLCO[QLZ[[DCL34-GMTS/CERH!F?NZ]MKK^JT]%A*@P-6<0D+0
M^BCZ=5[I7"HFJJPS!#S$^9;95K'H/4=0Y\;&6FC"-_A%Z):ZRS*D3551.&O!
M]O]OB/4)MVH>PS(!(?/LT@8BG/YHLAYE4FC&0P/OZ)*:N0*:H]5&6C!0PO"N
M\-<\*@Z3<TOF2P]2NX/RH=J>D]#_B%W:KK#EJO4DPG;QNQLM.%5 )H]/FNJ"
MWQGEOGQXU(I]O U"*'($42GA%@],*/XJ.?MA\ ]PR59%V@GGS<U)2LPT+\_Z
MILE?"6/6J<ONZ:@+Y3BC0HFEH;4(%HZ"&86;BLW4^6$Q_3NTN("+ M,A]$KM
MJ?7PK+CZS=1%3\=XL4[1H,.2/4OYNW86-NA\?/8S*L/U^.@K!;F0C_!+MH!+
MB%.X6>/EG*7Y<KGZPI>9U&O(X6>MV! M,"@)>,/BCL,%_3T'P8;WW$>@QP%_
M1FYOJ9$6$L/$93^(WT_@^I[B*-&RSH."X_62H6<8>-WYZ-3I/S^6E0O0[FEU
M^>[9LVA(7 ]D,4V**Z2N8G$Y\WI1+A>\@1<.+4M,X^'$#$V3UW$QW3?Z123\
M5OR4F>&<A<,YAXOE$XD:@Y<7K/V!=]N,S8&\:^N(Y1?TCGB9W_C&@OY%&X7X
MOW;Q7=]AN]S!ZNU*KK.'!5ZR,*"GN3F_;,&M9-E\JDJ;G_/PITM34(627##B
M*M7<YB/'/PAB"94<50D %H!I\2MP%Q0NI]O-"@/T[BF?2D7-8O6J9EH3N8.L
MT=OE BZ[*)N3$Y4O5[@TYP]SR1E:.3](&A.RK26'<Z^L0$)/E\VT[I*CC%4<
MD)A $N?3!1YW"KI/V=*&H@_*88DM\=/9[>KSK%NM(E@+2C$H?J/9>"'I7ZNE
MY-]H@DLDB65BNYW-<Q 4701,9O?D(<:^YYM-EGF_[=AM<9&JQ0]C&9$!@U!J
MTIHBN^_0J+,T&&MAEQ#HQ@J!1*0@UBC3NI_"I(1IX4B_K!; F4 $PPP[?2LG
M L[L,'%,TL#C:C6+4#Y>+>O:3O7I*!,["I=D)/FA2RQ8#4.8/\M9L06\76&)
M6:KGK)-E?W"LWIIMNOOLAJ,K";;PV<+C])&%,<<+FN\*^#'R0IFSTFW'W(^L
M1OI1]EBE3D*""SY8Y#3H6G5)5\X$>:BY,2)FAY0U1]+KI"0-VE)MQ$WD0$R+
MF3FARU6,[E9DLM!9JQ'/IJ^Y$R4,1U2QC\G=@6T4)J GWIT <A/)J4,H,(PG
M>:0*Y@Y-<G#4QHEP!RF4F';H$\+]D;)KQ@*1R\%?PHY2@[;JD*O/4):H!SUM
M/752G8A9I]3+ HJ1D5'B;$[9XH(L120$-^/\CK,^*0-VK:6SQG[M/><TEI%)
MY"P%Y8V\\HCA4L,[S^1 SM<>2.\-E;D1GC!$9D#UJ&8PX*7-IRL[,@FR"V$T
M1B&H9AGNF!SV\1'A<:Z)?3A<:,:A9U-]ZA3CPFF-Y*&B%,\T$Y41_='\F,;R
M ?GCA/FCQ 7A.-#]@C?']QRM-(>G$2P/!5!#490N35'FV5(X[ILEAH%4^"KE
M/MA!"?.1M.=GRABMV@?7T=YT@P5L?1 U1WAP""?_-UG-"[C?:CEO$@X%+'WS
MI,&&]'XG.6FVV8J>MI+V29^-Z#4UH >6\S3M)=U&^J?E_%_'<EZP%$=_L.4\
M+K&<1[_%<IZ76<Z_V: ;.P;=Z+_#H!N'!MWHCS3HQJ4&W>B/->C&!8-N],\U
MZ ;>:) 6QQ?#RT^C^&;P<YB/ EHZ&EQOIK^"%)QC) ]FP/_[X YW['[S'\'S
MU6V56X'=\X)F0%C4+56+P;S+3*U]^ \YXQ.):J>(/XL*2$FB]J; E,W[Z7K]
M"E1& BEOX+ZGR&0L9 &L%AN>;% (B7*0].XS<A!GF($J@U,3<_B&0Z <1E$(
M.&PEJ=1V/*B*P>_9\4FC>7#'OG6.,2WV+&(41E?"S=CJ<#2>R"*"0 CW-#+]
M6MIH=4'-S$B+!+:@%O3GU1JMYK]DA-,"3!F_)+D\WR+YSPFK"#."61_(28*+
M[ES2@%.Q1324OV>&Y>X:?D)*MHN 8B$NIBBC:+GE8@1ITFNW.7%C"D)TCAD$
M\_PI"XK#N-@-QCJ"=E4K#.%IN\XP[=$6>.U+X3H6.;%)CHNWPB600N)/+Q)J
M$2O$8OXL(<5&2KJ?K^^WSYB"2$S742D$V8(>YKB\N@GY;?53E?M)M4;SSK4@
M=0Y7LRRRZ#KSYY>5H(V(RDBC$-UAZ4P)6]Q[0&GO93H$'H-*V,-#GA$93+G"
M)7(L8!/D3K@7:6PNR2^TR(\HK+L%2A2,!":+2RG1/U]A$GCA:/:]^%)!-\7Z
M)6Q'49@?<T14A= $$J4]_&WO]!3-11!<"G*SHRO"HN:4Q4#$_^M4#7,&DI+3
MHMFT+88"RHPY.X3;>/*450S--8N=DH0[FZ-JK(HMCCR;X<9SN1ZZM>DYDTD!
M%"$Z6;@6(NP5:RNYD6IU0?.QY^/2J?"8IJYX34\^8I[YDM7PY912T=$T :)(
MMLQU*@L,;I? =+;M+5"'EJIEJ#_FYE@.MU(M^'^M[KC\\E%X8@71N7",'8);
MO$9<7R]W]AN.P^.*F+HL(E,R#?$.^ ,<$Q1\R"RZ0=D3#BSPHXQ"WVBV]T;U
M<%Y=TZU@-T\=R<VR L9X1$!EO=]RL/LT!AHC(J'V2P:FA6I];I@VWYOKY0'$
M!GA'"<ZKH!MY2 QIL][@][ ,.$,7N:_G&(7O0N568.O.S-;ARH&F[J/DV6V)
M<%N TV\7!EF8M<_\B=\5@PN5*51K1_%NJ[?B9W2SV<.W[RK'!;<<!SFNM9 4
M: 8UAKOU:CH3FQ#H[=FO6IL6V2XE?LS9E@>K<+\QT>J%EI!I\G&UIY5SA R<
M$9_,4D*+7 Z)+/\%Q1%CG@K[2V)6@.1D47J&6NZGL]D:<WY@@W,/3 *%KSL1
M H)6(\DL810L.YPI)WXQX@O\3HR4DPR52CG13[-?B^.G/!B\[7.3\>?/Q52M
ME&PPW :X099VK7=2(.<MHEI1@4#"822%*E4,G(#Z"!T]*]4Y]T8L%P>*^@6.
M"P/#0_@N/D+!I)7T$:V!/_8;6!:L$Q]'%T#LW]QZH]YY3W@!; #Q^O%Z.<>]
M_FR$J($1HNP;YO$($5=.=?5P&P:<]8D=#8U$\KE$)'L7=QM)FZ WCC#EKHLU
M[V L X(=6=Y3PI!CL?2EYC-F;='$GZC00W%_2Z["P_%(]NVW#"6V0[G&#FK(
M'N/W^G\T%NT3U\-J:3"5ZTQ=YGC0O]NS;-*J-&I5:3H"V&^#?N=_ ^WQ!(3"
MVP^3T5]O1Q<W\>@S1B0'Y<4L,Q]]H5-3K3[N;<R]K#*6S+/<O2\RZB(Q $ O
MVS5*H!8 CF^.-;G96)U-*%%3I"3RP*E7\<&XBO  L$&==TX1!F'^MF^*Y_=@
MLSEDC^/@/3-GC!QW/5<.[J7NB?G>&>%W%47L-?T6G4Y2=10+K4CAT4H@;[."
M(#WD)2\B,G^/E42^-MT,92?/&5;Q<GS*.<L54$^EI9%!\VTW Y2'R$2"HFFO
M7S9>%*$P4<G@U*9Z0@\882*N:<T4T+3VW$M@CZQE[;!L85[^J,3L3F*BY$G_
MF<C]_V8BMP\KX7O:OBVG6_/LC![TS\GI#FOX-I).NU./U I#QI(5HUPZA9_<
MDY;X [7F"&*9;J)?)F!@RYP-(C[L1)%K1*5<H]U,6I78,&_B&LTRKK$V9!2%
M\!R'< YCDY=D8P]@VL>]A=>Z[P^+DBV[\&9_[(7GI($=7,WISW)G?Y8[^[/<
MV9_ESO[IY<Y,.'>Y8%7D_5&3>3;%[$PRD(O@UPII@D4B#HL((1\3C1E3A <F
M+N.],\9([^Z([-TAV\>]>#&K/>=6L^'J9<YNL^E$7)$?JR:1(F6/#V"/-@E]
M;<.T8/@7*[8D"Y:BC67X2(94TAB')@01-$MD'+G/,*+5VT8='SQJ]"W@TZ,-
MT'8>7ZT6\_O7T*<)A.%B\ V&P\M;2I&-KR[/QY@E^UT\..5ZU_'EF?O Y&9P
M<3JX/IW$1]3Z/,N/B\U_&$S&$WSOZGHT 1UU@.T<=)=_X$(%#Q27C<D?M.YE
M*BX:M6CN+*Q/MPP&@P 9,"PBR:CTKA9[(IOW6)(N,HHZ.VT,K)8^19YJ5QDE
M'RNE963HM*&X3[6%92]39ITBKJ*0[ YSQJ*>.^ =P@6W)ZZI%0%^8AP;HP"1
M'=\XE!B>BS5+L?M%(M\CU,&1QH,-!E<2XW5<%+1^N+H>7PS'5^<CVL;AY<4$
MZ.+T\'V\LOW![(=FCB6[62W4[5\:V<MHQUZRJ(G+^+1:D':W-#D&_[E:8[$/
M_@H%QCD(,^LYBK,VHF#R"J+.<T[A^/0>P9F<2Y0]1^E'1"\UXXG"%PZC%ME/
MNSSA81T.)C]2TCK],?KK[?CSX+S$\E.^D$,TU1.GPC]&IH)#?O@^6)22:9YS
M^/D33!\6<S&']F"6V3,RP36*4WB="MT*=@DL\B-9XI^GF^U::FYX=<+@HL%0
M]Y@\DJI2DA9$C@9;=J)@0\$$J@TE4=%SXL@@0[*)?3-D X]MYINM1,1\D&?Q
M4KV=P*O+7]AN!8]MG5!6-36>9J RS#>PV^K7'#I^4]9^WZ4LHY=7N;!E%]A
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M^.MJ_8M7)-9I%_DSH75(!5"S*YK5)VJV,Q('S@E.\!:A3HN6"V,[8J"E3>X
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MX@\**7HF<00?"4?>8WSM3M($5D(,B89B?M2?SJEVD+I@<>E96?!G8%X[DO>
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M" ?["TY(Q:Z:@L-_BN@G4$L#!!0    ( /&%,T^?J,E:P@0   DE   /
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MP    !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( /&%,T\GZ(<.@@   +$    0              "  >D   !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ \84S3]"#6VKO    *P(  !$
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M970R+GAM;%!+ 0(4 Q0    ( /&%,T]A.ED,HP,  &X4   8
M  "  9<0  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #Q
MA3-/"'-OZDL%  "T&   &               @ %P%   >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ \84S3W%7@DN\!0  L!T  !@
M         ( !\1D  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( /&%,T]#V(4EBP<  $,J   8              "  >,?  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #QA3-/HI9U:,\!  !M!
M&               @ &D)P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ \84S3VE$X1/- 0  ;00  !@              ( !J2D  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( /&%,T_C2$J0T0$
M &T$   8              "  :PK  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " #QA3-/$XI\ ] !  !M!   &0              @ &S
M+0  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( /&%,T\?
M-+I&SP$  &T$   9              "  ;HO  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ \84S3V+>3S&Y 0  U ,  !D
M     ( !P#$  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /&%,T_1/</NT0$  &T$   9              "
M ;,[  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ \84S
M3_#.VT[, 0  ;00  !D              ( !NST  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " #QA3-/H^K:@]$!  !M!   &0
M        @ &^/P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( /&%,T_?0 :ES@$  &T$   9              "  <9!  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ \84S3X:^@!O/ 0  ;00
M !D              ( !RT,  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " #QA3-/-S:X^-(!  !M!   &0              @ '110
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( /&%,T]YVC.8
MS@$  &T$   9              "  =I'  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ \84S3_\FZC>X 0  U ,  !D
M ( !WTD  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #Q
MA3-/YYL]'<\!  !M!   &0              @ '.2P  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( /&%,T\$SE\"! ,  +<-   9
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M970S,"YX;6Q02P$"% ,4    " #QA3-/(G]H<>(!  #V!   &0
M    @ %,60  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M /&%,T_MU2%CT0$  &T$   9              "  65;  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ \84S3_0*Q&3$ 0  .00  !D
M             ( !;5T  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " #QA3-/%.<JU*<"  "A"   &0              @ %H7P  >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( /&%,T^JN(J 5@(
M '4(   9              "  49B  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ \84S3[=+\'8* @  >P4  !D              ( !
MTV0  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #QA3-/
M[EG$\^8!   $!0  &0              @ $49P  >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( /&%,T],;4+./0,  $8.   9
M      "  3%I  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ \84S3V*J4[Q8 @  ^@8  !D              ( !I6P  'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " #QA3-/V[FJ-!,"  !>!@
M&0              @ $T;P  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( /&%,T^E$QI*W0$  &($   9              "  7YQ  !X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ \84S3RBM30T2
M @  CP4  !D              ( !DG,  'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " #QA3-/;ZYN:L\!  !4!   &0
M@ ';=0  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( /&%
M,T^&**./^0$  #@%   9              "  >%W  !X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ \84S3T$#*!@T @  ;0<  !D
M         ( !$7H  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M    " #QA3-/3%H'IB(#  #?#   &0              @ %\?   >&PO=V]R
M:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( /&%,T\/:J:5%P4  *@>
M   9              "  =5_  !X;"]W;W)K<VAE971S+W-H965T-#<N>&UL
M4$L! A0#%     @ \84S3U4#3"Y0 @  2@@  !D              ( !(X4
M 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #QA3-/-_Q5
MCK4!  #) P  &0              @ &JAP  >&PO=V]R:W-H965T<R]S:&5E
M=#0Y+GAM;%!+ 0(4 Q0    ( /&%,T_CVXHTQ ,  *L0   9
M  "  9:)  !X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
M\84S3\*&\2]F!0  +B   !D              ( !D8T  'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    " #QA3-/.Y@>_=@"  #I"0  &0
M            @ $NDP  >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( /&%,T_'O;\5WP$  )$$   9              "  3V6  !X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ \84S3YU2L8,U @
M#0<  !D              ( !4Y@  'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    " #QA3-/H]<'J4H"   M!P  &0              @ &_
MF@  >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( /&%,T\^
M$NR& P(  +<%   9              "  4"=  !X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ \84S3Q?]2X)II@  =.," !0
M     ( !>I\  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ \84S
M3X_:>(Y8 @  8 P   T              ( !%48! 'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " #QA3-/GZC)6L($   ))0  #P              @ &82 $
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ \84S3V4-O+_] 0  #2(  !H
M             ( !ATT! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ \84S3U7=Y!#9 0  OB$  !,              ( !O$\! %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&     $$ 00"Y$0  QE$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6631706448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">OTHER SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Related Party Transactions with Ronald
P. Erickson</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">See Notes 10 and 13 for related party
transactions with Ronald P. Erickson.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Erickson and/or entities with which
he is affiliated also have accrued compensation, travel and interest of approximately $478,861 as of March 31, 2019.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>Related Party Transaction with Phillip A. Bosua</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">See Note 13 for related party transactions with Phillip A.
Bosua.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock Option Grants to Directors</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">See Note 13 for related party transactions with Directors.</p>



<p style="margin: 0pt"></p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Related Party Transactions with Ronald P.
Erickson</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Notes 11, 12 and 13 for related party transactions
with Ronald P. Erickson.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 7, 2017 Mr. Erickson was issued
200,000 of restricted common stock to at the grant date market value of $0.17 per share.&#160;&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 16, 2018 Mr. Erickson was issued
100,000 of restricted common stock on to at the grant date market value of $0.21 per share.&#160;&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 25, 2018, the Company entered into
amendments to two demand promissory notes, totaling $600,000 with Mr. Erickson, our Chief Executive Officer and/or entities in
which Mr. Erickson has a beneficial interest. The amendments extend the due date from December 31, 2017 to September 30, 2018 and
continue to provide for interest of 3% per annum and a third lien on company assets if not repaid by September 30, 2018 or converted
into convertible debentures or equity on terms acceptable to the Holder. On March 16, 2018, the demand promissory notes and accrued
interest were converted into convertible notes payable.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 16, 2018, the Company entered into
a Note and Account Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was
converted to a Convertible Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z
Account Payable was converted into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a
warrant to purchase up to 1,039,666 shares of our common stock for a period of five years. The initial exercise price of the warrants
described above is $0.50 per share, also subject to certain adjustments. The warrants had an estimated value of $0.12 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 9, 2018, the Company repaid a $199,935
Business Loan Agreement with Umpqua Bank from funds previously provided by an entity affiliated with Ronald P. Erickson, our Chairman
of the Board. The Company paid $27,041 and issued 800,000 shares of common stock in exchange for the conversion of this debt. Mr.
Erickson is an accredited investor. These shares were issued in transactions that were not registered under the Act in reliance
upon applicable exemptions from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Erickson and/or entities with which he is
affiliated also have accrued compensation, travel and interest of approximately $513,149 as of September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Related Party Transaction with Phillip A. Bosua</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 14, 2017, the Company issued 50,000
shares of our common stock to Phillip A. Bosua under the terms of a consulting agreement dated July 6, 2017. The fair value of
the stock was $8,500.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 7, 2018, the Company issued 50,000
shares of our common stock to Phillip A. Bosua under the terms of a consulting agreement dated July 6, 2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company issued 2,000,000
shares of our common stock to Phillip A. Bosua under the terms of the Merger Agreement with RAAI common stock. The fair value of
the stock was $520,000.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company issued 500,000
shares of our common stock to Phillip A. Bosua under the terms of an Employment agreement dated April 10, 2018. The fair value
of the stock was $165,000.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company closed a debt
conversion with an entity controlled by Phillip A. Bosua and issued 255,000 shares of common stock in exchange for the conversion
of $63,750 in preexisting debt owed by the Company to this entity.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 30, 2018, Mr. Bosua was awarded a stock
option grant for 1,000,000 shares of our common stock that was awarded at $1.28 per share and was valued at the black scholes value
of $1.22 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock Issuances to Named Executive Officers
and Directors</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 7, 2017, the Company issued 400,000
shares of restricted common stock to one Named Executive Officer and two directors for services during 2015-2017. The shares were
issued in accordance with the 2011 Stock Incentive Plan and were valued at $0.17 per share, the market price of our common stock.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During January to May 2018, the Company issued
275,000 shares of restricted common stock to one Named Executive Officer and two directors for services during 2018. The shares
were issued in accordance with the 2011 Stock Incentive Plan and were valued at $0.246 per share, the market price of our common
stock.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock Option Grant Cancellations</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2017, two
Named Executive Officers forfeited stock option grants for 35,366 shares of common stock at $19.53 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6813253408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">REVENUE</a></td>
<td class="nump">$ 1,092,228<span></span>
</td>
<td class="nump">$ 593,712<span></span>
</td>
<td class="nump">$ 1,195,921<span></span>
</td>
<td class="nump">$ 2,325,085<span></span>
</td>
<td class="nump">$ 4,303,296<span></span>
</td>
<td class="nump">$ 4,874,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">COST OF SALES</a></td>
<td class="nump">865,571<span></span>
</td>
<td class="nump">454,839<span></span>
</td>
<td class="nump">927,125<span></span>
</td>
<td class="nump">1,850,594<span></span>
</td>
<td class="nump">3,481,673<span></span>
</td>
<td class="nump">3,966,607<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="nump">226,657<span></span>
</td>
<td class="nump">138,873<span></span>
</td>
<td class="nump">268,796<span></span>
</td>
<td class="nump">474,491<span></span>
</td>
<td class="nump">821,623<span></span>
</td>
<td class="nump">907,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">RESEARCH AND DEVELOPMENT EXPENSES</a></td>
<td class="nump">153,300<span></span>
</td>
<td class="nump">184,024<span></span>
</td>
<td class="nump">391,014<span></span>
</td>
<td class="nump">241,020<span></span>
</td>
<td class="nump">570,514<span></span>
</td>
<td class="nump">79,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">SELLING, GENERAL AND ADMINISTRATIVE EXPENSES</a></td>
<td class="nump">578,097<span></span>
</td>
<td class="nump">1,678,335<span></span>
</td>
<td class="nump">2,367,781<span></span>
</td>
<td class="nump">992,462<span></span>
</td>
<td class="nump">2,508,846<span></span>
</td>
<td class="nump">3,088,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">IMPAIRMENT OF GOODWILL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">110,545<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">983,645<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">OPERATING LOSS</a></td>
<td class="num">(504,740)<span></span>
</td>
<td class="num">(1,723,486)<span></span>
</td>
<td class="num">(2,489,999)<span></span>
</td>
<td class="num">(758,991)<span></span>
</td>
<td class="num">(2,257,737)<span></span>
</td>
<td class="num">(3,243,476)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME (EXPENSE):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(793,837)<span></span>
</td>
<td class="num">(7,750)<span></span>
</td>
<td class="num">(16,876)<span></span>
</td>
<td class="num">(1,087,039)<span></span>
</td>
<td class="num">(1,195,329)<span></span>
</td>
<td class="num">(376,974)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="num">(577)<span></span>
</td>
<td class="nump">6,618<span></span>
</td>
<td class="nump">13,054<span></span>
</td>
<td class="nump">18,611<span></span>
</td>
<td class="nump">25,160<span></span>
</td>
<td class="num">(62,954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">(Loss) on change - derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(217,828)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on debt settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,309<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(794,414)<span></span>
</td>
<td class="num">(1,132)<span></span>
</td>
<td class="num">(3,822)<span></span>
</td>
<td class="num">(1,068,428)<span></span>
</td>
<td class="num">(999,860)<span></span>
</td>
<td class="num">(657,756)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">(LOSS) BEFORE INCOME TAXES</a></td>
<td class="num">(1,299,154)<span></span>
</td>
<td class="num">(1,724,618)<span></span>
</td>
<td class="num">(2,493,821)<span></span>
</td>
<td class="num">(1,827,419)<span></span>
</td>
<td class="num">(3,257,597)<span></span>
</td>
<td class="num">(3,901,232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Income taxes - current provision</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET (LOSS)</a></td>
<td class="num">$ (1,299,154)<span></span>
</td>
<td class="num">$ (1,724,618)<span></span>
</td>
<td class="num">$ (2,493,821)<span></span>
</td>
<td class="num">$ (1,827,419)<span></span>
</td>
<td class="num">$ (3,257,597)<span></span>
</td>
<td class="num">$ (3,901,232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic and diluted loss per common share attributable to Visualant, Inc. and subsidiaries common shareholders-</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share</a></td>
<td class="num">$ (0.25)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.14)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
<td class="num">$ (1.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares of common stock outstanding- basic and diluted</a></td>
<td class="nump">5,128,144<span></span>
</td>
<td class="nump">19,297,126<span></span>
</td>
<td class="nump">18,424,608<span></span>
</td>
<td class="nump">4,889,218<span></span>
</td>
<td class="nump">8,630,891<span></span>
</td>
<td class="nump">3,844,840<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6799789776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis of Presentation</b> &#8211; The accompanying
unaudited consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been
eliminated. The preparation of these unaudited condensed consolidated financial statements were prepared in conformity with U.S.
generally accepted accounting principles (&#8220;GAAP&#8221;).</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">The accompanying unaudited consolidated
financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation
of these unaudited condensed consolidated financial statements were prepared in conformity with U.S. generally accepted accounting
principles (&#8220;GAAP&#8221;).</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">PRINCIPLES OF CONSOLIDATION</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Principles of Consolidation</b> &#8211; The
consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries, TransTech
Systems, Inc and RAAI Lighting, Inc. Inter-Company items and transactions have been eliminated in consolidation.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of the Company and its wholly owned and majority-owned subsidiaries, TransTech Systems, Inc and RAAI Lighting, Inc.
Inter-Company items and transactions have been eliminated in consolidation.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">CASH AND CASH EQUIVALENTS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash and Cash Equivalents</b> &#8211;&#160;The
Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash
equivalents. The Company maintains cash balances at various financial institutions. Balances at US banks are insured by the Federal
Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not
exposed to any significant risk for cash on deposit.&#160;&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company classifies highly liquid temporary
investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances
at various financial institutions. Balances at US banks are insured by the Federal Deposit Insurance Corporation up to $250,000.
The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on
deposit.&#160;&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounts Receivable and Allowance for Doubtful
Accounts</b> &#8211; Accounts receivable consist primarily of amounts due to the Company from normal business activities. The Company
maintains an allowance for doubtful accounts to reflect the expected non-collection of accounts receivable based on past collection
history and specific risks identified within the portfolio. If the financial condition of the customers were to deteriorate resulting
in an impairment of their ability to make payments, or if payments from customers are significantly delayed, additional allowances
might be required.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable consist primarily of amounts
due to the Company from normal business activities. The Company maintains an allowance for doubtful accounts to reflect the expected
non-collection of accounts receivable based on past collection history and specific risks identified within the portfolio. If
the financial condition of the customers were to deteriorate resulting in an impairment of their ability to make payments, or
if payments from customers are significantly delayed, additional allowances might be required.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Inventories</b> &#8211; Inventories consist
primarily of printers and consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control
components held for resale and are stated at the lower of cost or market on the&#160;first-in, first-out (&#8220;FIFO&#8221;) method.&#160;&#160;Inventories
are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received
by TransTech at a warehouse location.&#160;&#160;The Company records a provision for excess and obsolete inventory whenever an
impairment has been identified. There is a $35,000 reserve for impaired inventory as of March 31, 2019 and September 30, 2018,
respectively.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consist primarily of printers and
consumable supplies, including ribbons and cards, badge accessories, capture devices, and access control components held for resale
and are stated at the lower of cost or market on the&#160;first-in, first-out (&#8220;FIFO&#8221;) method.&#160;&#160;Inventories
are considered available for resale when drop shipped and invoiced directly to a customer from a vendor, or when physically received
by TransTech at a warehouse location.&#160;&#160;The Company records a provision for excess and obsolete inventory whenever an
impairment has been identified. There is a $35,000 reserve for impaired inventory as of September 30, 2018 and 2017, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">EQUIPMENT</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Equipment</b> &#8211; Equipment consists
of machinery, leasehold improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation
and amortization. Depreciation is computed by the straight-line method over the estimated useful lives or lease period of the relevant
asset, generally 2-10 years, except for leasehold improvements which are depreciated over 2-3 years.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Equipment consists of machinery, leasehold
improvements, furniture and fixtures and software, which are stated at cost less accumulated depreciation and amortization. Depreciation
is computed by the straight-line method over the estimated useful lives or lease period of the relevant asset, generally 2-10
years, except for leasehold improvements which are depreciated over 2-3 years.&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">LONG-LIVED ASSETS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Long-Lived Assets</b> &#8211; The Company
reviews its long-lived assets for impairment annually or when changes in circumstances indicate that the carrying amount of an
asset may not be recoverable. Long-lived assets under certain circumstances are reported at the lower of carrying amount or fair
value. Assets to be disposed of and assets not expected to provide any future service potential to the Company are recorded at
the lower of carrying amount or fair value (less the projected cost associated with selling the asset). To the extent carrying
values exceed fair values, an impairment loss is recognized in operating results.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews its long-lived assets for
impairment annually or when changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived
assets under certain circumstances are reported at the lower of carrying amount or fair value. Assets to be disposed of and assets
not expected to provide any future service potential to the Company are recorded at the lower of carrying amount or fair value
(less the projected cost associated with selling the asset). To the extent carrying values exceed fair values, an impairment loss
is recognized in operating results.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">INTANGIBLE ASSETS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Intangible Assets</b> &#8211; Intangible
assets are capitalized and amortized on a straight-line basis over their estimated useful life, if the life is determinable. If
the life is not determinable, amortization is not recorded. We regularly perform reviews to determine if facts and circumstances
exist which indicate that the useful lives of our intangible assets are shorter than originally estimated or the carrying amount
of these assets may not be recoverable. When an indication exists that the carrying amount of intangible assets may not be recoverable,
we assess the recoverability of our assets by comparing the projected undiscounted net cash flows associated with the related asset
or group of assets over their remaining lives against their respective carrying amounts. Such impairment test is based on the lowest
level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Impairment,
if any, is based on the excess of the carrying amount over the estimated fair value of those assets.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets are capitalized and amortized
on a straight-line basis over their estimated useful life, if the life is determinable. If the life is not determinable, amortization
is not recorded. We regularly perform reviews to determine if facts and circumstances exist which indicate that the useful lives
of our intangible assets are shorter than originally estimated or the carrying amount of these assets may not be recoverable.
When an indication exists that the carrying amount of intangible assets may not be recoverable, we assess the recoverability of
our assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their
remaining lives against their respective carrying amounts. Such impairment test is based on the lowest level for which identifiable
cash flows are largely independent of the cash flows of other groups of assets and liabilities. Impairment, if any, is based on
the excess of the carrying amount over the estimated fair value of those assets.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">RESEARCH, DEVELOPMENT, AND ENGINEERING EXPENSES</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Research, Development and Engineering Expenses</b>
&#8211; Research, development and engineering expenses consist of the cost of employees, consultants and contractors who design,
engineer and develop new products and processes as well as materials, supplies and facilities used in producing prototypes.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s research and development
efforts are primarily focused improving the core foundational ChromaID technology and developing new and unique applications for
the technology. As part of this effort, the Company typically conduct testing to ensure that ChromaID application methods are compatible
with the customer&#8217;s requirements, and that they can be implemented in a cost effective manner. The Company is also actively
involved in identifying new application methods. Know Lab&#8217;s team has considerable experience working with the application
of light-based technologies and their application to various industries. The Company believes that its continued development of
new and enhanced technologies relating to our core business is essential to its future success. The Company spent $391,014, $570,514
and $79,405 during the six months ended March 31, 2019 and the years ended September 30, 2018 and 2017, respectively, on research
and development activities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research, development and engineering expenses
consist of the cost of employees, consultants and contractors who design, engineer and develop new products and processes as well
as materials, supplies and facilities used in producing prototypes.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s research and development
efforts are primarily focused improving the core foundational ChromaID technology and developing new and unique applications for
the technology. As part of this effort, the Company typically conduct testing to ensure that ChromaID application methods are compatible
with the customer&#8217;s requirements, and that they can be implemented in a cost effective manner. The Company is also actively
involved in identifying new application methods. Know Lab&#8217;s team has considerable experience working with the application
of light-based technologies and their application to various industries. The Company believes that its continued development of
new and enhanced technologies relating to our core business is essential to its future success. The Company spent $570,514 and
$79,405 during the years ended September 30, 2018 and 2017, respectively, on research and development activities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Fair Value Measurements and Financial Instruments</b>
&#8211;<b>&#160;</b>ASC Topic 820, <i>Fair Value Measurement and Disclosures</i>, defines fair value as the exchange price that
would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for
the asset or liability in an orderly transaction between market participants on the measurement date.&#160;&#160;This topic also
establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring fair
value.&#160;&#160;The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and an entity&#8217;s
own assumptions (unobservable inputs).&#160;&#160;The hierarchy consists of three levels:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Level 1 &#8211; Quoted prices in active markets for identical assets
and liabilities;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Level 2 &#8211; Inputs other than level one inputs that are either
directly or indirectly observable; and.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level&#160;3 - Inputs to the valuation methodology
are unobservable and significant to the fair value measurement.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The recorded value of other financial assets
and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts
payable and accrued expenses approximate the fair value of the respective assets and liabilities as of March 31, 2019 and September
30, 2018 are based upon the short-term nature of the assets and liabilities.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC Topic 820, <i>Fair Value Measurement and
Disclosures</i>, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability
(an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market
participants on the measurement date.&#160;&#160;This topic also establishes a fair value hierarchy, which requires classification
based on observable and unobservable inputs when measuring fair value.&#160;&#160;The fair value hierarchy distinguishes between
assumptions based on market data (observable inputs) and an entity&#8217;s own assumptions (unobservable inputs).&#160;&#160;The
hierarchy consists of three levels:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 100%; font: 12pt Times New Roman, Times, Serif"><font style="font-size: 8pt">Level 1 &#8211; Quoted prices in active markets for identical assets and liabilities;</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 100%">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Level 2 &#8211; Inputs other than level one inputs that are either
        directly or indirectly observable; and.</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level&#160;3 - Inputs to the valuation methodology
        are unobservable and significant to the fair value measurement.</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The recorded value of other financial assets
and liabilities, which consist primarily of cash and cash equivalents, accounts receivable, other current assets, and accounts
payable and accrued expenses approximate the fair value of the respective assets and liabilities as of September 30, 2018 and 2017
are based upon the short-term nature of the assets and liabilities.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness', window );">DERIVATIVE FINANCIAL INSTRUMENTS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative Financial Instruments -</b>The
Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in
the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton
option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of
derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the
end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based
on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet
date.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its financial
instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative
financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value
and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations.
For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative
instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such
instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument
liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative
instrument could be required within twelve months of the balance sheet date.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionSalesOfServices', window );">REVENUE RECOGNITION</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Revenue Recognition</b> &#8211; Know Lab
and TransTech revenue are derived from products and services. Revenue is considered realized when the products or services have
been provided to the customer, the work has been accepted by the customer and collectability is&#160;reasonably assured. Furthermore,
if an actual measurement of revenue cannot be determined, the Company defers all revenue recognition until such time that an actual
measurement can be determined. If during the course of a contract management determines that losses are expected to be incurred,
such costs are charged to operations in the period such losses are determined. Revenues are deferred when cash has been received
from the customer but the revenue has not been earned.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Know Lab and TransTech revenue are derived
from products and services. Revenue is considered realized when the products or services have been provided to the customer, the
work has been accepted by the customer and collectability is&#160;reasonably assured. Furthermore, if an actual measurement of
revenue cannot be determined, the Company defers all revenue recognition until such time that an actual measurement can be determined.
If during the course of a contract management determines that losses are expected to be incurred, such costs are charged to operations
in the period such losses are determined. Revenues are deferred when cash has been received from the customer but the revenue
has not been earned.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">STOCK BASED COMPENSATION</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock Based Compensation</b> &#8211; The
Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted
stock, as well as options to purchase shares of Company common stock at the fair market value at the time of grant. Stock-based
compensation cost is measured by the Company at the grant date, based on the fair value of the award, over the requisite service
period. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over
the related period of benefit.&#160;&#160;Grants of stock options and stock to non-employees and other parties are accounted for
in accordance with the ASC 505.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has share-based compensation plans
under which employees, consultants, suppliers and directors may be granted restricted stock, as well as options to purchase shares
of Company common stock at the fair market value at the time of grant. Stock-based compensation cost is measured by the Company
at the grant date, based on the fair value of the award, over the requisite service period. For options issued to employees, the
Company recognizes stock compensation costs utilizing the fair value methodology over the related period of benefit.&#160;&#160;Grants
of stock options and stock to non-employees and other parties are accounted for in accordance with the ASC 505.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">CONVERTIBLE SECURITIES</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Securities</b> &#8211; Based
upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will
evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC
815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated
on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an
instrument were required, it would result in the instrument issued latest being reclassified first.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based upon ASC 815-15, we have adopted a sequencing
approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest
issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability
to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with
the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would
result in the instrument issued latest being reclassified first.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">NET LOSS PER SHARE</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Net Loss per Share</b> &#8211; Under the
provisions of ASC 260, &#8220;Earnings Per Share,&#8221; basic loss per common share is computed by dividing net loss available
to common stockholders by the weighted average number of shares of common stock outstanding for the periods presented. Diluted
net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were
exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the
Company, subject to anti-dilution limitations. As of March 31, 2019, there were options outstanding for the purchase of 2,282,668
common shares, warrants for the purchase of 17,572,583 common shares, and 4,894,071&#160;shares of the Company&#8217;s common stock
issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, the Company has an unknown
number of shares (9,020,264 common shares at the current price of $0.25 per share) are issuable upon conversion of convertible
debentures of $2,255,065. All of which could potentially dilute future earnings per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2018, there were options outstanding
for the purchase of 4,736 common shares, warrants for the purchase of 11,837,422 common shares, 2,825,053 shares of the Company&#8217;s
common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, the Company
has an unknown number of shares issuable upon conversion of convertible debentures of $2,390,066. All of which could potentially
dilute future earnings per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the provisions of ASC 260, &#8220;Earnings
Per Share,&#8221; basic loss per common share is computed by dividing net loss available to common stockholders by the weighted
average number of shares of common stock outstanding for the periods presented. Diluted net loss per share reflects the potential
dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock
or resulted in the issuance of common stock that would then share in the income of the Company, subject to anti-dilution limitations.
The common stock equivalents have not been included as they are anti-dilutive. As of September 30, 2018, there were options outstanding
for the purchase of 2,182,668 common shares, warrants for the purchase of 15,473,398 common shares, 4,914,071 shares of the Company&#8217;s
common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. In addition, we have
an unknown number of shares (9,020,264 common shares at the current price of $0.25 per share) are issuable upon conversion of
convertible debentures of $2,255,066. All of which could potentially dilute future earnings per share. &#160;&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2017, there were options
outstanding for the purchase of 15,404 common shares, warrants for the purchase of 6,900,356 common shares, 2,825,053&#160;shares
of the Company&#8217;s common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock
and up to 332,940 shares of the Company&#8217;s common stock issuable upon the exercise of placement agent warrants. In addition,
the Company has an unknown number of shares are issuable upon conversion of convertible debentures of $570,000. All of which could
potentially dilute future earnings per share. &#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_DividendPolicy', window );">DIVIDEND POLICY</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Dividend Policy</b> &#8211; The Company has
never paid any cash dividends and intends, for the foreseeable future, to retain any future earnings for the development of our
business. Our future dividend policy will be determined by the board of directors on the basis of various factors, including our
results of operations, financial condition, capital requirements and investment opportunities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has never paid any cash dividends
and intends, for the foreseeable future, to retain any future earnings for the development of our business. Our future dividend
policy will be determined by the board of directors on the basis of various factors, including our results of operations, financial
condition, capital requirements and investment opportunities.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">USE OF ESTIMATES</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b> &#8211; The preparation
of financial statements in conformity with accounting principles generally accepted in the United States requires management to
make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in
conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ
from those estimates.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Recent Accounting Pronouncements</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A variety of proposed or otherwise potential
accounting standards are currently under study by standard setting organizations and various regulatory agencies. Due to the tentative
and preliminary nature of those proposed standards, management has not determined whether implementation of such proposed standards
would be material to the Company&#8217;s consolidated financial statements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2015, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) 2015-11, &#8220;Simplifying the Measurement of Inventory,&#8221; Topic 330,
&#8220;Inventory&#8221; (ASU 2015-11). The amendments in ASU 2015-11, which apply to inventory that is measured using any method
other than the last-in, first-out (LIFO) or retail inventory method, require that entities measure inventory at the lower of cost
and net realizable value. The amendments in ASU 2015-11 should be applied on a prospective basis. ASU 2015-11 is effective for
fiscal years beginning after December 15, 2016 and interim periods within those years. The Company adopted the amendments of ASU
2015-11 effective October 1, 2017. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated
financial statements for the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU 2016-09,
&#8220;Improvements to Employee Share-Based Payment Accounting,&#8221; Topic 718, &#8220;Compensation-Stock Compensation&#8221;
(ASU 2016-09). ASU 2016-09 includes provisions intended to simplify various aspects related to how share-based payments are accounted
for and presented in the Company&#8217;s financial statements, including income tax consequences, forfeitures and classification
on the statement of cash flows. Under previous guidance, excess tax benefits and deficiencies from share-based compensation arrangements
were recorded in equity when the awards vested or were settled. ASU 2016-09 requires prospective recognition of excess tax benefits
and deficiencies in income tax expense, rather than paid-in-capital. The Company adopted the amendments of ASU 2016-09 effective
October 1, 2017.The adoption of this standard did not have a material impact on the Company&#8217;s consolidated statements of
income for the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, under ASU 2016-09, excess tax income
tax benefits from share-based compensation arrangements are classified as cash flow from operations, rather than as cash flow from
financing activities. For the year ended September 30, 2018, there were no excess income tax benefits.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has elected to continue to estimate
the number of share-based awards expected to vest, as permitted by ASU 2016-09, rather than electing to account for forfeitures
as they occur.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2016-09 requires excess tax benefits and
deficiencies to be prospectively excluded from assumed future proceeds in the calculation of diluted shares, resulting in an immaterial
decrease in diluted weighted average shares outstanding for the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2017, the FASB issued ASU 2017-04,
&#8220;Simplifying the Test for Goodwill Impairment,&#8221; Topic 350, &#8220;Intangibles &#8211; Goodwill and Other&#8221; (ASU
2017-04). The amendments in ASU 2017-04 simplify the accounting for goodwill impairment for all entities by requiring impairment
charges to be based on the first step in the current two-step impairment test. An impairment charge for the amount by which the
carrying amount exceeds the reporting unit&#8217;s fair value should be recognized; however, the loss recognized should not exceed
the total amount of goodwill allocated to that reporting unit. The amendments should be applied on a prospective basis. Early adoption
is permitted for annual and interim goodwill impairment testing dates after January 1, 2017, and the ASU is effective for the Company&#8217;s
first quarter of the fiscal year ending September 30, 2020. The Company is currently evaluating the impact that the adoption of
these provisions will have on its consolidated financial statements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,
&#8220;Leases,&#8221; Topic 842, &#8220;Leases&#8221; (ASU 2016-02). ASU No. 2016-02 requires lessees to recognize a right-of-use
asset and corresponding lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation
of expenses will depend on classification as a finance or operating lease. ASU 2016-02 also requires certain quantitative and qualitative
disclosures. The provisions of ASU 2016-02 are effective for the Company&#8217;s first quarter of the fiscal year ending September
30, 2020, with early adoption permitted. The Company will apply the transition provisions of ASU 2016-02 at its adoption date,
rather than the earliest comparative period presented in the financial statements, as permitted by ASU 2018-11, &#8220;Leases,&#8221;
Topic 842, &#8220;Targeted Improvements,&#8221; released in July 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The adoption of ASU 2016-02 may result in a
material increase to the Company&#8217;s consolidated balance sheets for lease liabilities and right-of-use assets. The Company
is also performing a comprehensive review of its current processes to determine and implement changes required to support the adoption
of this standard. The Company is currently evaluating the other effects the adoption of ASU 2016-02 will have on its consolidated
financial statements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2018, the FASB issued ASU 2018-01,
&#8220;Leases,&#8221; Topic 842, &#8220;Land Easement Practical Expedient for Transition to Topic 842&#8221; (ASU 2018-01). ASU
2018-01 permits an entity to elect a transition practical expedient to not assess, under Accounting Standards Codification (ASC)
842, land easements that exist or expired before the standard&#8217;s effective date that were not previously accounted for as
leases under ASC 840. The Company plans to elect this practical expedient in implementing ASU 2016-02.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued ASU 2014-09, &#8220;Revenue
from Contracts with Customers,&#8221; Topic 606, &#8220;Revenue from Contracts with Customers&#8221; (ASU 2014-09). ASU 2014-09
provides guidance for revenue recognition and will replace most existing revenue recognition guidance in GAAP when it becomes effective.
ASU 2014-09&#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers
in an amount that reflects the consideration to which the company expects to be entitled for the transfer of those goods or services.
ASU 2014-09 permits the use of either the retrospective or cumulative effect transition method. Additionally, the amendments in
this ASU provide a practical expedient for entities to recognize the incremental costs of obtaining a contract as an expense when
incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less, The Company
plans to elect this practical expedient upon adoption.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2015, the FASB issued ASU 2015-14, &#8220;Revenue
from Contracts with Customers &#8211; Deferral of the Effective Date.&#8221; The FASB approved the deferral of ASU 2014-09, by
extending the new revenue recognition standard&#8217;s mandatory effective date by one year and permitting public companies to
apply the new revenue standard to annual reporting periods beginning after December 15, 2017. The guidance in ASU 2014-09 will
be effective for the Company in the first quarter of the fiscal year ending September 30, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further to ASU 2014-09 and ASU 2015-14, the
FASB issued ASU 2016-08, &#8220;Revenue from Contracts with Customers,&#8221; Topic 606, &#8220;Principal versus Agent Considerations
(Reporting Revenue Gross versus Net)&#8221; (ASU 2016-08) in March 2016, ASU 2016-12, &#8220;Revenue from Contracts with Customers,&#8221;
Topic 606, &#8220;Narrow-Scope Improvements and Practical Expedients&#8221; (ASU 2016-12) in May 2016 and ASU 2016-20, &#8220;Revenue
from Contracts with Customers,&#8221; Topic 606, &#8220;Technical Corrections and Improvements&#8221; (ASU 2016-20) in December
2016. The amendments in ASU 2016-08 clarify the implementation guidance on principal versus agent considerations, including indicators
to assist an entity in determining whether it controls a specified good or service before it is transferred to the customers. ASU
2016-12 addresses narrow-scope improvements to the guidance on collectability, non-cash consideration, and completed contracts
at transition. Additionally, the amendments in this ASU provide a practical expedient for contract modifications at transition
and an accounting policy election related to the presentation of sales taxes and other similar taxes collected from customers.
The Company plans to make such election. The Company also plans to elect the practical expedient in ASU 2016-20 that provides entities
do not need to disclose the transaction price allocated to performance obligations when the related contracts have a duration of
one year or less. This includes loyalty rewards, which can be redeemed in the month subsequent to the quarter earned, and marketing
promotions that cross accounting periods. Both of these classes of transactions are currently immaterial to the Company. The effective
date and transition requirements for ASU 2016-08, ASU 2016-12 and ASU 2016-20 are the same as for ASU 2014-09.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not plan to early adopt the
new revenue recognition guidance; adoption will be on the modified retrospective basis beginning in fiscal year 2019. The Company
has substantially concluded its assessment of the impact of the adoption of this standard on its consolidated financial statements.
Most of the Company&#8217;s revenue is expected to continue to be generated from point-of-sale transactions, which ASU 2014-09
treats generally consistent with current accounting standards. The Company does not expect this standard will have a material impact
on the accounting for point-of-sale transactions or related areas including the right of return and customer incentives. Although
the impact on the consolidated financial statements is not expected to be material, additional disclosures will be required.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07, &#8220;Compensation-Stock
Compensation,&#8221; Topic 718, &#8220;Improvements to Nonemployee Share-Based Payment Accounting&#8221; (ASU 2018-07) as part
of its Simplification Initiative to reduce complexity when accounting for share-based payments to non-employees. ASU 2018-07 expands
the scope of Topic 718 to more closely align share-based payment transactions for acquiring goods and services from non-employees
with the accounting for share-based payments to employees, with certain exceptions. The provisions of ASU 2018-07 are effective
for the Company&#8217;s first quarter of the fiscal year ending September 30, 2020, with early adoption permitted.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_DividendPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividend policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_DividendPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining hedging effectiveness and if hedge effectiveness was assessed on quantitative or qualitative basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 25<br> -Paragraph 79<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109976185&amp;loc=d3e60861-113975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesMethodsOfAccountingHedgeEffectiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109236672&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e4975-111524<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionSalesOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition for sales of a service. The entity also may disclose how it recognizes cost of sales for such a service transaction and its treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionSalesOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6636908144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. GOING CONCERN<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">GOING CONCERN</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying financial statements have been
prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal
course of business. The Company incurred net losses of $2,493,821, $3,257,597 and $3,901,232 for the six months ended March 31,
2019 and the years ended September 30, 2018 and 2017, respectively. Net cash used in operating activities was $1,462,737, $1,117,131
and $1,264,324 for the three months ended March 31, 2019 and for the years ended September 30, 2018 and 2017, respectively.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company anticipates that it will record
losses from operations for the foreseeable future. As of March 31, 2019, the Company&#8217;s accumulated deficit was $37,285,145.&#160;&#160;The
Company has limited capital resources, and operations to date have been funded with the proceeds from private equity and debt financings
and loans from Ronald P. Erickson, the Company&#8217;s Chief Executive Officer, or entities with which he is affiliated. These
conditions raise substantial doubt about our ability to continue as a going concern. The audit report prepared by the Company&#8217;s
independent registered public accounting firm relating to our financial statements for the year ended September 30, 2018 includes
an explanatory paragraph expressing the substantial doubt about the Company&#8217;s ability to continue as a going concern.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believe that its cash on hand will
be sufficient to fund our operations until December 31, 2019. We need additional financing to implement our business plan and to
service our ongoing operations and pay our current debts. There can be no assurance that we will be able to secure any needed funding,
or that if such funding is available, the terms or conditions would be acceptable to us. If we are unable to obtain additional
financing when it is needed, we will need to restructure our operations, and divest all or a portion of our business. <font style="background-color: white">We
may seek additional capital through a combination of private and public equity offerings, debt financings and strategic collaborations.
Debt financing, if obtained, may involve agreements that include covenants limiting or restricting our ability to take specific
actions, such as incurring additional debt, and could increase our expenses and require that our assets secure such debt. Equity
financing, if obtained, could result in dilution to the Company&#8217;s then-existing stockholders and/or require such stockholders
to waive certain rights and preferences. If such financing is not available on satisfactory terms, or is not available at all,
the Company may be required to delay, scale back, eliminate the development of business opportunities or file for bankruptcy and
our operations and financial condition may be materially adversely affected.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying financial statements
have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in
the normal course of business. The Company incurred net losses of $3,257,597 and $3,901,232 for the years ended September 30, 2018
and 2017, respectively. Net cash used in operating activities was $1,117,131 and $1,264,324 for the years ended September 30, 2018
and 2017, respectively.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company anticipates that it will
record losses from operations for the foreseeable future. As of September 30, 2018, the Company&#8217;s accumulated deficit was
$34,791,324.&#160;&#160;The Company has limited capital resources, and operations to date have been funded with the proceeds from
private equity and debt financings and loans from Ronald P. Erickson, the Company&#8217;s Chief Executive Officer, or entities
with which he is affiliated. These conditions raise substantial doubt about our ability to continue as a going concern. The audit
report prepared by the Company&#8217;s independent registered public accounting firm relating to our financial statements for the
year ended September 30, 2018 includes an explanatory paragraph expressing the substantial doubt about the Company&#8217;s ability
to continue as a going concern.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believe that its cash on
hand will be sufficient to fund our operations until March 31, 2019. We need additional financing to implement our business plan
and to service our ongoing operations and pay our current debts. There can be no assurance that we will be able to secure any needed
funding, or that if such funding is available, the terms or conditions would be acceptable to us. If we are unable to obtain additional
financing when it is needed, we will need to restructure our operations, and divest all or a portion of our business. <font style="background-color: white">We
may seek additional capital through a combination of private and public equity offerings, debt financings and strategic collaborations.
Debt financing, if obtained, may involve agreements that include covenants limiting or restricting our ability to take specific
actions, such as incurring additional debt, and could increase our expenses and require that our assets secure such debt. Equity
financing, if obtained, could result in dilution to the Company&#8217;s then-existing stockholders and/or require such stockholders
to waive certain rights and preferences. If such financing is not available on satisfactory terms, or is not available at all,
the Company may be required to delay, scale back, eliminate the development of business opportunities or file for bankruptcy and
our operations and financial condition may be materially adversely affected.</font>&#160;&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>




<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6612375504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. FIXED ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 197,536<span></span>
</td>
<td class="nump">$ 169,333<span></span>
</td>
<td class="nump">$ 133,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">717,019<span></span>
</td>
<td class="nump">670,666<span></span>
</td>
<td class="nump">662,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 46,354<span></span>
</td>
<td class="nump">60,393<span></span>
</td>
<td class="nump">38,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (113,244)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6812180272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. SIGNIFICANT ACCOUNTING POLICIES: ADOPTION OF ACCOUNTING STANDARDS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserve for impaired inventory</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of assets</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of assets</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6810076912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. STOCK OPTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock option activity</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>&#160;Weighted Average</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>&#160;Options</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>&#160;Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>$</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 58%"><font style="font-size: 8pt">Outstanding as of September 30, 2018</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td>
    <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">2,182,668</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: black 1pt solid"><font style="font-size: 8pt">$</font></td>
    <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1.698</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: black 1pt solid"><font style="font-size: 8pt">$</font></td>
    <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">3,706,519</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">100,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3.030</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">303,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Forfeitures</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Outstanding as of March 31, 2019</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">2,282,668</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">1.757</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">4,009,519</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted Average&#160;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Options&#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exercise Price&#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160; $</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 46%"><font style="font-size: 8pt">Outstanding as of September 30, 2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">50,908</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">18.045</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">918,627</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Forfeitures</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(35,504</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(19.507</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(692,568</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Outstanding as of September 30, 2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">15,404</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">14.675</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">226,059</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2,180,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.683</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3,668,500</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Forfeitures</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(12,736</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">14.764</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(188,040</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Outstanding as of September 30, 2018</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,182,668</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1.698</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">3,706,519</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock', window );">Stock options outstanding and exercisable</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt"><b>Range of</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Number</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Remaining Life</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise Price</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Number</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise Price</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercise Prices</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Outstanding</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>In Years</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: center"><font style="font-size: 8pt">0.25</font>&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">530,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">4.61</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">99,375</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">0.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">1.28</font>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,150,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.71</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">143,750</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.28</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">3.03</font>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">100,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.71</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3.03</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">100,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3.03</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">4.08-4.20</font>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">500,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.73</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.08-4.20</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">31,250</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.08-4.20</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">13.500</font>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.38</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">15.000</font>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">15.00</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">15.00</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">2,282,668</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">4.69</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">1.757</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">375,709</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">1.755</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Range of</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Number</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Remaining Life</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise Price</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Number</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise Price</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exercise Prices</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Outstanding</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">In Years</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exerciseable</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exerciseable</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exerciseable</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 17%; text-align: right"><font style="font-size: 8pt">0.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">530,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">4.98</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,150,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.96</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.08-4.20</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">500,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.98</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.500</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.44</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">15.000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">15.00</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">15.00</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,182,668</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">4.94</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1.698</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6630326736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. NOTES RECEIVABLE FROM BIOMEDX, INC<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">NOTES RECEIVABLE FROM BIOMEDX, INC</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 1, 2016, the Company purchased an
Original Issue Discount Convertible Promissory Note from BioMedx, Inc. The Company paid $260,000 for the Note with a principal
amount of $286,000. The Note matured one year from issuance and bears interest at 5%. The principal and interest was convertible
into BioMedx common stock at the option of the Company. The Company received 150,000 shares of BioMedx common stock as partial
consideration for purchasing the Note. In addition, if BioMedx does not repay the Promissory Note, the Company would have the right
to convert the Promissory Note into 51% of the ownership of BioMedx.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, the Company and BioMedx agreed
to negotiate in good faith to enter into a joint development agreement and subsequent merger transaction prior to December 31,
2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Due to the uncertainty involved with a start-up
company, The Company&#8217;s management determined that the value of the Promissory Note and BioMedx common stock was zero at December
31, 2016 and recorded an impairment reserve for the full value as of December 31, 2016. During the three months ended March 31,
2017, BioMedx paid the Company $290,608 in full satisfaction of the Note. The Company recorded the gain as a reduction in SG&#38;A
expense during the three months ended March 31, 2017. In addition, the Company has not valued the 150,000 shares of BioMedx common
stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5162-111524<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5066-111524<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6661690992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. ACCOUNTS PAYABLE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts payable were $1,298,278 and $1,517,617
as of&#160;March 31, 2019 and September 30, 2018, respectively. Such liabilities consisted of amounts due to vendors for inventory
purchases and technology development, external audit, legal and other expenses incurred by the Company. The Company had two vendors
(12.3% and 10.0%) with accounts payable in excess of 10% of its accounts payable as of March 31, 2019. The Company does expect
to have vendors with accounts payable balances of 10% of total accounts payable in the foreseeable future.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts payable were $1,512,618 and $2,154,646
as of&#160;September 30, 2018 and 2017, respectively. Such liabilities consisted of amounts due to vendors for inventory purchases
and technology development, external audit, legal and other expenses incurred by the Company. The Company had two vendors (13.2%
and 10.2%) with accounts payable in excess of 10% of its accounts payable as of September 30, 2018. The Company does expect to
have vendors with accounts payable balances of 10% of total accounts payable in the foreseeable future.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6814768064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. STOCK OPTIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted</a></td>
<td class="nump">2,462,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding, End</a></td>
<td class="nump">$ 14,664,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period</a></td>
<td class="nump">2,182,668<span></span>
</td>
<td class="nump">15,404<span></span>
</td>
<td class="nump">50,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">2,180,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares forfeitures</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(35,504)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period</a></td>
<td class="nump">2,282,668<span></span>
</td>
<td class="nump">2,182,668<span></span>
</td>
<td class="nump">15,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period</a></td>
<td class="nump">$ 1.698<span></span>
</td>
<td class="nump">$ 14.675<span></span>
</td>
<td class="nump">$ 18.045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Shares granted</a></td>
<td class="nump">3.030<span></span>
</td>
<td class="nump">1.683<span></span>
</td>
<td class="nump">0.000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Shares exercised</a></td>
<td class="nump">0.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Shares forfeitures</a></td>
<td class="nump">(0.000)<span></span>
</td>
<td class="nump">14.764<span></span>
</td>
<td class="num">(19.507)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period</a></td>
<td class="nump">$ 1.757<span></span>
</td>
<td class="nump">$ 1.698<span></span>
</td>
<td class="nump">$ 14.675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding, Beginning</a></td>
<td class="nump">$ 3,706,519<span></span>
</td>
<td class="nump">$ 226,059<span></span>
</td>
<td class="nump">$ 918,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding, Granted</a></td>
<td class="nump">$ 303,000<span></span>
</td>
<td class="nump">$ 3,668,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding, Exercised</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding, Forefeitures</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (188,040)<span></span>
</td>
<td class="num">$ (692,568)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding, End</a></td>
<td class="nump">$ 4,009,519<span></span>
</td>
<td class="nump">$ 3,706,519<span></span>
</td>
<td class="nump">$ 226,059<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6637193440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>17. COMMITMENTS, CONTINGENCIES AND LEGAL PROCEEDINGS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract', window );"><strong>Commitments Contingencies And Legal Proceedings Details Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2019</a></td>
<td class="nump">$ 187,652<span></span>
</td>
<td class="nump">$ 118,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="nump">196,526<span></span>
</td>
<td class="nump">85,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="nump">5,816<span></span>
</td>
<td class="nump">23,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Beyond</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 389,994<span></span>
</td>
<td class="nump">$ 227,602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_CommitmentsContingenciesAndLegalProceedingsDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6802685120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>14. EQUITY (Details Narrative)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_WarrantsVested', window );">Warrants vested | shares</a></td>
<td class="nump">16,613,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic value | $</a></td>
<td class="nump">$ 14,664,327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_WarrantsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Custom Element.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_WarrantsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6797265376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract', window );"><strong>Notes Payable Capitalized Leases And Long Term Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Capital Source&#160;Business&#160;Finance&#160;Group</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 145,186<span></span>
</td>
<td class="nump">$ 365,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableToBank', window );">Note payable to Umpqua Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">199,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Secured note payable to J3E2A2Z LP - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">145,186<span></span>
</td>
<td class="nump">1,165,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Less current portion of long term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(145,186)<span></span>
</td>
<td class="num">(1,165,660)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesPayableCapitalizedLeasesAndLongTermDebtDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital lease obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableToBank">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, the carrying value as of the balance sheet date of notes payable to banks, excluding mortgage notes, initially due beyond one year or beyond the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableToBank</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6637703920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. INTANGIBLE ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IntangibleAssetsDetailsNarrativeAbstract', window );"><strong>Intangible Assets Details Narrative Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 86,666<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IntangibleAssetsDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IntangibleAssetsDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6795285328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">EQUITY</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Authorized Capital Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company authorized 105,000,000 shares of
capital stock, of which 100,000,000 are shares of voting common stock, par value $0.001 per share, and 5,000,000 are shares preferred
stock, par value $0.001 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2019, the Company had 22,002,904
shares of common stock issued and outstanding, held by 122 stockholders of record. The number of stockholders, including beneficial
owners holding shares through nominee names, is approximately 2,300. Each share of common stock entitles its holder to one vote
on each matter submitted to the stockholders for a vote, and no cumulative voting for directors is permitted.&#160;&#160;Stockholders
do not have any preemptive rights to acquire additional securities issued by us.&#160;&#160;As of March 31, 2019, there were options
outstanding for the purchase of 2,282,668 common shares, warrants for the purchase of 17,572,583 common shares, and 4,894,071&#160;shares
of the Company&#8217;s common stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock.
In addition, the Company has an unknown number of shares (9,020,264 common shares at the current price of $0.25 per share) are
issuable upon conversion of convertible debentures of $2,255,066. All of which could potentially dilute future earnings per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Voting Preferred Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is authorized to issue up to 5,000,000
shares of preferred stock with a par value of $0.001.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Series A Preferred Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 29, 2019, a holder of Series A Preferred
Stock converted 20,000 shares into 80,000 shares of common stock. There are no Series A Preferred Stock outstanding as of March
31, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Series C and D Preferred Stock and Warrants</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 5, 2016, the Company closed a Series
C Preferred Stock and Warrant Purchase Agreement with Clayton A. Struve, an accredited investor for the purchase of $1,250,000
of preferred stock with a conversion price of $0.70 per share. The preferred stock has a yield of 8% and an ownership blocker of
4.99%. In addition, Mr. Struve received a five-year warrant to acquire 1,785,714 shares of common stock at $0.70 per share. On
August 14, 2017, the price of the Series C Stock were adjusted to $0.25 per share pursuant to the documents governing such instruments.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2019, the Company has 3,108,356
of Series D Preferred Stock outstanding with Clayton A. Struve, an accredited investor, outstanding. On August 14, 2017, the price
of the Series D Stock were adjusted to $0.25 per share pursuant to the documents governing such instruments.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Series F Preferred Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 1, 2018, the Company filed with the
State of Nevada a Certificate of Designation establishing the Designations, Preferences, Limitations and Relative Rights of Series
F Preferred Stock. The Designation authorized 500 shares of Series F Preferred Stock. The Series F Preferred Stock shall only be
issued to the current Board of Directors on the date of the Designation&#8217;s filing and is not convertible into common stock.
As set forth in the Designation, the Series F Preferred Stock has no rights to dividends or liquidation preference and carries
rights to vote 100,000 shares of common stock per share of Series F upon a Trigger Event, as defined in the Designation. A Trigger
Event includes certain unsolicited bids, tender offers, proxy contests, and significant share purchases, all as described in the
Designation. Unless and until a Trigger Event, the Series F shall have no right to vote. The Series F Preferred Stock shall remain
issued and outstanding until the date which is 731 days after the issuance of Series F Preferred Stock (&#8220;Explosion Date&#8221;),
unless a Trigger Event occurs, in which case the Explosion Date shall be extended by 183 days.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Securities Subject to Price Adjustments</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the future, if we sell our common stock at
a price below $0.25 per share, the exercise price of 1,785,715 outstanding shares of Series C Preferred Stock, 1,016,004 outstanding
shares Series D Preferred Stock that adjust below $0.25 per share pursuant to the documents governing such instruments. In addition,
the conversion price of a Convertible Note Payable of $2,255,066 (9,020,264 common shares at the current price of $0.25 per share)
and the exercise price of additional outstanding warrants to purchase 12,664,385 shares of common stock would adjust below $0.25
per share pursuant to the documents governing such instruments. &#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Common Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the offerings and sales described below
were deemed to be exempt under Rule 506 of Regulation D and/or Section 4(a)(2) of the Securities Act. No advertising or general
solicitation was employed in offering the securities, the offerings and sales were made to a limited number of persons, all of
whom were accredited investors and transfer was restricted by the company in accordance with the requirements of Regulation D and
the Securities Act. All issuances to accredited and non-accredited investors were structured to comply with the requirements of
the safe harbor afforded by Rule 506 of Regulation D, including limiting the number of non-accredited investors to no more than
35 investors who have sufficient knowledge and experience in financial and business matters to make them capable of evaluating
the merits and risks of an investment in our securities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following equity issuances occurred during
the six months ended March 31, 2019:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended March 31, 2019,
the Company issued 336,427 shares of common stock and cancelled warrants to purchase 26,573 shares of common stock at $0.25 per
share to two consultants and two investors related to the cashless exercise of warrants.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended March 31, 2019,
the Company issued 145,000 shares of common stock for services provided by two consultants. The shares were valued at $246,900
or $1.703 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 2, 2019, the Company issued 100,000
shares of common stock for services provided to Ronald P. Erickson. The shares were valued at $102,000 or $1.02 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 29, 2019, a holder of Series A Preferred
Stock converted 20,000 shares into 80,000 shares of common stock.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Private Placements</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 4, 2019, the Company closed rounds
one and two of a private placement and received gross proceeds of $2,409,975 in exchange for issuing Subordinated Convertible Notes
and Warrants in a private placement to 26 accredited investors, pursuant to a series of substantially identical Securities Purchase
Agreements, Common Stock Warrants, and related documents.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 18, 2019, Company closed round three
of a private placement and received gross proceeds of $1,400,000 in exchange for issuing Subordinated Convertible Notes and Warrants
in a private placement to 8 accredited investors, pursuant to a series of substantially identical Securities Purchase Agreements,
Common Stock Warrants, and related documents.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Convertible Notes have a principal amount
of $3,809,975 and bear annual interest of 8%. Both the principal amount of and the interest are payable on a payment-in-kind basis
in shares of Common Stock of the Company. They are due and payable in common stock on the earlier of (a) mandatory and automatic
conversion of the Convertible Notes into a financing that yields gross proceeds of at least $10,000,000 or (b) on the one-year
anniversary of the Convertible Notes. Investors will be required to convert their Convertible Notes into Common Stock in any $10,000,000
financing at a conversion price per share equal to the lower of (i) $1.00 per share or (ii) a 25% discount to the price per share
paid by investors in the $10,000,000 Financing. If the Convertible Notes have not been paid or converted prior to the Maturity
Date, the outstanding principal amount of the Convertible Notes will be automatically converted into shares of Common Stock at
the lesser of (a) $1.00 per share or (b) any adjusted price resulting from the application of a &#8220;most favored nations&#8221;
provision, which requires the issuance of additional shares of Common Stock to investors if the Company issues certain securities
at less than the then-current conversion price.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrants were granted on a 1:0.5 basis (one-half
Warrant for each full share of Common Stock into which the Convertible Notes are convertible). The Warrants have a five-year term
and an exercise price equal to 120% of the per share conversion price of the Qualified Financing or other mandatory conversion.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Convertible Notes are initially convertible
into 3,809,975 shares of Common Stock, subject to certain adjustments, and the Warrants are initially exercisable for 1,904,988
shares of Common Stock at an exercise price of $1.20 per share of Common Stock, also subject to certain adjustments.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the private placement, the
placement agent for the Convertible Notes and the Warrants received a cash fee of $324,798 and warrants to purchase 487,197 shares
of the Company&#8217;s common stock, all based on 8% of gross proceeds to the Company. The placement agent has also received a
$25,000 advisory fee.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of the Purchase Agreement, the Company
entered into a Registration Rights Agreement, which grants the investors &#8220;demand&#8221; and &#8220;piggyback&#8221; registration
rights to register the shares of Common Stock issuable upon the conversion of the Convertible Notes and the exercise of the Warrants
with the Securities and Exchange Commission for resale or other disposition. In addition, the Convertible Notes are subordinated
to certain senior debt of the Company pursuant to a Subordination Agreement executed by the investors.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Convertible Notes and Warrants were issued
in transactions that were not registered under the Securities Act of 1933, as amended (the &#8220;Act&#8221;) in reliance upon
applicable exemptions from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act. &#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expects to continue offering additional
Convertible Notes and Warrants on substantially the same terms until April 15, 2019 (unless extended at the discretion of the Company)
or until the Company has raised a maximum of $5 million in gross proceeds (or such other amount determined by the Company in its
discretion). The offering was extended until May 31, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Warrants to Purchase Common Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following warrants were issued during the
six months ended March 31, 2019:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company issued 336,427 shares of common
stock and cancelled warrants to purchase 26,573 shares of common stock at $0.25 per share to two consultants and two investors
related to the cashless exercise of warrants.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company issued warrants to purchase 70,000
shares of common stock at $1.61 to$2.72 per share to three consultants. The warrants were valued at $30,325 or 0.79 to $1.11 per
share. The warrants expire during the first quarter of 2024.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Private Placements</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrants issued for the private placements
discussed above were granted on a 1:0.5 basis (one-half Warrant for each full share of Common Stock into which the Convertible
Notes are convertible). The Warrants have a five-year term and an exercise price equal to 120% of the per share conversion price
of the Qualified Financing or other mandatory conversion.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrants are initially exercisable for 1,904,988
shares of Common Stock at an exercise price of $1.20 per share of Common Stock, also subject to certain adjustments.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the private placement, the
placement agent for the Convertible Notes and the Warrants received warrants to purchase 487,197 shares of the Company&#8217;s
common stock, all based on 8% of gross proceeds to the Company.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">A summary of the warrants outstanding as of March 31, 2019 were as
follows:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>March 31, 2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 70%"><font style="font-size: 8pt">Outstanding at beginning of period</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 8pt">0.326</font></td>
    <td style="width: 3%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2,462,185</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.222</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(336,427</font></td>
    <td><font style="font-size: 8pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(0.250</font></td>
    <td><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Expired</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">(26,573</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">(0.250</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Outstanding at end of period</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">17,572,583</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">0.453</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Exercisable at end of period</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">17,572,583</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">A summary of the status of the warrants outstanding as of March 31,
2019 is presented below:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="17" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>March 31, 2019</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Number of</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Remaining</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Shares</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Warrants</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Life ( In Years)</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 1%">&#160;</td>
    <td style="width: 23%; text-align: right"><font style="font-size: 8pt">13,507,286</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 8pt">3.50</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 8pt">13,507,286</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">714,286</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.33</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.700</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">714,286</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.700</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">882,159</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.62</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">882,159</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2,442,185</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.93</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.20-1.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2,442,185</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.20-1.50</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">20,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.92</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.34-4.08</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">20,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.34-4.08</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">6,667</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">30.000</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">6,667</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">30.000</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">17,572,583</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">3.78</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">0.453</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">17,572,583</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">0.453</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">The significant weighted average assumptions relating to the valuation
of the Company&#8217;s warrants for the six months ended March 31, 2019 were as follows:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b><u>Assumptions</u></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 77%"><font style="font-size: 8pt">Dividend yield</font></td>
    <td style="width: 23%; text-align: center"><font style="font-size: 8pt">0%</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Expected life</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">1 yr</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Expected volatility</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">125%</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Risk free interest rate</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">2.0%</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">There were vested warrants of 16,613,757 as of March 31, 2019 with
an aggregate intrinsic value of $14,664,327.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"></p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Authorized Capital Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company authorized 105,000,000 shares of
capital stock, of which 100,000,000 are shares of voting common stock, par value $0.001 per share, and 5,000,000 are shares preferred
stock, par value $0.001 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has authorized to issue up to 100,000,000
shares of common stock with a par value of $0.001. As of September 30, 2018, we had 17,531,502 shares of common stock issued and
outstanding, held by 122 shareholders of record. The number of shareholders, including beneficial owners holding shares through
nominee names, is approximately 2,300. Each share of common stock entitles its holder to one vote on each matter submitted to the
shareholders for a vote, and no cumulative voting for directors is permitted.&#160;&#160;Shareholders do not have any preemptive
rights to acquire additional securities issued by us.&#160;&#160;As of September 30, 2018, there were options outstanding for the
purchase of 2,182,668 common shares, warrants for the purchase of 15,473,398 common shares and 4,914,071&#160;shares of our common
stock issuable upon the conversion of Series A, Series C and Series D Convertible Preferred Stock. We have Convertible Note Payable
of $2,255,066 (9,020,264 common shares at the current price of $0.25 per share). All of which could potentially dilute future earnings
per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Voting Preferred Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is authorized to issue up to 5,000,000
shares of preferred stock with a par value of $0.001.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Series A Preferred Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2015, the Company sold Series A Preferred
Stock to two investors for a total of $350,000. As of December 21, 2018, the Company had 20,000 Series A Preferred Stock issued
and outstanding.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each holder of outstanding shares of Series
A Preferred is entitled to the number of votes equal to the number of whole shares of common stock into which the shares of Series
A Preferred held by such holder are then convertible as of the applicable record date. The Series A Preferred may not be redeemed
without the consent of the holder. The Company cannot amend, alter or repeal any preferences, rights, or other terms of the Series
A Preferred so as to adversely affect the Series A Preferred, without the written consent or affirmative vote of the holders of
at least 66% of the then outstanding shares of Series A Preferred, voting as a separate voting group, given by written consent
or by vote at a meeting called for such purpose for which notice shall have been duly given to the holders of the Series A Preferred.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the issuance of the Series
A Preferred, the Company also issued (i) a Series C five-year Warrant for 2 shares of common stock and (ii) a Series D five-year
Warrant for 23,334 shares of common stock. The Series A Preferred Stock and Series C and D Warrants currently have no registration
rights.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 14, 2017, the price of the Series
A Preferred Stock and Series C and D Warrants were adjusted to $0.25 per share pursuant to the documents governing such instruments.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 23, 2018, a holder of Series A
Preferred Stock converted 3,334 shares into 3,334 shares of common stock. In addition, the holder exercised Series C and D Warrants
for 6,668 shares of common stock at $0.25 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Series C and D Preferred Stock and Warrants</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 5, 2016, the Company closed a Series
C Preferred Stock and Warrant Purchase Agreement with Clayton A. Struve, an accredited investor for the purchase of $1,250,000
of preferred stock with a conversion price of $0.70 per share. The preferred stock has a yield of 8% and an ownership blocker of
4.99%. In addition, Mr. Struve received a five-year warrant to acquire 1,785,714 shares of common stock at $0.70 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To determine the effective conversion price,
a portion of the proceeds received by the Company upon issuance of the Series C Preferred Stock was first allocated to the freestanding
warrants issued as part of this transaction. Given that the warrants will not subsequently be measured at fair value, the Company
determined that the warrants should receive an allocation of the proceeds based on their relative fair value. This is based on
the understanding that the FASB staff and the SEC staff believe that a freestanding instrument issued in a basket transaction should
be initially measured at fair value if it is required to be subsequently measured at fair value pursuant to US generally accepted
accounting principles (&#8220;GAAP&#8221;), with the residual proceeds from the transaction allocated to any remaining instruments
based on their relative fair values. As such, the warrants were allocated a fair value of approximately $514,706 upon issuance,
with the remaining $735,294 of proceeds allocated to the Series C Preferred Stock.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Proportionately, this allocation resulted in
approximately 59% of the face amount of the Series C Preferred Stock issuance remaining, which applied to the stated conversion
price of $0.70 resulted in an effective conversion price of approximately $0.41.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Having determined the effective conversion price,
the Company then compared this to the fair value of the underlying Common Stock as of the commitment date, which was approximately
$1.06 per share, and concluded that the conversion feature did have an intrinsic value of $0.65 per share. As such, the Company
concluded that the Series C Preferred Stock did contain a beneficial conversion feature and an accounting entry and additional
financial statement disclosure was required.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because our preferred stock is perpetual, with
no stated maturity date, and the conversions may occur any time from inception, the dividend is recognized immediately when a beneficial
conversion exists at issuance. During the year ending September 30, 2016, the Company recognized preferred stock dividends of $1.16
million on Series C preferred stock related to the beneficial conversion feature arising from a common stock effective conversion
rate of $0.41 versus a current market price of $1.06 per common share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 14, 2016, the Company issued 187,500
shares of Series D Convertible Preferred Stock and a warrant to purchase 187,500 shares of common stock in a private placement
to certain accredited investors for gross proceeds of $150,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement
dated November 10, 2016.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The warrants associated with the November 14,
2016 issuance were allocated a fair value of approximately $56,539 upon issuance, with the remaining $63,539 of net proceeds allocated
to the Series D Preferred Stock. Proportionately, this allocation resulted in approximately 53% of the amount of the Series D Preferred
Stock issuance remaining, which applied to the stated conversion price of $0.80 resulted in an effective conversion price of approximately
$0.34. Having determined the effective conversion price, the Company then compared this to the fair value of the underlying Common
Stock as of the commitment date, which was approximately $1.14 per share, and concluded that the conversion feature did have an
intrinsic value of $0.80 per share. As such, the Company concluded that the Series D Preferred Stock did contain a beneficial conversion
feature of $150,211 which was recorded as a beneficial conversion in stockholders&#8217; equity.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 19, 2016, the Company issued 187,500
shares of Series D Convertible Preferred Stock and a warrant to purchase 187,500 shares of common stock in a private placement
to an accredited investor for gross proceeds of $150,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement
dated December 14, 2016.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The warrants associated with the December 19,
2016 issuance were allocated a fair value of approximately $60,357 upon issuance, with the remaining $69,643 of net proceeds allocated
to the Series D Preferred Stock. Proportionately, this allocation resulted in approximately 54% of the amount of the Series D Preferred
Stock issuance remaining, which applied to the stated conversion price of $0.80 resulted in an effective conversion price of approximately
$0.37. Having determined the effective conversion price, the Company then compared this to the fair value of the underlying Common
Stock as of the commitment date, which was approximately $0.81 per share, and concluded that the conversion feature did have an
intrinsic value of $0.44 per share. As such, the Company concluded that the Series C Preferred Stock did contain a beneficial conversion
feature of $82,232 which was recorded as a beneficial conversion in stockholders&#8217; equity.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because the Company&#8217;s preferred stock
is perpetual, with no stated maturity date, and the conversions may occur any time from inception, the dividend is recognized immediately
when a beneficial conversion exists at issuance. During the year ending September 30, 2017, the Company recognized preferred stock
dividends of $2.3 million on Series D preferred stock related to the beneficial conversion feature arising from a common stock
effective conversion rate of $0.34 and $0.37 versus the original market price of $1.14 and $1.06 per common share, respectively.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2017, the Company issued 357,143 shares
of Series D Convertible Preferred Stock and a warrant to purchase 357,143 shares of common stock in a private placement to an accredited
investor for gross proceeds of $250,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement dated May 1, 2016.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The initial conversion price of the Series D
Shares is $0.70 per share, subject to certain adjustments. The initial exercise price of the warrant is $0.70 per share, also subject
to certain adjustments. The Company also amended and restated the Certificate of Designations, resulting in an adjustment to the
conversion price of all currently outstanding Series D Shares to $0.70 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 14, 2017, the price of the Series
C and D Preferred Stock were adjusted to $0.25 per share pursuant to the documents governing such instruments. After adjustment
there were 3,108,356 shares of Series D preferred stock authorized.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2018, the Company filed with the
State of Nevada a second Amended and Restated Certificate of Designation of Preferences, Powers, and Rights of the Series D Convertible
Preferred Stock. The Amended Certificate restates the prior Certificate of Designation filed on May 8, 2017 to decrease the number
of authorized Series D shares from 3,906,250 shares to 1,016,014 shares. No other amendments were made to the preferences and rights
of the Series D Convertible Preferred Stock. The filing of the Amended Certificate was unanimously approved by the Board of Directors
and the shareholders of Series D Convertible Preferred Stock.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Series F Preferred Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 1, 2018, the Company filed with the
State of Nevada a Certificate of Designation establishing the Designations, Preferences, Limitations and Relative Rights of Series
F Preferred Stock (the &#8220;Designation&#8221;). The Designation authorized 500 shares of Series F Preferred Stock. The Series
F Preferred Stock shall only be issued to the current Board of Directors on the date of the Designation&#8217;s filing and is not
convertible into common stock. As set forth in the Designation, the Series F Preferred Stock has no rights to dividends or liquidation
preference and carries rights to vote 100,000 shares of common stock per share of Series F upon a Trigger Event, as defined in
the Designation. A Trigger Event includes certain unsolicited bids, tender offers, proxy contests, and significant share purchases,
all as described in the Designation. Unless and until a Trigger Event, the Series F shall have no right to vote. The Series F Preferred
Stock shall remain issued and outstanding until the date which is 731 days after the issuance of Series F Preferred Stock (&#8220;Explosion
Date&#8221;), unless a Trigger Event occurs, in which case the Explosion Date shall be extended by 183 days.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Securities Subject to Price Adjustments</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 14, 2017, a private placement triggered
a provision in the documents governing 23,334 outstanding shares of Series A Preferred Stock, 1,785,715 outstanding shares of Series
C Preferred Stock and 1,016,004 outstanding shares Series D preferred Stock, which adjusted the conversion price of such Preferred
Stock to $0.25 per share. In addition, the conversion price of a Convertible Note Payables of $2,390,066 and the exercise price
of outstanding warrants to purchase 9,548,741 shares of common stock were adjusted to $0.25 per share pursuant to the documents
governing such instruments.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 21, 2018, there were outstanding
warrants for the purchase of 15,473,398 shares of common stock. In the future, if we sell our common stock at a price below $0.25
per share, the exercise price of 20,000 outstanding shares of Series A Preferred Stock, 1,785,715 outstanding shares of Series
C Preferred Stock, 1,016,004 outstanding shares Series D Preferred Stock that adjust below $0.25 per share pursuant to the documents
governing such instruments. In addition, the conversion price of a Convertible Note Payable of $2,255,066 (9,020,264 common shares
at the current price of $0.25 per share) and the exercise price of additional outstanding warrants to purchase 13,865,286 shares
of common stock would adjust below $0.25 per share pursuant to the documents governing such instruments.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Common Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the offerings and sales described below
were deemed to be exempt under Rule 506 of Regulation D and/or Section 4(a)(2) of the Securities Act. No advertising or general
solicitation was employed in offering the securities, the offerings and sales were made to a limited number of persons, all of
whom were accredited investors and transfer was restricted by the company in accordance with the requirements of Regulation D and
the Securities Act. All issuances to accredited and non-accredited investors were structured to comply with the requirements of
the safe harbor afforded by Rule 506 of Regulation D, including limiting the number of non-accredited investors to no more than
35 investors who have sufficient knowledge and experience in financial and business matters to make them capable of evaluating
the merits and risks of an investment in our securities.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following equity issuances occurred during
the year ended September 30, 2018:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company issued 779,676 shares of common
stock to Names Executive Officers, directors, employees and consultants and for services during the year ended September 30, 2018.
The Company expensed $273,068.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company issued 2,000,000
shares of our common stock to Phillip A. Bosua under the terms of the Merger Agreement with RAAI common stock. The shares were
valued at the fair market value of $520,000 or $0.26 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company closed a private
placement and received gross proceeds of $1,750,000 ($1,710,000 as of June 30, 2018) in exchange for issuing 7,000,000 (6,840,000
as of June 30, 2018) shares of common stock and warrants to purchase 3,500,000 (3,420,000 as of June 30, 2018) shares of common
stock in a private placement to accredited investors pursuant to a series of substantially identical subscription agreements. The
initial exercise price of the warrants described above is $0.25 per share, subject to certain adjustments, and they expired five
years after their issuance. The shares and the warrants described above were issued in transactions that were not registered under
the Securities Act of 1933, as amended (the &#8220;Act&#8221;) in reliance upon applicable exemptions from registration under Section
4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act. &#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company issued 500,000
shares of our common stock to Phillip A. Bosua under the terms of an Employment agreement dated April 10, 2018. The shares were
valued at the fair market value of $165,000 or $0.33 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company closed debt conversions and issued
1,600,000 shares of common stock in exchange for the conversion of $464,000, 230,000 shares in exchange for $48,300 in legal services
and 605,000 shares in for $199.935 in preexisting debt owed by the Company to certain service providers, all of whom are accredited
investors. These shares were issued in transactions that were not registered under the Act in reliance upon applicable exemptions
from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2018, the
Company issued 158,000 shares of our common stock related to warrant exercises that were valued at $80,128.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 23, 2018, the Company issued 3,334
shares of our common stock related to the conversion of Series A Preferred Stock for $834.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following equity issuances occurred during
the year ended September 30, 2017:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 21, 2015, the Company entered into
a Public Relations Agreement with Financial Genetics LLC for public relation services. On October 18, 2016, the Company entered
into an Amendment to Public Relations Agreement with Financial Genetics LLC. Under the Agreements, Financial Genetics was issued
359,386 shares of our common stock during the year ended September 30, 2017. The Company expensed $271,309 during the year ended
September 30, 2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 6, 2016, the Company entered into
a Services Agreement with Redwood Investment Group LLC for financial services. Under the Agreement, Redwood was issued 200,000
shares of our common stock. The Company expensed $140,000 during the year ended September 30, 2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company entered into Convertible Promissory
Notes totaling $710,000 with accredited investors during September 2015 to February 2016 to fund short-term working capital. The
Notes accrued interest at a rate of 8% per annum and became due September 2016 to February 2017 and were convertible into common
stock as part of our next financing. On November 30, 2016, the Company converted $695,000 of the /Convertible Promissory Notes
and interest of $54,078 into 936,348 shares of comment stock. The Company also issued warrants to purchase 936,348 shares of the
Company&#8217;s common stock. The five-year warrants are exercisable at $1.00 per share, subject to adjustment.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2016, a supplier converted accounts
payable totaling $6,880 into 8,600 shares of common stock.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On the year ended September 30, 2017, the Company
issued 795,000 shares of restricted common stock to two Names Executive Officers employees, two directors and six employees and
consultants and for services during 2015-2017. The shares were issued in accordance with the 2011 Stock Incentive Plan and were
valued at $0.17 per share, the market price of our common stock. The Company expensed $135,150 during the year ended September
30, 2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Warrants to Purchase Common Stock</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following warrants were issued during the
year ended September 30, 2018:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 15, 2017, the Company received $250,000
and issued a senior convertible exchangeable debenture with a principal amount of $300,000 and a five year common stock purchase
warrant to purchase 1,200,000 shares of common stock in a private placement dated December 12, 2017 to an accredited investor pursuant
to a Securities Purchase Agreement dated August 14, 2017. See Note 12 for additional details. The initial exercise price of the
warrants described above is $0.25 per share, also subject to certain adjustments. The warrants were valued at $123,600 and the
beneficial conversion feature was valued at $93,174.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 2, 2018, the Company received gross
proceeds of $280,000 in exchange for issuing a senior convertible redeemable debenture with a principal amount of $336,000 and
a five year warrant to purchase 1,344,000 shares of common stock in a private placement dated February 28, 2018 to an accredited
investor pursuant to a Securities Purchase Agreement dated August 14, 2017 See Note 9 for additional details. The initial exercise
price of the warrants described above is $0.25 per share, also subject to certain adjustments. The warrants had an estimated fair
value of $348,096 and the beneficial conversion feature was value at $252,932.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company entered into a Note and Account
Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was converted to a Convertible
Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z Account Payable was converted
into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a warrant to purchase up to 1,039,666
shares of common stock of the Company for a period of five years. The initial exercise price of the warrants described above is
$0.50 per share, also subject to certain adjustments. See Note 9 for additional details. The warrants had an estimated value of
$60,820.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, effective as of January 31, 2018,
Mr. Erickson was issued a warrant to purchase up to 855,000 shares of common stock of the Company for a period of five years. The
initial exercise price of the warrants described above is $0.50 per share, also subject to certain adjustments. See Note 12 for
additional details. The warrants had an estimated value of $49,726.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2018, The
Company issued placement agent warrants related to the issuance of senior convertible redeemable debentures and Series D Preferred
Stock to purchase up to 538,400 shares of common stock for a period of five years. The initial exercise price of the warrants described
above is $0.25 per share, also subject to certain adjustments. The estimated fair value was $134,600.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company closed a private
placement and received gross proceeds of $1,750,000 ($1,710,000 as of June 30, 2018) in exchange for issuing 7,000,000 (6,840,000
as of June 30, 2018) shares of common stock and warrants to purchase 3,500,000 (3,420,000 as of June 30, 2018) shares of common
stock in a private placement to accredited investors pursuant to a series of substantially identical subscription agreements. The
initial exercise price of the warrants described above is $0.25 per share, subject to certain adjustments, and they expired five
years after their issuance. The shares and the warrants described above were issued in transactions that were not registered under
the Securities Act of 1933, as amended (the &#8220;Act&#8221;) in reliance upon applicable exemptions from registration under Section
4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act. &#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company issued warrants to purchase 1,229,000
shares of common stock to Named Executive Officers, directors, employees and consultants and for services during the year ended
September 30, 2018. The Company expensed $121,710.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2018, the
Company issued 158,000 shares of our common stock related to warrant exercises that were valued at $80,128.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2018, warrants
for the purchase of 544,998 shares of common stock valued at $136,250 expired.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following warrants were issued during the
year ended September 30, 2017:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company entered into Convertible Promissory
Notes totaling $710,000 with accredited investors during September 2015 to February 2016 to fund short-term working capital. The
Notes accrued interest at a rate of 8% per annum and became due September 2016 to February 2017 and were convertible into common
stock as part of our next financing. On November 30, 2016, the Company converted $695,000 of the /Convertible Promissory Notes
and interest of $54,078 into 936,348 shares of comment stock. The Company also issued warrants to purchase 936,348 shares of the
Company&#8217;s common stock. The five-year warrants are exercisable at $1.00 per share, subject to adjustment.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 14, 2016, the Company issued 187,500
shares of Series D Convertible Preferred Stock and a warrant to purchase 187,500 shares of common stock in a private placement
to certain accredited investors for gross proceeds of $150,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement
dated November 10, 2016. The warrant was valued at $189,938.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 19, 2016, the Company issued 187,500
shares of Series D Convertible Preferred Stock and a warrant to purchase 187,500 shares of common stock in a private placement
to an accredited investor for gross proceeds of $150,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement
dated December 14, 2016. The warrant was valued at $131,250.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 24, 2017, the Company issued 283,861
shares of Series D Convertible Preferred Stock and a warrant to purchase 283,861 shares of common stock in a private placement
to an accredited investor for conversion of a $220,000 Promissory Note and accrued interest of $7,089 pursuant to a Series D Preferred
Stock and Warrant Purchase Agreement dated February 28, 2017. The warrant was valued at $198,703.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2017, the
Company revised five year placement agent warrants to purchase 312,500 shares of common stock. The price was reduced from $1.00
to $0.70 per share and the exercise price is now subject to adjustment. The Company recorded 250,000 shares during the year ended
September 30, 2016 the fair value of these warrants is $218,751 as of June 30, 2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2017, the Company issued 357,143 shares
of Series D Convertible Preferred Stock and a warrant to purchase 357,143 shares of common stock in a private placement to an accredited
investor for gross proceeds of $250,000 pursuant to a Series D Preferred Stock and Warrant Purchase Agreement dated May 1, 2017.
The warrant was valued at $5,357.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 14, 2017, the Company issued a common
stock purchase warrant to purchase 1,440,000 shares of common stock in a private placement to Clayton Struve for gross proceeds
of $300,000 pursuant to a Securities Purchase Agreement dated August 14, 2017. The initial exercise price of the Warrant is $0.25
per share, also subject to certain adjustments. The warrants were valued at $111,429.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warrants to acquire 7,668 shares of common stock
at $30.00 per share expired.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The conversion price of the Series A, C and
D Shares and related warrants is currently $0.250 per share, subject to certain adjustments.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the warrants issued as of September
30, 2018 were as follows:&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">September 30, 2018 &#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Shares</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 64%"><font style="font-size: 8pt">Outstanding at beginning of period</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 8pt">6,900,356</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 8pt">0.428</font></td>
    <td style="width: 3%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">9,276,066</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(158,026</font></td>
    <td><font style="font-size: 8pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(0.507</font></td>
    <td><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(544,998</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(0.250</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Outstanding at end of period</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.326</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exerciseable at end of period</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the status of the warrants outstanding
as of September 30, 2018 is presented below:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">September 30, 2018 &#160; &#160; &#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Number of</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Remaining</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Shares</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Warrants</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Life ( In Years)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exerciseable</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: right"><font style="font-size: 8pt">13,870,286</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">4.04</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">13,870,286</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 7%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">714,286</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.83</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.700</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">714,286</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.700</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">882,159</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3.12</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">882,159</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">6,667</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">0.25</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">30.000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">6,667</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">30.000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">3.61</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.326</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.326</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The significant weighted average assumptions
relating to the valuation of the Company&#8217;s warrants for the year ended September 30, 2018 were as follows:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 67%"><font style="font-size: 8pt">Dividend yield</font></td>
    <td style="width: 33%; text-align: center"><font style="font-size: 8pt">0%</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 8pt">Expected life</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">1-2 years</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 8pt">Expected volatility</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">125%-145%</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 8pt">Risk free interest rate</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">.0202-.0214%</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">At September 30, 2018, vested warrants totaling 15,466,731 shares
had an&#160;aggregate intrinsic value of $13,870,286.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6813282720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,493,821)<span></span>
</td>
<td class="num">$ (1,827,419)<span></span>
</td>
<td class="num">$ (3,257,597)<span></span>
</td>
<td class="num">$ (3,901,232)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash (used in) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">133,019<span></span>
</td>
<td class="nump">30,462<span></span>
</td>
<td class="nump">132,615<span></span>
</td>
<td class="nump">81,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of capital stock for services and expenses</a></td>
<td class="nump">348,900<span></span>
</td>
<td class="nump">70,641<span></span>
</td>
<td class="nump">440,319<span></span>
</td>
<td class="nump">547,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_ShareBasedCompensationWarrants', window );">Stock based compensation- warrants</a></td>
<td class="nump">336,835<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_ConversionOfInterest', window );">Conversion of interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64,233<span></span>
</td>
<td class="nump">64,233<span></span>
</td>
<td class="nump">68,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation- stock option grants</a></td>
<td class="nump">263,147<span></span>
</td>
<td class="nump">7,334<span></span>
</td>
<td class="nump">50,899<span></span>
</td>
<td class="nump">37,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">(Loss) on sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">113,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on change - derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(145,282)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_ReclassificationOfDerivativeLiability', window );">Reclassification of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">410,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">475,174<span></span>
</td>
<td class="nump">475,174<span></span>
</td>
<td class="nump">158,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable', window );">Conversion of accrued liabilites- related parties to convertible notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">491,802<span></span>
</td>
<td class="nump">491,802<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Provision on loss on accounts receivable</a></td>
<td class="nump">8,728<span></span>
</td>
<td class="nump">21,406<span></span>
</td>
<td class="nump">10,747<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockCompensationExpenseWarrants', window );">Stock based compensation- warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,680<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IssuanceOfCommonStockForConversionOfLiabilities', window );">Issuance of common stock for conversion of liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NoncashGainOnAccountsPayable', window );">Non-cash gain on accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170,309)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">110,545<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">983,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">136,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">118,438<span></span>
</td>
<td class="nump">114,918<span></span>
</td>
<td class="nump">362,035<span></span>
</td>
<td class="num">(20,582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">7,296<span></span>
</td>
<td class="nump">4,292<span></span>
</td>
<td class="nump">7,547<span></span>
</td>
<td class="num">(7,204)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">102,593<span></span>
</td>
<td class="nump">21,616<span></span>
</td>
<td class="nump">22,327<span></span>
</td>
<td class="nump">69,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other assets</a></td>
<td class="num">(8,697)<span></span>
</td>
<td class="num">(2,100)<span></span>
</td>
<td class="num">(2,100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable - trade and accrued expenses</a></td>
<td class="num">(223,216)<span></span>
</td>
<td class="nump">33,193<span></span>
</td>
<td class="num">(176,495)<span></span>
</td>
<td class="nump">134,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(55,959)<span></span>
</td>
<td class="num">(58,615)<span></span>
</td>
<td class="num">(7,943)<span></span>
</td>
<td class="nump">63,902<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH (USED IN) OPERATING ACTIVITIES</a></td>
<td class="num">(1,462,737)<span></span>
</td>
<td class="num">(442,518)<span></span>
</td>
<td class="num">(1,117,131)<span></span>
</td>
<td class="num">(1,264,324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Investment in research and development equipment</a></td>
<td class="num">(74,556)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Investment in BioMedx, Inc., net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(260,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_RepaymentFromInvestment', window );">Proceeds from investment in BioMedx, Inc,</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">290,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,251)<span></span>
</td>
<td class="nump">2,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,434<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES:</a></td>
<td class="num">(74,556)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(97,251)<span></span>
</td>
<td class="nump">33,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">(Repayments) proceeds from line of credit</a></td>
<td class="num">(145,188)<span></span>
</td>
<td class="num">(190,663)<span></span>
</td>
<td class="num">(220,539)<span></span>
</td>
<td class="nump">30,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_ProceedsFromConvertibleNotesPayable', window );">Proceeds from convertible notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">530,000<span></span>
</td>
<td class="nump">636,000<span></span>
</td>
<td class="nump">690,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common/preferred stock, net of costs</a></td>
<td class="nump">3,809,975<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_StockIssuedDuringPeriodValueWarrantExercise', window );">Issuance of common stock for warrant exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,147<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfDebt', window );">Repayment of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(125,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH PROVIDED BY FINANCING ACTIVITIES</a></td>
<td class="nump">3,664,787<span></span>
</td>
<td class="nump">339,337<span></span>
</td>
<td class="nump">2,045,608<span></span>
</td>
<td class="nump">1,145,321<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">2,127,494<span></span>
</td>
<td class="num">(103,181)<span></span>
</td>
<td class="nump">831,226<span></span>
</td>
<td class="num">(85,128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">934,407<span></span>
</td>
<td class="nump">103,181<span></span>
</td>
<td class="nump">103,181<span></span>
</td>
<td class="nump">188,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">3,061,901<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">934,407<span></span>
</td>
<td class="nump">103,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">7,750<span></span>
</td>
<td class="nump">20,243<span></span>
</td>
<td class="nump">64,228<span></span>
</td>
<td class="nump">47,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Taxes paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1', window );">Beneficial conversion feature</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">482,014<span></span>
</td>
<td class="nump">348,096<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion of convertible debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 482,014<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">695,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Beneficial conversion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">559,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of convertible debt to preferred shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">220,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_RelatedPartyAccountsConvertedToNotes', window );">Related party accounts converted to notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,184,066<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_AcquisitionOfPatents', window );">Acquisition of patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_PenaltyOnNotesPayable', window );">Penalty on notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_AcquisitionOfPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_AcquisitionOfPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_ConversionOfAccruedLiabilitesRelatedPartiesToConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_ConversionOfInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_ConversionOfInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IssuanceOfCommonStockForConversionOfLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IssuanceOfCommonStockForConversionOfLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NoncashGainOnAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NoncashGainOnAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_PenaltyOnNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_PenaltyOnNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_ProceedsFromConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_ProceedsFromConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_ReclassificationOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_ReclassificationOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_RelatedPartyAccountsConvertedToNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_RelatedPartyAccountsConvertedToNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_RepaymentFromInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_RepaymentFromInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_ShareBasedCompensationWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_ShareBasedCompensationWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockCompensationExpenseWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockCompensationExpenseWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_StockIssuedDuringPeriodValueWarrantExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_StockIssuedDuringPeriodValueWarrantExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=109238393&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130534-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6812369056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,061,901<span></span>
</td>
<td class="nump">$ 934,407<span></span>
</td>
<td class="nump">$ 103,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $60,000 and $60,000, respectively</a></td>
<td class="nump">193,372<span></span>
</td>
<td class="nump">320,538<span></span>
</td>
<td class="nump">693,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">12,844<span></span>
</td>
<td class="nump">20,140<span></span>
</td>
<td class="nump">27,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">100,989<span></span>
</td>
<td class="nump">203,582<span></span>
</td>
<td class="nump">225,909<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,369,106<span></span>
</td>
<td class="nump">1,478,667<span></span>
</td>
<td class="nump">1,050,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">EQUIPMENT, NET</a></td>
<td class="nump">197,536<span></span>
</td>
<td class="nump">169,333<span></span>
</td>
<td class="nump">133,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">361,112<span></span>
</td>
<td class="nump">447,778<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">15,867<span></span>
</td>
<td class="nump">7,170<span></span>
</td>
<td class="nump">5,070<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">3,943,621<span></span>
</td>
<td class="nump">2,102,948<span></span>
</td>
<td class="nump">1,188,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">1,298,278<span></span>
</td>
<td class="nump">1,512,617<span></span>
</td>
<td class="nump">2,156,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accounts payable - related parties</a></td>
<td class="nump">7,395<span></span>
</td>
<td class="nump">12,019<span></span>
</td>
<td class="nump">2,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">81,339<span></span>
</td>
<td class="nump">72,140<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Accrued expenses - related parties</a></td>
<td class="nump">644,099<span></span>
</td>
<td class="nump">657,551<span></span>
</td>
<td class="nump">1,166,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">55,959<span></span>
</td>
<td class="nump">63,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable</a></td>
<td class="nump">2,255,065<span></span>
</td>
<td class="nump">2,255,066<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable - current portion of long term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">145,186<span></span>
</td>
<td class="nump">1,165,660<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,286,176<span></span>
</td>
<td class="nump">4,710,538<span></span>
</td>
<td class="nump">5,149,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">22,003<span></span>
</td>
<td class="nump">17,532<span></span>
</td>
<td class="nump">4,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
<td class="nump">36,917,782<span></span>
</td>
<td class="nump">32,163,386<span></span>
</td>
<td class="nump">27,565,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(37,285,145)<span></span>
</td>
<td class="num">(34,791,324)<span></span>
</td>
<td class="num">(31,533,727)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(342,555)<span></span>
</td>
<td class="num">(2,607,590)<span></span>
</td>
<td class="num">(3,960,791)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</a></td>
<td class="nump">3,943,621<span></span>
</td>
<td class="nump">2,102,948<span></span>
</td>
<td class="nump">1,188,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">1,790<span></span>
</td>
<td class="nump">1,790<span></span>
</td>
<td class="nump">1,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">$ 1,015<span></span>
</td>
<td class="nump">$ 1,015<span></span>
</td>
<td class="nump">$ 1,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6633388032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>18. INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has incurred losses since inception,
which have generated net operating loss carryforwards.&#160;&#160;The net operating loss carryforwards arise from United States
sources.&#160;&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pretax losses arising from United States operations
were approximately $3,258,000 for the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pretax losses arising from United States operations
were approximately $3,901,000 for the year ended September 30, 2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has net operating loss carryforwards
of approximately $27,352,000, which expire in 2022-2036. Because it is not more likely than not that sufficient tax earnings will
be generated to utilize the net operating loss carryforwards, a corresponding valuation allowance of approximately $5,744,000 was
established as of September 30, 2018. Additionally, under the Tax Reform Act of 1986, the amounts of, and benefits from, net operating
losses may be limited in certain circumstances, including a change in control.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Section&#160;382 of the Internal Revenue Code
generally imposes an annual limitation on the amount of net operating loss carryforwards that may be used to offset taxable income
when a corporation has undergone significant changes in its stock ownership. There can be no assurance that the Company will be
able to utilize any net operating loss carryforwards in the future. The Company is subject to possible tax examination for the
years 2012 through 2018&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended September 30, 2018, the Company&#8217;s
effective tax rate differs from the federal statutory rate principally due to net operating losses and warrants issued for services.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><i>U.S. Tax Reform</i>&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2017, the U.S. government enacted
comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the Tax Reform Act). The Tax Reform Act significantly
revises the future ongoing federal income tax by, among other things, lowering U.S. corporate income tax rates effective January
1, 2018. The Company has calculated a blended U.S. federal income tax rate of approximately 21% for the fiscal year ending September
30, 2018 and 21.0% for subsequent fiscal years. Remeasurement of the Company&#8217;s deferred tax balance under the Tax Reform
Act resulted in a non-cash tax benefit reduction of approximately $2.3 million for the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The changes included in the Tax Reform Act are
broad and complex. The final transition impacts of the Tax Reform Act may differ from the above estimate due to, among other things,
changes in interpretations of the Tax Reform Act, any legislative action to address questions that arise because of the Tax Reform
Act and any changes in accounting standards for income taxes or related interpretations in response to the Tax Reform Act.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">The principal components of the Company&#8217;s deferred tax assets
at September 30, 2018 and 2017 are as follows:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 64%"><font style="font-size: 8pt">U.S. operations loss carry forward at statutory rate of 21%</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">(5,743,840</font></td>
    <td style="width: 1%"><font style="font-size: 8pt">)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">(5,804,285</font></td>
    <td style="width: 1%"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Non-U.S. operations loss carry forward at statutory rate of 20.5%</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Total</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(5,743,840</font></td>
    <td><font style="font-size: 8pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(5,804,285</font></td>
    <td><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Less Valuation Allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">5,743,840</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">5,804,285</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Net Deferred Tax Assets</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Change in Valuation allowance</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">60,445</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">(1,036,276</font></td>
    <td style="padding-bottom: 3pt"><font style="font-size: 8pt">)</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A reconciliation of the United States Federal
Statutory rate to the Company&#8217;s effective tax rate for the years ended September 30, 2018 and 2017 are as follows:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 64%"><font style="font-size: 8pt">Federal Statutory Rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">-21.0</font></td>
    <td style="width: 1%"><font style="font-size: 8pt">%</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">-21.0</font></td>
    <td style="width: 1%"><font style="font-size: 8pt">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Increase in Income Taxes Resulting from:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">&#160;&#160;&#160;&#160;Change in Valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">21.0</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">%</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">21.0</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">%</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Effective Tax Rate</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.0</font></td>
    <td style="padding-bottom: 3pt"><font style="font-size: 8pt">%</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.0</font></td>
    <td style="padding-bottom: 3pt"><font style="font-size: 8pt">%</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6636790224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IntangibleAssetsTablesAbstract', window );"><strong>Intangible Assets Tables Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Estimated</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">September 30,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Useful Lives</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 22%">Technology</td><td style="width: 5%">&#160;</td>
    <td style="width: 21%; text-align: center">3 years</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 19%; text-align: right">520,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 19%; text-align: right">520,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(158,888</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(72,222</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;&#160;&#160;&#160;Intangible assets, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">361,112</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">447,778</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 8pt">Estimated</font></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">September 30,</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">September 30,</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid">Useful Lives</p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 47%"><font style="font-size: 8pt">Technology</font></td>
    <td style="width: 19%; text-align: center"><font style="font-size: 8pt">3 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 8pt">520,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Less: accumulated amortization</font></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(72,222</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">&#160;&#160;&#160;&#160;Intangible assets, net</font></td>
    <td>&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">447,778</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IntangibleAssetsTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IntangibleAssetsTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6800144224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">$ 156,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=KNWN_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=KNWN_ConvertibleRedeemablePromissoryNoteMember', window );">Convertible Redeemable Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,361<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositLiabilitiesAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued but unpaid interest on deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositLiabilitiesAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=KNWN_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=KNWN_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=KNWN_ConvertibleRedeemablePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=KNWN_ConvertibleRedeemablePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6806024080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>8. INTANGIBLE ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 361,112<span></span>
</td>
<td class="nump">$ 447,778<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=KNWN_TechnologyMember', window );">Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">520,000<span></span>
</td>
<td class="nump">520,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(158,888)<span></span>
</td>
<td class="num">(72,222)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 361,112<span></span>
</td>
<td class="nump">$ 447,778<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=KNWN_TechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=KNWN_TechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6810235136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. EQUITY (Details 2)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.02%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.14%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6630400880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. NOTES PAYABLE, CAPITALIZED LEASES AND LONG TERM DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Notes payable, capitalized leases and long term debt</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 8pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center">March 31,</td><td style="font-size: 8pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center">September 30,</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-size: 8pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 56%; font-size: 8pt; text-align: left; padding-bottom: 1pt">Capital Source Business Finance Group</td><td style="width: 8%; font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">$</td><td style="width: 12%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td><td style="width: 8%; font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">$</td><td style="width: 12%; border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">145,186</td><td style="width: 1%; padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: left">Total debt</td><td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt">&#160;</td>
    <td style="font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt; text-align: right">145,186</td><td style="font-size: 8pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: left; padding-bottom: 1pt">Less current portion of long term debt</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">(145,186</td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; text-align: left; padding-bottom: 2.5pt">Long term debt</td><td style="font-size: 8pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left">&#160;</td><td style="font-size: 8pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-size: 8pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">September 30,</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">September 30,</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 64%"><font style="font-size: 8pt">Capital Source Business Finance Group</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">145,186</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">365,725</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Note payable to Umpqua Bank</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">199,935</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Secured note payable to J3E2A2Z LP - related party</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">600,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Total debt</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">145,186</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,165,660</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Less current portion of long term debt</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(145,186</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(1,165,660</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Long term debt</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6631010432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. STOCK OPTIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK OPTIONS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2013, an amendment to the Stock
Option Plan was approved by the stockholders of the Company, increasing the number of shares reserved for issuance under the Plan
to 93,333 shares.<b>&#160;</b>On April 10, 2018, the Board approved an amendment to its 2011 Stock Incentive Plan increasing the
number of shares of common stock reserved under the Incentive Plan from 93,333 to 1,200,000. On August 7, 2018, the Board approved
an amendment to its 2011 Stock Incentive Plan increasing the number of shares of common stock reserved under the Incentive Plan
from 1,200,000 to 2,000,000 to common shares.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Determining Fair Value under ASC 505</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records compensation expense associated
with stock options and other equity-based compensation using the Black-Scholes-Merton option valuation model for estimating fair
value of stock options granted under our plan. The Company amortizes the fair value of stock options on a ratable basis over the
requisite service periods, which are generally the vesting periods. The expected life of awards granted represents the period of
time that they are expected to be outstanding.&#160;&#160;The Company estimates the volatility of our common stock based on the
historical volatility of its own common stock over the most recent period corresponding with the estimated expected life of the
award. The Company bases the risk-free interest rate used in the Black Scholes-Merton option valuation model on the implied yield
currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award.
The Company has not paid any cash dividends on our common stock and does not anticipate paying any cash dividends in the foreseeable
future. Consequently, the Company uses an expected dividend yield of zero in the Black-Scholes-Merton option valuation model and
adjusts share-based compensation for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience.
The effect of adjusting the forfeiture rate is recognized in the period the forfeiture estimate is changed.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Stock Option Activity</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company had the following stock option transactions
during the six months ended March 31, 2019:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 31, 2018, the Board awarded stock
option grants to two directors to acquire 50,000 shares each of the Company&#8217;s common stock. The grants were valued at $3.03
per share and expire on October 31, 2013. The grants vested immediately.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 31, 2018, the Board awarded Phillip
A. Bosua a stock option grant to acquire 100,000 shares of the Company&#8217;s Common stock for each $1,000,000 raised by the Company
in revenue generated in a planned Kickstarter campaign. In addition, Mr. Bosua was granted a stock option grant to acquire 1,000,000
shares of the Company&#8217;s common which vests upon approval of the Company&#8217;s blood glucose measurement technology by the
U.S. Food and Drug Administration. The grants were valued at $3.03 per share and expire on October 31, 2023.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 31, 2018, the Board awarded Ronald
P Erickson a stock option grant to acquire 1,000,000 shares of the Company&#8217;s common which vests upon the Company&#8217;s
successful listing of its Common Stock on Nasdaq or the New York Stock Exchange (including the NYSE American Market). The grant
was valued at $3.03 per share and expires on October 31, 2023.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2019, the Board awarded an employee
a stock option grant to acquire 10,000 shares of the Company&#8217;s Common stock for each $1,000,000 raised by the Company in
revenue generated in a planned Kickstarter campaign. In addition, the employee was granted a stock option grant to acquire 130,000
shares of the Company&#8217;s common which vests upon approval of the Company&#8217;s blood glucose measurement technology by the
U.S. Food and Drug Administration. The grants were valued at $1.50 per share and expire on March 26, 2024.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 26, 2019, the Board awarded an employee
a stock option grant to acquire 10,000 shares of the Company&#8217;s Common stock for each $1,000,000 raised by the Company in
revenue generated in a planned Kickstarter campaign. In addition, the employee was granted a stock option grant to acquire 130,000
shares of the Company&#8217;s common which vests upon approval of the Company&#8217;s blood glucose measurement technology by the
U.S. Food and Drug Administration. The grants were valued at $1.50 per share and expire on March 26, 2024.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are currently 2,282,668 options to purchase
common stock at an average exercise price of $1.757 per share outstanding as of March 31, 2019 under the 2011 Stock Incentive Plan.
The Company recorded $263,145 and $7,334 of compensation expense, net of related tax effects, relative to stock options for the
six months ended March 31, 2019 and 2018 and in accordance with ASC 505. Net loss per share (basic and diluted) associated with
this expense was approximately ($0.010) and ($0.000) per share, respectively. As of March 31, 2019, there is approximately $1,606,089,
net of forfeitures, of total unrecognized costs related to employee granted stock options that are not vested. These costs are
expected to be recognized over a period of approximately 4.69 years.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock option activity for the three months ended
March 31, 2019 was as follows:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>&#160;Weighted Average</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>&#160;Options</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>&#160;Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>$</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 58%"><font style="font-size: 8pt">Outstanding as of September 30, 2018</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: black 1pt solid">&#160;</td>
    <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">2,182,668</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: black 1pt solid"><font style="font-size: 8pt">$</font></td>
    <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1.698</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: black 1pt solid"><font style="font-size: 8pt">$</font></td>
    <td style="width: 11%; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">3,706,519</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">100,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3.030</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">303,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Forfeitures</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Outstanding as of March 31, 2019</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">2,282,668</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">1.757</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">4,009,519</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes information about
stock options outstanding and exercisable as of March 31, 2019:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt"><b>Range of</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Number</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Remaining Life</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise Price</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Number</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise Price</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercise Prices</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Outstanding</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>In Years</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%; text-align: center"><font style="font-size: 8pt">0.25</font>&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">530,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">4.61</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">99,375</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">0.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">1.28</font>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,150,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.71</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">143,750</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.28</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">3.03</font>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">100,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.71</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3.03</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">100,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3.03</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">4.08-4.20</font>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">500,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.73</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.08-4.20</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">31,250</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.08-4.20</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">13.500</font>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.38</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><font style="font-size: 8pt">15.000</font>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">15.00</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">15.00</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">2,282,668</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">4.69</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">1.757</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">375,709</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">1.755</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">There were stock option grants of 530,000 shares as of March 31,
2019 with an aggregate intrinsic value of $535,300.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2013, an amendment to the Stock
Option Plan was approved by the stockholders of the Company, increasing the number of shares reserved for issuance under the Plan
to 93,333 shares. On April 10, 2018, the Board approved an amendment to its 2011 Stock Incentive Plan increasing the number of
shares of common stock reserved under the Incentive Plan from 93,333 to 1,200,000. On August 7, 2018, the Board approved an amendment
to its 2011 Stock Incentive Plan increasing the number of shares of common stock reserved under the Incentive Plan from 1,200,000
to 2,000,000 to common shares.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b>Determining Fair Value under ASC
505</b></p>



<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records compensation expense associated
with stock options and other equity-based compensation using the Black-Scholes-Merton option valuation model for estimating fair
value of stock options granted under our plan. The Company amortizes the fair value of stock options on a ratable basis over the
requisite service periods, which are generally the vesting periods. The expected life of awards granted represents the period of
time that they are expected to be outstanding.&#160;&#160;The Company estimates the volatility of our common stock based on the
historical volatility of its own common stock over the most recent period corresponding with the estimated expected life of the
award. The Company bases the risk-free interest rate used in the Black Scholes-Merton option valuation model on the implied yield
currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award.
The Company has not paid any cash dividends on our common stock and does not anticipate paying any cash dividends in the foreseeable
future. Consequently, the Company uses an expected dividend yield of zero in the Black-Scholes-Merton option valuation model and
adjusts share-based compensation for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience.
The effect of adjusting the forfeiture rate is recognized in the period the forfeiture estimate is changed.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Stock Option Activity</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company had the following stock option transactions
during the year ended September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A former employee forfeited stock option grants
for 10,668 shares of common stock at $14.719 per share.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2018, four
employee and two consultants were granted options to purchase 1,180,000 shares of common stock at an exercise price of $2.024 per
share. The stock option grants vest quarterly over four years (none during the first six months) and are exercisable for 5 years.
The stock option grants were valued at an average of $2.38 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 30, 2018, Mr. Bosua was awarded a stock
option grant for 1,000,000 shares of common stock that was awarded at $1.28 per share and was valued at the black scholes value
of $1.22 per share.&#160;&#160;The stock option grant vests quarterly over four years and is exercisable for 5 years.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company had the following stock option transactions
during the year ended September 30, 2017:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended September 30, 2017, employees
forfeited stock option grants for 35,504 shares of common stock at $19.51 per share.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are currently 534,736 options to purchase
common stock at an average exercise price of $1.698 per share outstanding as of September 30, 2018 under the 2011 Stock Incentive
Plan. The Company recorded $50,899 and $37,848 of compensation expense, net of related tax effects, relative to stock options for
the year ended September 30, 2018 and in accordance with ASC 505. Net loss per share (basic and diluted) associated with this expense
was approximately ($0.006) and ($0.01) per share, respectively. As of September 30, 2018, there is approximately $1,789,384, net
of forfeitures, of total unrecognized costs related to employee granted stock options that are not vested. These costs are expected
to be recognized over a period of approximately 4.94 years.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Stock option activity for the years ended September 30, 2018 and
2017 was as follows:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted Average&#160;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Options&#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exercise Price&#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160; $</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 46%"><font style="font-size: 8pt">Outstanding as of September 30, 2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">50,908</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">18.045</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">918,627</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Forfeitures</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(35,504</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(19.507</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(692,568</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Outstanding as of September 30, 2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">15,404</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">14.675</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">226,059</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2,180,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.683</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3,668,500</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Forfeitures</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(12,736</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">14.764</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(188,040</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Outstanding as of September 30, 2018</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,182,668</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1.698</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">3,706,519</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes information about
stock options outstanding and exercisable as of September 30, 2018:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Range of</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Number</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Remaining Life</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise Price</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Number</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise Price</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exercise Prices</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Outstanding</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">In Years</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exerciseable</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exerciseable</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exerciseable</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 17%; text-align: right"><font style="font-size: 8pt">0.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">530,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">4.98</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,150,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.96</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.08-4.20</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">500,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.98</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.500</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.44</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">15.000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">15.00</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">15.00</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,182,668</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">4.94</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1.698</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,334</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">13.50</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">There were stock option grants of 1,680,000 shares as of September
30, 2018 with an aggregate intrinsic value of $4,964,300.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6591966832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. ORGANIZATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Know Labs, Inc. (the &#8220;Company&#8221;)
was incorporated under the laws of the State of Nevada in 1998. The Company has authorized 105,000,000 shares of capital stock,
of which 100,000,000 are shares of voting common stock, par value $0.001 per share, and 5,000,000 are shares preferred stock, par
value $0.001 per share.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is focused on the development, marketing
and sales of a proprietary technologies which are capable of uniquely authenticating or diagnosing almost any substance or material
using electromagnetic energy to create, record and detect the unique &#8220;signature&#8221; of the substance. The Company&#8217;s
call these our &#8220;ChromaID&#8482;&#8221; and &#8220;Bio-RFID&#8482;&#8221; technologies.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Overview</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Historically, the Company focused on the development
of our proprietary ChromaID technology. Using light from low-cost LEDs (light emitting diodes) the Company&#8217;s map the color
of substances, fluids and materials and with our proprietary processes we can authenticate, identify and diagnose based upon the
color that is present. The color is both visible to us as humans but also outside of the humanly visible color spectrum in the
near infra-red and near ultra-violet and beyond. The Company&#8217;s ChromaID scanner sees what we like to call &#8220;Nature&#8217;s
Color Fingerprint.&#8221; Everything in nature has a unique color identifier and with ChromaID the Company can see it, and identify,
authenticate and diagnose based upon the color that is present. The Company&#8217;s ChromaID scanner is capable of uniquely identifying
and authenticating almost any substance or liquid using light to create, record and detect its unique color signature. The Company
will continue to develop and enhance its ChromaID technology and extend its capacity. More recently, the Company has focused upon
extensions and new inventions that are derived from and extend beyond our ChromaID technology. The Company&#8217;s call this technology
Bio-RFID. The rapid advances made with our Bio-RFID technology in our laboratory have caused us to move quickly in to the commercialization
phase of our Company as we work to create revenue generating products for the marketplace. The Company will also, as resources
permit, pursue licensing opportunities with third parties who have ready applications for our technologies.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2010, the Company acquired TransTech Systems,
Inc. as an adjunct to its business. TransTech is a distributor of products for employee and personnel identification. TransTech
has provided all of the Company&#8217;s revenues.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is in the process of commercializing
its technology. To date, the Company has entered into License Agreements with Sumitomo Precision Products Co., Ltd. In addition,
it has a technology license agreement with Allied Inventors, formerly Xinova and Invention Development Management Company, a subsidiary
of Intellectual Ventures.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believes that its commercialization
success is dependent upon its ability to significantly increase the number of customers that are purchasing and using its products.
To date the Company has generated minimal revenue from sales of its ChromaID and Bio-RFID products. The Company is currently not
profitable. Even if the Company succeeds in introducing the ChromaID and Bio-RFID technology and related products to its target
markets, the Company may not be able to generate sufficient revenue to achieve or sustain profitability.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ChromaID was invented by scientists under contract
with the Company. Bio-RFID was invented by individuals working for the Company. The Company actively pursues a robust intellectual
property strategy and has been granted twelve patents. The Company also has 20 patents pending. The Company possesses all right,
title and interest to the issued patents. Ten of the pending patents are licensed exclusively to the Company in perpetuity by the
Company&#8217;s strategic partner, Allied Inventors.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Merger with RAAI Lighting, Inc.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company entered into
an Agreement and Plan of Merger with 500 Union Corporation, a Delaware corporation and a wholly owned subsidiary of the Company,
and RAAI Lighting, Inc., a Delaware corporation. Pursuant to the Merger Agreement, we have acquired all the outstanding shares
of RAAI&#8217;s capital stock through a merger of Merger Sub with and into RAAI (the &#8220;Merger&#8221;), with RAAI surviving
the Merger as a wholly owned subsidiary of the Company.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Merger Agreement, each
share of RAAI common stock issued and outstanding immediately before the Merger (1,000 shares) were cancelled and we issued 2,000,000
shares of our common stock. As a result, we issued 2,000,000 shares of its common stock to Phillip A. Bosua, formerly the sole
stockholder of RAAI. The consideration for the Merger was determined through arms-length bargaining by the Company and RAAI. The
Merger was structured to qualify as a tax-free reorganization for U.S. federal income tax purposes. As a result of the Merger,
the Company received certain intellectual property, related to RAAI.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Merger with Know Labs, Inc.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2018, Know Labs, Inc., a Nevada corporation
incorporated on April 3, 2018, and our wholly-owned subsidiary, merged with and into the Company pursuant to an Agreement and Plan
of Merger dated May 1, 2018. In connection with the merger, our Articles of Incorporation were effectively amended to change our
name to Know Labs, Inc. by and through the filing of Articles of Merger. This parent-subsidiary merger was approved by us, the
parent, in accordance with Nevada Revised Statutes Section 92A.180. Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Corporate Name Change and Symbol Change</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 24, 2018, the Financial Industry Regulatory
Authority (&#8220;FINRA&#8221;) announced the effectiveness of a change in our name from Visualant Incorporated to Know Labs, Inc.
and a change in our ticker symbol from VSUL to the new trading symbol KNWN which became effective on the opening of trading as
of May 25, 2018. In addition, in connection with the name change and symbol change, we were assigned the CUSIP number of 499238103.</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Know Labs, Inc. (the &#8220;Company&#8221;)
was incorporated under the laws of the State of Nevada in 1998. The Company has authorized 105,000,000 shares of capital stock,
of which 100,000,000 are shares of voting common stock, par value $0.001 per share, and 5,000,000 are shares preferred stock, par
value $0.001 per share.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is focused on the development, marketing
and sales of a proprietary technologies which are capable of uniquely authenticating or diagnosing almost any substance or material
using electromagnetic energy to create, record and detect the unique &#8220;signature&#8221; of the substance. The Company&#8217;s
call these our &#8220;ChromaID&#8482;&#8221; and &#8220;Bio-RFID&#8482;&#8221; technologies.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Overview</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Historically, the Company focused on the development
of our proprietary ChromaID technology. Using light from low-cost LEDs (light emitting diodes) the Company&#8217;s map the color
of substances, fluids and materials and with our proprietary processes we can authenticate, identify and diagnose based upon the
color that is present. The color is both visible to us as humans but also outside of the humanly visible color spectrum in the
near infra-red and near ultra-violet and beyond. The Company&#8217;s ChromaID scanner sees what we like to call &#8220;Nature&#8217;s
Color Fingerprint.&#8221; Everything in nature has a unique color identifier and with ChromaID the Company can see it, and identify,
authenticate and diagnose based upon the color that is present. The Company&#8217;s ChromaID scanner is capable of uniquely identifying
and authenticating almost any substance or liquid using light to create, record and detect its unique color signature. The Company
will continue to develop and enhance its ChromaID technology and extend its capacity. More recently, the Company has focused upon
extensions and new inventions that are derived from and extend beyond our ChromaID technology. The Company&#8217;s call this technology
Bio-RFID. The rapid advances made with our Bio-RFID technology in our laboratory have caused us to move quickly in to the commercialization
phase of our Company as we work to create revenue generating products for the marketplace. The Company will also, as resources
permit, pursue licensing opportunities with third parties who have ready applications for our technologies.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2010, the Company acquired TransTech Systems,
Inc. as an adjunct to its business. TransTech is a distributor of products for employee and personnel identification. TransTech
currently provides substantially all of the Company&#8217;s revenues.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is in the process of commercializing
its ChromaID&#8482; and Bio-RFID&#8482; technology. To date, the Company has entered into License Agreements with Sumitomo Precision
Products Co., Ltd. In addition, it has a technology license agreement with Allied Inventors, formerly Xinova and Invention Development
Management Company, a subsidiary of Intellectual Ventures.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believes that its commercialization
success is dependent upon its ability to significantly increase the number of customers that are purchasing and using its products.
To date the Company has generated minimal revenue from sales of its ChromaID and Bio-RFID products. The Company is currently not
profitable. Even if the Company succeeds in introducing the ChromaID and Bio-RFID technology and related products to its target
markets, the Company may not be able to generate sufficient revenue to achieve or sustain profitability.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ChromaID was invented by scientists under contract
with the Company. Bio-RFID was invented by individuals working for the Company. The Company actively pursues a robust intellectual
property strategy and has been granted twelve patents. The Company also has 20 patents pending. The Company possesses all right,
title and interest to the issued patents. Ten of the pending patents are licensed exclusively to the Company in perpetuity by the
Company&#8217;s strategic partner, Allied Inventors.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Merger with RAAI Lighting, Inc.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company entered into
an Agreement and Plan of Merger with 500 Union Corporation, a Delaware corporation and a wholly owned subsidiary of the Company,
and RAAI Lighting, Inc., a Delaware corporation. Pursuant to the Merger Agreement, we have acquired all the outstanding shares
of RAAI&#8217;s capital stock through a merger of Merger Sub with and into RAAI (the &#8220;Merger&#8221;), with RAAI surviving
the Merger as a wholly owned subsidiary of the Company.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Merger Agreement, each
share of RAAI common stock issued and outstanding immediately before the Merger (1,000 shares) were cancelled and we issued 2,000,000
shares of our common stock. As a result, we issued 2,000,000 shares of its common stock to Phillip A. Bosua, formerly the sole
stockholder of RAAI. The consideration for the Merger was determined through arms-length bargaining by the Company and RAAI. The
Merger was structured to qualify as a tax-free reorganization for U.S. federal income tax purposes. As a result of the Merger,
the Company received certain intellectual property, related to RAAI.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Appointment of Director</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Board increased the size
of the Board from three to four members and Phillip A. Bosua was appointed as a member of the Board. Mr. Bosua&#8217;s term of
office expires at the next annual meeting of our stockholders. On May 24, 2018, the Board of Directors increased the size of the
Board from four to five members and appointed (Ret.) Admiral William Owens as a member of the Board. Admiral Owen&#8217;s term
of office expires at the next annual meeting of our stockholders.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Appointment of Officer</b> &#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company appointed Mr.
Bosua as Chief Executive Officer of the Company, replacing Ronald P. Erickson, who remains Chairman of the Company. Previously,
Mr. Bosua served as the Company&#8217;s Chief Product Officer since August 2017. The Company entered into a Consulting Agreement
with Mr. Bosua&#8217;s company, Blaze Clinical on July 7, 2017.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company entered into
an Employment Agreement with Mr. Bosua reflecting Mr. Bosua&#8217;s appointment as Chief Executive Officer. The Employment Agreement
is for an initial term of 12 months (subject to earlier termination) and will be automatically extended for additional 12-month
terms unless either party notifies the other party of its intention to terminate the Employment Agreement. Mr. Bosua will be paid
a base salary of $225,000 per year, received 500,000 shares of common stock valued at $0.33 per share and may be entitled to bonuses
and equity awards at the discretion of the Board or a committee of the Board. The Employment Agreement provides for severance pay
equal to 12 months of base salary if Mr. Bosua is terminated without &#8220;cause&#8221; or voluntarily terminates his employment
for &#8220;good reason.&#8221;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2018, the Company entered into
an Amended Employment Agreement for Ronald P. Erickson which amends the Employment Agreement dated July 1, 2017. The Agreement
expires March 21, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Merger with Know Labs, Inc.</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 1, 2018, Know Labs, Inc., a Nevada corporation
incorporated on April 3, 2018, and our wholly-owned subsidiary, merged with and into the Company pursuant to an Agreement and Plan
of Merger dated May 1, 2018. In connection with the merger, our Articles of Incorporation were effectively amended to change our
name to Know Labs, Inc. by and through the filing of Articles of Merger. This parent-subsidiary merger was approved by us, the
parent, in accordance with Nevada Revised Statutes Section 92A.180. Stockholder approval was not required. This amendment was filed
with the Nevada Secretary of State and became effective on May 1, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Corporate Name Change and Symbol Change</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 24, 2018, the Financial Industry Regulatory
Authority (&#8220;FINRA&#8221;) announced the effectiveness of a change in our name from Visualant Incorporated to Know Labs, Inc.
and a change in our ticker symbol from VSUL to the new trading symbol KNWN which became effective on the opening of trading as
of May 25, 2018. In addition, in connection with the name change and symbol change, we were assigned the CUSIP number of 499238103.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Closing of Financing on June 25, 2018</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company closed a private
placement and received gross proceeds of $1,750,000 in exchange for issuing 7,000,000 shares of common stock and warrants to purchase
3,500,000 shares of common stock in a private placement to accredited investors pursuant to a series of substantially identical
subscription agreements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The initial exercise price of the warrants described
above is $0.25 per share, subject to certain adjustments, and the warrants expire five years after their issuance.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares and the warrants described above
were issued in transactions that were not registered under the Securities Act of 1933, as amended (the &#8220;Act&#8221;) in reliance
upon applicable exemptions from registration under Section 4(a)(2) of the Act and/or Rule 506 of SEC Regulation D under the Act.
&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6810072688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for Accounts receivable</a></td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">22,002,904<span></span>
</td>
<td class="nump">17,531,502<span></span>
</td>
<td class="nump">4,655,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="nump">22,002,904<span></span>
</td>
<td class="nump">17,531,502<span></span>
</td>
<td class="nump">4,655,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">23,334<span></span>
</td>
<td class="nump">23,334<span></span>
</td>
<td class="nump">23,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">23,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">23,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
<td class="nump">1,785,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ .001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">1,016,014<span></span>
</td>
<td class="nump">1,016,014<span></span>
</td>
<td class="nump">1,016,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">1,016,014<span></span>
</td>
<td class="nump">1,016,004<span></span>
</td>
<td class="nump">1,016,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="nump">1,016,014<span></span>
</td>
<td class="nump">1,016,004<span></span>
</td>
<td class="nump">1,016,004<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6633611184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>19. SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates subsequent events, for
the purpose of adjustment or disclosure, up through the date the financial statements are available. Subsequent to March 31, 2019,
there were the following material transactions that require disclosure:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Promissory Notes with Clayton
A. Struve</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2019, the Company owes Clayton
A. Struve $1,071,000 under convertible promissory or OID notes. The Company recorded accrued interest of $58,411 as of March 31,
2019. On May 8, 2019, the Company signed Amendment 2 to the convertible promissory or OID notes, extending the due dates to September
30, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Redeemable Promissory Notes with
Ronald P. Erickson and J3E2A2Z</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 16, 2018, the Company entered into
a Note and Account Payable Conversion Agreement pursuant to which (a) all $664,233 currently owing under the J3E2A2Z Notes was
converted to a Convertible Redeemable Promissory Note in the principal amount of $664,233, and (b) all $519,833 of the J3E2A2Z
Account Payable was converted into a Convertible Redeemable Promissory Note in the principal amount of $519,833 together with a
warrant to purchase up to 1,039,666 shares of common stock of the Company for a period of five years. The initial exercise price
of the warrants described above is $0.50 per share, also subject to certain adjustments. The warrants were valued at $110,545.
Because the note is immediately convertible, the warrants and beneficial conversion were expensed as interest. The Company recorded
accrued interest of $41,361 as of March 31, 2019. On May 8, 2019, the Company signed Amendment 1 to the convertible redeemable
promissory notes, extending the due dates to September 30, 2019 and increasing the interest rate to 6%.</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluated subsequent events, for
the purpose of adjustment or disclosure, up through the date the financial statements were issued.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 31, 2018, the Board awarded stock
option grants to two directors to acquire 50,000 shares each of the Company&#8217;s common stock. The grants were valued at $3.03
per share and expire on October 31, 2013. The grants vested immediately.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 31, 2018, the Board awarded Phillip
A. Bosua a stock option grant to acquire 100,000 shares of the Company&#8217;s Common stock for each $1,000,000 raised by the Company
in revenue generated in a planned Kickstarter campaign. In addition, Mr. Bosua was granted a stock option grant to acquire 1,000,000
shares of the Company&#8217;s common which vests upon approval of the Company&#8217;s blood glucose measurement technology by the
U.S. Food and Drug Administration. The grants were valued at $3.03 per share and expire on October 31, 2023.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 31, 2018, the Board awarded Ronald
P Erickson a stock option grant to acquire 1,000,000 shares of the Company&#8217;s common which vests upon the Company&#8217;s
successful listing of its Common Stock on Nasdaq or the New York Stock Exchange (including the NYSE American Market). The grant
was valued at $3.03 per share and expires on October 31, 2023.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 16, 2018, the Company signed Amendment
1 to Senior Secured Convertible Redeemable Notes dated September 30, 2016, August 14, 2017 and December 12, 2017, extending the
due dates of the Notes to February 27, 2019.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 21, 2018, the Company&#8217;s Board
of Directors amended the Company&#8217;s Audit, Compensation and Nominating and Corporate Governance Committee Charters. In addition,
on November 21, 2018, the Company&#8217;s Board of Directors amended the Company&#8217;s Code of Ethics Policy.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6813639744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. GOING CONCERN (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_GoingConcernDetailsNarrativeAbstract', window );"><strong>Going Concern</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,299,154)<span></span>
</td>
<td class="num">$ (1,724,618)<span></span>
</td>
<td class="num">$ (2,493,821)<span></span>
</td>
<td class="num">$ (1,827,419)<span></span>
</td>
<td class="num">$ (3,257,597)<span></span>
</td>
<td class="num">$ (3,901,232)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,462,737)<span></span>
</td>
<td class="num">$ (442,518)<span></span>
</td>
<td class="num">(1,117,131)<span></span>
</td>
<td class="num">(1,264,324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (37,285,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (37,285,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (34,791,324)<span></span>
</td>
<td class="num">$ (31,533,727)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_GoingConcernDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_GoingConcernDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6802824352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SummaryOfWarrantsIssuedTableTextBlock', window );">Summary of the warrants issued</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>March 31, 2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 70%"><font style="font-size: 8pt">Outstanding at beginning of period</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 8pt">0.326</font></td>
    <td style="width: 3%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2,462,185</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.222</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(336,427</font></td>
    <td><font style="font-size: 8pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(0.250</font></td>
    <td><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Expired</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">(26,573</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">(0.250</font></td>
    <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Outstanding at end of period</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">17,572,583</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">0.453</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Exercisable at end of period</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">17,572,583</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">September 30, 2018 &#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Shares</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 64%"><font style="font-size: 8pt">Outstanding at beginning of period</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 8pt">6,900,356</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 8pt">0.428</font></td>
    <td style="width: 3%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">9,276,066</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(158,026</font></td>
    <td><font style="font-size: 8pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">(0.507</font></td>
    <td><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(544,998</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(0.250</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Outstanding at end of period</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.326</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Exerciseable at end of period</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of the status of the warrants outstanding</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr>
    <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="17" style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>March 31, 2019</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Weighted</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Average</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Number of</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Remaining</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Shares</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt"><b>Exercise</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Warrants</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Life ( In Years)</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 1%">&#160;</td>
    <td style="width: 23%; text-align: right"><font style="font-size: 8pt">13,507,286</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 8pt">3.50</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 8pt">13,507,286</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">714,286</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.33</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.700</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">714,286</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.700</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">882,159</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.62</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">882,159</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2,442,185</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.93</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.20-1.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2,442,185</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.20-1.50</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">20,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">4.92</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.34-4.08</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">20,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.34-4.08</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">6,667</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">30.000</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">6,667</font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-size: 8pt">30.000</font></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">17,572,583</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">3.78</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">0.453</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">17,572,583</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font-size: 8pt">0.453</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">September 30, 2018 &#160; &#160; &#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Weighted</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Average</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Number of</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Remaining</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Shares</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 8pt">Exercise</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Warrants</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Life ( In Years)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Exerciseable</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 19%; text-align: right"><font style="font-size: 8pt">13,870,286</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">4.04</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">13,870,286</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 8pt">0.250</font></td>
    <td style="width: 7%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">714,286</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">2.83</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.700</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">714,286</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">0.700</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">882,159</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">3.12</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">882,159</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">1.000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">6,667</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">0.25</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">30.000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">6,667</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">30.000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">3.61</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.326</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double">&#160;</td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">15,473,398</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">0.326</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock', window );">Weighted average assumptions relating to the valuation of the Companys warrants</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 77%"><font style="font-size: 8pt">Dividend yield</font></td>
    <td style="width: 23%; text-align: center"><font style="font-size: 8pt">0%</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Expected life</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">1 yr</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Expected volatility</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">125%</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Risk free interest rate</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">2.0%</font></td></tr>
</table><span></span>
</td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 67%"><font style="font-size: 8pt">Dividend yield</font></td>
    <td style="width: 33%; text-align: center"><font style="font-size: 8pt">0%</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 8pt">Expected life</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">1-2 years</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 8pt">Expected volatility</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">125%-145%</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 8pt">Risk free interest rate</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">.0202-.0214%</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_SummaryOfWarrantsIssuedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Custom Element.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_SummaryOfWarrantsIssuedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Custom Element.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_WeightedAverageAssumptionsRelatingToValuationOfCompanysWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6799966880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>7. FIXED ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment (2-10 years)</a></td>
<td class="nump">$ 449,542<span></span>
</td>
<td class="nump">$ 374,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements (5-20 years)</a></td>
<td class="nump">276,112<span></span>
</td>
<td class="nump">276,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures (3-10 years)</a></td>
<td class="nump">153,071<span></span>
</td>
<td class="nump">153,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Software and websites (3- 7 years)</a></td>
<td class="nump">35,830<span></span>
</td>
<td class="nump">35,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(717,019)<span></span>
</td>
<td class="num">(670,666)<span></span>
</td>
<td class="num">$ (662,855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">197,536<span></span>
</td>
<td class="nump">169,333<span></span>
</td>
<td class="nump">$ 133,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=KNWN_PurchasedMember', window );">Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment (2-10 years)</a></td>
<td class="nump">406,861<span></span>
</td>
<td class="nump">332,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements (5-20 years)</a></td>
<td class="nump">276,112<span></span>
</td>
<td class="nump">276,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures (3-10 years)</a></td>
<td class="nump">58,051<span></span>
</td>
<td class="nump">58,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Software and websites (3- 7 years)</a></td>
<td class="nump">35,830<span></span>
</td>
<td class="nump">35,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(579,318)<span></span>
</td>
<td class="num">(532,966)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">197,536<span></span>
</td>
<td class="nump">169,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_CapitalLeaseObligationsMember', window );">Capital Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment (2-10 years)</a></td>
<td class="nump">42,681<span></span>
</td>
<td class="nump">42,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements (5-20 years)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures (3-10 years)</a></td>
<td class="nump">95,020<span></span>
</td>
<td class="nump">95,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Software and websites (3- 7 years)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(137,701)<span></span>
</td>
<td class="num">(137,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=KNWN_PurchasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=KNWN_PurchasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_CapitalLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_CapitalLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6610992736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. FIXED ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">FIXED ASSETS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets, net of accumulated depreciation,
was $197,536 and $169,333 as of March 31, 2019 and September 30, 2018, respectively. Accumulated depreciation was $717,019 and
$670,666 as of March 31, 2019 and September 30, 2018, respectively. Total depreciation expense was $46,354 and $30,462 for the
six months ended March 31, 2019 and 2017, respectively. All equipment is used for selling, general and administrative purposes
and accordingly all depreciation is classified in selling, general and administrative expenses.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Property and equipment as of March 31, 2019 was comprised of the
following:&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2019</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Estimated Useful Lives</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Purchased</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Capital Leases</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 18%; text-align: left">Machinery and equipment</td><td style="width: 3%">&#160;</td>
    <td style="width: 18%; text-align: center">2-10 years</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">406,861</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">42,681</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">449,542</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">2-3 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,112</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: center">2-3 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,051</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">153,071</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left">Software and websites</td><td>&#160;</td>
    <td style="text-align: center">3- 7 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,830</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,830</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Less:&#160;accumulated&#160;depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(579,318</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(137,701</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(717,019</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">197,536</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">197,536</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets, net of accumulated depreciation,
was $169,333 and $133,204 as of September 30, 2018 and 2017, respectively. Accumulated depreciation was $670,666 and $662,855 as
of September 30, 2018 and 2017, respectively. Total depreciation expense was $60,393 and 38,031 for the years ended September 30,
2018 and 2017, respectively. All equipment is used for selling, general and administrative purposes and accordingly all depreciation
is classified in selling, general and administrative expenses.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Property and equipment as of September 30, 2018 was comprised of
the following:&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 8pt">Estimated</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">September 30, 2018 &#160; &#160;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 0.75pt solid">Useful Lives</p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Purchased</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Capital Leases</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 32%"><font style="font-size: 8pt">Machinery and equipment</font></td>
    <td style="width: 17%; text-align: center"><font style="font-size: 8pt">2-10 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">332,305</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">42,681</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 8pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 8pt">374,986</font></td>
    <td style="width: 4%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Leasehold improvements</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">2-3 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">276,112</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">276,112</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Furniture and fixtures</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">2-3 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">58,051</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">95,020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">153,071</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Software and websites</font></td>
    <td style="text-align: center"><font style="font-size: 8pt">3- 7 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">35,830</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 8pt">35,830</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 8pt">Less: accumulated depreciation</font></td>
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(532,966</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(137,700</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1pt solid">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(670,666</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">169,332</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1</font></td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="padding-bottom: 3pt">&#160;</td>
    <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td>
    <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">169,333</font></td>
    <td style="padding-bottom: 3pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6633099936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. DERIVATIVE INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2008, the FASB issued a pronouncement
that provides guidance on determining what types of instruments or embedded features in an instrument held by a reporting entity
can be considered indexed to its own stock for the purpose of evaluating the first criteria of the scope exception in the pronouncement
on accounting for derivatives. This pronouncement was effective for financial statements issued for fiscal years beginning after
December 15, 2008. The adoption of these requirements can affect the accounting for warrants and many convertible instruments with
provisions that protect holders from a decline in the stock price (or &#8220;down-round&#8221; provisions). For example, warrants
or conversion features with such provisions are no longer recorded in equity. Down-round provisions reduce the exercise price of
a warrant or convertible instrument if a company either issues equity shares for a price that is lower than the exercise price
of those instruments or issues new warrants or convertible instruments that have a lower exercise price.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There was no derivative liability as of March
31, 2019 and September 30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2008, the FASB issued a pronouncement
that provides guidance on determining what types of instruments or embedded features in an instrument held by a reporting entity
can be considered indexed to its own stock for the purpose of evaluating the first criteria of the scope exception in the pronouncement
on accounting for derivatives. This pronouncement was effective for financial statements issued for fiscal years beginning after
December 15, 2008. The adoption of these requirements can affect the accounting for warrants and many convertible instruments with
provisions that protect holders from a decline in the stock price (or &#8220;down-round&#8221; provisions). For example, warrants
or conversion features with such provisions are no longer recorded in equity. Down-round provisions reduce the exercise price of
a warrant or convertible instrument if a company either issues equity shares for a price that is lower than the exercise price
of those instruments or issues new warrants or convertible instruments that have a lower exercise price.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There was no derivative liability as of September
30, 2018 and 2017. For the year ended September 30, 2017, the Company recorded non-cash loss of $217,828 related to the &#8220;change
in fair value of derivative&#8221; expense related to its derivative instruments. The Company early adopted ASU 2017-11 and has
reclassified its financial instrument with down round features to equity in the amount of $410,524.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6812914944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. STOCK OPTIONS (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="nump">15,473,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">3 years 9 months 11 days<span></span>
</td>
<td class="text">3 years 7 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 0.453<span></span>
</td>
<td class="nump">$ 0.326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="nump">17,572,583<span></span>
</td>
<td class="nump">15,473,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,182,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 11 months 8 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices5Member', window );">Exercise Price 0.25</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of Exercise Prices</a></td>
<td class="nump">$ 0.250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="nump">530,000<span></span>
</td>
<td class="nump">530,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">4 years 7 months 10 days<span></span>
</td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 0.250<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="nump">99,375<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 0.250<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices4Member', window );">Exercise Price 1.28</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of Exercise Prices</a></td>
<td class="nump">$ 1.280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="nump">1,150,000<span></span>
</td>
<td class="nump">1,150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">4 years 8 months 16 days<span></span>
</td>
<td class="text">4 years 11 months 16 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 1.280<span></span>
</td>
<td class="nump">$ 1.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="nump">143,750<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 1.280<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices3Member', window );">Exercise Price 4.08-4.20</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">4 years 8 months 23 days<span></span>
</td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="nump">31,250<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices3Member', window );">Exercise Price 4.08-4.20 | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of Exercise Prices</a></td>
<td class="nump">$ 4.080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">4.080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">4.080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices3Member', window );">Exercise Price 4.08-4.20 | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of Exercise Prices</a></td>
<td class="nump">4.200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">4.200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">4.200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices1Member', window );">Exercise Price 13.500</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of Exercise Prices</a></td>
<td class="nump">$ 13.500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="nump">1,334<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">4 months 17 days<span></span>
</td>
<td class="text">5 months 8 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 13.500<span></span>
</td>
<td class="nump">$ 13.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="nump">1,334<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 13.500<span></span>
</td>
<td class="nump">$ 13.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices2Member', window );">Exercise Price 15.000</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of Exercise Prices</a></td>
<td class="nump">$ 15.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="nump">1,334<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 15.000<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices6Member', window );">Exercise Price 3.03</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of Exercise Prices</a></td>
<td class="nump">$ 3.030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">4 years 8 months 16 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 3.030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 3.030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePricesTotalMember', window );">Exercise Price Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Outstanding Stock Options</a></td>
<td class="nump">2,282,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life (years)</a></td>
<td class="text">4 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 1.757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number Exercisable</a></td>
<td class="nump">375,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2', window );">Weighted Average Exercise Price Exerciseable</a></td>
<td class="nump">$ 1.755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePrices6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePricesTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=KNWN_RangeofExercisePricesTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6802029056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>18. INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_KNWN_IncomeTaxesDetailsAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">U.S. operations loss carry forward at statutory rate of 34%</a></td>
<td class="num">$ (5,743,840)<span></span>
</td>
<td class="num">$ (5,804,285)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Non-U.S. operations loss carry forward at statutory rate of 20.5%</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total</a></td>
<td class="num">(5,743,840)<span></span>
</td>
<td class="num">(5,804,285)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less Valuation Allowance</a></td>
<td class="num">(5,743,840)<span></span>
</td>
<td class="num">(5,804,285)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net Deferred Tax Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in Valuation allowance</a></td>
<td class="nump">$ 60,445<span></span>
</td>
<td class="num">$ (1,036,276)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_KNWN_IncomeTaxesDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">KNWN_IncomeTaxesDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>KNWN_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
